Citrus Sinensis ID: 047215
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 851 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SA72 | 849 | Probable receptor-like pr | yes | no | 0.968 | 0.970 | 0.682 | 0.0 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.901 | 0.924 | 0.441 | 0.0 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.882 | 0.878 | 0.463 | 0.0 | |
| Q9FN92 | 829 | Probable receptor-like pr | no | no | 0.893 | 0.916 | 0.440 | 0.0 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.881 | 0.854 | 0.439 | 1e-179 | |
| Q9SJT0 | 871 | Probable receptor-like pr | no | no | 0.882 | 0.862 | 0.438 | 1e-178 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.893 | 0.849 | 0.448 | 1e-177 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.887 | 0.879 | 0.451 | 1e-177 | |
| Q9SR05 | 850 | Receptor-like protein kin | no | no | 0.922 | 0.923 | 0.435 | 1e-176 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.880 | 0.889 | 0.444 | 1e-174 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1170 bits (3026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 569/834 (68%), Positives = 670/834 (80%), Gaps = 10/834 (1%)
Query: 1 MERVLLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIA 60
+E +L L+ V GEAQSKSFL++CG+N++ VDGR WVGDL+ N +VTL G
Sbjct: 9 LEHLLCVLIFFTYVIGYGEAQSKSFLVDCGSNATTEVDGRTWVGDLSPNKSVTLQ--GFD 66
Query: 61 ATTDSLS-GDSIYEPLYKTARVFADGLNYTFE-IIAGNYIVRLHFCPFPFEDYNVNKSSF 118
A T S S G S+Y +YKTARVF LNYTFE I GNY VRLHF PF E++NVN+SSF
Sbjct: 67 AITASTSKGSSVYAEIYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSF 126
Query: 119 GVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKG 178
V A+GL+L+ + + GEI+H+NL L+S+G N+++ SLVKE+ L KL++ FIP KG
Sbjct: 127 SVFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKG 186
Query: 179 SFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDL 238
SFGF+NAIEIV V DKLF +++ KVGG++V L GRG+ETMYRLNVGGP++ PS+D L
Sbjct: 187 SFGFVNAIEIVSVDDKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKL 246
Query: 239 WRMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNM 298
+R WE D SYM+ NAG E++NSSNITYA +DS VAPLLVYETAR MSNTEVLEKRFN+
Sbjct: 247 YRTWETDLSYMVIENAGVEVKNSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRFNI 306
Query: 299 SWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRD 358
SWKFEVDPNFDY VRLHFCEL+ +K NQRIFRIYINN+TA NFDIF AGGKN+G ++D
Sbjct: 307 SWKFEVDPNFDYLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQD 366
Query: 359 YFDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGH 418
Y D VSSK + LWIQLGPD++VGA+G DALL+GLEIFK S+NGNLA + RFDS+G+ V
Sbjct: 367 YLDPVSSKNDVLWIQLGPDSSVGASG-DALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSD 425
Query: 419 SNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNS 478
S I+ + +GAGIA ++ + L+ C CK R KS + KNN PGW PLF H NS
Sbjct: 426 SKMRIIWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVN--NS 483
Query: 479 TANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCT 538
TANAK +G ++A + G++FTLAEIR AT NFD+ L IGVGGFGKV++GE+ED T
Sbjct: 484 TANAKATGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGT 543
Query: 539 LAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRS 598
L AIKRA P S+QGLAEFETEI MLS+LRHRHLVSLIGFCDE NEMILVYEYMANGTLRS
Sbjct: 544 LIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRS 603
Query: 599 HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658
HLFGS+LPPL+WKQRL+ACIG+ARGLHYLHTG+ERGIIHRDVKTTNILLDENFVAKMSDF
Sbjct: 604 HLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDF 663
Query: 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINP 718
GLSK GPSM+HTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFE VCARAVINP
Sbjct: 664 GLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINP 723
Query: 719 TLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM 778
TLPKDQINLA+WA+ WQKQR+L+SIID +L+GNYSPESLEK+GEIAEKCL DEGKNRP M
Sbjct: 724 TLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMM 783
Query: 779 GEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAER---EAEDGQDAPTTD 829
GEVLW LEYVLQ+HEAW+R + +NSFSSSQA+ E E A QD+ T+
Sbjct: 784 GEVLWSLEYVLQIHEAWLRKQNGENSFSSSQAVEEAPESFTLPACSNQDSSETE 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/822 (44%), Positives = 504/822 (61%), Gaps = 55/822 (6%)
Query: 4 VLLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATT 63
+L+ + +L+ G ++LINCG+ ++ + GR ++ D S+ +T SS I A+
Sbjct: 10 ILISTISILLCICHGFTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLT-SSKEILASV 68
Query: 64 DSLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVAN 123
SG IY TARVF + +Y F + G + VRL+F PF ++++ + + F V +
Sbjct: 69 GGNSGSDIYH----TARVFTEVSSYKFSVTRGRHWVRLYFNPFDYQNFKMGSAKFAVSSQ 124
Query: 124 GLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFI 183
LLS+F+ +S +VKEY L V + L++ F PS GSF F+
Sbjct: 125 SHVLLSDFTV------------------TSSKVVKEYSLNVTTNDLVLTFTPSSGSFAFV 166
Query: 184 NAIEIVPVVDKLFADTINKVGGNDVNF-NLSGRGVETMYRLNVGGPEIKPSRDPDLWRMW 242
NAIE++ + D L + VG N F ++S +G+ET++R+N+GGP + + D L R W
Sbjct: 167 NAIEVISIPDTLITGSPRFVG-NPAQFPDMSMQGLETIHRVNMGGPLVASNND-TLTRTW 224
Query: 243 EADSSYMITANAGSEIRNSSNITYA---STNDSSVAPLLVYETARTMSNTEVLEKRFNMS 299
DS +++ N + S + + +T DS AP VY + M++ + FN++
Sbjct: 225 VPDSEFLLEKNLAKSMSKFSTVNFVPGYATEDS--APRTVYGSCTEMNSADNPNSIFNVT 282
Query: 300 WKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRG-YHRD 358
W+F+VDP F Y+ R HFC++V NQ F +Y+++ A + D+ G Y D
Sbjct: 283 WEFDVDPGFQYYFRFHFCDIVSLSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMD 342
Query: 359 YFDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGH 418
+ + + +GP T V +A++NGLEI K + + S F +
Sbjct: 343 FVTQTPKGSNKVRVSIGPST-VHTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPGSSSSSK 401
Query: 419 SNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNS 478
SN ++ +G+ I S+ LAV+F L C+ ++++ +S W P
Sbjct: 402 SNLGLI---VGSAIGSL--LAVVF-LGSCFVL-YKKRKRGQDGHSKTWMPF--------- 445
Query: 479 TANAKGSGTQYLKGSV---ALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIE 535
+ N G++Y G+ T A R A ++ ATNNFDES IGVGGFGKV+KGE+
Sbjct: 446 SINGTSMGSKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELN 505
Query: 536 DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595
D T A+KR NP+S+QGLAEF TEIEMLS+ RHRHLVSLIG+CDE NEMIL+YEYM NGT
Sbjct: 506 DGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGT 565
Query: 596 LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKM 655
++SHL+GS LP LTWKQRL+ CIGAARGLHYLHTG + +IHRDVK+ NILLDENF+AK+
Sbjct: 566 VKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKV 625
Query: 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV 715
+DFGLSKTGP ++ THVSTAVKGSFGYLDPEYF RQQLT+KSDVYSFGVVLFEV+CAR V
Sbjct: 626 ADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPV 685
Query: 716 INPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNR 775
I+PTLP++ +NLA+WAMKWQK+ L IID L+GN P+SL KF E EKCL D G +R
Sbjct: 686 IDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDR 745
Query: 776 PTMGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAER 817
P+MG+VLW+LEY LQL EA + + N S+ +GE +
Sbjct: 746 PSMGDVLWNLEYALQLQEAVIDGEPEDN---STNMIGELPPQ 784
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 660 bits (1702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/792 (46%), Positives = 499/792 (63%), Gaps = 41/792 (5%)
Query: 25 FLINCGTNSSVNVDGRKWVGD-LASNNNVTLSSSGIAATTDSLSGDSIYEPLYKTARVFA 83
+LI+CG++ ++ R +V D L S+ + + +S +A +T S + + +Y+TARVF+
Sbjct: 32 YLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSSVATSTTSNNSTNS---IYQTARVFS 88
Query: 84 DGLNYTFEIIA-GNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISHRNL 142
+Y F+I + G + +RLHF P +N+ +S VV LL+ FS
Sbjct: 89 SLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLNNFSFNNFNGSY-- 146
Query: 143 YLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKLFADTINK 202
+ KEY + V + L + FIPS S F+NAIE+V V D L D
Sbjct: 147 -------------IFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPDQALA 193
Query: 203 VGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYM-ITANAGSEIRNS 261
+ + LS ET+YRLN+GGP + S++ L R W+ D+ Y+ + ++ N
Sbjct: 194 LNPSTPFSGLSLLAFETVYRLNMGGPLLT-SQNDTLGRQWDNDAEYLHVNSSVLVVTANP 252
Query: 262 SNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVY 321
S+I Y+ + AP +VY TA TM + V FN++W VDP+F YFVR+HFC++V
Sbjct: 253 SSIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVS 312
Query: 322 EKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIE-TLWIQLGPDTAV 380
+ N +F +Y+N+ A + D+ G Y +D+ S + L + +GPD+
Sbjct: 313 QALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSVGPDSQ- 371
Query: 381 GAAGTDALLNGLEIFKFSQNG-NLASVERFDSSGNPVGHSNKWILLVGIGAGIASVVVLA 439
A T+A +NGLE+ K S +L+ V S S V IG+ + +V ++
Sbjct: 372 -ADITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAVTLIL 430
Query: 440 VIFALLFCYC---KNWREKSSDPKNNSPG--WWPLFFH---RGTLNSTANAKGSGTQYLK 491
+I + CYC + +++S+ P+ G W PL + + STA+ K + +
Sbjct: 431 LI--AVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATASCI- 487
Query: 492 GSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ 551
S+A T G+ F EI ATN FDES ++GVGGFG+V+KG +ED T A+KR NP+SEQ
Sbjct: 488 -SLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQ 546
Query: 552 GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWK 611
G+AEF TEIEMLSKLRHRHLVSLIG+CDE++EMILVYEYMANG LRSHL+G+DLPPL+WK
Sbjct: 547 GMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWK 606
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671
QRL+ CIGAARGLHYLHTGA + IIHRDVKTTNILLDEN VAK++DFGLSKTGPS++ TH
Sbjct: 607 QRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTH 666
Query: 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731
VSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVL EV+C R +NP LP++Q+N+A+WA
Sbjct: 667 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWA 726
Query: 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791
M WQK+ L I+D +L G +P SL+KFGE AEKCL + G +RP+MG+VLW+LEY LQL
Sbjct: 727 MAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQL 786
Query: 792 HE---AWMRTDD 800
E A M DD
Sbjct: 787 EETSSALMEPDD 798
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/809 (44%), Positives = 497/809 (61%), Gaps = 49/809 (6%)
Query: 12 LVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSI 71
L+ G ++LINCG++++V V R ++ D ++N +T + +AA+ + + D
Sbjct: 18 LIFLCYGYVPVDNYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEILAASNRNSNSD-- 75
Query: 72 YEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEF 131
+Y+TAR+F Y F + G + +RLHF PF ++++ + + F V + LLS+F
Sbjct: 76 ---IYQTARIFTGISKYRFSVARGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDF 132
Query: 132 SAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPV 191
+ +S R ++KEY L V D L + F PS SF F+NA+E+V V
Sbjct: 133 T----VSSR---------------VMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSV 173
Query: 192 VDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMIT 251
D LF+ + G LS + +ET+YR+N+GGP + PS D L R+WE DS +++
Sbjct: 174 PDTLFSGDPSFAGSPGKFQGLSWQALETVYRVNMGGPRVTPSND-TLSRIWEPDSEFLVE 232
Query: 252 ANAGSEIRNSSNITYAST-NDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDY 310
N + +++ Y AP VY T M++ + FN++W F+VDP F Y
Sbjct: 233 KNLVKSVSKIASVDYVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQY 292
Query: 311 FVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRG-YHRDYFDAVSSKIET 369
F+R HFC++V + NQ F +Y+++ N D+ G Y D+ + +
Sbjct: 293 FLRFHFCDIVSKALNQLYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKR 352
Query: 370 LWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWILLVGIG 429
+ + +G ++V A+LNGLEI K + + + S+ F SG+ +++G+
Sbjct: 353 IRVSIG-RSSVHTDYPTAILNGLEIMKMNNSKSQLSIGTFLPSGSSSTTKKNVGMIIGLT 411
Query: 430 AG-IASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNSTANAKGSGTQ 488
G + ++VVL F L ++++ D NS W PL S+ S
Sbjct: 412 IGSLLALVVLGGFFVL-------YKKRGRDQDGNSKTWIPL--------SSNGTTSSSNG 456
Query: 489 YLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ 548
S+A + + R L ++ ATN+FDE+ IGVGGFGKV+KGE+ D T A+KRANP+
Sbjct: 457 TTLASIA-SNSSYRIPLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPK 515
Query: 549 SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPL 608
S+QGLAEF TEIEMLS+ RHRHLVSLIG+CDE NEMILVYEYM NGTL+SHL+GS L L
Sbjct: 516 SQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSL 575
Query: 609 TWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668
+WKQRL+ CIG+ARGLHYLHTG + +IHRDVK+ NILLDEN +AK++DFGLSKTGP ++
Sbjct: 576 SWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEID 635
Query: 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA 728
THVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVV+FEV+CAR VI+PTL ++ +NLA
Sbjct: 636 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLA 695
Query: 729 DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788
+WAMKWQK+ L+ IIDP L+G P+SL KFGE EKCL D G +RP+MG+VLW+LEY
Sbjct: 696 EWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYA 755
Query: 789 LQLHEAWMRTDDRQNSFSSSQALGEFAER 817
LQL EA + D S+ +GE R
Sbjct: 756 LQLQEAVVDGDPED----STNMIGELPLR 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 628 bits (1619), Expect = e-179, Method: Compositional matrix adjust.
Identities = 346/787 (43%), Positives = 474/787 (60%), Gaps = 37/787 (4%)
Query: 18 GEAQSKSFLINCGTNSSVNV-DGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEPLY 76
G + LI+CG+ SS DGR + D + + + S D + P+Y
Sbjct: 51 GFKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPS---DKVASPIY 107
Query: 77 KTARVFADGLNYTFEII-AGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPG 135
TAR+F + Y F + G + VRLHF FP + +++ +++F V+ LL F
Sbjct: 108 LTARIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNF---- 163
Query: 136 EISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKL 195
+IS+ N N S ++ KEY + + + + F P K S FINAIE+V D+L
Sbjct: 164 KISNNN--------NDSQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDEL 215
Query: 196 FADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAG 255
+D+ + LS +++YR+NVGGP I P D L R W D ++ N
Sbjct: 216 ISDSGTALFPVIGFSGLSDYAYQSVYRVNVGGPLIMPQND-TLGRTWIPDKEFLKDENLA 274
Query: 256 SEIRNS-SNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRL 314
+++ + S I Y +AP VY TA M+N+ ++ FN+SW F +P+F+Y +RL
Sbjct: 275 KDVKTTPSAIKYPPEVTPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRL 334
Query: 315 HFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQL 374
HFC++V + N F +YIN +TA + D+ AG Y++D + L +Q+
Sbjct: 335 HFCDIVSKSLNDLYFNVYINGKTAISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQI 394
Query: 375 GP---DTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWILLVGIGAG 431
GP DT +A+LNG+E+ K S + N E F G G ++
Sbjct: 395 GPMGEDTGT----KNAILNGVEVLKMSNSVNSLDGE-FGVDGRTTGMGKHGMV------A 443
Query: 432 IASVVVLAVIFALLFCYCKNWREKSSD-PKNNSPGWWPLFFHRGTLNSTANAKGSGTQYL 490
A V++ F L W+++ D K NS W L H G +ST G+Q
Sbjct: 444 TAGFVMMFGAFIGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAG--DSTFMTSKGGSQKS 501
Query: 491 KGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE 550
+ G+ F+L+E++ AT NF+ S +IGVGGFG V+ G ++D T A+KR NPQSE
Sbjct: 502 NFYNSTLGLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSE 561
Query: 551 QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTW 610
QG+ EF+TEI+MLSKLRHRHLVSLIG+CDE +EMILVYE+M+NG R HL+G +L PLTW
Sbjct: 562 QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTW 621
Query: 611 KQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670
KQRL+ CIG+ARGLHYLHTG +GIIHRDVK+TNILLDE VAK++DFGLSK +
Sbjct: 622 KQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDV-AFGQN 680
Query: 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW 730
HVSTAVKGSFGYLDPEYF RQQLT+KSDVYSFGVVL E +CAR INP LP++Q+NLA+W
Sbjct: 681 HVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEW 740
Query: 731 AMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
AM+W+++ L+ IIDPHL G +PES++KF E AEKCL+D G +RPTMG+VLW+LEY LQ
Sbjct: 741 AMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQ 800
Query: 791 LHEAWMR 797
L EA+ +
Sbjct: 801 LQEAFTQ 807
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1610), Expect = e-178, Method: Compositional matrix adjust.
Identities = 343/782 (43%), Positives = 465/782 (59%), Gaps = 31/782 (3%)
Query: 18 GEAQSKSFLINCGTNSSVNV-DGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEPLY 76
G + LI+CG+ SS +GR + D + V + + D + P+Y
Sbjct: 50 GFKPADDILIDCGSKSSTKTPEGRVFKSD---SETVQYIEAKDDIQVSAPPSDKLPSPIY 106
Query: 77 KTARVFADGLNYTFEII-AGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPG 135
TA++F + Y F + G + VRLHF FP + +++ +++F V+ LL F
Sbjct: 107 LTAKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNF---- 162
Query: 136 EISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKL 195
++S+ N N S ++ KEY L + + + F P KGS FIN IE+V D+L
Sbjct: 163 KLSNDN--------NDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDEL 214
Query: 196 FADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAG 255
+D + + LS +++YR+NVGGP I P D L R W D Y+ N
Sbjct: 215 ISDAGTSLFPVNGFSGLSDYAYQSVYRVNVGGPLITPQND-TLGRTWTPDKEYLKDENLA 273
Query: 256 SEIR-NSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRL 314
+++ N + I Y +AP VY T M++++ ++ FN++W F +P+F YF+RL
Sbjct: 274 KDVKTNPTAIIYPPGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRL 333
Query: 315 HFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQL 374
HFC+++ + N F +YIN +TA + D+ AG + Y++D + L +Q+
Sbjct: 334 HFCDIISKSLNDLYFNVYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSELQVQI 393
Query: 375 GPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWILLVGIGAGIAS 434
GP +A+LNG+E+ K S + N E F G + ++ A
Sbjct: 394 GP-MGEDTGKKNAILNGVEVLKMSNSVNSLDGE-FGVDGQRASMGKQGMV------ATAG 445
Query: 435 VVVLAVIFALLFCYCKNWREKSSD-PKNNSPGWWPLFFHRGTLNSTANAKGSGTQYLKGS 493
V++ F L W+++ D K NS W L H G + GS L S
Sbjct: 446 FVMMFGAFVGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNS 505
Query: 494 VALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL 553
G+ F+L+E++ T NFD S +IGVGGFG V+ G I+D T AIKR NPQSEQG+
Sbjct: 506 A--LGLGRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGI 563
Query: 554 AEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQR 613
EF TEI+MLSKLRHRHLVSLIG+CDE EMILVYEYM+NG R HL+G +L PLTWKQR
Sbjct: 564 TEFHTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQR 623
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673
L+ CIGAARGLHYLHTG +GIIHRDVK+TNILLDE VAK++DFGLSK + HVS
Sbjct: 624 LEICIGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVS 682
Query: 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733
TAVKGSFGYLDPEYF RQQLT+KSDVYSFGVVL E +CAR INP LP++Q+NLA+WAM
Sbjct: 683 TAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAML 742
Query: 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
W+++ L+ IIDPHL G +PES++KF E AEKCL D G +RPTMG+VLW+LEY LQL E
Sbjct: 743 WKQKGLLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQE 802
Query: 794 AW 795
A+
Sbjct: 803 AF 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1608), Expect = e-177, Method: Compositional matrix adjust.
Identities = 359/801 (44%), Positives = 483/801 (60%), Gaps = 41/801 (5%)
Query: 20 AQSKSFLINCGTNSS--VNVDGRKWVGDLASNNNVTLSSSGIAATTDSLSGD-SIYEPLY 76
+ ++ L+NCG +S + D R W+ D+ S SSS + T+ +L+ D S+ E Y
Sbjct: 31 SPTEKILLNCGGGASNLTDTDNRIWISDVKSK--FLSSSSEDSKTSPALTQDPSVPEVPY 88
Query: 77 KTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGE 136
TARVF YTF + +G VRL+F P ++ N S F V LL FSA
Sbjct: 89 MTARVFRSPFTYTFPVASGRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSAS-- 146
Query: 137 ISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKG---SFGFINAIEIVPVVD 193
Q++ + + ++KE+ + V+ L + F P ++ F+N IE+ + D
Sbjct: 147 --------QTAEALTYAF-IIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPD 197
Query: 194 KLFAD--TINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMIT 251
+ T+ VG + + +E +YRLNVGG +I PS D L+R W D Y+
Sbjct: 198 MYSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFG 257
Query: 252 ANAGSEIRNSSNIT--YASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFD 309
A G N+T Y + + VAP+ VY TAR+M T + +N++W F +D F
Sbjct: 258 AGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFT 317
Query: 310 YFVRLHFCELV--YEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYF--DAVSS 365
Y VRLHFCE+ K NQR+F IY+NN+TAE D+ +H+DY +
Sbjct: 318 YLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPEGN 377
Query: 366 KIETLWIQLGPDTAVGAAGTDALLNGLEIFKF-SQNGNLASVERF-------DSSG--NP 415
+ LW+ L P+ D+LLNG+EIFK + +GNLA D S P
Sbjct: 378 GQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRP 437
Query: 416 VGHSNKWILLVGIGAGIASVVVLAVI-FALLFCYCKNWREKSSDPKNNSPGWWPLFFHRG 474
+K + GA +VV+ +I F + Y + R + + GW PL + G
Sbjct: 438 TTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLY-G 496
Query: 475 TLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEI 534
+S +AK + T S+ + + F+ AEI+ AT NFDES ++GVGGFGKV++GEI
Sbjct: 497 NSHSAGSAKTNTTGSYASSLP-SNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEI 555
Query: 535 ED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593
+ T AIKR NP SEQG+ EF+TEIEMLSKLRHRHLVSLIG+C+E EMILVY+YMA+
Sbjct: 556 DGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAH 615
Query: 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653
GT+R HL+ + P L WKQRL+ CIGAARGLHYLHTGA+ IIHRDVKTTNILLDE +VA
Sbjct: 616 GTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA 675
Query: 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR 713
K+SDFGLSKTGP+++HTHVST VKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFE +CAR
Sbjct: 676 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCAR 735
Query: 714 AVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGK 773
+NPTL K+Q++LA+WA K+ L I+DP+LKG +PE +KF E A KC+ D+G
Sbjct: 736 PALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGI 795
Query: 774 NRPTMGEVLWHLEYVLQLHEA 794
RP+MG+VLW+LE+ LQL E+
Sbjct: 796 ERPSMGDVLWNLEFALQLQES 816
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 372/824 (45%), Positives = 494/824 (59%), Gaps = 69/824 (8%)
Query: 5 LLFLVIMLVVARIGEAQSKSFLINCG-TNSSVNVDGRKWVGD---LASNNNV----TLSS 56
L F ++LV Q S ++CG + +V+ D +KW D L + N V T
Sbjct: 12 LCFFYVLLVSPSQSNGQDIS--LSCGASEPAVDQDKKKWEPDTKFLKTPNTVHAPATYQD 69
Query: 57 SGIAATTDSLSGDSIYEPLYKTARVFADGLNYTFEIIAGN-YIVRLHFCPFPFEDYNVNK 115
+ +T Y T+R+F Y + +++RLHF P + N+
Sbjct: 70 PSLLSTVP-----------YMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILD 118
Query: 116 SSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLG-VDLDKLMIEFI 174
S F V AN L LLS FSA I+ + L + LV+EY L + D L I F
Sbjct: 119 SYFSVAANDLTLLSNFSA--AITCQAL---------TQAYLVREYSLAPSEKDVLSIIFT 167
Query: 175 PS---KGSFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIK 231
PS +F FIN IE++P+ + LF DT + VG +D + ++TM+RLNVGG +I
Sbjct: 168 PSDKHPKAFAFINGIEVIPMPE-LF-DTASLVGFSDQTSDTKTANLQTMFRLNVGGQDIP 225
Query: 232 PSRDPD-LWRMWEADSSYMITANAGSEIRNSSN--ITYASTNDSSVAPLLVYETARTMSN 288
S+D L R W D+ Y+ +A G ++ S+N I Y S AP VY+TAR+
Sbjct: 226 GSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDYQKM-PVSTAPADVYKTARSQGP 284
Query: 289 TEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAE---NNFDIF 345
+ + N++W F+VD NF Y +RLHFCE K NQ++F I+INNRTA+ N DI
Sbjct: 285 NGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQLAKINQKVFNIFINNRTAQGDTNPADIL 344
Query: 346 VQAGGKNRGYHRDYFDAVSSKI----ETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNG 401
GGK ++DY V + E + +Q+ P T D+ LNGLEIFK
Sbjct: 345 GWTGGKGIPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKIDTMK 404
Query: 402 NLASVE--------RFDSSGNPVGHSNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWR 453
NLA D + G ++G G+A+V+ A+ F + Y + +
Sbjct: 405 NLAGPNPKPSPMQANEDVKKDFQGDKRITAFVIGSAGGVAAVLFCALCFTM---YQRKRK 461
Query: 454 EKSSDPKNNSPGWWPLF--FHRGTLNSTANAKGSGTQYLKGSVA-LTRAGKRFTLAEIRV 510
SD +S W P++ H ST + K + +L A L R RF+L+EI+
Sbjct: 462 FSGSDSHTSS--WLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCR---RFSLSEIKH 516
Query: 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH 570
T+NFDES +IGVGGFGKV+KG I+ T AIK++NP SEQGL EFETEIE+LS+LRH+H
Sbjct: 517 GTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKH 576
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
LVSLIG+CDE EM L+Y+YM+ GTLR HL+ + P LTWK+RL+ IGAARGLHYLHTG
Sbjct: 577 LVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTG 636
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
A+ IIHRDVKTTNILLDEN+VAK+SDFGLSKTGP+M HV+T VKGSFGYLDPEYF R
Sbjct: 637 AKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRR 696
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
QQLTEKSDVYSFGVVLFEV+CAR +NP+L K+Q++L DWAM +++ +L+ IIDP+LKG
Sbjct: 697 QQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKG 756
Query: 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794
+PE L+KF + AEKCL D G +RPTMG+VLW+LE+ LQL E
Sbjct: 757 KINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQET 800
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 620 bits (1598), Expect = e-176, Method: Compositional matrix adjust.
Identities = 364/835 (43%), Positives = 502/835 (60%), Gaps = 50/835 (5%)
Query: 3 RVLLFLVIM-LVVARIGEAQSKSFLINCGTN-SSVNVDGRKWVGDLASNNNVTLSSSGIA 60
R+L FL + ++ + + ++CGT+ +S + D +KW D + + I
Sbjct: 6 RILFFLTCLSFLLVFPTRSNGQDLALSCGTSEASADQDKKKWEPD----TKFLKTGNSIH 61
Query: 61 ATTDSLSGDSIYEPLYKTARVFADGLNYTFEIIAGN-YIVRLHFCPFPFEDYNVNKSSFG 119
AT + Y TAR+F Y I +++RL+F P + N++ S F
Sbjct: 62 ATATYQDPSLLSTVPYMTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFT 121
Query: 120 VVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLG-VDLDKLMIEFIPS-- 176
V AN + LLS FSA I+ + L + LVKEY L D D L I+F PS
Sbjct: 122 VEANDVTLLSNFSA--AITCQAL---------TQAYLVKEYSLAPTDKDVLSIKFTPSDK 170
Query: 177 -KGSFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRD 235
+ +F FIN IE++ + + LF DT VG D + +++M+RLNVGG +I S+D
Sbjct: 171 YRDAFAFINGIEVIQMPE-LF-DTAALVGFTDQTMDAKTANLQSMFRLNVGGQDIPGSQD 228
Query: 236 PD-LWRMWEADSSYMITANAGSEIRNSSNITYASTN-DSSVAPLLVYETARTMSNTEVLE 293
L R W D+ Y+ +A G ++ S+N N S+AP +Y+TAR+ +
Sbjct: 229 SGGLTRTWYNDAPYIFSAGLGVTLQASNNFRINYQNMPVSIAPADIYKTARSQGPNGDIN 288
Query: 294 KRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNF---DIFVQAGG 350
+ N++W F++D NF Y +RLHFCE K NQ++F IYINNRTA+ + DI G
Sbjct: 289 LKSNLTWMFQIDKNFTYILRLHFCEFQLSKINQKVFNIYINNRTAQADTTPADIIGWTGE 348
Query: 351 KNRGYHRDYFDAVSSKI--ETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLAS--- 405
K ++DY V + E + +Q+ P T D+ LNGLEIFK NLA
Sbjct: 349 KGIPMYKDYAIYVDANNGGEEITLQMTPSTFGQPEYYDSSLNGLEIFKMDTMKNLAGPNP 408
Query: 406 ----VERFDSSGNPVGHSNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKN 461
++ + + + ++G G+ +V++ A+ F Y K + D
Sbjct: 409 EPSPMQAEEEVKKEFKNEKRHAFIIGSAGGVLAVLIGALCFT---AYKKKQGYQGGDSHT 465
Query: 462 NSPGWWPLFFHR---GTLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDES 518
+S W P++ + GT ++ + +G+ + L R RF+L EI+ T NFD+S
Sbjct: 466 SS--WLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCR---RFSLPEIKHGTQNFDDS 520
Query: 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+IGVGGFGKV+KG I+ T A+K++NP SEQGL EFETEIE+LS+LRH+HLVSLIG+C
Sbjct: 521 NVIGVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYC 580
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
DE EM LVY+YMA GTLR HL+ + P LTWK+RL+ IGAARGLHYLHTGA+ IIHR
Sbjct: 581 DEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHR 640
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
DVKTTNIL+DEN+VAK+SDFGLSKTGP+M HV+T VKGSFGYLDPEYF RQQLTEKSD
Sbjct: 641 DVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSD 700
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLE 758
VYSFGVVLFE++CAR +NP+LPK+Q++L DWAM +++ +L+ IIDP+LKG + E L+
Sbjct: 701 VYSFGVVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLK 760
Query: 759 KFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQ-NSFSSSQALG 812
KF + AEKCL+D G RPTMG+VLW+LE+ LQL E T R N+ SS+ LG
Sbjct: 761 KFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTPNNGGSSEDLG 815
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 613 bits (1582), Expect = e-174, Method: Compositional matrix adjust.
Identities = 361/813 (44%), Positives = 483/813 (59%), Gaps = 64/813 (7%)
Query: 22 SKSFLINCGTNSSVNV-DGRKWVGD------LASNNNVTLSSSGIAATTDSLSGDSIYEP 74
+ ++LI+CG++ + DGR + D L ++ ++ S I T + S P
Sbjct: 31 ADNYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNAST----LP 86
Query: 75 LYKTARVFADGLNYTFEII-AGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSA 133
LY TAR+FA Y+F I G + +RLHF P YN+ S F V + LL +FSA
Sbjct: 87 LYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLLHDFSA 146
Query: 134 PGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVD 193
G++SSI + KEY + +KL + F P KGS FINA+EIV V D
Sbjct: 147 ---------------GDTSSI-VFKEYLI-YAAEKLSLYFKPHKGSTAFINAVEIVSVPD 189
Query: 194 KLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITAN 253
+L D+ + V LS +E ++R+N+GG I P DP L R W +D Y
Sbjct: 190 ELVPDSASSVPQAPDFKGLSSFSLEILHRINIGGDLISPKIDP-LSRTWLSDKPYNTFPE 248
Query: 254 AGSEIR-NSSNITYASTNDSS-VAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYF 311
+ + S ITY ++ +AP VY TA M++ + + FN+SW+ VD DYF
Sbjct: 249 GSRNVTVDPSTITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYF 308
Query: 312 VRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDY-FDAVSSKIETL 370
+RLHFC++V + N IF ++IN +A + D+ Y+ D+ +A + ++
Sbjct: 309 IRLHFCDIVSKSLNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTITNGSI 368
Query: 371 WIQLGPDTAVGAAGTDALLNGLEIFKFSQN-GNLASVERFDSS-GNPVG-HSNKWILLVG 427
+Q+GP + + +A+LNGLEI K + G+L + D P+G S+K + + G
Sbjct: 369 LVQVGPTPNLQSGKPNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAG 428
Query: 428 IGAGIASVVVLAVIFALLFCYCKNWREKSSD-PKNNSPGWWPLFFHRGTLNSTANAKGSG 486
IG +A L V+ L+ W+ + D K NS W L H + +S ++KG
Sbjct: 429 IGFVMALTAFLGVVVLLV-----RWQRRPKDWQKQNSFSSWLLPLH-ASHSSYISSKGGS 482
Query: 487 TQYLKGSVALTRA--------------GKRFTLAEIRVATNNFDESLMIGVGGFGKVFKG 532
T ++ G+ F E++ AT NFDE+ + GVGGFGKV+ G
Sbjct: 483 TSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIG 542
Query: 533 EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592
EI+ T AIKR + SEQG+ EF+TEI+MLSKLRHRHLVSLIGFCDE EMILVYEYM+
Sbjct: 543 EIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMS 602
Query: 593 NGTLRSHLFGSD------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646
NG LR HL+GS +P L+WKQRL+ CIG+ARGLHYLHTGA +GIIHRDVKTTNIL
Sbjct: 603 NGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNIL 662
Query: 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVL 706
LDEN VAK+SDFGLSK P M+ HVSTAVKGSFGYLDPEYF RQQLT+KSDVYSFGVVL
Sbjct: 663 LDENLVAKVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVL 721
Query: 707 FEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEK 766
FEV+CAR VINP LP++Q+NLA++AM ++ L+ IIDP + G S SL KF E AEK
Sbjct: 722 FEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEK 781
Query: 767 CLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799
CL + G +RP MG+VLW+LEY LQL EA + D
Sbjct: 782 CLAEYGVDRPGMGDVLWNLEYALQLQEASAQVD 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 851 | ||||||
| 297740842 | 844 | unnamed protein product [Vitis vinifera] | 0.987 | 0.995 | 0.747 | 0.0 | |
| 359483690 | 850 | PREDICTED: probable receptor-like protei | 0.987 | 0.988 | 0.747 | 0.0 | |
| 255564379 | 842 | kinase, putative [Ricinus communis] gi|2 | 0.967 | 0.977 | 0.755 | 0.0 | |
| 224056845 | 840 | predicted protein [Populus trichocarpa] | 0.972 | 0.985 | 0.724 | 0.0 | |
| 224122340 | 836 | predicted protein [Populus trichocarpa] | 0.962 | 0.979 | 0.722 | 0.0 | |
| 357448519 | 920 | Kinase-like protein [Medicago truncatula | 0.978 | 0.905 | 0.722 | 0.0 | |
| 147818022 | 802 | hypothetical protein VITISV_041657 [Viti | 0.937 | 0.995 | 0.713 | 0.0 | |
| 356532423 | 852 | PREDICTED: probable receptor-like protei | 0.965 | 0.964 | 0.716 | 0.0 | |
| 15221443 | 849 | hercules receptor kinase 2 [Arabidopsis | 0.968 | 0.970 | 0.682 | 0.0 | |
| 297845996 | 837 | kinase family protein [Arabidopsis lyrat | 0.934 | 0.949 | 0.680 | 0.0 |
| >gi|297740842|emb|CBI31024.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1296 bits (3355), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 638/853 (74%), Positives = 723/853 (84%), Gaps = 13/853 (1%)
Query: 1 MERVLLFLVIML-VVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGI 59
ME L LV+M+ V GEAQ+KS LINCGTNSSVNVDGR+WVGDLA +NN+TLSS G+
Sbjct: 1 MEVWGLILVVMVSVFVGNGEAQAKSLLINCGTNSSVNVDGRRWVGDLAPDNNLTLSSLGV 60
Query: 60 AATTDSLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFG 119
AA+TD+ SGD+ + LY+TAR+F D LNYT + GNY VRLHF PF FE YN N+SSF
Sbjct: 61 AASTDTFSGDTTFAQLYETARIFPDSLNYTASLNQGNYSVRLHFYPFSFEKYNTNESSFS 120
Query: 120 VVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGS 179
V ANGLKL S+ + PGEISH+N YLQSSG NSSS S++KEYFL VD L+IEF P+KGS
Sbjct: 121 VTANGLKLASQLNVPGEISHKNSYLQSSGSNSSSFSMIKEYFLTVDSGLLVIEFAPTKGS 180
Query: 180 FGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLW 239
FGFINAIEIVPVVD LF +++KVGG + NLSGRG+E MYRLNVGGPEI P +D DLW
Sbjct: 181 FGFINAIEIVPVVDNLFFSSVSKVGGTNSVLNLSGRGIEAMYRLNVGGPEITPDQDLDLW 240
Query: 240 RMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMS 299
R W+ DSSYM TANAGSE+ NSSNITYAS NDS VAPL VYETAR+MSNTEVLEKRFNMS
Sbjct: 241 RTWDVDSSYMFTANAGSEVHNSSNITYASMNDSVVAPLAVYETARSMSNTEVLEKRFNMS 300
Query: 300 WKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDY 359
WKFEVDP+F+Y +RLHFCEL YE+ANQR FRIYINNRTA +NFD+F++AGG N+ YH+D+
Sbjct: 301 WKFEVDPDFEYLIRLHFCELFYERANQRSFRIYINNRTAADNFDVFLRAGGMNKAYHQDF 360
Query: 360 FDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGH- 418
D VSSKI TLWIQLGPDT VGA+GTDA+LNGLEIFK S+NGNLA VERFDS+ + G
Sbjct: 361 LDMVSSKINTLWIQLGPDTTVGASGTDAILNGLEIFKLSRNGNLAYVERFDSTKSSAGSK 420
Query: 419 -SNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLN 477
S L VG+GAG+AS+ ++AVIF+L+F +CK WR+KSS KN SPGW PLF H +N
Sbjct: 421 TSKTQTLWVGLGAGVASIAMMAVIFSLIFYFCKRWRKKSSATKNKSPGWRPLFLH---VN 477
Query: 478 STANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDC 537
ST NAKG +Q L S+A RAGKRFTL EIR ATNNFDESL+IGVGGFGKV+KGEI+D
Sbjct: 478 ST-NAKGM-SQSLSVSLASNRAGKRFTLTEIRAATNNFDESLVIGVGGFGKVYKGEIDDG 535
Query: 538 TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597
T AAIKRANPQSEQGLAEF+TEIEMLSKLRHRHLVS+IGFC+EQNEMILVYEYMANGTLR
Sbjct: 536 TPAAIKRANPQSEQGLAEFQTEIEMLSKLRHRHLVSMIGFCEEQNEMILVYEYMANGTLR 595
Query: 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657
SHLFGS+LPPLTWKQRL+ACIGAARGLHYLHTGAERGIIHRDVKTTNIL+DENFVAKM+D
Sbjct: 596 SHLFGSELPPLTWKQRLEACIGAARGLHYLHTGAERGIIHRDVKTTNILIDENFVAKMAD 655
Query: 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVIN 717
FGLSKTGP+ EHTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFEVVCARAVIN
Sbjct: 656 FGLSKTGPAWEHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVVCARAVIN 715
Query: 718 PTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777
P+LP+DQINLA+WAM WQ QRSL++IIDPHLKGNYSP+SL KFGEIAEKCL DEGKNRPT
Sbjct: 716 PSLPRDQINLAEWAMHWQHQRSLETIIDPHLKGNYSPDSLRKFGEIAEKCLADEGKNRPT 775
Query: 778 MGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAEDGQDAPTTDAENCLGLK 837
MGEVLWHLEYVLQLHEAW+RT+ +NSFSSSQALG E+G ++ D EN + LK
Sbjct: 776 MGEVLWHLEYVLQLHEAWLRTNVGENSFSSSQALGNL-----EEGLESAHLDEENEISLK 830
Query: 838 MTGEVESATMGIS 850
M + ESAT GI+
Sbjct: 831 MKQKRESATRGIN 843
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483690|ref|XP_002264211.2| PREDICTED: probable receptor-like protein kinase At1g30570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1296 bits (3353), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 638/853 (74%), Positives = 723/853 (84%), Gaps = 13/853 (1%)
Query: 1 MERVLLFLVIML-VVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGI 59
ME L LV+M+ V GEAQ+KS LINCGTNSSVNVDGR+WVGDLA +NN+TLSS G+
Sbjct: 7 MEVWGLILVVMVSVFVGNGEAQAKSLLINCGTNSSVNVDGRRWVGDLAPDNNLTLSSLGV 66
Query: 60 AATTDSLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFG 119
AA+TD+ SGD+ + LY+TAR+F D LNYT + GNY VRLHF PF FE YN N+SSF
Sbjct: 67 AASTDTFSGDTTFAQLYETARIFPDSLNYTASLNQGNYSVRLHFYPFSFEKYNTNESSFS 126
Query: 120 VVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGS 179
V ANGLKL S+ + PGEISH+N YLQSSG NSSS S++KEYFL VD L+IEF P+KGS
Sbjct: 127 VTANGLKLASQLNVPGEISHKNSYLQSSGSNSSSFSMIKEYFLTVDSGLLVIEFAPTKGS 186
Query: 180 FGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLW 239
FGFINAIEIVPVVD LF +++KVGG + NLSGRG+E MYRLNVGGPEI P +D DLW
Sbjct: 187 FGFINAIEIVPVVDNLFFSSVSKVGGTNSVLNLSGRGIEAMYRLNVGGPEITPDQDLDLW 246
Query: 240 RMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMS 299
R W+ DSSYM TANAGSE+ NSSNITYAS NDS VAPL VYETAR+MSNTEVLEKRFNMS
Sbjct: 247 RTWDVDSSYMFTANAGSEVHNSSNITYASMNDSVVAPLAVYETARSMSNTEVLEKRFNMS 306
Query: 300 WKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDY 359
WKFEVDP+F+Y +RLHFCEL YE+ANQR FRIYINNRTA +NFD+F++AGG N+ YH+D+
Sbjct: 307 WKFEVDPDFEYLIRLHFCELFYERANQRSFRIYINNRTAADNFDVFLRAGGMNKAYHQDF 366
Query: 360 FDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGH- 418
D VSSKI TLWIQLGPDT VGA+GTDA+LNGLEIFK S+NGNLA VERFDS+ + G
Sbjct: 367 LDMVSSKINTLWIQLGPDTTVGASGTDAILNGLEIFKLSRNGNLAYVERFDSTKSSAGSK 426
Query: 419 -SNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLN 477
S L VG+GAG+AS+ ++AVIF+L+F +CK WR+KSS KN SPGW PLF H +N
Sbjct: 427 TSKTQTLWVGLGAGVASIAMMAVIFSLIFYFCKRWRKKSSATKNKSPGWRPLFLH---VN 483
Query: 478 STANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDC 537
ST NAKG +Q L S+A RAGKRFTL EIR ATNNFDESL+IGVGGFGKV+KGEI+D
Sbjct: 484 ST-NAKGM-SQSLSVSLASNRAGKRFTLTEIRAATNNFDESLVIGVGGFGKVYKGEIDDG 541
Query: 538 TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597
T AAIKRANPQSEQGLAEF+TEIEMLSKLRHRHLVS+IGFC+EQNEMILVYEYMANGTLR
Sbjct: 542 TPAAIKRANPQSEQGLAEFQTEIEMLSKLRHRHLVSMIGFCEEQNEMILVYEYMANGTLR 601
Query: 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657
SHLFGS+LPPLTWKQRL+ACIGAARGLHYLHTGAERGIIHRDVKTTNIL+DENFVAKM+D
Sbjct: 602 SHLFGSELPPLTWKQRLEACIGAARGLHYLHTGAERGIIHRDVKTTNILIDENFVAKMAD 661
Query: 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVIN 717
FGLSKTGP+ EHTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFEVVCARAVIN
Sbjct: 662 FGLSKTGPAWEHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVVCARAVIN 721
Query: 718 PTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777
P+LP+DQINLA+WAM WQ QRSL++IIDPHLKGNYSP+SL KFGEIAEKCL DEGKNRPT
Sbjct: 722 PSLPRDQINLAEWAMHWQHQRSLETIIDPHLKGNYSPDSLRKFGEIAEKCLADEGKNRPT 781
Query: 778 MGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAEDGQDAPTTDAENCLGLK 837
MGEVLWHLEYVLQLHEAW+RT+ +NSFSSSQALG E+G ++ D EN + LK
Sbjct: 782 MGEVLWHLEYVLQLHEAWLRTNVGENSFSSSQALGNL-----EEGLESAHLDEENEISLK 836
Query: 838 MTGEVESATMGIS 850
M + ESAT GI+
Sbjct: 837 MKQKRESATRGIN 849
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255564379|ref|XP_002523186.1| kinase, putative [Ricinus communis] gi|223537593|gb|EEF39217.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1295 bits (3351), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 625/827 (75%), Positives = 710/827 (85%), Gaps = 4/827 (0%)
Query: 5 LLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTD 64
L+ LV + + GEAQS+SFLINCGT SV VDGR+W+GDL NNNVTL SS ++ATT
Sbjct: 12 LVLLVTIFISFNSGEAQSQSFLINCGTTISVTVDGRRWIGDLVPNNNVTLDSSTVSATTS 71
Query: 65 SLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANG 124
+ +GDSI+ PLY+TAR+F+D LNYTF+ + GNY VRLHFCPFPFE+ NVN+SSF + ANG
Sbjct: 72 AATGDSIFGPLYQTARIFSDALNYTFKGMQGNYFVRLHFCPFPFENNNVNESSFSLRANG 131
Query: 125 LKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFIN 184
LKL+SEF+ PGEISH+NLY+Q S NSSS+ LV+EY L DLD L++EFIPSKGSFGFIN
Sbjct: 132 LKLVSEFNVPGEISHKNLYVQGSSSNSSSLFLVREYML-FDLDALLLEFIPSKGSFGFIN 190
Query: 185 AIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEA 244
AIE+V V D+LF D++++VGGN+VN NLSGRG++TMYRLNVGGPEIK ++D D WRMWE
Sbjct: 191 AIEVVSVADRLFQDSVSRVGGNEVNLNLSGRGIQTMYRLNVGGPEIKSNQDSDFWRMWEV 250
Query: 245 DSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEV 304
DSSYMIT NAGS I NSSNITYAS NDSSVAPLLVYETAR MSNTEVLEKRFNMSWKFEV
Sbjct: 251 DSSYMITENAGSVINNSSNITYASKNDSSVAPLLVYETARAMSNTEVLEKRFNMSWKFEV 310
Query: 305 DPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVS 364
DP+FDY VRLHFCEL Y+KANQRIFRIYINNRTA +NFD+ V+AGG NRGYH+DYFDAVS
Sbjct: 311 DPDFDYLVRLHFCELQYDKANQRIFRIYINNRTAADNFDVNVRAGGANRGYHQDYFDAVS 370
Query: 365 SKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWIL 424
SKI+TLWIQLGPDTA GA+GTDALLNGLEIFK S+NGNLA VERFDS+GN V S +L
Sbjct: 371 SKIDTLWIQLGPDTAAGASGTDALLNGLEIFKLSRNGNLAHVERFDSTGNRVRKSKYQML 430
Query: 425 LVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNSTANAKG 484
VGIGAG+ASV+VLA I + C+C+ R++SSD K N GW PLF H ++S NAKG
Sbjct: 431 WVGIGAGVASVLVLAAICIFILCFCRTHRKESSDTKENVTGWRPLFLHGAIVSSIGNAKG 490
Query: 485 SGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKR 544
G+Q GS R GKRFTLAEIR AT +FD+SL+IG+GGFGKV+KGE+E TLAAIKR
Sbjct: 491 -GSQSSHGSTV--RIGKRFTLAEIRTATKSFDDSLVIGIGGFGKVYKGELEYGTLAAIKR 547
Query: 545 ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSD 604
ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC+EQNEMILVYEYM NGTLRSHLFGSD
Sbjct: 548 ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCEEQNEMILVYEYMGNGTLRSHLFGSD 607
Query: 605 LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664
LPPLTWKQRL+ACIGAARGLHYLHTGA+RGIIHRDVKTTNILLDENFVAKMSDFGLSKTG
Sbjct: 608 LPPLTWKQRLEACIGAARGLHYLHTGADRGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 667
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724
P+ +HTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ
Sbjct: 668 PAWDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 727
Query: 725 INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
INLA+WAM+WQ+QRSL++IIDP +KG Y PESL KFGEIAEKCL D+GKNRPTMGE+LWH
Sbjct: 728 INLAEWAMRWQRQRSLETIIDPRMKGTYCPESLTKFGEIAEKCLADDGKNRPTMGEILWH 787
Query: 785 LEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAEDGQDAPTTDAE 831
LEYVLQLHEAW+ + +NS SSSQA+ + ER E Q + + E
Sbjct: 788 LEYVLQLHEAWVCANVTENSLSSSQAMEDVEERVQEKVQGQESINEE 834
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224056845|ref|XP_002299052.1| predicted protein [Populus trichocarpa] gi|222846310|gb|EEE83857.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1256 bits (3251), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/837 (72%), Positives = 711/837 (84%), Gaps = 9/837 (1%)
Query: 5 LLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTD 64
++FLVI+ + GEAQS+SFL+NCG NSSVNVDGR+W+GDL N+N T+SS G+AAT
Sbjct: 12 VVFLVIVFLSVSSGEAQSRSFLVNCGANSSVNVDGRRWIGDLVPNDNFTVSSPGVAATDS 71
Query: 65 SLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANG 124
+ +GDS LY+TAR+F +GLNYTF + GNY VRLHFCPFP E++NVN+S F VVANG
Sbjct: 72 TANGDS----LYRTARIFDNGLNYTFSGVQGNYFVRLHFCPFPIENHNVNESLFSVVANG 127
Query: 125 LKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFIN 184
LKLL++F+ PGEIS + L LQ+S NSSS+SLVKEY L ++ D L++EFIPSKGSFGFIN
Sbjct: 128 LKLLADFNVPGEISDKYLPLQNSNSNSSSLSLVKEYILAIN-DVLVVEFIPSKGSFGFIN 186
Query: 185 AIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEA 244
A+EIVPV+ LFAD + +VGG+D N +SGRG+ETMYRLNVGG EIKP +D DLWR WE
Sbjct: 187 AMEIVPVIGTLFADLVRRVGGSDAN--VSGRGIETMYRLNVGGQEIKPDQDSDLWRKWEV 244
Query: 245 DSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEV 304
DSSYMITA+AG EI+NSSN+TYAS NDSSVAPLLVYETAR MSNTEVLEK+FNMSWKFEV
Sbjct: 245 DSSYMITADAGVEIKNSSNVTYASNNDSSVAPLLVYETARIMSNTEVLEKKFNMSWKFEV 304
Query: 305 DPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVS 364
DP+FDY +RLHFCELVY+KANQRIF++YINN+TA +NFD++ ++GGKN YH+DYFDA+S
Sbjct: 305 DPDFDYLIRLHFCELVYDKANQRIFKVYINNKTAADNFDVYARSGGKNIAYHQDYFDAIS 364
Query: 365 SKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWIL 424
+KI TLWIQLGPDTAVGA GTDALLNGLEIFK S++GNLA +R +G H WIL
Sbjct: 365 AKINTLWIQLGPDTAVGAWGTDALLNGLEIFKLSRSGNLAYGDRIGPTGKSASHLKSWIL 424
Query: 425 LVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNSTANAKG 484
+GIGAG+AS +++A+ +FC+CK+ R + S+ K+N PGW PLF H L+S ANAKG
Sbjct: 425 WLGIGAGVASALIIAIACTCIFCFCKSQRNEMSNTKDNPPGWRPLFMHGAVLSSIANAKG 484
Query: 485 SGTQYLKGSVA-LTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIK 543
G Q L GSVA TR G+RFTL+EIR AT+NFD+SL+IGVGGFGKV+KGEIED TLAAIK
Sbjct: 485 -GAQTLNGSVAAFTRVGRRFTLSEIRAATDNFDDSLVIGVGGFGKVYKGEIEDGTLAAIK 543
Query: 544 RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGS 603
R+NPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE+MANGTLRSHLFGS
Sbjct: 544 RSNPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEFMANGTLRSHLFGS 603
Query: 604 DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
PPLTWKQRL+AC GAARGLHYLHTGA+RGIIHRDVKTTNILLDENFVAKM+DFGLSK
Sbjct: 604 GFPPLTWKQRLEACTGAARGLHYLHTGADRGIIHRDVKTTNILLDENFVAKMADFGLSKD 663
Query: 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
GP+++HTHVSTAVKGSFGYLDPEYF RQ LTEKSDVYSFGVVLFEVVC+R VINP+LPKD
Sbjct: 664 GPALDHTHVSTAVKGSFGYLDPEYFRRQHLTEKSDVYSFGVVLFEVVCSRPVINPSLPKD 723
Query: 724 QINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLW 783
QINLA+WAMKWQ+QRSL++IIDP L+GN PESL+KFGEIAEKCL DEG+NRPTMGEVLW
Sbjct: 724 QINLAEWAMKWQRQRSLETIIDPRLRGNSCPESLKKFGEIAEKCLADEGRNRPTMGEVLW 783
Query: 784 HLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAEDGQDAPTTDAENCLGLKMTG 840
HLEYVLQLHEAWMRT+ + S +SSQAL + R AED Q P++ E+ + + G
Sbjct: 784 HLEYVLQLHEAWMRTNATETSITSSQALEDLELRVAEDAQRRPSSLDEDTVRPRHEG 840
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122340|ref|XP_002330599.1| predicted protein [Populus trichocarpa] gi|222872157|gb|EEF09288.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1249 bits (3233), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/824 (72%), Positives = 709/824 (86%), Gaps = 5/824 (0%)
Query: 5 LLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTD 64
L+FL+++ + EAQSK L+NCG NSSVNVDGR+W+GDLA N+N T+SS G+AAT
Sbjct: 12 LVFLIMVFLSVSSREAQSKPVLVNCGANSSVNVDGRRWIGDLAPNDNFTVSSPGVAATDS 71
Query: 65 SLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANG 124
+ G+S PLYKTAR+F + LNYTF + GNY +RLHFCPFPFE+YNVN+SSF VVANG
Sbjct: 72 NADGNSTLGPLYKTARIF-NALNYTFAGMQGNYFLRLHFCPFPFENYNVNESSFSVVANG 130
Query: 125 LKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFIN 184
LKL++EF+ P EIS +NL+LQ+S NSSS+SLVKEY L ++ D L++EF+ S+GSFGFIN
Sbjct: 131 LKLMTEFNVPVEISDKNLHLQNSNSNSSSLSLVKEYILTIN-DVLVVEFVSSRGSFGFIN 189
Query: 185 AIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEA 244
AIE+VPVV LFAD+++KVGG++ NFN+SGRG+ETMYRLN+GG EIK ++D DLWR WE
Sbjct: 190 AIEVVPVVGTLFADSVSKVGGSNANFNVSGRGIETMYRLNIGGQEIKTNQDSDLWRKWEM 249
Query: 245 DSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEV 304
DSSYMITA+AG EIRN+SN+TYAS NDSSVAPLLVYETAR MSNTEVLEK+FNMSWKFEV
Sbjct: 250 DSSYMITADAGVEIRNTSNVTYASNNDSSVAPLLVYETARIMSNTEVLEKKFNMSWKFEV 309
Query: 305 DPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVS 364
DP+FDY +RLHFCELVY+KANQRIFR+YINN+TA ++FD++V+AGGKN YH+DYFD VS
Sbjct: 310 DPDFDYLIRLHFCELVYDKANQRIFRVYINNKTAADSFDVYVRAGGKNIAYHQDYFDTVS 369
Query: 365 SKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWIL 424
SK TLW+QLGPDTAVGA+GTDALLNGLEIFK S++ NLA +R DS+ HS WIL
Sbjct: 370 SKTNTLWVQLGPDTAVGASGTDALLNGLEIFKLSRSANLAYADRIDSTEKSGSHSKSWIL 429
Query: 425 LVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNSTANAKG 484
+G+GAG+ASV+++A+ F +FC+ KN R++ SD K+N PGW PLF H ++S AN KG
Sbjct: 430 WLGVGAGVASVLIIAITFTCIFCFGKNRRKQMSDAKDNPPGWRPLFMHGAVVSSIANNKG 489
Query: 485 SGTQYLKGSVAL-TRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIK 543
G + L GS+A TR G+RFTL+EIR ATNNFD+SL+IGVGGFGKV+ G+IED TLAAIK
Sbjct: 490 -GVRSLNGSLAASTRVGRRFTLSEIRAATNNFDDSLVIGVGGFGKVYSGKIEDGTLAAIK 548
Query: 544 RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGS 603
R+NPQS+QGL EFETEIEMLSKLRHRHLVSLIGFC+EQNEMILVYEYMANGTLRSHLFGS
Sbjct: 549 RSNPQSKQGLTEFETEIEMLSKLRHRHLVSLIGFCEEQNEMILVYEYMANGTLRSHLFGS 608
Query: 604 DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
D PPLTWKQRL+ACIGAARGLHYLHTGA+RGIIHRD+KTTNILLDENFVAKM+DFGLSK
Sbjct: 609 DFPPLTWKQRLEACIGAARGLHYLHTGADRGIIHRDIKTTNILLDENFVAKMADFGLSKA 668
Query: 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
GP+++HTHVSTAVKGSFGYLDPEY+ RQQLTEKSDVYSFGVVLFEVVC+R VINP+LPKD
Sbjct: 669 GPALDHTHVSTAVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLFEVVCSRPVINPSLPKD 728
Query: 724 QINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLW 783
QINLA+WAMKWQ+Q+SL++I+DP L+GN PESL+KFGEIAEKCL DEGKNRPTMGEVLW
Sbjct: 729 QINLAEWAMKWQRQKSLETIVDPRLRGNTCPESLKKFGEIAEKCLADEGKNRPTMGEVLW 788
Query: 784 HLEYVLQLHEAWMRTD-DRQNSFSSSQALGEFAEREAEDGQDAP 826
HLE+VLQLHEAWMR + + S +SSQAL + R AE+ + P
Sbjct: 789 HLEFVLQLHEAWMRANATTETSITSSQALEDLELRVAEEARRPP 832
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448519|ref|XP_003594535.1| Kinase-like protein [Medicago truncatula] gi|355483583|gb|AES64786.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1236 bits (3198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/840 (72%), Positives = 708/840 (84%), Gaps = 7/840 (0%)
Query: 5 LLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSS-GIAATT 63
LLF++I++ V++ EAQ KS LINCG+NSSVNVDGRKW+GD+A NNNVTLSSS G+ A+T
Sbjct: 9 LLFVLILMFVSKNVEAQQKSILINCGSNSSVNVDGRKWIGDMAPNNNVTLSSSPGVVAST 68
Query: 64 DSLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVAN 123
D LSG+SIYEPLYKTAR+F LNYT + + GNY VR H CPF D+NVN+SSFGVV N
Sbjct: 69 DGLSGNSIYEPLYKTARIFTASLNYTIKDVHGNYFVRFHLCPFEIVDHNVNESSFGVVVN 128
Query: 124 GLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFI 183
G+KLLSEF+ PG+IS +N+ LQ+SG NSSS L++EY L V+ L+IEF+PS SFGFI
Sbjct: 129 GMKLLSEFNVPGKISEKNVNLQNSGKNSSSFFLIREYILDVNDGMLLIEFLPSGNSFGFI 188
Query: 184 NAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWE 243
NAIEIVPVV +LF ++ KVGG N NL+G G+ETMYRLNVGGPEI+ ++DPDL R+WE
Sbjct: 189 NAIEIVPVVGELFDGSVGKVGGG--NLNLTGHGMETMYRLNVGGPEIQSNQDPDLRRIWE 246
Query: 244 ADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFE 303
DSSYM+T NAG+ I++SSNITYAS ND+SVAPLLVYETAR MSNTEVL+KRFNMSWKFE
Sbjct: 247 VDSSYMVTENAGAAIKSSSNITYASANDTSVAPLLVYETARAMSNTEVLDKRFNMSWKFE 306
Query: 304 VDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAV 363
VDP+FDY VRLHFCEL+Y+K+N+RIFRIYINNRTA +N D+FV+AGGKN+ YH+D++D+
Sbjct: 307 VDPDFDYVVRLHFCELMYDKSNERIFRIYINNRTAADNVDVFVRAGGKNKAYHQDHYDSA 366
Query: 364 SSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWI 423
S +++TLW+QLGPDTA GAAGTDALLNGLEIFK S+NGNLA VE+FD +G S +
Sbjct: 367 SLRMDTLWVQLGPDTAAGAAGTDALLNGLEIFKLSRNGNLAYVEKFDLAGKSGSSSKAKV 426
Query: 424 LLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGT-LNSTANA 482
L +G+GAGIASV ++A + +FC+CK R++SSD KNNSPGW P+F + G +NST A
Sbjct: 427 LWIGVGAGIASVAIVACVGVFVFCFCKRRRKESSDTKNNSPGWRPIFLYGGAAVNSTVGA 486
Query: 483 KGS-GTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAA 541
KGS G Q L G+V T AGKRFTLAEI ATNNFD+SL+IGVGGFGKV+KGE++D AA
Sbjct: 487 KGSTGNQKLYGTVTSTGAGKRFTLAEINAATNNFDDSLVIGVGGFGKVYKGEVDDGVPAA 546
Query: 542 IKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLF 601
IKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC+E++EMILVYEYMANGTLRSHLF
Sbjct: 547 IKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCEEKSEMILVYEYMANGTLRSHLF 606
Query: 602 GSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661
GSDLPPLTWKQRL+ACIGAARGLHYLHTGA+RGIIHRDVKTTNILLDENFVAKM+DFGLS
Sbjct: 607 GSDLPPLTWKQRLEACIGAARGLHYLHTGADRGIIHRDVKTTNILLDENFVAKMADFGLS 666
Query: 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP 721
K GP+ EHTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFE VCARAVINPTLP
Sbjct: 667 KDGPAFEHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLP 726
Query: 722 KDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEV 781
KDQINLA+WAM+WQK+RSL+ IIDP L GN+ PESL KFGEIAEKCL D+GK+RPTMGEV
Sbjct: 727 KDQINLAEWAMRWQKERSLEKIIDPRLNGNHCPESLSKFGEIAEKCLADDGKSRPTMGEV 786
Query: 782 LWHLEYVLQLHEAWMRTDDR--QNSFSSSQALGEFAEREAEDGQDAPTTDAENCLGLKMT 839
LWHLEYVLQLHEAW+ D+ +NSFS SQAL + E Q+ D E L K T
Sbjct: 787 LWHLEYVLQLHEAWLNRDNNSTENSFSGSQALSGLNDGRVEVAQEHSNQDEEVDLDSKNT 846
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147818022|emb|CAN73534.1| hypothetical protein VITISV_041657 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1212 bits (3137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 609/853 (71%), Positives = 688/853 (80%), Gaps = 55/853 (6%)
Query: 1 MERVLLFLVIML-VVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGI 59
ME L LV+M+ V GEAQ+KS LINCGTNSSVNVD
Sbjct: 1 MEVWGLILVVMVSVFVGNGEAQAKSLLINCGTNSSVNVD--------------------- 39
Query: 60 AATTDSLSGDSIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFG 119
D+ SGD+ + LY+TAR+F D LNYT + GNY VRLHF PF FE YN N+SSF
Sbjct: 40 ----DTFSGDTTFAQLYETARIFPDSLNYTASLNQGNYSVRLHFYPFSFEKYNTNESSFS 95
Query: 120 VVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGS 179
ISH+N YLQSSG NSSS S++KEYFL VD L+IEF P+KGS
Sbjct: 96 -----------------ISHKNSYLQSSGSNSSSXSMIKEYFLTVDSGLLVIEFAPTKGS 138
Query: 180 FGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLW 239
FGFINAIEIVPVVD LF +++KVGG + NLSGRG+E MYRLNVGGPEI P +D DLW
Sbjct: 139 FGFINAIEIVPVVDNLFFSSVSKVGGTNSVLNLSGRGIEAMYRLNVGGPEITPDQDLDLW 198
Query: 240 RMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMS 299
R WE DSSYM TANAGSE+ NSSNITYAS NDS VAPL VYETAR+MSNTEVLEKRFNMS
Sbjct: 199 RTWEVDSSYMFTANAGSEVHNSSNITYASMNDSVVAPLAVYETARSMSNTEVLEKRFNMS 258
Query: 300 WKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDY 359
WKFEVDP+F+Y +RLHFCEL YE+ANQR FRIYINNRTA +NFD+F++AGG N+ YH+D+
Sbjct: 259 WKFEVDPDFEYLIRLHFCELFYERANQRSFRIYINNRTAADNFDVFLRAGGMNKAYHQDF 318
Query: 360 FDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGH- 418
D VSSKI TLWIQLGPDT VGA+GTDA+LNGLEIFK S+NGNLA VERFDS+ + G
Sbjct: 319 LDMVSSKINTLWIQLGPDTTVGASGTDAILNGLEIFKLSRNGNLAYVERFDSTKSSAGSK 378
Query: 419 -SNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLN 477
S L VG+GAG+AS+ ++AVIF+L+F +CK WR+KSS KN SPGW PLF H +N
Sbjct: 379 TSKTQTLWVGLGAGVASIAMMAVIFSLIFYFCKRWRKKSSATKNKSPGWRPLFLH---VN 435
Query: 478 STANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDC 537
ST NAKG +Q L S+A RAGKRFTL EIR ATNNFDESL+IGVGGFGKV+KGEI+D
Sbjct: 436 ST-NAKGM-SQSLSVSLAXNRAGKRFTLTEIRAATNNFDESLVIGVGGFGKVYKGEIDDG 493
Query: 538 TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597
T AAIKRANPQSEQGLAEF+TEIEMLSKLRHRHLVS+IGFC+EQNEMILVYEYMANGTLR
Sbjct: 494 TPAAIKRANPQSEQGLAEFQTEIEMLSKLRHRHLVSMIGFCEEQNEMILVYEYMANGTLR 553
Query: 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657
SHLFGS+LPPLTWKQRL+ACIGAARGLHYLHTGAERGIIHRDVKTTNIL+D+NFVAKM+D
Sbjct: 554 SHLFGSELPPLTWKQRLEACIGAARGLHYLHTGAERGIIHRDVKTTNILIDDNFVAKMAD 613
Query: 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVIN 717
FGLSKTGP+ EHTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFEVVCARAVIN
Sbjct: 614 FGLSKTGPAWEHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVVCARAVIN 673
Query: 718 PTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777
PTLP+DQINLA+WAM WQ+QRSL++IIDPHLKGNYSP+SL KFGEIAEKCL DEGKNRPT
Sbjct: 674 PTLPRDQINLAEWAMHWQQQRSLETIIDPHLKGNYSPDSLRKFGEIAEKCLADEGKNRPT 733
Query: 778 MGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAEDGQDAPTTDAENCLGLK 837
MGEVLWHLEYVLQLHEAW+RT+ +NSFSSSQALG E+G ++ D EN + LK
Sbjct: 734 MGEVLWHLEYVLQLHEAWLRTNVGENSFSSSQALGNL-----EEGLESAHXDEENEISLK 788
Query: 838 MTGEVESATMGIS 850
M + +SAT GI+
Sbjct: 789 MKQKRDSATRGIN 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532423|ref|XP_003534772.1| PREDICTED: probable receptor-like protein kinase At1g30570-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1188 bits (3073), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/824 (71%), Positives = 687/824 (83%), Gaps = 2/824 (0%)
Query: 20 AQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEPLYKTA 79
Q KS L+NCG++SSVNVDGR+WVGD+A++NNVTLSS + +T + SG SIY+ LYKTA
Sbjct: 27 GQPKSILLNCGSDSSVNVDGRRWVGDMATDNNVTLSSPSVVVSTSTSSGSSIYDSLYKTA 86
Query: 80 RVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISH 139
R+F LNYTF+ + GNY VR HFCPF +DYNVN+SSFGVV N LKLLSEF PG+ISH
Sbjct: 87 RIFNSPLNYTFKDVQGNYFVRFHFCPFETDDYNVNESSFGVVVNSLKLLSEFDVPGKISH 146
Query: 140 RNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKLFADT 199
+N+ L +SG N+SS+ LVKEY + V+ D L+IEF+P++ SFGFINAIEIVPV +LFA +
Sbjct: 147 KNMNLLNSGRNASSLFLVKEYIVAVNGDMLLIEFVPTRSSFGFINAIEIVPVAGELFAGS 206
Query: 200 INKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIR 259
+++VGG+ N NL GRG+ETMYRLNVGGPEI+ ++D DLWR WE DS YMIT NAGS I+
Sbjct: 207 VSRVGGSGGNMNLPGRGMETMYRLNVGGPEIQSNQDHDLWRTWEVDSGYMITENAGSGIK 266
Query: 260 NSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCEL 319
NSSNITYAS ND++VAPLLVYETAR MSNTEVL+KRFNMSWKFEVDP+FDY VRLHFCEL
Sbjct: 267 NSSNITYASVNDTAVAPLLVYETARAMSNTEVLDKRFNMSWKFEVDPDFDYLVRLHFCEL 326
Query: 320 VYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLGPDTA 379
VY+KAN+RIFRIYINN+TA +N D+FV+AGG N+ YH+DYFD VS +I+T+W+QLGPDTA
Sbjct: 327 VYDKANERIFRIYINNKTAADNVDVFVRAGGMNKAYHQDYFDPVSPRIDTVWVQLGPDTA 386
Query: 380 VGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWILLVGIGAGIASVVVLA 439
GAAGTDALLNGLE+FK S+NGNLA VERFD GN S + VG+GAG+ASV ++A
Sbjct: 387 AGAAGTDALLNGLEVFKLSRNGNLAYVERFDLGGNSGNKSKARAIWVGVGAGVASVAIVA 446
Query: 440 VIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRG-TLNSTANAKGS-GTQYLKGSVALT 497
+I L+FC+C +++SSD KNN GW PLF + G +NST AKGS GTQ GSV T
Sbjct: 447 LIVGLVFCFCNGRKKQSSDTKNNPQGWRPLFLYGGAAVNSTVGAKGSAGTQKPYGSVGST 506
Query: 498 RAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFE 557
R GK+FTLAEI ATNNFD+SL+IGVGGFGKV+KGE+ED AIKRANPQSEQGLAEFE
Sbjct: 507 RVGKKFTLAEINAATNNFDDSLVIGVGGFGKVYKGEVEDGVPVAIKRANPQSEQGLAEFE 566
Query: 558 TEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC 617
TEIEMLSKLRHRHLVSLIGFC+E+NEMILVYEYMANGTLRSHLFGSDLPPL+WKQRL+ C
Sbjct: 567 TEIEMLSKLRHRHLVSLIGFCEEKNEMILVYEYMANGTLRSHLFGSDLPPLSWKQRLEVC 626
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
IGAARGLHYLHTGA+RGIIHRDVKTTNILLDENFVAKM+DFGLSK GP+ EHTHVSTAVK
Sbjct: 627 IGAARGLHYLHTGADRGIIHRDVKTTNILLDENFVAKMADFGLSKDGPAFEHTHVSTAVK 686
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
GSFGYLDPEYF RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA+WAM+WQ+Q
Sbjct: 687 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAEWAMRWQRQ 746
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797
RSL++IID L+GNY PESL K+GEIAEKCL D+GK+RPTMGEVLWHLEYVLQLHEAW+
Sbjct: 747 RSLETIIDSLLRGNYCPESLAKYGEIAEKCLADDGKSRPTMGEVLWHLEYVLQLHEAWLN 806
Query: 798 TDDRQNSFSSSQALGEFAEREAEDGQDAPTTDAENCLGLKMTGE 841
+ SFS+ AL + E + + D E K T E
Sbjct: 807 MGTTETSFSNDHALRGPKDGGLEMVHEPSSQDEEVGFDHKHTAE 850
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15221443|ref|NP_174345.1| hercules receptor kinase 2 [Arabidopsis thaliana] gi|75336895|sp|Q9SA72.1|Y1357_ARATH RecName: Full=Probable receptor-like protein kinase At1g30570; Flags: Precursor gi|4587513|gb|AAD25744.1|AC007060_2 Contains eukaryotic protein kinase domain PF|00069 [Arabidopsis thaliana] gi|332193124|gb|AEE31245.1| hercules receptor kinase 2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1170 bits (3026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 569/834 (68%), Positives = 670/834 (80%), Gaps = 10/834 (1%)
Query: 1 MERVLLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIA 60
+E +L L+ V GEAQSKSFL++CG+N++ VDGR WVGDL+ N +VTL G
Sbjct: 9 LEHLLCVLIFFTYVIGYGEAQSKSFLVDCGSNATTEVDGRTWVGDLSPNKSVTLQ--GFD 66
Query: 61 ATTDSLS-GDSIYEPLYKTARVFADGLNYTFE-IIAGNYIVRLHFCPFPFEDYNVNKSSF 118
A T S S G S+Y +YKTARVF LNYTFE I GNY VRLHF PF E++NVN+SSF
Sbjct: 67 AITASTSKGSSVYAEIYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSF 126
Query: 119 GVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKG 178
V A+GL+L+ + + GEI+H+NL L+S+G N+++ SLVKE+ L KL++ FIP KG
Sbjct: 127 SVFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKG 186
Query: 179 SFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDL 238
SFGF+NAIEIV V DKLF +++ KVGG++V L GRG+ETMYRLNVGGP++ PS+D L
Sbjct: 187 SFGFVNAIEIVSVDDKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKL 246
Query: 239 WRMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNM 298
+R WE D SYM+ NAG E++NSSNITYA +DS VAPLLVYETAR MSNTEVLEKRFN+
Sbjct: 247 YRTWETDLSYMVIENAGVEVKNSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRFNI 306
Query: 299 SWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRD 358
SWKFEVDPNFDY VRLHFCEL+ +K NQRIFRIYINN+TA NFDIF AGGKN+G ++D
Sbjct: 307 SWKFEVDPNFDYLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQD 366
Query: 359 YFDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGH 418
Y D VSSK + LWIQLGPD++VGA+G DALL+GLEIFK S+NGNLA + RFDS+G+ V
Sbjct: 367 YLDPVSSKNDVLWIQLGPDSSVGASG-DALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSD 425
Query: 419 SNKWILLVGIGAGIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNS 478
S I+ + +GAGIA ++ + L+ C CK R KS + KNN PGW PLF H NS
Sbjct: 426 SKMRIIWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVN--NS 483
Query: 479 TANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCT 538
TANAK +G ++A + G++FTLAEIR AT NFD+ L IGVGGFGKV++GE+ED T
Sbjct: 484 TANAKATGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGT 543
Query: 539 LAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRS 598
L AIKRA P S+QGLAEFETEI MLS+LRHRHLVSLIGFCDE NEMILVYEYMANGTLRS
Sbjct: 544 LIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRS 603
Query: 599 HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658
HLFGS+LPPL+WKQRL+ACIG+ARGLHYLHTG+ERGIIHRDVKTTNILLDENFVAKMSDF
Sbjct: 604 HLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDF 663
Query: 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINP 718
GLSK GPSM+HTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFE VCARAVINP
Sbjct: 664 GLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINP 723
Query: 719 TLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM 778
TLPKDQINLA+WA+ WQKQR+L+SIID +L+GNYSPESLEK+GEIAEKCL DEGKNRP M
Sbjct: 724 TLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMM 783
Query: 779 GEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAER---EAEDGQDAPTTD 829
GEVLW LEYVLQ+HEAW+R + +NSFSSSQA+ E E A QD+ T+
Sbjct: 784 GEVLWSLEYVLQIHEAWLRKQNGENSFSSSQAVEEAPESFTLPACSNQDSSETE 837
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297845996|ref|XP_002890879.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297336721|gb|EFH67138.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1136 bits (2938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 556/817 (68%), Positives = 658/817 (80%), Gaps = 22/817 (2%)
Query: 18 GEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTDSLS-GDSIYEPLY 76
GE+QSKSFLI+CG+N++ VDGR WVGDL+ N +VTL G A T S S G S++ +Y
Sbjct: 26 GESQSKSFLIDCGSNTTTEVDGRTWVGDLSPNKSVTLQ--GFDAITASTSKGGSVFGEIY 83
Query: 77 KTARVFADGLNYTFE-IIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPG 135
KTARVF LNYTFE I GNY VRLHF PFP E++NVN+SSF V A+GL+L+ + + G
Sbjct: 84 KTARVFEAVLNYTFEGITQGNYFVRLHFSPFPIENHNVNESSFSVFADGLRLMLDINIAG 143
Query: 136 EISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKL 195
EI+H+NL L+S+G N+++ SLVKE+ L + KL++ F+P KGSFGF+NAIEI+ +V+
Sbjct: 144 EIAHKNLILESTGHNATASSLVKEFLLPMGPGKLVLSFMPEKGSFGFVNAIEILLLVEVK 203
Query: 196 FADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAG 255
++ + RG+ETMYRLNVGGP++ PS+D L+R WE D SYM+ NAG
Sbjct: 204 WSLVWGR------------RGIETMYRLNVGGPKLGPSQDLKLYRTWETDLSYMVIENAG 251
Query: 256 SEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLH 315
E++NSSNITYA +DS VAPLLVYETAR MSNTEVLEKRFN+SWKFEVDPNFDY VRLH
Sbjct: 252 VEVKNSSNITYAMADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLH 311
Query: 316 FCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLG 375
FCEL+ +K NQRIFRIYINN+TA NFDIF AGGKN+G ++DYFD VSSK + LWIQLG
Sbjct: 312 FCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYFDPVSSKNDVLWIQLG 371
Query: 376 PDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGHSNKWILLVGIGAGIASV 435
PD++VGA+G DALL+GLEIFK S+NGNLA + RFDS+G+ V S I+ + +GAGIA++
Sbjct: 372 PDSSVGASG-DALLSGLEIFKLSKNGNLAHLIRFDSTGHSVDDSKMRIIWISVGAGIATI 430
Query: 436 VVLAVIFALLFCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNSTANAKGSGTQYLKGSVA 495
+ + L+ C CK R KS++ KNN PGW PLF H NSTANAK +G ++A
Sbjct: 431 IFFVFLGILVVCLCKKRRNKSNESKNNPPGWRPLFLHVN--NSTANAKATGGSLRLNTLA 488
Query: 496 LTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAE 555
+ G++FTLAEIR AT NFD+ L IGVGGFGKV++GE+ED TL AIKRA P S+QGLAE
Sbjct: 489 ASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAE 548
Query: 556 FETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD 615
FETEI MLS+LRHRHLVSLIGFCDE NEMILVYEYMANGTLRSHLFGS+LPPL+WKQRL+
Sbjct: 549 FETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLE 608
Query: 616 ACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA 675
ACIG+ARGLHYLHTG+ERGIIHRDVKTTNILLDENFVAKMSDFGLSK GPSM+HTHVSTA
Sbjct: 609 ACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTA 668
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735
VKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFE VCARAVINPTLPKDQINLA+WA+ WQ
Sbjct: 669 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQ 728
Query: 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795
KQRSL+SIIDP+L+GNYSPESLEK+GEIAEKCL DEGKNRP MGEVLW LEYVLQLHEAW
Sbjct: 729 KQRSLESIIDPNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQLHEAW 788
Query: 796 MRTDDRQNSFSSSQALGEFAEREAEDG---QDAPTTD 829
+R + +NSFSSSQA+ E E G QD+ T+
Sbjct: 789 LRKQNGENSFSSSQAVEEAPESYTLQGCSNQDSSETE 825
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 851 | ||||||
| TAIR|locus:2204564 | 849 | HERK2 "hercules receptor kinas | 0.968 | 0.970 | 0.655 | 1.6e-290 | |
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.887 | 0.883 | 0.449 | 3e-165 | |
| TAIR|locus:2075346 | 830 | HERK1 "hercules receptor kinas | 0.741 | 0.760 | 0.461 | 6.5e-164 | |
| TAIR|locus:2174249 | 829 | AT5G59700 [Arabidopsis thalian | 0.753 | 0.773 | 0.460 | 1.2e-162 | |
| TAIR|locus:2081895 | 895 | FER "FERONIA" [Arabidopsis tha | 0.911 | 0.867 | 0.425 | 1.8e-156 | |
| TAIR|locus:2084953 | 850 | ANX1 "ANXUR1" [Arabidopsis tha | 0.928 | 0.929 | 0.421 | 8.5e-152 | |
| TAIR|locus:2148830 | 858 | ANX2 "ANXUR2" [Arabidopsis tha | 0.904 | 0.897 | 0.434 | 1.8e-151 | |
| TAIR|locus:2039717 | 815 | AT2G39360 [Arabidopsis thalian | 0.383 | 0.4 | 0.555 | 7.1e-145 | |
| TAIR|locus:2050080 | 871 | AT2G21480 [Arabidopsis thalian | 0.790 | 0.772 | 0.443 | 4.6e-144 | |
| TAIR|locus:2136338 | 878 | AT4G39110 [Arabidopsis thalian | 0.742 | 0.719 | 0.455 | 7.5e-144 |
| TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2790 (987.2 bits), Expect = 1.6e-290, P = 1.6e-290
Identities = 547/834 (65%), Positives = 635/834 (76%)
Query: 1 MERVLLFLVIMLVVARIGEAQSKSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIA 60
+E +L L+ V GEAQSKSFL++CG+N++ VDGR WVGDL+ N +VTL G
Sbjct: 9 LEHLLCVLIFFTYVIGYGEAQSKSFLVDCGSNATTEVDGRTWVGDLSPNKSVTLQ--GFD 66
Query: 61 ATTDSLS-GDSIYEPLYKTARVFADGLNYTFE-IIAGNYIVRLHFCPFPFEDYNVNKSSF 118
A T S S G S+Y +YKTARVF LNYTFE I GNY VRLHF PF E++NVN+SSF
Sbjct: 67 AITASTSKGSSVYAEIYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSF 126
Query: 119 GVVANGLKLLSEFSAPGEISHRNLYLQXXXXXXXXXXLVKEYFLGVDLDKLMIEFIPSKG 178
V A+GL+L+ + + GEI+H+NL L+ LVKE+ L KL++ FIP KG
Sbjct: 127 SVFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKG 186
Query: 179 SFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDL 238
SFGF+NAIEIV V DKLF +++ KVGG++V L GRG+ETMYRLNVGGP++ PS+D L
Sbjct: 187 SFGFVNAIEIVSVDDKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKL 246
Query: 239 WRMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNM 298
+R WE D SYM+ NAG E++NSSNITYA +DS VAPLLVYETAR MSNTEVLEKRFN+
Sbjct: 247 YRTWETDLSYMVIENAGVEVKNSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRFNI 306
Query: 299 SWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRD 358
SWKFEVDPNFDY VRLHFCEL+ +K NQRIFRIYINN+TA NFDIF AGGKN+G ++D
Sbjct: 307 SWKFEVDPNFDYLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQD 366
Query: 359 YFDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVERFDSSGNPVGH 418
Y D VSSK + LWIQLGPD++VGA+G DALL+GLEIFK S+NGNLA + RFDS+G+ V
Sbjct: 367 YLDPVSSKNDVLWIQLGPDSSVGASG-DALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSD 425
Query: 419 SNKWILXXXXXXXXXXXXXXXXXXXXXXCYCKNWREKSSDPKNNSPGWWPLFFHRGTLNS 478
S I+ C CK R KS + KNN PGW PLF H NS
Sbjct: 426 SKMRIIWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVN--NS 483
Query: 479 TANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMXXXXXXXXXXXXXXXDCT 538
TANAK +G ++A + G++FTLAEIR AT NFD+ L D T
Sbjct: 484 TANAKATGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGT 543
Query: 539 LAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRS 598
L AIKRA P S+QGLAEFETEI MLS+LRHRHLVSLIGFCDE NEMILVYEYMANGTLRS
Sbjct: 544 LIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRS 603
Query: 599 HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658
HLFGS+LPPL+WKQRL+ACIG+ARGLHYLHTG+ERGIIHRDVKTTNILLDENFVAKMSDF
Sbjct: 604 HLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDF 663
Query: 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINP 718
GLSK GPSM+HTHVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVLFE VCARAVINP
Sbjct: 664 GLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINP 723
Query: 719 TLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM 778
TLPKDQINLA+WA+ WQKQR+L+SIID +L+GNYSPESLEK+GEIAEKCL DEGKNRP M
Sbjct: 724 TLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMM 783
Query: 779 GEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAER---EAEDGQDAPTTD 829
GEVLW LEYVLQ+HEAW+R + +NSFSSSQA+ E E A QD+ T+
Sbjct: 784 GEVLWSLEYVLQIHEAWLRKQNGENSFSSSQAVEEAPESFTLPACSNQDSSETE 837
|
|
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1608 (571.1 bits), Expect = 3.0e-165, P = 3.0e-165
Identities = 359/798 (44%), Positives = 483/798 (60%)
Query: 24 SFLINCGTNSSVNVDGRKWVGD-LASNNNVTLSSSGIA-ATTDSLSGDSIYEPLYKTARV 81
++LI+CG++ ++ R +V D L S+ + + +S +A +TT + S +SIY+ TARV
Sbjct: 31 NYLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSSVATSTTSNNSTNSIYQ----TARV 86
Query: 82 FADGLNYTFEIIA-GNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISHR 140
F+ +Y F+I + G + +RLHF P +N+ +S VV LL+ FS ++
Sbjct: 87 FSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLNNFS----FNNF 142
Query: 141 NLYLQXXXXXXXXXXLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKLFADTI 200
N + KEY + V + L + FIPS S F+NAIE+V V D L D
Sbjct: 143 N-----------GSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPDQA 191
Query: 201 NKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYM-ITANAGSEIR 259
+ + LS ET+YRLN+GGP + S++ L R W+ D+ Y+ + ++
Sbjct: 192 LALNPSTPFSGLSLLAFETVYRLNMGGP-LLTSQNDTLGRQWDNDAEYLHVNSSVLVVTA 250
Query: 260 NSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCEL 319
N S+I Y+ + AP +VY TA TM + V FN++W VDP+F YFVR+HFC++
Sbjct: 251 NPSSIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDI 310
Query: 320 VYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIE-TLWIQLGPDT 378
V + N +F +Y+N+ A + D+ G Y +D+ S + L + +GPD+
Sbjct: 311 VSQALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSVGPDS 370
Query: 379 AVGAAGTDALLNGLEIFKFSQNG-NLASVERFDSSGNPVGHSNKWILXXXXXXXXXXXXX 437
T+A +NGLE+ K S +L+ V S P G +K
Sbjct: 371 QADI--TNATMNGLEVLKISNEAKSLSGVSSVKSL-LPGGSGSK-SKKKAVIIGSLVGAV 426
Query: 438 XXXXXXXXXCYC---KNWREKSSDPKNNSPG--WWPLFFH--RGTLN-STANAKGSGTQY 489
CYC + +++S+ P+ G W PL + TL STA+ K +
Sbjct: 427 TLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATASC 486
Query: 490 LKGSVALTRAGKRFTLAEIRVATNNFDESLMXXXXXXXXXXXXXXXDCTLAAIKRANPQS 549
+ S+A T G+ F EI ATN FDES + D T A+KR NP+S
Sbjct: 487 I--SLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRS 544
Query: 550 EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLT 609
EQG+AEF TEIEMLSKLRHRHLVSLIG+CDE++EMILVYEYMANG LRSHL+G+DLPPL+
Sbjct: 545 EQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLS 604
Query: 610 WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669
WKQRL+ CIGAARGLHYLHTGA + IIHRDVKTTNILLDEN VAK++DFGLSKTGPS++
Sbjct: 605 WKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQ 664
Query: 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729
THVSTAVKGSFGYLDPEYF RQQLTEKSDVYSFGVVL EV+C R +NP LP++Q+N+A+
Sbjct: 665 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAE 724
Query: 730 WAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789
WAM WQK+ L I+D +L G +P SL+KFGE AEKCL + G +RP+MG+VLW+LEY L
Sbjct: 725 WAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYAL 784
Query: 790 QLHE---AWMRTDDRQNS 804
QL E A M DD +
Sbjct: 785 QLEETSSALMEPDDNSTN 802
|
|
| TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1450 (515.5 bits), Expect = 6.5e-164, Sum P(2) = 6.5e-164
Identities = 302/654 (46%), Positives = 402/654 (61%)
Query: 156 LVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKLFADTINKVGGNDVNF-NLSG 214
+VKEY L V + L++ F PS GSF F+NAIE++ + D L + VG N F ++S
Sbjct: 139 VVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLITGSPRFVG-NPAQFPDMSM 197
Query: 215 RGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIRNSSNITYA---STND 271
+G+ET++R+N+GGP + + D L R W DS +++ N + S + + +T D
Sbjct: 198 QGLETIHRVNMGGPLVASNNDT-LTRTWVPDSEFLLEKNLAKSMSKFSTVNFVPGYATED 256
Query: 272 SSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRI 331
S AP VY + M++ + FN++W+F+VDP F Y+ R HFC++V NQ F +
Sbjct: 257 S--APRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSLNQLYFNL 314
Query: 332 YINNRTAENNFDIFVQAGGKNRG-YHRDYFDAVSSKIETLWIQLGPDTAVGAAGTDALLN 390
Y+++ A + D+ G Y D+ + + +GP T V +A++N
Sbjct: 315 YVDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKVRVSIGPST-VHTDYPNAIVN 373
Query: 391 GLEIFKFSQNGNLASVERFDSSGNPVGHSNKWILXXXXXXXXXXXXXXXXXXXXXXCYCK 450
GLEI K + + S F + SN ++ C+
Sbjct: 374 GLEIMKMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGSLLAVVFLGS------CFVL 427
Query: 451 NWREKSSDPKNNSPGWWPLFFHRGTLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRV 510
++++ +S W P F GT S + +GT S+ T A R A ++
Sbjct: 428 -YKKRKRGQDGHSKTWMP-FSINGT--SMGSKYSNGTTLT--SIT-TNANYRIPFAAVKD 480
Query: 511 ATNNFDESLMXXXXXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH 570
ATNNFDES D T A+KR NP+S+QGLAEF TEIEMLS+ RHRH
Sbjct: 481 ATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRH 540
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
LVSLIG+CDE NEMIL+YEYM NGT++SHL+GS LP LTWKQRL+ CIGAARGLHYLHTG
Sbjct: 541 LVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTG 600
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
+ +IHRDVK+ NILLDENF+AK++DFGLSKTGP ++ THVSTAVKGSFGYLDPEYF R
Sbjct: 601 DSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRR 660
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
QQLT+KSDVYSFGVVLFEV+CAR VI+PTLP++ +NLA+WAMKWQK+ L IID L+G
Sbjct: 661 QQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRG 720
Query: 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNS 804
N P+SL KF E EKCL D G +RP+MG+VLW+LEY LQL EA + + NS
Sbjct: 721 NIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNS 774
|
|
| TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1436 (510.6 bits), Expect = 1.2e-162, Sum P(2) = 1.2e-162
Identities = 306/664 (46%), Positives = 406/664 (61%)
Query: 156 LVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGR 215
++KEY L V D L + F PS SF F+NA+E+V V D LF+ + G LS +
Sbjct: 138 VMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSGDPSFAGSPGKFQGLSWQ 197
Query: 216 GVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIRNSSNITYA-STNDSSV 274
+ET+YR+N+GGP + PS D L R+WE DS +++ N + +++ Y
Sbjct: 198 ALETVYRVNMGGPRVTPSNDT-LSRIWEPDSEFLVEKNLVKSVSKIASVDYVPGFATEET 256
Query: 275 APLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYIN 334
AP VY T M++ + FN++W F+VDP F YF+R HFC++V + NQ F +Y++
Sbjct: 257 APRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKALNQLYFNLYVD 316
Query: 335 NRTAENNFDIFVQAGGKNRG-YHRDYFDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLE 393
+ N D+ G Y D+ + + + + +G ++V A+LNGLE
Sbjct: 317 SMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGR-SSVHTDYPTAILNGLE 375
Query: 394 IFKFSQNGNLASVERFDSSGNPVGHSNKWILXXXXXXXXXXXXXXXXXXXXXXCYCKNWR 453
I K + + + S+ F SG+ + K + Y K R
Sbjct: 376 IMKMNNSKSQLSIGTFLPSGS--SSTTKKNVGMIIGLTIGSLLALVVLGGFFVLYKKRGR 433
Query: 454 EKSSDPKNNSPGWWPLFFHRGTLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATN 513
D NS W PL + GT +S+ +GT S+A + + R L ++ ATN
Sbjct: 434 ----DQDGNSKTWIPLSSN-GTTSSS-----NGTTL--ASIA-SNSSYRIPLVAVKEATN 480
Query: 514 NFDESLMXXXXXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+FDE+ D T A+KRANP+S+QGLAEF TEIEMLS+ RHRHLVS
Sbjct: 481 SFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVS 540
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
LIG+CDE NEMILVYEYM NGTL+SHL+GS L L+WKQRL+ CIG+ARGLHYLHTG +
Sbjct: 541 LIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAK 600
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
+IHRDVK+ NILLDEN +AK++DFGLSKTGP ++ THVSTAVKGSFGYLDPEYF RQQL
Sbjct: 601 PVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 660
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753
TEKSDVYSFGVV+FEV+CAR VI+PTL ++ +NLA+WAMKWQK+ L+ IIDP L+G
Sbjct: 661 TEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIR 720
Query: 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGE 813
P+SL KFGE EKCL D G +RP+MG+VLW+LEY LQL EA + D S+ +GE
Sbjct: 721 PDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDPED----STNMIGE 776
Query: 814 FAER 817
R
Sbjct: 777 LPLR 780
|
|
| TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1525 (541.9 bits), Expect = 1.8e-156, P = 1.8e-156
Identities = 351/824 (42%), Positives = 474/824 (57%)
Query: 3 RVLLFLVIMLVVAR--IGEAQ---SKSFLINCGTNSS--VNVDGRKWVGDLASNNNVTLS 55
R+ L L+++L+ A I A ++ L+NCG +S + D R W+ D+ S S
Sbjct: 9 RLSLLLLLLLISAATLISAADYSPTEKILLNCGGGASNLTDTDNRIWISDVKSK--FLSS 66
Query: 56 SSGIAATTDSLSGD-SIYEPLYKTARVFADGLNYTFEIIAGNYIVRLHFCPFPFEDYNVN 114
SS + T+ +L+ D S+ E Y TARVF YTF + +G VRL+F P ++ N
Sbjct: 67 SSEDSKTSPALTQDPSVPEVPYMTARVFRSPFTYTFPVASGRKFVRLYFYPNSYDGLNAT 126
Query: 115 KSSFGVVANGLKLLSEFSAPGEISHRNLYLQXXXXXXXXXXLVKEYFLGVDLDKLMIEFI 174
S F V LL FSA + + Y ++KE+ + V+ L + F
Sbjct: 127 NSLFSVSFGPYTLLKNFSA-SQTAEALTY----------AFIIKEFVVNVEGGTLNMTFT 175
Query: 175 PSKG---SFGFINAIEIVPVVDKLFAD--TINKVGGN-DVNFNLSGRGVETMYRLNVGGP 228
P ++ F+N IE+ + D + T+ VG + V + S +E +YRLNVGG
Sbjct: 176 PESAPSNAYAFVNGIEVTSMPDMYSSTDGTLTMVGSSGSVTIDNS-TALENVYRLNVGGN 234
Query: 229 EIKPSRDPDLWRMWEADSSYMITANAGSEIRNSSNIT--YASTNDSSVAPLLVYETARTM 286
+I PS D L+R W D Y+ A G N+T Y + + VAP+ VY TAR+M
Sbjct: 235 DISPSADTGLYRSWYDDQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSM 294
Query: 287 SNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYE--KANQRIFRIYINNRTAENNFDI 344
T + +N++W F +D F Y VRLHFCE+ K NQR+F IY+NN+TAE D+
Sbjct: 295 GPTAQINLNYNLTWIFSIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADV 354
Query: 345 FVQAGGKNRGYHRDYF--DAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFS-QNG 401
+H+DY + + LW+ L P+ D+LLNG+EIFK + +G
Sbjct: 355 IAWTSSNGVPFHKDYVVNPPEGNGQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDG 414
Query: 402 NLASVERFDS---SGNP---VGHSNKWILXXXXXXXXXXXXXXXXXXXXXXCYCKNWRE- 454
NLA + +P + + + C +R
Sbjct: 415 NLAGTNPIPGPQVTADPSKVLRPTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRR 474
Query: 455 KSSD--PKNNSP-GWWPLFFHRGTLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVA 511
K D P +++ GW PL + G +S +AK + T S+ + + F+ AEI+ A
Sbjct: 475 KRGDYQPASDATSGWLPLSLY-GNSHSAGSAKTNTTGSYASSLP-SNLCRHFSFAEIKAA 532
Query: 512 TNNFDES-LMXXXXXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH 570
T NFDES ++ T AIKR NP SEQG+ EF+TEIEMLSKLRHRH
Sbjct: 533 TKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRH 592
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
LVSLIG+C+E EMILVY+YMA+GT+R HL+ + P L WKQRL+ CIGAARGLHYLHTG
Sbjct: 593 LVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTG 652
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
A+ IIHRDVKTTNILLDE +VAK+SDFGLSKTGP+++HTHVST VKGSFGYLDPEYF R
Sbjct: 653 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 712
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
QQLTEKSDVYSFGVVLFE +CAR +NPTL K+Q++LA+WA K+ L I+DP+LKG
Sbjct: 713 QQLTEKSDVYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKG 772
Query: 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794
+PE +KF E A KC+ D+G RP+MG+VLW+LE+ LQL E+
Sbjct: 773 KITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQES 816
|
|
| TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1481 (526.4 bits), Expect = 8.5e-152, P = 8.5e-152
Identities = 350/830 (42%), Positives = 472/830 (56%)
Query: 3 RVLLFLVIM-LVVARIGEAQSKSFLINCGTN-SSVNVDGRKWVGDLASNNNVTLSSSGIA 60
R+L FL + ++ + + ++CGT+ +S + D +KW D + + I
Sbjct: 6 RILFFLTCLSFLLVFPTRSNGQDLALSCGTSEASADQDKKKWEPD----TKFLKTGNSIH 61
Query: 61 ATTDSLSGDSIYEPLYKTARVFADGLNYTFEIIAGN-YIVRLHFCPFPFEDYNVNKSSFG 119
AT + Y TAR+F Y I +++RL+F P + N++ S F
Sbjct: 62 ATATYQDPSLLSTVPYMTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFT 121
Query: 120 VVANGLKLLSEFSAPGEISHRNLYLQXXXXXXXXXXLVKEYFLG-VDLDKLMIEFIPS-- 176
V AN + LLS FSA I+ + L LVKEY L D D L I+F PS
Sbjct: 122 VEANDVTLLSNFSAA--ITCQAL---------TQAYLVKEYSLAPTDKDVLSIKFTPSDK 170
Query: 177 -KGSFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSRD 235
+ +F FIN IE++ + + LF DT VG D + +++M+RLNVGG +I S+D
Sbjct: 171 YRDAFAFINGIEVIQMPE-LF-DTAALVGFTDQTMDAKTANLQSMFRLNVGGQDIPGSQD 228
Query: 236 PD-LWRMWEADSSYMITANAGSEIRNSSNITYASTN-DSSVAPLLVYETARTMSNTEVLE 293
L R W D+ Y+ +A G ++ S+N N S+AP +Y+TAR+ +
Sbjct: 229 SGGLTRTWYNDAPYIFSAGLGVTLQASNNFRINYQNMPVSIAPADIYKTARSQGPNGDIN 288
Query: 294 KRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNF---DIFVQAGG 350
+ N++W F++D NF Y +RLHFCE K NQ++F IYINNRTA+ + DI G
Sbjct: 289 LKSNLTWMFQIDKNFTYILRLHFCEFQLSKINQKVFNIYINNRTAQADTTPADIIGWTGE 348
Query: 351 KNRGYHRDYFDAVSSKI--ETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLASVER 408
K ++DY V + E + +Q+ P T D+ LNGLEIFK NLA
Sbjct: 349 KGIPMYKDYAIYVDANNGGEEITLQMTPSTFGQPEYYDSSLNGLEIFKMDTMKNLAGPNP 408
Query: 409 FDSSGNPVGHSNKWILXXXXXXXXXXXXXXXXXXXXXXCYCKNWREKSSDPKNNS--PGW 466
S K +++K +S W
Sbjct: 409 EPSPMQAEEEVKKEFKNEKRHAFIIGSAGGVLAVLIGALCFTAYKKKQGYQGGDSHTSSW 468
Query: 467 WPLFFHRGT--LNSTANAKGSGTQYLKGSVA-LTRAGKRFTLAEIRVATNNFDESLMXXX 523
P++ + T ST + K + +L A L R RF+L EI+ T NFD+S +
Sbjct: 469 LPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCR---RFSLPEIKHGTQNFDDSNVIGV 525
Query: 524 XXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583
T A+K++NP SEQGL EFETEIE+LS+LRH+HLVSLIG+CDE E
Sbjct: 526 GGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGE 585
Query: 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTT 643
M LVY+YMA GTLR HL+ + P LTWK+RL+ IGAARGLHYLHTGA+ IIHRDVKTT
Sbjct: 586 MCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTT 645
Query: 644 NILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFG 703
NIL+DEN+VAK+SDFGLSKTGP+M HV+T VKGSFGYLDPEYF RQQLTEKSDVYSFG
Sbjct: 646 NILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 705
Query: 704 VVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEI 763
VVLFE++CAR +NP+LPK+Q++L DWAM +++ +L+ IIDP+LKG + E L+KF +
Sbjct: 706 VVLFEILCARPALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADT 765
Query: 764 AEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQ-NSFSSSQALG 812
AEKCL+D G RPTMG+VLW+LE+ LQL E T R N+ SS+ LG
Sbjct: 766 AEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTPNNGGSSEDLG 815
|
|
| TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1478 (525.3 bits), Expect = 1.8e-151, P = 1.8e-151
Identities = 354/815 (43%), Positives = 469/815 (57%)
Query: 3 RVLLFLVIMLVVARIGEAQS--KSFLINCGTNS-SVNVDGRKWVGDLASNNNVTLSSSGI 59
R+L + V + +QS + ++CG + +V+ D +KW D T ++
Sbjct: 6 RILFSFLCFFYVLLVSPSQSNGQDISLSCGASEPAVDQDKKKWEPDTKFLK--TPNTVHA 63
Query: 60 AATTDSLSGDSIYEPLYKTARVFADGLNYTFEIIAGN-YIVRLHFCPFPFEDYNVNKSSF 118
AT S S P Y T+R+F Y + +++RLHF P + N+ S F
Sbjct: 64 PATYQDPSLLSTV-P-YMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILDSYF 121
Query: 119 GVVANGLKLLSEFSAPGEISHRNLYLQXXXXXXXXXXLVKEYFLGV-DLDKLMIEFIPSK 177
V AN L LLS FSA I+ + L LV+EY L + D L I F PS
Sbjct: 122 SVAANDLTLLSNFSAA--ITCQAL---------TQAYLVREYSLAPSEKDVLSIIFTPSD 170
Query: 178 G---SFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKPSR 234
+F FIN IE++P+ + LF DT + VG +D + ++TM+RLNVGG +I S+
Sbjct: 171 KHPKAFAFINGIEVIPMPE-LF-DTASLVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQ 228
Query: 235 DPD-LWRMWEADSSYMITANAGSEIRNSSN--ITYASTNDSSVAPLLVYETARTMSNTEV 291
D L R W D+ Y+ +A G ++ S+N I Y S AP VY+TAR+
Sbjct: 229 DSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDYQKM-PVSTAPADVYKTARSQGPNGD 287
Query: 292 LEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAE---NNFDIFVQA 348
+ + N++W F+VD NF Y +RLHFCE K NQ++F I+INNRTA+ N DI
Sbjct: 288 INMKSNLTWMFQVDTNFTYIMRLHFCEFQLAKINQKVFNIFINNRTAQGDTNPADILGWT 347
Query: 349 GGKNRGYHRDYFDAVSSKI----ETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQNGNLA 404
GGK ++DY V + E + +Q+ P T D+ LNGLEIFK NLA
Sbjct: 348 GGKGIPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKIDTMKNLA 407
Query: 405 SVERFDSSGNPVGHSNKWILXXXXXXXXXXXXXXXXXXXX--XXCYCKNWRE-KSSDPKN 461
S K C+ R+ K S +
Sbjct: 408 GPNPKPSPMQANEDVKKDFQGDKRITAFVIGSAGGVAAVLFCALCFTMYQRKRKFSGSDS 467
Query: 462 NSPGWWPLF--FHRGTLNSTANAKGSGTQYLKGSVA-LTRAGKRFTLAEIRVATNNFDES 518
++ W P++ H ST + K + +L A L R RF+L+EI+ T+NFDES
Sbjct: 468 HTSSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCR---RFSLSEIKHGTHNFDES 524
Query: 519 LMXXXXXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+ T AIK++NP SEQGL EFETEIE+LS+LRH+HLVSLIG+C
Sbjct: 525 NVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYC 584
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
DE EM L+Y+YM+ GTLR HL+ + P LTWK+RL+ IGAARGLHYLHTGA+ IIHR
Sbjct: 585 DEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHR 644
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
DVKTTNILLDEN+VAK+SDFGLSKTGP+M HV+T VKGSFGYLDPEYF RQQLTEKSD
Sbjct: 645 DVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSD 704
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLE 758
VYSFGVVLFEV+CAR +NP+L K+Q++L DWAM +++ +L+ IIDP+LKG +PE L+
Sbjct: 705 VYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLK 764
Query: 759 KFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
KF + AEKCL D G +RPTMG+VLW+LE+ LQL E
Sbjct: 765 KFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQE 799
|
|
| TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 7.1e-145, Sum P(3) = 7.1e-145
Identities = 186/335 (55%), Positives = 240/335 (71%)
Query: 466 WWPLFFHR--GTLNSTANAKGSGTQYLKGSV------ALTRAGKRFTLAEIRVATNNFDE 517
WW + R T +++G Q K + ++ G R+ LA I+ AT++FDE
Sbjct: 430 WWCIRKRRRRNRQMQTVHSRGDDHQIKKNETGESLIFSSSKIGYRYPLALIKEATDDFDE 489
Query: 518 SLMXXXXXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
SL+ D T A+KR PQS QGLAEF+TE+EML++ RHRHLVSLIG+
Sbjct: 490 SLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFRHRHLVSLIGY 549
Query: 578 CDEQNEMILVYEYMANGTLRSHLFG-SDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
CDE +EMI+VYEYM GTL+ HL+ D P L+W+QRL+ C+GAARGLHYLHTG+ R II
Sbjct: 550 CDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHYLHTGSTRAII 609
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
HRDVK+ NILLD+NF+AK++DFGLSKTGP ++ THVSTAVKGSFGYLDPEY RQQLTEK
Sbjct: 610 HRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVSTAVKGSFGYLDPEYLTRQQLTEK 669
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756
SDVYSFGVV+ EVVC R VI+P+LP++++NL +WAMK K+ L+ IIDP L G E
Sbjct: 670 SDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKKGKLEDIIDPFLVGKVKLEE 729
Query: 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791
++K+ E+ EKCL G RP MG++LW+LE++LQ+
Sbjct: 730 VKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQV 764
|
|
| TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1408 (500.7 bits), Expect = 4.6e-144, P = 4.6e-144
Identities = 308/694 (44%), Positives = 408/694 (58%)
Query: 158 KEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGV 217
KEY L + + + F P KGS FIN IE+V D+L +D + + LS
Sbjct: 177 KEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLFPVNGFSGLSDYAY 236
Query: 218 ETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIR-NSSNITYASTNDSSVAP 276
+++YR+NVGGP I P D L R W D Y+ N +++ N + I Y +AP
Sbjct: 237 QSVYRVNVGGPLITPQNDT-LGRTWTPDKEYLKDENLAKDVKTNPTAIIYPPGVTPLIAP 295
Query: 277 LLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNR 336
VY T M++++ ++ FN++W F +P+F YF+RLHFC+++ + N F +YIN +
Sbjct: 296 QTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDLYFNVYINGK 355
Query: 337 TAENNFDIFVQAGGKNRGYHRDYFDAVSSKIET--LWIQLGPDTAVGAAGTDALLNGLEI 394
TA + D+ AG + Y++D V+S + T L +Q+GP +A+LNG+E+
Sbjct: 356 TAISGLDLSTVAGDLSAPYYKDI--VVNSTLMTSELQVQIGP-MGEDTGKKNAILNGVEV 412
Query: 395 FKFSQNGNLASVERFDSSGNPVGHSNKWILXXXXXXXXXXXXXXXXXXXXXXCYCKNWRE 454
K S + N E F G + ++ Y W++
Sbjct: 413 LKMSNSVNSLDGE-FGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMV----Y--KWKK 465
Query: 455 KSSD-PKNNSPGWWPLFFHRGTLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATN 513
+ D K NS W L H G + GS L S AL G+ F+L+E++ T
Sbjct: 466 RPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNS-ALG-LGRYFSLSELQEVTK 523
Query: 514 NFDESLMXXXXXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
NFD S + D T AIKR NPQSEQG+ EF TEI+MLSKLRHRHLVS
Sbjct: 524 NFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVS 583
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
LIG+CDE EMILVYEYM+NG R HL+G +L PLTWKQRL+ CIGAARGLHYLHTG +
Sbjct: 584 LIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQ 643
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
GIIHRDVK+TNILLDE VAK++DFGLSK + HVSTAVKGSFGYLDPEYF RQQL
Sbjct: 644 GIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQL 702
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753
T+KSDVYSFGVVL E +CAR INP LP++Q+NLA+WAM W+++ L+ IIDPHL G +
Sbjct: 703 TDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVN 762
Query: 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGE 813
PES++KF E AEKCL D G +RPTMG+VLW+LEY LQL EA+ + + + +
Sbjct: 763 PESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQGKAEAEEVETPKPV-- 820
Query: 814 FAEREAEDGQDAPTTDAENCLGLKMTGEVESATM 847
A A A TT A + + T E + +T+
Sbjct: 821 -AVPAAAPTSPAATTAAASERPVSQTEEKDDSTV 853
|
|
| TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1406 (500.0 bits), Expect = 7.5e-144, P = 7.5e-144
Identities = 298/654 (45%), Positives = 403/654 (61%)
Query: 158 KEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVVDKLFADTINKVGGNDVNFN-LSGRG 216
KEY + + + + F P K S FINAIE+V D+L +D+ + + F+ LS
Sbjct: 178 KEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPV-IGFSGLSDYA 236
Query: 217 VETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIRNS-SNITYASTNDSSVA 275
+++YR+NVGGP I P D L R W D ++ N +++ + S I Y +A
Sbjct: 237 YQSVYRVNVGGPLIMPQNDT-LGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPEVTPLIA 295
Query: 276 PLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINN 335
P VY TA M+N+ ++ FN+SW F +P+F+Y +RLHFC++V + N F +YIN
Sbjct: 296 PQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFNVYING 355
Query: 336 RTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLGPDTAVGA-AGT-DALLNGLE 393
+TA + D+ AG Y++D + L +Q+GP +G GT +A+LNG+E
Sbjct: 356 KTAISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQIGP---MGEDTGTKNAILNGVE 412
Query: 394 IFKFSQNGNLASVERFDSSGNPVGHSNKWILXXXXXXXXXXXXXXXXXXXXXXCYCKNWR 453
+ K S + N E F G G ++ Y W+
Sbjct: 413 VLKMSNSVNSLDGE-FGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMV----Y--KWK 465
Query: 454 EKSSD-PKNNSPGWWPLFFHRGTLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVAT 512
++ D K NS W L H G +ST G+Q + G+ F+L+E++ AT
Sbjct: 466 KRPQDWQKRNSFSSWLLPIHAG--DSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEAT 523
Query: 513 NNFDESLMXXXXXXXXXXXXXXXDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV 572
NF+ S + D T A+KR NPQSEQG+ EF+TEI+MLSKLRHRHLV
Sbjct: 524 KNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 583
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
SLIG+CDE +EMILVYE+M+NG R HL+G +L PLTWKQRL+ CIG+ARGLHYLHTG
Sbjct: 584 SLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTA 643
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
+GIIHRDVK+TNILLDE VAK++DFGLSK + HVSTAVKGSFGYLDPEYF RQQ
Sbjct: 644 QGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQ 702
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
LT+KSDVYSFGVVL E +CAR INP LP++Q+NLA+WAM+W+++ L+ IIDPHL G
Sbjct: 703 LTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTI 762
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWM--RTDDRQNS 804
+PES++KF E AEKCL+D G +RPTMG+VLW+LEY LQL EA+ + ++ +N+
Sbjct: 763 NPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETENA 816
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9SA72 | Y1357_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6822 | 0.9682 | 0.9705 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00029752001 | SubName- Full=Chromosome chr10 scaffold_50, whole genome shotgun sequence; (850 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 851 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 7e-63 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-29 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-29 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-16 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-11 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 8e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 7e-63
Identities = 99/382 (25%), Positives = 148/382 (38%), Gaps = 60/382 (15%)
Query: 27 INCGTNSSVNV----DGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEPLYKTARVF 82
I+CG S+ + G WV D +G + + S YKT R F
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSD------AGFIDTGKSGNISKENSSSFLSKPYKTLRSF 54
Query: 83 ADG--LNYTFEIIAG---NYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEI 137
DG YT + G Y++R F ++ N S L + +
Sbjct: 55 PDGKRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSF-----DLYLGVNLWTTV 109
Query: 138 SHRNLYLQSSGGNSSSISLVKEYFLGV-DLDKLMIEFIPSKGSFGFINAIEIVPVVDKLF 196
+ N S S+VKEY + V D L + + + FI+A+E+ P+ D L+
Sbjct: 110 NLSN---------DSGDSVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLY 160
Query: 197 ADTINKVGGNDVNFNLSGRGVETMYRLNVG--GPEIKPSRDPDLWRMWEADSSYMITANA 254
+ + ++ + RLN G I+ D R+WE S +
Sbjct: 161 PSS------------GGSQALKLVARLNFGGSEGTIRYPDDV-YDRIWEPFFS----SPG 203
Query: 255 GSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRL 314
S+I S ++ +S N + P V +TA T +N N +W VDPNF+Y+V L
Sbjct: 204 WSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNA---SAPLNFTWDL-VDPNFEYYVYL 259
Query: 315 HFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQL 374
HF E+ + R F IYIN +T + G + D+ VS I L
Sbjct: 260 HFAEI--QSLETREFDIYINGKTVYGDVSPKY-LGTDTGALYLDFPVNVSGGGLL-NISL 315
Query: 375 GPDTAVGAAGTDALLNGLEIFK 396
P + LLN LEIFK
Sbjct: 316 VP---TSGSTLPPLLNALEIFK 334
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 521 IGVGGFGKVFKGEIED----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG+V+KG+++ T A+K SE+ +F E ++ KL H ++V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL-------FGSDLPPLTWKQRLDACIGAARGLHYLH 628
G C E+ + LV EYM G L +L + L+ K L I A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+ +HRD+ N L+ E+ V K+SDFGLS+ ++ T K ++ PE
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH- 747
T KSDV+SFGV+L+E+ A P L +++ L+ + +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--------------LEYLRKGYR 225
Query: 748 -LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
K Y P+ L E+ C + ++RPT E++ LE
Sbjct: 226 LPKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 4e-50
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 37/278 (13%)
Query: 520 MIGVGGFGKVFKGEIEDC-----TLAAIKRA-NPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG+V+KG ++ A+K SEQ + EF E ++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L+G C E+ +++V EYM G L +L + L+ L + ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA---VKGSFGYLDPEYFWR 690
IHRD+ N L+ EN V K+SDFGLS+ ++ V ++ ++ PE
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKE 178
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTL---PKDQINLADWAMKWQKQRSLKSIIDPH 747
+ T KSDV+SFGV+L+E+ TL P ++ A+ +++ K+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIF--------TLGEEPYPGMSNAE-VLEYLKKGYRLPKPP-- 227
Query: 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785
P L K + +C ++ ++RPT E++ L
Sbjct: 228 ----NCPPELYK---LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 80/278 (28%), Positives = 131/278 (47%), Gaps = 38/278 (13%)
Query: 520 MIGVGGFGKVFKGEIEDC-----TLAAIKRA-NPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG+V+KG+++ A+K SEQ + EF E ++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L+G C E+ + +V EYM G L S+L + P L+ L + ARG+ YL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLE---SK 121
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA---VKGSFGYLDPEYFWR 690
IHRD+ N L+ EN V K+SDFGLS+ ++ ++ ++ PE
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKE 177
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTL---PKDQINLADWAMKWQKQRSLKSIIDPH 747
+ T KSDV+SFGV+L+E+ TL P ++ + +++ K
Sbjct: 178 GKFTSKSDVWSFGVLLWEIF--------TLGEQPYPGMSNEE-VLEYLKNGYRLPQPP-- 226
Query: 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785
P L + +C ++ ++RPT E++ L
Sbjct: 227 ----NCPPELYD---LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 8e-49
Identities = 70/200 (35%), Positives = 103/200 (51%), Gaps = 10/200 (5%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGFC 578
+G GGFG V+ + AIK + L E EIE+L KL H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
+++N + LV EY G+L+ L + L+ + L + GL YLH GIIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 639 DVKTTNILLDE-NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ-LTEK 696
D+K NILLD N K++DFGLSK + + G+ Y+ PE + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 697 SDVYSFGVVLFEVVCARAVI 716
SD++S GV+L+E+ + +I
Sbjct: 175 SDIWSLGVILYELPELKDLI 194
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 66/197 (33%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 521 IGVGGFGKVFKGEI-----EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FG+V+KG + T A+K SE+ EF E ++ KL H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+G C + + +V EYM G L L LT K L + A+G+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
+HRD+ N L+ EN V K+SDFGLS+ ++ K ++ PE + T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 695 EKSDVYSFGVVLFEVVC 711
KSDV+SFGV+L+E+
Sbjct: 183 SKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 87/270 (32%), Positives = 134/270 (49%), Gaps = 25/270 (9%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G FG V+K + A+K +SE + EI +L +L H ++V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
++++ + LV EY G L +L S PL+ + + RGL YLH GIIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIH 121
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE-YFWRQQLTEK 696
RD+K NILLDEN V K++DFGL+K ++ + T G+ Y+ PE K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756
DV+S GV+L+E++ + P N+ D Q Q ++ I+ P L+ + S
Sbjct: 180 VDVWSLGVILYELLTGK------PPFSGENILD-----QLQL-IRRILGPPLEFDEPKWS 227
Query: 757 L--EKFGEIAEKCLDDEGKNRPTMGEVLWH 784
E+ ++ +KCL+ + RPT E+L H
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 2e-42
Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 27/268 (10%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGFC 578
+G G FGKV+ + + L AIK + + E EI++L KL+H ++V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLT--WKQRLDACIGAARGLHYLHTGAERGII 636
++++++ LV EY G L L L+ + I L YLH +GI+
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQI--LSALEYLH---SKGIV 119
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
HRD+K NILLDE+ K++DFGL++ ++ T G+ Y+ PE + +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756
D++S GV+L+E++ + P P D ++K K P + SPE+
Sbjct: 177 VDIWSLGVILYELLTGK----PPFPGDD----QLLELFKKIGKPKPPFPPPEW-DISPEA 227
Query: 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
++ K L + + R T E L H
Sbjct: 228 K----DLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 80/272 (29%), Positives = 132/272 (48%), Gaps = 28/272 (10%)
Query: 520 MIGVGGFGKVFKGEIEDC-TLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
++G G FG V+ +D L A+K SE+ L E EI +LS L+H ++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 577 FC-DEQNEMILVY-EYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
DE+ + ++ EY++ G+L S L FG P+ ++ I GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI--RKYTRQI--LEGLAYLH---S 119
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
GI+HRD+K NIL+D + V K++DFG +K +E + +V+G+ ++ PE ++
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
+D++S G + E+ + P ++ A+ + S P + +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKP------PWSELGNPMAALY----KIGSSGEPPEIPEHL 229
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
S E+ + F KCL + K RPT E+L H
Sbjct: 230 SEEAKD-F---LRKCLRRDPKKRPTADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G FGKV+ D L +K + SE+ + E+++L KL H +++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 577 FCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+E+ ++ +V EY G L + + P +Q LD + L YLH R
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT--HVSTAVKGSFGYLDPEYFWRQQ 692
I+HRD+K NI L N + K+ DFG+SK + T T V G+ YL PE +
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVV-GTPYYLSPELCQNKP 179
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
KSD++S G VL+E+ + P + NL + A+K LK P + Y
Sbjct: 180 YNYKSDIWSLGCVLYELCTLK------HPFEGENLLELALK-----ILKGQYPP-IPSQY 227
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
S E + L + + RP++ ++L
Sbjct: 228 SSE----LRNLVSSLLQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKR-ANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FGKVF GE D L A+K S +FE E E+L+ +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 574 LIGFCDEQNEMILVYEYMANGT----LRSH--------LFGSDLPPLTWKQRLDACIGAA 621
G C E + I+V+EYM +G LRSH S + LT Q L + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
G+ YL A + +HRD+ T N L+ + V K+ DFG+S+ + ++ V
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ PE ++ T +SDV+SFGVVL+E+
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 77/271 (28%), Positives = 123/271 (45%), Gaps = 22/271 (8%)
Query: 515 FDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
F+ IG GGFG+V+K AIK +S++ + EI++L K +H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
G +++E+ +V E+ + G+L+ L S LT Q C +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
GIIHRD+K NILL + K+ DFGLS + T + G+ ++ PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753
K+D++S G+ E+ A P + A+ + +P +S
Sbjct: 175 DYKADIWSLGITAIEL----AEGKPPYSELPPMK---ALFKIATNGPPGLRNPE---KWS 224
Query: 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
E F + +KCL + RPT ++L H
Sbjct: 225 DE----FKDFLKKCLQKNPEKRPTAEQLLKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 20/196 (10%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FG V+KG +E AIK+ + + E+ L EI++L L+H ++V IG
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 578 CDEQNEMILVYEYMANGTLRS-----HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+ + + ++ EY NG+LR F L + Q L +GL YLH E
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------QGLAYLH---E 117
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
+G+IHRD+K NIL ++ V K++DFG++ + +V G+ ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSG 175
Query: 693 LTEKSDVYSFGVVLFE 708
+ SD++S G + E
Sbjct: 176 ASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 37/272 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLA--AIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G FG V G+ +A +K + ++ LAE ++ LRH +LV L+G
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASV----MTTLRHPNLVQLLGVV 69
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
+ N + +V EYMA G+L +L +T Q+L + G+ YL E+ +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
D+ N+L+ E+ VAK+SDFGL+K S VK + PE ++ + KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEA-SQGQDSGKLPVK----WTAPEALREKKFSTKSD 181
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLE 758
V+SFG++L+E+ V P +P LK ++ PH++ Y E+ E
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIP------------------LKDVV-PHVEKGYRMEAPE 222
Query: 759 K----FGEIAEKCLDDEGKNRPTMGEVLWHLE 786
++ + C + + RPT ++ L
Sbjct: 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 7e-30
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 18/275 (6%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH-RHLVSLIGFC 578
+G G FG+V+ + L + + + + F EI++L+ L H ++V L F
Sbjct: 8 LGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67
Query: 579 DEQNEMILVYEYMANGTLRSHL-FGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
++ + LV EY+ G+L L PL+ + L L YLH +GIIH
Sbjct: 68 QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIH 124
Query: 638 RDVKTTNILLDEN-FVAKMSDFGLSK----TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
RD+K NILLD + V K+ DFGL+K G + + + G+ GY+ PE
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 693 L---TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
L + SD++S G+ L+E++ P + + +K + S+ P
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGL---PPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ + ++ +K L + KNR + L H
Sbjct: 242 -SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 6e-29
Identities = 71/210 (33%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FGKVF E +D L A+K SE +F+ E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 575 IGFCDEQNEMILVYEYMANGTL----RSHLFGSD-----------LPPLTWKQRLDACIG 619
G C E +++V+EYM +G L RSH G D LT Q L
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSH--GPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 620 AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS 679
A G+ YL A +HRD+ T N L+ + V K+ DFG+S+ S ++ V
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 680 FGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ PE ++ T +SD++SFGVVL+E+
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 38/286 (13%)
Query: 514 NFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQSEQG-LAEFETEIEMLSKL 566
N E +G G FG+VF + TL +K ++ +EF E++M KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 567 RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGS-------DLPPLTWKQRLDACIG 619
H+++V L+G C E ++ EY G L+ L + PPL+ KQ++ C
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 620 AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME-HTHVSTAVKG 678
A G+ +L +HRD+ N L+ K+S LSK + E + + +
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-- 180
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI--NLADWAMKWQK 736
+L PE + KSDV+SFGV+++EV + L +++ L ++
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
Query: 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
P L K + +C K+RP+ E++
Sbjct: 241 PEG-------------CPSRLYK---LMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 5/190 (2%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V++G ++ AIK +F+ E++ L +LRH+HL+SL C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ ++ E M G+L + L + L +D A G+ YL E+ IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
NIL+ E+ V K++DFGL++ E ++S+ K + + PE + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 701 SFGVVLFEVV 710
SFG++L+E+
Sbjct: 189 SFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FGKVF E +D L A+K S+ +F E E+L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 575 IGFCDEQNEMILVYEYMANGTL----RSH-----LFGSDLPP--LTWKQRLDACIGAARG 623
G C E + +I+V+EYM +G L R+H L P LT Q L A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
+ YL A + +HRD+ T N L+ EN + K+ DFG+S+ S ++ V ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEV 709
PE ++ T +SDV+S GVVL+E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 75/232 (32%), Positives = 114/232 (49%), Gaps = 37/232 (15%)
Query: 502 RFTLAEIRVATNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIK----RANPQSEQ 551
L+ +R F E L G G FGKV+KGE+ T AIK A P+ +Q
Sbjct: 1 EIPLSAVR-----FLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ 53
Query: 552 GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLF--------GS 603
EF E E++S L+H ++V L+G C ++ +++EY+A+G L L G+
Sbjct: 54 ---EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110
Query: 604 DLPPLTWKQRLDA------CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657
+ T K LD I A G+ YL + +HRD+ N L+ E K+SD
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISD 167
Query: 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
FGLS+ S ++ V + ++ PE + T +SD++SFGVVL+E+
Sbjct: 168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 520 MIGVGGFGKVFKGEIE---DCT--LAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FGKV + D T A+K N EQ ++FE EIE+L L H ++V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 574 LIGFCDEQ--NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
G C++ + L+ EY+ +G+LR +L + K+ L +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG--- 126
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS--FGYLDPEYFW 689
+ IHRD+ NIL++ + K+SDFGL+K P + + S F Y PE
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLR 185
Query: 690 RQQLTEKSDVYSFGVVLFE 708
+ + SDV+SFGV L+E
Sbjct: 186 TSKFSSASDVWSFGVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 36/271 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL-AEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G FG V+KG ++ T A+K L +F E E+L + H ++V LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
++ + +V E + G+L + L LT K+ L + AA G+ YL + + IHRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRD 118
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG----SFGYLDPEYFWRQQLTE 695
+ N L+ EN V K+SDFG+S+ E + T G + PE + T
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 696 KSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY--- 752
+SDV+S+G++L+E P Q++ + I + Y
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPG--------------MSNQQTRERI-----ESGYRMP 215
Query: 753 SPESL-EKFGEIAEKCLDDEGKNRPTMGEVL 782
+P+ E+ + +C + +NRP+ E+
Sbjct: 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/197 (34%), Positives = 97/197 (49%), Gaps = 22/197 (11%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAE--FETEIEMLSKLRHRHLVSLIGFC 578
+G G FG V G+ AIK E ++E F E +++ KL H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 579 DEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+Q + +V EYMANG L R G++ LD C + YL
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTE-------WLLDMCSDVCEAMEYLE---S 118
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
G IHRD+ N L+ E+ V K+SDFGL++ ++T S K + PE F +
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSR 177
Query: 693 LTEKSDVYSFGVVLFEV 709
+ KSDV+SFGV+++EV
Sbjct: 178 FSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 67/191 (35%), Positives = 102/191 (53%), Gaps = 10/191 (5%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G FG V+ G + AIK R SE+ +F E +++ KL H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
E++ + LV+E+M +G L +L + + + L C+ G+ YL +IHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHR 124
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
D+ N L+ EN V K+SDFG+++ ++T ST K + PE F + + KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 699 VYSFGVVLFEV 709
V+SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 521 IGVGGFGKVFKGEI----EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLI 575
IG G FG+V +G + + AIK S++ +F TE ++ + H +++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G + ++++ EYM NG+L L +D T Q + G A G+ YL +E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE 695
+HRD+ NIL++ N V K+SDFGLS+ E T+ + K + PE ++ T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187
Query: 696 KSDVYSFGVVLFEV 709
SDV+SFG+V++EV
Sbjct: 188 ASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
IG G FG+VF+ E T+ A+K + S A+F+ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--------------------FGSDLPPLTWKQR 613
L+G C M L++EYMA G L L G + PL+ ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673
L A G+ YL +ER +HRD+ T N L+ EN V K++DFGLS+ S ++ S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ PE + + T +SDV+++GVVL+E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 63/213 (29%), Positives = 113/213 (53%), Gaps = 25/213 (11%)
Query: 520 MIGVGGFGKVFKGEI-------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHL 571
+G G FG+V K E E T+A + +E+ L++ +E+EM+ + +H+++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHL-----------FGSDLPP---LTWKQRLDAC 617
++L+G C ++ + +V EY A+G LR L PP LT K +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
ARG+ +L A + IHRD+ N+L+ E+ V K++DFGL++ +++ +T +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
++ PE + + T +SDV+SFGV+L+E+
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 521 IGVGGFGKVFKGE------IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FGKVF E +D L A+K + +F+ E E+L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 575 IGFCDEQNEMILVYEYMANGTL----RSH----LFGSDLPPLTWK------QRLDACIGA 620
G C + + +I+V+EYM +G L R+H + D P K Q L
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
A G+ YL A + +HRD+ T N L+ N + K+ DFG+S+ S ++ V
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ PE ++ T +SDV+SFGV+L+E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/190 (35%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T A+K P + F E +++ KLRH LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ + +V EYM+ G+L L + L Q +D A G+ YL R IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
NIL+ EN V K++DFGL++ E+T K + PE + T KSDV+
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 701 SFGVVLFEVV 710
SFG++L E+V
Sbjct: 189 SFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 28/270 (10%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V++G + T A+K P + +F E +++ KLRH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ + +V E M G+L +L G L Q +D A G+ YL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
N+L+ EN + K++DFGL++ + K + PE + + KSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 701 SFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY---SPESL 757
SFG++L E+V + P + ++ Q+ + Y P
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTNAEV--------LQQ-----------VDQGYRMPCPPGC 229
Query: 758 EK-FGEIAEKCLDDEGKNRPTMGEVLWHLE 786
K +I C ++ +RPT + W LE
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 67/196 (34%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSL-I 575
IG G FGKV + D + A+K N Q + + E +L +L H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQ-RL-DACIGAARGLHYLHTGAER 633
F DE+N M LV + + G LR HL S + +Q + I A L YLH +
Sbjct: 68 SFQDEEN-MYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEYLH---SK 119
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV-STAVKGSFGYLDPEYFWRQQ 692
GIIHRD+K NILLDE ++DF ++ + +T+ G+ GY+ PE RQ
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIA----TKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 693 LTEKSDVYSFGVVLFE 708
+ D +S GV +E
Sbjct: 176 YSVAVDWWSLGVTAYE 191
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 61/229 (26%), Positives = 118/229 (51%), Gaps = 27/229 (11%)
Query: 521 IGVGGFGKVFKGEI---------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V E E T+A + +E+ L++ +E+EM+ + +H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLP--------------PLTWKQRLDA 616
+++L+G C + + ++ EY + G LR +L P +T+K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL A + IHRD+ N+L+ EN V K++DFGL++ ++++ +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725
+ ++ PE + + T +SDV+SFGV+++E+ P +P +++
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 81/264 (30%), Positives = 122/264 (46%), Gaps = 25/264 (9%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G FG V G+ AIK + SE EF E +++ KL H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
+Q + +V EYM+NG L ++L Q L+ C G+ YL + + IHR
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
D+ N L+D+ K+SDFGLS+ E+T S K + PE + + KSD
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLE 758
V++FGV+++EV +P ++ N ++ K + L PHL E
Sbjct: 184 VWAFGVLMWEVYSL-----GKMPYERFNNSETVEKVSQGLRLYR---PHLAS-------E 228
Query: 759 KFGEIAEKCLDDEGKNRPTMGEVL 782
K I C ++ + RPT ++L
Sbjct: 229 KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 52/283 (18%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKR-----ANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG V++G ++D A+K ++ + + E EI +LSKL+H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLT---WKQRLDACIGAARGLHYLH 628
+G E++ + + E + G+L L +GS P+ +Q L GL YLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH 119
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST-----AVKGSFGYL 683
+R +HRD+K NIL+D N V K++DFG++K V + KGS ++
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWM 168
Query: 684 DPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742
PE +Q +D++S G + E+ + P Q+ K + + L
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKP------PWSQLEGVAAVFKIGRSKELPP 222
Query: 743 IIDPHLKGNYSPESLEKFG-EIAEKCLDDEGKNRPTMGEVLWH 784
I P+ L + KCL + RPT E+L H
Sbjct: 223 I----------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 53/284 (18%)
Query: 521 IGVGGFGKVFK-GEIEDCTLAAIK-----RANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
IG G FG V K D + K + +Q L +E+ +L +L+H ++V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVRY 64
Query: 575 IG-FCDEQNEMI-LVYEYMANGTL-----RSHLFGSDLP-PLTWK---QRLDACIGAARG 623
D N+ + +V EY G L + + W+ Q L A
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA------- 117
Query: 624 LHYLHTGAERG--IIHRDVKTTNILLDENFVAKMSDFGLSK---TGPSMEHTHVSTAVKG 678
L+ H ++ G ++HRD+K NI LD N K+ DFGL+K S T+V T
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY-- 175
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
Y+ PE EKSD++S G +++E +CA + P ++Q+ L
Sbjct: 176 ---YMSPEQLNHMSYDEKSDIWSLGCLIYE-LCALS--PPFTARNQLQL---------AS 220
Query: 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
+K + YS E E+ + L+ + RP+ E+L
Sbjct: 221 KIKEGKFRRIPYRYSSE----LNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 35/282 (12%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSL 574
+IG G FG V+ G + D A+K N ++ + + +F E ++ H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 575 IGFC-DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+G C + ++V YM +G LR+ + P T K + + A+G+ YL A +
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---ASK 117
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME------HTHVSTAVKGSFGYLDPEY 687
+HRD+ N +LDE+F K++DFGL++ E HT VK ++ E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALES 173
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747
Q+ T KSDV+SFGV+L+E++ A P ++ D + + R L
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRL------- 221
Query: 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789
L+ Y P+ L E+ C + + RPT E++ +E +
Sbjct: 222 LQPEYCPDPLY---EVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 76/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G G V+K + A+K+ + E+ + E++ L ++V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIG--AARGLHYLHTGAERGII 636
++ E+ +V EYM G+L L + + A I +GL YLHT +R II
Sbjct: 69 YKEGEISIVLEYMDGGSLAD-LLKKVGK---IPEPVLAYIARQILKGLDYLHT--KRHII 122
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSK---TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
HRD+K +N+L++ K++DFG+SK +T V T Y+ PE +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT-----YMSPERIQGESY 177
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---PHL-K 749
+ +D++S G+ L E CA P LP Q + + + +++I D P L
Sbjct: 178 SYAADIWSLGLTLLE--CALGK-FPFLPPGQPSF--FEL-------MQAICDGPPPSLPA 225
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+SPE F + CL + K RP+ E+L H
Sbjct: 226 EEFSPE----FRDFISACLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 82/258 (31%), Positives = 121/258 (46%), Gaps = 23/258 (8%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T AIK P + A F E +++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRD 639
+ + +V EYM+ G+L L G L Q +D A G+ Y+ ER +HRD
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV----ERMNYVHRD 127
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDV 699
++ NIL+ EN V K++DFGL++ E+T K + PE + T KSDV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 700 YSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEK 759
+SFG++L E+ V P + ++ D Q +R + P PESL
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREV--LD-----QVERGYRMPCPPE-----CPESLH- 233
Query: 760 FGEIAEKCLDDEGKNRPT 777
++ +C E + RPT
Sbjct: 234 --DLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 41/284 (14%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRAN-PQSEQG---------LAEFETEIEMLSKLRH 568
+IG G +G+V+ + + A+K+ P + G + +EIE L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARG 623
++V +GF + + + EY+ G++ S L F L +Q L G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-------EG 120
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
L YLH+ +GI+HRD+K N+L+D + + K+SDFG+SK + + +++GS ++
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 684 DPE--YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM-KWQKQRSL 740
PE + + Q + K D++S G V+ E+ R P ++ I AM K +RS
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEEAIA----AMFKLGNKRS- 229
Query: 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
I P + N SP +L+ C NRPT E+L H
Sbjct: 230 APPIPPDVSMNLSPVALDFLNA----CFTINPDNRPTARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 84/267 (31%), Positives = 124/267 (46%), Gaps = 23/267 (8%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T AIK P + A F E +++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRD 639
+ + +V E+M G+L L D L Q +D A G+ Y+ ER IHRD
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI----ERMNYIHRD 127
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDV 699
++ NIL+ +N V K++DFGL++ E+T K + PE + T KSDV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 700 YSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEK 759
+SFG++L E+V V P + ++ Q +R + P +G PESL
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREV-------LEQVERGYRM---PCPQG--CPESLH- 233
Query: 760 FGEIAEKCLDDEGKNRPTMGEVLWHLE 786
E+ + C + RPT + LE
Sbjct: 234 --ELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 34/270 (12%)
Query: 521 IGVGGFGK-VFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIG- 576
+G G FG+ ED +L K N SE+ + EI +LS L+H ++++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
F D+ +I + EY GTL + + L + Y+H + GI+
Sbjct: 68 FMDDNTLLIEM-EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
HRD+KT NI L + + K+ DFG+SK S E++ T V G+ Y+ PE + K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVV-GTPYYMSPELCQGVKYNFK 181
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPE- 755
SD+++ G VL+E++ + + T + +NL + +GNY+P
Sbjct: 182 SDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIV----------------QGNYTPVV 222
Query: 756 ---SLEKFGEIAEKCLDDEGKNRPTMGEVL 782
S E + L + + RPT EVL
Sbjct: 223 SVYSSE-LISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-22
Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 520 MIGVGGFGKVFKGEIE----DCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSL 574
+IG G FG+VF+G ++ AIK P +E+ +F +E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
G + +++ EYM NG L +L D + Q + G A G+ YL ++
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
+HRD+ NIL++ N K+SDFGLS+ E T+ ++ K + PE ++
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 694 TEKSDVYSFGVVLFEVV 710
T SDV+SFG+V++EV+
Sbjct: 188 TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 23/264 (8%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLA-EFETEIEMLSKLRHRHLVSLIGFC 578
++G G FG+VFKG ++D T A+K Q L +F +E +L + H ++V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
++ + +V E + G S L L KQ + + AA G+ YL + + IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG-SFGYLDPEYFWRQQLTEKS 697
D+ N L+ EN V K+SDFG+S+ + + S+ +K + PE + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 698 DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757
DV+S+G++L+E P + Q + Q ++ + P+ +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRMSCPQK-----CPDDV 223
Query: 758 EKFGEIAEKCLDDEGKNRPTMGEV 781
K + ++C D + +NRP E+
Sbjct: 224 YK---VMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 43/275 (15%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G +G V+K E + AIK E+ L E EI +L + ++V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD----ACI--GAARGLHYLHTGAER 633
+ ++ +V EY G++ SD+ +T K L A I +GL YLH+
Sbjct: 69 KNTDLWIVMEYCGAGSV------SDIMKITNK-TLTEEEIAAILYQTLKGLEYLHS---N 118
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST-AVKGSFGYLDPEYFWRQQ 692
IHRD+K NILL+E AK++DFG+S + T V G+ ++ PE
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG---QLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 693 LTEKSDVYSFGVV---LFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
K+D++S G+ + E + I+P A+ + ++ DP
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMR----------AIFMIPNKPPPTLSDPE-- 223
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+SPE F + +KCL + + RP+ ++L H
Sbjct: 224 -KWSPE----FNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG-FCD 579
IG G FG V G+ +A N + Q F E ++++LRH +LV L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
E+ + +V EYMA G+L +L L L + + YL +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDV 699
+ N+L+ E+ VAK+SDFGL+K S + T K + PE ++ + KSDV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDV 182
Query: 700 YSFGVVLFEVVCARAVINPTLP 721
+SFG++L+E+ V P +P
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 68/193 (35%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFE---TEIEMLSKLRHRHLVSLI- 575
+G G FGKV +D L A+K + E E TE +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
F E+ + LV EY G L SHL + A I A L YLH GI
Sbjct: 61 AFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA--LEYLH---SLGI 114
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE 695
I+RD+K NILLD + K++DFGL+K S E + +T G+ YL PE + +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 696 KSDVYSFGVVLFE 708
D +S GV+L+E
Sbjct: 173 AVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 40/228 (17%)
Query: 513 NNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-R 567
++F +IG G F V E E AIK + + E+ + + E E+L++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 568 HRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHL--FGS-DLPPLTW--KQRLDACIGAA 621
H ++ L F DE+N + V EY NG L ++ +GS D + + L A
Sbjct: 61 HPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA----- 114
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--------------M 667
L YLH+ +GIIHRD+K NILLD++ K++DFG +K
Sbjct: 115 --LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 668 EHTHVSTAVKGSF-G---YLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
+ SF G Y+ PE + + SD+++ G ++++++
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 72/215 (33%), Positives = 111/215 (51%), Gaps = 35/215 (16%)
Query: 520 MIGVGGFGKVFKGEIEDCTL---AAIKRANP-QSEQGLAEFETEIEMLSKL-RHRHLVSL 574
+IG G FG+V K I+ L AAIKR S+ +F E+E+L KL H ++++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 575 IGFCDEQNEMILVYEYMANGTL-----RSHLFGSD---------LPPLTWKQRLDACIGA 620
+G C+ + + L EY +G L +S + +D L+ +Q L
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
ARG+ YL +++ IHRD+ NIL+ EN+VAK++DFGLS+ VK +
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 182
Query: 681 GYLDPEYFWRQQL-----TEKSDVYSFGVVLFEVV 710
G L + + L T SDV+S+GV+L+E+V
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 35/215 (16%)
Query: 520 MIGVGGFGKVFKGEIEDCTL---AAIKRANP-QSEQGLAEFETEIEMLSKL-RHRHLVSL 574
+IG G FG+V + I+ L AAIK SE +F E+E+L KL H ++++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 575 IGFCDEQNEMILVYEYMANGTL-----RSHLFGSD---------LPPLTWKQRLDACIGA 620
+G C+ + + + EY G L +S + +D LT +Q L
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
A G+ YL +E+ IHRD+ N+L+ EN +K++DFGLS+ E + VK +
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVY----VKKTM 177
Query: 681 GYLDPEYFWRQQL-----TEKSDVYSFGVVLFEVV 710
G L + + L T KSDV+SFGV+L+E+V
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 69/257 (26%), Positives = 121/257 (47%), Gaps = 20/257 (7%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G + T A+K P + + F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ + ++ EYMA G+L L + + + +D A G+ Y+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
+ N+L+ E+ + K++DFGL++ E+T A K + PE T KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSDVW 188
Query: 701 SFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKF 760
SFG++L+E+V + P + + A QR + P ++ P+ L
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSA-------LQRGYRM---PRMEN--CPDELY-- 234
Query: 761 GEIAEKCLDDEGKNRPT 777
+I + C ++ + RPT
Sbjct: 235 -DIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-21
Identities = 57/229 (24%), Positives = 119/229 (51%), Gaps = 27/229 (11%)
Query: 521 IGVGGFGKVFKGEI---------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V + E + T+A + +++ LA+ +E+E++ + +H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHL---------FGSDLP-----PLTWKQRLDA 616
+++L+G C ++ + ++ EY A G LR L + D+ L++K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL R IHRD+ N+L+ E+ V K++DFGL++ +++ ++
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725
+ ++ PE + + T +SDV+SFG++++E+ P +P +++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-21
Identities = 61/229 (26%), Positives = 118/229 (51%), Gaps = 27/229 (11%)
Query: 521 IGVGGFGKVFKGEI--------EDCTLAAIKR-ANPQSEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V E T A+K + +E+ L++ +E+EM+ + +H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHL-----------FGSDLPP---LTWKQRLDA 616
+++L+G C + + ++ EY + G LR +L + P L++K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL A + IHRD+ N+L+ E+ V K++DFGL++ +++ +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725
+ ++ PE + + T +SDV+SFGV+L+E+ P +P +++
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-21
Identities = 60/229 (26%), Positives = 118/229 (51%), Gaps = 27/229 (11%)
Query: 521 IGVGGFGKVFKGEI---------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V E + T+A + +++ L++ +E+EM+ + +H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLP--------------PLTWKQRLDA 616
+++L+G C + + ++ EY + G LR +L P LT+K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL A + IHRD+ N+L+ E+ V K++DFGL++ ++++ +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725
+ ++ PE + + T +SDV+SFGV+L+E+ P +P +++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQG--LAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FGKV+ ++ L A+K Q + E E+++L L+H +LV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+ ++ + EY + GTL L + + + GL YLH GI+H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGIVH 122
Query: 638 RDVKTTNILLDENFVAKMSDFGLSK---TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
RD+K NI LD N V K+ DFG + + V + G+ Y+ PE +
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPEVITGGKGK 181
Query: 695 EK---SDVYSFGVVLFEVVCAR 713
+D++S G V+ E+ +
Sbjct: 182 GHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 521 IGVGGFGKVFKG--------EIEDCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHL 571
+G G FG V KG E+E A+K G EF E ++++L H +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE----VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
V LIG C + ++LV E G L + + + A G+ YL
Sbjct: 59 VRLIGVCKGE-PLMLVMELAPLGPL--LKYLKKRREIPVSDLKELAHQVAMGMAYLE--- 112
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSK-TGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
+ +HRD+ N+LL AK+SDFG+S+ G ++ +TA + + PE
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
+ + KSDV+S+GV L+E
Sbjct: 173 GKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 520 MIGVGGFGKVFK---GEIEDCT--LAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FG V ++D T + A+K+ + + L +FE EIE+L L+H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 575 IGFCDE--QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA----------CIGAAR 622
G C + + LV EY+ G+LR +L ++RLD C +
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-------RERLDHRKLLLYASQIC----K 119
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS--F 680
G+ YL + +HRD+ T NIL++ K+ DFGL+K P + + S F
Sbjct: 120 GMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
Y PE + + SDV+SFGVVL+E+
Sbjct: 177 WYA-PESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHRHLVSLIGF 577
IG G FG VFK D + A+K+ + E E +L+KL +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
++ ++ +V EY NG L L PL Q I GL +LH+ + I+H
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILH 124
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
RD+K+ N+ LD K+ D G++K + T+ + + G+ YL PE + EK
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756
SDV++ GVVL+E + P D N +K + P + YS +
Sbjct: 182 SDVWALGVVLYECCTGKH------PFDANNQGALILKIIRGVF------PPVSQMYSQQ- 228
Query: 757 LEKFGEIAEKCLDDEGKNRPTMGEVL 782
++ ++CL + + RP ++L
Sbjct: 229 ---LAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 56/291 (19%)
Query: 512 TNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRH 568
+ IG G G+V+K + AIK R Q+++ + EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTW-KQRLDACIGAA------ 621
++V +E+ +V EYM G+L +D+ +T R++ A
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSL------TDI--ITQNFVRMNEPQIAYVCREVL 126
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKG 678
+GL YLH+ + +IHRD+K+ NILL ++ K++DFG + S ++ V T
Sbjct: 127 QGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY-- 181
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
++ PE R+ K D++S G++ E+ P ++ R
Sbjct: 182 ---WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG----EPPY-----------LREPPLR 223
Query: 739 SLKSIID---PHLKG--NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+L I P LK +SPE F + KCL + + RP+ E+L H
Sbjct: 224 ALFLITTKGIPPLKNPEKWSPE----FKDFLNKCLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 519 LMIGVGGFGKVFKGEIED----------CTLAAIKRANPQSEQGLAEFETEIEMLSKLRH 568
+G G FG+V++G D + +++ E+ EF E ++S H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDL-----PPLTWKQRLDACIGAARG 623
++V L+G C ++ E M G L S+L + + P LT K+ LD C+ A+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDE-----NFVAKMSDFGLSKTGPSMEHTHVSTAVKG 678
YL + IHRD+ N L+ E + V K+ DFGL++ ++
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
++ PE + T +SDV+SFGV+++E++
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 63/189 (33%), Positives = 100/189 (52%), Gaps = 12/189 (6%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
IG G FG V +GE +A N + + F E +++KL H++LV L+G
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAV---KNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI-L 69
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
N + +V E M+ G L + L ++ Q L + A G+ YL + + ++HRD+
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDL 126
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
NIL+ E+ VAK+SDFGL++ G M + VK + PE ++ + KSDV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGS-MGVDNSKLPVK----WTAPEALKHKKFSSKSDVW 181
Query: 701 SFGVVLFEV 709
S+GV+L+EV
Sbjct: 182 SYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 77/286 (26%), Positives = 122/286 (42%), Gaps = 43/286 (15%)
Query: 521 IGVGGFGKVFKGEIEDC------TLAAIKRANPQSEQG-LAEFETEIEMLSKLRHRHLVS 573
+G G FG V++G + T AIK N + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--------FGSDLPPLTWKQRLDACIGAARGLH 625
L+G ++V E MA G L+S+L L P T ++ + A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG--YL 683
YL A + +HRD+ N ++ E+ K+ DFG+++ E + KG ++
Sbjct: 134 YL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWM 188
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
PE T KSDV+SFGVVL+E+ L +++ LK +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--------------LKFV 234
Query: 744 IDPHLKGNY--SPESL-EKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
ID G + PE+ +K E+ C K RPT E++ L+
Sbjct: 235 ID----GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 68/198 (34%), Positives = 97/198 (48%), Gaps = 24/198 (12%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAE--FETEIEMLSKLRHRHLVSLIGFC 578
+G G FG V G+ AIK N E ++E F E +++ KL H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 579 DEQNEMILVYEYMANGTLRSHL------FGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+Q + +V E+M NG L ++L D+ L C G+ YL E
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM-------LLSMCQDVCEGMEYL----E 117
Query: 633 R-GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
R IHRD+ N L+ V K+SDFG+++ E+T S A K + PE F
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA-KFPVKWSPPEVFNFS 176
Query: 692 QLTEKSDVYSFGVVLFEV 709
+ + KSDV+SFGV+++EV
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FGKV+K + E AA K +SE+ L +F EI++LS+ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+N++ ++ E+ G L S + + LT Q C L++LH +IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY-----FWRQQLT 694
+K NILL + K++DFG+S S T + G+ ++ PE F
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
K+D++S G+ L E+ A + P P ++N +K K ++ P +
Sbjct: 187 YKADIWSLGITLIEL----AQMEP--PHHELNPMRVLLKILKSEP-PTLDQPSKWSS--- 236
Query: 755 ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
F + + CL + +RPT E+L H
Sbjct: 237 ----SFNDFLKSCLVKDPDDRPTAAELLKH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 78/309 (25%), Positives = 124/309 (40%), Gaps = 69/309 (22%)
Query: 521 IGVGGFGKVFKGE---------IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL 571
+G G FGKV K + +K SE L + +E +L ++ H H+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPHV 65
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHL----------------------FGSDLPPLT 609
+ L G C + ++L+ EY G+LRS L D LT
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 610 WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669
+ +RG+ YL AE ++HRD+ N+L+ E K+SDFGLS+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-----DV 177
Query: 670 THVSTAVKGSFG-----YLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724
+ VK S G ++ E + T +SDV+SFGV+L+E+V P + ++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 725 INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGE----IAEKCLDDEGKNRPTMGE 780
+ + + LK Y E E E + C E RPT +
Sbjct: 238 L----FNL---------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD 278
Query: 781 VLWHLEYVL 789
+ LE ++
Sbjct: 279 ISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T AIK S A F E ++ +L+H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
Q + ++ EYM NG+L L + LT + +D A G+ ++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
+ NIL+ E K++DFGL++ E+T A K + PE T KSDV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSDVW 187
Query: 701 SFGVVLFEVV 710
SFG++L E+V
Sbjct: 188 SFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 48/279 (17%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVS---- 573
+G G +G V+K + + D A+K + S++ + EI +L+ + H +++S
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 574 -LIGFCDEQNEMILVYEYMANGTL-----RSHLFGSDLPP-LTWKQRLDACIGAARGLHY 626
L G N++ +V EY G L + +P W+ + RGL
Sbjct: 68 FLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQA 118
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS-MEHTHVSTAVKGSFGYLDP 685
LH E+ I+HRD+K+ NILL N + K+ D G+SK M T + T Y+ P
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH-----YMAP 170
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745
E + + + KSD++S G +L+E + A P + ++ D K Q+ +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYE-MATFAP-----PFEARSMQDLRYKVQRGKY------ 218
Query: 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
P + YS + L + K RP ++L
Sbjct: 219 PPIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 521 IGVGGFGKVFKGEIED-----------------CTLAAIKRANP-QSEQGLAEFETEIEM 562
+G G FG+V E + L A+K P S+ +F E+++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 563 LSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT----LRSHLFGSDLPPLTWKQRLDAC- 617
LS+L ++ L+G C + ++ EYM NG L+ H+ + K +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 618 --IGA--ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673
+ A G+ YL +HRD+ T N L+ +N+ K++DFG+S+ S ++ V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ E + T KSDV++FGV L+E+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 38/214 (17%)
Query: 521 IGVGGFGKVFKGEI-------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG+V++G + +A SEQ ++F E ++SK H+++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGS----DLP-PLTWKQRLDACIGAARGLHYLH 628
LIG E+ ++ E MA G L+S L + + P LT K L A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 629 TGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLS----------KTGPSMEHTHVSTA 675
E IHRD+ N LL VAK++DFG++ K G +M
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM------LP 184
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
+K ++ PE F T K+DV+SFGV+L+E+
Sbjct: 185 IK----WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 520 MIGVGGFGKVFKG----EIEDCTLA-AIKR-ANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG V+KG E E + AIK S + E E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL------FGSDLPPLTWKQRLDACIGAARGLHYL 627
L+G C ++ L+ + M G L ++ GS + L+ C+ A+G+ YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGS-------QYLLNWCVQIAKGMSYL 125
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
E+ ++HRD+ N+L+ K++DFGL+K E + + K ++ E
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 688 FWRQQLTEKSDVYSFGVVLFEV 709
+ T KSDV+S+GV ++E+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 8/201 (3%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T A+K P + + F E +++ KLRH LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRD 639
+ + +V EYM+ G+L L + L +D A G+ Y+ ER IHRD
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI----ERMNYIHRD 127
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDV 699
+++ NIL+ + V K++DFGL++ E+T A K + PE + T KSDV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSDV 186
Query: 700 YSFGVVLFEVVCARAVINPTL 720
+SFG++L E+V V P +
Sbjct: 187 WSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 521 IGVGGFGKVF---KGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI- 575
I G +G+VF K D + IK+A+ + + + TE ++LS+ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 576 GFCDEQNEMILVYEYMANGTLRS--HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
F ++N + LV EY+ G L S GS L + + A I A L YLH
Sbjct: 61 SFQGKKN-LYLVMEYLPGGDLASLLENVGS-LDEDVARIYI-AEIVLA--LEYLH---SN 112
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK------GSFGYLDPEY 687
GIIHRD+K NIL+D N K++DFGLSK G +++ K G+ Y+ PE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVC 711
Q ++ D +S G +L+E +
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 514 NFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHR 569
++ IG G FGK++ K + E C + I ++ A + E+ +L+K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHP 59
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTL-------RSHLFGSDLPPLTWKQRLDACIGAAR 622
++V+ E + +V EY G L R LF D Q L + +
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED-------QILSWFVQISL 112
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKT-GPSMEHTHVSTAVKGSF 680
GL ++H +R I+HRD+K+ NI L +N VAK+ DFG+++ SME ++ G+
Sbjct: 113 GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTP 166
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCA 712
YL PE + K+D++S G VL+E +C
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYE-LCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 77/274 (28%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 521 IGVGGFGKVF--------KGEIEDCTLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHL 571
+G G FGKV G E + +KR Q+ G ++ EI +L L H ++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG---WKKEINILKTLYHENI 68
Query: 572 VSLIGFCDEQNEMI--LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
V G C EQ L+ EY+ G+LR +L L Q L G+ YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL---NLAQLLLFAQQICEGMAYLHS 125
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS-MEHTHVSTAVKGSFGYLDPEYF 688
+ IHRD+ N+LLD + + K+ DFGL+K P E+ V + E
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 689 WRQQLTEKSDVYSFGVVLFEVV--CARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746
+ + SDV+SFGV L+E++ C P ++ I Q Q ++ +I+
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK------QGQMTVVRLIEL 236
Query: 747 HLKGNYSP---ESLEKFGEIAEKCLDDEGKNRPT 777
+G P ++ + + C + E K RPT
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGL-AEFETEIEMLSKLRHRHLVSLIGFC 578
IG G FG+VF G + D T A+K L A+F E +L + H ++V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
++ + +V E + G + L ++ P L K+ + AA G+ YL + + IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHR 118
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG----SFGYLDPEYFWRQQLT 694
D+ N L+ E V K+SDFG+S+ E V + G + PE + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE----EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724
+SDV+SFG++L+E AV L Q
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 50/153 (32%), Positives = 78/153 (50%), Gaps = 20/153 (13%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSE-QGLAEFET-EIEMLSKLRHRHLVSLIGF 577
IG G +G+V+K + L A+K+ ++E +G EI++L KLRH ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 578 C--DEQNEMILVYEYMA---NGTLRSHLFGSDLPPLT--WKQRLDACIGAARGLHYLHTG 630
+ + +V+EYM G L S + KQ L GL YLH
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL-------EGLQYLH-- 117
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
GI+HRD+K +NIL++ + V K++DFGL++
Sbjct: 118 -SNGILHRDIKGSNILINNDGVLKLADFGLARP 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 20/159 (12%)
Query: 219 TMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLL 278
+ +N GGPE S +EAD+ + + + + + A T D +
Sbjct: 1 VVLAINCGGPEHTDSDG----ITYEADTYFTGGSADYYVSDTNGSSSIAGTTDPEL---- 52
Query: 279 VYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKA--NQRIFRIYINNR 336
Y+T R S + + S+ N +Y V LHF E+ + + +R+F +Y+ +
Sbjct: 53 -YQTER-YSPS-------SFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGK 103
Query: 337 TAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLG 375
+FDI +AGGK + H++Y + TL I
Sbjct: 104 LVLKDFDIVAEAGGKGKTAHKEYIPVTVTD-GTLEIHFY 141
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 520 MIGVGGFGKVFKGEIE-----DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+IG G FG+V G ++ + +A +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
G + +++V EYM NG+L + L D T Q + G A G+ YL ++ G
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
+HRD+ NIL++ N V K+SDFGLS+ E + + K + PE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 694 TEKSDVYSFGVVLFEVV 710
T SDV+S+G+V++EV+
Sbjct: 187 TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 35/215 (16%)
Query: 520 MIGVGGFGKVFKGEIEDCTL---AAIKRANP-QSEQGLAEFETEIEMLSKL-RHRHLVSL 574
+IG G FG+V K I+ L AAIKR S+ +F E+E+L KL H ++++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 575 IGFCDEQNEMILVYEYMANGTL-----RSHLFGSD---------LPPLTWKQRLDACIGA 620
+G C+ + + L EY +G L +S + +D L+ +Q L
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
ARG+ YL +++ IHRD+ NIL+ EN+VAK++DFGLS+ + + VK +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKKTM 170
Query: 681 GYLDPEYFWRQQL-----TEKSDVYSFGVVLFEVV 710
G L + + L T SDV+S+GV+L+E+V
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 71/286 (24%), Positives = 127/286 (44%), Gaps = 34/286 (11%)
Query: 520 MIGVGGFGKVFKGEI--EDCTL--AAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG V +G++ +D + A+K + + + + EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 574 LIGFCDEQNEM------ILVYEYMANGTLRSHLFGS---DLPP-LTWKQRLDACIGAARG 623
LIG C E + + +++ +M +G L S L S LP L + L + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
+ YL R IHRD+ N +L E+ ++DFGLSK S ++ K ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
E + T KSDV++FGV ++E+ P + +I + R +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI--------YDYLRHGNRL 234
Query: 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789
P + L++ ++ C + K+RPT ++ LE +L
Sbjct: 235 KQP-------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 44/279 (15%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G +G V+K +I L AIK + + EI ML + RH ++V+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
++++ +V EY G+L ++ PL+ Q C +GL YLH E G IHRD
Sbjct: 71 RRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRD 126
Query: 640 VKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVST---------AVKGSFGYLDPEY 687
+K NILL E+ K++DFG+S + + + T AV+ GY
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY----- 181
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747
K D+++ G+ E+ A + P + +L M+ S + P
Sbjct: 182 ------DGKCDIWALGITAIEL----AELQPPM----FDLH--PMRALFLISKSNFPPPK 225
Query: 748 L--KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
L K +SP F + +KCL + K RPT ++L H
Sbjct: 226 LKDKEKWSP----VFHDFIKKCLTKDPKKRPTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 26/270 (9%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FGKV+K + E LAA K +SE+ L ++ EIE+L+ H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
++ ++ E+ G + + + D LT Q C L YLH+ IIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRD 135
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE---- 695
+K N+LL + K++DFG+S +++ + G+ ++ PE + + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 696 -KSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
K+D++S G+ L E+ A I P P ++N +K K +P S
Sbjct: 194 YKADIWSLGITLIEM----AQIEP--PHHELNPMRVLLKIAKS-------EPPTLSQPSK 240
Query: 755 ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
S+E F + + LD + RP+ ++L H
Sbjct: 241 WSME-FRDFLKTALDKHPETRPSAAQLLEH 269
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 79/287 (27%), Positives = 131/287 (45%), Gaps = 51/287 (17%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRA--NPQSEQG-------LAEFETEIEMLSKLRHR 569
+IG G FG V+ G L A+K+ S L EI +L +L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTW---KQRLDACIGAARGL 624
++V +G + + + + EY+ G++ + L +G+ L +Q L +GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA-------VK 677
+YLH RGIIHRD+K NIL+D K+SDFG+SK +E +ST ++
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQ 173
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
GS ++ PE + T K+D++S G ++ E++ + +P Q+ Q
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK---HPFPDCTQL---------QAI 221
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ P + N S E++ + EK + + RPT E+L H
Sbjct: 222 FKIGENASPEIPSNISSEAI----DFLEKTFEIDHNKRPTAAELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 81/280 (28%), Positives = 125/280 (44%), Gaps = 51/280 (18%)
Query: 520 MIGVGGFGKVFKGEIEDC-TLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FG+V+K + + AIK + ++E + + + EI+ LS+ R ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD----ACI--GAARGLHYLHTGA 631
+ +++ ++ EY G+ L +LD A I GL YLH
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLD---------LLKPGKLDETYIAFILREVLLGLEYLH--- 115
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV--STAVKGSFGYLDPEYFW 689
E G IHRD+K NILL E K++DFG+S + T +T V F ++ PE
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPF-WMAPEVIK 171
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW-AMKWQKQRSLKSIID--- 745
+ EK+D++S G+ E L K + L+D M R L I
Sbjct: 172 QSGYDEKADIWSLGITAIE-----------LAKGEPPLSDLHPM-----RVLFLIPKNNP 215
Query: 746 PHLKGN-YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
P L+GN +S F + CL+ + K RP+ E+L H
Sbjct: 216 PSLEGNKFSKP----FKDFVSLCLNKDPKERPSAKELLKH 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 26/224 (11%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVFKGEI-----EDCTLAAIKR-ANPQSEQGLAEFETEI 560
E+ ++ F E L G FGK++KG + + L AIK + + Q EF+ E
Sbjct: 1 ELPLSAVRFMEEL--GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 561 EMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLF---------------GSDL 605
++++L H ++V L+G ++ + +++EY+ G L L G+
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 606 PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665
L L I A G+ YL + +H+D+ NIL+ E K+SD GLS+
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
S ++ V ++ PE + + SD++SFGVVL+E+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 10/195 (5%)
Query: 521 IGVGGFGKVFKGEIEDCTL----AAIKRANPQSEQG-LAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V +GE A+K + +F E ++ L H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G + +++V E G+L L L D + A G+ YL + +
Sbjct: 63 GVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA-VKGSFGYLDPEYFWRQQLT 694
IHRD+ NILL + K+ DFGL + P E +V +K F + PE + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 695 EKSDVYSFGVVLFEV 709
SDV+ FGV L+E+
Sbjct: 179 HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 42/243 (17%)
Query: 559 EIEMLSKLRHRHLVSLIG-FCDEQNEMI-LVYEYMANGTLRSHLFGSDLPPLTWKQ--RL 614
E+E+ + ++V G F DE + I + EY G+L S +K+ +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS----------IYKKVKKR 98
Query: 615 DACIG----------AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KT 663
IG +GL YLH R IIHRD+K +NILL K+ DFG+S +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155
Query: 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
S+ T T SF Y+ PE + + SDV+S G+ L EV R P P+
Sbjct: 156 VNSLAGTFTGT----SF-YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF---PFPPEG 207
Query: 724 QINLA--DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEV 781
+ L + + + +P +S E+F + ++CL+ + RPT ++
Sbjct: 208 EPPLGPIELLSYIVNMPNPELKDEPGNGIKWS----EEFKDFIKQCLEKDPTRRPTPWDM 263
Query: 782 LWH 784
L H
Sbjct: 264 LEH 266
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLA------EFETEIEMLSKLRHRHLVS 573
++G G +G V+ G L A+K+ + LA + + E+++L L+H ++V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTW----KQRLDACIGAARGLHYL 627
+G C + N + + E++ G++ S L FG LP + KQ LD G+ YL
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGP-LPEPVFCKYTKQILD-------GVAYL 118
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK----TGPSMEHTHVSTAVKGSFGYL 683
H ++HRD+K N++L N + K+ DFG ++ G H+++ ++ G+ ++
Sbjct: 119 H---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEV 709
PE KSD++S G +FE+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 26/270 (9%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FGKV+K + E LAA K + +SE+ L ++ EI++L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+N + ++ E+ A G + + + + PLT Q C L+YLH E IIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE---- 695
+K NIL + K++DFG+S + + G+ ++ PE + +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 696 -KSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
K+DV+S G+ L E+ A I P P ++N +K K ++ P +S
Sbjct: 187 YKADVWSLGITLIEM----AQIEP--PHHELNPMRVLLKIAKSEP-PTLAQP---SRWSS 236
Query: 755 ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
E F + +KCL+ R T ++L H
Sbjct: 237 E----FKDFLKKCLEKNVDARWTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSL 574
+IG G FG+V +G ++ AIK +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
G + ++++ E+M NG L S L +D T Q + G A G+ YL +E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG------YLDPEYF 688
+HRD+ NIL++ N V K+SDFGLS+ +E S G + PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 689 WRQQLTEKSDVYSFGVVLFEVV 710
++ T SDV+S+G+V++EV+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 52/191 (27%), Positives = 96/191 (50%), Gaps = 8/191 (4%)
Query: 521 IGVGGFGKVFKG--EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G +G+V++G + T+A + + + EF E ++ +++H +LV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAV--KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
+ ++ E+M G L +L + + L + + YL ++ IHR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 128
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
D+ N L+ EN + K++DFGLS+ +T + A K + PE + + KSD
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYNKFSIKSD 187
Query: 699 VYSFGVVLFEV 709
V++FGV+L+E+
Sbjct: 188 VWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G GGFG+V +++ + A K+ + + +G E ++L K+ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR---GLHYLHTGAER 633
+ ++++ LV M G L+ H++ P A AA+ GL +LH +R
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF---PEARAIFYAAQIICGLEHLH---QR 114
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
I++RD+K N+LLD++ ++SD GL+ + G+ GY+ PE +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVY 171
Query: 694 TEKSDVYSFGVVLFEVVCARA 714
D ++ G L+E++ R+
Sbjct: 172 DFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 26/165 (15%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR-ANPQSEQGLAEFET---EIEMLSKLRHRHLVSLI 575
+G G +G V+K + + + A+K+ E+G+ T EI +L +L+H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI--PSTALREISLLKELKHPNIVKLL 64
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWK----QRLDACIGAARGLHYLHT 629
+ ++ LV+EY L+ +L L P K Q L RGL Y H+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL-------RGLAYCHS 116
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHTHV 672
I+HRD+K NIL++ + V K++DFGL++ P +TH
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDC--TLAA----IKRANPQSEQGLAEFETEIEMLSKL 566
N+ ++G G FG+V+ D LA +P++++ + E EI++L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 567 RHRHLVSLIGFCDEQNEMILVY-EYMANGTLRSHL--FGSDLPPLTWK---QRLDACIGA 620
+H +V G C +E + ++ EYM G+++ L +G+ +T K Q L+
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----- 115
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--MEHTHVSTAVKG 678
G+ YLH+ I+HRD+K NIL D K+ DFG SK + T + + V G
Sbjct: 116 --GVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTG 169
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR 713
+ ++ PE + K+DV+S G + E++ +
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 521 IGVGGFGKVFKGEIEDC----------TLAAIKRANPQS-EQGLAEFETEIEMLSKLRHR 569
+G G FGKV E C A+K P+S +A+ + EIE+L L H
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 570 HLVSLIGFCDEQ--NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
++V G C E N + L+ E++ +G+L+ +L + + KQ+L + +G+ YL
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL 125
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPE 686
R +HRD+ N+L++ K+ DFGL+K E+ V + + PE
Sbjct: 126 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 687 YFWRQQLTEKSDVYSFGVVLFEVV 710
+ + SDV+SFGV L+E++
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 35/279 (12%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRA----NPQSEQG--LAEFETEIEMLSKLRHRHLV 572
+G G F ++ +++ TL A+K+ N SEQ + EI ++++L H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
++G E + L E+MA G++ L S ++ RGL YLH E
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLSYLH---E 121
Query: 633 RGIIHRDVKTTNILLDEN-FVAKMSDFGLSKTGPSMEHTHVSTA-----VKGSFGYLDPE 686
IIHRDVK N+L+D +++DFG + + G+ ++ PE
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFG---AAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 687 YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746
+Q DV+S G V+ E+ A+ N + + L K + SI
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATTAPSI--- 232
Query: 747 HLKGNYSPESLEK-FGEIAEKCLDDEGKNRPTMGEVLWH 784
PE L ++ +CL+ + ++RP E+L H
Sbjct: 233 -------PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 27/203 (13%)
Query: 520 MIGVGGFGKVFKG---EIEDCTLA-AIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSL 574
IG G FG V++G E+ +A A+K + + E F E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA------CIGAARGLHYLH 628
IG E N + +V E G LRS+L K LD + L YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL-------QVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF--GYLDPE 686
+ + +HRD+ N+L+ K+ DFGLS+ +E A KG ++ PE
Sbjct: 125 S---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR---YLEDESYYKASKGKLPIKWMAPE 178
Query: 687 YFWRQQLTEKSDVYSFGVVLFEV 709
++ T SDV+ FGV ++E+
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 29/273 (10%)
Query: 521 IGVGGFGKVFKGEIEDCT--LAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FG+VFKG I++ T + AIK + ++E + + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+ ++ ++ EY+ G+ L + PL Q +GL YLH+ + IH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK---IH 124
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKS 697
RD+K N+LL E+ K++DFG++ G + G+ ++ PE + K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 698 DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757
D++S G+ E+ A+ P P +++ K P L+GNYS
Sbjct: 183 DIWSLGITAIEL--AKG--EP--PHSELHPMKVLFLIPKNNP------PTLEGNYS---- 226
Query: 758 EKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ E E CL+ E RPT E+L H +++++
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLKH-KFIVR 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHRHLVSLIGF 577
IG G +G V+K + + AIK+ + E EI++L +L H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 578 CDEQNEMILVYEYMANG------TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
+ ++ LV+E+M + L S + + Q L +GL + H
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLY-QLL-------QGLAFCH--- 115
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT--GPSMEHTH-VSTAVKGSFGYLDPEYF 688
GI+HRD+K N+L++ V K++DFGL+++ P +TH V T Y PE
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELL 170
Query: 689 WR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPK----DQINL 727
+ + D++S G + E++ R P P DQ+
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 48/294 (16%)
Query: 511 ATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLR 567
+++ +G G FG+V+K +I+ + A+K+ +E+ EI++L KL+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 568 HRHLVSLI--------GFCDEQNEMILVYEYMA---NGTL---RSHLFGSDLPPLTWKQR 613
H ++V LI ++ + +V YM +G L L S + Q
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK-CYMLQL 124
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK---------TG 664
L+ G++YLH E I+HRD+K NIL+D + K++DFGL++ G
Sbjct: 125 LE-------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYF--WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPK 722
T T + + Y PE R+ T D++ G V E+ R ++
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDI 233
Query: 723 DQINLADWAM-------KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLD 769
DQ++L + + W RSL H NY E+FG++ + LD
Sbjct: 234 DQLHLI-FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD 286
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 47/182 (25%), Positives = 91/182 (50%), Gaps = 14/182 (7%)
Query: 539 LAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597
L A+K ++ +F EI+++S+L++ +++ L+G C + + ++ EYM NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 598 SHL----------FGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647
L +++P ++ L + A G+ YL A +HRD+ T N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLF 707
++ K++DFG+S+ S ++ + ++ E + T SDV++FGV L+
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 708 EV 709
E+
Sbjct: 223 EM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 30/277 (10%)
Query: 514 NFDESLMIGVGGFGKVF--KGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHR 569
+++ ++G G FG V + + D L IK+ + ++ + E ++L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
+++ E +++V EY GTL ++ L L + LH++HT
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 630 GAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+ I+HRD+KT NILLD++ V K+ DFG+SK S + T V G+ Y+ PE
Sbjct: 120 ---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS--KSKAYTVV-GTPCYISPELC 173
Query: 689 WRQQLTEKSDVYSFGVVLFEVV-CARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747
+ +KSD+++ G VL+E+ RA LP A+ + + I
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---------ALVLKIMSGTFAPISDR 224
Query: 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
YSP+ ++ L+ + RP + +++
Sbjct: 225 ----YSPD----LRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IGVG V+ + + AIKR + + + + E E++ +S+ H ++V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI--GAARGLHYLHTGAERGII 636
+E+ LV Y++ G+L + S P + + A + +GL YLH G I
Sbjct: 69 VVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSK---TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ- 692
HRD+K NILL E+ K++DFG+S G T V G+ ++ PE +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVMEQVHG 183
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
K+D++SFG+ E LA A + K +K ++ L
Sbjct: 184 YDFKADIWSFGITAIE------------------LATGAAPYSKYPPMKVLM---LTLQN 222
Query: 753 SPESLE------KFG----EIAEKCLDDEGKNRPTMGEVLWH 784
P SLE K+ ++ CL + RPT E+L H
Sbjct: 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 58/294 (19%)
Query: 512 TNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKR------ANPQSEQGLAEFETEIEMLS 564
NF IG G F V+K + D + A+K+ + ++ Q + EI++L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL---FGSD---LPPLT-WKQRLDAC 617
+L H +++ + E NE+ +V E G L S + F +P T WK + C
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL-----SKTGPSMEHTHV 672
L ++H + I+HRD+K N+ + V K+ D GL SKT + H+ V
Sbjct: 117 ----SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLV 167
Query: 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM 732
T Y+ PE KSD++S G +L+E+ ++ D++NL
Sbjct: 168 GTPY-----YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS----PFYGDKMNLYSLCK 218
Query: 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGE----IAEKCLDDEGKNRPTMGEVL 782
K I+ K +Y P + + E + +C++ + + RP + VL
Sbjct: 219 K----------IE---KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 37/236 (15%)
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI 618
E+++L K ++V G ++ + EYM G+L + + + +
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL------DKILKEVQGRIPERIL 102
Query: 619 GA-----ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHV 672
G +GL YLH + IIHRDVK +NIL++ K+ DFG+S + S+ T V
Sbjct: 103 GKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV 160
Query: 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM 732
T+ Y+ PE + KSD++S G+ L E+ R P N
Sbjct: 161 GTSS-----YMAPERIQGNDYSVKSDIWSLGLSLIELATGR------FPYPPEN-DPPDG 208
Query: 733 KWQKQRSLKSIID---PHL-KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
++ L+ I++ P L G +SP+ F + CL + + RP+ E+L H
Sbjct: 209 IFEL---LQYIVNEPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 25/200 (12%)
Query: 521 IGVGGFGKV----FKGEIEDCTLAAIKR----ANPQSEQGLAE---FETEIEMLSKLRHR 569
+G G FGKV +K E + A+K+ A + E + E FET + RH
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----ANSERHP 62
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
LV+L ++ + V EY A G L H+ +D+ AC+ GL YLH
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACV--VLGLQYLH- 118
Query: 630 GAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
E I++RD+K N+LLD E FV K++DFGL K G M ++ G+ +L PE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEG--MGFGDRTSTFCGTPEFLAPEVL 173
Query: 689 WRQQLTEKSDVYSFGVVLFE 708
T D + GV+++E
Sbjct: 174 TETSYTRAVDWWGLGVLIYE 193
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ T A+K P S + F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ + ++ E+MA G+L L + + +D A G+ ++ +R IHRD+
Sbjct: 73 E-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
+ NIL+ + V K++DFGL++ E+T A K + PE T KSDV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSDVW 187
Query: 701 SFGVVLFEVV 710
SFG++L E+V
Sbjct: 188 SFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 32/238 (13%)
Query: 556 FETEIEMLSKLRHRHLVSLIGF----CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWK 611
E EI+ L ++ +++ + GF D+ + L+ EY G LR L L++K
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFK 122
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671
+LD I +GL+ L+ + ++++ + + L+ EN+ K+ GL K S +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 672 VSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729
V+ V Y + + T K D+YS GVVL+E+ + +P + + +
Sbjct: 181 VNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK------IPFENLTTKE 229
Query: 730 -WAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ + K SLK +D L+ I E C + RP + E+L++L
Sbjct: 230 IYDLIINKNNSLKLPLDCPLEIKC----------IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 520 MIGVGGFGKVFKGEIEDCT----LAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG++ +G ++ + AI RA +Q F E L + H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L G N M++V EYM+NG L S L + L Q + G A G+ YL +E
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
G +H+ + +L++ + V K+S F + E + + + K + PE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQED-KSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 694 TEKSDVYSFGVVLFEVV 710
+ SDV+SFG+V++EV+
Sbjct: 186 SSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 14/195 (7%)
Query: 521 IGVGGFGKVFKGEIE------DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FG V KG + D + +K N +S + E E E++ +L + ++V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD--EMMREAEIMHQLDNPYIVRM 60
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
IG C+ + M LV E MA+G + +T ++ + G+ YL +
Sbjct: 61 IGVCEAEALM-LVME-MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKN 115
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
+HRD+ N+LL AK+SDFGLSK G + +A K + PE ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 694 TEKSDVYSFGVVLFE 708
+ +SDV+S+G+ ++E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 520 MIGVGGFGKVFKG----EIEDCTL-AAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG V+KG E E + AIK N + + EF E +++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL------FGSDLPPLTWKQRLDACIGAARGLHYL 627
L+G C + LV + M +G L ++ GS L L W C+ A+G+ YL
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLL-LNW------CVQIAKGMMYL 125
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
ER ++HRD+ N+L+ K++DFGL++ E + + K ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 688 FWRQQLTEKSDVYSFGVVLFEVV 710
++ T +SDV+S+GV ++E++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 35/303 (11%)
Query: 497 TRAGKRFTLAEIRVATNNFDESLMI----GVGGFGKVFKGEIEDCTLAAIKRANPQSEQG 552
++ K T+ +I + +E+++ G GK K ++ + I N
Sbjct: 677 SKVSKSITINDILSSLK--EENVISRGKKGASYKGKSIKNGMQ-FVVKEINDVNSIPSSE 733
Query: 553 LAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQ 612
+A+ KL+H ++V LIG C + L++EY+ L L L+W++
Sbjct: 734 IADM-------GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWER 781
Query: 613 RLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP-SMEHTH 671
R IG A+ L +LH ++ ++ I++D + LS G +
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKC 838
Query: 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN--LAD 729
++ Y+ PE + +TEKSD+Y FG++L E++ + +P + ++ + +
Sbjct: 839 FISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVE 890
Query: 730 WAMKWQKQRSLKSIIDPHLKGNYSPESLE--KFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787
WA L IDP ++G+ S E + +A C + RP +VL LE
Sbjct: 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
Query: 788 VLQ 790
+
Sbjct: 951 ASR 953
|
Length = 968 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 40/231 (17%)
Query: 515 FDESLMIGVGGFGKVFKGEIED-----------------CTLAAIKRANPQ-SEQGLAEF 556
F E L G G FG+V E+ + L A+K P ++ +F
Sbjct: 9 FKEKL--GEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66
Query: 557 ETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLF----------GSD-- 604
E+++LS+L+ +++ L+G C +++ + ++ EYM NG L L G+D
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 605 -----LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659
LP +++ L + A G+ YL + +HRD+ T N L+ EN K++DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
+S+ + ++ + ++ E + T SDV++FGV L+E++
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 79/297 (26%), Positives = 115/297 (38%), Gaps = 71/297 (23%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGF- 577
IG G +GKV+K + L AIK + ++ E + E +L K H ++ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 578 -----CDEQNEMILVYEYMANGTLRSHLFGSDLPP--LTWKQRLDA------CIGAARGL 624
+++ LV E G++ +DL +RL RGL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSV------TDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTA------ 675
YLH E +IHRD+K NILL +N K+ DFG+S + +T + T
Sbjct: 127 AYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPE 183
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA---M 732
V D Y +SDV+S G+ I LAD
Sbjct: 184 VIACDEQPDASY------DARSDVWSLGIT------------------AIELADGKPPLC 219
Query: 733 KWQKQRSLKSII---DPHLK--GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
R+L I P LK N+S +KF + +CL + RP M E+L H
Sbjct: 220 DMHPMRALFKIPRNPPPTLKSPENWS----KKFNDFISECLIKNYEQRPFMEELLEH 272
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 520 MIGVGGFGKVFKGEIEDCT-LAAIKRANPQSEQGLAEFETEIEMLSKL------RHRHLV 572
++G G FGKV E++ L A+K + + L + + E M K +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 573 SLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
L Q + + V EY+ G L H+ S + A I GL +LH
Sbjct: 60 QL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLH-- 113
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
ERGII+RD+K N+LLD K++DFG+ K G + ++ G+ Y+ PE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTFCGTPDYIAPEILSY 170
Query: 691 QQLTEKSDVYSFGVVLFEVVCARA 714
Q D ++ GV+L+E++ ++
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 520 MIGVGGFGKVFKG----EIEDCTL-AAIKR-ANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG V KG E + + AIK + Q E + + L H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
L+G C + LV + G+L H+ L P ++ L+ C+ A+G++YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP---QRLLNWCVQIAKGMYYLE--- 126
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
E ++HR++ NILL + + +++DFG++ + + + K ++ E
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 692 QLTEKSDVYSFGVVLFEVV 710
+ T +SDV+S+GV ++E++
Sbjct: 187 RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 18/196 (9%)
Query: 521 IGVGGFGKVFK-GEIEDCTLAAIKR-ANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGF 577
IG G G VFK + E A+K+ A + E G+ EI+ L +H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLP-PLTWKQRLDACIGAARGLHYLHTGAERGII 636
+ +LV EYM L L + P P + + +G+ Y+H GI+
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMH---ANGIM 121
Query: 637 HRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKGSFGYLDPEYFW-RQQ 692
HRD+K N+L+ + V K++DFGL+ ++H V + Y PE + ++
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH---QV-ATRWYRAPELLYGARK 177
Query: 693 LTEKSDVYSFGVVLFE 708
D+++ G + E
Sbjct: 178 YDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 521 IGVGGFGKVFKG------EIEDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG V++G + E T AIK N S + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFG--------SDLPPLTWKQRLDACIGAARGLH 625
L+G + +++ E M G L+S+L P + K+ + A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG---- 681
YL+ +HRD+ N ++ E+F K+ DFG+++ ++ KG G
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185
Query: 682 -YLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ PE T SDV+SFGVVL+E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 512 TNNFDESLMIGVGGFGKV--FKGEIEDCTLAAIKRANPQSEQGLAEFE-TEIEMLSKLRH 568
TN + + +G+G FG V + ++ +A K P S LA+ E+++L LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 569 RHLVSLIG-FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA------CIGAA 621
+++SL F ++ V E L G+DL L + L+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTE----------LLGTDLHRLLTSRPLEKQFIQYFLYQIL 118
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
RGL Y+H+ G++HRD+K +NIL++EN K+ DFGL++ +VST
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 682 YLDPEYF--WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP-KDQIN 726
Y PE W Q+ + D++S G + E++ + P P KD +N
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGK----PLFPGKDHVN 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 40/289 (13%)
Query: 520 MIGVGGFGKVFKGEI--EDCTL--AAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
M+G G FG V + ++ ED + A+K +A+ S + EF E + + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 574 LIGFCDEQNEM------ILVYEYMANGTLRSHLFGSDL--PPLTWKQR--LDACIGAARG 623
LIG +++ +M +G L + L S + P T + + I A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
+ YL + + IHRD+ N +L+EN ++DFGLSK S ++ A K +L
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
E T SDV++FGV ++E++ + + I
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------------------I 224
Query: 744 IDPHLKGN---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789
+ +KGN P+ LE E+ +C E K RP+ + LE +
Sbjct: 225 YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 49/285 (17%)
Query: 521 IGVGGFGKVFKGEIEDC------TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG V++G D T A+K N S + EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--FGSDL------PPLTWKQRLDACIGAARGLH 625
L+G + ++V E MA+G L+S+L + PP T ++ + A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG---- 681
YL+ + +HRD+ N ++ +F K+ DFG+++ ++ KG G
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185
Query: 682 -YLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740
++ PE T SD++SFGVVL+E+ L +Q+ L
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--------------L 231
Query: 741 KSIIDPHLKGNY--SPESL-EKFGEIAEKCLDDEGKNRPTMGEVL 782
K ++D G Y P++ E+ ++ C K RPT E++
Sbjct: 232 KFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 81/315 (25%), Positives = 124/315 (39%), Gaps = 73/315 (23%)
Query: 513 NNFDESLMIGVGGFGKVFK------GEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLS 564
N ++ ++G G +G V K GEI AIK + + E E+++L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEI-----VAIKKFKESEDDEDVKKTALREVKVLR 55
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPP-----LTWKQRLDAC 617
+LRH ++V+L + + LV+EY+ TL L LPP W Q L
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW-QLL--- 110
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEH--THVS 673
+ + Y H IIHRD+K NIL+ E+ V K+ DFG ++ +V+
Sbjct: 111 ----QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163
Query: 674 TAVKGSFGYLDPEYFWRQQLTEKS-DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM 732
T Y PE K DV++ G ++ E++ + DQ+
Sbjct: 164 TR-----WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL------- 211
Query: 733 KWQKQRSLKSII---------DPHLKGN-----YSPESLE-----KFGEIA----EKCLD 769
+ Q+ L + +P G PESLE K A + CL
Sbjct: 212 -YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLR 270
Query: 770 DEGKNRPTMGEVLWH 784
+ K R T E+L H
Sbjct: 271 MDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 28/202 (13%)
Query: 521 IGVGGFGKVF----KGEIEDCTLAAIKRANPQS--EQGLAE-FETEIEMLSKLRHRHLVS 573
+G G FG+V KG + A+K + + E E +L +RH LV+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYY---ALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 574 LIG-FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR---GLHYLHT 629
L G F D+ N + LV EY+ G L SHL S P A AA+ L YLH+
Sbjct: 66 LYGSFQDDSN-LYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVLALEYLHS 119
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
I++RD+K N+LLD + K++DFG +K +T T YL PE
Sbjct: 120 ---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTP-----EYLAPEIIL 171
Query: 690 RQQLTEKSDVYSFGVVLFEVVC 711
+ + D ++ G++++E++
Sbjct: 172 SKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 72/293 (24%), Positives = 133/293 (45%), Gaps = 56/293 (19%)
Query: 514 NFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRA-----NPQSEQGLAEFETEIEMLSKLR 567
N+ ++G G FG+V+ +++ A K+ +P++ + ++ E EI++L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 568 HRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHL--FGSDLPPLTWK---QRLDACIGA 620
H +V G ++ E + + EYM G+++ L +G+ +T K Q L+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE----- 117
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--MEHTHVSTAVKG 678
G+ YLH+ I+HRD+K NIL D K+ DFG SK + M T + + V G
Sbjct: 118 --GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTG 171
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
+ ++ PE + K+DV+S G + E++ + W +
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP------------------PWAEYE 213
Query: 739 SLKSII-------DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
++ +I +P L + S + + G C+ E ++RP+ E+L H
Sbjct: 214 AMAAIFKIATQPTNPQLPSHISEHARDFLG-----CIFVEARHRPSAEELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 37/286 (12%)
Query: 521 IGVGGFGKVFKGEI--EDCTL-AAIKRAN----PQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG V +G++ +D L A+K +SE + +F +E + + H +++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMR 64
Query: 574 LIGFCDEQNEM------ILVYEYMANGTLRSHLFGS---DLPPLTWKQRLDACIG-AARG 623
LIG C + E +++ +M +G L S L S D P Q L + A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
+ YL + + IHRD+ N +L+EN ++DFGLSK + ++ K ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
E + T KSDV+SFGV ++E+ P + +I D+ ++ LK
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI--YDYL---RQGNRLKQ- 235
Query: 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789
P+ L+ + C K+RP+ + LE L
Sbjct: 236 ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 42/222 (18%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANP----QSEQGLAEFETEIEMLSKLRHRHLVSLI 575
IG G FG+V+ + + + A+K + Q +A E ++L+ +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67
Query: 576 -GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
F DE++ + LV EYM G L + L D+ P + A + A L +H + G
Sbjct: 68 YSFQDEEH-LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA--LDSVH---KLG 121
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPS---------------------------- 666
IHRD+K NIL+D + K++DFGL K
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFE 708
++ V G+ Y+ PE + D +S GV+L+E
Sbjct: 182 QRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 48/222 (21%)
Query: 579 DEQNE-----MILVYEYMANGTLRSHL---------FGSDLPPLTWKQRLDACIGAARGL 624
D +N + LV +Y G LR + F L + Q L A +
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA-------V 156
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG--- 681
H++H+ + +IHRD+K+ NILL N + K+ DFG SK M VS V +F
Sbjct: 157 HHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAATVSDDVGRTFCGTP 209
Query: 682 -YLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740
Y+ PE + R+ ++K+D++S GV+L+E++ + P D N+ + M ++L
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR------PFDGENMEE-VM----HKTL 258
Query: 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
DP L + SPE EI L + K RP+ ++L
Sbjct: 259 AGRYDP-LPPSISPE----MQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 68/269 (25%), Positives = 121/269 (44%), Gaps = 31/269 (11%)
Query: 521 IGVGGFGKV-FKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLI-G 576
+G G +G+V D IK+ N + S + E E ++LS+L+H ++V+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
+ E + +V + G L L L Q ++ + A L YLH E+ I+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
HRD+KT N+ L + K+ D G+++ + +++ + G+ Y+ PE F + K
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---PHLKGNYS 753
SDV++ G ++E+ + N KD +L + II+ P + +YS
Sbjct: 183 SDVWALGCCVYEMATLKHAFN---AKDMNSL------------VYRIIEGKLPPMPKDYS 227
Query: 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
PE GE+ L + RP++ +L
Sbjct: 228 PE----LGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G GGFG+V ++ L A K+ N + +G E +L+K+ R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLP-PLTWKQRLDACIGAAR---GLHYLHTGAE 632
+ ++ LV M G LR H++ D P + R AC A+ GL +LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR--ACFYTAQIISGLEHLH---Q 115
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
R II+RD+K N+LLD + ++SD GL+ K G S + T G++ PE
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP-----GFMAPELLQ 170
Query: 690 RQQLTEKSDVYSFGVVLFEVVCAR 713
++ D ++ GV L+E++ AR
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 74/269 (27%), Positives = 125/269 (46%), Gaps = 32/269 (11%)
Query: 521 IGVGGFGKVFKGEIEDCT--LAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FG+V+KG I++ T + AIK + ++E + + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+ ++ ++ EY+ G+ L L L + +GL YLH+ ER I H
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHS--ERKI-H 124
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV--STAVKGSFGYLDPEYFWRQQLTE 695
RD+K N+LL E K++DFG++ + T + +T V F ++ PE +
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDF 180
Query: 696 KSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPE 755
K+D++S G+ E+ + P + L + P L+G YS
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPTLEGQYS-- 226
Query: 756 SLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ F E E CL+ + + RPT E+L H
Sbjct: 227 --KPFKEFVEACLNKDPRFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 40/273 (14%)
Query: 521 IGVGGFGKVFKGEIEDCT--LAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FG+VFKG I++ T + AIK + ++E + + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 578 CDEQNEMILVYEYMANGT----LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ ++ ++ EY+ G+ LR+ F K+ L +GL YLH+ +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-------KGLDYLHSEKK- 122
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV--STAVKGSFGYLDPEYFWRQ 691
IHRD+K N+LL E K++DFG++ + T + +T V F ++ PE +
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPF-WMAPEVIQQS 176
Query: 692 QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751
K+D++S G+ E+ + P + L + P L G
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL------------IPKNNPPTLTGE 224
Query: 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+S + F E + CL+ + RPT E+L H
Sbjct: 225 FS----KPFKEFIDACLNKDPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 10/156 (6%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR 567
R +F+ IG G +G V+K + LAAIK + + A + EI M+ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 568 HRHLVSLIGFCDEQNEMILVYEYMANGTLRS--HLFGSDLPPLTWKQRLDACIGAARGLH 625
H ++V+ G ++++ + E+ G+L+ H+ G PL+ Q +GL+
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLY 120
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661
YLH+ +G +HRD+K NILL +N K++DFG+S
Sbjct: 121 YLHS---KGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQSEQGL-AEFETE 559
EI ++T F E L G FGKV+KG + E AIK ++E L EF+ E
Sbjct: 1 EINLSTVRFMEEL--GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 560 IEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL--------FGSDLPPLTWK 611
M S+L+H ++V L+G ++ + +++ Y ++ L L GS T K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 612 QRLDA------CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665
L+ A G+ +L + ++H+D+ T N+L+ + K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
+ ++ + ++ PE + + SD++S+GVVL+EV
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 10/193 (5%)
Query: 521 IGVGGFGK-VFKGEIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FGK + ED IK N S + E E+ +LS ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+E + +V +Y G L + Q LD + L ++H +R I+H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILH 124
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
RD+K+ NI L ++ K+ DFG+++ ++E ++ G+ YL PE + K
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNK 181
Query: 697 SDVYSFGVVLFEV 709
SD+++ G VL+E+
Sbjct: 182 SDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFE---TEIEMLSKLRH 568
+F +G GG+G+VF + +D + A+KR L E TE ++L+ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 569 RHLVSLI-GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQR---LDACIGAARGL 624
LV L+ F D++ + L EY+ G R+ L ++L L+ + A L
Sbjct: 61 EWLVKLLYAFQDDEY-LYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
H L G IHRD+K N L+D + K++DFGLSK + ++ V GS Y+
Sbjct: 118 HEL------GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMA 166
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVVC 711
PE + D +S G +L+E +C
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 33/169 (19%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAE---FET--EIEMLSKLRHRHLVSL 574
+G G + V+K E + AIK+ + + F EI++L +L+H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 575 IG-FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQR----LDACIGA-----ARGL 624
+ F + N + LV+E+M +DL + K + A I + RGL
Sbjct: 68 LDVFGHKSN-INLVFEFME----------TDLEKV-IKDKSIVLTPADIKSYMLMTLRGL 115
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT--GPSMEHTH 671
YLH I+HRD+K N+L+ + V K++DFGL+++ P+ + TH
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-14
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 26/185 (14%)
Query: 547 PQSEQGLAEFETEIEMLSKLRHRHLVSLI--GFCDEQNEMILVYEYMANGTLRSHLFGSD 604
P+ E A F E + ++L H ++V+L+ G + V+EY+ TLR L
Sbjct: 16 PEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADG 74
Query: 605 -LPPLT----WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMS 656
LP Q LDA A +GI+HRD+K NI++ AK+
Sbjct: 75 ALPAGETGRLMLQVLDALACAHN----------QGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 657 DFGLSKTGPSMEHTHVSTA-----VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
DFG+ P + V+T V G+ Y PE + +T SD+Y++G++ E +
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
Query: 712 ARAVI 716
+ V+
Sbjct: 185 GQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 38/282 (13%)
Query: 514 NFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRA------NPQSEQGLAEFETEIEMLSKL 566
NF IG G F +V++ + D A+K+ + ++ Q + EI++L +L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59
Query: 567 RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSD---LPPLT-WKQRLDACIGA 620
H +++ + E NE+ +V E G L + F +P T WK + C
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC--- 116
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
+ ++H+ R ++HRD+K N+ + V K+ D GL + S T + ++ G+
Sbjct: 117 -SAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTP 170
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740
Y+ PE KSD++S G +L+E+ A + D++NL K ++
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKIEQCD-- 224
Query: 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
P +YS EK E+ C+ + RP +G V
Sbjct: 225 ---YPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVH 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 515 FDESLMIGVGGFGKV------FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH 568
F + ++G GGFG+V G++ C KR + + +A E +I L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNS 59
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLH 628
+ +V+L + ++ + LV M G L+ H++ P ++ L GL LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
++RD+K NILLD+ ++SD GL+ P E G+ GY+ PE
Sbjct: 120 ---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVL 173
Query: 689 WRQQLTEKSDVYSFGVVLFEVV 710
Q+ T D + G +++E++
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 32/273 (11%)
Query: 514 NFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRA---NPQSEQGLAEFETEIEMLSKLRHR 569
NF IG G F +V++ + D A+K+ + + A+ EI++L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSD---LPPLT-WKQRLDACIGAARG 623
+++ E NE+ +V E G L + F +P T WK + C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
L ++H+ R ++HRD+K N+ + V K+ D GL + S T + ++ G+ Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYM 173
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
PE KSD++S G +L+E+ A + D++NL K ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKK------IEQC 223
Query: 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP 776
P L ++ E L + + C++ + + RP
Sbjct: 224 DYPPLPSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSK 565
E + E +++G G +G V+ ++ AIK + + + EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 566 LRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA--RG 623
L+HR++V +G E + E + G+L S L S PL ++ G
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
L YLH + I+HRD+K N+L++ + V K+SDFG SK + + G+ Y
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQY 175
Query: 683 LDPEYFWRQQ--LTEKSDVYSFGVVLFEVVCAR 713
+ PE + +D++S G + E+ +
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 520 MIGVGGFGKVFKGEIEDCT-LAAIKRANPQSEQGLAEFETEIEMLSK------LRHRHLV 572
M+G G FGKVF E++ AIK + + L + + E M+ K H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 573 SLIGFCDEQNE--MILVYEYMANGTLRSHLFGS---DLPPLTWKQRLDACIGAARGLHYL 627
L +C Q + + V EY+ G L H+ DLP T+ C GL +L
Sbjct: 60 HL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFL 112
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
H+ +GI++RD+K NILLD + K++DFG+ K +M + G+ Y+ PE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDYIAPEI 167
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARA 714
Q+ D +SFGV+L+E++ ++
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 513 NNFDESLMIGVGGFGKVFKGEI-----EDCTL-AAIKRANPQSEQGLAE-FETEIEMLSK 565
NN +G G FGKV + D + A+K P + E +E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 566 L-RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624
L H ++V+L+G C ++++ EY G L + L LT + L A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST-AVKGS---- 679
+L A + IHRD+ N+LL + K+ DFGL++ + + S VKG+
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLP 206
Query: 680 FGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ PE + T +SDV+S+G++L+E+
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 515 FDESLMIGVGGFGKVFKGEIE--------DCT---------LAAIK--RANPQSEQGLAE 555
F E L G G FG+V E E D + L A+K R + ++ +
Sbjct: 9 FKEKL--GEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARND 65
Query: 556 FETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL---------FGSDLP 606
F EI+++S+L+ +++ L+ C + + ++ EYM NG L L +D+
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 607 PLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666
+++ + A G+ YL + +HRD+ T N L+ +N+ K++DFG+S+ S
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
++ + ++ E + T SDV++FGV L+E+
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRA-----NPQSEQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG+V+ + + A+K+ +P++ + + E EI++L L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 574 LIGFCDEQNEMIL--VYEYMANGTLRSHL--FGSDLPPLTWK---QRLDACIGAARGLHY 626
G + E L E+M G+++ L +G+ +T K Q L+ G+ Y
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-------GVSY 121
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK-------TGPSMEHTHVSTAVKGS 679
LH+ I+HRD+K NIL D K+ DFG SK +G M+ +V G+
Sbjct: 122 LHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK------SVTGT 172
Query: 680 FGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR 713
++ PE + K+D++S G + E++ +
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 521 IGVGGFGKVF----KGEIEDCTLAAIKRA-----NPQSEQGLAEFETEIEMLSKLRHRHL 571
+G G FG V+ K + + L +K NP + E ++LSKL H +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNET---VQANQEAQLLSKLDHPAI 64
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYLHT 629
V E++ ++ EY L L L+ Q + I G+HY+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
+R I+HRD+K NI L N + K+ DFG+S+ M ++T G+ Y+ PE
Sbjct: 124 --QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALK 178
Query: 690 RQQLTEKSDVYSFGVVLFEVVC 711
Q KSD++S G +L+E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 47/173 (27%), Positives = 73/173 (42%), Gaps = 56/173 (32%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFET---------EIEMLSKLRHRH 570
IG G +G V + AIK+ + F+ EI++L LRH +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 571 LVSLIGF-----CDEQNEMILVYEYMANGTLRSHLFGSDL-------PPLTWK------- 611
++ L+ ++ N++ +V E M +DL PLT
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELM----------ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664
Q L RGL YLH+ +IHRD+K +NIL++ N K+ DFGL++
Sbjct: 111 QIL-------RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 521 IGVGGFGKVF------KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G GGFG+V G++ C KR +S + +A E EI L K+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+ + + LV M G L+ H++ L ++ + G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
I++RD+K N+LLD+ ++SD GL+ + T G+ GY+ PE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYS 172
Query: 695 EKSDVYSFGVVLFEVVCAR 713
D ++ G ++E+V R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 41/274 (14%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G G V+ ++ AIK+ N Q + EI ++ + +H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA-----RGLHYLHTGAERG 634
+E+ +V EY+A G+L +D+ +T + I A + L +LH+
Sbjct: 87 VGDELWVVMEYLAGGSL------TDV--VTETCMDEGQIAAVCRECLQALEFLHS---NQ 135
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
+IHRD+K+ NILL + K++DFG + E + ST V G+ ++ PE R+
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII---DPHLKGN 751
K D++S G++ E+V P L ++ + R+L I P L+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEP---PYLNENPL------------RALYLIATNGTPELQN- 237
Query: 752 YSPESLEK-FGEIAEKCLDDEGKNRPTMGEVLWH 784
PE L F + +CL+ + + R + E+L H
Sbjct: 238 --PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 520 MIGVGGFGKVFKGEIEDCT-LAAIKRANPQSEQGLAEFETEIEMLSK------LRHRHLV 572
++G G FGKV E++ AIK + + L + + E M+ + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKAL--KKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 573 SLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLD---ACIGAAR---GL 624
L FC Q + + V EY+ G L H+ S R D A AA GL
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSS--------GRFDEARARFYAAEIICGL 109
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
+LH +GII+RD+K N+LLD++ K++DFG+ K + E ++ G+ Y+
Sbjct: 110 QFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIA 164
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE Q+ E D +SFGV+L+E++
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 27/166 (16%)
Query: 515 FDESLMIGVGGFGKVFKG-EIEDCTLAAIKRAN-PQSEQGLAEFET-EIEMLSKLR---H 568
++E IG G +G V+K ++ A+K+ P SE+G+ EI +L +L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 569 RHLVSLIGFC-----DEQNEMILVYEYMAN--GTLRSHLFGSDLPPLTWK----QRLDAC 617
++V L+ C D + ++ LV+E++ T S LPP T K Q L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
RG+ +LH+ I+HRD+K NIL+ + K++DFGL++
Sbjct: 118 ----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 47/294 (15%)
Query: 520 MIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAE--FETEIEMLSKLRHRHLVSLIG 576
++G G +G V K + ++ + AIK+ + + + EI ML +LRH +LV+LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 577 FCDEQNEMILVYEYMANGTLRS-HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
+ + LV+E++ + L + + L ++ L + RG+ + H+ I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL---RGIEFCHS---HNI 121
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKT--GPSMEHT-HVSTAVKGSFGYLDPEYFWRQQ 692
IHRD+K NIL+ ++ V K+ DFG ++T P +T +V+T Y PE
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLVGDT 176
Query: 693 LTEKS-DVYSFGVVLFEVVCARAVINPTLPKDQ-INLADWAMK------------WQKQR 738
++ D+++ G ++ E++ P P D I+ +K +QK
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 739 SLKSIIDPHLKGNYSPESLEK--------FGEIAEKCLDDEGKNRPTMGEVLWH 784
+ P +K E LEK ++A++CL + +RP+ ++L H
Sbjct: 233 LFAGMRLPEVK---EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 84/286 (29%), Positives = 123/286 (43%), Gaps = 52/286 (18%)
Query: 521 IGVGGFGKV-FKGEIEDCTLAAIKRAN---PQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G FG V F ++ + AIK+ + QS + + E+ L +LRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 577 FCDEQNEMILVYEYM---ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
++ LV EY A+ L H PL + C GA +GL YLH+
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHS---H 134
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-- 691
IHRD+K NILL E K++DFG S + S ++ V T ++ PE
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGTPY-----WMAPEVILAMDE 188
Query: 692 -QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
Q K DV+S G+ E+ A P L N+ AM +L H+
Sbjct: 189 GQYDGKVDVWSLGITCIEL----AERKPPL----FNMN--AMS-----ALY-----HIAQ 228
Query: 751 NYSPESLEK------FGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
N SP +L F + CL ++RP+ E+L H +VL+
Sbjct: 229 NDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH-RFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 524 GGFGKVFKGEIED-----CTLAAIKR-ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
G FG++F G + D +K + SE + E +L L H++++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 578 CDEQNEMILV-YEYMANGTLRSHLFGSDLPP------LTWKQRLDACIGAARGLHYLHTG 630
C E E V Y YM G L+ L L L+ +Q + I A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
+RG+IH+D+ N ++DE K++D LS+ M++ + ++ E
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
++ + SDV+SFGV+L+E++
Sbjct: 194 KEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 49/283 (17%)
Query: 521 IGVGGFGKVFKGEIEDC--TLAAIKRA---NPQSEQGLAEFETEIEML--------SKLR 567
+G G FG V+K ++ L A+K NP + E + I + +LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 568 HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL---------FGSDLPPLTWKQRLDACI 618
H ++V E + + +V + + L H F + W + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER---IWNIFVQMVL 124
Query: 619 GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG 678
L YLH E+ I+HRD+ NI+L E+ ++DFGL+K T+V G
Sbjct: 125 A----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVG 175
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
+ Y PE + EK+DV++FG +L+++ + P P N+ A K
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM----CTLQP--PFYSTNMLSLATK----- 224
Query: 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEV 781
++++ +P +G YS E ++ CL + + RP + +V
Sbjct: 225 IVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 520 MIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
++G G FGKV K + + +K+ ++ +A TE +L RH L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
++ + V EY+ G L HL F D + + A L YLH+G
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA-------LDYLHSG 114
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
I++RD+K N++LD++ K++DFGL K G + T + G+ YL PE
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC--GTPEYLAPEVLED 169
Query: 691 QQLTEKSDVYSFGVVLFEVVCAR 713
D + GVV++E++C R
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 515 FDESLMIGVGGFGKV------FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH 568
F + ++G GGFG+V G++ C KR + + +A E +I L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNS 59
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLF-----GSDLPPLTWKQRLDACIGAARG 623
R +VSL + ++ + LV M G L+ H++ G + + C G
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC-----G 114
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
L LH ER I++RD+K NILLD++ ++SD GL+ P E + V G+ GY+
Sbjct: 115 LEDLHQ--ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYM 168
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARA 714
PE ++ T D ++ G +L+E++ ++
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 82/289 (28%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 521 IGVGGFGKVFKGEIEDCTLAA---IKR----ANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
IG G FGKV GE A +K A P EQ L F E++ +L H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-EQLL--FLQEVQPYRELNHPNVLQ 59
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFG-----SDLPPLTWKQRLDACIGAARGLHYLH 628
+G C E +LV E+ G L+++L + + QR+ AC A+ GL +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS-GLLWLH 117
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG--YLDPE 686
+ IH D+ N L + K+ D+GL+ + T + +L PE
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALE--QYPEDYYITKDCHAVPLRWLAPE 172
Query: 687 YF-WRQQ------LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS 739
R Q T+KS+++S GV ++E+ A P L +Q+ L ++
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVR----EQD 227
Query: 740 LKSIIDPHLKGNYSPESLEKFGEIAEKC-LDDEGKNRPTMGEVLWHLEY 787
+K + P L YS +++ E+ + C LD E RPT EV L Y
Sbjct: 228 IK-LPKPQLDLKYS----DRWYEVMQFCWLDPE--TRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G +G V+K + LAA+K + + + EI M+ + +H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 580 EQNEMILVYEYMANGTLRS--HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+ ++ + EY G+L+ H+ G PL+ Q C +GL YLH+ +G +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMH 129
Query: 638 RDVKTTNILLDENFVAKMSDFGLS 661
RD+K NILL +N K++DFG++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 46/236 (19%)
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR--SHLFGSDLPPLTWKQRLDA 616
E++++ + R ++VS G +N + + E+M G+L G P+ ++
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG----PI----PVEI 104
Query: 617 C----IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTH 671
+ GL YL+ I+HRD+K +NIL++ K+ DFG+S + S+ T
Sbjct: 105 LGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162
Query: 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731
V T+ Y+ PE + T KSDV+S G+ + E+ + P N+ D
Sbjct: 163 VGTST-----YMSPERIQGGKYTVKSDVWSLGISIIELALGK------FPFAFSNIDDDG 211
Query: 732 MKWQKQRSLKSIID----------PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777
Q I+D P L + PE L F + CL + RPT
Sbjct: 212 -----QDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF---VDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 70/273 (25%), Positives = 104/273 (38%), Gaps = 65/273 (23%)
Query: 528 KVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587
KV G ED I R EIE+L + H ++V D E+ ++
Sbjct: 105 KVIYGNHEDTVRRQICR--------------EIEILRDVNHPNVVKCHDMFDHNGEIQVL 150
Query: 588 YEYMANGTLRSH-----LFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKT 642
E+M G+L F +D+ +Q L G+ YLH R I+HRD+K
Sbjct: 151 LEFMDGGSLEGTHIADEQFLADVA----RQILS-------GIAYLH---RRHIVHRDIKP 196
Query: 643 TNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE------ 695
+N+L++ K++DFG+S+ +M+ + S G+ Y+ PE L
Sbjct: 197 SNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPERI-NTDLNHGAYDGY 252
Query: 696 KSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII----DPHLKGN 751
D++S GV + E R P DWA SL I P
Sbjct: 253 AGDIWSLGVSILEFYLGR------FPFGVGRQGDWA-------SLMCAICMSQPPEAPAT 299
Query: 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
S E F CL E R + ++L H
Sbjct: 300 ASRE----FRHFISCCLQREPAKRWSAMQLLQH 328
|
Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 521 IGVGGFGKVFKG-----EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V KG + E I + + E E ++ +L + ++V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G C+ ++ M LV E G L + F +T K + + G+ YL E
Sbjct: 63 GICEAESWM-LVMELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNF 116
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH-VSTAVKGSFGYLDPEYFWRQQLT 694
+HRD+ N+LL AK+SDFGLSK + E+ + T K + PE + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 695 EKSDVYSFGVVLFE 708
KSDV+SFGV+++E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 520 MIGVGGFGKVF--KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
++G G FG+ + D A + P+S + + E +L+K++H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 578 CDEQNEMILVYEYMANGTL-------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+ + +V EY G L R LF D L W ++ C+G + ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQM--CLG----VQHIH-- 117
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGP-SMEHTHVSTAVKGSFGYLDPEY 687
E+ ++HRD+K+ NI L +N K+ DFG ++ T P + T+V T Y+ PE
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY-----YVPPEI 171
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCAR 713
+ KSD++S G +L+E+ +
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 38/90 (42%), Positives = 58/90 (64%), Gaps = 5/90 (5%)
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
A L +LH+ GII+RD+K NILLDE K++DFGLSK S++H + + G+
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTV 162
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
Y+ PE R+ T+ +D +SFGV++FE++
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGL-AEFETEIEMLSKLRHRHLVSLIGFC 578
+G G + VFKG + L A+K + E+G E+ +L L+H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC-------------IGAARGLH 625
+ + LV+EY+ SDL KQ LD C RGL
Sbjct: 73 HTERCLTLVFEYL----------DSDL-----KQYLDNCGNLMSMHNVKIFMFQLLRGLS 117
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
Y H +R I+HRD+K N+L++E K++DFGL++ T+ + V + Y P
Sbjct: 118 YCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 172
Query: 686 EYFWRQQLTEKS---DVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ TE S D++ G +L+E+ R + + K++++L
Sbjct: 173 DVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 521 IGVGGFGKVF--KGEIEDCTLA-------AIKRANPQSEQGLAEFETEIEMLSKLRHRHL 571
IG G FGKV K + + A AI + Q +AE +L ++H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHI-MAERNV---LLKNVKHPFL 58
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
V L +++ V +Y+ G L HL P + A I +A G YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLH--- 113
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
II+RD+K NILLD ++DFGL K G +EH+ ++ G+ YL PE +Q
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--IEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 692 QLTEKSDVYSFGVVLFEVV 710
D + G VL+E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 514 NFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRA--NPQSEQGLAE---FETEIEMLSKLR 567
N+ ++G G FG+V+ + + A+K+ +P S++ E E EI++L LR
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 568 HRHLVSLIGFC---DEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAAR 622
H +V G C E+ ++ + EYM G+++ L +G+ LT +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQ 117
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--MEHTHVSTAVKGSF 680
G+ YLH+ I+HRD+K NIL D K+ DFG SK + M T + + V G+
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTP 173
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR 713
++ PE + K+DV+S + E++ +
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 520 MIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
++G G FGKV K + + +K+ ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRL-DACIGAARGLHYLHT 629
+ + V EY G L HL F D + R A I +A L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSA--LGYLH- 112
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
+++RD+K N++LD++ K++DFGL K G S T G+ YL PE
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 168
Query: 690 RQQLTEKSDVYSFGVVLFEVVCAR 713
D + GVV++E++C R
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 31/269 (11%)
Query: 521 IGVGGFGKVFKGEIEDCTLA---AIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G G VF D AIK+ N Q + EI ++ +L++ ++V+ +
Sbjct: 27 IGQGASGTVFTAI--DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+E+ +V EY+A G+L + + + Q C + L +LH +IH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTETCMDE---AQIAAVCRECLQALEFLHANQ---VIH 138
Query: 638 RDVKTTNILLDENFVAKMSDFGL-SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
RD+K+ N+LL + K++DFG ++ P E + ST V G+ ++ PE R+ K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756
D++S G++ E+V P L ++ + R+L I +PE
Sbjct: 196 VDIWSLGIMAIEMVEGEP---PYLNENPL------------RALYLIATNGTPELQNPEK 240
Query: 757 LEK-FGEIAEKCLDDEGKNRPTMGEVLWH 784
L F + +CL+ + + R + E+L H
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 515 FDESLMIGVGGFGKVFKG----EIEDCTL-AAIKR----ANPQSEQGLAEFETEIEMLSK 565
F + ++G G FG V+KG E E + AIK +P++ + E E +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK---EILDEAYVMAS 65
Query: 566 LRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLH 625
+ + H+ L+G C + + L+ + M G L ++ + + L+ C+ A+G++
Sbjct: 66 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMN 123
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
YL ER ++HRD+ N+L+ K++DFGL+K + E + + K ++
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVV 710
E + T +SDV+S+GV ++E++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 520 MIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSK----LRHRHLVSL 574
++G G FGKV + E L A+K + + L + + E M K L H
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 575 IGFCDEQ--NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD---ACIGAAR---GLHY 626
+C Q + + V E++ G L H+ S +R D A AA L +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--------RRFDEARARFYAAEITSALMF 111
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV-KGSFGYLDP 685
LH ++GII+RD+K N+LLD K++DFG+ K G +T+ G+ Y+ P
Sbjct: 112 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI---FNGKTTSTFCGTPDYIAP 165
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVVCARA 714
E D ++ GV+L+E++C A
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHA 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 74/271 (27%), Positives = 109/271 (40%), Gaps = 33/271 (12%)
Query: 521 IGVGGFGKV-FKGEIEDCTLAAIKR---ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G FG V F ++ + + AIK+ + QS + + E+ L KLRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
++ LV EY S L PL + GA +GL YLH+ +I
Sbjct: 83 CYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 137
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ---QL 693
HRDVK NILL E + K+ DFG S + G+ ++ PE Q
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFG------SASIMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753
K DV+S G+ E+ + P +N + S P L+ +
Sbjct: 192 DGKVDVWSLGITCIELAERKP------PLFNMNAMSALYHIAQNES------PALQSGHW 239
Query: 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
E F + CL ++RPT +L H
Sbjct: 240 SEYFRNF---VDSCLQKIPQDRPTSEVLLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 59/250 (23%), Positives = 103/250 (41%), Gaps = 35/250 (14%)
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI 618
E+++L + ++V G E+ + E+M G+L L + P ++ +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 619 GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHVSTAVK 677
RGL YL + I+HRDVK +NIL++ K+ DFG+S + SM ++ V
Sbjct: 109 --LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 159
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
G+ Y+ PE T +SD++S G+ L E+ R I P K+ + + +
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA 219
Query: 738 RSLKSIIDPHLKGNYSPESL-----------------------EKFGEIAEKCLDDEGKN 774
+ + H SP + ++F + +KCL K
Sbjct: 220 KESHRPVSGH--PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKE 277
Query: 775 RPTMGEVLWH 784
R + E+ H
Sbjct: 278 RADLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
++ + LV EY+ G S + P W ++ A + G+ LH +RGIIHR
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV--VLGVEDLH---QRGIIHR 121
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
D+K N+L+D+ K++DFGLS+ G + G+ YL PE + SD
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 699 VYSFGVVLFE 708
+S G V+FE
Sbjct: 176 WWSLGCVIFE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 81/311 (26%), Positives = 125/311 (40%), Gaps = 61/311 (19%)
Query: 521 IGVGGFGKVFKGEIEDC---TLAAIKRANPQSEQGLAEFET--EIEMLSKLRHRHLVSLI 575
IG G +G V AIK+ +P Q + T EI++L + +H +++ ++
Sbjct: 13 IGEGAYGMVCSAT--HKPTGVKVAIKKISPFEHQTFCQ-RTLREIKILRRFKHENIIGIL 69
Query: 576 -----GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRL--DAC------IGAAR 622
+ N++ +V E M +DL L Q L D I R
Sbjct: 70 DIIRPPSFESFNDVYIVQELME----------TDLYKLIKTQHLSNDHIQYFLYQI--LR 117
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK-TGPSMEHTHVSTAVKGSFG 681
GL Y+H+ ++HRD+K +N+LL+ N K+ DFGL++ P +HT T +
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 682 YLDPEYFWRQQLTEKS-DVYSFGVVLFEVVCARAVINPTLP----KDQINLADWAMKWQK 736
Y PE + K+ D++S G +L E++ R P P Q+NL +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR----PLFPGKDYLHQLNLILGVLGTPS 230
Query: 737 QRSLKSIIDPHLKG------NYSPESLEK-FGEIAEKCLDDEGK-------NRPTMGEVL 782
Q L II + K F K LD K R T+ E L
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290
Query: 783 WHLEYVLQLHE 793
H Y+ Q H+
Sbjct: 291 AH-PYLEQYHD 300
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 521 IGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI- 575
+GVGGFG+V K + L +K+ + +E E+L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 576 GFCDEQNEMILVY---EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
F D++ +Y EY G L + L L + AC+ A YLH
Sbjct: 61 TFKDKKY----IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLH---N 111
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
RGII+RD+K N+LLD N K+ DFG +K S + T T G+ Y+ PE +
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKG 168
Query: 693 LTEKSDVYSFGVVLFEVVCAR 713
D +S G++L+E++ R
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 30/232 (12%)
Query: 515 FDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSE-QGLAEFET-EIEMLSKLRHRHL 571
FD IG G +G+V+K +D L A+K+ +E +G EI++L +L HR++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 572 VSL----------IGFCDEQNEMILVYEYMAN---GTLRSHL--FGSDLPPLTWKQRLDA 616
V+L + F ++ LV+EYM + G L S L F D KQ L+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE- 127
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
GL+Y H ++ +HRD+K +NILL+ K++DFGL++ S E + V
Sbjct: 128 ------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 677 KGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ Y PE ++ DV+S G +L E+ + + Q+ L
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 31/180 (17%)
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
+ L YLH+ + +IHRDVK +N+L++ N K+ DFG+S + + T G
Sbjct: 114 KALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKP 168
Query: 682 YLDPEYF----WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
Y+ PE ++ KSDV+S G+ + E+ R P D W +Q+
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGR------FPYDS-----WKTPFQQ- 216
Query: 738 RSLKSIID---PHL-KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
LK +++ P L +SPE F + KCL K RP E+L H + L L +
Sbjct: 217 --LKQVVEEPSPQLPAEKFSPE----FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 517 ESLMIGVGGFGKVFKG---EIED-----CTLAAIKRANPQSEQGLAEFETEIEMLSKLRH 568
ESL G G F K+FKG E+ D T +K + F M+S+L H
Sbjct: 1 ESL--GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH 58
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHL-FGSDLPPLTWKQRLDACIGAARGLHYL 627
+HLV G C +E I+V EY+ G+L ++L +L ++WK L+ A LH+L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFL 116
Query: 628 HTGAERGIIHRDVKTTNILLDEN---------FVAKMSDFGLSKTGPSMEHTHVSTAVKG 678
++G+ H +V N+LL F+ K+SD G+S T E +
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKE------ILLE 166
Query: 679 SFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVC 711
++ PE Q L+ +D +SFG L+E+
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 71/310 (22%), Positives = 128/310 (41%), Gaps = 52/310 (16%)
Query: 521 IGVGGFGKVFKG--EIEDCTLAAIKRANPQSEQGL-AEFETEIEMLSKLRHRHLVSLIGF 577
+G G + V+KG ++ D L A+K + E+G E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC-------------IGAARGL 624
+ + LV+EY+ DL KQ LD C RGL
Sbjct: 73 IHTEKSLTLVFEYL----------DKDL-----KQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
+Y H R ++HRD+K N+L++E K++DFGL++ T+ + V + Y
Sbjct: 118 NYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRP 172
Query: 685 PEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
P+ + + D++ G + +E+ R + + ++Q++ + + + I
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232
Query: 744 I-DPHLKG----NYSPESLEKFG--------EIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ + K Y + L E+ K L EG+ R + E + H Y
Sbjct: 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP-YFHC 291
Query: 791 LHEAWMRTDD 800
L E + D
Sbjct: 292 LGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 77/342 (22%), Positives = 133/342 (38%), Gaps = 93/342 (27%)
Query: 521 IGVGGFGKVFK------GEIEDCTLAAIKR----ANPQSEQGLAEFETEIEMLSKL-RHR 569
+G G FGKV + + C A+K A + L TE+++L + H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM---TELKILIHIGHHL 71
Query: 570 HLVSLIGFCDEQN-EMILVYEYMANGTLRSHL----------------FGSDLPPLTWKQ 612
++V+L+G C + ++++ EY G L ++L KQ
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 613 RLDACIGA-------------------------------------------ARGLHYLHT 629
RLD+ + ARG+ +L
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL-- 189
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
A R IHRD+ NILL EN V K+ DFGL++ + ++ PE +
Sbjct: 190 -ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
+ T +SDV+SFGV+L+E+ A P + D+ ++ + ++ ++
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRRLKEGTRMR-------- 296
Query: 750 GNYSPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+PE + + I C + ++RPT E++ L +LQ
Sbjct: 297 ---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 34/165 (20%)
Query: 514 NFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSE-QGLAEFET-EIEMLSKLRHRH 570
+++ IG G +G VFK E + A+KR + +G+ EI +L +L+H++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA--------- 621
+V L ++ LV+EY DL K+ D+C G
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC----------DQDL-----KKYFDSCNGDIDPEIVKSFM 105
Query: 622 ----RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662
+GL + H ++HRD+K N+L+++N K++DFGL++
Sbjct: 106 FQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 515 FDESLMIGVGGFGKV------FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH 568
F ++G GGFG+V G++ C KR + + +A E I L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNS 59
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR---GLH 625
R +VSL + ++ + LV M G L+ H++ P +QR A AA GL
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD-EQR--AIFYAAELCCGLE 116
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
L ER I++RD+K NILLD+ ++SD GL+ P E G+ GY+ P
Sbjct: 117 DLQR--ER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAP 170
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVV 710
E ++ T D + G +++E++
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 520 MIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
++G G FGKV K + +K+ ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
+ + V EY G L HL + + A I +A L YLH +E+ +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH--SEKNV 117
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE 695
++RD+K N++LD++ K++DFGL K G ++ G+ YL PE
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 696 KSDVYSFGVVLFEVVCAR 713
D + GVV++E++C R
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFET-EIEMLSKLRHRHL 571
NF + +G G + V+KG + A+K + +E+G EI ++ +L+H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLR---SHLFGSDLPPLTWK----QRLDACIGAARGL 624
V L +N+++LV+EYM + +H L P T K Q L +G+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL-------KGI 113
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
+ H E ++HRD+K N+L+++ K++DFGL++ +T + V + Y
Sbjct: 114 AFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRA 168
Query: 685 PEYFWRQQLTEKS-DVYSFGVVLFEVVCARAVINPTLPKDQINL 727
P+ + S D++S G ++ E++ R + T +DQ+
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLR---HRHLVSL 574
IGVG +G V+K + A+K Q+ + T E+ +L +L H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 575 IGFC-----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
+ C D + ++ LV+E++ + LR++L P L + D RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS-TAVKGSFGYLDPEYF 688
I+HRD+K NIL+ K++DFGL++ + ++ T V + Y PE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTPVVVTLWYRAPEVL 179
Query: 689 WRQQLTEKSDVYSFGVVLFEV 709
+ D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 79/288 (27%), Positives = 123/288 (42%), Gaps = 44/288 (15%)
Query: 515 FDESLMIGVGGFGKV-FKGEIEDCTLAAIKR---ANPQSEQGLAEFETEIEMLSKLRHRH 570
F + IG G FG V F ++ + AIK+ + QS + + E++ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+ G ++ LV EY S L PL + GA +GL YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQGLAYLHS- 143
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
+IHRD+K NILL E K++DFG S + S ++ V T ++ PE
Sbjct: 144 --HNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSFVGTPY-----WMAPEVILA 195
Query: 691 Q---QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747
Q K DV+S G+ E+ A P L N+ + + H
Sbjct: 196 MDEGQYDGKVDVWSLGITCIEL----AERKPPL----FNMNAMSALY------------H 235
Query: 748 LKGNYSP-----ESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ N SP E + F + CL ++RPT E+L H+ +VL+
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM-FVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 520 MIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
++G G FGKV K + +++ ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+ + V EY G L HL F + + + A L YLH+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA-------LEYLHS- 113
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
R +++RD+K N++LD++ K++DFGL K G S T + G+ YL PE
Sbjct: 114 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLED 169
Query: 691 QQLTEKSDVYSFGVVLFEVVCAR 713
D + GVV++E++C R
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 34/171 (19%)
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHVSTAVKGSFGY 682
LHYL + G+IHRDVK +NILLD + K+ DFG+S + S T G Y
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR----SAGCAAY 180
Query: 683 LDPEYFWRQQLTEK----SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
+ PE K +DV+S G+ L E+ + P ++ +
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ------FPYKNCK-TEFEV------ 227
Query: 739 SLKSIID-----PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
L I+ +SP+ F + CL + + RP E+L H
Sbjct: 228 -LTKILQEEPPSLPPNEGFSPD----FCSFVDLCLTKDHRKRPKYRELLQH 273
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 38/264 (14%)
Query: 515 FDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLV 572
F+ ++G G +G+V+KG ++ LAAIK + ++ E + EI ML K HR++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 573 SLIGFCDEQN------EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHY 626
+ G ++N ++ LV E+ G++ + + L + C RGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT-HVSTAVKGSFGYLDP 685
LH + +IHRD+K N+LL EN K+ DFG+S ++ T G+ ++ P
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAP 180
Query: 686 EYFWRQQLTE-----KSDVYSFGVVLFEV------VC----ARAV-INPTLPKDQINLAD 729
E + + KSD++S G+ E+ +C RA+ + P P ++
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240
Query: 730 WAMKWQKQRSLKSIIDPHLKGNYS 753
W+ K+Q S I+ L N+S
Sbjct: 241 WSKKFQ------SFIESCLVKNHS 258
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSL 574
+IG G + KV ++ + +K+ ++ + +TE + + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
++ + V EY+ G L H+ P + A I A L+YLH ERG
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH---ERG 116
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
II+RD+K N+LLD K++D+G+ K G + ++ G+ Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 695 EKSDVYSFGVVLFEVVCARA 714
D ++ GV++FE++ R+
Sbjct: 175 FSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 514 NFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANP----QSEQGLAEFETEIEMLSK 565
NF+ ++G G +GKVF G + L A+K Q + TE ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 566 LRHR-HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624
+R LV+L ++ L+ +Y+ G L +HL+ + + + A I A L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA--L 118
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHTHVSTAVKGSFGY 682
+LH + GII+RD+K NILLD ++DFGLSK E + + G+ Y
Sbjct: 119 DHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEY 172
Query: 683 LDPEYFWRQQLTEKS--DVYSFGVVLFEVV 710
+ PE D +S GV+ FE++
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 64/281 (22%), Positives = 120/281 (42%), Gaps = 41/281 (14%)
Query: 514 NFDESLMIGVGGFGKV-FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV 572
D + IG G G V + A+K+ + + +Q E+ ++ +H ++V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPP---LTWKQRLDACIGAARGLHYLHT 629
+ +E+ +V E++ G L +D+ + +Q C+ + L +LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFG----LSKTGPSMEHTHVSTAVKGSFGYLDP 685
+G+IHRD+K+ +ILL + K+SDFG +SK P + ++ G+ ++ P
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK------SLVGTPYWMAP 184
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745
E R + D++S G+++ E+V P + Q + ++ +
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGE----PPYFNEP--------PLQAMKRIRDNLP 232
Query: 746 PHLKG--NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
P LK SP L F ++ L + R T E+L H
Sbjct: 233 PKLKNLHKVSPR-LRSF---LDRMLVRDPAQRATAAELLNH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 25/167 (14%)
Query: 521 IGVGGFGKVFK-GEIEDCTLAAIKRANPQSEQGLAEFET---EIEMLSKLRHRHLVSLIG 576
IG G +G VFK E + AIK+ +SE + EI ML +L+H +LV+LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 577 FCDEQNEMILVYEYMAN---GTLRSHLFGSD---LPPLTWKQRLDACIGAARGLHYLHTG 630
+ ++ LV+EY + L + G + + W Q L A +++ H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW-QTLQA-------VNFCH-- 117
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHT-HVST 674
+ IHRDVK NIL+ + K+ DFG ++ TGP ++T +V+T
Sbjct: 118 -KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 66/277 (23%), Positives = 124/277 (44%), Gaps = 45/277 (16%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQG-LAEFETEIEMLSKLRH---RHLVSL 574
+IG G +G V++G + + A+K N + +++ + E+ +LS+LR ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI--GAARGLHYLHTGAE 632
G + + ++ EY G++R+ + + ++ + I L Y+H +
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI-----AEKYISVIIREVLVALKYIH---K 119
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
G+IHRD+K NIL+ K+ DFG++ S T V T ++ PE
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-----WMAPEVIT 174
Query: 690 R-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID--- 745
+ K+D++S G+ ++E+ NP P ++ R++ I
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG----NP--PYSDVDAF---------RAMMLIPKSKP 219
Query: 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
P L+ N + L +F +A CLD+E K R + E+L
Sbjct: 220 PRLEDNGYSKLLREF--VA-ACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGL-AEFETEIEMLSKLRHRHLVSLIGFC 578
+G G + VFKG + L A+K + E+G E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC-------------IGAARGLH 625
+ LV+EY+ DL KQ +D C RGL
Sbjct: 74 HTDKSLTLVFEYL----------DKDL-----KQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
Y H R ++HRD+K N+L++E K++DFGL++ T+ + V + Y P
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 173
Query: 686 EYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ + + + D++ G + FE+ R + + +D+++L
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 520 MIGVGGFGKVFKGEIEDCT-------LAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHL 571
++G GG+GKVF+ + +K+A ++++ A + E +L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAAR---G 623
V LI ++ L+ EY++ G L HL F D AC +
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT----------ACFYLSEISLA 112
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
L +LH +GII+RD+K NILLD K++DFGL K S+ V+ G+ Y+
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE--SIHEGTVTHTFCGTIEYM 167
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE R + D +S G ++++++
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 512 TNNFDESLMIGVGGFGKVFK-GEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHR 569
T+ ++ IG G +GKV+K +D +LAA+K +P S+ E E E +L L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 570 HLVSLIGFCDEQNEMI-----LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI------ 618
++V G + ++++ LV E G++ + G L QRLD +
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL----LICGQRLDEAMISYILY 135
Query: 619 GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG 678
GA GL +LH IIHRDVK NILL K+ DFG+S S +T+V
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGT 191
Query: 679 SFGYLDPEYFWRQQLTEKS-----DVYSFGVVLFEV 709
F ++ PE +Q + S DV+S G+ E+
Sbjct: 192 PF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 514 NFDESLMIGVGGFGKVFKGE-IEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRH 570
NF + IG G +G V+K + A+K R + ++E + EI +L +L H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+V L+ +N++ LV+E++ + L+ + S L + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG--PSMEHTH-VSTAVKGSFGYLDPEY 687
+ R ++HRD+K N+L++ K++DFGL++ P +TH V T Y PE
Sbjct: 118 SHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT-----LWYRAPEI 171
Query: 688 FWRQQL-TEKSDVYSFGVVLFEVVCARAV 715
+ + D++S G + E+V RA+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 78/343 (22%), Positives = 143/343 (41%), Gaps = 49/343 (14%)
Query: 513 NNFDESLMIGVGGFGKV------FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL 566
+FD ++G G FG+V G+I + +K++ +++ ++ FE E ++LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDI--YAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 567 RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL------FGSDLPPLTWKQRLDACIGA 620
+ L +++ + LV EY G L S L F D+ + + A
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA---- 114
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
+H +H + G +HRD+K N+L+D K++DFG S + S G+
Sbjct: 115 ---IHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTP 167
Query: 681 GYLDPEYFWRQQLTEKS------DVYSFGVVLFEVVCARAVINP-TLPKDQINLADWAMK 733
Y+ PE K D +S GV+ +E++ R+ + T K N+ ++
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--- 224
Query: 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEG-KNRPTMGEVLWH-LEYVLQL 791
QR LK DP + ++ + ++ ++ L EG P ++ W+ + L
Sbjct: 225 ---QRFLKFPEDPKVSSDFL-DLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPP 280
Query: 792 HEAWMRTDD--------RQNSFSSSQALGEFAEREAEDGQDAP 826
+++DD +NS SQ+ + G+D P
Sbjct: 281 FVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLP 323
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLA--AIKR-ANP-QSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G +G+V + T AIK+ + P QS E+ +L + H +++ L+
Sbjct: 23 VGSGAYGQVCSA-FDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 577 -FC-DEQNEMIL-VYEYMANGTLRSHLFGSDLPPLTWKQRL-DACI-----GAARGLHYL 627
F E VY L +HL G+DL + Q+L D I RGL Y+
Sbjct: 82 VFTPASSLEDFQDVY-------LVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYI 134
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE- 686
H+ GIIHRD+K +NI ++E+ K+ DFGL++ +V+T Y PE
Sbjct: 135 HSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 186
Query: 687 YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726
+ D++S G ++ E++ + + + DQ+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK 226
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 57/190 (30%), Positives = 88/190 (46%), Gaps = 25/190 (13%)
Query: 605 LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664
PLT + + ARG+ +L A R IHRD+ NILL EN V K+ DFGL++
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD- 223
Query: 665 PSMEHTHVSTAVKGS----FGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTL 720
+ KGS ++ PE + + T +SDV+SFGV+L+E+ A P +
Sbjct: 224 ---IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280
Query: 721 PKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGE 780
QIN ++ + + +++ N +PE I C + K RPT
Sbjct: 281 ---QIN-EEFCQRLKDGTRMRA------PENATPE----IYRIMLACWQGDPKERPTFSA 326
Query: 781 VLWHLEYVLQ 790
++ L +LQ
Sbjct: 327 LVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 607 PLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666
LT + + A+G+ +L A R IHRD+ NILL EN V K+ DFGL++
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726
+ ++ PE + + T +SDV+SFGV+L+E+ A P + D+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 289
Query: 727 LADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ R LK +PE + + C E RPT E++ HL
Sbjct: 290 --------EFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 337
Query: 787 YVLQ 790
+LQ
Sbjct: 338 NLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 57/177 (32%), Positives = 84/177 (47%), Gaps = 24/177 (13%)
Query: 557 ETEIEMLSKLRHRHLVSLIGFCDEQNEMILV---YEYMANGTLRSHLFGSDLPPLTWKQR 613
EI++L + HR +++LI ++ + +V Y+ L +++ S PL +Q
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSG--PLPLEQA 187
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHV 672
+ L YLH RGIIHRDVKT NI LDE A + DFG + K H
Sbjct: 188 ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD---AHPD- 240
Query: 673 STAVKGSFGYLD---PEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726
+ G G L+ PE K+D++S G+VLFE+ +V N TL Q+
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM----SVKNVTLFGKQVK 293
|
Length = 392 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 42/149 (28%), Positives = 82/149 (55%), Gaps = 14/149 (9%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQSE-QGLAEFET-EIEMLSKLRHRHLVSLIGF 577
IG G +G V+KG + + A+K+ +SE +G+ EI +L +L+H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 578 CDEQNEMILVYEYMANGTLRSHL----FGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+++ + L++E+++ L+ +L G + K L + +G+ + H+ R
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL---QGILFCHS---R 120
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSK 662
++HRD+K N+L+D V K++DFGL++
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 49/184 (26%), Positives = 68/184 (36%), Gaps = 40/184 (21%)
Query: 23 KSFLINCGTNSSVNVDGRKWVGDLASNN-------NVTLSSSGIAATTDSLSGDSIYEPL 75
INCG + DG + D + T SS IA TTD L
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAGTTDPE--------L 52
Query: 76 YKTARVFADGLNYTFEIIA-GNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAP 134
Y+T R +Y + GNY V LHF F + + + F V G +L +F
Sbjct: 53 YQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGKLVLKDF--- 109
Query: 135 GEISHRNLYLQSSGGNSSSISLVKEYF-LGVDLDKLMIEF---------IPSKGSFG--F 182
++ +GG + KEY + V L I F IP +G +G
Sbjct: 110 ------DIV-AEAGGKGKTA--HKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVYGNPK 160
Query: 183 INAI 186
I+AI
Sbjct: 161 ISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 54/171 (31%), Positives = 84/171 (49%), Gaps = 24/171 (14%)
Query: 505 LAEIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEML 563
L+ +R F+ ++G G +G+V+KG ++ LAAIK + +E E + EI ML
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINML 66
Query: 564 SKL-RHRHLVSLIG-FCDEQ-----NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA 616
K HR++ + G F + +++ LV E+ G++ +DL T L
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV------TDLVKNTKGNALKE 120
Query: 617 ------CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661
C RGL +LH +IHRD+K N+LL EN K+ DFG+S
Sbjct: 121 DWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 515 FDESLMIGVGGFGKV-FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
D + IG G G V E A+K+ + + +Q E+ ++ H ++V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ +E+ +V E++ G L + + + +Q C+ R L YLH +
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRM---NEEQIATVCLSVLRALSYLHN---Q 137
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFG----LSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
G+IHRD+K+ +ILL + K+SDFG +SK P + ++ G+ ++ PE
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK------SLVGTPYWMAPEVIS 191
Query: 690 RQQLTEKSDVYSFGVVLFEVV 710
R + D++S G+++ E++
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 520 MIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-----EQGLAEFETEIEMLSKLRHRHLVS 573
+IG G FGKV + + D + A+K ++ EQ E + +L L+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGA 631
L ++ V +Y+ G L HL L P + R A A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAA-EVASAIGYLHS-- 114
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
II+RD+K NILLD ++DFGL K G +E ++ G+ YL PE ++
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 692 QLTEKSDVYSFGVVLFEVV 710
D + G VL+E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 521 IGVGGFGKVFKGE--IEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLR---HRHLVS 573
IG G +GKVFK A+KR Q+ + T E+ +L L H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 574 LIGFC-----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLH 628
L C D + ++ LV+E++ + L ++L P + + D RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+ ++HRD+K NIL+ + K++DFGL++ T+V + Y PE
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 181
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725
+ D++S G + E+ + + + DQ+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G G V+ +I AIK+ N Q + EI ++ + ++ ++V+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+E+ +V EY+A G+L + + + Q C + L +LH+ +IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALDFLHSNQ---VIHRD 140
Query: 640 VKTTNILLDENFVAKMSDFGL-SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
+K+ NILL + K++DFG ++ P E + ST V G+ ++ PE R+ K D
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLE 758
++S G++ E+V P L ++ + R+L I +PE L
Sbjct: 198 IWSLGIMAIEMVEGEP---PYLNENPL------------RALYLIATNGTPELQNPERLS 242
Query: 759 K-FGEIAEKCLDDEGKNRPTMGEVLWH 784
F + +CL+ + R + E+L H
Sbjct: 243 AVFRDFLNRCLEMDVDRRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 68/234 (29%), Positives = 99/234 (42%), Gaps = 40/234 (17%)
Query: 553 LAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL-FGSDLPPLTWK 611
LA FET ++S+L H+HLV L G C E I+V EY+ G L L + L WK
Sbjct: 46 LAFFET-ASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK 103
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL-----DENFV--AKMSDFGLSKTG 664
LD A LHYL ++ ++H +V NIL+ +E +V K+SD G+ T
Sbjct: 104 --LDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQ--LTEKSDVYSFGVVLFEVVCARAVINPTLPK 722
S E V ++ PE Q LT +D +SFG L E+ N P
Sbjct: 159 LSREER-VERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEPL 207
Query: 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP 776
++ ++ +Q Q L P+ E + +C + RP
Sbjct: 208 STLSSSEKERFYQDQHRLP-----------MPDCAE-LANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 40/174 (22%)
Query: 513 NNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET---------EIEM 562
+ +++ IG G FG+VFK + + A+K+ L E E EI++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-------LMENEKEGFPITALREIKI 64
Query: 563 LSKLRHRHLVSLIGFCDEQNEM--------ILVYEYMAN---GTLRSHLFGSDLPPL--T 609
L L+H ++V+LI C + LV+E+ + G L + L +
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 610 WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
K L+ GL+Y+H I+HRD+K NIL+ ++ + K++DFGL++
Sbjct: 125 MKMLLN-------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 521 IGVGGFGKV----FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI- 575
+G G FG+V KG E + +K+ + + E +L +L H +V+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
F DE N + + E++ G L +HL F +D+ + + A YLH
Sbjct: 86 SFQDE-NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA-------FEYLH-- 135
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
+ II+RD+K N+LLD K++DFG +K P T + G+ YL PE
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQS 189
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
+ + D ++ GV+L+E +
Sbjct: 190 KGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-10
Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 47/291 (16%)
Query: 550 EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLT 609
E+ A +E+ L+ H +V ++++L+ EY + G L +
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--------- 156
Query: 610 WKQRLDACIGAAR---GLHY------LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660
KQRL + GL + L R ++HRD+K+ NI L + K+ DFG
Sbjct: 157 -KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGF 215
Query: 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTL 720
SK V+++ G+ YL PE + R++ ++K+D++S GV+L+E++ TL
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL--------TL 267
Query: 721 PKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL---EKFGEIAEKCLDDEGKNRPT 777
+ K QR I+ L G Y P + + L RPT
Sbjct: 268 HR--------PFKGPSQR---EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPT 316
Query: 778 MGEVLWH--LEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAEDGQDAP 826
++L L+YV L + +R + + + L + E G+ AP
Sbjct: 317 TQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQL----QESGERAP 363
|
Length = 478 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 515 FDESLMIGVGGFGKV------FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH 568
F ++G GGFG+V G++ C KR + + +A E +I L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNS 59
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLH 628
R +VSL + ++ + LV M G L+ H++ P ++ + GL LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
ER I++RD+K NILLD+ ++SD GL+ P E + V G+ GY+ PE
Sbjct: 120 R--ER-IVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRV-GTVGYMAPEVV 173
Query: 689 WRQQLTEKSDVYSFGVVLFEVV 710
++ T D + G +++E++
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 520 MIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSL 574
+IG G + KV K + + +K+ ++ + +TE + + + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+ + LV EY+ G L H+ P + A I A L++LH ERG
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLH---ERG 116
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
II+RD+K N+LLD + K++D+G+ K G + ++ G+ Y+ PE ++
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW 730
D ++ GV++FE++ R+ + +N D+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 515 FDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
D + IG G G V ++ L A+K+ + + +Q E+ ++ +H ++V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ +E+ +V E++ G L + + + +Q C+ + L LH +
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRM---NEEQIAAVCLAVLKALSVLHA---Q 135
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFG----LSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
G+IHRD+K+ +ILL + K+SDFG +SK P + ++ G+ ++ PE
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK------SLVGTPYWMAPELIS 189
Query: 690 RQQLTEKSDVYSFGVVLFEVV 710
R + D++S G+++ E+V
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 73/272 (26%), Positives = 115/272 (42%), Gaps = 35/272 (12%)
Query: 521 IGVGGFGKV-FKGEIEDCTLAAIKR---ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G FG V F + A+K+ + Q+ + + E++ L +L+H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
+++ LV EY S L PL + GA +GL YLH+ +I
Sbjct: 89 CYLKEHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143
Query: 637 HRDVKTTNILLDENFVAKMSDFG-LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ---Q 692
HRD+K NILL E K++DFG SK+ P + + G+ ++ PE Q
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQ 196
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
K DV+S G+ E+ A P L N+ + + ++ P L+ N
Sbjct: 197 YDGKVDVWSLGITCIEL----AERKPPL----FNMNAMSALYHIAQN----DSPTLQSNE 244
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+S F + CL + RP E+L H
Sbjct: 245 WTDSFRGF---VDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 27/205 (13%)
Query: 520 MIGVGGFGKVFKG----EIEDCTL-AAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLV 572
++G G FG V+KG + E+ + AIK R N S + E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVC 72
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHL------FGS-DLPPLTWKQRLDACIGAARGLH 625
L+G C + + LV + M G L ++ GS DL L W C+ A+G+
Sbjct: 73 RLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL--LNW------CVQIAKGMS 123
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
YL E ++HRD+ N+L+ K++DFGL++ E + + K ++
Sbjct: 124 YLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVV 710
E ++ T +SDV+S+GV ++E++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 43/235 (18%)
Query: 514 NFDESLMIGVGGFGKVFK------GEIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSK 565
F++ IG G +G V++ GEI A+K+ +E+ + EI +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEI-----VALKKVRMDNERDGIPISSLREITLLLN 62
Query: 566 LRHRHLVSL----IGFCDEQNEMILVYEY----MANGTLRSHLFGSDLPPLTWKQRLDAC 617
LRH ++V L +G + + LV EY +A+ L + P + Q
Sbjct: 63 LRHPNIVELKEVVVG--KHLDSIFLVMEYCEQDLAS------LLDNMPTPFSESQVKCLM 114
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
+ RGL YLH E IIHRD+K +N+LL + K++DFGL++T V
Sbjct: 115 LQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 678 GSFGYLDPE-YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP----KDQINL 727
+ Y PE T D+++ G +L E++ P LP +Q++L
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL----AHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G G V+ ++ AI++ N Q + EI ++ + ++ ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+E+ +V EY+A G+L + + + Q C + L +LH+ +IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 640 VKTTNILLDENFVAKMSDFGL-SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
+K+ NILL + K++DFG ++ P E + ST V G+ ++ PE R+ K D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLE 758
++S G++ E++ P L ++ + R+L I +PE L
Sbjct: 199 IWSLGIMAIEMIEGEP---PYLNENPL------------RALYLIATNGTPELQNPEKLS 243
Query: 759 K-FGEIAEKCLDDEGKNRPTMGEVLWH 784
F + +CLD + + R + E+L H
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 46/231 (19%)
Query: 521 IGVGGFGKVFK-GEIEDCTLAAIKRANPQSEQGLAEFET---EIEMLSKLRHRHLVSLI- 575
IG G FG V+ + D A+K+ P Q L + E++ML +H +++S +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 576 ----GFCDEQNEMILVYEYMANGTLRSHLFGSDL-------PPLTWK-------QRLDAC 617
D E+ +V E M SDL PL+ Q L
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQ----------SDLHKIIVSPQPLSSDHVKVFLYQIL--- 113
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
RGL YLH+ GI+HRD+K N+L++ N V K+ DFGL++ E H++ V
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 678 GSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ Y PE + T D++S G + E++ R + P Q++L
Sbjct: 167 TQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 36/238 (15%)
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI 618
E+++L K ++V G + + + EYM G+L L+ + + + I
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRI 107
Query: 619 GAA--RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHVSTA 675
A +GL +L E IIHRDVK TN+L++ N K+ DFG+S S+ T++
Sbjct: 108 TYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--- 162
Query: 676 VKGSFGYLDPEYF------WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729
G Y+ PE T +SDV+S G+ + E+ R P P+ N+
Sbjct: 163 --GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY---PYPPETYANIFA 217
Query: 730 WAMKWQKQRSLKSIID---PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
L +I+D P L YS ++ + KCL+ RPT ++L H
Sbjct: 218 ---------QLSAIVDGDPPTLPSGYSDDA----QDFVAKCLNKIPNRRPTYAQLLEH 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 520 MIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSK------LRHR 569
++G G FGKV KG+ E + A+K+ + L + + E M+ K +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKK-----DVVLIDDDVECTMVEKRVLALAWENP 56
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD---ACIGAAR---G 623
L L + + V E++ G L H+ K R D A AA G
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI--------QDKGRFDLYRATFYAAEIVCG 108
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
L +LH+ +GII+RD+K N++LD + K++DFG+ K ++ ++ G+ Y+
Sbjct: 109 LQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYI 163
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARA 714
PE + T D +SFGV+L+E++ ++
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 5e-10
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 39/208 (18%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFET-----EIEMLSKL-RHRHLVS 573
+G G FG V+ ++ L AIK+ + +E E++ L KL H ++V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLF----GSDLPPLTWK----QRLDACIGAARGLH 625
L E +E+ V+EYM G L L G + Q L GL
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLY-QLMKDRKGKPFSESVIRSIIYQILQ-------GLA 113
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME-HT-HVSTAVKGSFGYL 683
++H G HRD+K N+L+ V K++DFGL++ S +T +VST Y
Sbjct: 114 HIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYR 165
Query: 684 DPEYFWRQQL-TEKSDVYSFGVVLFEVV 710
PE R + D+++ G ++ E+
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 31/232 (13%)
Query: 558 TEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC 617
+E+E+L K +++ G +N + + E+M G+L ++ + +
Sbjct: 48 SELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL--DVYRKIPEHVLGR----IA 101
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHVSTAV 676
+ +GL YL + I+HRDVK +N+L++ K+ DFG+S + S+ T+V
Sbjct: 102 VAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---- 154
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736
G+ Y+ PE +Q SDV+S G+ E+ R P + K+Q +L +
Sbjct: 155 -GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR-FPYPQIQKNQGSLMPLQL---- 208
Query: 737 QRSLKSIID---PHLK-GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
L+ I+D P L G +S EKF +C+ + K RP ++ H
Sbjct: 209 ---LQCIVDEDPPVLPVGQFS----EKFVHFITQCMRKQPKERPAPENLMDH 253
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 31/284 (10%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSL 574
+IG G + KV E++ + IK+ ++ + +TE + H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
++ + V E+++ G L H+ P + A I A L++LH ERG
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNFLH---ERG 116
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
II+RD+K N+LLD K++D+G+ K G + ++ G+ Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 695 EKSDVYSFGVVLFEVVCARA---VINPTLPKDQINLADWAMK--WQKQ----RSLKSIID 745
D ++ GV++FE++ R+ ++ + DQ N D+ + +KQ RSL
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ-NTEDYLFQVILEKQIRIPRSLSVKAS 233
Query: 746 PHLKGNYSPESLEKFGEIAEKCLDDEG----KNRPTMGEVLWHL 785
LKG + + E+ G C G K+ P + W L
Sbjct: 234 SVLKGFLNKDPKERLG-----CHPQTGFRDIKSHPFFRNIDWDL 272
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 35/165 (21%)
Query: 521 IGVGGFGKVFKG---EIEDCTLAAIKRANPQSEQGLAEFET---EIEMLSKLRHRHLVSL 574
IG G +G+V+K +D AIK+ EQ ++ EI +L +L+H ++VSL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 575 IGFCDEQNEMI--LVYEYMANGTL-----------RSHLFGSDLPPLTWKQRLDACIGAA 621
+ E + L+++Y A L R + S + L W Q L+
Sbjct: 68 VEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN------ 119
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSK 662
G+HYLH ++HRD+K NIL+ E V K+ D GL++
Sbjct: 120 -GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 36/91 (39%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
+ L+YL E IIHRDVK +NILLD N K+ DFG+S + + T G
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRP 172
Query: 682 YLDPEY---FWRQQLTEKSDVYSFGVVLFEV 709
Y+ PE R +SDV+S G+ L+EV
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 505 LAEIRVATNNFDESLMIGVGGFGKV-FKGEIEDCTLAAIKRANP-----QSEQGLAEFET 558
+ ++R+ +FD +IG G FG+V + A+K + +S+ A F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS--AFFWE 92
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA 616
E ++++ +V L Q++ + +V EYM G L + + D+P W + A
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTA 149
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT---HVS 673
+ A L +H+ G IHRDVK N+LLD++ K++DFG T M+
Sbjct: 150 EVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCD 201
Query: 674 TAVKGSFGYLDPEYFWRQ----QLTEKSDVYSFGVVLFEVV 710
TAV G+ Y+ PE Q + D +S GV L+E++
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 26/183 (14%)
Query: 538 TLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595
TL A+K+ N S++ L + EI +L+H +++ + +E+ +V MA G+
Sbjct: 26 TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85
Query: 596 ----LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF 651
L++H F LP L L L Y+H +G IHR VK ++ILL +
Sbjct: 86 CEDLLKTH-FPEGLPELAIAFILK---DVLNALDYIH---SKGFIHRSVKASHILLSGDG 138
Query: 652 VAKMSDFGLSKTGPSMEHTHVSTAVKGS-------FGYLDPEYFWRQQL---TEKSDVYS 701
+S GL + ++H V +L PE +Q L EKSD+YS
Sbjct: 139 KVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL-QQNLQGYNEKSDIYS 195
Query: 702 FGV 704
G+
Sbjct: 196 VGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 520 MIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-----SEQGLAEFETEIEMLSKLRHRHLVS 573
+IG G FGKV + + D A+K + EQ E + +L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L ++ V +++ G L HL P + A I +A G YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---I 115
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
I++RD+K NILLD ++DFGL K G + T +T G+ YL PE +Q
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPY 173
Query: 694 TEKSDVYSFGVVLFEVV 710
D + G VL+E++
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 10/166 (6%)
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI 618
E+++L + ++V G E+ + E+M G+L L + P ++ I
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS--I 110
Query: 619 GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHVSTAVK 677
RGL YL + I+HRDVK +NIL++ K+ DFG+S + SM ++ V
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 163
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
G+ Y+ PE + +SD++S G+ L E+ R I P K+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 521 IGVGGFGKVFKGE--IEDCTLAAIKRANPQSEQGLAEFET-EIEMLSKLRHRHLVSLIGF 577
IG G +G V+K + + T+A K Q ++G+ EI +L +++H ++V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI--GAARGLHYLHTGAERGI 635
+ + LV+EY+ + L+ H+ S P RL RG+ Y H+ +
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS---HRV 123
Query: 636 IHRDVKTTNILLDENFVA-KMSDFGLSKTG--PSMEHTH-VSTAVKGSFGYLDPEYFW-R 690
+HRD+K N+L+D A K++DFGL++ P TH V T Y PE
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT-----LWYRAPEILLGS 178
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
+ + D++S G + E+V + P P D
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK----PLFPGD 207
|
Length = 294 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 508 IRVATNNFDESLMIGVGGFGKV----FKGEIEDCTLAAIKRANPQSEQGLAEFETEIEML 563
+++ ++D +IG G FG+V K + + + + A F E +++
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 564 SKLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
+ +V L FC Q++ + +V EYM G L + + D+P W + A + A
Sbjct: 98 AFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLA 154
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
L +H+ G+IHRDVK N+LLD++ K++DFG TAV G+
Sbjct: 155 --LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPD 208
Query: 682 YLDPEYFWRQ----QLTEKSDVYSFGVVLFEVV 710
Y+ PE Q + D +S GV LFE++
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHR 569
+++++ +G G + V+KG+ + + L A+K Q E+G F E +L L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGT---LRSHLFGSDLPPLTWKQRLDACIGAARGLHY 626
++V L + + LV+EY+ + H G L P K L + RGL Y
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG--LHPENVKLFLFQLL---RGLSY 118
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
+H +R I+HRD+K N+L+ + K++DFGL++ HT+ + V + Y P+
Sbjct: 119 IH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPD 173
Query: 687 YFWRQQLTEKS---DVYSFGVVLFEVV 710
TE S D++ G + E++
Sbjct: 174 VLLGS--TEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 39/170 (22%)
Query: 521 IGVGGFGKVFKG--EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHRHLVSLIG 576
+G G + V+KG ++ L A+K + E+G A F E +L L+H ++V+L
Sbjct: 13 LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA-------------RG 623
+ + LV+EY+ +DL KQ +D C G RG
Sbjct: 71 IIHTKKTLTLVFEYLD----------TDL-----KQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL--SKTGPSMEHTH 671
L Y H +R ++HRD+K N+L+ E K++DFGL +K+ PS +++
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 75/284 (26%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 521 IGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAE---FETEIEMLSKLRHRHLVSLIG 576
IG G FGKV GE+ T A + + + E F E + L+H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFG-----SDLPPLTWKQRLDACIGAARGLHYLHTGA 631
C E +LV E+ G L+ +L P T QR+ AC A GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM-AC-EIALGLLHLH--- 117
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY---- 687
+ IH D+ N LL + K+ D+GLS ++ + ++ PE
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 688 ---FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744
T++S+V+S GV ++E+ + L +Q+ + ++ Q+ + K
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVREQQLKLPK--- 232
Query: 745 DPHLKGNYSPESLEKFGEIAEKC-LDDEGKNRPTMGEVLWHLEY 787
P LK S +++ E+ + C L E RP+ EV L Y
Sbjct: 233 -PRLKLPLS----DRWYEVMQFCWLQPE--QRPSAEEVHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-09
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 521 IGVGGFGKVFKGEIEDCT-LAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
I G FGKV+ G ++ + L A+K +A+ ++ + + + E + L+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 577 FCDEQNEMILVYEYMANGTLRS--HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
N + LV EY+ G ++S H++G + K + A L YLH G
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEV----ALALDYLH---RHG 124
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSK 662
IIHRD+K N+L+ K++DFGLSK
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 16/174 (9%)
Query: 541 AIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL 600
A+K + + +Q E+ ++ +H+++V + E+ ++ E++ G L +
Sbjct: 50 AVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 109
Query: 601 FGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG- 659
+ L +Q C + L YLH+ +G+IHRD+K+ +ILL + K+SDFG
Sbjct: 110 SQTRL---NEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGF 163
Query: 660 ---LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
+SK P + ++ G+ ++ PE R + D++S G+++ E+V
Sbjct: 164 CAQISKDVPKRK------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRL-DAC 617
E+++L + ++V G E+ + E+M G+L L + P +Q L
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 109
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHVSTAV 676
I +GL YL + I+HRDVK +NIL++ K+ DFG+S + SM ++ V
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---- 163
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
G+ Y+ PE + +SD++S G+ L E+ R I P K+
Sbjct: 164 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 43/150 (28%), Positives = 81/150 (54%), Gaps = 17/150 (11%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSE-QGLAEFET---EIEMLSKLRHRHLVSLI 575
IG G +G V+K + + A+K+ ++E +G+ T EI +L +L H ++V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS--TAIREISLLKELNHPNIVRLL 64
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGS---DLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+N++ LV+E++ + L+ ++ S L P K L + +G+ Y H+
Sbjct: 65 DVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL---QGIAYCHS--- 117
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSK 662
++HRD+K N+L+D K++DFGL++
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGA-ARGLHYLHTGAERGIIHRDV 640
+++ LV +YM+ G L HL + R I L +LH + I++RD+
Sbjct: 69 SDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLH---KYDIVYRDL 122
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ-LTEKSDV 699
K NILLD + DFGLSK ++ + G+ YL PE ++ T+ D
Sbjct: 123 KPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 700 YSFGVVLFEVVC 711
+S GV++FE+ C
Sbjct: 181 WSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 8e-09
Identities = 32/112 (28%), Positives = 59/112 (52%), Gaps = 19/112 (16%)
Query: 559 EIEMLSKLRHRHLVSL--IGFCDEQNEMILVYEYMANG--TLRSHLFGSDLPP----LTW 610
EI +L KL+H ++V++ + +++ +V EY+ + +L + L L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM- 112
Query: 611 KQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662
Q L G+ +LH + I+HRD+KT+N+LL+ + K+ DFGL++
Sbjct: 113 LQLL-------SGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 520 MIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-----EQGLAEFETEIEMLSKLRHRHLVS 573
+IG G FGKV + + A+K ++ E+ E + +L ++H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG 60
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L +++ V +Y+ G L HL + L + R A A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAA-EIASALGYLHS---L 115
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
I++RD+K NILLD ++DFGL K ++EH ++ G+ YL PE +Q
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 694 TEKSDVYSFGVVLFEVV 710
D + G VL+E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 514 NFDESLMIGVGGFGKVF----KGEIEDCTLAAIK----RANPQSEQGLAEFETEIEMLSK 565
NF+ ++G G +GKVF + L A+K A Q + + TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 566 LRHR-HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR-- 622
+R LV+L + ++ L+ +Y++ G + +HL+ QR + R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFY 110
Query: 623 ------GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
L +LH + GI++RD+K NILLD ++DFGLSK S E + +
Sbjct: 111 SGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSF 166
Query: 677 KGSFGYLDPEYFWRQQLTEKS-DVYSFGVVLFEVV 710
G+ Y+ PE + K+ D +S G+++FE++
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 514 NFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSK----LRH 568
+F+ +++G G FGKV E + L AIK + + + + + E M+ K L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--KKDVVIQDDDVECTMVEKRVLALQD 58
Query: 569 R--HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHY 626
+ L L + + V EY+ G L H+ + Q + + GL +
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFF 116
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
LH RGII+RD+K N++LD K++DFG+ K M + G+ Y+ PE
Sbjct: 117 LH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPDYIAPE 171
Query: 687 YFWRQQLTEKSDVYSFGVVLFEVVCAR 713
Q + D +++GV+L+E++ +
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 61/239 (25%), Positives = 94/239 (39%), Gaps = 69/239 (28%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLR-HRHLVSLIG 576
IG G F +V K + AIK + + L + EI+ L +L H +++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 577 FC-DEQN----------EMILVYEYMANGTLRSHLFGSDLPPLTWK----QRLDACIGAA 621
D + +M L YE + R P K Q L
Sbjct: 66 VLFDRKTGRLALVFELMDMNL-YELIKG---RKRPL----PEKRVKSYMYQLL------- 110
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT----GPSMEHTHVSTAVK 677
+ L ++H GI HRD+K NIL+ ++ + K++DFG + P E ++ST
Sbjct: 111 KSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE--YISTR-- 162
Query: 678 GSFGYLDPE------YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPK----DQIN 726
Y PE Y+ K D+++ G V FE++ + P P DQI
Sbjct: 163 ---WYRAPECLLTDGYY-----GPKMDIWAVGCVFFEIL----SLFPLFPGTNELDQIA 209
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 38/142 (26%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647
Y A R ++ P L++ + A G+ +L A + +HRD+ N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272
Query: 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAV-KGS----FGYLDPEYFWRQQLTEKSDVYSF 702
E + K+ DFGL++ + S + KGS ++ PE + T SDV+SF
Sbjct: 273 CEGKLVKICDFGLAR-----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327
Query: 703 GVVLFEVVCARAVINPTLPKDQ 724
G++L+E+ P LP ++
Sbjct: 328 GILLWEIFTLGGTPYPELPMNE 349
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 514 NFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFE---TEIEMLSKLRHR 569
+ + +G G FG+V + A+K L + + E +L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
++ L +Q + ++ EY+ G L S+L S + + I A L YLH+
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA--LEYLHS 119
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
+ I++RD+K NILLD+ K++DFG +K + + + G+ YL PE
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQ 171
Query: 690 RQQLTEKSDVYSFGVVLFEVV 710
+ + D ++ G++++E++
Sbjct: 172 SKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 33/183 (18%)
Query: 559 EIEMLSKLRHRHLVSLIGF------CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQ 612
E+ +L ++H +++ L+ +E N++ LV +HL G+DL + Q
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQ 115
Query: 613 RLD------ACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666
+L RGL Y+H+ IIHRD+K +N+ ++E+ K+ DFGL++
Sbjct: 116 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172
Query: 667 MEHTHVSTAVKGSFGYLDPEYF--WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724
+V+T Y PE W + D++S G ++ E++ R + T DQ
Sbjct: 173 EMTGYVATR-----WYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226
Query: 725 INL 727
+ L
Sbjct: 227 LKL 229
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 513 NNFDESLMIGVGGFGKVFK-GEIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHR 569
N F+ ++G G +G V K E + AIK+ E + T E++ML L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLR---SHLFGSDLPPLTWKQRLDACIGAARGLHY 626
++V L + ++ LV+EY+ L G PP + + I A +H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKA---IHW 115
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
H + I+HRD+K N+L+ N V K+ DFG ++ + + + V + Y PE
Sbjct: 116 CH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPE 171
Query: 687 YFWRQQLTEKSDVYSFGVVLFEV 709
+ D++S G +L E+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 183 INAIEIVPVVDKLFADTINKVGGNDVNFNLS-GRGV--ETMYRLNVGGPEIKPSRDPDL- 238
I +IEI+ V DK + NF S G+GV T RL+ G K D D
Sbjct: 165 ILSIEILQVDDKAY------------NFGPSWGQGVILRTAKRLSCGAG--KSKFDEDYS 210
Query: 239 ---W---RMWEADSSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVL 292
W R W ++ + + I + I AS N + P +Y++A ++T+
Sbjct: 211 GDHWGGDRFWNRMQTF--GSGSDQAISTENVIKKAS-NAPNFYPESLYQSALVSTDTQP- 266
Query: 293 EKRFNMSWKFEVDPNFDYFVRLHFCEL--VYEKANQRIFRIYINNRTAENNFDIFVQAGG 350
++S+ +VDPN +Y V LHF E+ +R+F + IN TA + DI +G
Sbjct: 267 ----DLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGE 322
Query: 351 KNRGYHRDYFDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFK 396
+ + AVS + TL I L P GT A++N +E+F+
Sbjct: 323 RYTALVLNKTVAVSGR--TLTIVLQP-----KKGTHAIINAIEVFE 361
|
Length = 623 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 84/308 (27%), Positives = 127/308 (41%), Gaps = 44/308 (14%)
Query: 496 LTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFK-GEIEDCTLAAIKRANPQSEQGLA 554
+GK ++ ++ IG G +GKVFK ++ + AA+K +P +
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-E 59
Query: 555 EFETEIEMLSKLR-HRHLVSLIGFC---DEQN--EMILVYEYMANGTLRSHLFGSDLPPL 608
E E E +L L H ++V G D +N ++ LV E G++ + G L
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF----L 115
Query: 609 TWKQRLDACI------GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662
+R++ I A GL +LH IHRDVK NILL K+ DFG+S
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172
Query: 663 TGPSMEHTHVSTAVKGSFGYLDPEYF-WRQQL----TEKSDVYSFGVVLFEVVCARAVIN 717
S +T+V F ++ PE QQL + DV+S G+ E
Sbjct: 173 QLTSTRLRR-NTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIE--------- 221
Query: 718 PTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLE-KFGEIAEKCLDDEGKNRP 776
L LAD R+L I + PE +F + KCL + + RP
Sbjct: 222 --LGDGDPPLAD----LHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275
Query: 777 TMGEVLWH 784
T+ ++L H
Sbjct: 276 TVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 59/279 (21%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQS-EQGLAEFE-TEIEMLSKLRHR-HLVSLIG 576
IG G +GKV+K + L A+K+ + E+G+ EI +L L ++V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 577 F--CDEQN---EMILVYEYMANGTLRSHL------FGSDLPPLTWKQRLDACIGAARGLH 625
+E+N + LV+EY+ + L+ + G LP T K +G+
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKS---FMYQLLKGVA 124
Query: 626 YLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSK--TGPSMEHTH-VSTAVKGSFG 681
+ H + G++HRD+K N+L+D + + K++D GL + + P +TH + T
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVT-----LW 176
Query: 682 YLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAV------------INPTL--PKDQI- 725
Y PE + D++S G + E+ + + I L P +Q+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236
Query: 726 ----NLADWAM--KWQKQRSLKSIIDPHLKGNYSPESLE 758
L DW +W+ Q L + + SPE L+
Sbjct: 237 PGVSKLRDWHEFPQWKPQ-DLSRAVP-----DLSPEGLD 269
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 11/93 (11%)
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK--- 677
A GL +LH+ +GII+RD+K N++LD K++DFG+ K E+ +
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFC 162
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
G+ Y+ PE Q + D ++FGV+L+E++
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 80/302 (26%), Positives = 122/302 (40%), Gaps = 71/302 (23%)
Query: 521 IGVGGFGKVFKGEI---EDCTLAAIK--RANPQS-EQGLAEFETEIEMLSKLRHRHLVSL 574
IG G FGKV EI +K +AN S EQ EF + + L+H +++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN--EFLQQGDPYRILQHPNILQC 60
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWK---------QRLDACIGAARGLH 625
+G C E +LV+EY G L+S+L W QR+ AC AA G+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRM-ACEIAA-GVT 113
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS-MEHTHVSTAVKGSFG--Y 682
++H + +H D+ N L + K+ D+G+ GPS + ++ T +
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLRW 167
Query: 683 LDPEYFWRQQ-------LTEKSDVYSFGVVLFEVV-CA---------RAVINPTLPKDQI 725
L PE T+ S+V++ GV L+E+ A R V+N + Q+
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV 227
Query: 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785
L P L+ YS E++ E+ + C K R T EV L
Sbjct: 228 KL----------------FKPQLELPYS----ERWYEVLQFCWLSPEK-RATAEEVHRLL 266
Query: 786 EY 787
Y
Sbjct: 267 TY 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL----SKTGPSMEHTHVSTAVKG 678
GL ++H R +++RD+K NILLDE+ ++SD GL SK P H S G
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---G 157
Query: 679 SFGYLDPEYFWRQQLTEKS-DVYSFGVVLFEVV 710
+ GY+ PE + + S D +S G +LF+++
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 71/314 (22%), Positives = 127/314 (40%), Gaps = 59/314 (18%)
Query: 515 FDESLMIGVGGFGKVFKG-EIEDCTLAAIKRA-NP-QSEQGLAEFETEIEMLSKLRHRHL 571
+ + +G G +G V + AIK+ P QSE E+ +L ++H ++
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 572 VSLIGF------CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA------CIG 619
+ L+ D ++ LV +M G+DL L ++L
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM----------GTDLGKLMKHEKLSEDRIQFLVYQ 126
Query: 620 AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS 679
+GL Y+H GIIHRD+K N+ ++E+ K+ DFGL++ S +V T
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR---- 179
Query: 680 FGYLDPEYF--WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN---------LA 728
Y PE W T+ D++S G ++ E++ + + DQ+
Sbjct: 180 -WYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237
Query: 729 DWAMKWQKQRSLKSIID-PHLKG--------NYSPESLEKFGEIAEKCLDDEGKNRPTMG 779
++ K Q + + + P + N +P ++ + EK L + ++R T
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAV----NVLEKMLVLDAESRITAA 293
Query: 780 EVLWHLEYVLQLHE 793
E L H Y + H+
Sbjct: 294 EALAH-PYFEEFHD 306
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+IG GGFG+V+ D + + + + +QG E L+ L R ++SL+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNERIMLSLV 51
Query: 576 GFCD------------EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARG 623
D +++ + + M G L HL S + K+ G
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILG 109
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
L ++H R +++RD+K NILLDE+ ++SD GL+ S + H S G+ GY+
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASV---GTHGYM 162
Query: 684 DPEYFWRQQLTEKS-DVYSFGVVLFEVV 710
PE + + S D +S G +LF+++
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
A+G+ +L A + IHRD+ NILL + K+ DFGL++ + + V +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740
++ PE + T +SDV+S+G++L+E+ + P +P D K+ K
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--------KFYKM--- 329
Query: 741 KSIIDPHLKGNY---SPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+K Y SPE + + +I + C D + RPT +++ +E
Sbjct: 330 -------IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 514 NFDESLMIGVGGFGKVF---KGEIEDC----TLAAIKRANPQSEQGLAEF-ETEIEMLSK 565
NF+ ++G G +GKVF K D + +K+A + E TE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 566 LRHR-HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGA-ARG 623
+R LV+L ++ L+ +Y+ G L +HL S +Q + G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFK-EQEVQIYSGEIVLA 117
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
L +LH + GII+RD+K NILLD N ++DFGLSK E + + G+ Y+
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYM 173
Query: 684 DPEYFWRQQLTEKS--DVYSFGVVLFEVV 710
P+ D +S GV+++E++
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
GL YLH A+R IIHRDVKT NI +++ + D G ++ P + + A G+
Sbjct: 168 EGLRYLH--AQR-IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA--GTVE 221
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE R + K+D++S G+VLFE++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 514 NFDESLMIGVGGFGKVFKGEI--EDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRH 568
NF +L G G FG+V ED AIKR ++ + +E ++L+ + H
Sbjct: 33 NFIRTL--GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTL-----RSHLFGSDLPPLTWKQRLDACIGAARG 623
V+L G +++ + LV E++ G R+ F +D+ C AA+
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDV----------GCFYAAQI 140
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
+ I++RD+K N+LLD++ KM+DFG +K + +T + G+ Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPEYI 195
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE + +D ++ G+ ++E++
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 48/173 (27%), Positives = 69/173 (39%), Gaps = 27/173 (15%)
Query: 521 IGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G G+VF KG + L + + + TE E+L+ L H L +L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIG--AAR--------GLHY 626
+ + LV +Y G L L +++ C+ AR L Y
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL----------QRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS 679
LH GI++RD+K NILL E+ +SDF LSK KGS
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 521 IGVGGFGKVFKGEIEDCTL-AAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV------- 572
+G G G VF DC A+K+ Q + EI+++ +L H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 573 -------SLIGFCDEQNEMILVYEYMANG---TLRSHLFGSDLPPLTWKQRLDACIGAAR 622
+G E N + +V EYM L + L Q L R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL-------R 125
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSK-TGPSMEHT-HVSTAVKGS 679
GL Y+H+ ++HRD+K N+ ++ E+ V K+ DFGL++ P H ++S +
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 680 FGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ Y P T+ D+++ G + E++ + + +Q+ L
Sbjct: 183 W-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 68/315 (21%), Positives = 133/315 (42%), Gaps = 69/315 (21%)
Query: 521 IGVGGFGKV-FKGEIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G+G FG+V +++ L A+K + + + +A + E ++L++ + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
+++ + V +Y+ G + S L ++ P + A + A + +H + G I
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA--IESVH---KMGFI 123
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH--------THV---------------- 672
HRD+K NIL+D + K++DFGL TG H +H+
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLC-TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 673 ----------------------STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
+ ++ G+ Y+ PE R+ T+ D +S GV+LFE++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 711 CAR-AVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLD 769
+ + PT + Q+ + +W I P +K SPE+++ ++ C
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLH--------IPPQVK--LSPEAVDLITKLC--CSA 290
Query: 770 DEGKNRPTMGEVLWH 784
+E R ++ H
Sbjct: 291 EERLGRNGADDIKAH 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 520 MIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS-KLRHRHLVSL 574
++G G FGKV KG E + +K+ + + TE +L+ +H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 575 IGFCDEQNEMILVYEYMANGTL-----RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
++ + V EY+ G L RS F + R A L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAA-EVTLALMFLHR 114
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
G+I+RD+K NILLD K++DFG+ K G + + +T G+ Y+ PE
Sbjct: 115 ---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYIAPEILQ 169
Query: 690 RQQLTEKSDVYSFGVVLFEVV 710
+ D ++ GV+++E++
Sbjct: 170 ELEYGPSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 45/187 (24%), Positives = 81/187 (43%), Gaps = 35/187 (18%)
Query: 559 EIEMLSKLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHLFGSDL-------PPLTW 610
E+++L +H +++++ + VY M L SDL PLT
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM-------DLMESDLHHIIHSDQPLTE 106
Query: 611 K-------QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK- 662
+ Q L RGL Y+H+ +IHRD+K +N+L++E+ ++ DFG+++
Sbjct: 107 EHIRYFLYQLL-------RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156
Query: 663 -TGPSMEHTHVSTAVKGSFGYLDPE-YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTL 720
+ EH + T + Y PE + T D++S G + E++ R +
Sbjct: 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216
Query: 721 PKDQINL 727
Q+ L
Sbjct: 217 YVHQLKL 223
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 31/204 (15%)
Query: 521 IGVGGFGKVFKGEIEDCT----LAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G FGKV + D L I++A+ S + E +L+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR----------GLHY 626
++ LV ++ G L HL QR + +R L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----------QR-EGRFDLSRARFYTAELLCALEN 108
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
LH + +I+RD+K NILLD + DFGL K +M+ + G+ YL PE
Sbjct: 109 LH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPE 163
Query: 687 YFWRQQLTEKSDVYSFGVVLFEVV 710
T+ D ++ GV+L+E++
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 29/221 (13%)
Query: 505 LAEIRVATNNFDESLMIGVGGFGKV------FKGEIEDCTLAA----IKRANPQSEQGLA 554
+ ++R+ +++ +IG G FG+V ++ L + IKR++ A
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS------A 88
Query: 555 EFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRL 614
F E ++++ +V L + + +V EYM G L + + D+P W +
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY 147
Query: 615 DA-CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673
A + A +H + G IHRDVK N+LLD++ K++DFG
Sbjct: 148 TAEVVLALDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201
Query: 674 TAVKGSFGYLDPEYFWRQ----QLTEKSDVYSFGVVLFEVV 710
TAV G+ Y+ PE Q + D +S GV L+E++
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQS-------EQGLAEFETEIEMLS 564
+F+ +I G +G V+ ++ A+K+ N Q+ +Q E + +L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERD----ILT 56
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANG---TLRSHLFGSDLPPLTWKQRLDACIGAA 621
+ +VS+ + + + +V EY+ G TL ++ LP + + A
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLA- 113
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG-----PSMEHTHVSTAV 676
L YLH GI+HRD+K N+L+ K++DFGLSK G ++ H+
Sbjct: 114 --LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 677 K--------GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFE 708
+ G+ Y+ PE RQ + D ++ G++L+E
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 559 EIEMLSKLRHRHLVSLIGF------CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQ 612
E+ +L + H++++SL+ +E ++ LV E M + D +++
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL 129
Query: 613 RLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--MEHT 670
C G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++T + M
Sbjct: 130 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
Query: 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726
+V T Y PE E D++S G ++ E+V + T DQ N
Sbjct: 182 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 27/162 (16%)
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV-KGS 679
ARG+ +L A + +HRD+ N+LL + + K+ DFGL++ + H S V KGS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGS 298
Query: 680 ----FGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735
++ PE + T SDV+S+G++L+E+ P + D + +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-------STFYN 351
Query: 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777
K +S + P +++ + + +I KC + E + RP+
Sbjct: 352 KIKSGYRMAKP----DHATQEVY---DIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
A GL +LH+ +GII+RD+K N++LD K++DFG+ K +M + G+
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGTP 165
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA 714
Y+ PE Q + D ++FGV+L+E++ +A
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 602 GSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661
D PL L A+G+ +L A + IHRDV N+LL + VAK+ DFGL+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 662 KTGPSMEHTHVSTAVKGS----FGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
+ M ++ VKG+ ++ PE + T +SDV+S+G++L+E+
Sbjct: 260 RD--IMNDSNY--VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 10/106 (9%)
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--MEHTHVSTAVKGSF 680
G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++T + M +V T
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726
Y PE E D++S G ++ E++ + T DQ N
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 65/310 (20%), Positives = 121/310 (39%), Gaps = 65/310 (20%)
Query: 515 FDESLMIGVGGFGKV-FKGEIEDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRH 570
F + +G+G FG+V +++ L A+K + +A + E ++L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA-CIGAARGLHYLHT 629
+V L +++ + V +Y+ G + S L + P + A A +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM-- 120
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGL---------SKTGPSMEHTH--------- 671
G IHRD+K NIL+D + K++DFGL SK S +H
Sbjct: 121 ----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 672 ---------------------------VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGV 704
++ ++ G+ Y+ PE R T+ D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 705 VLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIA 764
+L+E++ + P L + + + WQ + + SPE+ + ++
Sbjct: 237 ILYEMLVGQP---PFLAQTPLETQMKVINWQTSLHIP------PQAKLSPEASDLIIKLC 287
Query: 765 EKCLDDEGKN 774
D GKN
Sbjct: 288 RGPEDRLGKN 297
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 48/238 (20%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDC----TLAAIKRANPQSEQGLAEFETEIEMLSKLRH 568
++F+ +IG G FG+V + +D + +++A+ ++ +A E ++L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 569 RHLVSLI-GFCDEQNEMILVYEYMANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHY 626
+V + F D++N + L+ E++ G + + L D L + + + A +H
Sbjct: 61 AWVVKMFYSFQDKRN-LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH--------TH------- 671
L G IHRD+K N+LLD K+SDFGL TG H TH
Sbjct: 120 L------GFIHRDIKPDNLLLDAKGHVKLSDFGLC-TGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 672 -------------------VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
++ + G+ Y+ PE F + + D +S GV+++E++
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 25/118 (21%)
Query: 559 EIEMLSKLRHRHLVSLIGFC-----DEQNEMILVYEYM---ANGTLRSHLFGSDLPPLTW 610
EI++L L H +++++ + N++ +VYE M + +RS SD
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSD------ 107
Query: 611 KQRLDAC----IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664
D C RGL Y+H+ ++HRD+K +N+LL+ N K+ DFGL++T
Sbjct: 108 ----DHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 514 NFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAE---FETEIEMLSKLRHR 569
+F+ +IG G FG+V ++++ + A+K N AE F E ++L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYL 627
+ +L ++N + LV +Y G L + L F LP + L + A +H L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK-GSFGYLDPE 686
H +HRD+K NIL+D N +++DFG ME V ++V G+ Y+ PE
Sbjct: 122 H------YVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 687 YFW-----RQQLTEKSDVYSFGVVLFEVV 710
+ + + D +S GV ++E++
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 33/171 (19%)
Query: 559 EIEMLSKLRHRHLVSLIGF------CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQ 612
E+ +L ++H +++ L+ + NE+ LV ++L G+DL + Q
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV----------TNLMGADLNNIVKCQ 113
Query: 613 RL-DACIG-----AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666
+L D + RGL Y+H+ GIIHRD+K +N+ ++E+ ++ DFGL++
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170
Query: 667 MEHTHVSTAVKGSFGYLDPEYF--WRQQLTEKSDVYSFGVVLFEVVCARAV 715
+V+T Y PE W + D++S G ++ E++ +A+
Sbjct: 171 EMTGYVATR-----WYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKAL 215
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 538 TLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595
TL ++ + + +E+ L + E+ + RH ++++ + + ++ +MA G+
Sbjct: 26 TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85
Query: 596 LRSHLFGSDLPPLTWKQRLDACI--GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653
S L P + L I GA RGL+YLH + G IHR++K ++IL+ + +
Sbjct: 86 ANSLL--KTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLV 140
Query: 654 KMSDFGLS----------KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL---TEKSDVY 700
+S GLS K + ST+V +L PE RQ L KSD+Y
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELL-RQDLYGYNVKSDIY 194
Query: 701 SFGVVLFEVVCAR 713
S G+ E+ R
Sbjct: 195 SVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 18/42 (42%), Positives = 31/42 (73%), Gaps = 3/42 (7%)
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
+ L Y+H+G +IHRD+K +NILL+ + K++DFGL+++
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 64/253 (25%)
Query: 513 NNFDESLMIGVGGFGKV-FKGEIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRH 568
+F +IG G FG+V + + + A+K ++ + LA + E ++L++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARG 623
+VSL + + L+ E++ G L + L F D+ + + C+ A
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT----RFYMAECVLAIEA 116
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS------------------KTGP 665
+H L G IHRD+K NIL+D K+SDFGLS K+
Sbjct: 117 VHKL------GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 666 SMEHTHVSTAVK---------------------------GSFGYLDPEYFWRQQLTEKSD 698
+ S AV G+ Y+ PE F +Q ++ D
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 699 VYSFGVVLFEVVC 711
+S G ++FE +
Sbjct: 231 WWSLGAIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 521 IGVGGFGKVFKGE---------IEDCTLAAIKRANPQSEQGLAE----FET--EIEMLSK 565
+G G +GKV K I+ + I + Q + F T E++++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 566 LRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPL-TWKQRLD----ACI-- 618
++H +++ L+ E + + LV + MA SDL + K RL CI
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA----------SDLKKVVDRKIRLTESQVKCILL 126
Query: 619 GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSM 667
GL+ LH + +HRD+ NI ++ + K++DFGL+ + G
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173
|
Length = 335 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 55/243 (22%)
Query: 513 NNFDESLMIGVGGFGKV-FKGEIEDCTLAAIKRANP----QSEQGLAEFETEIEMLSKLR 567
++F+ +IG G FG+V + + + A+K+ + EQ +A E ++L++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 568 HRHLVSLI-GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQR---LDACIGAARG 623
+ +V L F DE + L+ EY+ G + + L D T ++ + I A
Sbjct: 60 NPWVVKLYYSFQDENY-LYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDS 116
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL----------------------- 660
+H L G IHRD+K N+LLD K+SDFGL
Sbjct: 117 IHKL------GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 661 -----SKTGPSMEHTH--------VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLF 707
SK S ++ + G+ Y+ PE F + ++ D +S GV+++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 708 EVV 710
E++
Sbjct: 231 EML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 27/162 (16%)
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--MEHTHVSTAVKGSF 680
G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++T + M +V T
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740
Y PE E D++S G ++ E++ V+ P D I+ +W K
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT-VLFPG--TDHID------QWNK---- 228
Query: 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
II+ G S E + + +++ K E L
Sbjct: 229 --IIE--QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL 266
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 521 IGVGGFGKVFKG--EIEDCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G G V + D +A K + P Q++ E+ ++ + H++++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 578 ------CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
+E ++ LV E M + D +++ C G+ +LH+
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA- 138
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS--MEHTHVSTAVKGSFGYLDPEYFW 689
GIIHRD+K +NI++ + K+ DFGL++T + M +V T Y PE
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVIL 191
Query: 690 RQQLTEKSDVYSFGVVLFEVV 710
E D++S G ++ E+V
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 514 NFDESLMIGVGGFGKVFKGEIEDC----TLAAIKRANPQSEQGLAEFETEIEMLSKLRHR 569
+F+ +IG G FG+V + +D + +++A+ ++ + E ++L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 570 HLVSLI-GFCDEQNEMILVYEYMANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYL 627
+V + F D+ N + L+ E++ G + + L D L + + + A +H L
Sbjct: 62 WVVKMFYSFQDKLN-LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH------------------ 669
G IHRD+K N+LLD K+SDFGL TG H
Sbjct: 121 ------GFIHRDIKPDNLLLDSKGHVKLSDFGLC-TGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 670 ----------------THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
++ + G+ Y+ PE F + + D +S GV+++E++
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 55/258 (21%)
Query: 521 IGVGGFGKV-FKGEIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLI- 575
IG+G FG+V +++ L A+K +A+ A + E ++L++ + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
F D+ N + V +Y+ G + S L + + A + A + +H + G
Sbjct: 69 SFQDKDN-LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA--IESVH---KMGF 122
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTG------------------PSME--------- 668
IHRD+K NIL+D + K++DFGL TG SME
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 669 --------------HTHVST-AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR 713
H ++ G+ Y+ PE R T+ D +S GV+L+E++ +
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 714 A-VINPTLPKDQINLADW 730
+ T + Q+ + +W
Sbjct: 242 PPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 38/207 (18%)
Query: 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHRHLVSLIGF 577
+G G + V+KG + L A+K + ++E+G+ F E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 578 CDEQNEMILVYEYMAN----------GTLRSH---LFGSDLPPLTWKQRLDACIGAARGL 624
+ + V+EYM G L + LF L RGL
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL---------------LRGL 116
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
Y+H + I+HRD+K N+L+ K++DFGL++ T+ S V + Y
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRP 171
Query: 685 PEYFW-RQQLTEKSDVYSFGVVLFEVV 710
P+ + D++ G + E++
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAE---FETEIEMLSKLRH 568
++F+ +IG G FG+V ++++ + A+K N AE F E ++L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 569 RHLVSL-IGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLH 625
R + +L F DE N + LV +Y G L + L F LP + L + A +H
Sbjct: 61 RWITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG----LSKTGPSMEHTHVST------- 674
L +HRD+K N+LLD+N +++DFG L G + V T
Sbjct: 120 QLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 675 ---AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
A++ G PE W +S GV ++E+
Sbjct: 174 ILQAMEDGKGRYGPECDW----------WSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 12/148 (8%)
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
++V L + ++ + LV ++ G L SH+ P +R A + A L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA--LDALH- 102
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFG-LSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
GI+ RD+ NILLD+ +++ F S+ S + V Y PE
Sbjct: 103 --REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVG 154
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVI 716
+ TE D +S G +LFE++ + ++
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDCT-LAAIKRANPQSEQGLAE---FETEIEMLSKLRH 568
++F+ +IG G FG+V +++ + A+K N AE F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHY 626
+ + +L ++N + LV +Y G L + L F LP + + + A +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
LH +HRD+K N+LLD N +++DFG S + + T S+ G+ Y+ PE
Sbjct: 121 LH------YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 687 YFWRQQ-----LTEKSDVYSFGVVLFEVV 710
+ + D +S GV ++E++
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 27/169 (15%)
Query: 553 LAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLF---GSDLPPLT 609
LA FET M+ ++ H+H+V L G C E I+V E++ G L LF SD+
Sbjct: 49 LAFFETA-SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTP 105
Query: 610 WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN--------FVAKMSDFGLS 661
WK ++ + +A L YL ++ ++H +V T NILL F+ K+SD G+
Sbjct: 106 WKFKVAKQLASA--LSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFI-KLSDPGIP 159
Query: 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEV 709
T S + ++ PE + L+ +D +SFG L+E+
Sbjct: 160 ITVLSRQEC------VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 40/243 (16%)
Query: 553 LAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLP-PLTWK 611
LA FET ++S++ H HL + G C +E I+V E++ +G L L P+ WK
Sbjct: 61 LAFFETA-SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK 119
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA-------KMSDFGLSKTG 664
+ + +A L YL ++ ++H +V NILL +A K+SD G+S T
Sbjct: 120 ITVAQQLASA--LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
S E ++ PE L+ +D +SFG L E +C + +P
Sbjct: 175 LSREER------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLE-IC----FDGEVPLK 223
Query: 724 QINLADWAMKWQKQRSLKSIIDPHLKGNYSPE-SLEKFGEIAEKCLDDEGKNRPTMGEVL 782
+ ++ ++K+ L PE S ++ + +CL E RP+ +L
Sbjct: 224 ERTPSEKERFYEKKHRL-------------PEPSCKELATLISQCLTYEPTQRPSFRTIL 270
Query: 783 WHL 785
L
Sbjct: 271 RDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 63/304 (20%), Positives = 112/304 (36%), Gaps = 76/304 (25%)
Query: 520 MIGVGGFGKVFKGEIEDCTL-AAIKRANPQSEQGLAEFE-------TEIEMLSKLRHRHL 571
+IG GG G+V+ C+ A+K+ + L+E E ++ + L H +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI----REDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHL--------FGSDLPPLTW-KQRLDACIGAAR 622
V + C + + + Y+ TL+S L +L T L
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG--LSKTGPSMEHTHVSTAVKGSF 680
+ Y+H+ +G++HRD+K NILL + D+G + K + + +
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 681 --------------GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD--- 723
Y+ PE +E +D+Y+ GV+L++++ P K
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS---FPYRRKKGRK 238
Query: 724 ------------------------QINL----ADWAMKWQKQRSLKSIIDPHLKGNYSPE 755
QI + D A ++ + LK ++PHL+G SPE
Sbjct: 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG--SPE 296
Query: 756 SLEK 759
K
Sbjct: 297 WTVK 300
|
Length = 932 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 521 IGVGGFGKV----FKGEIEDCTLAAIKRANPQSEQGLAEFET-EIEMLSKLR-HRHLVSL 574
+G G +G V E+ T+A K N S++ LA+ E+++L R H+++ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 575 ----IGFCDEQNEMILVYEYMA---NGTLRSHLFGSDLPPLTWKQRLDACIGA-----AR 622
I F NE+ L E M + +RS PLT DA +
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ------PLT-----DAHFQSFIYQILC 116
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK---TGPSMEHTHVSTAVKGS 679
GL Y+H+ ++HRD+K N+L++ + K+ DFGL++ P ++ V +
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172
Query: 680 FGYLDPEYFWRQQLTEKS-DVYSFGVVLFEVVCARAVINPTLPKDQINL 727
Y PE Q K+ DV+S G +L E++ + V DQ+N
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-05
Identities = 62/270 (22%), Positives = 93/270 (34%), Gaps = 96/270 (35%)
Query: 521 IGVGGFGKVFKGEIEDCTLAA-----IKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V+K + + +K+A E G EI M ++R S
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKAT---EYG----AVEIWMNERVRRACPNSCA 192
Query: 576 GFC---------DEQNEMILVYEYMANGTL-------------RSHLFGS--DLPPLTWK 611
F +++E LV+ Y TL +L G DLP +
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLER 252
Query: 612 QR------LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---------------- 649
+ + + A GLH GI+HRDVK NI+ E
Sbjct: 253 ENKIIQTIMRQILFALDGLH------STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306
Query: 650 ----NFVAKMSDFGL------------SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
N++ K +F L S PS V+TA L P W+ L
Sbjct: 307 RVGINYIPK--EFLLDPRYAAPEQYIMSTQTPSAPSAPVATA-------LSP-VLWQLNL 356
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
++ D+YS G++ ++ P L D
Sbjct: 357 PDRFDIYSAGLIFLQMAF------PNLRSD 380
|
Length = 566 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 59/244 (24%)
Query: 513 NNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFET-----EIEML 563
N ++ IG G FG+VF K E AI S +GL E E E+ ++
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI------SYRGLKEREKSQLVIEVNVM 66
Query: 564 SKLRHRHLVSLIG-FCDEQNE-MILVYEYMANGTLRSH------LFGSDLPPLTWKQRLD 615
+L+H+++V I F ++ N+ + ++ E+ G L + +FG + +D
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK----IEEHAIVD 122
Query: 616 ACIGAARGLHYLHT-----GAERGIIHRDVKTTNILLDENF-----------------VA 653
L Y H ER ++HRD+K NI L +A
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 654 KMSDFGLSKT--GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT--EKSDVYSFGVVLFEV 709
K+ DFGLSK SM H+ V T Y PE + + +KSD+++ G +++E+
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPY-----YWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 710 VCAR 713
+
Sbjct: 237 CSGK 240
|
Length = 1021 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 31/204 (15%)
Query: 521 IGVGGFGKVFKGEIEDCT--LAAIKR-ANP-QSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G +G V I+ T AIK+ + P QSE E+ +L ++H +++ L+
Sbjct: 23 VGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 577 F------CDEQNEMILVYEYMAN--GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLH 628
DE + LV YM + H D Q L GL Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-------CGLKYIH 134
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+ GIIHRD+K N+ ++E+ K+ DFGL++ + +V T Y PE
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 186
Query: 689 --WRQQLTEKSDVYSFGVVLFEVV 710
W + D++S G ++ E++
Sbjct: 187 LNW-MHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 55/223 (24%)
Query: 524 GGFGKVFKGEIEDCTLAAIKR--------ANPQSEQGLAEF-----------ETEIEMLS 564
G FGK+F + T A R P+ E+ +A+ E EI L
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYE---YMANGT----LRSHLFGSDLP----PLTWKQR 613
+L H +++ + E IL E YM L S ++ PL + R
Sbjct: 219 RLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270
Query: 614 --LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG----LSKTGPSM 667
+ + A + Y+H ++ +IHRD+K NI L+ + + DFG K +
Sbjct: 271 AIMKQLLCA---VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710
++ V T S PE E +D++S G++L +++
Sbjct: 325 DYGWVGTVATNS-----PEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 26/180 (14%)
Query: 27 INCGTNSS---VNVDGRKWVGDLASNNNVTL-SSSGIAATTD------SLSGDSIYEPLY 76
++CG S + G W GD N T S S A +T+ S + + E LY
Sbjct: 196 LSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLY 255
Query: 77 KTARVFAD---GLNYTFEIIAG-NYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFS 132
++A V D L+YT ++ NY V LHF K F V+ NG +
Sbjct: 256 QSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVD 315
Query: 133 APGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVPVV 192
++ SG +++ L K + V L I P KG+ INAIE+ ++
Sbjct: 316 I----------VKMSGERYTALVLNKT--VAVSGRTLTIVLQPKKGTHAIINAIEVFEII 363
|
Length = 623 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
R + YLH E IIHRD+K NI ++ + DFG + P + + G+
Sbjct: 193 RAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
PE R D++S G+VLFE+
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 28/170 (16%)
Query: 559 EIEMLSKLRHRHLVSLIGFC-----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQR 613
EI++L LRH +V + E ++ +V+E M + + DL P +
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF 108
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK-----TGPSME 668
L + R L Y+HT + HRD+K NIL + + K+ DFGL++ T ++
Sbjct: 109 LYQLL---RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162
Query: 669 HT-HVSTAVKGSFGYLDPE----YFWRQQLTEKSDVYSFGVVLFEVVCAR 713
T +V+T Y PE +F + T D++S G + EV+ +
Sbjct: 163 WTDYVATR-----WYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 7/85 (8%)
Query: 626 YLHTGAERGIIHRDVKTTNILLD--ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
Y+H GIIHRD+KT N+L++ E+ + DFG + T + G+
Sbjct: 275 YIHG---EGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFE 708
PE T D++S G+V+FE
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 851 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.98 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.35 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.96 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.89 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| KOG3593 | 355 | consensus Predicted receptor-like serine/threonine | 97.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.75 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.62 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.33 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.28 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.27 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.13 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.46 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.34 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.19 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.1 | |
| PLN02236 | 344 | choline kinase | 96.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.47 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.47 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.22 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.19 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.15 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.11 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-55 Score=518.98 Aligned_cols=327 Identities=26% Similarity=0.339 Sum_probs=256.3
Q ss_pred CCCceEEecCCCCccc--cCCcceeccCCCCCccccccCCcccccCCCCCCCCCcccccceeeecc----CceeeEee-c
Q 047215 21 QSKSFLINCGTNSSVN--VDGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEPLYKTARVFAD----GLNYTFEI-I 93 (851)
Q Consensus 21 ~~~~~~i~cG~~~~~~--~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~----~~~y~~~~-~ 93 (851)
++++|+||||++.+++ .+||+|++|.. ++++..... . .+...+++|+|||+|+. ++||.||+ +
T Consensus 22 ~~~~~~I~CGs~~~~~~d~~~~~w~~D~~------~~~~~~~~~-~---~~~~~~~~~~t~R~F~~~~g~~~cY~~~~~~ 91 (623)
T PLN03150 22 EPFTMRISCGARVNVRTAPTNTLWYKDFA------YTGGIPANA-T---RPSFIAPPLKTLRYFPLSDGPENCYNINRVP 91 (623)
T ss_pred CCccEEEeCCCCCCcccCCCCCEEcCCcc------cccCccccc-c---CcccccchhhccccCCcccccccceEeeecC
Confidence 7889999999987643 78999999921 222111111 1 22345678999999986 78999997 5
Q ss_pred cceEEEEEEeccCCCCCcccccceEEEEEcc---eEEeecCCCCccccccccccccCCCCCcccceEEEEEeeccCCeEE
Q 047215 94 AGNYIVRLHFCPFPFEDYNVNKSSFGVVANG---LKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDKLM 170 (851)
Q Consensus 94 ~g~~~~R~~f~~~~~~~~~~~~~~f~v~~~g---~~~l~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~ 170 (851)
+|+|+||+||+|++|+++| +.+.|||+++| ++++.+|+.. ..++++|+++.++++.+.
T Consensus 92 ~g~ylVRl~F~~~~y~~~~-~~~~Fdv~~~~~~~~tv~~~~~~~------------------~~~v~~E~i~~~~~~~l~ 152 (623)
T PLN03150 92 KGHYSVRVFFGLVAEPNFD-SEPLFDVSVEGTQISSLKSGWSSH------------------DEQVFAEALVFLTDGSAS 152 (623)
T ss_pred CCcEEEEEEeecCCcCCCC-CCCceEEEECcEEEEEEecCcccC------------------CCcEEEEEEEEecCCcEE
Confidence 7999999999999999999 67899999999 7788888742 347899999999999999
Q ss_pred EEEecCCCcceeeeeeEEEeccccccccccccccCcccCCCcccceeEEEEEEecCCCCCcC---CCCccc--ccccccC
Q 047215 171 IEFIPSKGSFGFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPEIKP---SRDPDL--WRMWEAD 245 (851)
Q Consensus 171 i~f~~~~~~~~fi~~iEl~~~~~~~y~~~~~~~~~~~~~~~~~~~~l~~~~Rin~Gg~~~~~---~~d~~~--~r~W~~d 245 (851)
|||+|+++++||||+|||||+|+.+|..... . .-+++|+++||+||||.++++ +.||.+ ||+|.+|
T Consensus 153 vcf~~~~~~~pFIs~iEv~~l~~~~y~~~~~-~--------~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d 223 (623)
T PLN03150 153 ICFHSTGHGDPAILSIEILQVDDKAYNFGPS-W--------GQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRM 223 (623)
T ss_pred EEEecCCCCCCceeEEEEEEcCccccccccc-c--------cCceEEEEEEEEEecCcccccccCCCCCcccCccccCcC
Confidence 9999999999999999999999999963310 0 116789999999999987543 223344 8999999
Q ss_pred CCcccccCCCcccccCcceEeccCCCccccchhhHHHhhccCCCcccccccceeeeeecCCCCceEEEEEeeeEEE--ec
Q 047215 246 SSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVY--EK 323 (851)
Q Consensus 246 ~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~P~~vy~tA~~~~~~~~~~~~~~lt~~~~vd~~~~Y~v~LhF~Ei~~--~~ 323 (851)
.+|..+. ...+.....+.+. +...+.+|+.||||||++... ..+++|.|++++++.|+|||||||++. ..
T Consensus 224 ~~~~~~~--~~~~st~~~I~~~-~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~ 295 (623)
T PLN03150 224 QTFGSGS--DQAISTENVIKKA-SNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITA 295 (623)
T ss_pred cccCCCc--ccccccccccccc-cCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCC
Confidence 8875322 1122223344443 345678899999999997652 247999999999999999999999963 35
Q ss_pred CCeEEEEEEEcCccccCCcchhhhcCCCCceeEEEeEecccccceeeeEEeCCccCCCCCCchhhccccccccccCC
Q 047215 324 ANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFSQN 400 (851)
Q Consensus 324 ~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~~~~~~~~~~~~~~~lng~Ei~~~~~~ 400 (851)
.++|+|||||||+.+.+++||..++++...++|.++......+.+. +++++..+ .+|+|||+||+++...
T Consensus 296 ~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~--isl~p~~~-----s~pilNaiEI~~~~~~ 365 (623)
T PLN03150 296 EGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLT--IVLQPKKG-----THAIINAIEVFEIITA 365 (623)
T ss_pred CceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEE--EEEeeCCC-----Ccceeeeeeeeecccc
Confidence 6899999999999999999999988877789999987444445455 99998765 3689999999999863
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-55 Score=480.08 Aligned_cols=290 Identities=51% Similarity=0.875 Sum_probs=259.3
Q ss_pred CCcccCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEE
Q 047215 499 AGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578 (851)
Q Consensus 499 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 578 (851)
..+.|++.+++.||++|...++||+|+||.||+|.++++..+|||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45789999999999999999999999999999999999999999988776544245699999999999999999999999
Q ss_pred ccCC-cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEee
Q 047215 579 DEQN-EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 579 ~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~D 657 (851)
.+++ +.+||||||++|+|.++|+.....+++|.+|++||.++|+||+|||+.+.++|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999886644899999999999999999999998888999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
||+|+..+.. .........||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+.+|++.....
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999875542 222222117999999999999999999999999999999999999988877666777899999999888
Q ss_pred cccccccCccCC-CCCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 738 RSLKSIIDPHLK-GNYSP-ESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 738 ~~~~~i~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+.+.+++||.+. +.++. ++...+..++.+|++.+|.+||+|.||++.|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 899999999997 66665 68888999999999999999999999999985443
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=474.21 Aligned_cols=323 Identities=38% Similarity=0.587 Sum_probs=235.5
Q ss_pred EecCCCCccc--cC---CcceeccCCCCCccccccC-CcccccCCCCCCCCCcccccceeeec--cCceeeEeec-c--c
Q 047215 27 INCGTNSSVN--VD---GRKWVGDLASNNNVTLSSS-GIAATTDSLSGDSIYEPLYKTARVFA--DGLNYTFEII-A--G 95 (851)
Q Consensus 27 i~cG~~~~~~--~~---~~~~~~D~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~t~R~f~--~~~~y~~~~~-~--g 95 (851)
||||++.+.. .| ||+|++|. .+.. .+. +.++. ......+...++|+|||+|+ .++||+||+. + +
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~--~~~~--~g~~~~i~~-~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~ 75 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDD--DFID--TGKSGNISS-QPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGG 75 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCC--Cccc--CCCcccccc-ccCCcCCccccccceEEEcCCCCccEEEeeccCCCCc
Confidence 8999886633 44 99999994 2221 111 11110 11123456678999999998 6799999985 3 3
Q ss_pred eEEEEEEeccCCCCCcc--c--ccceEEEEEcceEEeecCCCCccccccccccccCCCCCcccceEEEEEeecc-CCeEE
Q 047215 96 NYIVRLHFCPFPFEDYN--V--NKSSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVD-LDKLM 170 (851)
Q Consensus 96 ~~~~R~~f~~~~~~~~~--~--~~~~f~v~~~g~~~l~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~ 170 (851)
+|+||+||+|++|++.+ + +++.|++++|+. +|.++... ++...++++|+++.+. ++.|.
T Consensus 76 ~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n-------------~~~tV~~~---~~~~~~~~~E~ii~v~~~~~l~ 139 (347)
T PF12819_consen 76 KYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFN-------------FWSTVNLS---NSPSSPVVKEFIINVTWSDTLS 139 (347)
T ss_pred eEEEEEEeccccccccccccccCCcceEEEECCc-------------eeEEEEec---CCCcceEEEEEEEEEcCCCcEE
Confidence 88999999999999743 1 356788877762 23333221 1123579999999998 57999
Q ss_pred EEEecCCCcc-eeeeeeEEEeccccccccccccccCcccCCCcccceeEEEEEEecCCCC--CcCCCCcccccccccC--
Q 047215 171 IEFIPSKGSF-GFINAIEIVPVVDKLFADTINKVGGNDVNFNLSGRGVETMYRLNVGGPE--IKPSRDPDLWRMWEAD-- 245 (851)
Q Consensus 171 i~f~~~~~~~-~fi~~iEl~~~~~~~y~~~~~~~~~~~~~~~~~~~~l~~~~Rin~Gg~~--~~~~~d~~~~r~W~~d-- 245 (851)
|||+|++.+. ||||+|||||||+++|+.. ....+.||+++||+||||.. ++++ +|.+||.|.+.
T Consensus 140 vclv~~~~g~~pFIsaiEl~~lp~~ly~~~----------~~~~s~~L~~~~R~n~G~~~~~iryp-~D~~dR~W~~~~~ 208 (347)
T PF12819_consen 140 VCLVPTGSGTFPFISAIELRPLPDSLYPDT----------DANSSQALETVYRLNVGGSSSFIRYP-DDTYDRIWQPYSS 208 (347)
T ss_pred EEEEeCCCCCCCceeEEEEEECCccceecc----------ccCCCceeEEEEeecCCCcccccCCC-CCcceeecccccc
Confidence 9999999655 9999999999999999643 23557899999999999998 8877 66799999953
Q ss_pred CCcccccCCCcccccCcceEeccCCCccccchhhHHHhhccCCCcccccccceeeeeecCCCCceEEEEEeeeEEE--ec
Q 047215 246 SSYMITANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVY--EK 323 (851)
Q Consensus 246 ~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~P~~vy~tA~~~~~~~~~~~~~~lt~~~~vd~~~~Y~v~LhF~Ei~~--~~ 323 (851)
.+.|...++. ..+......+.+.||..||+||+++.+.. ..++|+|.+ ++++..|+|+||||||+. ..
T Consensus 209 ~~~~~~ist~------~~i~~~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~ 278 (347)
T PF12819_consen 209 SPGWSNISTT------SNININSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPN 278 (347)
T ss_pred Cccccccccc------eeeecccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCC
Confidence 2223322221 12222234457789999999999986643 348999999 899999999999999976 35
Q ss_pred CCeEEEEEEEcCccccCCcchhhhcCCCCceeEEEeEecc-cccceeeeEEeCCccCCCCCCchhhccccccccc
Q 047215 324 ANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAV-SSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKF 397 (851)
Q Consensus 324 ~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~~~~~~~~-~~~~~~l~~s~~~~~~~~~~~~~~~lng~Ei~~~ 397 (851)
.++|+|||||||+.+.+++... ..+....++|.+++... ..+.+ ++++++...+. .+|||||+|||++
T Consensus 279 ~~~R~F~IyiN~~~~~~~~~~~-~~~~~~~~~~~d~~~~~~~~~~~--~isL~~t~~S~---lppiLNalEIy~v 347 (347)
T PF12819_consen 279 NNQREFDIYINGQTAYSDVSPP-YLGADTVPYYSDYVVNVPDSGFL--NISLGPTPDST---LPPILNALEIYKV 347 (347)
T ss_pred CCeEEEEEEECCeEccCccCcc-cccCcceEeecceEEEecCCCEE--EEEEEeCCCCC---cCceeEeeeeEeC
Confidence 5689999999999999744432 24445578899998433 33444 49999988874 6999999999985
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=405.28 Aligned_cols=253 Identities=33% Similarity=0.565 Sum_probs=214.9
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCC-cEEEEEEecCCc
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN-EMILVYEYMANG 594 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~lV~Ey~~~g 594 (851)
.+.||+|+||+||+|.+.+...||||++..... ...+.|.+|+.+|++++|||||+++|+|.+.. .++||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 445999999999999999887799999887532 22569999999999999999999999999887 799999999999
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC-eEEcCCCCCCeEEcCCC-eEEEeeccccccCCCCCcccc
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG-IIHRDVKTTNILLDENF-VAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~-iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|.++|+......+++..+++++.|||+||.|||+ .+ |||||||++||||+.++ .+||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 99999987656789999999999999999999996 55 99999999999999997 99999999998643211 22
Q ss_pred ccccccCCcccCccccc--ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 673 STAVKGSFGYLDPEYFW--RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~--~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+ .+. .. .+.....+.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~--~~------------~v~~~~~Rp 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQV--AS------------AVVVGGLRP 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHH--HH------------HHHhcCCCC
Confidence 34478999999999999 66999999999999999999999999987654 211 11 111223344
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.++..++..+..++.+||+.||.+||++.+++..|+.+..
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 5556688889999999999999999999999999998865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=384.94 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=212.3
Q ss_pred ccCHHHHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc
Q 047215 502 RFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579 (851)
Q Consensus 502 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 579 (851)
.+++.+++. .+.||+|..|+|||++++ .++.+|+|.+... .+...+++.+|++++++.+||+||.++|.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 455666554 568999999999999986 4677899998543 5556688999999999999999999999998
Q ss_pred cCC-cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 580 EQN-EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 580 ~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
.+. +..|+||||++|+|.+++... +.+++..+-+|+.++++||.|||. +++||||||||+|||++..|++|||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccc
Confidence 888 599999999999999998544 568999999999999999999996 599999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCC--cchhcHHHHHHHHhh
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP--KDQINLADWAMKWQK 736 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~--~~~~~l~~~~~~~~~ 736 (851)
|.++...+. ...+..||..|||||.+++..|+.++||||||+.++|+.+|+.|+.+..+ ....++.
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll-------- 291 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL-------- 291 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH--------
Confidence 999864332 45667899999999999999999999999999999999999999877511 1112221
Q ss_pred hcccccccCccCCCCCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSP-ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..|++..- +..+. .++++++.++..||++||.+||++.|+++|
T Consensus 292 ----~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 292 ----CAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----HHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22333111 12233 367779999999999999999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=394.57 Aligned_cols=251 Identities=30% Similarity=0.450 Sum_probs=214.1
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
.+.||+|-||.||.|.+++...||+|.++... ...++|.+|+++|++|+|+|||+++|+|..+..++||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 55799999999999999999899999988753 33578899999999999999999999999988999999999999999
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
++|+......+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+||||||...+ +....+....
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~~k 365 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEGGK 365 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC-CceeecCCCC
Confidence 99988667789999999999999999999995 9999999999999999999999999999994332 3333445555
Q ss_pred cCCcccCcccccccCCCchHHHHHHHHHHHHHHhC-CcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCA-RAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 678 gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
-+..|.|||.+....++.|||||||||+||||+|- +.|+.... ..+. .+.++...+-..|+.|
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev----------~~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEV----------LELLERGYRLPRPEGC 429 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHH----------HHHHhccCcCCCCCCC
Confidence 67899999999999999999999999999999995 44443322 2221 1223444555667889
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+..+.+++..||+.+|++|||++.+...|+.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 999999999999999999999998888877654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=409.68 Aligned_cols=260 Identities=30% Similarity=0.486 Sum_probs=220.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
+.+....+.||+|.||+||+|+.. +.+.||||.++..... ...+|++|+++|..|+|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345556778999999999999853 3467999999887554 788999999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCC------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 585 ILVYEYMANGTLRSHLFGSD------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
+||+|||.+|||.++|.... .++|+..+.+.||.|||.||.||-+ +.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 99999999999999995321 3448999999999999999999985 89999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHH
Q 047215 653 AKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~ 731 (851)
|||+||||+|.....+..+....-.-+.+|||||.|..+++|.+||||||||+|||+++ |+.|+......+ +
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence 99999999998777666555544456789999999999999999999999999999998 777776654433 2
Q ss_pred HHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..+.+.+. + -+.+..|+..+..||..||+.+|.+||+++||-..|+...+
T Consensus 715 Ie~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 22333332 2 24578899999999999999999999999999998874433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=390.29 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=212.7
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
..|...+.||+|||+.||+++. +.|..+|+|++.+. ...+.+...+||++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4577788999999999999997 88999999998763 4455678899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|+|++|+|..+++ .++++++.++..+..||+.||.|||+ ++|||||||..|++|+++.++||+|||||......
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 9999999999985 55789999999999999999999995 89999999999999999999999999999875432
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....+.||||.|+|||++.....+..+||||+|||||.||+|++||....-.+ -... |....
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~---------Ik~~~- 234 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNK---------IKLNE- 234 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHH---------HHhcC-
Confidence 234567899999999999999999999999999999999999999997542111 1111 11111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
-.+|...+...++|+.++|+.||.+|||+++||.|
T Consensus 235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12334555668999999999999999999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=376.23 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=209.3
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh-------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE-------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
+.|.+.+.||+|+||.|-+|.- +.|+.+|||++....- .......+|+++|++|+|||||+++++++..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 5577788999999999999974 5789999999875411 1123357999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC---CeEEEeecccc
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN---FVAKMSDFGLS 661 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~---~~~kl~DFGla 661 (851)
|||||||++|+|.+.+-.+. .+.+.....++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+|
T Consensus 252 YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999985544 46677778899999999999995 999999999999999655 78999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccC---CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ---LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
+... ......+.|||+.|.|||++.... +..++|+||+||+||-++||.+||....... ++.+... .+
T Consensus 327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~----~G 397 (475)
T KOG0615|consen 327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQIL----KG 397 (475)
T ss_pred hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHh----cC
Confidence 9743 445567899999999999998654 3348899999999999999999997654322 1211110 01
Q ss_pred ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCC
Q 047215 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~ 801 (851)
...+-| ....+..++..+|+.+||..||++|||+.|+|+| +|+++...
T Consensus 398 --~y~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h---------pW~~~~~~ 445 (475)
T KOG0615|consen 398 --RYAFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH---------PWFKDAPC 445 (475)
T ss_pred --cccccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC---------hhhhcccc
Confidence 111111 2234667889999999999999999999999999 99986543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=366.19 Aligned_cols=250 Identities=27% Similarity=0.413 Sum_probs=207.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.+|...+.||+|+||+||+|++. ++..||||.+... ..+..+.+..|+++|+.++|||||+|+++++.++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56777788999999999999974 5688999998876 67777889999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC------CeEEEeecccccc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN------FVAKMSDFGLSKT 663 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~------~~~kl~DFGla~~ 663 (851)
||.+|+|.++|+... .+++.....++.|+|.||++|| +++||||||||.||||+.. -.+||+|||+||.
T Consensus 90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999996654 6899999999999999999999 4999999999999999754 5689999999998
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.. ......+.||++-|||||+++.++|+.|+|+||+|++|||+++|+.||....+.+- ........
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL------~~~~~k~~----- 230 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL------LLYIKKGN----- 230 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH------HHHHhccc-----
Confidence 55 33445778999999999999999999999999999999999999999986554332 11111111
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+....+......+.+++...++.+|.+|.+..+-+.|
T Consensus 231 ---~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 231 ---EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ---cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 11111223333445678888888999999888877766
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=361.01 Aligned_cols=265 Identities=27% Similarity=0.457 Sum_probs=219.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+.....+.++||+|-||+|..+..++...||||+++.... ...++|.+||++|.+|+|||||+|+|+|..++.++||+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4455667789999999999999999999999999998754 445899999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
||++|+|.++|..+..+.+.-...++||.|||.||+||.+ .++|||||.++|||+|.++++||+|||++|.....+.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999987765556677888999999999999996 8999999999999999999999999999998776666
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHH--hCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV--CARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLl--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.+......-+.+|||||.+..++++.++|||+||++|||++ |...|+.....+ ..++-...+...+.. .
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~------~ 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGR------Q 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCc------c
Confidence 66666666788999999999999999999999999999985 455565432221 112212222111111 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
.-...|+-|+..+.+++.+||..|.++||+++++..+|..
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 1123467788899999999999999999999999888764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=384.72 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=222.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
+...+.++||.|.||+|++|+++ ....||||.++.. .+++..+|..|..+|.+++||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 44567889999999999999975 2357899999877 567788999999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
.|||++|+|..+|+.++ +.+++.++..++++||.||+||. +.++|||||.++||||+.+..+|++||||+|...+.
T Consensus 709 TEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999998887 45999999999999999999998 599999999999999999999999999999976443
Q ss_pred Cccc-cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 668 EHTH-VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 668 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.... .....+-+.+|.|||.+..+++|.++|||||||||||.++ |.+|+.+....+.+ +.++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----------------kaIe 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----------------KAIE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------------HHHH
Confidence 3221 2223344679999999999999999999999999999887 77887655432211 1223
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
..++-.-|.+|+..+.+|++.||++|-.+||++.|++.+|.++++-..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 334445578999999999999999999999999999999998876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=349.49 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=207.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|+..++||+|+||+||.++.+ .++.+|+|.+++. .....+...+|..+|.+++||.||+++-.+++...+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999865 4678899988765 344567788999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
+||+.||.|..+|... ..+++..+.-.+..|+.||.|||+ ++||||||||+|||||.+|.++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999554 468888888899999999999994 9999999999999999999999999999986332
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
......+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...... ++....... +
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~---------k 241 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKG---------K 241 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcC---------c
Confidence 333455689999999999999999999999999999999999999999865322 222221111 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRP----TMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~~ 784 (851)
+ ...+.-.....++++.++|..||++|. .+.++-+|
T Consensus 242 ~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1 111222456689999999999999995 56676666
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=342.73 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=205.5
Q ss_pred CCceeeeeeeecceEEEEEE-EcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEE-EEccCCc-EEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIG-FCDEQNE-MILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g-~~~~~~~-~~lV~ 588 (851)
+|.+.++||+|.||+|||+. +.++..+|.|.+.-. +.+..+++..|+.+|++|+|||||++++ .+.++++ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45667789999999999997 578889999987743 5566678999999999999999999999 4555566 89999
Q ss_pred EecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCC-CeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~-~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
|||.+|+|..+++. +....++++.+++++.|+++||.++|+...+ -|+||||||.||+|+.+|.+||+||||++...
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999843 4456789999999999999999999963333 38999999999999999999999999999754
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
. .........|||.||+||.+...+|+.|+||||+||++|||..-+.||.+. ++.+...... .+..
T Consensus 180 s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~-qgd~----- 245 (375)
T KOG0591|consen 180 S--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIE-QGDY----- 245 (375)
T ss_pred c--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHH-cCCC-----
Confidence 3 233445678999999999999999999999999999999999999999865 2222222211 1111
Q ss_pred ccCCCCCC-hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 746 PHLKGNYS-PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 746 ~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
| ..+ .--+..+.+|+..|+..||+.||+.-.++..+.
T Consensus 246 ~----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 P----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred C----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1 112 345677999999999999999999655555543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=339.67 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=210.0
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.|+...++|+|+||.|||++.+ .|+.||||++..... .-.+-..+||++|++|+|||+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4666778999999999999975 578999999876533 3345678999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
|++.-|.++-+.. ..++...+.+++.|+++|++|+|+ +++|||||||+||||+.++.+||||||+||.... ..
T Consensus 83 ~dhTvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg 155 (396)
T KOG0593|consen 83 CDHTVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG 155 (396)
T ss_pred cchHHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence 9985555443222 347788899999999999999994 9999999999999999999999999999997553 23
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH---------hhhccc
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW---------QKQRSL 740 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~~~ 740 (851)
...+....|..|.|||.+.+ .+|...+||||+||++.||++|.+.|.+...-++..++.....- .....+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 33456678999999999987 79999999999999999999999988887776666554333211 111111
Q ss_pred ccccCccCC-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 741 KSIIDPHLK-----GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 741 ~~i~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.-+.-|... ..--+.....+.+++..||+.||.+|++.+|++.|--
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y 286 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY 286 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence 111111111 0111344567889999999999999999999999943
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.42 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=204.3
Q ss_pred CCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC--cEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN--EMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~lV~Ey 590 (851)
++...+.||+|+||.||++...+ +...|||.....+....+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 44556789999999999998754 7889999887664444677899999999999999999999854443 69999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccccCCC-CC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPS-ME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~-~~ 668 (851)
+++|+|.+++..... .+++..+.+...||++||+|||+ ++||||||||+||||+. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999977665 79999999999999999999995 99999999999999999 79999999999986442 11
Q ss_pred ccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.........||+.|||||++..+ ....++|||||||+++||+||+.||... . ...++....... .
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~---~~~~~~~~ig~~---------~ 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F---EEAEALLLIGRE---------D 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c---chHHHHHHHhcc---------C
Confidence 22233457899999999999853 3445999999999999999999998753 1 111111111111 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.++...++..++++.+|++.+|++|||++++|+|
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1124556677789999999999999999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.43 Aligned_cols=266 Identities=24% Similarity=0.340 Sum_probs=209.3
Q ss_pred cCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV 587 (851)
+.|+.+++||+|.||.||||+ ...++.||+|++.... +.......+||.+|++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457777889999999999998 5678999999987653 44456678999999999999999999998766 789999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
+|||++ ||.-++.... -.+++.++..++.|++.||+|||+ ++|+|||||.+|||||.+|.+||+|||||+.....
T Consensus 197 FeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999998 8887775543 468999999999999999999995 99999999999999999999999999999975443
Q ss_pred CccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc-----
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK----- 741 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----- 741 (851)
... ..+...-|+.|.|||.+.+. .|+.++|+||.||||.||++|++.+.+..+-+|...+-....-..+....
T Consensus 272 ~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 322 24555679999999999864 89999999999999999999999999887766654432221111111111
Q ss_pred --cccCccCC--CCC---ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 --SIIDPHLK--GNY---SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 --~i~d~~l~--~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.++.+... ..+ -...+....+|+..+|..||.+|.|+.++|++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11111100 000 11234557789999999999999999999999
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=362.39 Aligned_cols=262 Identities=25% Similarity=0.443 Sum_probs=205.4
Q ss_pred HhcCCceeeeeeeecceEEEEEEE------cCcceeEEeecCCCC-hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC-
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQS-EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ- 581 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~- 581 (851)
..++|+..++||+|+||.||+|.. ..+..||+|++.... ......+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788899999999999999974 234578999887543 33456789999999999 899999999998654
Q ss_pred CcEEEEEEecCCcchhhhccCCC---------------------------------------------------------
Q 047215 582 NEMILVYEYMANGTLRSHLFGSD--------------------------------------------------------- 604 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~--------------------------------------------------------- 604 (851)
+..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999885421
Q ss_pred ---CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCc
Q 047215 605 ---LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681 (851)
Q Consensus 605 ---~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 681 (851)
..++++.++.+++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1347888999999999999999995 8999999999999999999999999999976432211112223446788
Q ss_pred ccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHH
Q 047215 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKF 760 (851)
Q Consensus 682 y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 760 (851)
|+|||++.+..++.++|||||||+||||++ |+.||......+. ..... ..+. ....+..++..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~-~~~~---------~~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRL-KDGT---------RMRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHH-hcCC---------CCCCCCCCCHHH
Confidence 999999999999999999999999999997 8888865432211 11111 1110 011223455678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 761 GEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 761 ~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.+++.+||+.||.+|||+.|+++.|+.+++
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=346.07 Aligned_cols=265 Identities=24% Similarity=0.351 Sum_probs=211.1
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..++||.|..++||+|+. ..+..||||++... +....+.+++|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46889999999999999999985 55689999998765 33446889999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC-
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME- 668 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~- 668 (851)
||.+|++.++++..-...+.+..+..|++++++||.||| ++|.||||||+.||||+.+|.+||+|||.+.......
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999997654455899999999999999999999 5999999999999999999999999999875433221
Q ss_pred ccccc-cccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 669 HTHVS-TAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 669 ~~~~~-~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
..... ....||+.|||||+++. ..|+.|+||||||+..+||.+|..||....|.... .+.+. +......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLq--n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQ--NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhc--CCCCCccc
Confidence 11122 56789999999999653 47999999999999999999999999876543211 11111 11100000
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
..+..+........+++++..||+.||++|||++++++|-.
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 01111111233457999999999999999999999999943
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=355.27 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=212.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|.+.+.||+|+||.||||+-+ ..+.||+|.+.+. .++..+.+.+|++++++|+|||||.++++++...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999865 4578899988764 45567789999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+.+ +|..+|... ..++++++..|+.++..||.|||+ .+|+|||+||.||||+.++.+|+||||+||.+.. .
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9987 999999543 468999999999999999999995 9999999999999999999999999999997543 4
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
+.+.+.+.||+.|||||...+++|+..+|+||+||+|||+.+|++||.... +.+.+.... -||.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~--------~d~v-- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSIL--------KDPV-- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHh--------cCCC--
Confidence 556678899999999999999999999999999999999999999997432 112222111 1222
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
..+......+..++...|.+||.+|.|-.+++.|-.
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 224466778999999999999999999999999943
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.42 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=212.6
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
..|....+||+|..|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||.++..+..++++|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 3456667899999999999974 567889999988776666677899999999999999999999998889999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.|.+... .+++.++..||++++.||+|||. ++|||||||..|||++.++.+||+|||++....... .
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--S 424 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc--C
Confidence 999999998544 48999999999999999999995 999999999999999999999999999987654322 2
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
...+..||+.|||||++....|.+|+||||||++++||+-|.+||-...|...+.+ .... -.|.+ .
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia~n-----g~P~l--k 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATN-----GTPKL--K 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------Hhhc-----CCCCc--C
Confidence 45667899999999999999999999999999999999999999876544332211 1111 11222 3
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.++..+..+++|+.+||+.|+.+|+++.|+|+|
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 456677889999999999999999999999999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=359.40 Aligned_cols=269 Identities=26% Similarity=0.467 Sum_probs=217.7
Q ss_pred ccCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc
Q 047215 502 RFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579 (851)
Q Consensus 502 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 579 (851)
..+.++++...+.+.+...||+|.||+||+|++.+ .||||++... ...+.+.|+.|+.++++-+|.||+-+.|||.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 44456666666777778899999999999999875 4788887654 5567889999999999999999999999999
Q ss_pred cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
.+.. .||+.+|++-+|+.+|+-.+ ..+...+.+.|+.|||.||.|||+ ++|||||||..||+|.+++.|||+|||
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccc
Confidence 8877 99999999999999998765 568889999999999999999996 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCcccCccccccc---CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh-cHHHHHHHHh
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ---QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI-NLADWAMKWQ 735 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~-~l~~~~~~~~ 735 (851)
|+................|...|||||+++.+ +|++.+||||||+|+|||+||..|+... ..++. -.+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmV------- 605 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMV------- 605 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEe-------
Confidence 98653322222233445688899999999854 7999999999999999999999998733 32221 000
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..+. ..+++ ......|++++++|+..||..++++||.+.+++..|+.++.
T Consensus 606 GrG~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 GRGY----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccc----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0000 00111 12335788899999999999999999999999999887765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.27 Aligned_cols=238 Identities=29% Similarity=0.497 Sum_probs=202.6
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
.+-||.|+.|.||+|++++. .||||+++.. -..+|+-|++|+||||+.+.|+|.....+|||||||+.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~ne-tVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNE-TVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeeccCc-eehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 45699999999999999875 4688876532 245899999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
..|+.. ..++......+..+||.||+|||. +.|||||||+-||||..+..+||+|||-++..... ...-.++
T Consensus 201 ~VLka~--~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa 272 (904)
T KOG4721|consen 201 EVLKAG--RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA 272 (904)
T ss_pred HHHhcc--CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence 999554 468888999999999999999995 99999999999999999999999999998864332 2334578
Q ss_pred cCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHH
Q 047215 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757 (851)
Q Consensus 678 gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 757 (851)
||..|||||+++..+.++|+|||||||||||||||..|+.+...... +.-+-...|.-..+..|+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccCCcccccCcccCc
Confidence 99999999999999999999999999999999999998865432211 111112334445678899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 758 EKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 758 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+.++-|+++||+..|..||++++++.||+
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 99999999999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=353.17 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=213.6
Q ss_pred HHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 584 (851)
...++|...+.||+|+|++|++|+. +.++.+|||++.+. .+.-.+....|-.+|.+| .||.|++|+-.|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457888899999999999999985 56788999988754 233345677899999999 899999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
|+|+||+++|+|.++|+.. +.+++......+.+|+.||+|||+ +|||||||||+|||||+++++||+|||-|+..
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999554 578999999999999999999995 99999999999999999999999999999875
Q ss_pred CCCCcc-----------ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH
Q 047215 665 PSMEHT-----------HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 665 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~ 733 (851)
...... .......||..|.+||++.....+..+|+|+|||+||+|+.|.+||....+.-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---------- 294 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---------- 294 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----------
Confidence 432211 11245789999999999999999999999999999999999999998764321
Q ss_pred HhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 734 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.+++|++ +.-.+++..++.+.+|+++.|..||.+|+|.+|+-+|.-
T Consensus 295 -----iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 295 -----IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred -----HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 1222332 223455666678999999999999999999999999943
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=355.48 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=211.5
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC----Ch-hhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ----SE-QGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNE 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 583 (851)
..++|...+.||+|+||.|++|.. ..+..+|+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346788889999999999999975 45688999976653 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC-CeEEEeeccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSK 662 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~ 662 (851)
.++||||+.+|+|.+++.. ..++.+.+..+++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999966 4578889999999999999999995 999999999999999999 999999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccccC-CC-chHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ-LT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....... + ...
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l---~~k------- 234 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---L---YRK------- 234 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---H---HHH-------
Confidence 753 2334456789999999999999877 86 78999999999999999999998732211 1 111
Q ss_pred ccccCccCCCCCChhH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 741 KSIIDPHLKGNYSPES-LEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
|.... -.++... +..++.|+.+||..||.+|+|+.+++.| +|++.
T Consensus 235 --i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h---------~w~~~ 280 (370)
T KOG0583|consen 235 --IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH---------PWFQK 280 (370)
T ss_pred --HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC---------hhhcc
Confidence 11111 1223333 6778999999999999999999999988 88876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=364.01 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=216.6
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEcCc----ce-eEEeecCC---CChhhHHHHHHHHHHHHhcCCcceeeEEEEEc
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIEDC----TL-AAIKRANP---QSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~----~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 579 (851)
++...++....++||+|+||.||+|++... .. ||||.... .......+|.+|.++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 444455556668999999999999987532 23 79998875 35777899999999999999999999999999
Q ss_pred cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
....+++|||+|+||+|.++|..... .++..++++++.++|.||+|||+ +++|||||.++|||++.++.+||+|||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999976553 68999999999999999999995 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
|++........ ...-.-+..|+|||.+....++.++|||||||++||+++ |..|+.+.... .+..
T Consensus 308 Ls~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~--------- 373 (474)
T KOG0194|consen 308 LSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKA--------- 373 (474)
T ss_pred cccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHH---------
Confidence 99875421111 111235679999999999999999999999999999999 66666554322 1111
Q ss_pred ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhh
Q 047215 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (851)
.+.-...+...+...+..+..++.+|+..+|++||||.++.+.|+.+....++
T Consensus 374 ---kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 ---KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 12122333445567788899999999999999999999999999988765543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=346.05 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=209.5
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.|...++||+|.||.||||... .++.||+|++... .....++.++|+.+|.+++|+||.+++|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3455568999999999999854 5678999998765 5566788999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
.+|++.+.|... ..+.+.++.-|++++..||.|||+ ++.+|||||+.|||+..+|.+||+|||.+....... .
T Consensus 94 ~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--K 166 (467)
T ss_pred cCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh--h
Confidence 999999999544 345888889999999999999995 899999999999999999999999999997654322 2
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
...+..||+.|||||++++..|+.|+||||||++++||++|.+|+....|...+.+ +.+-..|.+.+
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~- 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG- 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc-
Confidence 23678899999999999999999999999999999999999999887665332111 11122344444
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+++|+..||++||+.||++.++|+|
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 445569999999999999999999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=351.10 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=211.0
Q ss_pred cCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCCChhhHHH--HHHHHHHHHhcC-CcceeeEEEEEccCC-cEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAE--FETEIEMLSKLR-HRHLVSLIGFCDEQN-EMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l~-HpnIv~l~g~~~~~~-~~~lV 587 (851)
++|...++||.|.||.||+|+ .+.+..||||+++..-.. +++ =.+|++.|++|+ |||||+|.+++.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 567788899999999999997 467888999998765322 232 357999999998 999999999997777 99999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
||||+. +|.++++.+ ...+++..+..|+.||++||+|+| ++|+.|||+||+|||+..+..+||+||||||.....
T Consensus 89 fE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred HHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence 999987 999999777 678999999999999999999999 699999999999999999999999999999975432
Q ss_pred CccccccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc------c
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS------L 740 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~ 740 (851)
...+....|..|.|||++. ...|+.+.|||++|||++||.+-++.|.+..+.++...+.-+........ +
T Consensus 164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 2345566899999999875 56899999999999999999999999988777666544333322111111 1
Q ss_pred cccc---CccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSII---DPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~---d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+ -|...+ ..-+.++.++.+++.+||+.||.+|||+.|+|+|
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111 111111 1112367789999999999999999999999999
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=382.20 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=216.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC--c----ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED--C----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~--~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
..+.+..+.||+|.||.||+|++.+ + ..||||.+.+. +.+...+|.+|..+|+.++|||||+++|+|......
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455667889999999999998754 2 24789988775 667788999999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCC-----CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 585 ILVYEYMANGTLRSHLFGSD-----LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
+|++|||++|+|..+|++.+ ...++..+++.++.|||+|+.|||+ +++|||||.++|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997752 3468899999999999999999995 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCc-CCCCCCCcchhcHHHHHHHHhhhc
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA-VINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~-p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
|||.....+..+......-+..|||||.+..+.++.|+|||||||+|||++|-.. |+......+... .+...+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC
Confidence 9996554444433333334579999999999999999999999999999999655 444333222110 111111
Q ss_pred ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhh
Q 047215 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (851)
+-+.+..|++.+.++|..||+.+|++||++..+++.+..+.+....
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 2245678999999999999999999999999999998888765443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.85 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=206.3
Q ss_pred cccCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhh---HHHHHHHHHHHHhcCCcceeeEEEE
Q 047215 501 KRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQG---LAEFETEIEMLSKLRHRHLVSLIGF 577 (851)
Q Consensus 501 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~ 577 (851)
+.++.+++.. .....||+|++|.||+|.+ +++.+|||++....... .+.|.+|+.+|++++||||++++|+
T Consensus 13 ~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 3455555522 2235799999999999998 56788999887643322 5678899999999999999999999
Q ss_pred Ecc----CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 578 CDE----QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 578 ~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
+.+ ....++||||+++|+|.+++... ..+++....+++.+++.||.|||+ ..+++||||||+|||+++++.+
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcE
Confidence 866 45789999999999999999654 468899999999999999999995 3578899999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~ 731 (851)
||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ + .
T Consensus 163 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~---~ 231 (283)
T PHA02988 163 KIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I---Y 231 (283)
T ss_pred EEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H---H
Confidence 99999998753321 123457899999999976 689999999999999999999999997543221 1 1
Q ss_pred HHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.... ........+..++..+.+++.+||+.||.+|||++|+++.|+...+
T Consensus 232 ~~i~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 232 DLII---------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHH---------hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111 0111112334567789999999999999999999999999886653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=394.14 Aligned_cols=268 Identities=25% Similarity=0.435 Sum_probs=218.5
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ 581 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 581 (851)
++++++. ..+...++||+|+||.||+|+. .++..+|||++...... ...|++.+++++|||||+++|+|..+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4455543 3566778899999999999986 57788999988654322 23568899999999999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
+..++|||||++|+|.++++ .++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||..
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 99999999999999999994 37899999999999999999997666899999999999999999888876 6665
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
..... .....+|..|+|||++.+..++.++|||||||++|||+||+.|+..... ......+|+..........
T Consensus 830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 830 GLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred ccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchh
Confidence 43211 1123578999999999999999999999999999999999999865432 2345777877655555556
Q ss_pred cccCccCCCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 742 SIIDPHLKGN--YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 742 ~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.++|+.+... ...+....+.+++.+||+.||++||||+|+++.|+.+.+
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 6677766443 345667788999999999999999999999999987754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=324.17 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=209.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||.|+||.|.+.+.+ ++..+|+|++... ...+.+...+|..+|+.+.||.+++|.+.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777889999999999999865 5678899998865 3455677889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|.|..+|+.. +++++......+.+|+.||+|||+ .+|++|||||+|||||.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999554 479999999999999999999995 9999999999999999999999999999987433
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
..-+.|||+.|+|||.++..++..++|.|||||++|||++|.+||....+.. ..+.|+...+
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---------------iY~KI~~~~v 258 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---------------IYEKILEGKV 258 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---------------HHHHHHhCcc
Confidence 2567899999999999999999999999999999999999999998776521 1122333332
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCC-----CCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNR-----PTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~R-----Pt~~evl~~ 784 (851)
.+|.-....+++|+.+.|+.|-.+| +...+|-.|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 3455556678999999999999999 345677777
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=318.12 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=210.6
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChh--hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQ--GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.+|...++||+|.||.||+|+. +.++.||||+++..... ......+||+.|+.++|+||+.|++++...+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3566677899999999999985 56889999998866332 23457899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
||+. +|...++.+. ..++..++..++.++++||+|||+ +.|+||||||.|+|++.+|.+||+|||+|+.......
T Consensus 82 fm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9986 9998887665 468899999999999999999995 9999999999999999999999999999998655443
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc--------
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL-------- 740 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------- 740 (851)
.. +...-|..|.|||.+.+ +.|+..+||||.||++.||+-|.+.+.+...-+|...+-.+.........
T Consensus 157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 32 23357899999999875 57999999999999999999998888776665555433222211111111
Q ss_pred ----ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 ----KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ----~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+.+. ..-+.+.....+|+.+++..||.+|+|++|+++|
T Consensus 235 Y~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111111 2334566677999999999999999999999999
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=340.83 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=204.3
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999986 567889999876432 2334567899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999988865544568999999999999999999995 899999999999999999999999999987643211
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ..... +... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~---------~~~~--~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDRR---------VKED--Q 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHHH---------hhcc--c
Confidence 1234568999999999999999999999999999999999999997643321110 00000 0000 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
..++...+..+.+|+.+||+.||.+||+ ++++++|
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1233345567899999999999999997 8999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=353.22 Aligned_cols=245 Identities=26% Similarity=0.331 Sum_probs=206.8
Q ss_pred CceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 515 FDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
|+..+.||+|+.|.|-.|++ ..|+.+|||++... +......+.+||.+|+-+.||||++|++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 45566799999999999986 57899999998765 333345688999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|.|.++|.. .+++++.+..+.++||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.... ..
T Consensus 94 v~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~g 165 (786)
T KOG0588|consen 94 VPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV---PG 165 (786)
T ss_pred cCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc---CC
Confidence 999999999954 4579999999999999999999995 999999999999999999999999999998733 33
Q ss_pred ccccccccCCcccCcccccccCCC-chHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
....+-||++.|.+||++++.+|+ .++||||+|||||.||||+.||++..- ..+.. . .+.+ .
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLl---K-V~~G----------~ 228 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLL---K-VQRG----------V 228 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHH---H-HHcC----------c
Confidence 345678999999999999999885 689999999999999999999984321 11111 1 1111 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
-+.|...+.++++|+.+||..||++|.|++||++|
T Consensus 229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 13345666779999999999999999999999999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=340.87 Aligned_cols=263 Identities=24% Similarity=0.435 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-----------------cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceee
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-----------------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~ 573 (851)
.++|...++||+|+||.||++..++ +..+|+|.+... ......+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997543 236899988764 3445567999999999999999999
Q ss_pred EEEEEccCCcEEEEEEecCCcchhhhccCCC-----------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeE
Q 047215 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSD-----------------LPPLTWKQRLDACIGAARGLHYLHTGAERGII 636 (851)
Q Consensus 574 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~ii 636 (851)
+++++...+..++||||+++|+|.+++.... ...+++.++.+++.|++.||.|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999884321 1347888999999999999999995 8999
Q ss_pred EcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhC--Cc
Q 047215 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCA--RA 714 (851)
Q Consensus 637 HrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG--~~ 714 (851)
||||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999764332222222334567899999999988999999999999999999874 44
Q ss_pred CCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 715 VINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 715 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
|+...... ............... ......++.++..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 55543221 122222221111100 0111223456678999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=316.02 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=211.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|++.+.||+|.||.||.|+.+ ++-.+|+|++.+. ..+...++.+|+++-+.|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56888899999999999999865 4567899987654 2233457899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||.+.|+|...|+.....++++........|+|.||.|+| .++||||||||+|+|++..+..||+|||-+...+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 9999999999998777788999999999999999999999 5999999999999999999999999999987633
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....+.|||..|++||+..+...+.++|+|++|++.||++.|.+||......+ . ..+|...
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---t------------YkrI~k~-- 237 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---T------------YKRIRKV-- 237 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---H------------HHHHHHc--
Confidence 334567899999999999999999999999999999999999999997654211 1 0111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.-.++...+..+++++.+|+..+|.+|.+..|+++|
T Consensus 238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 112334555678999999999999999999999999
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=342.73 Aligned_cols=262 Identities=22% Similarity=0.358 Sum_probs=207.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-Ccc----eeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCT----LAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.+|+..+.||+|+||.||+|++. ++. .+|+|.+... .....+++.+|+.+++.++||||++++|+|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56888999999999999999863 333 3789988654 344567899999999999999999999999765 5789
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
++||+++|+|.+++.... ..+++..+++++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999986543 357889999999999999999995 8999999999999999999999999999986543
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........++..|+|||++.+..++.++|||||||++|||++ |+.|+......+ +.. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~-------- 226 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEK-------- 226 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhC--------
Confidence 222212223335678999999999999999999999999999998 888876432211 111 1111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
......++.+...+.+++.+||+.+|.+||++.+++.+|..+......|
T Consensus 227 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 227 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 1111123345567899999999999999999999999988877655544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=346.20 Aligned_cols=262 Identities=24% Similarity=0.312 Sum_probs=204.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||+++.. .+..+|+|.+... .......+.+|+++|++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999875 5677888887654 33445679999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999998553 358899999999999999999996 457999999999999999999999999998754221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh-h--h---------
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ-K--Q--------- 737 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~-~--~--------- 737 (851)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +........ . .
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1234568999999999999999999999999999999999999986433211 100000000 0 0
Q ss_pred ----------------------cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 ----------------------RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 ----------------------~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+.............+..+++|+.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000011245679999999999999999999999999
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=355.35 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=202.6
Q ss_pred hcCCceeeeeeeecceEEEEEEE------cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 583 (851)
.++|+..+.||+|+||.||+|+. +.+..+|||++... .....+.+.+|+.+++.+ +||||++++++|..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45677788999999999999964 23457899988654 234456788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCC-----------------------------------------------------------
Q 047215 584 MILVYEYMANGTLRSHLFGSD----------------------------------------------------------- 604 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------------- 604 (851)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999885421
Q ss_pred --------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 605 --------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 605 --------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
...+++..+.+++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1247888999999999999999995 89999999999999999999999999999764332221
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+ ...+ ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~---------~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEG---------YR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhC---------cc
Confidence 12223345678999999999999999999999999999998 777775432211 11111 1111 01
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
...+...+..+.+|+.+||+.||++|||+.|+++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111223346789999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.30 Aligned_cols=250 Identities=34% Similarity=0.530 Sum_probs=197.6
Q ss_pred eeeeeeeecceEEEEEEEc-----CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 517 ESLMIGVGGFGKVFKGEIE-----DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..+.||.|.||.||+|.+. .+..|+||.+... .....+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999987 2467899999664 444578999999999999999999999999988889999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.++|.......+++.++.+|+.|+++||.|||+ .+++|+||+++||+++.++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999988756779999999999999999999996 88999999999999999999999999999875322222
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
...........|+|||.+....++.++||||||+++|||++ |+.|+..... .+..........
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~~~~~~---------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKLKQGQR---------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHHHTTEE----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccc----------
Confidence 33344457789999999999889999999999999999999 6677654321 112222211111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
...+..++..+.+++.+||+.+|.+|||++++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 122344567799999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.08 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=203.7
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh--------------hhHHHHHHHHHHHHhcCCcceeeEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE--------------QGLAEFETEIEMLSKLRHRHLVSLI 575 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~HpnIv~l~ 575 (851)
.-|.|++.+.||+|.||.|-+|+. .+++.+|||++.+... ...+...+||.+|++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 347899999999999999999985 4678999998765421 1235788999999999999999999
Q ss_pred EEEcc--CCcEEEEEEecCCcchhhhccCCCCCC-CchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 576 GFCDE--QNEMILVYEYMANGTLRSHLFGSDLPP-LTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 576 g~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~-l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
.+..+ .+.+|||+|||..|.+... ....+ +++.+..+++.++..||+|||. ++||||||||+|+||+++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 99864 4689999999999888544 23334 9999999999999999999996 99999999999999999999
Q ss_pred EEEeeccccccCCC---CCccccccccccCCcccCcccccccC----CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh
Q 047215 653 AKMSDFGLSKTGPS---MEHTHVSTAVKGSFGYLDPEYFWRQQ----LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725 (851)
Q Consensus 653 ~kl~DFGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~ 725 (851)
+||+|||.+..... ...........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-- 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-- 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--
Confidence 99999999875321 11222233467999999999998632 4568899999999999999999997653221
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+|+...+.-...++..+.+++|++++|++||++|.+..+|..|
T Consensus 327 -------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 327 -------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred -------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 1233444444333344677889999999999999999999999999
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=352.36 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=205.4
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ 581 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 581 (851)
...++|+..+.||+|+||.||+|+.. +...+|+|++... .......+.+|+.+++.+ +||||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34467888899999999999998742 2357899998754 334456788999999999 899999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCCC---------------------------------------------------------
Q 047215 582 NEMILVYEYMANGTLRSHLFGSD--------------------------------------------------------- 604 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~--------------------------------------------------------- 604 (851)
+..++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred -----------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 605 -----------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 605 -----------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
..++++.++.+++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1247888899999999999999995 89999999999999999999999999998764332221122
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
....++..|+|||++.+..++.++|||||||++|||++ |+.||........ . . ..... ......
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~---~-~~~~~---------~~~~~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F---Y-KMVKR---------GYQMSR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H---H-HHHHc---------ccCccC
Confidence 23345678999999998899999999999999999997 9988865432211 0 0 00000 111111
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2233567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=340.64 Aligned_cols=263 Identities=21% Similarity=0.344 Sum_probs=214.1
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
+...++|+..++||+|+||.||+++.+ .|..+|+|++++. ...+.+..+.|-.+|...++|+||+|+..|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 335688999999999999999999865 5788999999876 345667788999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
||||||++||++..+|... ..|++......+.+++.|+.-|| +.|+|||||||+|+|||..|.+||+||||+.-.
T Consensus 217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999999554 46888888899999999999999 699999999999999999999999999998421
Q ss_pred CC----------------------CCcc----cc-------------------ccccccCCcccCcccccccCCCchHHH
Q 047215 665 PS----------------------MEHT----HV-------------------STAVKGSFGYLDPEYFWRQQLTEKSDV 699 (851)
Q Consensus 665 ~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~t~ksDV 699 (851)
.. .+.. .. .....|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 00 0000 00 113469999999999999999999999
Q ss_pred HHHHHHHHHHHhCCcCCCCCCCcch-hcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC-
Q 047215 700 YSFGVVLFEVVCARAVINPTLPKDQ-INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT- 777 (851)
Q Consensus 700 wS~GvvL~eLltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt- 777 (851)
||+|||+||||.|.+||....+.+. ..+..|...+.. .-...+..+..+||.+||. ||.+|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999999998876543 233334322211 1112334778999999999 9999974
Q ss_pred --HHHHHHHHHHHHHhhhhhcccCC
Q 047215 778 --MGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 778 --~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
++||-+| +|+..-+
T Consensus 437 ~G~~EIK~H---------PfF~~v~ 452 (550)
T KOG0605|consen 437 KGAEEIKKH---------PFFKGVD 452 (550)
T ss_pred ccHHHHhcC---------CccccCC
Confidence 8888888 7766544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.31 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=206.5
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc------ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC------TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|+..+.||+|+||.||+|..... ..+++|.+... .......|.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 3577788999999999999986432 46888987654 3344567999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCC--------------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC
Q 047215 586 LVYEYMANGTLRSHLFGSDL--------------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF 651 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~ 651 (851)
++|||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999854321 457889999999999999999995 8999999999999999999
Q ss_pred eEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHH
Q 047215 652 VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADW 730 (851)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~ 730 (851)
.+||+|||+++...............+++.|+|||.+....++.++|||||||++|||++ |+.||....+.+ +...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999876433222222334456889999999988899999999999999999998 988887543321 1111
Q ss_pred HHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 731 AMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 731 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
... ......+..++..+.+|+.+||+.||.+||++.|++++|+.
T Consensus 239 ----i~~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRS---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHc---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 11112345667889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=335.01 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=203.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||.||+++.. ++..+|+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 5678899987653 23345678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|++++.+..+... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999877655432 2468899999999999999999995 8999999999999999999999999999976432211
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH---------HHHhhhccc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA---------MKWQKQRSL 740 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~ 740 (851)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||......+........ .........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1223456899999999999889999999999999999999999998764332221111100 000000001
Q ss_pred ccccCccCCC------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKG------NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+.... ......+..+.+|+.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111100 1112345679999999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=340.09 Aligned_cols=245 Identities=22% Similarity=0.267 Sum_probs=202.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..++||+|+||.||+|... +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999875 5788999987643 2234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999998543 468899999999999999999995 89999999999999999999999999998764321
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...... ...
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~---------~~~- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKIL---------AGK- 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH---------hCC-
Confidence 223568999999999999999999999999999999999999987543221 111111 001
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
..++......+++++.+||+.||.+||+ ++++++|
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1123334566899999999999999995 9999999
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.34 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=205.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..+.||+|+||.||+|.+. .+..+|+|.+... .......|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999763 3467899988765 33445678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+|||++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999986543 46899999999999999999999 48999999999999999999999999998765322
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. ........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+ ..+ .. ..+
T Consensus 160 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~---~~-~~~------- 224 (266)
T cd05064 160 EA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK---AV-EDG------- 224 (266)
T ss_pred cc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---HH-HCC-------
Confidence 11 111122345678999999999999999999999999999875 988886543221 111 11 111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.....+..++..+.+++.+||+.+|.+||+++++++.|..+
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122345667799999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=345.42 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=204.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+.. .++.+|+|++... .......+..|+.++.+++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 4678999988653 2234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999543 468899999999999999999995 8999999999999999999999999999875332
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+. .. +..+..
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~--~~---~~~~~~ 222 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYWK--ET---LQRPVY 222 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHhcc--cc---ccCCCC
Confidence 223456899999999999999999999999999999999999998764432211 1111100 00 001111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ......+..+.+++.+||..+|.+||+++++++|
T Consensus 223 ~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 D-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred C-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 0012345678999999999999999999999999
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.72 Aligned_cols=265 Identities=23% Similarity=0.378 Sum_probs=201.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|...++||+|+||.||+|+.+ ++..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 56789999876442 23345678999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++ +|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 985 8888875432 357889999999999999999995 8999999999999999999999999999875332111
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH------Hh---hhccc
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK------WQ---KQRSL 740 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~------~~---~~~~~ 740 (851)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+.......... +. .....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1233467899999999865 5689999999999999999999999876543332211110000 00 00000
Q ss_pred ccccCccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+.... ...+.....+.+++.+||+.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111100 0112345668899999999999999999999999
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.57 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=198.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc--CcceeEEeecCCCC--hhhHHHHHHHHHHHHhc---CCcceeeEEEEEc-----c
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE--DCTLAAIKRANPQS--EQGLAEFETEIEMLSKL---RHRHLVSLIGFCD-----E 580 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~-----~ 580 (851)
++|+..+.||+|+||.||+|+.. ++..+|+|++.... ......+.+|+.+++++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46788999876432 22234566788777766 6999999999984 3
Q ss_pred CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
...+++||||++ ++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 589888866555668999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh---h
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK---Q 737 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~---~ 737 (851)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+... ....... .
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~---~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPGE 230 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHHhCCCCh
Confidence 9764322 22334568999999999998899999999999999999999999987654332211 1111000 0
Q ss_pred ccc-------ccccCccCC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 RSL-------KSIIDPHLK---GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 ~~~-------~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
... .....+... ....+..+..+.+++.+||+.||++|||+.|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000000000 01112345678899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=333.08 Aligned_cols=266 Identities=24% Similarity=0.414 Sum_probs=200.0
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHh--cCCcceeeEEEEEccCC----cEEEEEEec
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSK--LRHRHLVSLIGFCDEQN----EMILVYEYM 591 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~~----~~~lV~Ey~ 591 (851)
.++||+|+||.||||.+.+ +.||||++... ..+.|.+|-++.+. ++|+||+++++.-+... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 4469999999999999887 78999998754 44567777777665 58999999999987666 899999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC------CCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG------AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
++|+|.++|..+. ++|....+|+..+++||+|||++ .+++|+|||||++||||..++++.|+|||||....
T Consensus 291 ~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 291 PKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred cCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999996654 89999999999999999999975 36679999999999999999999999999998766
Q ss_pred CCCccccccccccCCcccCccccccc-CCC-----chHHHHHHHHHHHHHHhCCcCCCC-CCCcchhcHHHHHHHHhhhc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQ-QLT-----EKSDVYSFGVVLFEVVCARAVINP-TLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t-----~ksDVwS~GvvL~eLltG~~p~~~-~~~~~~~~l~~~~~~~~~~~ 738 (851)
............||.+|||||++.+. .+. .+.||||+|.|||||++......+ ..++-+..+...+......+
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 54444445568899999999999753 222 468999999999999998765542 22221211111111100001
Q ss_pred cccc-ccCccCCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 739 SLKS-IIDPHLKGNYS-----PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 739 ~~~~-i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.+++ ++..+.++.++ ...+..+++.+..||+.||+.|.|+.=|-+.+..+..
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111 11111122221 2456779999999999999999999988888766543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=344.25 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=198.7
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
++||+|+||.||+++.. +++.+|+|++... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 6788999987653 2334566788999999999999999999999999999999999999
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccc
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST 674 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (851)
+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 999988543 468899999999999999999995 89999999999999999999999999998753221 12233
Q ss_pred ccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCCh
Q 047215 675 AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754 (851)
Q Consensus 675 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 754 (851)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... . ..+ +. .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~---~-~~~------~~----~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---I-LME------EI----RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH---H-HcC------CC----CCCC
Confidence 4679999999999999999999999999999999999999986532211 1110 0 000 11 2234
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 755 ESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..+..+.+++.+||+.||++|| ++.++++|
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 4556789999999999999999 89999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.93 Aligned_cols=271 Identities=23% Similarity=0.325 Sum_probs=211.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-hhH-HHHHHHHHHHHhcCCcceeeEEEEEc--cCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-QGL-AEFETEIEMLSKLRHRHLVSLIGFCD--EQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~-~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~lV 587 (851)
++|+..+.|++|+||.||+|+.+ ....||+|+++...+ .+. -.-.+||.+|.+++|||||.+-.+.. +-+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677788999999999999864 567899999876532 221 23578999999999999999988864 44679999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
||||++ +|..++.... +++...++.-+..|+++|++||| ...|+|||||++|+|++..|.+||+||||||.....
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999998 8888886655 67899999999999999999999 489999999999999999999999999999976543
Q ss_pred CccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC-
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID- 745 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d- 745 (851)
.. ..+...-|+.|.|||.+.+. .|+...|+||+|||+.||+++++.|.+....+|.+.+-.......+........
T Consensus 231 ~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 LK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred cc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 22 23556679999999999865 699999999999999999999999988776666544322222111111100000
Q ss_pred -------------ccCCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 746 -------------PHLKGNYSPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 746 -------------~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
..++..+... ..+.-.+|+..+|..||.+|.|++|.|+| .|+.+.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h---------~~F~e~ 367 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH---------EYFRET 367 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc---------cccccC
Confidence 0122222222 44677899999999999999999999999 888763
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.73 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=203.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..++||+|+||.||++... .+..+++|.+... .......+.+|++++++++||||++++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478899999999999999999876 4677888877654 33445678999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999998543 357889999999999999999995 457999999999999999999999999998753221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc---------
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL--------- 740 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------- 740 (851)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .......+..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL----MFGCPVEGDPAESETSPRP 231 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH----HhcCcccCCccccccCccc
Confidence 1233568999999999999899999999999999999999999986543211100 0000000000
Q ss_pred --------------------ccccCcc---CCCCCC-hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 --------------------KSIIDPH---LKGNYS-PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 --------------------~~i~d~~---l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.+.. .....+ ......+++|+.+||+.||++|||+.|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 000000 1134568999999999999999999999999
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=353.13 Aligned_cols=252 Identities=20% Similarity=0.280 Sum_probs=205.1
Q ss_pred CCceeeeeeeecceEEEEEEEc-C-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-D-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.|...+.||+|+||.||+|... + +..+++|.+..........+.+|+.+|+.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999753 3 4677888776655566677889999999999999999999999999999999999
Q ss_pred CCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 592 ANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 592 ~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
++|+|.++|+. ....++++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999988754 234568899999999999999999995 8999999999999999999999999999986433222
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... .+ ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~-~~--------~~- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVL-YG--------KY- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hC--------CC-
Confidence 22334567999999999999999999999999999999999999998643221 1111110 01 00
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+..++..+.+++.+||+.+|++||++++++.+
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01223445678999999999999999999999887
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.45 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=212.7
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+..+|+..++||+|+||.||+|...++..+++|.+..........+..|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44567888899999999999999888889999998877665677899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++.......+++.++.+++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 999999999977666678999999999999999999994 8999999999999999999999999999876432211
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
......++..|+|||.+....++.++||||||+++++|++ |+.|+......+ .... .. ....
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~---~~----------~~~~ 222 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ---IT----------AGYR 222 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH---HH----------hCCc
Confidence 1223345778999999998899999999999999999998 788876543211 1111 10 1111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
...+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 22334566779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.83 Aligned_cols=264 Identities=24% Similarity=0.308 Sum_probs=197.1
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----CcEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NEMI 585 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~ 585 (851)
+|+..++||+|+||.||+|+.. ++..+|||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999864 6788999987643 223445688999999999999999999988533 3589
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||++ ++|.+++... ..+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999996 6888888543 358999999999999999999995 899999999999999999999999999997533
Q ss_pred CCCcc-ccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH---------HHHH
Q 047215 666 SMEHT-HVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD---------WAMK 733 (851)
Q Consensus 666 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~---------~~~~ 733 (851)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. +...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 21111 11234568999999999875 678999999999999999999999986543322111100 0000
Q ss_pred Hhhh---cccccccCccCCCCC---ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 WQKQ---RSLKSIIDPHLKGNY---SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 ~~~~---~~~~~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.... ..+..+ .+...... -+..+..+.+++.+||+.||++|||++|+++|
T Consensus 235 i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 000000 00000000 11234568899999999999999999999999
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.04 Aligned_cols=245 Identities=23% Similarity=0.348 Sum_probs=202.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 5678999987643 2234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999998654 357888899999999999999995 89999999999999999999999999998764321
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+... ... +....+
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~---------i~~~~~ 232 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------YEK---------ILAGRL 232 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------HHH---------HhcCCc
Confidence 1235789999999999999999999999999999999999999865432111 111 111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
.++...+..+.+|+.+||+.||.+||+ +++++.|
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 122334456899999999999999997 7999999
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.92 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=207.7
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|+..+.||+|++|.||+|...+++.+++|.+.... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788899999999999999998777889999886543 3356789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 999999999976555578999999999999999999994 8999999999999999999999999999876432111
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
........+..|+|||++.+..++.++||||||++++||++ |+.|+....... +.. .. .. ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~-~~---------~~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ---QV-DQ---------GYR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HH-Hc---------CCC
Confidence 11112223457999999999999999999999999999999 888876432211 110 00 00 011
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
...+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 12233456779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.94 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=207.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..+.||+|+||.||+|.+.. ...+++|.+... ......+|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998743 357899987654 34445678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++++|.+++.... ..+++.++.+++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999986543 368999999999999999999994 9999999999999999999999999999987542
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ...+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~------- 224 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----EDG------- 224 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcC-------
Confidence 222222223345678999999998999999999999999999998 88887543211 111111 110
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.....+..++..+.+++.+||+.+|++||+++|++++|+.+
T Consensus 225 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 --YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112234567799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.74 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=209.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 585 (851)
.-++|...++||+|.||+|+++..+. ++.+|||.+++. ..+..+....|.+++... +||.+++|+.+++..++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 44789999999999999999999764 568899988875 456678888999998887 5999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||+.||++..+.+ ...+++..+.-++..|+.||+||| +++||+||||.+|||||.+|.+||+||||++...
T Consensus 446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999554443 245899999999999999999999 5999999999999999999999999999998744
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
. ......+.|||+.|||||++.+..|+..+|.|||||+|||||.|..||.+..+++. ...|+.
T Consensus 520 ~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---------------FdsI~~ 582 (694)
T KOG0694|consen 520 G--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---------------FDSIVN 582 (694)
T ss_pred C--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHHhc
Confidence 3 23356789999999999999999999999999999999999999999987654331 111221
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
. ...+|.-++.+...|++++|.++|++|..+ ++|.+|
T Consensus 583 d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 583 D--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred C--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 1 123456667778999999999999999865 566666
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.94 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=207.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|+..++||+|+||.||+|...++..+++|.+.... ...+.+.+|+.++++++||||+++++++..++..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36788899999999999999998888889999876543 33578899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....... .
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence 99999999976555678899999999999999999995 8999999999999999999999999999976432211 1
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||++....++.++|||||||++|||++ |+.||....... ...+ .. .. . ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~---~~-~~-----~----~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA---LQ-RG-----Y----RM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH---HH-cC-----C----CC
Confidence 1223345678999999998899999999999999999998 888876432211 1111 11 00 0 01
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
.....++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=341.62 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=204.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCC-hhhHHHHHHHHHHHHhc-CCcceeeEEEEEc-cC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQS-EQGLAEFETEIEMLSKL-RHRHLVSLIGFCD-EQ 581 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~-~~ 581 (851)
..++|++.++||+|+||.||+|... .++.+|+|++.... ......+.+|+.++.++ +||||++++++|. .+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457888899999999999999642 24679999887542 33456688899999999 8999999999885 45
Q ss_pred CcEEEEEEecCCcchhhhccCCC---------------------------------------------------------
Q 047215 582 NEMILVYEYMANGTLRSHLFGSD--------------------------------------------------------- 604 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~--------------------------------------------------------- 604 (851)
...++++||+++|+|.++|....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 67899999999999998885321
Q ss_pred --CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcc
Q 047215 605 --LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682 (851)
Q Consensus 605 --~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 682 (851)
..+++|..+.+++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1268899999999999999999995 89999999999999999999999999999864332221122334567789
Q ss_pred cCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHH
Q 047215 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFG 761 (851)
Q Consensus 683 ~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 761 (851)
+|||++.+..++.++|||||||+|+||++ |..||......+. +. .....+ .....+...+..+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEG---------TRMRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhcc---------CCCCCCccCCHHHH
Confidence 99999999999999999999999999998 8888865432211 11 111111 01111233456789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 762 EIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 762 ~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
+++.+||+.+|++||++.|++++|+.+++
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=346.15 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=205.4
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCC-hhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQS-EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQN 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~ 582 (851)
..++|.+.++||+|+||.||+|+... +..+|||++.... ....+.+.+|+++|+++. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45678888999999999999998532 2468999987543 344567999999999996 999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCC----------------------------------------------------------
Q 047215 583 EMILVYEYMANGTLRSHLFGSD---------------------------------------------------------- 604 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 604 (851)
..+|||||+++|+|.++|+...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875321
Q ss_pred ------------------------------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc
Q 047215 605 ------------------------------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD 648 (851)
Q Consensus 605 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld 648 (851)
...+++.++++++.|+++||.|||+ .+++||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 1247788899999999999999995 8999999999999999
Q ss_pred CCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcH
Q 047215 649 ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINL 727 (851)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l 727 (851)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+........ +
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence 999999999999876432222112223446788999999998899999999999999999997 8888764322111 0
Q ss_pred HHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 728 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
......+ .....+..++..+.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 350 ----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 ----YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0000000 111223455677999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=330.69 Aligned_cols=264 Identities=28% Similarity=0.431 Sum_probs=210.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|...+.||+|+||.||++... ++..+++|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57788889999999999999742 235678998877666667789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCC-----------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEE
Q 047215 587 VYEYMANGTLRSHLFGSD-----------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKM 655 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl 655 (851)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999985322 2358999999999999999999994 89999999999999999999999
Q ss_pred eeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..|+......+ .. ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~---~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI---ECI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHH
Confidence 99999875433222222223345778999999999999999999999999999998 787775443211 11 111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
..+.. + ..+...+..+.+++.+||+.+|.+|||++++++.|+.+.+....|
T Consensus 236 -~~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~ 286 (288)
T cd05093 236 -TQGRV-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY 286 (288)
T ss_pred -HcCCc-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence 11110 0 111234456899999999999999999999999999887655444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=329.84 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=203.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
.+++|+..+.||+|+||.||+|...+ +..+|+|++... ......+|.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 56789999999999999999997542 356899987643 23445678999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCC--------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEE
Q 047215 584 MILVYEYMANGTLRSHLFGSD--------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKM 655 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl 655 (851)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999985422 2346788999999999999999995 89999999999999999999999
Q ss_pred eeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----
Confidence 99999875433222211222345778999999998999999999999999999999 677775432211 1111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
...... ...+..++..+.+++.+||+.+|++|||+.|++++|+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111110 1123345667999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.48 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=209.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.+|...+.||+|+||.||+|... +...+++|..........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999743 345688898877666666789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 587 VYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
||||+++++|.+++.... ...+++.++++++.|++.||.|||+ ++++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999985432 2348899999999999999999994 89999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHH
Q 047215 653 AKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~ 731 (851)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||+| |+.|+......+ ..+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence 99999999976433222222233456788999999999999999999999999999998 888876543221 111
Q ss_pred HHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
. ...+.. ...+..++..+.+++.+||+.+|++|||++++++.|+.+...
T Consensus 237 -~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 -C-ITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -H-HhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 111111 111223456789999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.19 Aligned_cols=245 Identities=21% Similarity=0.314 Sum_probs=201.7
Q ss_pred cCCceeeeeeeecceEEEEEEEcC--cceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED--CTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..+.||+|+||.||+|...+ +..+|+|++... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568889999999999999998654 357899987542 233456788999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999998544 358899999999999999999995 89999999999999999999999999998764221
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. . ... +....
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~---~~~---------i~~~~ 244 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---I---YQK---------ILEGI 244 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---H---HHH---------HhcCC
Confidence 234579999999999999899999999999999999999999997543211 0 001 11110
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..++...+..+.+++.+||+.||++|+ +++++++|
T Consensus 245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 012333445688999999999999995 89999999
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=332.42 Aligned_cols=263 Identities=25% Similarity=0.465 Sum_probs=209.7
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEc
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCD 579 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~ 579 (851)
+....++|+..+.||+|+||.||++...+ ...+++|..... .......+.+|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 33455678889999999999999998643 357889987754 334456789999999999 8999999999999
Q ss_pred cCCcEEEEEEecCCcchhhhccCC--------------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCe
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGS--------------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNI 645 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NI 645 (851)
.++..+++|||+++|+|.+++... ....+++..+++++.|++.||.|||+ .+|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence 999999999999999999998532 23568899999999999999999994 8999999999999
Q ss_pred EEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcch
Q 047215 646 LLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQ 724 (851)
Q Consensus 646 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~ 724 (851)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 999999999999999986443222222233345678999999988999999999999999999998 877775432211
Q ss_pred hcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 725 INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+. .. .. .......+..++..+.+|+.+||+.+|.+|||+.|++++|+.++
T Consensus 243 --~~---~~-~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 --LF---KL-LK---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HH---HH-HH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 00 00 11111233455677999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.62 Aligned_cols=269 Identities=21% Similarity=0.295 Sum_probs=202.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 577899998865432 233467889999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|++ ++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 57777775432 458889999999999999999995 899999999999999999999999999987532211
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc---c---cc
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS---L---KS 742 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~ 742 (851)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.......... . ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhh
Confidence 12234568999999999865 4689999999999999999999999975432111 1111100000000 0 00
Q ss_pred --ccCc-cCCCCCC---------hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 743 --IIDP-HLKGNYS---------PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 743 --i~d~-~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..++ ......+ ...+..+.+++.+||+.||++|||++|+++| +|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h---------~~f~~ 293 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH---------EYFSD 293 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC---------ccccc
Confidence 0000 0000000 0123567899999999999999999999999 88764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.96 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=204.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-Ccc----eeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCT----LAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|+..+.||+|+||.||+|.+. ++. .+++|...... .....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45677789999999999999863 333 36778775443 3345678889999999999999999999864 45789
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999996543 468999999999999999999995 8899999999999999999999999999986433
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........++..|+|||.+.+..++.++|||||||++|||++ |+.|+....+.. ..+. ...+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~--~~-- 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGE--RL-- 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC--cC--
Confidence 222222334557789999999998899999999999999999998 888886543221 1111 11110 11
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
..+..+...+.+++.+||..+|.+|||+.|+++.|..+.+-...|
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 231 -----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 112234456789999999999999999999999988876654444
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=339.62 Aligned_cols=242 Identities=26% Similarity=0.333 Sum_probs=198.1
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
+.||+|+||.||+++.. ++..+|+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999864 6788999987653 2344567788999999999999999999999999999999999999
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccc
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST 674 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (851)
+|..++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 153 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence 999888543 368899999999999999999995 899999999999999999999999999987532211 1223
Q ss_pred ccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCCh
Q 047215 675 AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754 (851)
Q Consensus 675 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 754 (851)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .. +.... ..++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~---~~---------~~~~~--~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---F---EL---------ILMEE--IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HH---------HhcCC--CCCCC
Confidence 45699999999999999999999999999999999999999865432211 0 00 00000 11233
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 755 ESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..++.+.+++.+||+.||.+|| ++.++++|
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 4556789999999999999998 89999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.52 Aligned_cols=255 Identities=24% Similarity=0.429 Sum_probs=203.6
Q ss_pred cCCceeeeeeeecceEEEEEEE-----cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-----EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|+..+.||+|+||.||+|.. ..+..+++|.+... ..+....+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999984 24567899988754 34445789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCC---------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC
Q 047215 587 VYEYMANGTLRSHLFGSD---------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF 651 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~ 651 (851)
||||+++++|.+++.... ...+++.+++.++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999884321 2347888999999999999999995 8999999999999999999
Q ss_pred eEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHH
Q 047215 652 VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADW 730 (851)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~ 730 (851)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+....+.. ..+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH-
Confidence 999999999976433222222333446778999999988899999999999999999998 887776543211 111
Q ss_pred HHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 731 AMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 731 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
...... ....+..++..+.+++.+||+.+|.+||++.+++++|.
T Consensus 238 ---~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 238 ---MVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ---HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 111111 11123345677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.06 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=201.9
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
++|+..+.||+|+||.||+++++++..+++|.+.... .....|.+|+.++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577888999999999999998888789999876432 334678899999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 999999986543 358899999999999999999994 8999999999999999999999999999875432211 11
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ . ....... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~---~~~i~~~---~~~~------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V---VEMISRG---FRLY------- 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHHCC---CCCC-------
Confidence 122335678999999998899999999999999999999 888876443211 1 1111111 0111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
.+...+..+.+++.+||+.+|.+||+++++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1222345689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.20 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=209.5
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCC--CChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-----CCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANP--QSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-----QNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~ 583 (851)
...|...+.||+|+||.|+++.. .++..||||++.. ...-..+.-.+|+++|+.++|+||+.+++.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34555567899999999999985 4678999999883 355566778899999999999999999998854 467
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.|+|+|+|+ -+|...++.. +.|+...+..+..|+++||.|+|| .+|+||||||+|+|++.+..+||+||||||.
T Consensus 101 vYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceee
Confidence 899999995 4999998544 358999999999999999999996 8999999999999999999999999999998
Q ss_pred CCCCCccccccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
..........+....|..|.|||.+. ...|+...||||.||++.||++|++.|.+...-.|..+............+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 64432333445667899999999875 56899999999999999999999999988776666554432221111111111
Q ss_pred cc--------C--ccCC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 II--------D--PHLK----GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~--------d--~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+- . |... ...-+...+...+|+.+||..||.+|+|++|+|+|
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 0 0000 01113455678899999999999999999999999
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.73 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=206.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.+|...+.||+|+||.||+|... .+..+++|..... .....++.+|++++++++||||++++++|..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999865 4678899987654 334567899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 99999999976555678999999999999999999995 89999999999999999999999999998764332111
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+...... +..... ......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~----------~~~~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL----------EKGYRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH----------HCCCCC
Confidence 1112234668999999999999999999999999999998 88787543221 111111 111122
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
..+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 33445667799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.50 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=210.2
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.+|++.+.||+|.||.|-+|+- ..+..||||.+++. ++++.-.+++||++|+.|+||||++++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677778899999999999974 77899999987654 5667778999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||..+|.|.+++ ...+.|++.+...+++||..|++|+| +++++|||||.+|||||.|+++||+||||+....
T Consensus 133 EYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~--- 204 (668)
T KOG0611|consen 133 EYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--- 204 (668)
T ss_pred EecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc---
Confidence 999999999999 44567999999999999999999999 6999999999999999999999999999987632
Q ss_pred ccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.....+++||++.|.+||++.+.+| .+.+|-|||||+||.|+.|..||++..-. ..+++.. ...
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQIs---------~Ga 269 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQIS---------RGA 269 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHHhh---------ccc
Confidence 2334577899999999999999988 47899999999999999999999765321 1122211 111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+ ..++.+....-|+++||..+|++|.|+++|..|-|
T Consensus 270 Y---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 Y---REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred c---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1 12344556788999999999999999999999943
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=339.72 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=198.4
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
+.||+|+||.||+++.. ++..+|+|++... .......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 5788999988653 2344567889999999999999999999999999999999999999
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccc
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST 674 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (851)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 999888543 468899999999999999999995 89999999999999999999999999998753221 11223
Q ss_pred ccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCCh
Q 047215 675 AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754 (851)
Q Consensus 675 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 754 (851)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... . .+. .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~-~------~~~----~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL-M------EDI----KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhc-c------CCc----cCCC
Confidence 45799999999999999999999999999999999999999865432111 11000 0 011 2233
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 755 ESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..+..+.+++.+||+.||.+|| ++.|+++|
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 4556789999999999999997 89999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.99 Aligned_cols=263 Identities=22% Similarity=0.390 Sum_probs=222.8
Q ss_pred HHHHHHhcCCceeeeeeeecceEEEEEEEcCcc-eeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 506 AEIRVATNNFDESLMIGVGGFGKVFKGEIEDCT-LAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 506 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~-~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
++++...-+.....+||-|.||.||.|.|+.-. -||||.++. +....++|..|..+|+.++|||+|+|+|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 345555566667789999999999999987643 578888774 455689999999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
|||.|||..|+|.++|+..++..++...++.++.||+.||.||. ++++|||||.++|+|+.++..+|++||||+|++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999888888888999999999999999999 699999999999999999999999999999986
Q ss_pred CCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.....+ ......-+..|.|||.+....++.|+|||+|||+|||+.| |..|+.+.. +. .+-.+
T Consensus 416 tgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lS----------qVY~L 478 (1157)
T KOG4278|consen 416 TGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LS----------QVYGL 478 (1157)
T ss_pred cCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HH----------HHHHH
Confidence 554333 2233445778999999999999999999999999999988 444554321 11 12233
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+...++.+.++.|++.+.+|+++||+.+|.+||++.|+-+.+|.+.
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 4455666778999999999999999999999999999999988775
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.60 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=204.2
Q ss_pred CCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
+|+..+.||+|+||.||+|... ....+++|.+.... ......+.+|+.++++++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667788999999999999753 22467888876543 3445678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCC----------------------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCC
Q 047215 587 VYEYMANGTLRSHLFGS----------------------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTN 644 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~N 644 (851)
++||+++|+|.+++... ...++++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999987532 12357899999999999999999994 899999999999
Q ss_pred eEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcc
Q 047215 645 ILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKD 723 (851)
Q Consensus 645 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~ 723 (851)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.|+....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875433222111233446778999999988899999999999999999999 888886543221
Q ss_pred hhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 724 QINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+.++ .. .......+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 238 ---~~~~----~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 ---LFNL----LK---------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ---HHHH----Hh---------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1111 11 11111223445567999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.95 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=205.1
Q ss_pred cCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|...+.||+|+||.||+|+..+ +..+++|.+...... ....+.+|++++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457777899999999999998643 367899988765444 5678999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCC------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 586 LVYEYMANGTLRSHLFGSD------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
+||||+++++|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999986432 2457899999999999999999994 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~ 732 (851)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-
Confidence 9999999875432222222233346788999999999999999999999999999998 988876543221 11111
Q ss_pred HHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 733 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
..+.. ...+...+..+.+++.+||+.||.+||++.|+++.|+
T Consensus 238 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11110 1122345567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.44 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=204.0
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+|+..++||+|+||.||++... ++..+|+|++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 57889999886532 2223457789999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999998865544568999999999999999999995 899999999999999999999999999987643211
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......... +..... +. ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~--------~~--~~~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERR--------VK--EDQ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHH--------hh--hcc
Confidence 123346899999999999889999999999999999999999999754322111 001100 00 011
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..++...+..+.+++.+||+.||.+|| +++++++|
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 123344556789999999999999999 89999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.48 Aligned_cols=240 Identities=22% Similarity=0.259 Sum_probs=197.0
Q ss_pred eeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 521 LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
||+|+||.||+++.. ++..+|+|++... .......+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 4678899987643 334456788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 676 (851)
.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 153 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF 153 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence 9998553 458899999999999999999995 89999999999999999999999999998753221 1223446
Q ss_pred ccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 677 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... . ...++...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~---------~--~~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ---------E--PLRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc---------C--CCCCCCcC
Confidence 7999999999999999999999999999999999999998754221 11111111 0 11233445
Q ss_pred HHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRP---TMGEVLWH 784 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 784 (851)
+..+.+++.+||+.||.+|| ++.|++.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 56789999999999999997 57888888
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.67 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=197.3
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+|+..++||+|+||.||+|+.. +++.+|||++... .......+.+|++++++++|+||+++++++..++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445678999999999999865 5788999988654 3344567899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+.. ...+..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 223 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D 223 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence 999986543 34567788999999999999995 899999999999999999999999999987643211 1
Q ss_pred cccccccCCcccCcccccc-----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 672 VSTAVKGSFGYLDPEYFWR-----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ |........ .
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~~~-~------ 290 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAIC-M------ 290 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHHh-c------
Confidence 1234568999999998843 334568999999999999999999987332211 111110000 0
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
......+..++..+.+|+.+||+.||++|||+.|+++| +|+..
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h---------p~~~~ 333 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH---------PFILR 333 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC---------ccccc
Confidence 00111233455679999999999999999999999999 88764
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.78 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=205.8
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc-c--eeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC-T--LAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~-~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..++||+|+||.||+|..++. . .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 5688889999999999999987543 2 3677777643 344567789999999999 799999999999999999999
Q ss_pred EEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 588 YEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
+||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999985432 1358889999999999999999994 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~ 732 (851)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 99999998642211 01111223567999999998899999999999999999997 888886543221 111
Q ss_pred HHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhh
Q 047215 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794 (851)
Q Consensus 733 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (851)
.. ........+..++..+.+|+.+||+.+|.+|||++++++.|+.+.+..++
T Consensus 230 ~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KL----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HH----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11 01111122334556789999999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=350.14 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=217.1
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCc-ceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEE-Ec-----c-C
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGF-CD-----E-Q 581 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~-~~-----~-~ 581 (851)
...++.+.+.|.+|||+.||.++...+ ..+|+|++...++...+...+||++|++|+ |||||.+++. .. . .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 456778889999999999999998766 899999988889999999999999999996 9999999993 21 1 2
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
-+.+|.||||.+|.|-|++..+....|++.++++|+.|+++|+.+||. ++.+|||||||-+||||+.++..||||||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 478999999999999999976555569999999999999999999996 5678999999999999999999999999998
Q ss_pred ccCCCCC--cccc-----ccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH
Q 047215 662 KTGPSME--HTHV-----STAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 662 ~~~~~~~--~~~~-----~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~ 731 (851)
......- ...+ .-...-|+.|.+||++. +...++|+|||+|||+||-|+....||.....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 7532211 1110 01223689999999984 77899999999999999999999999975422
Q ss_pred HHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
..|+...+.-.-.+..+..+++||..||+.||.+||++-||+.++..+...+
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 2344444433333577889999999999999999999999999988776543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.99 Aligned_cols=257 Identities=26% Similarity=0.360 Sum_probs=202.4
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
.+++|...+.||+|+||.||+|...+ ...+++|...... ......|..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999998754 4567888776443 3445679999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCC-----CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC---eEEE
Q 047215 584 MILVYEYMANGTLRSHLFGSD-----LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF---VAKM 655 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~---~~kl 655 (851)
.++||||+++++|.+++.... ...+++.++++++.|++.||+|||+ .+++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999985532 1358999999999999999999995 8999999999999998654 6999
Q ss_pred eeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+ +. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~---~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM---EFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HHH
Confidence 99999986432211111112233568999999998999999999999999999997 888876543221 11 111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
. .......+..++..+.+++.+||+.+|++||++.+|++||.
T Consensus 235 ~----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T----------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H----------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 01111233455677999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=336.71 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=196.9
Q ss_pred eeeeeecceEEEEEEE----cCcceeEEeecCCC----ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 519 LMIGVGGFGKVFKGEI----EDCTLAAIKRANPQ----SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++||+|+||.||+++. ..++.+|+|.+... .......+..|+.+|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35678999987642 223345678899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++... ..+.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G 154 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence 9999999998543 357788889999999999999995 89999999999999999999999999998743221 1
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +.... .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~---------~~~~~--~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDK---------ILKGK--L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHH---------HHcCC--C
Confidence 12234579999999999999899999999999999999999999987543211 1111 11111 1
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..++..+..+.+++.+||+.+|++|| +++++++|
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 23344556789999999999999999 89999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.60 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=200.4
Q ss_pred CCceeeeeeeecceEEEEEEE----cCcceeEEeecCCC----ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI----EDCTLAAIKRANPQ----SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 584 (851)
+|+..+.||+|+||.||+++. ..+..+|+|++... .....+.+..|+.+++++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999875 35678999987642 223345688899999999 599999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998543 358899999999999999999995 89999999999999999999999999998753
Q ss_pred CCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~------- 225 (332)
T cd05614 156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK------- 225 (332)
T ss_pred cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc-------
Confidence 32211 122345799999999999865 4789999999999999999999998654322111 111111100
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
.++ .++...+..+.+++.+||+.||++|| +++++++|
T Consensus 226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 112 22334556689999999999999999 88899999
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.83 Aligned_cols=265 Identities=25% Similarity=0.421 Sum_probs=204.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-----CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-----DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~ 585 (851)
++|+..+.||+|+||.||++..+ .+..+++|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56788899999999999999753 467899999887777777889999999999999999999998743 35689
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+|+||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986443 458999999999999999999994 899999999999999999999999999998654
Q ss_pred CCCccc-cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh-------
Q 047215 666 SMEHTH-VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ------- 737 (851)
Q Consensus 666 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 737 (851)
...... ......++..|+|||++.+..++.++|||||||+++||++|..++...... +.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 232 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIV 232 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccch
Confidence 322111 111223445699999999889999999999999999999987654322110 00000000
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
..+.+++........+..++..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000011111111122345567799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=342.82 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=204.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+.. +++.+|+|++... .......+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999875 5788999988643 2244567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999654 468899999999999999999995 999999999999999999999999999987543322
Q ss_pred ---------------------------ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCC
Q 047215 669 ---------------------------HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP 721 (851)
Q Consensus 669 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~ 721 (851)
.........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00122345689999999999999999999999999999999999999876542
Q ss_pred cchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 047215 722 KDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-MGEVLWH 784 (851)
Q Consensus 722 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 784 (851)
... ....... . ..+........++.+.+++.+||+ ||.+||+ ++++++|
T Consensus 236 ~~~------~~~i~~~--~-----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QET------YNKIINW--K-----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HHHHhcc--C-----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 1111100 0 011111111245678999999998 9999999 9999999
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.57 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=209.1
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC-----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-CCc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED-----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-QNE 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~ 583 (851)
..++|+..++||+|+||.||+|...+ +..+++|++... .......+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999999765 677889987654 44556778999999999999999999999865 577
Q ss_pred EEEEEEecCCcchhhhccCCCC------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEee
Q 047215 584 MILVYEYMANGTLRSHLFGSDL------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~D 657 (851)
.++++||+++|+|.+++..... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999854322 46899999999999999999999 48999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.|+....+. .+..+. ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYL---KD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHH---Hc
Confidence 999986433222222233446778999999998899999999999999999999 98888654322 111111 11
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
. .....+..+++.+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 235 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 G----------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C----------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0111123345678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.64 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=201.7
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
++|...+.||+|+||.||+|+..++..+|+|.+.... .....|.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577788999999999999998877779999877543 234678999999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|+|.+++.... ..+++.++++++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 999999986543 268999999999999999999994 8999999999999999999999999999875432211 11
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....++..|++||++.+..++.++|||||||++|||++ |+.|+......+ ... .... +. ...
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~~-~~---------~~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---KVSQ-GL---------RLY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---HHhc-CC---------CCC
Confidence 122335678999999998889999999999999999998 888876433211 111 1100 00 001
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.+...+..+.+++.+||+.+|.+||++.+++++|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12223567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.65 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=199.0
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+++.. ++..+|+|.+... .......+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999865 5678999988753 233456688999999998 799999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 9999888543 468999999999999999999995 89999999999999999999999999998742211 1223
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc--hhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD--QINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....++........ .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QI--R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CC--C
Confidence 34679999999999999999999999999999999999999996432211 111122222211111 11 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPT------MGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 784 (851)
.+...+..+.+++.+||+.||.+||+ ++++++|
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 23345567899999999999999997 7899988
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.91 Aligned_cols=260 Identities=25% Similarity=0.450 Sum_probs=206.3
Q ss_pred cCCceeeeeeeecceEEEEEEEcC--------cceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED--------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN 582 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 582 (851)
++|.+.+.||+|+||.||+++..+ ...+|+|.+... ......++..|+++++++ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 578889999999999999997532 246899988754 344556788999999999 7999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc
Q 047215 583 EMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD 648 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld 648 (851)
..++||||+++|+|.+++.... ...+++.++++++.|++.||+|||+ .+++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999996532 1358899999999999999999994 8999999999999999
Q ss_pred CCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcH
Q 047215 649 ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINL 727 (851)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l 727 (851)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 999999999999875432221111222334578999999998899999999999999999998 7777654321
Q ss_pred HHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 728 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.+...... . ......+..++..+.+++.+||+.+|.+|||+.+++++|+.+...
T Consensus 249 ~~~~~~~~-~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKLLK-E---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHH-c---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 0 111123345567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=323.87 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=205.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-Ccc----eeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCT----LAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
.++|+..++||+|+||.||+|++. ++. .+|+|..... ......++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 357888899999999999999853 333 3789987654 344456789999999999999999999999754 578
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+++||+++|+|.++++... ..+++.+++.++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999986543 468899999999999999999995 899999999999999999999999999998653
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .+..+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~------ 227 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KG------ 227 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CC------
Confidence 3222111222335678999999999999999999999999999998 88887643221 1111111 10
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
.....+..++..+.+++.+||+.||.+||++.++++.|+.+.+...+|
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05109 228 ---ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275 (279)
T ss_pred ---CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence 011122345567899999999999999999999999988776554443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=327.85 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=206.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCC-hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQS-EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 582 (851)
..++|...+.||+|+||.||++... .+..+|+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467888999999999999999742 23468899877543 34456789999999999 7999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++|+|.++++......+++.++..++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999976544458999999999999999999995 899999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+. ... ...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~----- 258 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIK----- 258 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHH-----
Confidence 6433222112223346778999999999999999999999999999998 8888765432111 111 100
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.......+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 259 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 ----EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111223456799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=351.75 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=206.9
Q ss_pred HHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC----
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN---- 582 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---- 582 (851)
...++|.+.++||+|+||.||+|+. .+++.+|||++... .......+.+|+..+..++|+|++++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999985 46789999987653 4455677889999999999999999988764332
Q ss_pred ----cEEEEEEecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEe
Q 047215 583 ----EMILVYEYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~ 656 (851)
.+++||||+++|+|.++|... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999998543 23568899999999999999999995 899999999999999999999999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
|||+++...............||+.|+|||++.+..++.++|||||||+||||++|+.||...... +......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~- 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL- 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh-
Confidence 999997644322222334567999999999999999999999999999999999999998654221 1111111
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
.+ .. ...++..++.+.+++.+||+.||.+||++.++++|.
T Consensus 259 ~~----~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 259 AG----RY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred cC----CC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 00 01 123345567799999999999999999999999884
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=338.48 Aligned_cols=243 Identities=24% Similarity=0.321 Sum_probs=197.4
Q ss_pred eeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 519 LMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
+.||+|+||.||+++. ..+..+|+|.+... .......+..|+++++.++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 46778999987653 2334567788999999999999999999999999999999999999
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccc
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST 674 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (851)
+|.+++... ..+++.++..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence 999888543 368899999999999999999995 479999999999999999999999999998753221 11223
Q ss_pred ccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCCh
Q 047215 675 AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754 (851)
Q Consensus 675 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 754 (851)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ... ... .. .++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~---~~i-~~~------~~----~~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---F---ELI-LME------EI----RFPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---H---HHH-hcC------CC----CCCC
Confidence 45699999999999999999999999999999999999999865432211 0 000 000 01 1233
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 755 ESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..+..+.+++.+||+.||++|+ ++.++++|
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3456689999999999999996 89999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=339.00 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=196.9
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||+||+++.. .++.+|+|++... .......+..|+.++.+++||||+++++.+.++...+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999864 5678999988653 2334467888999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999998653 468999999999999999999995 899999999999999999999999999987532110
Q ss_pred c---------------------------------cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcC
Q 047215 669 H---------------------------------THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV 715 (851)
Q Consensus 669 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p 715 (851)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 0011245799999999999999999999999999999999999999
Q ss_pred CCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 047215 716 INPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLD--DEGKNRPTMGEVLWH 784 (851)
Q Consensus 716 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~--~dP~~RPt~~evl~~ 784 (851)
|....+.+. . ...... ...+..|. . ....+.+++++.+++. .++..||+++|+++|
T Consensus 236 f~~~~~~~~---~---~~i~~~--~~~~~~p~---~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQET---Y---KKVMNW--KETLIFPP---E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHH---H---HHHHcC--cCcccCCC---c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 976543221 1 111000 00111111 0 1233456777776443 334457999999999
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.89 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=196.2
Q ss_pred eeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 520 MIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
.||+|+||.||+|+.. +++.+++|..... .......+.+|++++++++||||++++++|......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5999999999999874 6788999987654 3445567999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...............
T Consensus 82 ~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 82 TFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9985432 468899999999999999999994 899999999999999999999999999987533211111111122
Q ss_pred cCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 678 gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.+..|+|||.+.+..++.++||||||+++|||++ |..|+....+... ..... .......+..+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~---------~~~~~~~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIE---------QGVRLPCPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHH---------cCCCCCCcccC
Confidence 3457999999999999999999999999999998 7777654322110 01000 11111233445
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 667999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=343.39 Aligned_cols=255 Identities=23% Similarity=0.262 Sum_probs=202.2
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
...++|+..++||+|+||.||+++.. .+..+|+|.+... .......+.+|+.+++.++||||+++++++..++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999875 5678999987542 2233456788999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998543 47788888999999999999995 899999999999999999999999999987643
Q ss_pred CCCccccccccccCCcccCccccccc----CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQ----QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||........ ........
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~--- 263 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHK--- 263 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCC---
Confidence 211 1122345799999999998653 488999999999999999999999876432111 11111000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKN--RPTMGEVLWH 784 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 784 (851)
..+........+..+.+++.+||+.+|.+ ||+++|+++|
T Consensus 264 ----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 ----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00110111234567899999999999987 9999999999
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=339.83 Aligned_cols=261 Identities=22% Similarity=0.385 Sum_probs=204.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQN 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~ 582 (851)
..++|...+.||+|+||.||+|++. .+..+|+|++.... ......+.+|+++|.++. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456777789999999999999864 23578999987542 333457889999999997 999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCC----------------------------------------------------------
Q 047215 583 EMILVYEYMANGTLRSHLFGSD---------------------------------------------------------- 604 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 604 (851)
..++||||+++|+|.++|+...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999985421
Q ss_pred --------------------------------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 605 --------------------------------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 605 --------------------------------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
...+++.++++++.|++.||.|||+ .+++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence 1246777889999999999999995 89999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchh
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQI 725 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~ 725 (851)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999875322111111223356788999999998899999999999999999998 7777754322111
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
...... .......+..++..+.+++.+||+.+|.+||+++++++.|+.++
T Consensus 351 -----~~~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -----FYNAIK---------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHH---------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 001100 11111223345677999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.48 Aligned_cols=263 Identities=24% Similarity=0.453 Sum_probs=208.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc--------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE--------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ 581 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 581 (851)
.++|...+.||+|+||.||+|+.. ++..+++|..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 466778889999999999999742 2346888887654 344567899999999999 899999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE
Q 047215 582 NEMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl 647 (851)
...++||||+++|+|.+++.... ...+++.+++.++.|+++||.|||+ .+++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999986432 2357888999999999999999995 899999999999999
Q ss_pred cCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhc
Q 047215 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQIN 726 (851)
Q Consensus 648 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~ 726 (851)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999986543322222333456778999999998899999999999999999998 666664332
Q ss_pred HHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 727 LADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
..++....... .....+..++..+.+++.+||+.+|.+|||+.|+++.|..+..+..
T Consensus 245 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 245 VEELFKLLKEG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHHHHHcC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 11211111111 0112234566779999999999999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=337.30 Aligned_cols=265 Identities=21% Similarity=0.226 Sum_probs=201.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|+..+.||+|+||.||++... .+..+|+|.... ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999864 567889996542 3467899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+. ++|..++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 95 6888887443 358899999999999999999995 899999999999999999999999999997532211 1
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh-----cHHHHHHHHhh---------
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI-----NLADWAMKWQK--------- 736 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~-----~l~~~~~~~~~--------- 736 (851)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... .+.........
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 1223457999999999999999999999999999999999999876543221100 00000000000
Q ss_pred hcccccc---------cCccCCCCC--ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 737 QRSLKSI---------IDPHLKGNY--SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 737 ~~~~~~i---------~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...+..+ ..+..+... ....+..+.+|+.+||+.||.+|||++|+++| +|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h---------p~f~~ 381 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF---------AAFQD 381 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC---------hhhcc
Confidence 0000000 000000000 01345678999999999999999999999999 78764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.76 Aligned_cols=256 Identities=23% Similarity=0.289 Sum_probs=202.1
Q ss_pred HHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 507 EIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 507 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
++....++|+..++||+|+||.||+++.. ++..+|+|.+... .......+.+|+.+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999875 4678899987542 2233456889999999999999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999998543 47888999999999999999995 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCccccccc----CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQ----QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
...... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||........ ...
T Consensus 191 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~----- 258 (370)
T cd05621 191 KMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSK----- 258 (370)
T ss_pred ecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHH-----
Confidence 643211 1122356799999999999754 378999999999999999999999975432111 111
Q ss_pred ccccccCccCCCCCC--hhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047215 739 SLKSIIDPHLKGNYS--PESLEKFGEIAEKCLDDEGKN--RPTMGEVLWH 784 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 784 (851)
+.+......++ ...+..+++++.+||..++.+ ||++.|+++|
T Consensus 259 ----i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 ----IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111111 234567889999999865543 8999999999
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.70 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=197.3
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.|+..+.||+|+||+||+|+.. .+..+|+|++... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 5678999988653 23445678999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998554 357888899999999999999995 8999999999999999999999999999753210000
Q ss_pred ---------------------------------------------cccccccccCCcccCcccccccCCCchHHHHHHHH
Q 047215 670 ---------------------------------------------THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGV 704 (851)
Q Consensus 670 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gv 704 (851)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012356999999999999999999999999999
Q ss_pred HHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHH--hcccCCCCCCCHHHHH
Q 047215 705 VLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEK--CLDDEGKNRPTMGEVL 782 (851)
Q Consensus 705 vL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~evl 782 (851)
++|||++|+.||....+.+.. ....... ..+........+..+.+++.+ |+..++..||++++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQ------LKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHH------HHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999764432110 0000000 000001111234567788877 5566666799999999
Q ss_pred HH
Q 047215 783 WH 784 (851)
Q Consensus 783 ~~ 784 (851)
.|
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 99
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=341.91 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=201.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..++||+|+||.||+++.. .++.+|||++... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999875 5788999988643 2344566889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998653 358999999999999999999995 899999999999999999999999999986432111
Q ss_pred cc------------------------------------ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhC
Q 047215 669 HT------------------------------------HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCA 712 (851)
Q Consensus 669 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG 712 (851)
.. .......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 001124699999999999999999999999999999999999
Q ss_pred CcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 047215 713 RAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT---MGEVLWH 784 (851)
Q Consensus 713 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 784 (851)
+.||....+.+. . ....... ..+........++.+.+++.+|+. +|.+|++ ++|+++|
T Consensus 236 ~~Pf~~~~~~~~---~---~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQET---Y---RKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHH---H---HHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999976533211 1 1110000 000000111234568899999996 8999998 9999999
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=320.14 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=197.3
Q ss_pred ceeeeeeeecceEEEEEEEcCcc---eeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------CcE
Q 047215 516 DESLMIGVGGFGKVFKGEIEDCT---LAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------NEM 584 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~ 584 (851)
.+.++||+|+||.||+|...+.. .+|+|.+... .....+.+..|++++++++||||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999875442 5788877653 345567899999999999999999999988432 356
Q ss_pred EEEEEecCCcchhhhccCC----CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 585 ILVYEYMANGTLRSHLFGS----DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
++++||+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887321 23458899999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
++...............++..|++||++.+..++.++||||||+++|||++ |+.||...... .. .... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~---~~~~-~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EI---YDYL-RQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHHH-HcCC
Confidence 986433222111223346778999999999999999999999999999999 77777543221 11 1111 1111
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
. ...+..++..+.+++.+||+.+|.+|||+.+++++|+.+
T Consensus 232 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 012234556789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.49 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=201.9
Q ss_pred CCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
+|+..+.||+|+||.||+|...+ +..+|+|++..... ...+.+..|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35556789999999999998643 46789999875533 334678899999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCC--------------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 587 VYEYMANGTLRSHLFGS--------------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
++||+++++|.+++... ....+++..+.+++.|++.||.|||+ .+++||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999988421 12357888899999999999999995 89999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHH
Q 047215 653 AKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~ 731 (851)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+...... ++.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence 99999999886433222222233456789999999988889999999999999999998 77676543221 111
Q ss_pred HHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.... +.. ....+..++..+.+++.+||+.+|.+||++.+++..|+
T Consensus 237 ~~i~---------~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 237 EMIR---------NRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHH---------cCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1111 111 11234456677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.74 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=197.5
Q ss_pred eeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 521 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 56789999876532 23345678899999999999999999999999999999999999999
Q ss_pred hhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccc
Q 047215 597 RSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST 674 (851)
Q Consensus 597 ~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (851)
.+++.. .....+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 888743 233568999999999999999999995 899999999999999999999999999987543221 1223
Q ss_pred ccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCCh
Q 047215 675 AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754 (851)
Q Consensus 675 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 754 (851)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... .+.... ..++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~---------~~~~~~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQ---------RILNDS--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHH---------hhcccC--CCCcc
Confidence 45689999999999999999999999999999999999999875432211 000000 111111 12234
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 755 ESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..+..+.+++.+||+.||++|| +++++++|
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 4566789999999999999999 88999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=324.70 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=203.7
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
..+++|++.++||+|+||.||+|..++ +..+|+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356788999999999999999997542 3478999876543 334456889999999999999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCC--------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEE
Q 047215 583 EMILVYEYMANGTLRSHLFGSD--------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAK 654 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~k 654 (851)
..++||||+++|+|.+++.... ....++..+.+++.|++.||.|||+ ++++||||||+|||++.++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999995421 2445778889999999999999994 8999999999999999999999
Q ss_pred EeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHH
Q 047215 655 MSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~ 733 (851)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+ .. ..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~---~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL---KF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH
Confidence 999999886433222222222345678999999998899999999999999999998 677775432211 11 11
Q ss_pred HhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 734 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
+.+... ...+..++..+.+++.+||+.+|++|||+.++++.|...
T Consensus 234 ---------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 ---------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111 112334457799999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=319.74 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=200.3
Q ss_pred CceeeeeeeecceEEEEEEEcC----cceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc-----
Q 047215 515 FDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE----- 583 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----- 583 (851)
|++.+.||+|+||.||+|.... ...+|+|++... .......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999998643 256899987753 33445689999999999999999999999866554
Q ss_pred -EEEEEEecCCcchhhhccCC----CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 584 -MILVYEYMANGTLRSHLFGS----DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 584 -~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
.++++||+++|+|..++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999888442 23468899999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ...++. . .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~---~-~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL---R-H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---H-c
Confidence 99986433222111222335678999999988899999999999999999999 77777543221 111111 1 1
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
+ . ....+..++..+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 231 ~--------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 G--------N-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C--------C-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 0 1122345567799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=337.01 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=200.4
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC-----cEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN-----EMI 585 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 585 (851)
+|+..++||+|+||.||++.. .+++.+|+|++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477888999999999999986 46788999988653 3344567889999999999999999999998776 789
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+|+||+. ++|.+.+... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999997 5777777433 468999999999999999999995 899999999999999999999999999997643
Q ss_pred CCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH----------HHH
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA----------MKW 734 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~----------~~~ 734 (851)
... ........+++.|+|||++.+. .++.++|||||||++|||++|+.||....+..+....... ...
T Consensus 155 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 221 1122334578999999998764 5899999999999999999999999765543332211110 000
Q ss_pred --hhhcccccccCc-cC--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 735 --QKQRSLKSIIDP-HL--KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 735 --~~~~~~~~i~d~-~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...........+ .. .........+.+.+|+.+||+.||.+|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 00 001223345678999999999999999999999999
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.24 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=197.4
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+++.. +++.+|+|.+... .......+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 4678899987653 333455678899988877 799999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence 9999888543 468899999999999999999995 89999999999999999999999999998753221 1122
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc--hhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD--QINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+........ . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~--~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q--IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------C--CC
Confidence 34678999999999999999999999999999999999999986322111 111112221111111 1 12
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPT------MGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 784 (851)
++...+..+.+++.+||+.||.+||+ +.++++|
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 33445567899999999999999998 6899888
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=318.02 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=202.7
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
++|++.++||+|+||.||+|..+++..+++|.+..... ....+.+|+.++++++|||++++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 56777889999999999999988888899998875433 34578999999999999999999999854 56899999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+++|.+++.......+++.++..++.+++.||.|||+ .+++||||||+||++++++.+||+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence 9999999976555568999999999999999999995 8999999999999999999999999999876432211 11
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..+ ... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~----------~~~~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE---QVE----------RGYRMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHH----------cCCCCC
Confidence 122235668999999988899999999999999999999 777775432211 111 111 011112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 23445667999999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.82 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHH---HhcCCcceeeEEEEEccCCcEEEE
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEML---SKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l---~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
|++.+.||+|+||.||+|... .++.+|||++... .....+.+.+|++++ ++++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999865 5788999988643 223345566676655 566899999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|...+.. ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988754 358999999999999999999995 89999999999999999999999999998753221
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... ..
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~---------~~ 217 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVN---------DE 217 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh---------CC
Confidence 1 22334679999999999999999999999999999999999999987543221 1111110 00
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..++...+..+.+++.+||+.||.+|| ++.++++|
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112334456688999999999999999 68888887
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=326.76 Aligned_cols=261 Identities=29% Similarity=0.457 Sum_probs=204.9
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cc--eeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CT--LAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..+.||+|+||.||+|..+. +. .+++|+.... .......+.+|++++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578888999999999999998643 33 4577776543 345567889999999999 899999999999999999999
Q ss_pred EEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 588 YEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
|||+++|+|.++++... ...+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999986432 2357899999999999999999994 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~ 732 (851)
||+|||+++..... .......++..|+|||++.+..++.++|||||||+++||+| |..||......+ ...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHH
Confidence 99999998642111 11112234668999999988889999999999999999998 888886432211 111
Q ss_pred HHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 733 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
... .......+...+..+.+++.+||+.+|++||++++++++|+.+.+-...|
T Consensus 235 ~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 235 KLP----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HHh----------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 110 00111122234567899999999999999999999999998776554444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=317.69 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=203.9
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|.+.++||+|+||.||+|+.++...+++|++.... ...+.|.+|++++++++||||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35688899999999999999998777779999887533 234678999999999999999999998754 5689999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.......+++.++..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence 99999999976544568899999999999999999995 8999999999999999999999999999875432221 1
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||++.+..++.++||||||+++|||++ |+.||....+.+. .... .. ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~-~~---------~~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQV-ER---------GYRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHH-hc---------CCCC
Confidence 1123346678999999988899999999999999999999 6767754332111 0000 00 0011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
..+.+++..+.+++.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 22345667789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.56 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=205.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
.++|...+.||+|+||.||+|...+ +..+++|..... .......+.+|+.++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998643 357899987654 334456789999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCC--------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEe
Q 047215 585 ILVYEYMANGTLRSHLFGSD--------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~ 656 (851)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 99999999999999985422 2347889999999999999999994 899999999999999999999999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.|+......+ ..++.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH----
Confidence 9999876433222222233456789999999988889999999999999999998 887775433221 11111
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
..+. ....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1110 11223345677999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.02 Aligned_cols=266 Identities=25% Similarity=0.366 Sum_probs=202.4
Q ss_pred ceeeeeeeecceEEEEEEE-----cCcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcEEEE
Q 047215 516 DESLMIGVGGFGKVFKGEI-----EDCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEMILV 587 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV 587 (851)
...+.||+|+||.||++.. .++..+|+|...... ......|.+|++++++++||||+++++++.. ....++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7778999999999988653 346788999887543 3445678899999999999999999999854 3468999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++... .+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999998543 48999999999999999999995 89999999999999999999999999998764332
Q ss_pred Ccc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 668 EHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 668 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
... .......++..|+|||++....++.++||||||++++||++|+.|+....... .....+..............+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence 111 11222345667999999998899999999999999999999998875432210 0111110000000011111222
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
......+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 222233455667899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=306.69 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=204.5
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+.|++.++||+|.|+.||+... ..|+..++|.+... +..+.+++.+|+++.+.|+||||++|...+.+....+||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4566677899999999998864 45677777765432 34467889999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeeccccccCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~~ 666 (851)
+|++++|..-+-.+ .-+++...-....||+++|.|+|+ ++|||||+||+|+||- ..--+||+|||+|....
T Consensus 91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999997765322 345677777889999999999995 9999999999999993 44569999999998754
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.........|||+|||||+++..+|+..+|||+.||+||-|+.|+.||.+.... .+.+- .+ .-..-+++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~---I~---~g~yd~~~ 233 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQ---IK---AGAYDYPS 233 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHH---Hh---ccccCCCC
Confidence 223345677999999999999999999999999999999999999999864321 11111 10 01111222
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
.. .+...++.++|+++||..||.+|.|+.|+|+| +|..+.+
T Consensus 234 ~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H---------pWi~~r~ 274 (355)
T KOG0033|consen 234 PE----WDTVTPEAKSLIRRMLTVNPKKRITADEALKH---------PWICNRE 274 (355)
T ss_pred cc----cCcCCHHHHHHHHHHhccChhhhccHHHHhCC---------chhcchH
Confidence 22 23455668999999999999999999999999 7776544
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=323.01 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=204.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++...++||+|+||.||++... .+..+++|............+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999642 345788898887777777889999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCC-------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 587 VYEYMANGTLRSHLFGSD-------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
+|||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 999999999999986432 1358899999999999999999994 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~ 732 (851)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+. . .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I---E 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H---H
Confidence 9999999875433222122223345678999999999999999999999999999998 8877754332211 1 1
Q ss_pred HHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 733 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.. ..+ .....+..++..+.+++.+||+.||.+||+++++++.|+
T Consensus 236 ~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CI-TQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HH-HcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 10 000 001122345567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=331.40 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=199.0
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCC-cceeeEEEEEccCCcEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRH-RHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~lV~ 588 (851)
+|+..+.||+|+||.||+|+.. .++.+|+|++... .....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 4568999987643 23445678889999999976 46888999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999988543 358899999999999999999995 899999999999999999999999999987432211
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.. .. ...
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i---------~~~-- 216 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ---SI---------MEH-- 216 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HH---------HcC--
Confidence 12334579999999999999999999999999999999999999987543221 111 11 110
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
...++...+..+.+++.+||+.||.+|++. +++++|
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112233455678999999999999999976 788777
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.94 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=202.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. +++.+|+|++... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999864 5778999988753 2234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999986542 468899999999999999999995 899999999999999999999999999997643222
Q ss_pred ccccccccccCCcccCccccc------ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFW------RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..........
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~--- 226 (330)
T cd05601 157 M-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQR--- 226 (330)
T ss_pred c-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCC---
Confidence 1 1223456899999999987 4567899999999999999999999987543221 1111111100
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.....+..+..+.+|+.+||+ +|.+|||+++++.|
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01101112345668999999998 99999999999999
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.92 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=214.4
Q ss_pred cCCceeeeeeeecceEEEEEEEcC---c--ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED---C--TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~---~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
......++||+|-||.||+|.+-+ + -.||||..+.. ..+..+.|..|..+|+.++|||||+|+|+|.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999998632 2 35789988874 55667889999999999999999999999975 57999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|||.++.|.|..+|+.+. ..|+.......|.||+.+|.|||| ..+|||||..+|||+...--+||+||||+|....
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999997654 468888999999999999999996 8999999999999999999999999999998665
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...... +...-+..|||||.+.-++++.++|||.|||++||++. |..||.+-...+.. . -+.
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------~-~iE 606 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------G-HIE 606 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------E-Eec
Confidence 444332 34456778999999999999999999999999999876 77888765433211 1 112
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
..-+...|+.|++.+.-|+.+||+.||.+||.+.|+...|+.+++.
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 2223456789999999999999999999999999999999998874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=339.10 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=197.9
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..++||+|+||.||+++. .++..+|||++... .......+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999986 46788999987643 2334567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998543 458888999999999999999995 899999999999999999999999999986321100
Q ss_pred cc---------------------------------------------ccccccccCCcccCcccccccCCCchHHHHHHH
Q 047215 669 HT---------------------------------------------HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFG 703 (851)
Q Consensus 669 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~G 703 (851)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124699999999999999999999999999
Q ss_pred HHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCC---CCHHH
Q 047215 704 VVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNR---PTMGE 780 (851)
Q Consensus 704 vvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~e 780 (851)
|+||||++|+.||....+.+.. ...... ...+. +.. ....+..+.+++.+||. +|.+| +++.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~------~~i~~~--~~~~~---~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETY------RKIINW--RETLY---FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHH------HHHHcc--CCccC---CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999764432110 010000 00000 000 11234568899999997 66665 69999
Q ss_pred HHHH
Q 047215 781 VLWH 784 (851)
Q Consensus 781 vl~~ 784 (851)
+++|
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 9999
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.77 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=199.9
Q ss_pred CCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
+|+..+.||+|+||.||+|..+++..+++|.+..... ....|.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4666778999999999999987777889998764332 345688899999999999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ...
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~ 158 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS 158 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence 99999986543 368999999999999999999995 8999999999999999999999999999876432111 111
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....+.+ .. .... . ......
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~~------~----~~~~~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV---ESVS------A----GYRLYR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH---HHHH------c----CCcCCC
Confidence 12224567999999999999999999999999999999 777776432211 11 1110 0 011122
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
+..++..+.+++.+||+.+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 234566799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.80 Aligned_cols=250 Identities=27% Similarity=0.370 Sum_probs=205.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|++|.||+|... ++..+++|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 5678899987543 345567889999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++.++.+++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 999999999976555678999999999999999999994 899999999999999999999999999987643321
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......|++.|+|||++.+..++.++|+||||++++||++|+.|+...... .... .. ..+ . ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~-~~~----~-----~~ 219 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALIL---KI-IRG----V-----FP 219 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HH-HcC----C-----CC
Confidence 1223456889999999999999999999999999999999999998654311 1111 10 011 0 11
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222445678999999999999999999999988
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.96 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=205.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-c---ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-C---TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..+.||+|+||.||+|+... + ..+++|.+... .....+.+..|++++++++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999998753 2 36889988755 34456779999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999986543 468999999999999999999995 8999999999999999999999999999875432
Q ss_pred CCccc-cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 667 MEHTH-VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 667 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
..... .......+..|+|||++....++.++|||||||++|||++ |+.|+...... ++......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~-------- 225 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIND-------- 225 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhc--------
Confidence 21111 1111223457999999998899999999999999999997 99888654321 11111111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
......+.+++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 226 --~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 --GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011122334567789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=317.43 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=203.3
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC-----hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS-----EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|...++||+|++|.||++.. +.+..+++|.+.... ......+.+|++++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688889999999999999986 457888999865432 2234578899999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|+||+++++|.+++... ..+++..+.+++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999988543 358889999999999999999994 8999999999999999999999999999875432
Q ss_pred CCccc-cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTH-VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ... +..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~---------~~~ 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFK---------IAT 221 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHH---------Hhc
Confidence 21111 11234578899999999998999999999999999999999999865422111 000 001
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.......+......+.+++.+||+.+|.+|||+.++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122344556678999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=314.31 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=210.4
Q ss_pred CceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 515 FDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
|++.++||+|+||.|||+.+ +.|.++|||+....+ +.+++..||.+|++++.|++|+++|.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 66678899999999999986 467889999886543 457889999999999999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|++.+.++.++ ++|++.++..++.+.++||+||| ...-||||||+.||||+-+|.+||+|||.|.... +.....
T Consensus 113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKR 186 (502)
T KOG0574|consen 113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKR 186 (502)
T ss_pred CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhh
Confidence 99999986554 68999999999999999999999 4888999999999999999999999999986532 233345
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc-CccCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII-DPHLKGNY 752 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~-d~~l~~~~ 752 (851)
.++.||+.|||||++..-.|..++||||+|+...||.-|++|+.+..|.....+ |. .|...-.-
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------IPT~PPPTF~K 251 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------IPTKPPPTFKK 251 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------ccCCCCCCCCC
Confidence 678899999999999999999999999999999999999999987665432110 11 11111123
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
++.-+..+-+++++||-+.|++|-|+.++++|
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 45667889999999999999999999999999
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.28 Aligned_cols=242 Identities=24% Similarity=0.352 Sum_probs=195.8
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|+.+ +++.+|+|++... .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 5678999987643 233456678899988877 699999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 9999988544 358899999999999999999995 89999999999999999999999999998753221 1123
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ...... . . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~---~~~i~~-~--------~--~~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---L---FEAILN-D--------E--VVYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---H---HHHHhc-C--------C--CCCC
Confidence 34579999999999999999999999999999999999999987543221 1 111110 0 0 0122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTM------GEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 784 (851)
...+..+.+++.+||+.||.+||++ ++++.|
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 3345678999999999999999998 788887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=332.83 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=201.6
Q ss_pred hcCCceeeeeeeecceEEEEEEE------cCcceeEEeecCCCC-hhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc-CC
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQS-EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE-QN 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-~~ 582 (851)
.++|+..+.||+|+||.||+|.. ..++.+|||++.... ......+.+|+.++.++ +||||++++++|.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46788899999999999999973 346789999987542 33456788999999999 68999999998854 45
Q ss_pred cEEEEEEecCCcchhhhccCCC----------------------------------------------------------
Q 047215 583 EMILVYEYMANGTLRSHLFGSD---------------------------------------------------------- 604 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~---------------------------------------------------------- 604 (851)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999885421
Q ss_pred -------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccc
Q 047215 605 -------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 605 -------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
...+++.++.+++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1236788899999999999999995 899999999999999999999999999987643221111122334
Q ss_pred cCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 678 gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ . ......+. ....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~---------~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGT---------RMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccC---------CCCCCCCC
Confidence 5678999999998899999999999999999997 7777754322111 0 01111110 01111223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
++.+.+++.+||+.+|.+|||+.|++++|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.90 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=205.8
Q ss_pred HHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 507 EIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 507 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
|++.+++++.....||+|+||.||+|+.. ++..+++|..........+.+.+|+.++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34557788888889999999999999864 56778999888776667788999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCC--chhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPL--TWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~ 662 (851)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999986542 234 788889999999999999995 89999999999999976 6799999999987
Q ss_pred cCCCCCccccccccccCCcccCccccccc--CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQ--QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
....... ......|+..|+|||++... .++.++||||||+++|||++|+.|+....... ...+....
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~------ 226 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGM------ 226 (268)
T ss_pred ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhh------
Confidence 5332111 12234578999999998654 38899999999999999999999886432211 01111000
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......++....+.+.+++.+||+.+|.+|||+.|++.|
T Consensus 227 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 -----FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 001112334456678999999999999999999999998
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=305.50 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=203.7
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-----h---hhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-----E---QGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-----~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
.-+.|...+.||+|..+.|-+...+ .+...|+|++.... + .-.+.-.+|+.+|+++ .||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456777889999999999888654 45667777764321 1 1234456799999999 69999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
+..+++|+|.|+.|.|.|+|... -.+++++..+|+.|+.+|++|||. ++||||||||+|||+|++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999543 468999999999999999999994 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccc------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWR------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
++..+... .....|||++|+|||.+.. ..|+..+|+|++||+||.|+.|.+||... .++-+ .++
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlM----LR~ 239 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLM----LRM 239 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHH----HHH
Confidence 98755433 3467899999999999864 36889999999999999999999998532 11111 111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
...+.. ....+-..+.+...++|+.+||+.||.+|.|++|+|.|..+
T Consensus 240 ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 240 IMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 111111 11122234566778999999999999999999999999443
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=317.58 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=205.7
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|+..++||+|+||.||+|..++++.+++|.+..... ....+.+|+.++++++||||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3467888999999999999999988889999998875433 3467899999999999999999999874 4578999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 999999999876666678999999999999999999994 8999999999999999999999999999876432111
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......++..|+|||++....++.++||||||++++||++ |+.||......+ . ..... . ...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~---~~~~~-~---------~~~ 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V---IQNLE-R---------GYR 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H---HHHHH-c---------CCC
Confidence 11223345678999999998899999999999999999999 888886543211 1 11110 0 011
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
...+...+..+.+++.+||+.+|++||++++++..|+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 1122334567999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.50 Aligned_cols=262 Identities=23% Similarity=0.411 Sum_probs=201.1
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc---------------ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC---------------TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIG 576 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~---------------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g 576 (851)
++|++.+.||+|+||.||+++..+. ..+|+|..... .......|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5788888999999999999875431 24789988764 3444567999999999999999999999
Q ss_pred EEccCCcEEEEEEecCCcchhhhccCCC----------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 577 FCDEQNEMILVYEYMANGTLRSHLFGSD----------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
++..++..++||||+++++|.+++.... ...+++.++++++.|++.||.|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999885432 1347889999999999999999995 89999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhC--CcCCCCCCCcch
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCA--RAVINPTLPKDQ 724 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG--~~p~~~~~~~~~ 724 (851)
+++++.+||+|||+++...............++..|+|||++....++.++|||||||+++||+++ ..|+......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 999999999999998764332222222334457789999999988999999999999999999984 44554332211
Q ss_pred hcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 725 INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
............. .......++..+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus 241 --~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111100 00111122334567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.52 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=204.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-----------------cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceee
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-----------------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~ 573 (851)
..+|+..+.||+|+||.||+++..+ ...+++|.+... .....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578888999999999999997643 235788987754 3445678999999999999999999
Q ss_pred EEEEEccCCcEEEEEEecCCcchhhhccCCC---------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCC
Q 047215 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSD---------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTN 644 (851)
Q Consensus 574 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~N 644 (851)
++++|..++..++++||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999985432 2368899999999999999999995 899999999999
Q ss_pred eEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh--CCcCCCCCCCc
Q 047215 645 ILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC--ARAVINPTLPK 722 (851)
Q Consensus 645 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt--G~~p~~~~~~~ 722 (851)
|+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876433332223334556789999999988899999999999999999998 5555543221
Q ss_pred chhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.............. ........+..++..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 240 --~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111111110 111111122344567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.85 Aligned_cols=260 Identities=24% Similarity=0.466 Sum_probs=204.9
Q ss_pred hcCCceeeeeeeecceEEEEEEEc--------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE--------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ 581 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 581 (851)
.++|.+.+.||+|+||.||+++.. ....+++|.+... .......+..|+++++++ +||||++++++|..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999742 2346788887754 344567789999999999 699999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE
Q 047215 582 NEMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl 647 (851)
+..+++|||+++|+|.+++.... ...+++.++.+++.|++.||.|||+ .+++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 99999999999999999985432 2458899999999999999999994 899999999999999
Q ss_pred cCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhc
Q 047215 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQIN 726 (851)
Q Consensus 648 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~ 726 (851)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999986433221111122234567999999998899999999999999999999 777775432211
Q ss_pred HHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 727 LADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
+.+ ....+ .....+..++..+.+++.+||+.+|++|||+.++++.|..+..
T Consensus 245 ~~~----~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFK----LLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH----HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 11111 1112234556678999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.14 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=196.0
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhc---CCcceeeEEEEEcc-----CC
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKL---RHRHLVSLIGFCDE-----QN 582 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~-----~~ 582 (851)
+|+..+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 57789999876432 12223456777777665 69999999998854 34
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++ +|.+++.......+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 58999999985 88888866555568999999999999999999995 899999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh--hhccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ--KQRSL 740 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~~ 740 (851)
..... .......||..|+|||++.+..++.++|||||||++|||++|++||......+. +........ .....
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhC
Confidence 64321 112335678999999999988999999999999999999999998865433221 111100000 00000
Q ss_pred -c------cccCccC---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 -K------SIIDPHL---KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 -~------~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ....+.. .....++..+.+.+++.+||+.||++|||+.|++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000 011123455678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=330.27 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=198.6
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+++.. +++.+|+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 5678899988753 233456688999999888 699999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|..++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 9999888543 368999999999999999999995 89999999999999999999999999998752221 1123
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||+||||++|+.||............++........ . ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~--~~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------P--IRIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------C--CCCC
Confidence 34679999999999999999999999999999999999999996543322222222222211111 1 1123
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPT------MGEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 784 (851)
...+..+.+++.+||+.||.+||+ ++++++|
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 344566889999999999999998 5688888
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=327.39 Aligned_cols=270 Identities=23% Similarity=0.374 Sum_probs=203.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|...+.||+|+||.||+|+.+ .+..+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999865 56778999876542 23334678899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++ +|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 985 7777775432 357888999999999999999995 8999999999999999999999999999875322111
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH---------HHhhhccc
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM---------KWQKQRSL 740 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~ 740 (851)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+......... ........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999998865 468999999999999999999999987654332221111100 00000000
Q ss_pred ccccCccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 741 KSIIDPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 741 ~~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...-.+.... ...+..+..+.+++.+||+.||.+|||++|+++| +|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h---------~~~~~ 291 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH---------AYFRS 291 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC---------hhhhh
Confidence 0000011000 0112345678899999999999999999999999 77764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=329.00 Aligned_cols=242 Identities=25% Similarity=0.353 Sum_probs=196.5
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+++.. ++..+|+|.+... .......+..|+++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 4678899987643 234456678899999888 799999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT 153 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence 9999888544 368999999999999999999995 89999999999999999999999999998752221 1122
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ..... ... ..++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~---~~~i~---------~~~--~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---L---FQSIL---------EDE--VRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---H---HHHHH---------cCC--CCCC
Confidence 34568999999999999999999999999999999999999986543211 1 11111 000 1123
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
...+..+.+++.+||+.||.+||++ .++++|
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 3445678999999999999999999 999888
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=329.57 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=192.5
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|+.. .+..+|+|.+... .....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 4678999987643 223344556677777654 899999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 9999988543 358889999999999999999995 899999999999999999999999999987532211 223
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... ....++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~-----------~~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILN-----------DRPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc-----------CCCCCC
Confidence 44679999999999999999999999999999999999999987543211 1111100 011223
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTMG-EVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~~ 784 (851)
...+..+.+++.+||+.+|.+||++. ++++|
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 34456688999999999999999875 66676
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=338.38 Aligned_cols=262 Identities=21% Similarity=0.228 Sum_probs=196.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
...|.+.+.||+|+||.||++.... ++.|+||.... ..+.+|+++|++++|||||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999999998754 56789996432 3457899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+. ++|.+++.... ..++|.+++.++.|+++||.|||+ .+||||||||+|||++.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 68888875432 368999999999999999999995 89999999999999999999999999999764332222
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCC--cchh---cHHHHHHHHhhh-ccccc--
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP--KDQI---NLADWAMKWQKQ-RSLKS-- 742 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~--~~~~---~l~~~~~~~~~~-~~~~~-- 742 (851)
.......||..|+|||++.+..++.++|||||||+||||++|..++..... .... .+.......... .....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 223346799999999999999999999999999999999998876543211 1111 111111110000 00000
Q ss_pred --------------ccCccCCC-CCC--hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 --------------IIDPHLKG-NYS--PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 --------------i~d~~l~~-~~~--~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+.... ... ......+.+|+.+||+.||.+|||+.|+|+|
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 000 0123468899999999999999999999999
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=328.90 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=193.4
Q ss_pred eeeeeecceEEEEEEEcC-cceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIED-CTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
+.||+|+||.||+|+..+ +..+|+|.+... .......+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999998754 678999987653 123345567788888764 899999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 9999998543 458899999999999999999995 899999999999999999999999999987522111 122
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+ ... . ..+. ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~---~i~-~------~~~~----~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQ---SIR-M------DNPC----YP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHH-h------CCCC----CC
Confidence 34568999999999999999999999999999999999999987543211 111 110 0 0111 22
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTMG-EVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~~ 784 (851)
......+.+++.+||+.||.+||++. ++++|
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 23445688999999999999999996 77777
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=343.20 Aligned_cols=263 Identities=21% Similarity=0.248 Sum_probs=194.4
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--------
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-------- 581 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-------- 581 (851)
...+|...++||+|+||.||+|... .+..+|||++.... ....+|+.+|++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999874 56789999875432 2345799999999999999999876321
Q ss_pred CcEEEEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeec
Q 047215 582 NEMILVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDF 658 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DF 658 (851)
..+++||||+++ +|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 66665532 234568899999999999999999995 8999999999999998654 7999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
|+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|++||......+..............
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998643221 1233568999999999865 47999999999999999999999999765433221111000000000
Q ss_pred -------cccccc-----cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 -------RSLKSI-----IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 -------~~~~~i-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+ ....+...++...+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 01111112333455679999999999999999999999999
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.32 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=202.5
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
++|...+.||+|++|.||+|..+++..+++|+..... ...+.+.+|++++++++|||++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4577888999999999999998877778999876543 234678899999999999999999998854 56899999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|+|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 9999999976555568999999999999999999994 8999999999999999999999999999875432111 11
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....+.+ ...+ .. .. ....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~---~~-~~---------~~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQ---VE-RG---------YRMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HH-cC---------CCCC
Confidence 122345678999999998899999999999999999999 888876543211 1111 10 00 1112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
.+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233456779999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.19 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=201.2
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC------
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ------ 581 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~------ 581 (851)
.+++.|+..+.||+|+||.||+|... .+..+|+|...... .....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888889999999999999865 46778999876543 3346788999999999 799999999998642
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
...+++|||+++|+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 468999999999999999876555678999999999999999999995 89999999999999999999999999998
Q ss_pred ccCCCCCccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
+..... ........|+..|+|||++. ...++.++|||||||++|||++|+.|+....+.... .. ..
T Consensus 159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~-~~- 229 (272)
T cd06637 159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FL-IP- 229 (272)
T ss_pred eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HH-Hh-
Confidence 753221 11233456899999999986 346888999999999999999999988654322111 00 00
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ...+.+ ....++..+.+++.+||+.+|.+|||+.++++|
T Consensus 230 ~-----~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 R-----NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred c-----CCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 001111 112344578999999999999999999999999
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=331.26 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=196.1
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|+.. .++.+|+|.+... .......+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 4678999987653 234455678899999876 799999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|...+... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 9999888543 358899999999999999999995 899999999999999999999999999987532211 123
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+ + ...... .. ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~---~~~i~~---------~~--~~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---L---FESILH---------DD--VLYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---H---HHHHHc---------CC--CCCC
Confidence 34568999999999999999999999999999999999999997543221 1 111110 00 0122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRP-------TMGEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RP-------t~~evl~~ 784 (851)
...+..+.+++.+||+.||++|| +++++++|
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 23456689999999999999999 89999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.30 Aligned_cols=246 Identities=27% Similarity=0.441 Sum_probs=198.6
Q ss_pred eeeeecceEEEEEEEcCcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchhh
Q 047215 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRS 598 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 598 (851)
+||+|+||.||+|...++..+++|...... ......+.+|++++++++||||++++++|...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 689999999999998888899999887653 3334578899999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccccc
Q 047215 599 HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG 678 (851)
Q Consensus 599 ~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 678 (851)
++.... ..+++.++..++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||+++...... ........+
T Consensus 82 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 82 FLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 886543 457899999999999999999994 899999999999999999999999999987532211 111122234
Q ss_pred CCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHH
Q 047215 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757 (851)
Q Consensus 679 t~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 757 (851)
+..|+|||++.+..++.++||||||+++||+++ |..||....... .. ... .. ......+..++
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~---~~~-~~---------~~~~~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR---EQV-EK---------GYRMSCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH---HHH-Hc---------CCCCCCCCCCC
Confidence 678999999998999999999999999999998 888876442211 10 010 01 11112334456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 758 EKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 758 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.36 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=202.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|+||.||++... .+..+++|.+... .......+.+|++++++++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999865 4667788877654 334456788999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999654 468899999999999999999995 468999999999999999999999999998753221
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc-----------
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS----------- 739 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------- 739 (851)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+....... ...+.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCC
Confidence 1234568899999999988889999999999999999999999986433211 1110000000000
Q ss_pred -------------cccccCccCCCCCC-hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 -------------LKSIIDPHLKGNYS-PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 -------------~~~i~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+... .....+ ......+.+++.+||+.+|++|||++++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 000111 1234568999999999999999999999999
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.75 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=202.3
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|+..+.||+|+||.||+|+. .++..+++|+...........+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5688889999999999999986 467788999887655555667889999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++... .++++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A 161 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence 999999988543 468899999999999999999995 899999999999999999999999999987543211 1
Q ss_pred cccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 672 VSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+....+..... .. .......+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~----~~~~~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM----SKSNFQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------ee----ecCCCCCCCC
Confidence 123346888999999884 4457889999999999999999999885433221100 00 0000111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
. .....+..+.+++.+||+.+|++|||++++++||
T Consensus 232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1 1123456789999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.88 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=205.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|+..+.||+|+||.||+|... ++.+++|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788889999999999999865 57789999876544 5678899999999999999999999999899999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99999999976655578999999999999999999994 899999999999999999999999999988642211
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.....+..|+|||++....++.++||||||++++|+++ |+.|+......+ +.... .. ....
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~---------~~~~ 218 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EK---------GYRM 218 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hc---------CCCC
Confidence 12334668999999988899999999999999999997 888876442211 11110 00 1111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
..+...++.+.+++.+||+.+|++||++.++++.|..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 2233456778999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.55 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=192.5
Q ss_pred eeeeecceEEEEEEEcCc---ceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcc
Q 047215 520 MIGVGGFGKVFKGEIEDC---TLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
.||+|+||.||+|...++ ..+++|++.... ......+.+|+.++++++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 589999999999986543 467888876543 3344578899999999999999999999999999999999999999
Q ss_pred hhhhccCCC---CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 596 LRSHLFGSD---LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 596 L~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
|.+++.... ....++..+.+++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986432 2345677888999999999999995 8999999999999999999999999999875332222122
Q ss_pred ccccccCCcccCccccccc-------CCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 673 STAVKGSFGYLDPEYFWRQ-------QLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||....+.+. .. ....+....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT----YTVREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH----HHhhcccCCCC
Confidence 2334578899999998642 36889999999999999996 9888865432211 11 11111112222
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
++.+. ....+.+.+++..|+ .+|++|||++||+..|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 23222 234456888999998 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=328.57 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=198.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
+|+..+.||+|+||.||+|+.. ++..+|+|.+... .......+..|..++..+ +||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999875 4568899987653 223345567788888877 5899999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+.+... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 999999999988543 358899999999999999999995 89999999999999999999999999998753211
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ... ....
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~---~~i---------~~~~- 217 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF---QSI---------MEHN- 217 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HH---HHH---------HhCC-
Confidence 112234579999999999999999999999999999999999999987543221 11 111 1111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
..++...+..+.+++.+||+.+|.+|++. .++++|
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 12233455678999999999999999984 777777
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=339.52 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=198.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. .++.+|+|.+.... ......+.+|+++|++++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999864 56789999876432 233466889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999998554 357888889999999999999995 899999999999999999999999999974211000
Q ss_pred -----------------------------------------ccccccccccCCcccCcccccccCCCchHHHHHHHHHHH
Q 047215 669 -----------------------------------------HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLF 707 (851)
Q Consensus 669 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ 707 (851)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000012356999999999999999999999999999999
Q ss_pred HHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 047215 708 EVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP---TMGEVLWH 784 (851)
Q Consensus 708 eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 784 (851)
||++|+.||....+.+.. ....... ..+........+..+.+++.+|+ .+|.+|+ ++.|+++|
T Consensus 236 ell~G~~Pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQ------LKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHH------HHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999765432211 1100000 00111111234456778888876 4999999 99999999
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.22 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=201.7
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
|+..++||+|+||.||++... .++.+|+|.+.... ......+..|+.++++++|++++++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 56789999876432 22334577899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 999999999865555568999999999999999999995 999999999999999999999999999987533211
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............ .... .. ...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~-----~~-----~~~ 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLV-----KE-----VQE 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhh-----hh-----hhh
Confidence 112346899999999999999999999999999999999999999754322110000 0000 00 001
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
.++...+..+.+|+.+||+.||++||| ++|+++|
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 122334556899999999999999999 8999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=339.16 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=196.7
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+|+..++||+|+||.||+|+.. .++.+|+|++... .......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 5678899988653 23345678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC-
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME- 668 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~- 668 (851)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998554 357888899999999999999995 899999999999999999999999999975211000
Q ss_pred --------------------------------------------ccccccccccCCcccCcccccccCCCchHHHHHHHH
Q 047215 669 --------------------------------------------HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGV 704 (851)
Q Consensus 669 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gv 704 (851)
.........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000112346999999999999999999999999999
Q ss_pred HHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 047215 705 VLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT---MGEV 781 (851)
Q Consensus 705 vL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev 781 (851)
+||||++|+.||....+.+. ....... ...+........++.+.+++.+|+ .+|.+|++ ++|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999976543211 0110000 001111111223455777777766 49999997 9999
Q ss_pred HHH
Q 047215 782 LWH 784 (851)
Q Consensus 782 l~~ 784 (851)
++|
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.60 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=199.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--C---cEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--N---EMILV 587 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~---~~~lV 587 (851)
.|...+++|.|+||.||+|.+. .+..+|||+.-...+. -.+|+++|++++|||||+|+-++... + ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556789999999999999875 4588999987655432 24699999999999999999887432 2 34699
Q ss_pred EEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC-CeEEEeeccccccC
Q 047215 588 YEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKTG 664 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~~ 664 (851)
|||||. +|.+.++. .....++...+.-...|+.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999997 89888863 224567778888899999999999995 999999999999999965 99999999999975
Q ss_pred CCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc--
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK-- 741 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 741 (851)
...+.+ .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+....++....-.+......+.+.
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 443332 33456889999999875 589999999999999999999999998876666543332222111111111
Q ss_pred -----cccCccCCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 -----SIIDPHLKG-----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 -----~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+...|.+.. -+....+++..+|+.++|+.+|.+|.++.|++.|
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111122211 1334566779999999999999999999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.33 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=198.0
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHH--hcCCcceeeEEEEEccC----Cc
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS--KLRHRHLVSLIGFCDEQ----NE 583 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~HpnIv~l~g~~~~~----~~ 583 (851)
.........+.||+|.||+||+|++.+ ..||||++...++.. +.+|.++.+ .|+|+||+.+++.-..+ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrG-e~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRG-EDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccC-CceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 344667778899999999999999986 457999998776554 445555555 46999999999886443 47
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhc-----CCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT-----GAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs-----~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
+|||.+|.++|||.|+|.. ..++....+++++.+|.||+|||. ..++.|.|||||++||||..++.+.|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 8999999999999999955 458999999999999999999994 35777999999999999999999999999
Q ss_pred cccccCCCCC--ccccccccccCCcccCcccccccC----C--CchHHHHHHHHHHHHHHhCC----------cCCCCCC
Q 047215 659 GLSKTGPSME--HTHVSTAVKGSFGYLDPEYFWRQQ----L--TEKSDVYSFGVVLFEVVCAR----------AVINPTL 720 (851)
Q Consensus 659 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--t~ksDVwS~GvvL~eLltG~----------~p~~~~~ 720 (851)
|||....... ..-......||.+|||||++...- + -..+||||||.|+||+.... .||.+..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9996533321 111223457999999999996431 1 13589999999999996543 3444433
Q ss_pred CcchhcHHHHHHHHhhhcccccc-cCccCCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 721 PKDQINLADWAMKWQKQRSLKSI-IDPHLKGNY-----SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~i-~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
+.+. +. +.+.++ ...++++.+ +.+++..+.++++.||..+|..|-|+-.+-+.|.++.+
T Consensus 441 p~DP-s~----------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDP-SF----------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCC-CH----------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3221 11 111111 122333322 35788899999999999999999999888877776653
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.81 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=195.8
Q ss_pred eeeeecceEEEEEEEc---CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcc
Q 047215 520 MIGVGGFGKVFKGEIE---DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
.||+|+||.||+|.+. .+..+|+|...... ....+.+.+|+.++++++||||++++++|.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 34468999887653 3445679999999999999999999999864 57899999999999
Q ss_pred hhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc-cccc
Q 047215 596 LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT-HVST 674 (851)
Q Consensus 596 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~ 674 (851)
|.+++.... ..+++.++++++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++........ ....
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986432 468999999999999999999995 89999999999999999999999999998753322111 1112
Q ss_pred ccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 675 AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 675 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
...++..|+|||++....++.++|||||||++|||++ |+.|+....+.+ +.. ....+ .....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~---------~~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMS-FIEQG---------KRLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHCC---------CCCCCC
Confidence 2234578999999988889999999999999999996 888886543221 111 11111 112234
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
..+++.+.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 4566789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.39 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=206.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+.. +++.++||.+... .......+.+|++++++++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888899999999999999864 6788899976542 3344567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 589 EYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||+++|+|.+++.. .....+++.++..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988743 223457889999999999999999994 8999999999999999999999999999876432
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.. .......|++.|+|||.+.+..++.++|+||||+++|||++|+.|+...... ..++...... ...+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~------~~~~ 226 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQ------CDYP 226 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhc------CCCC
Confidence 11 1123346888999999999888999999999999999999999998643221 1111111110 1111
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
. ......+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 227 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 11234556799999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.15 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=215.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCCh---hhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSE---QGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~l 586 (851)
...|+..+.||+|.||.||+++.+. ++.+|+|.+..... .....+.+|+.+|+++. |||||.+.+.++..+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4567777899999999999999765 88899998876533 34568999999999998 9999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC----CCeEEEeeccccc
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE----NFVAKMSDFGLSK 662 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~----~~~~kl~DFGla~ 662 (851)
|||++.+|.|.+.+... .+++.....++.|++.+++|||+ .+|+||||||+|+|+.. ++.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998665 39999999999999999999995 99999999999999952 3589999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... ....+
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~---- 253 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG---- 253 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC----
Confidence 7544 334567899999999999999999999999999999999999999998765432211 00011
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
+........+.....+++++..|+..||.+|+|+.++|+| +|....
T Consensus 254 --~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H---------pWi~~~ 299 (382)
T KOG0032|consen 254 --DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH---------PWIKSI 299 (382)
T ss_pred --CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC---------ccccCC
Confidence 1122233345667889999999999999999999999999 887754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.55 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=202.3
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChh--hHHHHHHHHHHHHhcCCcc-eeeEEEEEccCC------c
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQ--GLAEFETEIEMLSKLRHRH-LVSLIGFCDEQN------E 583 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~------~ 583 (851)
.|+..++||+|+||+||+|+. ..++.||+|++...... ......+|+.+|++|+|+| ||+|.+++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455566799999999999985 46789999998765432 3345689999999999999 999999998877 7
Q ss_pred EEEEEEecCCcchhhhccCCCC--CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDL--PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
++||+||++. +|..++..... ..++...+..++.|+++||+|||+ ++|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999976 88888855432 356668899999999999999995 99999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
+...-.. ...+...+|..|.|||++.+. .|+...||||+||++.||+++++.|.+..+.++...+-...........
T Consensus 168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9643222 224456789999999999876 7999999999999999999999988877664443222111111111111
Q ss_pred cccc-CccCCCC---------CCh---hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSII-DPHLKGN---------YSP---ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~-d~~l~~~---------~~~---~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+. -+..... ... .......+++.+||+.+|.+|.|++.++.|
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100 0111101 111 112478899999999999999999999999
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.78 Aligned_cols=255 Identities=30% Similarity=0.474 Sum_probs=207.4
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|.+.++||+|+||.||+|..+++..+++|.+.... ...+++.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457888899999999999999998887889999887543 3356789999999999999999999999998999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++.++..++.+++.||.|||+ .+++|+||||+||++++++.+||+|||+++...... .
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence 999999999977655678999999999999999999994 899999999999999999999999999987643211 1
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......++..|+|||.+.+..++.++||||||++++||++ |+.|+....... ..+ ... ....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~---~~~----------~~~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE---QVE----------RGYR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHH----------cCCC
Confidence 11122334568999999998899999999999999999999 888875432211 111 110 0011
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
...+...+..+.+++.+||+.+|.+||+++++++.|+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 1222344567999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.50 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=202.3
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+|+..++||+|+||.||+|.. ..+..+|+|..... .......+.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999985 46678999987654 3444567899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|..+. .+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999996542 46788889999999999999995 89999999999999999999999999998753221
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh-cHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI-NLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ....+...... . ..+.+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~- 221 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E-----DPPVLP- 221 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c-----CCCCCC-
Confidence 123456899999999999999999999999999999999999998653322111 11111111000 0 011111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
....+..+.+++.+||+.+|.+||+++|+++| +|+...
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~---------~~~~~~ 259 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH---------PFIVQY 259 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC---------cccccc
Confidence 12234568999999999999999999999999 887643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.15 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=195.6
Q ss_pred eeeeecceEEEEEEEc---CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 520 MIGVGGFGKVFKGEIE---DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
.||+|+||.||+|.++ ++..+++|++.... ....+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 46788999876542 3456789999999999999999999999864 5679999999999
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc-cc
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH-VS 673 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~ 673 (851)
+|.+++... ..+++..+.+++.|++.||.|||+ ++++||||||.|||++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998543 368899999999999999999994 899999999999999999999999999987643322111 11
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+ +.... ..+ .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~i-~~~---------~~~~~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQMI-ESG---------ERMEC 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-HCC---------CCCCC
Confidence 22234578999999988889999999999999999998 888886543221 11111 111 11123
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
+..++..+.+++.+||+.||.+||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 34566779999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.47 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=203.6
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-c---ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-C---TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..+.||+|+||.||+|+... + ..+++|.+... .......|..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 356778899999999999998753 2 35899988764 455567899999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999986543 468999999999999999999995 89999999999999999999999999998754322
Q ss_pred Cccccccc-c--ccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 668 EHTHVSTA-V--KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 668 ~~~~~~~~-~--~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
........ . ..+..|+|||++.+..++.++|||||||++||+++ |..|+...... ...++.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~------ 226 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----Q------ 226 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----c------
Confidence 11111111 1 12457999999999999999999999999999886 88887654321 1111111 0
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
......+.+++..+.+++.+||+.+|.+||++++++..|+.+
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ---DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122345567789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.16 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=200.5
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEE-ccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC-DEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~lV~Ey~ 591 (851)
++|+..+.||+|+||.||++... +..+++|...... ..+.+.+|+.++++++|+|++++++++ ..++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999865 5667888876443 346789999999999999999999976 4556789999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++.......+++..+++++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999976655568999999999999999999995 899999999999999999999999999987532211
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
....++..|+|||++....++.++|||||||++|||++ |+.|+.... ..+....... ....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~----------~~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEK----------GYKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhc----------CCCC
Confidence 22345678999999998899999999999999999998 887775332 1111111110 1111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
..+..++..+.+++.+||+.+|++|||+.+++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 2234556779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.00 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=195.7
Q ss_pred eeeeeecceEEEEEEE----cCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 519 LMIGVGGFGKVFKGEI----EDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
+.||+|+||.||+++. ..++.+|+|++.... ......+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 356789999886532 2234567789999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 99999998543 468999999999999999999995 899999999999999999999999999987633221 12
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. .... .... ..+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i---------~~~~--~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMI---------LKAK--LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHH---------HcCC--CCC
Confidence 2345789999999999988999999999999999999999999875432111 1111 0001 123
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
+...+..+.+++.+||+.||++||+ +++++.|
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 3445567899999999999999999 5667766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.65 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=201.7
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
|...++||+|+||+||+|... +++.+|+|.+.... ......+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 57789999876532 22334578899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999998866555579999999999999999999995 899999999999999999999999999986533211
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||......... ..+... +... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~---------~~~~--~~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRR---------VLET--EE 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHh---------hhcc--cc
Confidence 123456899999999999889999999999999999999999998754322111 111000 0000 01
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
.++...+..+.+|+.+||+.||++||+ +.+++.|
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 123344566889999999999999999 7788888
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.76 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=203.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
..++|+..+.||+|+||.||++... .+..+++|.+... ......++.+|+.++++++||||++++++|..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999864 3567899988754 34455779999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCC--------------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCC
Q 047215 584 MILVYEYMANGTLRSHLFGSD--------------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTT 643 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~ 643 (851)
.++|+||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 999999999999999985321 2347888999999999999999995 89999999999
Q ss_pred CeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCc
Q 047215 644 NILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPK 722 (851)
Q Consensus 644 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~ 722 (851)
||+++.++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432221111222334678999999998999999999999999999998 77777543221
Q ss_pred chhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
++..... .+. .. ..+..++..+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 240 ------~~~~~~~-~~~--------~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 ------EVIYYVR-DGN--------VL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ------HHHHHHh-cCC--------CC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111111 111 10 122345567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.48 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=204.7
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.+|+..+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.++++++||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999985 467789999887665555678899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 999999998543 47899999999999999999995 899999999999999999999999999987533221 1
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+... +.. ... .+.....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~~-~~~--------~~~~~~~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYL-IAT--------NGTPELQ 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HHH-Hhc--------CCCCCCC
Confidence 12234688999999999988899999999999999999999999865433211 110 000 0000111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+...+..+.+++.+||+.+|.+|||+.++++|
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 223445678999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=296.68 Aligned_cols=263 Identities=23% Similarity=0.331 Sum_probs=210.9
Q ss_pred HhcCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----CcE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NEM 584 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~ 584 (851)
..++|.+.+.||+|||+-||.++ ..++..+|+|++...+.++.+...+|++..++++||||+++++++..+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678889999999999999998 566788999999888878888999999999999999999999987433 458
Q ss_pred EEEEEecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 585 ILVYEYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
||+++|...|+|.+.+... +...+++.++++|+.++++||++||+ ...++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998643 23468999999999999999999996 33459999999999999999999999999987
Q ss_pred cCCCCCccc-------cccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH
Q 047215 663 TGPSMEHTH-------VSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 663 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~ 732 (851)
..+-.-... .-.....|..|.|||.+. +...++++|||||||+||+|+.|..||+......
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 643211111 112345788999999986 4568899999999999999999999997643321
Q ss_pred HHhhhcccc-cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 733 KWQKQRSLK-SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 733 ~~~~~~~~~-~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
+.+. .+..+.+.-.-....++.+.+++++||+.||.+||++.+++.+++.+
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 12222332222233567799999999999999999999999998765
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=328.67 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=193.5
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|+.. .+..+|+|.+.... ......+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999875 56789999876531 23345667788888765 899999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence 9999988543 458899999999999999999995 89999999999999999999999999998742211 1123
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ..... . ..+ .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~~~~-~------~~~----~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FESIR-V------DTP----HYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-h------CCC----CCC
Confidence 45679999999999999999999999999999999999999997543211 1 11110 0 011 122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH-HHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTM-GEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~-~evl~~ 784 (851)
......+.+++.+||+.||++||++ +++++|
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 3345668999999999999999998 577777
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.57 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=193.3
Q ss_pred eeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 521 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
||+|+||.||+++.+ +++.+|+|.+.... ......+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 57889999876421 12234556799999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 676 (851)
.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 998866555568999999999999999999995 899999999999999999999999999987543211 12335
Q ss_pred ccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 677 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+.... ........ .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~---------~~~~~~~~-~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR---------TLEDEVKF-EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH---------hhcccccc-ccccC
Confidence 689999999999988899999999999999999999999865432111 1111111 11111100 01234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+..+.+++.+||+.||.+||+++|++++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 4568999999999999999999665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.31 Aligned_cols=248 Identities=30% Similarity=0.470 Sum_probs=195.7
Q ss_pred eeeeecceEEEEEEEcCc-c--eeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 520 MIGVGGFGKVFKGEIEDC-T--LAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~-~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
+||+|+||.||+|+..+. . .+++|..... .....+.+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 589999999999987543 2 4678877643 345567889999999999 8999999999999999999999999999
Q ss_pred chhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 595 TLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 595 sL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
+|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999986432 2357899999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
++.... .........+..|+|||++....++.++|||||||+++||++ |..||...... +......
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~---- 225 (270)
T cd05047 159 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP---- 225 (270)
T ss_pred ccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHh----
Confidence 864211 111112234667999999988899999999999999999997 88887543211 1111110
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.......+..++..+.+++.+||+.+|.+|||+.++++.|..++
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 ------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111122344567899999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.92 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=204.4
Q ss_pred CceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 515 FDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556789999999999998764 567788888776666778899999999999999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
++|..++.... .++++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 99988875432 468999999999999999999995 89999999999999999999999999998753221 1122
Q ss_pred cccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 674 TAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
....++..|+|||++. +..++.++|||||||++|||++|+.|+....+.+. ........ .+.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~------~~~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------PPTL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcC------CCCC
Confidence 3456889999999984 45678899999999999999999998865432211 11110000 0111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+...+..+.+++.+||+.+|.+||++.++++| +|+..
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~---------~~~~~ 267 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH---------PFVTV 267 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC---------CCEec
Confidence 1122345678999999999999999999999999 88764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=333.90 Aligned_cols=262 Identities=23% Similarity=0.265 Sum_probs=199.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC---cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED---CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
..+|.+.+.||+|+||.||++...+ +..+++|.+... ..+.+|+++|++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3579999999999999999997533 457888887643 23468999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|++. ++|.+++. ....+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9996 58888873 33568999999999999999999995 899999999999999999999999999987644322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc-------
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK------- 741 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 741 (851)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.............-...........
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2222334679999999999999999999999999999999999999987644322111111011100000000
Q ss_pred ------cccCccCCCCCC-------hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 ------SIIDPHLKGNYS-------PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 ------~i~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.......+..+. ......+.+++.+||..||.+|||+.|++.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 1223568899999999999999999999999
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.65 Aligned_cols=253 Identities=30% Similarity=0.498 Sum_probs=201.2
Q ss_pred CceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHH--HHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 515 FDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLA--EFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
|+..+.||+|+||+||+++... ++.+|+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999765 457899998877544332 3456999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++. ....+++.++..++.|+++||.+||+ .+++|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccc
Confidence 9999999996 33468999999999999999999996 899999999999999999999999999987431 1222
Q ss_pred cccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||++. +..++.++||||+|+++++|++|+.|+......+...... ...... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~----~~~~~--- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRP----LPSSS--- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTH----HHHHT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccccc----ccccc---
Confidence 334566899999999998 8899999999999999999999999987652111111111 100000 00000
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.........+.+++.+||+.||++||++.++++|
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011123679999999999999999999999999
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.33 Aligned_cols=249 Identities=30% Similarity=0.476 Sum_probs=203.7
Q ss_pred eeeeeecceEEEEEEEcC----cceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIED----CTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|.... +..+++|.+...... ..+.+.+|++++++++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999998754 677899988765433 367899999999999999999999999999999999999999
Q ss_pred cchhhhccCCC-------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 594 GTLRSHLFGSD-------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 594 gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
++|.+++.... ...+++.++.+++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999996642 3578999999999999999999994 9999999999999999999999999999987554
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........++..|+|||.+....++.++||||||++++||++ |+.|+....+.+ + ...... +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~-~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---V---LEYLRK-G------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHHHc-C-------
Confidence 332223344567889999999988899999999999999999999 577776542211 1 111111 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.....+..++..+.+++.+||+.+|.+|||+.|++++|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223445677999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=343.02 Aligned_cols=272 Identities=19% Similarity=0.319 Sum_probs=199.9
Q ss_pred HHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCC------cceeeEEEEEc
Q 047215 507 EIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH------RHLVSLIGFCD 579 (851)
Q Consensus 507 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~l~g~~~ 579 (851)
++...+++|++.++||+|+||.||+|... .+..||||++.... ....++..|++++++++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456789999999999999999999864 56789999986432 223456778888877755 45889999886
Q ss_pred cC-CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-------
Q 047215 580 EQ-NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF------- 651 (851)
Q Consensus 580 ~~-~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~------- 651 (851)
.+ ...++|||++ +++|.+++... ..+++.++..|+.|++.||+|||+ +.+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence 54 5789999988 67888887543 468999999999999999999995 35999999999999998665
Q ss_pred ---------eEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCc
Q 047215 652 ---------VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPK 722 (851)
Q Consensus 652 ---------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~ 722 (851)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 59999999876421 1233567999999999999999999999999999999999999999765443
Q ss_pred chhcHHH---------HHHHH--------h-hhcccccccCccC----CC-C-C-ChhHHHHHHHHHHHhcccCCCCCCC
Q 047215 723 DQINLAD---------WAMKW--------Q-KQRSLKSIIDPHL----KG-N-Y-SPESLEKFGEIAEKCLDDEGKNRPT 777 (851)
Q Consensus 723 ~~~~l~~---------~~~~~--------~-~~~~~~~i~d~~l----~~-~-~-~~~~~~~l~~l~~~Cl~~dP~~RPt 777 (851)
+...+.. |...+ . ....+....++.. .. . . .......+.+|+.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 3222211 11000 0 0000000000000 00 0 0 0012356789999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhccc
Q 047215 778 MGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 778 ~~evl~~L~~~~~~~~~w~~~ 798 (851)
++|+|+| +|+..
T Consensus 432 a~e~L~H---------p~~~~ 443 (467)
T PTZ00284 432 ARQMTTH---------PYVLK 443 (467)
T ss_pred HHHHhcC---------ccccc
Confidence 9999999 77764
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.17 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=203.9
Q ss_pred cCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.+|+..+.||+|+||.||+|+.. .+..+++|.+... .......+..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999863 2336889987654 234456899999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999986543 458999999999999999999994 89999999999999999999999999999864332
Q ss_pred Cccc-cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 668 EHTH-VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 668 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.... ......++..|+|||++.+..++.++||||||++++|+++ |+.|+......+ ...+. . ..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---~-~~------- 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI---E-EG------- 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH---h-CC-------
Confidence 1111 1112233568999999998899999999999999999886 988886543221 11111 0 00
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.....+..++..+.+++.+|++.+|.+||++.++++.|..+
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 --YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01112234566789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.00 Aligned_cols=263 Identities=22% Similarity=0.373 Sum_probs=201.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-----------------cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceee
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-----------------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~ 573 (851)
.++|+..+.||+|+||.||++...+ ...+|+|+.... .......|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3578889999999999999985432 335789988754 3445578999999999999999999
Q ss_pred EEEEEccCCcEEEEEEecCCcchhhhccCCCC---------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCC
Q 047215 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDL---------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTN 644 (851)
Q Consensus 574 l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~---------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~N 644 (851)
+++++..++..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 99999999999999999999999999865321 246788999999999999999995 899999999999
Q ss_pred eEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh--CCcCCCCCCCc
Q 047215 645 ILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC--ARAVINPTLPK 722 (851)
Q Consensus 645 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt--G~~p~~~~~~~ 722 (851)
||++.++.+||+|||+++...............++..|++||...+..++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433222122222345678999999888899999999999999999998 55666543222
Q ss_pred chhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+. ............ .... ...+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 241 ~~---~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV---IENTGEFFRDQG-RQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHHhhcc-cccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 111111111110 0000 1112345578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=328.89 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=191.9
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHH-HHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIE-MLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||+||+|+.. +++.+|+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999874 67889999876431 222344555554 56789999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT 153 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence 9999988543 468889999999999999999995 8999999999999999999999999999875322 11223
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..... ..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i---------~~~~~--~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNI---------LNKPL--RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHH---------HcCCC--CCC
Confidence 4457999999999999999999999999999999999999998754221 111111 11110 122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTM----GEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~~ 784 (851)
+..+..+.+++.+||+.||.+||++ .++++|
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 3345678999999999999999987 577766
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.02 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=204.5
Q ss_pred cCCceeeeeeeecceEEEEEEEcC--------cceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED--------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN 582 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 582 (851)
.+|.+.+.||+|+||.||+++..+ ...+++|..... ......++.+|+++++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 467888999999999999997421 235789987653 344567899999999999 7999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc
Q 047215 583 EMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD 648 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld 648 (851)
..++++||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999985421 2357889999999999999999994 8999999999999999
Q ss_pred CCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcH
Q 047215 649 ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINL 727 (851)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l 727 (851)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 999999999999876433222112222344568999999999999999999999999999998 7777654321
Q ss_pred HHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 728 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.++...... ......+..++..+.+++.+||+.+|.+||++.|++++|+.+..
T Consensus 243 ~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKLLKE----------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHc----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111111111 01112233455679999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.41 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=211.9
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc-EEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE-MILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-~~lV~ 588 (851)
++|...+++|+|+||.++..+.+ +.+.+++|++... +....+...+|+.++++++|||||.+.+.+..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777889999999999988754 4567888876543 44445578899999999999999999999998888 99999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
+|++||+|.+.|...+...++++++.+++.|++.|+.||| +..|+|||||+.||+++.+..+||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998877778999999999999999999999 4899999999999999999999999999999865433
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|....... + +... ...+.
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---L---i~ki-----~~~~~---- 223 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---L---ILKI-----NRGLY---- 223 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---H---HHHH-----hhccC----
Confidence 24566889999999999999999999999999999999999999887653221 1 1111 11111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
...+...+..++.++..||+.+|..||++.++|.+.
T Consensus 224 -~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 224 -SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred -CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 233455566799999999999999999999999883
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=334.17 Aligned_cols=261 Identities=22% Similarity=0.264 Sum_probs=203.6
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 580 (851)
+.++....++|+..+.||+|+||.||+++.. .++.+|+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999875 4677899987542 22334567889999999999999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
++..++||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998543 47888889999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCccccccc----CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ----QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
++...... ........||+.|+|||++... .++.++|||||||+||||++|+.||....... .......
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 261 (371)
T cd05622 189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 261 (371)
T ss_pred eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence 97643221 1122356799999999999754 37899999999999999999999997543211 1111111
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKN--RPTMGEVLWHL 785 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~L 785 (851)
... .+........+..+++++.+||..++.+ ||+++++++|.
T Consensus 262 ~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 100 0111112245567899999999854443 78999999994
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.45 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=204.6
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|+..++||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++||||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678888899999999999999765 67889998865433 678999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999985433 468999999999999999999995 8999999999999999999999999999876433211
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....+..... . ......+.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------~------~~~~~~~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------M------IPNKPPPTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------h------hccCCCCCC--C
Confidence 2233457889999999999999999999999999999999999987543321100 0 000000111 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+......+.+++.+||+.+|.+|||++|+++|
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 223345678999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.93 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=200.3
Q ss_pred eeeeeecceEEEEEEEcC--c--ceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIED--C--TLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~--~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|++|.||+|.+.+ + ..+++|.+..... ...+.+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 2 3589999887655 667789999999999999999999999988 899999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc-cc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT-HV 672 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~-~~ 672 (851)
|+|.+++.......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999866543568999999999999999999994 89999999999999999999999999999865332211 11
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....++..|+|||++....++.++|||||||++|||++ |+.|+......+ ......... . ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~-------~--~~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEG-------E--RLE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC-------C--cCC
Confidence 223457789999999999999999999999999999998 998876432211 111111100 0 011
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 22345567999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=348.39 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=208.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..++||+|+||.||+|+.. .++.+|+|++... .....+.|.+|++++++++||||+++++++..++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999865 4788999988653 2233567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCC---------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 589 EYMANGTLRSHLFGS---------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~---------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
||+++|+|.+++... ....+++..+++++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 12345677889999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCc----------------cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc
Q 047215 660 LSKTGPSMEH----------------THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723 (851)
Q Consensus 660 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~ 723 (851)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976411100 001123469999999999999999999999999999999999999986532211
Q ss_pred hhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHhhhhhcc
Q 047215 724 QINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP-TMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~~w~~ 797 (851)
.. .. ..+.++... ....+.+..+.+++.+||+.||++|| +++++++.|+..++....|..
T Consensus 239 i~----------~~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~~ 299 (932)
T PRK13184 239 IS----------YR---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWTV 299 (932)
T ss_pred hh----------hh---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccccc
Confidence 10 00 011111100 00124456688999999999999996 577788888877766556643
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.22 Aligned_cols=267 Identities=22% Similarity=0.392 Sum_probs=203.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|...+.||+|+||.||+|+.. .+..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 56788999876442 23345678899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
++ ++|.+++.... ..+++..+..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 97 58888875432 357889999999999999999995 899999999999999999999999999987532211
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh---hccccccc--
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK---QRSLKSII-- 744 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~i~-- 744 (851)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+... ....... ......+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhcc
Confidence 11223456889999999865 458899999999999999999999987654322211 1111000 00000000
Q ss_pred -------CccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 745 -------DPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 745 -------d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+.... ...+..+..+++|+.+||+.||.+|||++|+++| +|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h---------~~f~~ 291 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH---------PYFHC 291 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC---------ccccc
Confidence 011100 1112345678999999999999999999999999 88754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=327.53 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=193.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
...+|...+.||+|+||.||+|+... +..+|+|..... ....|+.++++++||||+++++++..+...++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 45689999999999999999998754 567888875432 23569999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
++. ++|.+++... ...+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 138 HYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred ccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 995 5888887543 3468999999999999999999995 8999999999999999999999999999875221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhc--------HHHHHHHHhhh-ccc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN--------LADWAMKWQKQ-RSL 740 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~--------l~~~~~~~~~~-~~~ 740 (851)
........||..|+|||++.+..++.++|||||||++|||+++..++....+..... +.......... ...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 112234568999999999999999999999999999999999766554332222110 00000000000 000
Q ss_pred c---------cccC--ccCCCCC-------ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 K---------SIID--PHLKGNY-------SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~---------~i~d--~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ...+ ...+... ....+..+.+++.+||+.||.+|||+.|+++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 0000 0000000 01223456779999999999999999999999
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.64 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=205.9
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+. .++..++||.+... ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577778899999999999985 46788899976543 3344568899999999999999999999999999999999
Q ss_pred EecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 589 EYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||+++++|.+++.. .....+++.++.+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 223568899999999999999999994 8999999999999999999999999999875432
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.. .......|+..|+|||++.+..++.++||||||+++|||++|..|+...... ..++... ......+
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~------~~~~~~~ 226 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK------IEQCDYP 226 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh------hhcCCCC
Confidence 11 1123356889999999999889999999999999999999999998643221 1111111 1111111
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.+ .....+..+.+++.+||+.+|.+||||.+|++.+..+
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 1223556799999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=333.90 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=199.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. .+..+|+|++... .......+..|+.++.+++||||+++++.+..++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 5678999987643 2334567888999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998543 458899999999999999999995 999999999999999999999999999986432110
Q ss_pred c---------------------------------cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcC
Q 047215 669 H---------------------------------THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV 715 (851)
Q Consensus 669 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p 715 (851)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 0011235699999999999999999999999999999999999999
Q ss_pred CCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 047215 716 INPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP---TMGEVLWH 784 (851)
Q Consensus 716 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 784 (851)
|....+... ....... ...+..+ . ....+..+++++.+|+. +|.+|+ +++|+++|
T Consensus 236 f~~~~~~~~------~~~i~~~--~~~~~~p---~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQET------YRKVMNW--KETLVFP---P--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHHHH------HHHHHcC--CCceecC---C--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 976543221 1111100 0001001 0 11234567888888764 999998 48999999
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=326.47 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=196.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN------ 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 582 (851)
.++|+..+.||+|+||.||++... .+..+|+|++... .......+.+|+.++++++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999864 5788999988643 3344567889999999999999999999985443
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++ +|.+.+. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999976 5555553 237788899999999999999995 899999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhc------------HH--
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN------------LA-- 728 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~------------l~-- 728 (851)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..
T Consensus 172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 5322 112234568999999999999999999999999999999999999997653221100 00
Q ss_pred --HHHHHHhhhc-cc-----ccccCccCC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 729 --DWAMKWQKQR-SL-----KSIIDPHLK---GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 729 --~~~~~~~~~~-~~-----~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+.... .. .+....... ..........+++|+.+||+.||++|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 00 000000000 00111234568999999999999999999999999
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=317.53 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=208.7
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.+|...+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788899999999999999985 567889999887665555677899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 99999999854 347889999999999999999995 8999999999999999999999999999875332211
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...... . .........
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------------~--~~~~~~~~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------I--ATNGTPELQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------------e--ccCCCCCCC
Confidence 12334688899999999999999999999999999999999999865433221100 0 000000111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+...+..+.+++.+||+.+|.+||+++++++| +|++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~---------~~~~~ 274 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH---------PFLKL 274 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC---------chhcc
Confidence 223445668899999999999999999999999 88764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=315.89 Aligned_cols=262 Identities=22% Similarity=0.284 Sum_probs=198.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|++|.||+|+.. ++..+++|++... .......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999875 5788999987643 223346788999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 591 MANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 591 ~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
++ ++|.+++.... ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888775432 3568999999999999999999995 899999999999999999999999999987533211
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh-----------hh
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ-----------KQ 737 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~ 737 (851)
.......+++.|+|||++.+ ..++.++|||||||+++||+||+.|+......... ......+. ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhh
Confidence 11223456889999998865 45799999999999999999999988754322111 00000000 00
Q ss_pred cccc----cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 RSLK----SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 ~~~~----~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.... ......+ .......+..+.+++.+||+.||.+|||+.+++.|
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0000000 00112345668899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=325.30 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~ 588 (851)
+|+..+.||+|+||.||+++.. ++..+|+|++... .....+.+..|+.+++.+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777889999999999999864 5778999987643 2334456788999998885 578888999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999998543 458999999999999999999995 899999999999999999999999999987532211
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. +. ... ....
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~---~~i---------~~~~- 217 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LF---QSI---------MEHN- 217 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHH---------HhCC-
Confidence 12234568999999999999999999999999999999999999987543211 11 111 1111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
..++...+..+.+++.+||+.+|.+|++. +++++|
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 12233445678999999999999999974 667666
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.73 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=189.1
Q ss_pred eeeeecceEEEEEEEcCc---ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcc
Q 047215 520 MIGVGGFGKVFKGEIEDC---TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
.||+|+||.||+|...++ ..+++|.+... .......|.+|+..++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999975433 46788876544 33445678899999999999999999999999999999999999999
Q ss_pred hhhhccCCC---CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 596 LRSHLFGSD---LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 596 L~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
|.+++.... .....+.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999986543 2334677889999999999999995 8999999999999999999999999999875332221111
Q ss_pred ccccccCCcccCcccccc-------cCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 673 STAVKGSFGYLDPEYFWR-------QQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.....++..|+|||++.. ..++.++|||||||++|||++ |..|+....+.+. + .... ......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~----~~~~-~~~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--L----KQVV-REQDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--H----HHHh-hccCccCC
Confidence 223345678999998753 457889999999999999999 6666654322110 0 0000 11111222
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
++. .+...+..+.+++..|+ .||++|||+++|++.|
T Consensus 232 ~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 222 23345566788999998 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=311.37 Aligned_cols=238 Identities=21% Similarity=0.364 Sum_probs=187.8
Q ss_pred eeeeecceEEEEEEEcC-------------cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 520 MIGVGGFGKVFKGEIED-------------CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.||+|+||.||+|+... ...+++|.+..........|.+|+.++++++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999997532 12478888776655556688999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe-------EEEeecc
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV-------AKMSDFG 659 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~-------~kl~DFG 659 (851)
||||+++|+|..++.... ..+++.++.+++.|+++||+|||+ ++|+||||||+|||++.++. +|++|||
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999988875433 458999999999999999999995 89999999999999986654 8999999
Q ss_pred ccccCCCCCccccccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
++...... ....++..|+|||++. +..++.++|||||||++|||++ |+.|+......+. .....
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~~- 223 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFYE- 223 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHHh-
Confidence 98653221 2235788899999987 5678999999999999999984 6666654321111 00000
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
. .. .........+.+|+.+||+.||.+||++.+++++|
T Consensus 224 ~--------~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 G--------QC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c--------Cc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00 01122345689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=308.45 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=198.7
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
++||+|+||.||++...+++.+++|....... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999987788999998776533 35678999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
+++.... ..+++..++.++.+++.+|+|||+ .+++||||||+|||++.++.+||+|||+++...............
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986543 357899999999999999999994 899999999999999999999999999987543211111111223
Q ss_pred cCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 678 gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
++..|+|||.+.+..++.++|||||||+++||++ |..|+....+.. ... .. ........+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~---~~----------~~~~~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRE---RI----------ESGYRMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHH---HH----------hcCCCCCCCccC
Confidence 4567999999998899999999999999999999 677765443211 111 10 001111223345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+..+.+++.+||+.+|.+|||+.|+++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 667999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=313.70 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=204.7
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-c----ceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-C----TLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.+|+..+.||+|+||.||+|...+ + ..+++|...... ......+.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567778899999999999998643 2 257888876553 3455788999999999999999999999987 78999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999986543 358999999999999999999995 9999999999999999999999999999986543
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........++..|+|||.+....++.++|+||||+++|||++ |+.|+......+ +..... .+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~~------- 227 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLE-KG------- 227 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHh-CC-------
Confidence 222111122234568999999988899999999999999999998 998886543221 111111 10
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..+...+.+++.+||..+|.+||++.++++.|..+.+.
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 228 --ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 01112233456789999999999999999999999998877553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.99 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=196.3
Q ss_pred eeeeeecceEEEEEEEcCc----ceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIEDC----TLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|..... ..+++|....... ...+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 3699999999999975322 5789998876543 34567899999999999999999999886 4568999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc-c
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH-V 672 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~-~ 672 (851)
|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996543 68999999999999999999995 899999999999999999999999999987643222111 1
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....+. .+..+.. .. . ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~--~-------~~~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SG--E-------RLP 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cC--C-------cCC
Confidence 122234568999999998999999999999999999998 88888654321 1111111 11 0 112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2334556789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.13 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=207.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|... +++.+++|.+... .......+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 7788999977532 3344678999999999999999999999999999999999
Q ss_pred EecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 589 EYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||+++|+|.+++.. .....+++.++..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 223558899999999999999999994 8999999999999999999999999999875332
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.|+..... +..+....... +
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-~-------- 223 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK-C-------- 223 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc-C--------
Confidence 11 112334588899999999988999999999999999999999998854321 12111111110 0
Q ss_pred cCCCCCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 747 HLKGNYSP-ESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 747 ~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.....+. ..+..+.+++.+||+.+|.+|||+.++++.|..+
T Consensus 224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0111122 4456789999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=317.55 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=205.5
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.+|+..+.||.|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 567889999887665555678899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 999999988543 48899999999999999999995 8999999999999999999999999999875432211
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+.... ..... .. .+.+ .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~-~~-----~~~~--~ 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT-NG-----TPEL--Q 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-cC-----Cccc--C
Confidence 123346888999999999889999999999999999999999998665432211 00000 00 0011 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+...+..+.+++.+||+.||.+|||+.+++.|
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 223455678999999999999999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.77 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=205.7
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc-ceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+.|+++..||-|+||.||||..++. ...|.|.+...+....++|.-||++|..++||+||+|++.+..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3456677899999999999987654 456788888888888999999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
.||-+...+..-. ..|++.++.-+|.|++.||.|||+ ++|||||||+.|||+.-+|.++|+|||.+.... ....
T Consensus 112 ~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ 185 (1187)
T ss_pred CCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence 9999988764433 468999999999999999999996 899999999999999999999999999975421 1222
Q ss_pred cccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 672 VSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
....+.||+.|||||+.. ..+|+.++||||||+.|.||..+.+|-....+... ..... .--.|
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKia------KSePP 253 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA------KSEPP 253 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHh------hcCCC
Confidence 345678999999999875 46899999999999999999999887665433211 11110 00112
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.|. .|......+.+++.+||.+||..||++.++++|
T Consensus 254 TLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 221 133455679999999999999999999999999
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.13 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=201.9
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+|+..+.||+|+||.||++... .+..+++|.+... .......+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999875 6788899987654 3444578899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 592 ANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 592 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
++++|..++.... ...+++..+..++.+++.||.|||+ +.+++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 9999998885532 3468999999999999999999995 468999999999999999999999999998753221
Q ss_pred ccccccccCCcccCccccccc------CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQ------QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .... ..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~~~------~~~~ 223 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI------FAQL------SAIV 223 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH------HHHH------HHHh
Confidence 12334578899999998544 358899999999999999999999865422111 0000 1111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.. ....+...+..+.+++.+||+.+|.+||++++++.|
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 112334466778999999999999999999999999
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.69 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=207.4
Q ss_pred ccCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEc
Q 047215 502 RFTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCD 579 (851)
Q Consensus 502 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~ 579 (851)
..++.++..+.+.|+..+.||+|+||.||+|.. ..++.+++|...... ....++..|+.+++++ +||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 346667777888999999999999999999987 456788999876543 3346788999999999 7999999999984
Q ss_pred ------cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 580 ------EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 580 ------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
.....+++|||+++|+|.+++.......+++..+..++.|+++||.|||+ .+++||||||+||++++++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence 34678999999999999999876555568888899999999999999995 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA 728 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~ 728 (851)
+|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+......
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~- 237 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL- 237 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence 999999987532211 1123356889999999986 34688899999999999999999999875433221100
Q ss_pred HHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 729 DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 729 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+.. .....+..+.+++.+||+.||.+||++.|+++|
T Consensus 238 -----------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 -----------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -----------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000001111 112345679999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.92 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=207.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||.|++|.||+|... ++..+++|...... ......+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777788999999999999865 57789999876543 44556789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++... ++++.++..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999998643 68999999999999999999994 899999999999999999999999999987644321
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+....+... .... ... ..+.+..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~-~~~-----~~~~~~~ 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLI-PKN-----NPPSLEG 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHh-hhc-----CCCCCcc
Confidence 122344678899999999988899999999999999999999999865432111 1100 000 1111111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
. ..+..+.+++.+||..+|++|||++++++| +|+....
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~---------~~~~~~~ 258 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH---------KFIKKAK 258 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC---------hhhcCCC
Confidence 1 145568999999999999999999999999 8876533
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=314.31 Aligned_cols=238 Identities=23% Similarity=0.365 Sum_probs=187.4
Q ss_pred eeeeecceEEEEEEEcC-------------------------cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeE
Q 047215 520 MIGVGGFGKVFKGEIED-------------------------CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 574 (851)
+||+|+||.||+|.+.. ...+++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13478888876555555678899999999999999999
Q ss_pred EEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC---
Q 047215 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF--- 651 (851)
Q Consensus 575 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~--- 651 (851)
+++|..+...++||||+++|+|..++... ...+++..+.+++.|+++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999888543 3468899999999999999999994 8999999999999997543
Q ss_pred ----eEEEeeccccccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHH-hCCcCCCCCCCcchh
Q 047215 652 ----VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVV-CARAVINPTLPKDQI 725 (851)
Q Consensus 652 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLl-tG~~p~~~~~~~~~~ 725 (851)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....+.+.
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 4899999997643221 12346788999998875 56899999999999999995 68888765433221
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
..+ .... . ..+......+.+++.+||+.+|++|||+.+++++|
T Consensus 231 --~~~----~~~~-------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 --ERF----YEKK-------H----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHH----HHhc-------c----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 110 0000 0 11122234689999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=315.77 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=203.3
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+.|++.++||+|+||.||+|+... +..+++|..........+.+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 567788899999999999998754 6788999988777777788999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|..++.... ..+++.++..++.|++.+|.||| +.+++||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 9999988775433 45899999999999999999999 489999999999999999999999999998653221 11
Q ss_pred cccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 672 VSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
......++..|+|||++. ...++.++|||||||++|||++|+.|+....+.. ........ ..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~------~~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS------EPP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcC------CCc
Confidence 123455788999999984 3457889999999999999999999886543211 11111100 011
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. ..+...+..+.+++.+||+.+|++||+++++++|
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 1123445568999999999999999999999999
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=311.14 Aligned_cols=252 Identities=22% Similarity=0.414 Sum_probs=201.5
Q ss_pred CCceeeeeeeecceEEEEEEEcCcceeEEeecCCCC------hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS------EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
+|...+.||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++|+||++++++|...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 356678899999999999998888889999876432 22345688999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
+||+++++|.+++... .++++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999998543 357899999999999999999995 88999999999999999999999999998753211
Q ss_pred ----CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 668 ----EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 668 ----~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
..........|+..|+|||++.+..++.++|||||||+++||++|+.||......... ... .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~---~~~~-~ 225 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYI---GAHR-G 225 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHh---hhcc-C
Confidence 1111223456889999999999989999999999999999999999998643221110 000 0000 0
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+ ..+...+..+.+++.+||+.+|.+||++.|++.|
T Consensus 226 ~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111 1233455668999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=327.63 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=207.1
Q ss_pred eeeeeecceEEEEEEEcCc-ceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 519 LMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
-+||+|.||+||-|+..+. ..+|||.+........+-+..||.+.++|+|.|||+++|.|.+++.+-|.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999996554 457999988877777788999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCC--chhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEEeeccccccCCCCCcccccc
Q 047215 598 SHLFGSDLPPL--TWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVST 674 (851)
Q Consensus 598 ~~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (851)
++|+.+- +++ .+..+-...+||++||.||| +..|||||||-.|||++ -.|.+||+|||-++.... .+....
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 9997654 345 67788889999999999999 59999999999999996 789999999999887543 333456
Q ss_pred ccccCCcccCccccccc--CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 675 AVKGSFGYLDPEYFWRQ--QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 675 ~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
+..||+.|||||++..+ .|..++|||||||.+.||.||++||........ ++ .++---+..+++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AM--------FkVGmyKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AM--------FKVGMYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hh--------hhhcceecCCCC
Confidence 78899999999999754 699999999999999999999999976433211 11 111111234567
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
|.+.....+.++.+|+.+||.+||++.++|+.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 88889999999999999999999999999887
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=310.00 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=204.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|+..++||+|+||.||++...++..+++|..... ......+.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999877788899987654 3345678999999999999999999999887 7889999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 99999999976555678899999999999999999994 8999999999999999999999999999875432111 1
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||++....++.++|+|||||+++|+++ |+.|+....... +..+. ..+ ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~---------~~~ 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERG---------YRM 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCC---------CCC
Confidence 1122345678999999998899999999999999999999 887876432211 11111 010 011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223445678999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.50 Aligned_cols=262 Identities=25% Similarity=0.430 Sum_probs=202.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-----CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-----DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 584 (851)
..|+..+.||+|+||.||+++++ .+..+++|.+.... ......+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677889999999999999753 46778999987553 44456799999999999999999999998765 568
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999985432 358999999999999999999994 89999999999999999999999999998864
Q ss_pred CCCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCc---------chhcHHHHHHHH
Q 047215 665 PSMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPK---------DQINLADWAMKW 734 (851)
Q Consensus 665 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~---------~~~~l~~~~~~~ 734 (851)
..... ........++..|+|||++.+..++.++|||||||++|||++++.|....... .+.....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 32211 11223345677899999998889999999999999999999987654321110 001111111110
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.. ......+..++..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus 240 -~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 -EE---------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -Hc---------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 011112334567799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.97 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=193.2
Q ss_pred eeeeeecceEEEEEEEcC----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc-cCCcEEEEEEecC
Q 047215 519 LMIGVGGFGKVFKGEIED----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD-EQNEMILVYEYMA 592 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~lV~Ey~~ 592 (851)
+.||+|+||.||+|...+ ...+|+|+.... .......+.+|+.+++.++||||++++++|. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998632 356899987543 3445678899999999999999999999875 4566899999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc--
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT-- 670 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~-- 670 (851)
+|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986543 346778889999999999999994 89999999999999999999999999998753321111
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......++..|+|||.+....++.++|||||||++|||++|+.|+..... ...+... ... + ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~---~~~-~---------~~~ 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVY---LLQ-G---------RRL 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH---Hhc-C---------CCC
Confidence 111234467789999999888999999999999999999996554332211 1111111 110 0 001
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
..+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 112234567899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=311.48 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=197.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-----ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-----SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~ 584 (851)
.+|+..++||+|+||.||+|... .+..+++|++... .......+.+|+.++++++||||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888899999999999999864 5778899977533 22345678899999999999999999998864 4678
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++++||+++++|.+++... ..+++.....++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999998543 358899999999999999999994 89999999999999999999999999998754
Q ss_pred CCCC-ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 665 PSME-HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 665 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... .........++..|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~--------- 221 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKI--------- 221 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHH---------
Confidence 3211 11112234588999999999998999999999999999999999999875422111 1110
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
........++....+.+.+++ +||..+|++||+++|+++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 000011223344455677777 6888899999999999999
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.30 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=202.3
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-CCcEEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-QNEMILVYE 589 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~lV~E 589 (851)
+|+..+.||+|++|.||++... +++.+++|++... .....+.+.+|++++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999865 4577899987643 33445678999999999999999999998764 446799999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++.......+++.++..++.+++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 9999999999976555668999999999999999999994 899999999999999999999999999987643221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......+++.|+|||.+.+..++.++||||||++++||++|+.|+...... ....... .+..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~-~~~~--------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII-EGKL--------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hcCC---------
Confidence 1233456889999999999999999999999999999999999887643211 1111111 1110
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+...+..+.+++.+|++.+|.+|||+.++++|
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11233455679999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=313.25 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=196.3
Q ss_pred eeeeecceEEEEEEEcC-------cceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 520 MIGVGGFGKVFKGEIED-------CTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.||+|+||.||+|+..+ +..+++|.+.... ......+.+|+.++++++||||++++++|......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2467888776543 344668899999999999999999999999999999999999
Q ss_pred CCcchhhhccCC-----CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-----eEEEeecccc
Q 047215 592 ANGTLRSHLFGS-----DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-----VAKMSDFGLS 661 (851)
Q Consensus 592 ~~gsL~~~L~~~-----~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-----~~kl~DFGla 661 (851)
++++|.+++... ....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998643 22347899999999999999999994 8899999999999998877 8999999998
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
+...............++..|+|||++.+..++.++|||||||++|||++ |+.|+...... .... .. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~---~~-~~--- 228 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ---HV-TA--- 228 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH---HH-hc---
Confidence 76433222222223345778999999999999999999999999999998 88887543221 1111 10 00
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
......+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0111223345677899999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=309.13 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=203.1
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+|+..++||+|+||.||++... ++..+++|.+... .....+.+.+|+.++++++||||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999864 5678899987543 3445677889999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence 99999998865555568899999999999999999994 899999999999999999999999999987543221 1
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....... ...... .+.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~---------~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVC-QGSY---------KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHh-cCCC---------CC
Confidence 2234568899999999998899999999999999999999999987542211 111110 1110 11
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+...+..+.+++.+||+.||.+|||+.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223345668999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.99 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=204.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|+||+||++... +++.+++|..... .....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777789999999999999865 5778888876654 234457889999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++... +++++..+..++.+++.+|.|||+ ..+++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999988543 468999999999999999999995 468999999999999999999999999998653221
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch-----hcHHHHHHHHhhhcccccccC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ-----INLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~i~d 745 (851)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.+. ....++........ .
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 230 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P 230 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence 11235689999999999888999999999999999999999999876443211 11112211111100 1
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
+.+. ....+..+.+++.+||+.||.+|||+.|+++|+
T Consensus 231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 122556789999999999999999999999993
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.30 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=191.3
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHH-HHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIE-MLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||+||+|+.. +++.+|+|++... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999864 6788999987643 2233345556655 46778999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|..++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 9999888543 468899999999999999999995 89999999999999999999999999998753221 1123
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... ..+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~---------~~~--~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILH---------KPL--VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHc---------CCc--cCC
Confidence 44579999999999999999999999999999999999999987543211 1111110 000 112
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTMG----EVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~~----evl~~ 784 (851)
+..+..+.+++.+||+.+|.+||++. ++++|
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 23455688999999999999999874 66666
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.69 Aligned_cols=254 Identities=27% Similarity=0.342 Sum_probs=212.8
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc-ceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|.-|+||++++.+. ...|+|++.+.. .+.....+.|-++|+.++||-++.|++.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 4566677899999999999998764 788999988753 344566788999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC--
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS-- 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~-- 666 (851)
|||+||+|..+++.+....+++..+...+..++-||+||| -.|||.|||||+||||-++|.+.|+||.|+..+..
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999999988889999999999999999999999 59999999999999999999999999998753210
Q ss_pred -------------------------------CCc---------------------cccccccccCCcccCcccccccCCC
Q 047215 667 -------------------------------MEH---------------------THVSTAVKGSFGYLDPEYFWRQQLT 694 (851)
Q Consensus 667 -------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~t 694 (851)
... ...+....||-.|+|||++++..-+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 0112235699999999999999999
Q ss_pred chHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCC
Q 047215 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKN 774 (851)
Q Consensus 695 ~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 774 (851)
.++|+|+|||+||||+.|..||.+....+ .+..|+-..+.-...+..+..+++||++.|.+||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999998765432 223344333332233467788999999999999999
Q ss_pred CCC----HHHHHHH
Q 047215 775 RPT----MGEVLWH 784 (851)
Q Consensus 775 RPt----~~evl~~ 784 (851)
|.. +.||-+|
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 998 8999888
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=321.13 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=195.3
Q ss_pred eeeeeee--cceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 518 SLMIGVG--GFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 518 ~~~LG~G--~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
.++||+| +|++||+++. .++..+|+|++... .......+.+|+.+++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 7899999986 46788999998754 23344567889999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc---
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH--- 669 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~--- 669 (851)
+|+|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999865544568999999999999999999995 8999999999999999999999999986543211110
Q ss_pred --cccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc-
Q 047215 670 --THVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII- 744 (851)
Q Consensus 670 --~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~- 744 (851)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... .+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-----~~~~~~~~~ 232 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-----NGTVPCLLD 232 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-----cCCcccccc
Confidence 001122346778999999975 4689999999999999999999999864322110 00000 00000000
Q ss_pred ------------------Cc-----------------cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 745 ------------------DP-----------------HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 745 ------------------d~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+. .............+.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 00001122345678999999999999999999999999
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.31 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=200.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-Ccc----eeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCT----LAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|+..+.||+|+||.||+|... ++. .+++|...... .....++.+|+.++++++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56777889999999999999863 333 46888776543 33345788999999999999999999999764 4679
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999986542 357899999999999999999995 8999999999999999999999999999986433
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........++..|+|||++.+..++.++|||||||++|||++ |+.|+...... ...++. ..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~------- 227 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLL----EKG------- 227 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HCC-------
Confidence 222111223345778999999999999999999999999999997 88887543211 111111 111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....++.++..+.+++.+||..+|++||+++++++.|..+...
T Consensus 228 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 --ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111233456789999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.35 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=203.8
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc----ceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC----TLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|...++||+|+||.||+|...+. ..+++|...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 5677888999999999999986432 467888877654 4556789999999999999999999999875 567899
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++.... ..+++.++..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999986533 358999999999999999999995 89999999999999999999999999998764332
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.. .......++..|+|||.+....++.++||||||++++||++ |+.||......+ ... .... + .
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~~~~-~--~----- 225 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIG---RIEN-G--E----- 225 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHc-C--C-----
Confidence 11 11122334568999999988899999999999999999986 998886543221 111 1110 0 0
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
....+..++..+.+++.+|+..+|.+|||+.++++.|+.+..
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011234556779999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=327.48 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=197.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------C
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------N 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 582 (851)
.++|+..+.||+|+||.||++... .+..+|+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 468999999999999999999854 5678899988754 334456788999999999999999999988543 3
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++ +|.+.+.. .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 57999999976 56665532 47888999999999999999994 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH---------HH---
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA---------DW--- 730 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~---------~~--- 730 (851)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++
T Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6322 11223456899999999999999999999999999999999999998754322111000 00
Q ss_pred ----HHHHhhh-cccccccCccC--------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 731 ----AMKWQKQ-RSLKSIIDPHL--------KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 731 ----~~~~~~~-~~~~~i~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+... .....+..+.. ...........+++++.+||+.||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000000000 001112234678999999999999999999999999
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.24 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=200.9
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
.+|+..+.||+|+||.||+|...++..+++|.+..... ....|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46777889999999999999887777889998765432 34578999999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+++|.+++.... ..+++..+..++.+++.+|+|||+ .+++||||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 999999986543 357899999999999999999995 8999999999999999999999999999875432211 11
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.|+...... +........ .....+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~---~~~~~~----- 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINAG---FRLYKP----- 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHhCC---CCCCCC-----
Confidence 122335678999999998899999999999999999998 88887643221 111111100 011111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
...+..+.+|+.+||+.+|++|||+.+++++|
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 12346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.72 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=205.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|++.+.||.|+||.||+|... ++..+++|..........+.|.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888889999999999999875 5788999998877767778899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 99999999885533 468999999999999999999995 899999999999999999999999999986533211
Q ss_pred ccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 671 HVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.......++..|++||.+. ...++.++||||||+++|||++|+.|+....... ....... . ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~-----~~ 225 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILK-S-----EP 225 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhc-C-----CC
Confidence 1223456889999999975 3457889999999999999999999986543221 1111110 0 00
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.+ ..+...+..+.+++.+||+.+|.+||+++++++|
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111 1123345678999999999999999999999999
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=321.40 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=197.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999865 5788999987642 2234456889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999998543 2458889999999999999999995 899999999999999999999999999986533211
Q ss_pred ccccccccccCCcccCcccccc-----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR-----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +.............
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~- 228 (331)
T cd05597 157 -TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ- 228 (331)
T ss_pred -CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc-
Confidence 111223468999999999863 45788999999999999999999998654221 11111111110000
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGK--NRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPt~~evl~~ 784 (851)
+. ......+..+++++.+||..++. .||+++++++|
T Consensus 229 ----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 10 11123456688889887765443 48899999999
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=328.32 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=207.0
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-C-----cceeeEEEEEccCCcEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-H-----RHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~g~~~~~~~~~l 586 (851)
+|++.+.||+|+||.|-|+.. +.++.||||++++...- ..+-..|+.+|..|+ | -|+|++++++...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999975 45789999999876443 345578999999997 4 399999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC--CCeEEEeeccccccC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE--NFVAKMSDFGLSKTG 664 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~ 664 (851)
|+|.+.. +|.++|+.+....++...+..|+.||+.||.+|| +.+|||+||||+||||.+ ...+||+|||.++..
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999865 9999999888888999999999999999999999 599999999999999953 347999999999873
Q ss_pred CCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh--------
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK-------- 736 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~-------- 736 (851)
... .. ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.++...+.-+.....
T Consensus 342 ~q~----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 321 12 34567789999999999999999999999999999999888888777776543322211100
Q ss_pred -------h-ccc------ccc----------------cCc-cCC-------CCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 047215 737 -------Q-RSL------KSI----------------IDP-HLK-------GNYSPESLEKFGEIAEKCLDDEGKNRPTM 778 (851)
Q Consensus 737 -------~-~~~------~~i----------------~d~-~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 778 (851)
. ... ... .+. ... ..........+.+++++||+.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0 000 000 000 000 00111334678999999999999999999
Q ss_pred HHHHHH
Q 047215 779 GEVLWH 784 (851)
Q Consensus 779 ~evl~~ 784 (851)
.|+|+|
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999999
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=318.87 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=186.0
Q ss_pred eeeeeecceEEEEEEEc---CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEc--cCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE---DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD--EQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|+.. .+..+|+|.+..... ...+.+|++++++++||||+++++++. .+...+++|||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 47999999999999864 346789998765422 245678999999999999999999884 35568999999865
Q ss_pred cchhhhccCC-------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE----cCCCeEEEeeccccc
Q 047215 594 GTLRSHLFGS-------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSK 662 (851)
Q Consensus 594 gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla~ 662 (851)
+|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 777766321 12358889999999999999999995 899999999999999 466789999999997
Q ss_pred cCCCCCc-cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh------cHHHHHHH-
Q 047215 663 TGPSMEH-THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI------NLADWAMK- 733 (851)
Q Consensus 663 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~------~l~~~~~~- 733 (851)
....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ...+....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 6432211 112234568999999999876 46899999999999999999999998653321110 00000000
Q ss_pred --------Hhhhcccc---ccc---Cc------cCC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 --------WQKQRSLK---SII---DP------HLK---GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 --------~~~~~~~~---~i~---d~------~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+....... ... .. .+. ..........+.+++.+||+.||.+|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000 00 000 00001122457899999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.18 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=190.6
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHH-HHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIE-MLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|+.. ++..+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 56789999876432 222344555554 67889999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|..++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 9999888543 457888899999999999999995 89999999999999999999999999998753221 1123
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i---------~~~~--~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNI---------LHKP--LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHH---------hcCC--CCCC
Confidence 3457899999999999999999999999999999999999998754211 111111 1111 1223
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTM----GEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~~ 784 (851)
......+.+++.+||+.||.+||+. .++++|
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 4455678999999999999999975 466666
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.51 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=206.1
Q ss_pred eeeeeeecceEEEEEEEc--Ccc--eeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 518 SLMIGVGGFGKVFKGEIE--DCT--LAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~--~~~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
.++||+|.||.|++|.|. +|+ .||||.+...... ...+|.+|+.+|.+|+|||+++|+|+... ..+.||+|+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 457999999999999875 343 5799998876544 67899999999999999999999999987 78899999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc-
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH- 671 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~- 671 (851)
.|+|.+.|++.....+....+...|.|||.||.||.+ +++|||||..+|+||-....+||+||||.|.....+...
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999988666778888999999999999999996 899999999999999989999999999999765433332
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCC-cCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR-AVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......-...|+|||.++...++.++|||+|||.||||+++. .||.+-.... +.+.+|..-+-
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~erL 334 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGERL 334 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhccccccC
Confidence 223344567899999999999999999999999999999964 4655433221 11223333334
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
..+..|++++.++++.||..+|.+|||+..+.+.+
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 56788999999999999999999999999997553
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.52 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=203.8
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.|+..+.||+|+||.||+|... .+..+++|..... .......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4566678999999999999865 5678899987644 3455678999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.. .++++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence 99999999854 357889999999999999999995 899999999999999999999999999987643321 1
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......++..|+|||++.+..++.++|+|||||++|||++|..|+....+.... . .........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~----------~~~~~~~~~ 220 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F----------LIPKNNPPT 220 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h----------hhhcCCCCC
Confidence 223345788999999999889999999999999999999999988754332111 0 001111123
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+..+.+++.+||+.+|.+||++++++.|
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 345667789999999999999999999999999
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=326.64 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=195.5
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------ 581 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------ 581 (851)
..++|...+.||+|+||.||+|.. ..+..+|||++... .......+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457888899999999999999986 45678999988653 223445678899999999999999999987533
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
...++++|++ +++|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence 4579999988 6789887743 358999999999999999999995 89999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh-----
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ----- 735 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~----- 735 (851)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..+.....
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~ 238 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGTPSPE 238 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCCHH
Confidence 763321 233468999999999876 57899999999999999999999998654322111 11000000
Q ss_pred -----hhc-------ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 736 -----KQR-------SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 736 -----~~~-------~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
... .+.......+. .......+.+.+|+.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000000 0001223457899999999999999999999999
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.88 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=204.9
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCCh---hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSE---QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||++...+ +..+++|.+..... .....+..|++++++++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999998754 78899998876432 24567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+.+++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999876555678999999999999999999995 899999999999999999999999999986532211
Q ss_pred cc---------------------------ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCC
Q 047215 669 HT---------------------------HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP 721 (851)
Q Consensus 669 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~ 721 (851)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 011123578899999999998999999999999999999999999865432
Q ss_pred cchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 047215 722 KDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT----MGEVLWH 784 (851)
Q Consensus 722 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~~ 784 (851)
... + ..+.............+..+.+++.+||+.+|++||| ++|++.|
T Consensus 238 ~~~--~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DET--F-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHH--H-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211 0 0111111111111225677999999999999999999 8999888
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=314.53 Aligned_cols=271 Identities=25% Similarity=0.398 Sum_probs=205.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-----CcceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-----DCTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~ 584 (851)
..|+..+.||+|+||.||+|++. .+..+|+|.+...... ....|.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34666788999999999999864 3568899988765443 56789999999999999999999999977 5678
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
+++|||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999996543 358999999999999999999995 89999999999999999999999999999865
Q ss_pred CCCCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 665 PSMEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 665 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
...... .......++..|++||.+....++.++||||||++++||++|+.|+............. .........+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHH
Confidence 422111 11122345567999999988899999999999999999999998875432211000000 0000000000111
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
+........+..++..+.+++.+||+.+|.+|||+.|+++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111222344557799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.31 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=201.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|...++||+|+||.||+|+.. ++..+++|.+..........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46677788999999999999864 57788999887665555667889999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 999999988543 468899999999999999999995 89999999999999999999999999998653221 11
Q ss_pred cccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 672 VSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+....+.... ... ... ....+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~-~~~---~~~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLM-TKS---NFQPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhh-hcc---CCCCCcc
Confidence 223456899999999974 456889999999999999999999988654332211 000 000 0111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. ....+..+.+++.+||+.+|++||+++++++|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11 11234568999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=313.31 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=200.4
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
|+..+.||+|+||.||+|... ++..+|+|..... .....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455667999999999999864 4678899987644 33455679999999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++....... ..
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence 9999998854 358899999999999999999994 899999999999999999999999999987543211 12
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
.....|+..|+|||++.+..++.++|||||||+++||++|+.|+....+.... .. .........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~----------~~~~~~~~~ 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL----------IPKNSPPTL 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh----------hhcCCCCCC
Confidence 23345788999999999989999999999999999999999988654332110 00 000111122
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+..+.+++.+||+.+|.+||++.++++|
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 33455678999999999999999999999999
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.87 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=201.9
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-----hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-----EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
|+..+.||+|+||.||+|... ++..+++|.+.... .+..+.+.+|+.++++++||||+++++++..+...++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566678999999999999876 67889999875432 335577999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++... .++++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 82 ELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999998543 358899999999999999999995 899999999999999999999999999987643322
Q ss_pred ccccccccccCCcccCcccccccC-CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQ-LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
......|+..|++||.+.... ++.++|+||||+++|+|++|+.|+....+.. ..........
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~-------- 219 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKE-------- 219 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhccc--------
Confidence 223456889999999987766 8999999999999999999999986543211 1111111000
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....++.....+.+++.+||+.+|.+||++.+++.|
T Consensus 220 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 112334455778999999999999999999999988
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.84 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=201.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||.||+|+.. +++.+++|++.... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888889999999999999875 57889999876432 2234568899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|..++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999988876433 358999999999999999999995 8999999999999999999999999999876433221
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHH-H----HH---Hh-hhcc
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW-A----MK---WQ-KQRS 739 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~-~----~~---~~-~~~~ 739 (851)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+......- . .. .. ....
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1223457889999999876 5688999999999999999999999875443322111000 0 00 00 0000
Q ss_pred cccccCccCCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 LKSIIDPHLKGNY-----SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ~~~i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+...... .+..+..+.+++.+||+.+|++||++.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0001111111000 01235678899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.38 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=204.3
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|+||.||+++.. +++.+++|++... ......++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 5678899987643 334456889999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++.++++++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 999999999866554568899999999999999999995 899999999999999999999999999987543211
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......|++.|+|||++.+..++.++|+|||||++++|++|+.|+...... +....... +. ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~~---------~~ 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIR-GS---------YP 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhc-CC---------CC
Confidence 1122345788999999999889999999999999999999999988643221 11111111 00 01
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+...+..+.+++.+||+.+|.+||++.++++|
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1233455679999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.67 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=202.4
Q ss_pred cCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
.+|+....||+|+||.||+|+.+. .+.+++|........ ....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568888899999999999998642 356888887665433 4578999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCC-------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 586 LVYEYMANGTLRSHLFGSD-------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
+||||+++|+|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+|||++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986543 1268999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
|+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..||....... . .... ..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~---~~~~-~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V---LNRL-QA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H---HHHH-Hc
Confidence 99875322111 11223346778999999988889999999999999999999 666765332111 1 1111 11
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+ .+....+..++..+.+++.+||+.+|.+||++.|++.+|.
T Consensus 234 ~--------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 G--------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1 1111123345567999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.49 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=199.7
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh----------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE----------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
+|...+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566778999999999999754 577899997653211 12346888999999999999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999998654 468899999999999999999995 899999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCcccCcccccccC--CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ--LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
...............|+..|+|||.+.... ++.++|+||||+++||+++|+.|+....... ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGN-KRS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhc-ccc
Confidence 643322222223456889999999987654 8999999999999999999999885432111 0111100 001
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. +..........+..+.+++.+||+.+|.+|||++++++|
T Consensus 230 ~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 A----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred C----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 111112223456779999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=333.99 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=213.8
Q ss_pred eeeeeeecceEEEEEEE-cCc----ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 518 SLMIGVGGFGKVFKGEI-EDC----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~-~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++||+|+||+||||.+ .++ .+||||++... ..+...++.+|+-+|.+|+||||++|+|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 56899999999999975 333 46889987654 5556688999999999999999999999998766 89999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
+.|+|.++++.++ ..+..+..+.++.|||+||.||| ++.+|||||..+||||..-..+||.|||+++.........
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999997754 56888999999999999999999 5999999999999999999999999999999877655554
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......-.+.|||-|.++...++.++|||||||.+|||+| |..|+......+..+ ++....+-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d----------------lle~geRL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD----------------LLEKGERL 919 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH----------------HHhccccC
Confidence 4455556778999999999999999999999999999999 566666543332211 12222223
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhc
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWM 796 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~ 796 (851)
..++-|..++..++.+||..|+..||+++++...+....+....++
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl 965 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL 965 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence 4567888899999999999999999999999999887765554443
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.80 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=199.7
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh---------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE---------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
|.....||+|++|.||+|... ++..+++|.+..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 555678999999999999864 567889997764322 2235688999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999543 468889999999999999999995 89999999999999999999999999998764
Q ss_pred CCCCc----cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 665 PSMEH----THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 665 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
..... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~------ 224 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKI------ 224 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHH------
Confidence 32111 1111234588899999999988999999999999999999999999875322110 0000
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..... ...+...+..+.+++.+||+.+|.+||++.|+++|
T Consensus 225 ~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00111 12334456778999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.35 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=204.8
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..++||+|+||.||.++. +++..+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999998875 45678899986543 345567789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999976545678999999999999999999995 8999999999999999999999999999876433221
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......+++.|+|||++.+..++.++||||||+++|||++|+.|+......+ ...... .+ ...
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~--------~~~- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV-QG--------NYT- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cC--------CCC-
Confidence 2234568999999999988889999999999999999999999886543221 111111 11 111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+...+..+.+++.+||+.+|.+||++++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1123445678999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=323.45 Aligned_cols=255 Identities=20% Similarity=0.260 Sum_probs=198.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. .+..+|+|.+... .......+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999875 4677899987642 2233456888999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999996532 358888999999999999999995 999999999999999999999999999987543221
Q ss_pred ccccccccccCCcccCcccccc-----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR-----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
........||+.|+|||++.+ ..++.++|||||||+||||++|+.||......+ ......... ..+
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~--~~~ 227 (331)
T cd05624 157 -TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHE--ERF 227 (331)
T ss_pred -ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCC--Ccc
Confidence 112233569999999999875 568899999999999999999999987543211 111111100 000
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKN--RPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 784 (851)
.+. ......++.+.+++.+||..++.+ |++++++++|
T Consensus 228 ---~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ---QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 011 111234567889999999866544 5689999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.88 Aligned_cols=238 Identities=25% Similarity=0.396 Sum_probs=188.9
Q ss_pred eeeeecceEEEEEEEcC--------cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 520 MIGVGGFGKVFKGEIED--------CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.||+|+||.||+|.... ...+++|..........+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 59999999999997642 2347788876655555678899999999999999999999999989999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe--------EEEeecccccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV--------AKMSDFGLSKT 663 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~--------~kl~DFGla~~ 663 (851)
++|+|.+++.... ..+++..+++++.|++.||.|||+ ++|+||||||+|||++.++. ++++|||++..
T Consensus 82 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 82 KFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999986543 368899999999999999999994 99999999999999987665 69999998865
Q ss_pred CCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCc-CCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARA-VINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
... .....++..|+|||++.+ ..++.++|||||||++|||++|.. |+....+... .. ....
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~------~~-~~~~---- 220 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK------LQ-FYED---- 220 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH------HH-HHHc----
Confidence 322 123457889999999986 458999999999999999999964 4332221110 00 0000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
....+......+.+++.+||+.+|.+|||++++++.|
T Consensus 221 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 -------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0112233345689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=325.36 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=196.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------C
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------N 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 582 (851)
.++|...+.||+|+||.||++... .+..+|||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999864 5678899988653 334456788999999999999999999987543 3
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++ +|.+.+. ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 57999999976 6666663 247788999999999999999995 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH---------HHHHH
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA---------DWAMK 733 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~---------~~~~~ 733 (851)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++...
T Consensus 175 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 6322 11223456899999999999999999999999999999999999999754332211000 00000
Q ss_pred -------Hhhh-ccc-----ccccCccC---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 -------WQKQ-RSL-----KSIIDPHL---KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 -------~~~~-~~~-----~~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.... ... ..+....+ ...........+++++.+||+.||.+|||+.|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000 00000000 001111234568999999999999999999999999
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.84 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=200.3
Q ss_pred CCceeeeeeeecceEEEEEEEcC--cceeEEeecCCC----------ChhhHHHHHHHHHHHHh-cCCcceeeEEEEEcc
Q 047215 514 NFDESLMIGVGGFGKVFKGEIED--CTLAAIKRANPQ----------SEQGLAEFETEIEMLSK-LRHRHLVSLIGFCDE 580 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~ 580 (851)
+|+..+.||+|+||.||+|..+. ++.+++|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677889999999999999765 577888876532 22344567889998875 799999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 581 QNEMILVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
++..+++|||+++++|.+++.. .....+++.++++++.|++.||.|||+ ..+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 233568899999999999999999995 468999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
|++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+...... .......
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~--- 226 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIV--- 226 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHh---
Confidence 9987643322 233456889999999999888999999999999999999999988643221 1111111
Q ss_pred ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+...........+..+.+++.+||+.||++||++.|+..+++
T Consensus 227 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 ------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111110011133466899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=323.21 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=197.3
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..++||+|+||.||+++.+. +..+|+|.+... .......+..|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999998764 567889987542 2233456888999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 155 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccC-
Confidence 9999999999996532 358889999999999999999995 99999999999999999999999999998653221
Q ss_pred ccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ......... ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~--~~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHK--ERF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCC--ccc
Confidence 111223456999999999986 3468899999999999999999999987543211 111111110 000
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKN--RPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 784 (851)
. . ......++..+.+++.+|+..++.+ |++++|+++|
T Consensus 228 ~---~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q---F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c---C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 0111234567889999988654443 7899999999
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.47 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=189.3
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHH-HHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEI-EMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
+.||+|+||.||+++.. ++..+|+|++.... ......+..|. .+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 45678999876431 12223444444 456788999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+.+.+...++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~ 153 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTT 153 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCc
Confidence 9999998553 357788888999999999999995 8999999999999999999999999999875322 11223
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ..... ... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~---~~~i~---------~~~--~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---M---YDNIL---------NKP--LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---H---HHHHH---------hCC--cCCC
Confidence 45679999999999999999999999999999999999999987543211 1 11110 000 1122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTMG----EVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~~----evl~~ 784 (851)
+..+..+.+++.+||+.+|.+||++. ++++|
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~ 251 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH 251 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence 34556789999999999999999876 45554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.77 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=189.0
Q ss_pred eeeeecceEEEEEEEcCc---ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcc
Q 047215 520 MIGVGGFGKVFKGEIEDC---TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
.||+|+||.||+|...++ ..+++|.+... .....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975443 34567766543 23456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 596 LRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 596 L~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|.+++.... .....+..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999986532 2346677788999999999999995 89999999999999999999999999998642221111122
Q ss_pred cccccCCcccCcccccc-------cCCCchHHHHHHHHHHHHHHhC-CcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 674 TAVKGSFGYLDPEYFWR-------QQLTEKSDVYSFGVVLFEVVCA-RAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~GvvL~eLltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
....++..|+|||++.. ..++.++|||||||++|||+++ ..|+....+. +...... .+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVI-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-hhcccccCC
Confidence 34567889999998753 2467899999999999999975 4455433221 1111111 111222333
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+.+. ....+.+.+++..|| .+|.+||+++++++.|.
T Consensus 232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 4333 234456888999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.13 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=203.8
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEc-
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCD- 579 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~- 579 (851)
+.++.+..+.++|+..+.||+|+||.||++... .++.+++|...... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566667899999999999999999999864 56788999876432 2235688899999999 6999999999873
Q ss_pred ----cCCcEEEEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 580 ----EQNEMILVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 580 ----~~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
.++..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 44678999999999999988753 223468889999999999999999995 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccc-----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA 728 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~ 728 (851)
||+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....+.... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence 999999987543221 11233468999999999853 45789999999999999999999998754322110 0
Q ss_pred HHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 729 DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 729 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
.. .....+.+ ..+......+.+++.+||+.+|++|||+.|+++|+
T Consensus 240 ----~~------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 ----KI------PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ----hc------cccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00000111 01122345689999999999999999999999983
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.90 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=207.5
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|++|.||+++..+ ++.+++|++..... .....+.+|+.++++++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468888999999999999998764 78899998876543 4567899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 9999999999654 568999999999999999999993 28999999999999999999999999999876432221
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||.+....++.++|+||||+++|||++|+.|+..........+..+.. ....+
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------~~~~~---- 221 (264)
T cd06623 156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---------DGPPP---- 221 (264)
T ss_pred -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---------cCCCC----
Confidence 1124457889999999999999999999999999999999999987654212111111111 00111
Q ss_pred CCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.. .+..+.+++.+||+.+|++||++.++++|
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12223 55679999999999999999999999999
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.65 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=206.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|+..+.||+|+||.||+|... ++..+++|..........+.+.+|++++++++||||+++++++..++..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367888999999999999999864 4677899988766555678899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++...... .
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--I 155 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhh--h
Confidence 99999999885542 468899999999999999999994 89999999999999999999999999998753321 1
Q ss_pred ccccccccCCcccCccccccc---CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQ---QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+....+..... .. .... ...+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~~-~~~~---~~~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LI-SKSN---FPPPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-Hhcc---CCCcc
Confidence 122345678899999999776 89999999999999999999999987544322110 00 0000 00111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+ ......+..+.+++.+||+.+|.+|||+++++.|
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 1223445679999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=324.30 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=200.1
Q ss_pred CceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh---hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 515 FDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE---QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
|...+.||.|+||.||.|+. .+...||||+++-... ..+.++..|++.|++++|||+|.+.|++..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55566799999999999985 4567899999886543 4467899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
|-| +-.|+|.-. .+++.+.++..|+.+++.||.|||| ++.||||||+.||||++.|.|||+|||.|....+
T Consensus 108 ClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred Hhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 954 666665322 2568899999999999999999996 9999999999999999999999999999876433
Q ss_pred ccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 671 HVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
...+.|||.|||||++. .+.|+-|+||||||++..||.-.++|+........ .-.. ..--.|.
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------LYHI------AQNesPt 244 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHI------AQNESPT 244 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------HHHH------HhcCCCC
Confidence 23568999999999986 56899999999999999999999988754322111 0000 0111233
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+. +.+-+..++.++..||++-|.+|||.++++.|
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 33 45677889999999999999999999999988
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.23 Aligned_cols=236 Identities=25% Similarity=0.403 Sum_probs=187.2
Q ss_pred eeeeecceEEEEEEEcCcc-----------eeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 520 MIGVGGFGKVFKGEIEDCT-----------LAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.||+|+||.||+|...+.. .+++|........ ...|.+|+.++++++||||++++++|.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6899999999999876433 4667766554333 6788999999999999999999999988 7889999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-------eEEEeecccc
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-------VAKMSDFGLS 661 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-------~~kl~DFGla 661 (851)
||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++++||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999865432 68899999999999999999994 8999999999999999887 7999999998
Q ss_pred ccCCCCCccccccccccCCcccCccccccc--CCCchHHHHHHHHHHHHHHhC-CcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ--QLTEKSDVYSFGVVLFEVVCA-RAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~eLltG-~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
+.... .....++..|+|||++... .++.++||||||+++|||++| ..|+......+ +...+. ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~-~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQ-DQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHh-cC
Confidence 76332 1223466789999999876 789999999999999999995 55554432211 111111 00
Q ss_pred ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
. ..+......+.+++.+||..+|.+|||+.++++.|
T Consensus 223 --~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 --H---------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --C---------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 01111126789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.92 Aligned_cols=262 Identities=28% Similarity=0.363 Sum_probs=205.1
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
+++.++..++++|+..+.||+|+||.||++.. ++++.+++|....... ....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566667789999999999999999999987 4577889998765432 245678899999999 89999999999864
Q ss_pred C-----CcEEEEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 581 Q-----NEMILVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 581 ~-----~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
. ...++|+||+++|+|.++++. .....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 358999999999999998853 223568899999999999999999994 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCccccccc-----CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-----QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA 728 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~ 728 (851)
||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.|+....+... +.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 9999999876432211 12234688899999998643 368999999999999999999999875432211 11
Q ss_pred HHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 729 DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 729 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.... ... +.+ ..+......+.+++.+||+.+|++||++.|+++|
T Consensus 244 ----~~~~-~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 ----KIPR-NPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HHhc-CCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1100 000 111 1123344569999999999999999999999999
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=310.14 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=204.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|+||.||++... +++.+++|++.... ......+.+|++++++++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35677788999999999999875 57788999877653 34556789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.... ..+++..+.+++.|++.||.|||+ ..+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 99999999986543 568899999999999999999994 389999999999999999999999999998653211
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||++.+..++.++||||||+++++|++|+.|+....... ....+........ ..+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~------~~~~--- 223 (265)
T cd06605 155 -LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE------PPPR--- 223 (265)
T ss_pred -HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC------CCCC---
Confidence 1112568889999999999999999999999999999999999986543211 1111111111110 0111
Q ss_pred CCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.. .+..+.+++.+||..+|++|||+.+++.|
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 -LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1122 55668999999999999999999999999
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.87 Aligned_cols=260 Identities=20% Similarity=0.255 Sum_probs=186.1
Q ss_pred eeeeeecceEEEEEEEcC---cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEc--cCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIED---CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD--EQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~lV~Ey~~~ 593 (851)
.+||+|+||.||+|+..+ +..+|+|.+..... ...+.+|++++++++||||+++++++. .+...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998653 36789998765432 245788999999999999999999884 45678999999875
Q ss_pred cchhhhccCC-------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE----cCCCeEEEeeccccc
Q 047215 594 GTLRSHLFGS-------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSK 662 (851)
Q Consensus 594 gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla~ 662 (851)
+|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 22357888999999999999999995 899999999999999 567799999999998
Q ss_pred cCCCCCc-cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch-------hcHHHHHHH
Q 047215 663 TGPSMEH-THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ-------INLADWAMK 733 (851)
Q Consensus 663 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~-------~~l~~~~~~ 733 (851)
....... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 6432211 111234568999999999876 4589999999999999999999999864322110 000000000
Q ss_pred -----------HhhhcccccccC---------ccC---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 -----------WQKQRSLKSIID---------PHL---KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 -----------~~~~~~~~~i~d---------~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
............ +.+ ...........+.+|+.+||+.||.+|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000000 000 000011223458889999999999999999999999
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.00 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=198.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-----ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-----SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 584 (851)
.+|+..++||+|+||.||+|... ++..+++|.+... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999864 4778999976532 223456788999999999999999999988653 567
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
+++|||+++++|.+++... ..+++....+++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998543 357888899999999999999995 89999999999999999999999999998753
Q ss_pred CCCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 665 PSMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 665 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
..... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~--------- 221 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKI--------- 221 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHH---------
Confidence 32111 1112234588999999999888899999999999999999999999864321110 0000
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.........+......+.+++.+|+. +|++||+++++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00011122344555678899999995 89999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.45 Aligned_cols=258 Identities=21% Similarity=0.349 Sum_probs=218.0
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.-|+..+.||+|.|..|-+|++ -.|..||||++.+.. ......+.+|++.|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3455667899999999999975 467889999988763 3344568899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE-cCCCeEEEeeccccccCCCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL-DENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl-d~~~~~kl~DFGla~~~~~~~ 668 (851)
.-++|+|+++|.++. ..+.+....+.+.||+.|+.|+| +..+|||||||+||.+ .+-|-+||.|||++-...+
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 999999999997665 35888999999999999999999 5899999999999887 6778999999999865333
Q ss_pred ccccccccccCCcccCcccccccCCC-chHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.....+.||++.|-|||++.+..|+ +++||||||||||-|+||++||+.....+ .+..|+|-+
T Consensus 172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCK 235 (864)
T KOG4717|consen 172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCK 235 (864)
T ss_pred -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhccc
Confidence 2334678999999999999998886 57899999999999999999998654433 234456654
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCCCC
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQN 803 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~~~ 803 (851)
+ ..|...+.++++||..||..||.+|.+.+|+..+ +|++..++..
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~---------~Wlq~~D~~~ 280 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST---------SWLQAGDRGL 280 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc---------ccccCCCCCc
Confidence 4 4567788889999999999999999999999998 9988766544
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.67 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=203.0
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|+||.||++... .+..+++|.+... .......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 5677899987654 344567899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccccCCCCCc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~ 669 (851)
+++++|.+++.......+++.++.+++.+++.+|.|||+ ++++||||||+||++++ ++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999976555668999999999999999999995 89999999999999975 4568999999987643221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ....... .. .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~-~~---------~ 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMS-GT---------F 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHh-cC---------C
Confidence 1223568889999999998889999999999999999999999886543221 1111111 00 0
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+...+..+.+++.+||+.+|.+|||+.|+++|
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11223355678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.03 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=199.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|++|.||+|+.. +++.++||++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 57889999876432 23345788999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+. ++|.+++.......+++.++..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 688888866555678999999999999999999995 8999999999999999999999999999875332111
Q ss_pred ccccccccCCcccCcccccccC-CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh------------
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQ-LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ------------ 737 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~------------ 737 (851)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||......+. +..........
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence 122334688999999887644 68999999999999999999998865432211 11111100000
Q ss_pred ---cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 ---RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 ---~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..........+ ....+.....+.+++.+||+.||.+|||+++++.|
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 00112234567899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.83 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=206.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||.|+||+||+|... ++..+++|++... .......+.+|+++++.++|+||+++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 5678899987643 233567899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCC-CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 591 MANGTLRSHLFGSDL-PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865432 568999999999999999999994 8999999999999999999999999999875443222
Q ss_pred c--ccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 670 T--HVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 670 ~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
. .......|+..|+|||++... .++.++|+|||||+++||++|+.|+....+... +.+. ... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~----~~~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLT----LQN------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHH----hcC------CCC
Confidence 1 122344688999999998876 789999999999999999999999875433211 1110 000 111
Q ss_pred cCCCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 747 HLKGNY-SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 747 ~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.... ....+..+.+++.+||+.||.+||+++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 12455778999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=307.01 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=204.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV~ 588 (851)
++|+..+.||.|++|.||++... .++.+++|.+... .......+.+|++++++++||||++++++|.. .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999974 5678899987654 33445678999999999999999999998854 44789999
Q ss_pred EecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 589 EYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||+++++|.+++.. .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999888643 233568889999999999999999995 8999999999999999999999999999865322
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCc--chhcHHHHHHHHhhhccccccc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPK--DQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ....+..+... .....+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhc
Confidence 11 12345788999999999999999999999999999999999998755321 11122222111 0000110
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
+. . ......++.+.+++.+||+.+|.+|||+.|+++| +|+..
T Consensus 230 ~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~---------~~~~~ 271 (287)
T cd06621 230 DE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH---------PWIKA 271 (287)
T ss_pred cC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC---------ccccc
Confidence 00 0 0012345678999999999999999999999999 88754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=315.71 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=207.3
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCC--CChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANP--QSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
..|++.++||+||.+.||++...+.+.+|+|+... .+.+....|..|+..|.+| .|.+||+|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45777889999999999999998888888887654 4667778899999999999 49999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|-+. +|..+|.........| .+..+..|++.++.++| +++|||.||||.|+|+-. |++||+|||+|........
T Consensus 441 ~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 8654 9999997766555556 67788899999999999 599999999999999854 6999999999998776666
Q ss_pred cccccccccCCcccCccccccc-----------CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQ-----------QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
.-.....+||+.||+||.+... +.+.++||||+|||||+|+.|+.||..... .| .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~-------a 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI-------A 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH-------H
Confidence 6666778999999999998633 256799999999999999999999864311 11 2
Q ss_pred ccccccCccCCCCCChhH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 739 SLKSIIDPHLKGNYSPES-LEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+..|.||.-.-+|+.-- ...+.++++.||+.||++|||..|+|+|
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 345666764433333211 1238999999999999999999999999
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.34 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=200.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..++||+|+||.||+|..+ .++.+|+|+..... ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999975 47889999876432 2234678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.++.... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998876433 348999999999999999999995 899999999999999999999999999987643322
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhc-HHHHHH-------HHhhhcc-
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN-LADWAM-------KWQKQRS- 739 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~-l~~~~~-------~~~~~~~- 739 (851)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+... ...+.. .......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 12233457889999999875 457889999999999999999998886443221110 000000 0000000
Q ss_pred cccccCccCCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 LKSIIDPHLKG-----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ~~~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+.... ...+..+..+.+++.+||+.+|.+||++.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000010000 0112446779999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.90 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=197.6
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
++|...+.||+|+||.||+|.. .+..+++|...... ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577788999999999999975 45678999876432 245788999999999999999999998764 4799999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 9999999976655568899999999999999999994 89999999999999999999999999998753221
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......+..|+|||++.+..++.++||||||+++|||++ |+.|+......+ ..... ..+ ....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~---------~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECV-EKG---------YRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHH-hCC---------CCCC
Confidence 112234568999999998899999999999999999998 888876543221 11111 111 1111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.+...+..+.+++.+||+.+|.+||+++++++.|+
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 22345567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.71 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=204.0
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChh-----hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQ-----GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
+|+..+.||+|+||.||+|... +++.+++|++...... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999864 5788999988754322 345577899999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+ +|+|.+++.... ..+++.++.+++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999986543 368999999999999999999995 89999999999999999999999999999764332
Q ss_pred CccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH--------hhhc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW--------QKQR 738 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~ 738 (851)
.. ......++..|+|||.+.+ ..++.++|||||||+++||++|.+++....+.+.. ....... ....
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHHHcCCCchhhhhhcc
Confidence 11 1223346788999998864 46789999999999999999997776644332211 1100000 0000
Q ss_pred ccccccCccCCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 739 SLKSIIDPHLKGN-----YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 739 ~~~~i~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
............. .....+..+.+++.+||+.+|++|||+.|+++| +|++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~---------~~~~~~~ 289 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH---------PYFSNDP 289 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC---------ccccCCC
Confidence 0000000000001 112345678999999999999999999999999 8887543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.77 Aligned_cols=250 Identities=28% Similarity=0.485 Sum_probs=199.9
Q ss_pred ceeeeeeeecceEEEEEEEcC-----cceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 516 DESLMIGVGGFGKVFKGEIED-----CTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+..+.||.|+||.||++...+ +..+++|.+...... ....+..|+.++++++||||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998754 367899998765433 56789999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999866543338999999999999999999994 8999999999999999999999999999876443322
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.. .....++..|+|||.+....++.++||||+|++++||++ |+.|+..... ..+.+. ... ..
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~---~~~-~~--------- 221 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEY---LKK-GY--------- 221 (258)
T ss_pred cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---Hhc-CC---------
Confidence 11 112337789999999988889999999999999999998 6666654221 111111 111 10
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
....+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112233566799999999999999999999998763
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.25 Aligned_cols=254 Identities=25% Similarity=0.306 Sum_probs=196.5
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|...++||+|+||.||++... .+..+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4445668999999999999864 56889999876542 344567889999999996 99999999999999999999999
Q ss_pred cCCcchhh---hccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 591 MANGTLRS---HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 591 ~~~gsL~~---~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
++. +|.+ .+.......+++..+.+++.+++.||+|||+ +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 4433 3333334578999999999999999999996 468999999999999999999999999998753221
Q ss_pred CccccccccccCCcccCccccccc---CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQ---QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+..... ....
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~------~~~~ 227 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV------VKGD 227 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh------cCCC
Confidence 1 11233578899999999765 689999999999999999999999864321 11111110 0011
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.+........+..+.+|+.+||+.+|.+|||+++++.|
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223223334466779999999999999999999999999
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.56 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=202.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||.||+|... +++.+++|++... .......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999875 4678999987653 23345678999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|++++.+..++.. ...+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9998877766533 2458899999999999999999995 8999999999999999999999999999876443221
Q ss_pred cccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH---------HHhhhcc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM---------KWQKQRS 739 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~ 739 (851)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.|+......+......... .+.....
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122335678899999999887 88999999999999999999998886543221110000000 0000000
Q ss_pred cc-----cccCcc-CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 LK-----SIIDPH-LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ~~-----~i~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. .+.++. ....++..++..+.+++++||+.+|++|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 000000 0001223346789999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.85 Aligned_cols=265 Identities=22% Similarity=0.344 Sum_probs=196.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999865 568899998765422 2234567899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++ +|.+++.... ..+++.++..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 985 8988886543 368899999999999999999995 8999999999999999999999999999875322111
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCC-cchhcHHHHHHHHhhhcccccc-----
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLP-KDQINLADWAMKWQKQRSLKSI----- 743 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~i----- 743 (851)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .++..................+
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346789999999875 5689999999999999999999999865431 1111100000000000000000
Q ss_pred --------c-CccCCCCCC-hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 --------I-DPHLKGNYS-PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 --------~-d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ...+....+ ......+.+++.+||+.+|++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000000000 0112567899999999999999999999988
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.79 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=197.2
Q ss_pred CceeeeeeeecceEEEEEEEc----CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC------
Q 047215 515 FDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN------ 582 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 582 (851)
|...+.||+|+||.||+|... .+..+|||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999864 2567899987654 3445677899999999999999999999885432
Q ss_pred cEEEEEEecCCcchhhhccCC----CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 583 EMILVYEYMANGTLRSHLFGS----DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
..++++||+++|+|.+++... ....+++..+.+++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998887432 22357889999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.|+...... .+..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cC
Confidence 99886432221112223345678999999998899999999999999999999 77777543221 1111111 00
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
. .+ ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 232 ~--------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N--------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C--------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 11234556799999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=341.63 Aligned_cols=255 Identities=21% Similarity=0.344 Sum_probs=197.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc--cCCcEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD--EQNEMI 585 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~ 585 (851)
..++|.+.++||+|+||.||+++.. .+..+++|.+... .......|..|+.+|++|+|||||++++++. ....++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3468999999999999999999865 4567788877643 3344567899999999999999999999874 345789
Q ss_pred EEEEecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCC----CCCeEEcCCCCCCeEEcC----------
Q 047215 586 LVYEYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGA----ERGIIHRDVKTTNILLDE---------- 649 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~----~~~iiHrDlk~~NILld~---------- 649 (851)
|||||+++|+|.++|... ....+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998542 2346899999999999999999999622 146999999999999964
Q ss_pred -------CCeEEEeeccccccCCCCCccccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCC
Q 047215 650 -------NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTL 720 (851)
Q Consensus 650 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~ 720 (851)
...+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 335899999999764321 12234568999999999864 458999999999999999999999986533
Q ss_pred CcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 721 PKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
... ......... +.+. ....+..+.+|+..||+.+|.+||++.|+|.|
T Consensus 248 ~~~-----qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NFS-----QLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cHH-----HHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 211 111111100 1111 11234568999999999999999999999987
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=308.32 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=201.9
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|+||.||+|... ++..+++|++.... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999864 67889999876543 33456789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+ +++|.+++.... .++++.++..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999986544 568999999999999999999995 8999999999999999999999999999876433221
Q ss_pred ccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh---------c--
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ---------R-- 738 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~-- 738 (851)
.......|+..|+|||++.+. .++.++||||+|++++||++|++++....+... ..+....... .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence 122335688999999998654 468999999999999999999777654332211 1111110000 0
Q ss_pred -ccccccCccCC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 739 -SLKSIIDPHLK----GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 739 -~~~~i~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+..+... ....++....+.+++.+||+.+|.+|||+++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 01112345789999999999999999999999999
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.22 Aligned_cols=262 Identities=22% Similarity=0.334 Sum_probs=196.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|+||.||+|+.. .+..+++|++.... ......+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999874 57788999876432 22335678899999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++ +|.+++.... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 974 7777765432 458999999999999999999995 899999999999999999999999999987532211
Q ss_pred ccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc------ccccc
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR------SLKSI 743 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~i 743 (851)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+........ .+ +......... .....
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhc
Confidence 112234578899999998764 479999999999999999999988654322111 00 0000000000 00000
Q ss_pred cC----ccCCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 ID----PHLKG-----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d----~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+ +.... ...+..+..+.+++.+||+.||.+|||+++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 00000 1112345678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.22 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=202.3
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC------hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS------EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
+|+..+.||+|++|.||+|.. .++..+++|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 466778899999999999985 567788999876432 1235678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccccCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSKTGP 665 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~ 665 (851)
|+||+++++|.+++... .++++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999998543 468899999999999999999995 8999999999999998765 69999999987643
Q ss_pred CCCc--cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 666 SMEH--THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 666 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... ........++..|+|||.+.+..++.++||||+|+++++|++|+.|+......... ..... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~---------~ 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFK---------I 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHH---------H
Confidence 3211 11122346888999999998889999999999999999999999988643322111 11110 0
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.........+......+.+++.+||+.+|.+||++.++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00111123344556779999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.13 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=197.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHH-HHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEM-LSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||.||+++.. ++..+|+|++.... ......+..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999875 57889999876542 2333455566665 566789999999999999999999999
Q ss_pred ecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 590 YMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 590 y~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|++ |+|.+++... ....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6787776432 23568999999999999999999995 338999999999999999999999999998753221
Q ss_pred CccccccccccCCcccCcccccc----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWR----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.......++..|+|||.+.+ ..++.++|+|||||++|||++|+.|+....... ..+. ... ..
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~----~~~-~~----- 223 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK----QVV-EE----- 223 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH----HHH-hc-----
Confidence 11223457889999998864 457899999999999999999999986432110 0010 000 00
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
..+.+. ....+..+.+++.+||+.+|.+||++.++++| +|+...
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~---------~~~~~~ 267 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH---------PFFELH 267 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC---------chhhhc
Confidence 111111 11245668999999999999999999999999 777653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.84 Aligned_cols=254 Identities=23% Similarity=0.413 Sum_probs=203.6
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcC---CcceeeEEEEEccCCcEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLR---HRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.|+..+.||+|+||.||+|.. .++..+++|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466677899999999999986 46788999987654 3445677889999999997 999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988543 68899999999999999999994 899999999999999999999999999987643322
Q ss_pred ccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.|+........ ... ......+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~------~~~~~~~~ 221 (277)
T cd06917 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML------IPKSKPPR 221 (277)
T ss_pred --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc------cccCCCCC
Confidence 11233468899999999865 4578999999999999999999999865432111 100 01111111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
+.. ...+..+.+++.+||+.||.+||++.+++.| +|++..
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~---------~~~~~~ 261 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKS---------KWIKAH 261 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC---------hHhhcc
Confidence 111 1245678999999999999999999999998 787643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.34 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=203.8
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|...+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788889999999999999985 456789999886655555677899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999998543 47889999999999999999994 8999999999999999999999999999865433221
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......|++.|+|||.+....++.++||||||+++||+++|+.||....+...... .. ..+.....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~--------~~~~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IA--------TNGTPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hh--------cCCCCCCC
Confidence 12334688899999999888899999999999999999999999875433221100 00 00000011
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+...+..+.+++.+||+.+|.+||++.+++.|
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123345678999999999999999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.10 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=202.7
Q ss_pred eeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 518 SLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
...||+|+||.||++... ++..++||++........+.+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 346999999999999864 5678999988766656667799999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 676 (851)
.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++....... ......
T Consensus 107 ~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 178 (292)
T cd06658 107 TDIVTH---TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSL 178 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCcee
Confidence 998843 347899999999999999999995 899999999999999999999999999987533211 112335
Q ss_pred ccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 677 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.|+..|+|||.+.+..++.++||||||+++|||++|+.|+....+.... ... .....+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~------~~~~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------RRI------RDNLPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH------HhcCCCcccc--cccc
Confidence 6889999999998889999999999999999999999998754322111 000 0111111111 1233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
+..+.+++.+||+.||.+|||++++++| +|+...
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~---------~~~~~~ 278 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH---------PFLKLA 278 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC---------hhhhcc
Confidence 4568899999999999999999999999 777643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.17 Aligned_cols=267 Identities=20% Similarity=0.257 Sum_probs=197.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++++|...+.||+|+||.||+|... ++..+++|++..... .....+.+|+.++++++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 577899998765432 22346788999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+. ++|.+.+.... ..+.+.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 57766654332 457788899999999999999995 899999999999999999999999999987532211
Q ss_pred ccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH----------HHhhh
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM----------KWQKQ 737 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~----------~~~~~ 737 (851)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.........-...|.. .....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 1223357889999999875 458899999999999999999999987543221100000000 00000
Q ss_pred -cccccccCccCCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 -RSLKSIIDPHLKGNY-----SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 -~~~~~i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
............... ....+..+.+++.+|++.||++|||+.|++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 00124568899999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.03 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=219.7
Q ss_pred CHHHHHHHhcCCceeeeeeeecceEEEEEEE------cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEE
Q 047215 504 TLAEIRVATNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIG 576 (851)
Q Consensus 504 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g 576 (851)
..+++.....++....++-+|.||.||+|.+ .+.+.+.+|.++.. +.-+...+..|-.++..+.|||+.+..+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3556667777888888999999999999954 44566778876654 6667788999999999999999999999
Q ss_pred EEcc-CCcEEEEEEecCCcchhhhccC------CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC
Q 047215 577 FCDE-QNEMILVYEYMANGTLRSHLFG------SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649 (851)
Q Consensus 577 ~~~~-~~~~~lV~Ey~~~gsL~~~L~~------~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~ 649 (851)
++.+ ....+.+|.++.-|+|..+|.. +....++-.+...++.|++.||+||| ++++||.||.++|+++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence 9854 4567889999999999999962 22345778899999999999999999 599999999999999999
Q ss_pred CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHH
Q 047215 650 NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLA 728 (851)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~ 728 (851)
..++||+|=.|+|...+.+..........+..||+||.+....|+.++|||||||+||||+| |+.|+-..+|++....
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y- 510 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY- 510 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-
Confidence 99999999999998777666665555667889999999999999999999999999999998 6777766666543211
Q ss_pred HHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 729 DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 729 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
..+ ..+-..|-.|++++..++.-||+..|++||+++|++.-|.+.
T Consensus 511 ------lkd---------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 ------LKD---------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ------Hhc---------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 111 122234567889999999999999999999999999988754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.15 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=207.0
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEMILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~ 588 (851)
+|+..+.||+|++|.||+|... +++.+++|+..... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999876 67889999876554 35567899999999999999999999999888 8999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++.... .+++.++..++.|++++|.|||+ .+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999986543 78999999999999999999995 899999999999999999999999999987644332
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.........++..|++||.+.....+.++||||||+++++|++|+.|+...... ...... +.....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---------~~~~~~ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYK---------IGSSGE 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHh---------ccccCC
Confidence 211123456888999999998888999999999999999999999998765411 110111 111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+...+..+.+++.+|++.+|.+||++.+++.|
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 223344456789999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.63 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=188.6
Q ss_pred eeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhc---CCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKL---RHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 521 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
||+|+||+||+|+.. .+..+|+|++.... ......+..|..++.++ +||||+++++++..++..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 57889999876431 22234455677777665 699999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 9999988543 468899999999999999999995 899999999999999999999999999987532211 223
Q ss_pred cccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ..... ..+. ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i-~~~~------~~~~--- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNI-AFGK------VRFP--- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHH-HcCC------CCCC---
Confidence 346799999999998754 58999999999999999999999986543211 11111 0010 1111
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRP----TMGEVLWH 784 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~~ 784 (851)
....+..+.+++.+||+.||.+|| ++.++++|
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 012345688999999999999998 68888888
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.33 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=198.9
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||++... .+..+++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999875 45678999876543 234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999554 468899999999999999999995 899999999999999999999999999987421100
Q ss_pred c-------------cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh
Q 047215 669 H-------------THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 669 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
. ........++..|+|||.+....++.++|+|||||++|||++|+.||....+. ++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 0 00112245788999999998889999999999999999999999998654321 1111111
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT---MGEVLWH 784 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 784 (851)
. + .+..+.. ....+..+.+++.+||+.+|++||+ +.++++|
T Consensus 230 ~-~---~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 S-D---DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred h-c---ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 0 1111111 1134566899999999999999998 5666666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.68 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=201.1
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC------
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN------ 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~------ 582 (851)
++++|+..+.||+|++|.||+|... ++..+++|.+..... ....+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999975 467788998765543 346789999999999 7999999999996544
Q ss_pred cEEEEEEecCCcchhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999885433 4578999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccc-----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
+...... ........|+..|+|||.+.. ..++.++|||||||+|+||++|+.||....+... +. ...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF----KIP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH----Hhh
Confidence 8753321 122234568899999998753 3578899999999999999999999864322111 10 000
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+.+ ..+...+..+.+++.+||..||++|||+.++++|
T Consensus 232 ------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 ------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0001111 1122355678999999999999999999999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=308.09 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=202.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|...+.||+|+||.||++... +++.+++|.+... .......+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999865 5678899987643 2234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998554 468899999999999999999995 99999999999999999999999999998764332
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.|+....... ... . +...
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~---------~~~~-- 213 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYE---K---------ILEG-- 213 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H---------HhcC--
Confidence 234468899999999988889999999999999999999999986543111 000 0 0100
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
...++...+..+++++.+||+.+|.+|| +++|+++|
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1122334456789999999999999999 88999988
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.19 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=202.2
Q ss_pred CCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc--cCCcEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD--EQNEMILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~lV~ 588 (851)
+|+..+.||.|+||.||++.. .++..+++|.+... .....+.+..|++++++++||||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467788999999999999985 45678888987643 3444567889999999999999999999874 345689999
Q ss_pred EecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCC--CCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 589 EYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGA--ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
||+++++|.+++... ...++++.+++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 2356899999999999999999999432 488999999999999999999999999998864
Q ss_pred CCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
..... ......++..|+|||.+....++.++|+||||+++++|++|+.|+...... .+.+ .. ..+
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~~-~~~------ 225 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS---KI-KEG------ 225 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH---HH-hcC------
Confidence 33221 123346899999999999888999999999999999999999998754311 1111 11 111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+...+..+.+++.+||+.+|.+||++.++++|
T Consensus 226 ---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 ---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112334455678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=302.04 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=202.2
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999864 678889998765533 3678899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++... ..+++..+..++.++++||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998654 357889999999999999999995 89999999999999999999999999998764332221
Q ss_pred cc--ccccccCCcccCcccccccC---CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 671 HV--STAVKGSFGYLDPEYFWRQQ---LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 671 ~~--~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. .....++..|+|||++.+.. ++.++||||||++++|+++|+.||....... ........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~~~~~~~~----~~~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------QIMFHVGA----GHK 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------HHHHHHhc----CCC
Confidence 11 12356788999999998766 8999999999999999999999986543211 11111000 011
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.+. ....+...+.+++.+||+.+|.+|||+.+++.|
T Consensus 225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111 112235668899999999999999999999988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.18 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=200.8
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
-|+..+.||+|+||.||+|... ++..+|+|..... .......+.+|++.+++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3556778999999999999864 5678999987643 2344567899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++.. ..+++.++..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch--h
Confidence 99999998854 358899999999999999999994 999999999999999999999999999987543221 1
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......++..|+|||.+.+..++.++|+|||||++|+|++|..|+....+.. +..... .. ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~---------~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLIP-KN---------NPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHHh-cC---------CCCC
Confidence 1233467889999999988889999999999999999999999886433211 111110 00 0112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+..+.+++.+||+.+|.+||++.++++|
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233455678999999999999999999999999
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=321.83 Aligned_cols=243 Identities=26% Similarity=0.392 Sum_probs=191.3
Q ss_pred eeeeeecceEEEEEEEc-CcceeE---EeecC-CCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC--cEEEEEEec
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAA---IKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN--EMILVYEYM 591 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~va---vK~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~lV~Ey~ 591 (851)
.+||+|+|-+||||... .|..|| ||.-. ..++...+.|..|+.+|+.|+||||++++.++.+.. ...+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 36999999999999764 344444 33221 124556688999999999999999999999986554 478999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEEeeccccccCCCCCcc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~~~~~~~ 670 (851)
..|+|..++...+ .++.+.+..+|+||++||.|||+ ..++|||||||+.||+|+ .-|.|||+|+|||.....
T Consensus 126 TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---- 198 (632)
T KOG0584|consen 126 TSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---- 198 (632)
T ss_pred cCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhc----
Confidence 9999999995544 57888999999999999999997 567999999999999997 568999999999987432
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.....+.|||.|||||+.. ..|.+.+||||||++++||+|+..|+..-....+. ...+..-.....+.++-|
T Consensus 199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI--YKKV~SGiKP~sl~kV~d----- 270 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI--YKKVTSGIKPAALSKVKD----- 270 (632)
T ss_pred cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH--HHHHHcCCCHHHhhccCC-----
Confidence 1233478999999999986 88999999999999999999999998653322221 111211122222222322
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.+++||.+||.. .++|||+.|+|+|
T Consensus 271 -------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 -------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3578999999999 9999999999999
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.64 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=198.7
Q ss_pred eeeecceEEEEEEEcC-cceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 521 IGVGGFGKVFKGEIED-CTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 521 LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
||+|++|.||+++... ++.+++|.+.... ....+.+.+|+.++++++||||+++++++..++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999754 6788999876432 23456799999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 676 (851)
.+++... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 9999654 358899999999999999999995 999999999999999999999999999987643321 12334
Q ss_pred ccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 677 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.++..|++||.+....++.++|+||||+++|||++|..|+....... .+.... +.+......++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~---------~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYND---------ILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHH---------HhccCCCCCCCccc
Confidence 67889999999988889999999999999999999999987654211 111111 11111122334444
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
+..+.+++.+||+.+|.+||+ ++|+++|
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 678999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=302.17 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=202.1
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|+||.||+|... ++..+++|.+... .....+.+.+|+.++++++||||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999875 4677899987653 223456788999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccccCCCCCc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~~ 669 (851)
+++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 999999999866555568999999999999999999995 8999999999999998875 57999999987643211
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......|++.|+|||++....++.++||||||++++||++|+.|+..... .++...... .. .
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~----~----- 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GY----F----- 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-cc----C-----
Confidence 122234588999999999888899999999999999999999998864321 222221111 10 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+..+..+.+++.+||+.+|++|||+.++++|
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223445679999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=310.51 Aligned_cols=245 Identities=23% Similarity=0.345 Sum_probs=198.6
Q ss_pred eeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 518 SLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
...||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 446999999999999864 5788999988665555567788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 676 (851)
..++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 177 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL 177 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence 988744 357899999999999999999994 899999999999999999999999999986533211 112345
Q ss_pred ccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 677 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.|+..|+|||++.+..++.++|||||||+++||++|+.||....+.+.. ..... . ..+.. ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-~-----~~~~~--~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRD-S-----PPPKL--KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-c-----CCCCc--cccCCC
Confidence 6889999999999889999999999999999999999998754322111 11100 0 00101 112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+..+.+++.+||+.+|.+||+++++++|
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 4568899999999999999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=307.65 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=199.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV 587 (851)
++|+..+.||+|+||.||+|... +++.+++|.+.... ......+.+|+.++++++||||+++++++..+ +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999975 46788999876442 22234567899999999999999999998776 899999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++ +|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999974 8988875543 368999999999999999999995 89999999999999999999999999998764332
Q ss_pred CccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH----------HHHHH--H
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA----------DWAMK--W 734 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~----------~~~~~--~ 734 (851)
. .......+++.|+|||.+.+. .++.++|+||||++++||++|+.|+......+..... .|... +
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 1 112334578899999998754 4689999999999999999999998754332211000 00000 0
Q ss_pred h--hhcccccccCccCCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 735 Q--KQRSLKSIIDPHLKGNYSPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 735 ~--~~~~~~~i~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ............+...++.. ..+.+.+++.+||+.+|++|||+.|++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000011111122222222 46678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=294.69 Aligned_cols=250 Identities=29% Similarity=0.475 Sum_probs=205.1
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
+|+..+.||+|++|.||++... ++..+++|+...........+.+|++++++++|||++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 678899999877665567889999999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+++|.+++.... ..+++.++..++.|++.+|.|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999986543 468999999999999999999994 9999999999999999999999999999876443221
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
.....++..|++||.+....++.++||||||+++++|++|+.|+......... ..... ... +.+. .
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~-----~~~~--~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------FKIAT-NGP-----PGLR--N 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHh-cCC-----CCcC--c
Confidence 23456889999999999888999999999999999999999988654321111 11000 101 1111 1
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+...+..+.+++.+||+.||++|||+.++++|
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11225668999999999999999999999988
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.26 Aligned_cols=267 Identities=21% Similarity=0.277 Sum_probs=197.4
Q ss_pred CCceeeeeeeecceEEEEEEEcC---cceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIED---CTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEMI 585 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~ 585 (851)
.|+..++||+|+||.||+|.... +..+|+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999998754 6889999887632 33446678899999999999999999999877 8899
Q ss_pred EEEEecCCcchhhhccCC---CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC----CCeEEEeec
Q 047215 586 LVYEYMANGTLRSHLFGS---DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE----NFVAKMSDF 658 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~----~~~~kl~DF 658 (851)
+||||+++ +|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 565555321 22368899999999999999999995 89999999999999999 999999999
Q ss_pred cccccCCCCCc-cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch-------hcHHH
Q 047215 659 GLSKTGPSMEH-THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ-------INLAD 729 (851)
Q Consensus 659 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~-------~~l~~ 729 (851)
|+++....... ........++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886433221 111233467889999998876 4689999999999999999999999875433220 11111
Q ss_pred HHHHHh-----------hhcccccccCccCCCCCC---------h--hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 730 WAMKWQ-----------KQRSLKSIIDPHLKGNYS---------P--ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 730 ~~~~~~-----------~~~~~~~i~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+. .........+......++ . .....+.+++.+||+.||++|||+.|+++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111100 000000000000000111 0 334568899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.22 Aligned_cols=248 Identities=22% Similarity=0.356 Sum_probs=201.0
Q ss_pred CceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 515 FDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
|...+.||+|++|.||++.. .++..+++|++........+.+.+|+.++++++||||+++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44456899999999999986 46678999988665555566789999999999999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
++|.+++.. .++++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~ 172 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR 172 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence 999999865 358899999999999999999995 899999999999999999999999999876533211 112
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....|+..|+|||.+.+..++.++|||||||+++||++|+.|+....+.. ........ ..+... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~~~------~~~~~~--~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIRDN------LPPKLK--NL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHhc------CCCCCc--cc
Confidence 33458899999999988889999999999999999999999986543211 11111110 011111 11
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+..+.+++.+||+.+|++|||+.++++|
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 2345679999999999999999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.84 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=197.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|++|.||+|... +++.+++|++.... ......+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999875 57789999876432 2334678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccccCCCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~ 668 (851)
|++ ++|.+++.......+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 578777755444456788888999999999999995 89999999999999984 5689999999987533211
Q ss_pred ccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc--c------
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR--S------ 739 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~------ 739 (851)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....+.+.. ... ....... .
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FKI-FRILGTPNEETWPGVT 232 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH-HHHhCCCChhhccccc
Confidence 11223456889999999876 46899999999999999999999988754332111 100 0000000 0
Q ss_pred -ccccc--CccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 -LKSII--DPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 -~~~i~--d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.... -+.... ...+..++.+.+++.+||+.+|++||++.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000000 0122345668999999999999999999999999
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.71 Aligned_cols=246 Identities=28% Similarity=0.405 Sum_probs=195.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
..|+..+.||+|+||.||+|... +++.+++|.+... .......+.+|++++++++||||+++.++|..++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999864 5788999987543 2344467889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||++ |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 56766664322 458999999999999999999995 89999999999999999999999999998754321
Q ss_pred ccccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
....++..|+|||++. ...++.++||||||+++|||++|+.|+........ ...... . ..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~-~-----~~ 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-N-----DS 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhc-C-----CC
Confidence 2345788999999874 45688999999999999999999998864322110 000000 0 00
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.+ .....+..+.+++.+||+.+|.+||++.+++.|
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 122355679999999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=328.17 Aligned_cols=268 Identities=19% Similarity=0.219 Sum_probs=188.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCc--ceeEE------------------eecCCCChhhHHHHHHHHHHHHhcCCcc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDC--TLAAI------------------KRANPQSEQGLAEFETEIEMLSKLRHRH 570 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~--~~vav------------------K~~~~~~~~~~~~~~~Ei~~l~~l~Hpn 570 (851)
..++|++.++||+|+||+||++..+.. ...++ |+.. ........+.+|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 347899999999999999999875321 11111 1111 12233456889999999999999
Q ss_pred eeeEEEEEccCCcEEEEEEecCCcchhhhccCCC---CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE
Q 047215 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSD---LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647 (851)
Q Consensus 571 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl 647 (851)
|+++++++...+..++|+|++.. +|.+++.... .......+...++.|++.||.|||+ ++||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 99999999999999999999864 6666664322 1223456678899999999999995 899999999999999
Q ss_pred cCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCC-CCCcchhc
Q 047215 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINP-TLPKDQIN 726 (851)
Q Consensus 648 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~-~~~~~~~~ 726 (851)
+.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||+||||++|+.++.. ........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999997643321 1122345799999999999999999999999999999999999864432 22221111
Q ss_pred HHHHHHHHhh-hc-------ccccccCc-cC---CCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 727 LADWAMKWQK-QR-------SLKSIIDP-HL---KGNYS-----PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 727 l~~~~~~~~~-~~-------~~~~i~d~-~l---~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.+....... .. .+...++. .+ ....+ ...+..+.+++.+||+.||.+|||+.|+|.|
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111110000 00 00000000 00 00000 1123457888999999999999999999999
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.04 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=195.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCc-----
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNE----- 583 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~----- 583 (851)
++|+..+.||+|+||.||+|... +++.+++|+..... ......+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999865 57889999866432 223457888999999995 6999999999876655
Q ss_pred EEEEEEecCCcchhhhccCCC---CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeecc
Q 047215 584 MILVYEYMANGTLRSHLFGSD---LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFG 659 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFG 659 (851)
.++||||+++ +|.+++.... ...+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 7888775432 3468999999999999999999995 89999999999999998 8999999999
Q ss_pred ccccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh--
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK-- 736 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~-- 736 (851)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||....+... +.........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 9875322111 1122346788999998865 4679999999999999999999988865432211 1100000000
Q ss_pred hcccccccC-------ccCC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 QRSLKSIID-------PHLK----GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ~~~~~~i~d-------~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+.. +... ....+..+..+.+++.+||+.+|.+||++.|++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 0000 00112355678999999999999999999999999
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=289.17 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=194.9
Q ss_pred ceeeeeeeecceEEEEEEEcC-cceeEEeecCCC-ChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEecC
Q 047215 516 DESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
+....||.|+.|.|++.+... +...|||.+.+. +....+.+...+.++...+ .|.||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 345579999999999999764 678899988775 5555667777887776664 8999999999999999999999984
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
- .+..+|.. -.+++++..+-++...+.+||.||.+ +++|||||+||+|||+|+.|++||||||++..... +..
T Consensus 175 ~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkA 247 (391)
T KOG0983|consen 175 T-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKA 247 (391)
T ss_pred H-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---ccc
Confidence 3 44444433 33568899999999999999999998 89999999999999999999999999999866432 223
Q ss_pred ccccccCCcccCcccccc---cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCc-chhcHHHHHHHHhhhcccccccCccC
Q 047215 673 STAVKGSFGYLDPEYFWR---QQLTEKSDVYSFGVVLFEVVCARAVINPTLPK-DQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.+...|.+.|||||.+.- ..|+.++||||||+.|+||.||+.||..-..+ +.... +..-..|.|
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk------------vln~ePP~L 315 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK------------VLNEEPPLL 315 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH------------HHhcCCCCC
Confidence 445679999999999963 47899999999999999999999998763221 11100 000011333
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
++. ..-++.+++++..||.+|+.+||...++|+|
T Consensus 316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 322 1145669999999999999999999999999
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.06 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=205.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++.|+..+.||+|++|.||+|..+ ++..+++|.+..... ....+.+|++++++++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566777788999999999999876 577889998876544 56778999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999996643 368999999999999999999994 999999999999999999999999999976533221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......++..|++||.+.+..++.++|||||||++|+|++|+.|+....+... ..... .... +..
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~-~~~~-----~~~- 236 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLIT-TKGI-----PPL- 236 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCC-----CCC-
Confidence 122334578899999999888899999999999999999999998865433211 00100 0000 001
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+..+.+++.+||+.+|.+|||+.++++|
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112245678999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.12 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=198.2
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
|+..++||.|++|.||+|... ++..+++|++.... ......+.+|++++++++|||++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999864 67889999876442 233457889999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
+ ++|.+++.......+++.++..++.|+++||.|||+ ++++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 689998865544568999999999999999999995 8999999999999999999999999999875332111
Q ss_pred cccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh--------c---c
Q 047215 672 VSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ--------R---S 739 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~--------~---~ 739 (851)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ +.......... . .
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 11223468899999988654 578999999999999999999998865432111 11111100000 0 0
Q ss_pred ----cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 ----LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ----~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+.. ....+..+..+.+++.+||+.+|.+|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 11123344678899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.06 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=198.5
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcEEEEEE
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEMILVYE 589 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~E 589 (851)
|+..+.||+|+||.||+|... +++.+++|++.... ......+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999875 46788999987653 34456788999999999999999999999877 89999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++ +|.+++.... ..+++.++..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9985 8888875543 468999999999999999999995 8999999999999999999999999999876433221
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc-----
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI----- 743 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i----- 743 (851)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..........................+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 11223456788999998765 46899999999999999999999998754432211110000000000000000
Q ss_pred ---------cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 ---------IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+...+...++..+.+++.+||+.+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000001111135678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.15 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=188.6
Q ss_pred eeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHh---cCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 520 MIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSK---LRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~---l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 57889999775432 1222334455544443 479999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|+|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++...... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 99999988543 468999999999999999999995 89999999999999999999999999998653221 1
Q ss_pred ccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....|+..|+|||.+. +..++.++|||||||+++||++|+.||..........+. ... ......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~----------~~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT----------LTVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHh----------hcCCcC
Confidence 12346899999999986 456899999999999999999999998754332211111 000 001112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
.++..+..+.+++.+||+.||.+|| +++|+++|
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 3344566789999999999999999 69999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.38 Aligned_cols=268 Identities=25% Similarity=0.323 Sum_probs=199.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~l 586 (851)
.++|+..+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367889999999999999999874 57889999876432 22233567899999999999999999998654 56899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++ +|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 7877775432 568999999999999999999995 8999999999999999999999999999876433
Q ss_pred CCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh---ccccc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ---RSLKS 742 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 742 (851)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+.+.... ....... .....
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~ 235 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPNESIWPG 235 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChhhchh
Confidence 211 1122345788999999865 5689999999999999999999999875443322111 1110000 00000
Q ss_pred ccC------ccCCC----C---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 743 IID------PHLKG----N---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 743 i~d------~~l~~----~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+ ..+.. . .....++.+.+++.+||+.||++|||++|++.| +|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h---------~~f~~ 295 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES---------SYFKE 295 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC---------hhhcc
Confidence 000 00000 0 001135667899999999999999999999999 88763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.11 Aligned_cols=266 Identities=25% Similarity=0.317 Sum_probs=197.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC-----
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN----- 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----- 582 (851)
..++|+..+.||+|+||.||+|... +++.+++|++.... ......+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578889999999999999999975 56788999886542 233456788999999999999999999987654
Q ss_pred -----cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEee
Q 047215 583 -----EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 583 -----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~D 657 (851)
..++|+||+++ +|.+.+... ...+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 666666443 3468999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+......+. +.........
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~~~~~~~ 236 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELISRLCGS 236 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCC
Confidence 999876433221 11222345778999998864 4578999999999999999999988875432211 1111100000
Q ss_pred --hccccccc--------CccC--C---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 --QRSLKSII--------DPHL--K---GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 --~~~~~~i~--------d~~l--~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+. ++.. . .......+..+.+++.+||+.+|.+|||+++++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 0000 0 00111245678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=311.97 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=197.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------C
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------N 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 582 (851)
.++|+..+.||+|+||.||+|... .+..+|+|.+... .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 478999999999999999999864 6788999987643 334456778899999999999999999988543 3
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+.+ +|.+.+... +++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 57999999964 787777432 7888999999999999999995 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH---------HHHHHH
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL---------ADWAMK 733 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l---------~~~~~~ 733 (851)
..... .......++..|+|||.+.+..++.++|||||||++++|++|+.||........... .++...
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 64321 112334578899999999999999999999999999999999999865432111000 000000
Q ss_pred -------Hhhhcc------cccccCccC----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 -------WQKQRS------LKSIIDPHL----KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 -------~~~~~~------~~~i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+..... ...+....+ ........+..+.+++.+||+.||++|||+.|+|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 001111000 001112345678999999999999999999999999
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.28 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=195.8
Q ss_pred eeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 521 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
||+|+||+||++... ++..+++|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 57788999876432 23345677899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 676 (851)
.+++.......+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 999876555578999999999999999999995 8999999999999999999999999999875332 1112234
Q ss_pred ccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 677 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.++..|+|||++.+..++.++|||||||++++|++|+.||......... .... .. +. ......+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~-----~~----~~--~~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELK-----RR----TL--EMAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHHH-----hc----cc--cccccCCccC
Confidence 5788999999998888999999999999999999999998754331110 0000 00 00 0011223344
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
+..+.+++.+||+.+|.+|| ++.+++.|
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 56789999999999999999 88888888
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.00 Aligned_cols=267 Identities=22% Similarity=0.315 Sum_probs=194.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC-------
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN------- 582 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------- 582 (851)
++|+..++||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57888999999999999999865 57789999875432 222345678999999999999999999986544
Q ss_pred -cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 583 -EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
..++||||+.+ +|.+.+.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999975 7777775433 358999999999999999999995 89999999999999999999999999998
Q ss_pred ccCCCCCcc--ccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 662 KTGPSMEHT--HVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 662 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+.................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 754322111 112234578899999988654 47899999999999999999999887654332222211111000000
Q ss_pred cccc-----ccCc-cCCCCC---------ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 739 SLKS-----IIDP-HLKGNY---------SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 739 ~~~~-----i~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.... ..+. .+.... +......+.+++.+||+.||.+|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 0000 000000 00123457899999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.80 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=204.9
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+|+..++||.|+||.||++... .+..+++|.+.... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999875 57888999886532 2456789999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++... .++++.++..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998554 468899999999999999999994 899999999999999999999999999987643321
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
......|+..|+|||.+....++.++|+||||+++|+|++|+.|+....... .++....... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence 2234568889999999998889999999999999999999999987654321 1111111110 11
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCH--HHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTM--GEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl~~ 784 (851)
...++..+..+.+++.+||+.||.+||++ +|+++|
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 12334455779999999999999999999 888877
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.33 Aligned_cols=265 Identities=21% Similarity=0.319 Sum_probs=199.3
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+|+..++||+|++|.||+|+.. ++..+++|.+..... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 578899998875532 23456788999999999999999999999999999999999
Q ss_pred CCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 592 ANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 592 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
++ +|.+++.... ...+++.++.+++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 8888775432 3468999999999999999999995 899999999999999999999999999987532211
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH-HHHHH-----HHhhhcccccc
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL-ADWAM-----KWQKQRSLKSI 743 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l-~~~~~-----~~~~~~~~~~i 743 (851)
.......++..|++||++.+ ..++.++|||||||++|||++|+.|+......+.... .+... .+.........
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 11223456889999999865 4578999999999999999999999876543221110 00000 00000000000
Q ss_pred cC--ccC----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 ID--PHL----KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d--~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. +.. .....+..+..+.+++.+||+.||.+||++.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000 001112345678899999999999999999999988
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=306.17 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=196.8
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
|+..+.||+|+||.||+|+.. ++..+++|++... .......+.+|++++++++|||++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556778999999999999864 5778899987643 233446788999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++ +|.+.+... ..++++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 974 777776433 3458999999999999999999995 8999999999999999999999999999865322
Q ss_pred ccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 671 HVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.....|+..|+|||++. ...++.++|||||||++|||++|+.|+........ ....... .
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~---------~ 240 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN---------E 240 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhc---------c
Confidence 12345788999999974 45789999999999999999999998765322111 0111000 0
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.........+..+.+++.+||+.+|.+||++.++++|+....
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 111112344567899999999999999999999999955443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.39 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=198.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC--CcEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ--NEMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~--~~~~ 585 (851)
.++|+..+.||+|+||.||+|... ++..+++|++... .......+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888889999999999999875 5678899987542 334455678899999999 999999999998543 4689
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||++ ++|.+++... .+.+..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5998888543 57899999999999999999995 899999999999999999999999999987643
Q ss_pred CCCcc---ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH---------
Q 047215 666 SMEHT---HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM--------- 732 (851)
Q Consensus 666 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~--------- 732 (851)
..... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....+.+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 12234568899999998764 568899999999999999999999986544332211100000
Q ss_pred HH---hhhcccccccCccCC--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 733 KW---QKQRSLKSIIDPHLK--GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 733 ~~---~~~~~~~~i~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+ .....+..+...... ....+..+..+.+++.+||+.+|.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 000000000000000 01112245678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.50 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=196.2
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----CcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~ 584 (851)
+++|+..++||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 467889999886532 33446688899999999999999999987543 358
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++|+||+++ +|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999975 78777743 358899999999999999999995 89999999999999999999999999998754
Q ss_pred CCCCc-cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh---cc
Q 047215 665 PSMEH-THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ---RS 739 (851)
Q Consensus 665 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 739 (851)
..... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence 32111 111233568899999998754 5689999999999999999999998865322111 0000000000 00
Q ss_pred cccccCcc---------CCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 LKSIIDPH---------LKGN-----YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ~~~i~d~~---------l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+.+.. .... ..+..+..+.+++.+||+.+|++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 011234668899999999999999999999999
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.93 Aligned_cols=258 Identities=24% Similarity=0.291 Sum_probs=193.0
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcC-CcceeeEEEEEccC--CcEEEEEE
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQ--NEMILVYE 589 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~lV~E 589 (851)
|+..++||+|+||.||+|... ++..+++|+..... ........+|+.+++++. |||++++++++..+ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999864 57788999876542 222234457899999985 99999999999877 89999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|++ |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 57777775433 468999999999999999999995 89999999999999999 9999999999876432211
Q ss_pred cccccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh-----------hh
Q 047215 670 THVSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ-----------KQ 737 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~ 737 (851)
.....++..|+|||++. ...++.++|||||||++|||++|..||....+.+ ...+..... ..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 12345788999999765 4567899999999999999999999986543322 111111100 00
Q ss_pred cccccccCccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 RSLKSIIDPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 ~~~~~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
........+.... ...+..+..+.+++.+||+.+|++||+++++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000010000 0112456789999999999999999999999999
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.49 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=197.9
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----Cc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~ 583 (851)
.++|...+.||+|+||.||+|+.. .+..++||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357889999999999999999864 5788999987653 333445678899999999999999999988543 35
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++|+||+. ++|.+++... .++++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999996 6888887543 468999999999999999999995 8999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH--------HH
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM--------KW 734 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~--------~~ 734 (851)
..... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.............-.. ..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 43321 12233457889999998864 568999999999999999999999986542211111000000 00
Q ss_pred hhhcccc-------cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 735 QKQRSLK-------SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 735 ~~~~~~~-------~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....... ...++... ...+.++..+.+++.+||+.+|++|||++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 00001000 1123456778999999999999999999999999
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.74 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=195.2
Q ss_pred eeeee--cceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 520 MIGVG--GFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 520 ~LG~G--~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
.||+| +||+||+++. ..++.||+|..... .....+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999986 46789999987643 3344578899999999999999999999999999999999999999
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc---
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH--- 671 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~--- 671 (851)
+|.+++.......+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999876544568899999999999999999995 899999999999999999999999998653221110000
Q ss_pred --cccccccCCcccCccccccc--CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH---------------
Q 047215 672 --VSTAVKGSFGYLDPEYFWRQ--QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM--------------- 732 (851)
Q Consensus 672 --~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~--------------- 732 (851)
......++..|+|||++.+. .++.++|||||||+++||++|+.||........ ......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccchh
Confidence 01112345679999999763 578999999999999999999999875432211 000000
Q ss_pred --HH---------------hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 733 --KW---------------QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 733 --~~---------------~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. ........+.+..+.......+...+.+|+.+||+.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 00000001111222222334567789999999999999999999999999
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=294.74 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=205.5
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|+||.||++... ++..+++|++.... ......+.+|++++++++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999875 56788999887653 35567789999999999999999999999988999999999
Q ss_pred cCCcchhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 591 MANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
+++++|.+++.... ...+++.++..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986543 4678999999999999999999995 899999999999999999999999999987643322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.......|++.|+|||.+....++.++||||+|+++++|++|+.|+...... +....... ..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~--------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK-GQ--------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc-CC---------
Confidence 1233456888999999999889999999999999999999999988654321 11111110 00
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+...+..+.+++.+||..+|++|||+.++++|
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112233455678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.67 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=193.9
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCC-hhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQS-EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||.||+|..++ ++.+|||++.... ......+..|+.++.++. ||||++++++|..+...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888899999999999999865 7889999986542 234456677887777775 9999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++ +|.+++.... ..+++.++.+++.|++.||+|||+ ..+++||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 9864 6666654322 368999999999999999999995 4689999999999999999999999999987532211
Q ss_pred cccccccccCCcccCcccccccC----CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQ----LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||....... +........ ..
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-~~----- 236 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQE-EP----- 236 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcC-CC-----
Confidence 112335788999999987554 8899999999999999999999986422110 001111000 00
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.. ......+..+.+++.+||+.||.+||++++++.|
T Consensus 237 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011 1111345678999999999999999999999999
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.07 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++||||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999864 678889998765432 34567889999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++ +|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 8887775543 568999999999999999999995 899999999999999999999999999987644322 1
Q ss_pred cccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh--hcccccccC---
Q 047215 672 VSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK--QRSLKSIID--- 745 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~i~d--- 745 (851)
......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+...... ..... ......+.+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchhhhh
Confidence 12234578889999998876 78999999999999999999998886543322111100 00000 000000000
Q ss_pred ------ccC----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 ------PHL----KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ------~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.. .....+..+..+.+++.+||+.||.+||++++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 011123456789999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=299.30 Aligned_cols=261 Identities=26% Similarity=0.332 Sum_probs=196.2
Q ss_pred CceeeeeeeecceEEEEEEEcC-cceeEEeecCCCC--hhhHHHHHHHHHHHHhc---CCcceeeEEEEEccCCc-----
Q 047215 515 FDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQS--EQGLAEFETEIEMLSKL---RHRHLVSLIGFCDEQNE----- 583 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~----- 583 (851)
|+..+.||+|+||.||+|+.+. ++.+++|++.... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999764 7889999886432 22234566788877766 59999999999987776
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.+++|||+++ +|.+++.......+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 88888865444568999999999999999999995 8999999999999999999999999999876
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc--
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK-- 741 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 741 (851)
...... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+......+. +..............
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence 432211 1233478899999999999999999999999999999999888765433211 111111100000000
Q ss_pred -------cccCccCC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 -------SIIDPHLK---GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 -------~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
........ ....++....+.+++.+||+.||.+||++++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 11123445778899999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.22 Aligned_cols=242 Identities=26% Similarity=0.372 Sum_probs=196.1
Q ss_pred eeeecceEEEEEEEcC-cceeEEeecCCCCh---hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 521 IGVGGFGKVFKGEIED-CTLAAIKRANPQSE---QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 521 LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
||+|+||.||+++... ++.+++|.+..... .....+.+|++++++++||||+++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 78899998865433 4566789999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc------c
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH------T 670 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~------~ 670 (851)
.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99986543 68999999999999999999994 8999999999999999999999999999875432211 1
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......++..|++||.+.....+.++||||||++++||++|+.|+....+.+ ....... + ..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~--------~~-- 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN-G--------KI-- 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-C--------Cc--
Confidence 12234557889999999988889999999999999999999999986543221 1111111 0 00
Q ss_pred CCChh--HHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 047215 751 NYSPE--SLEKFGEIAEKCLDDEGKNRPTM---GEVLWH 784 (851)
Q Consensus 751 ~~~~~--~~~~l~~l~~~Cl~~dP~~RPt~---~evl~~ 784 (851)
..+.. .+..+.+++.+||+.+|.+|||+ .++++|
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 11112 25678999999999999999999 887777
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=289.30 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=204.5
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..++||+|.||+|.+++- ..++.+|+|++++. .++....-..|-++|+..+||.+..|.-.++..+++|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 6788899999999999999974 46788999998765 4455566678999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||..+|.|.-+|... ..+++......-..|+.||.|||+ ++||.||||.+|.|||.+|.+||+||||++... .
T Consensus 248 eyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--K 320 (516)
T ss_pred EEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc--c
Confidence 999999999998543 457777777788899999999996 999999999999999999999999999998643 3
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
........|||+.|+|||++....|...+|.|.+||++|||+||+.||.......-..+ |+-..+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL---------------Il~ed~ 385 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL---------------ILMEDL 385 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH---------------HHhhhc
Confidence 44456789999999999999999999999999999999999999999976543221111 111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
.+|....++.+.|+...|.+||.+|.. +.||.+|
T Consensus 386 --kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 386 --KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 234444556788999999999999963 6677666
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.28 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=199.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-----ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-----SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 584 (851)
.+|+..+.||+|+||.||+|+.. ++..+++|..... .......+.+|++++++++||||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999864 5788999976432 234456789999999999999999999998653 568
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++++||+++++|.+++... ..+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999998543 357889999999999999999995 89999999999999999999999999998754
Q ss_pred CCCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 665 PSMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 665 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
..... ........++..|+|||++.+..++.++|+|||||+++||++|+.||........ ... +
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~---------~ 221 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFK---------I 221 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHH---------H
Confidence 22111 1111234588999999999988899999999999999999999999865322111 000 1
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
........++....+.+.+++.+||+ +|..||+..+++.|
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11111123445566779999999999 57999999999887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=309.35 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=193.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------C
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------N 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 582 (851)
.++|...+.||+|+||.||+|... ++..+|+|++... .......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999864 6788999987643 223345688999999999999999999998654 3
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++|+||+.. +|..++. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46999999974 6766542 357899999999999999999995 899999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH---------H
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA---------M 732 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~---------~ 732 (851)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............... .
T Consensus 166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 63221 123457889999999876 56899999999999999999999999754322111100000 0
Q ss_pred HHhhhcccccccC--ccC-CCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 733 KWQKQRSLKSIID--PHL-KGN---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 733 ~~~~~~~~~~i~d--~~l-~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.... ........ +.. ... ..+.....+.+++.+||+.||.+||++++++.|
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 241 KLED-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred Hhcc-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000000 000 000 011234568899999999999999999999999
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.64 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=203.9
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..+.||+|++|.||+++.. .++.+++|....... .....+.+|++++++++|||++++++++..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 567899998876643 4567899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++... ..+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999998554 568999999999999999999995 8999999999999999999999999999876443222
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||.+.+..++.++||||+|+++++|++|+.|+....+... .|. .. .. ...
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~--~~-~~---------~~~ 217 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFR--IV-QD---------DHP 217 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHH--Hh-cc---------CCC
Confidence 12345678899999999888899999999999999999999998864332110 010 00 00 111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 2334456678999999999999999999999987
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.19 Aligned_cols=267 Identities=20% Similarity=0.286 Sum_probs=199.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEcc----CCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDE----QNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~ 584 (851)
.++|+..+.||+|+||.||+|... .+..+++|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999864 57889999876542 2345667889999999999999999998753 3568
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+. |+|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 6898888543 358999999999999999999995 89999999999999999999999999998754
Q ss_pred CCCCc--cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH--------
Q 047215 665 PSMEH--THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK-------- 733 (851)
Q Consensus 665 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~-------- 733 (851)
..... ........|+..|+|||.+.. ..++.++|||||||++|||++|+.||.................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32211 111234468899999999865 5689999999999999999999999976443222111000000
Q ss_pred Hhhhccccccc---CccCC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 WQKQRSLKSII---DPHLK---GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 ~~~~~~~~~i~---d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
........+.. ..... ....+..+..+.+++++||+.+|.+||++++++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 00000 00112346779999999999999999999999999
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.98 Aligned_cols=248 Identities=18% Similarity=0.232 Sum_probs=191.7
Q ss_pred HHHHhcCCceeeee--eeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCc
Q 047215 508 IRVATNNFDESLMI--GVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 508 l~~~t~~f~~~~~L--G~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 583 (851)
+....++|++.+.+ |+|+||.||++... ++..+++|......... .|+.....+ +||||+++++++..++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33344566666666 99999999999864 56778888876432111 122222222 79999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSK 662 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~ 662 (851)
.++||||+++|+|.+++.... .+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999986543 78999999999999999999995 8899999999999999888 99999999987
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
..... ....++..|+|||++.+..++.++||||||++++||++|+.|+..... +......+....
T Consensus 159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-------- 223 (267)
T PHA03390 159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ-------- 223 (267)
T ss_pred ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--------
Confidence 53221 224578999999999998999999999999999999999999874322 222222222111
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-MGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 784 (851)
... .......+..+.+++.+||+.+|.+||+ ++|+++|
T Consensus 224 --~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 --QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000 0112245567899999999999999996 6999999
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=300.77 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=197.5
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
.+||+|+||.||++..+ ++..+++|++..........+.+|+.++++++||||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999874 67889999886655556677999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
+++.. ..+++.....++.|++.+|+|||+ .+++||||||+||+++.++.++|+|||++....... .......
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 98743 347899999999999999999995 899999999999999999999999999986543221 1123356
Q ss_pred cCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHH
Q 047215 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757 (851)
Q Consensus 678 gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 757 (851)
|+..|+|||.+.+..++.++|+||||+++|||++|..|+........ .. ... . ...+.+. .....+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~---~~~-~-----~~~~~~~--~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK---MIR-D-----NLPPKLK--NLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHH-h-----hCCcccC--CcccCC
Confidence 88999999999888899999999999999999999998865332211 11 000 0 0111111 112334
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 758 EKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 758 ~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.+++.+||+.+|.+||++.+++.|
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 568899999999999999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=297.49 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=197.4
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-hhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEec
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-QGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
|+..+.||+|++|.||+|... .+..++||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999975 467889998765422 22234567999999999 999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
+|+|.+++.......+++.++..++.|++.+|.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 7899998866554578999999999999999999995 899999999999999999999999999987543211
Q ss_pred cccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH----------HHHHHHHhhhccc
Q 047215 672 VSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL----------ADWAMKWQKQRSL 740 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l----------~~~~~~~~~~~~~ 740 (851)
......++..|+|||++. ...++.++|+||||++++||++|+.|+......+.... ..|..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 122345788999999885 45689999999999999999999988865533221100 0011111000001
Q ss_pred ccccCccC---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHL---KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
........ .....+.....+.+++.+||+.+|.+|||++|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 001111224678999999999999999999999988
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=308.11 Aligned_cols=262 Identities=25% Similarity=0.330 Sum_probs=201.3
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC-----cEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN-----EMI 585 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 585 (851)
+|+..+.||+|++|.||+|+.. .+..+++|++.... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778889999999999999975 47889999887643 444567899999999999999999999987765 789
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||++ ++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||.|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999998 48888885433 78999999999999999999995 899999999999999999999999999998644
Q ss_pred CCCc-cccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh-------
Q 047215 666 SMEH-THVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK------- 736 (851)
Q Consensus 666 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~------- 736 (851)
.... ........++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+.... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHh
Confidence 3221 0112334578899999999887 899999999999999999999999876543221110 000000
Q ss_pred ----hcccccccC---ccC---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 ----QRSLKSIID---PHL---KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ----~~~~~~i~d---~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.......+. ..- .....+..+..+.+++.+||+.+|.+|||+++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000 000112345678999999999999999999999999
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.36 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=207.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
..+.|..-++||+||||.||-.+.. .|+.+|.|++.+. .+++......|-.+|.+++.+.||.|--.++.++.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888999999999999988754 5788888876543 33444557789999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|+..|.||+|.-||.+...+.+++..++..+.+|+.||++|| +.+||.|||||+|||||+.|.++|+|+|||...+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999999888888999999999999999999999 59999999999999999999999999999987543
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.. ......||.+|||||+++...|+...|.||+||+||||+.|+.||..........- +.+ .+..
T Consensus 340 g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdr--------r~~~- 404 (591)
T KOG0986|consen 340 GK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDR--------RTLE- 404 (591)
T ss_pred CC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHH--------HHhc-
Confidence 22 23344799999999999999999999999999999999999999865432211100 000 0110
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
-...++..-+++++.|.+..|++||++|.. +++|-+|
T Consensus 405 -~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 405 -DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred -chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 011344455566888999999999999874 5678777
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=292.68 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=202.9
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..++||+|+||.||++... ++..+++|.+... .......+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999754 5678899987653 334456788999999999999999999999989999999999
Q ss_pred cCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 591 MANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988542 23568899999999999999999995 89999999999999999999999999999764432
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......++..|++||.+.+..++.++|+||||++++||++|+.|+......+ +.. .. .. ..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~-~~---------~~ 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRY---KV-QR---------GK 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HH-hc---------CC
Confidence 2223457889999999999999999999999999999999999986543221 111 00 01 11
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+...+..+.+++.+||+.+|.+||++.++++|
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112233456779999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.25 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=192.2
Q ss_pred eeeeecceEEEEEEEc-CcceeEEeecCCCCh---hhHHHHHHHHH---HHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 520 MIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE---QGLAEFETEIE---MLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~---~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
+||+|+||.||++... .++.+|+|.+..... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 567899998765421 22223444444 3444579999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|+|.+++... ..+++.++..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++..... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 99999988543 468999999999999999999995 89999999999999999999999999998753221 1
Q ss_pred ccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....|+..|+|||.+.+. .++.++||||+||++|||++|+.||............ ... ....+ .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~------~~~~~----~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT------LTMAV----E 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHh------hccCC----C
Confidence 2234689999999998744 6899999999999999999999998765332211110 000 00111 2
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHHhhhhhcccC
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.+...+..+.+++.+||..+|.+|| ++.++++| +|+.+.
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~---------~~~~~~ 261 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH---------PFFRSL 261 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC---------ccccCC
Confidence 2333456789999999999999999 99999998 777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.77 Aligned_cols=270 Identities=23% Similarity=0.289 Sum_probs=202.1
Q ss_pred ccCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEE
Q 047215 502 RFTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578 (851)
Q Consensus 502 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 578 (851)
.....++...+++|+..+.||+|+||.||+|.. .++..+|+|++... .....+.+.+|+.++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 445566777889999999999999999999985 46788999988653 233356688899999999999999999988
Q ss_pred ccC------CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 579 DEQ------NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 579 ~~~------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
... ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 533 3468888876 77998887543 48899999999999999999995 89999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHH-
Q 047215 653 AKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW- 730 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~- 730 (851)
+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus 159 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 159 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999875322 1233467889999998866 5789999999999999999999998865432211100000
Q ss_pred --------HHHHhhh------cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 731 --------AMKWQKQ------RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 731 --------~~~~~~~------~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....... ..+..+...... .........+.+++.+||+.||.+||++.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 000000000000 0011234568899999999999999999999999
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=325.71 Aligned_cols=265 Identities=25% Similarity=0.441 Sum_probs=209.6
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEcC--------cceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEE
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIED--------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGF 577 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~ 577 (851)
++...++..+.+.||+|.||.|++|.... ...||||.++.. ...+.+.+..|+++|+.+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34444555566689999999999997531 346899998765 445678899999999999 69999999999
Q ss_pred EccCCcEEEEEEecCCcchhhhccCCC------C--------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCC
Q 047215 578 CDEQNEMILVYEYMANGTLRSHLFGSD------L--------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTT 643 (851)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~------~--------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~ 643 (851)
|..++..++|+||+.+|+|.++|+.++ . ..++..+++.++.|||.||+||++ .++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence 999999999999999999999997654 1 138889999999999999999995 88999999999
Q ss_pred CeEEcCCCeEEEeeccccccCCCCCcccccc-ccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCc
Q 047215 644 NILLDENFVAKMSDFGLSKTGPSMEHTHVST-AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPK 722 (851)
Q Consensus 644 NILld~~~~~kl~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~ 722 (851)
|||+.++..+||+|||+++............ ...-+..|||||.+....|+.|+|||||||+||||++...++.+..+.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999755443332221 111345799999999999999999999999999999965543333221
Q ss_pred chhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
. ..+.+ +.+ +..+...|..|..++.++++.||+.+|++||++.++.+.++..+
T Consensus 528 ~-~~l~~----~l~---------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 528 T-EELLE----FLK---------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred H-HHHHH----HHh---------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1 11111 111 22233446677888999999999999999999999999998753
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=302.58 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=191.6
Q ss_pred eeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchhh
Q 047215 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRS 598 (851)
Q Consensus 521 LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 598 (851)
+|.|+++.||++.. +++.+|+|++... .......+.+|++++++++||||+++++++..++..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44445555555554 5788999987654 44556789999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc-----cccc
Q 047215 599 HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH-----THVS 673 (851)
Q Consensus 599 ~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-----~~~~ 673 (851)
++.......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||.+........ ....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 9976544568899999999999999999995 8999999999999999999999999998865322111 1112
Q ss_pred cccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh-----------hccc
Q 047215 674 TAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK-----------QRSL 740 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~~~~ 740 (851)
....++..|+|||++.. ..++.++|||||||++|||++|+.||........ +.+....... ....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCc
Confidence 33457788999999875 4588999999999999999999999875432211 1110000000 0000
Q ss_pred cc----ccCccC----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KS----IIDPHL----KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~----i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. ..++.. ...........+.+++.+||+.||++|||++++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 000000 011122344678899999999999999999999999
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=306.09 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=208.7
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
....|.+.+.||+|.|+.|..|+. ..+..||||.+.+. +......+.+|+++|+.|+|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346788899999999999999986 45788999998775 333345688999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+.+|.++++|.... .+.+.....++.|+.++++|||+ +.|||||||++||||+.+..+||+|||++....
T Consensus 134 ~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999996654 46668889999999999999995 999999999999999999999999999987633
Q ss_pred CccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
......+.+|++.|.|||++.+..| .+++|+||+|++||.|++|..||++..-.+ +-++
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~r 266 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPR 266 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccch
Confidence 4445677899999999999998766 579999999999999999999998643221 1111
Q ss_pred cCCC--CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 747 HLKG--NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 747 ~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.+.+ .++.....++.++++++|..+|.+|++++++.+|-+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 1211 233445566889999999999999999999999944
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=289.97 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=188.7
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCCCh---hhHHHHHHHHHHH-HhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE---QGLAEFETEIEML-SKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
+.||+|+||.||+|... +++.+|+|.+..... .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 578899998865432 2223445555544 455899999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 9999998543 358899999999999999999995 8999999999999999999999999999875322 2
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....++..|++||.+.+..++.++||||||++++||++|..|+....... ...... .... .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~------~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNIL-SRRI------NWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hccc------CCCCccc
Confidence 23457889999999988889999999999999999999999986543221 111110 0000 0111122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTM---GEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~---~evl~~ 784 (851)
..++..+.+++.+||+.+|++||++ +|++.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 3456779999999999999999955 677777
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=302.30 Aligned_cols=270 Identities=20% Similarity=0.269 Sum_probs=198.9
Q ss_pred cCCce-eeeeeeecceEEEEEEEc-CcceeEEeecCCCChhh--------------HHHHHHHHHHHHhcCCcceeeEEE
Q 047215 513 NNFDE-SLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQG--------------LAEFETEIEMLSKLRHRHLVSLIG 576 (851)
Q Consensus 513 ~~f~~-~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~HpnIv~l~g 576 (851)
++|.. .+.||+|+||.||+|... .++.+|+|......... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34433 457999999999999864 57889999876432211 124778999999999999999999
Q ss_pred EEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEe
Q 047215 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~ 656 (851)
++..++..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999997 689888854 3458899999999999999999994 899999999999999999999999
Q ss_pred eccccccCCCCC------------ccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc
Q 047215 657 DFGLSKTGPSME------------HTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723 (851)
Q Consensus 657 DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~ 723 (851)
|||+++...... .........++..|+|||++.+. .++.++|||||||++|||++|+.|+....+.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999987543100 01111233468889999998764 47999999999999999999999887554322
Q ss_pred hhcHHHHHHHHhhhcc---cccc--------cCccCC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 724 QINLADWAMKWQKQRS---LKSI--------IDPHLK---GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 724 ~~~l~~~~~~~~~~~~---~~~i--------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.. ........... .... ...... .......+..+.+++.+||+.+|++|||++|++.|
T Consensus 242 ~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~----- 313 (335)
T PTZ00024 242 QL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH----- 313 (335)
T ss_pred HH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC-----
Confidence 11 11111100000 0000 000000 00112335678899999999999999999999999
Q ss_pred HhhhhhcccCC
Q 047215 790 QLHEAWMRTDD 800 (851)
Q Consensus 790 ~~~~~w~~~~~ 800 (851)
+|++...
T Consensus 314 ----~~~~~~~ 320 (335)
T PTZ00024 314 ----EYFKSDP 320 (335)
T ss_pred ----cccCCCC
Confidence 8887543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.32 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=203.9
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV 587 (851)
++|...+.||+|+||.||+|... +++.+++|..... .......+..|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999875 6788999987652 2344567889999999998 99999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999998554 369999999999999999999995 89999999999999999999999999998754322
Q ss_pred Cc------------------cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH
Q 047215 668 EH------------------THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729 (851)
Q Consensus 668 ~~------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~ 729 (851)
.. ........++..|+|||.+....++.++||||||++++++++|+.|+....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~- 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TF- 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HH-
Confidence 11 012233457889999999988889999999999999999999999987543111 00
Q ss_pred HHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 047215 730 WAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM----GEVLWH 784 (851)
Q Consensus 730 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~~ 784 (851)
... . .....++...++.+.+++.+||+.+|.+||++ +++++|
T Consensus 232 --~~~---------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 --QKI---------L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred --HHH---------H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 000 0 01112334446678999999999999999999 999988
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=294.80 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=198.3
Q ss_pred CCceeeeeeeecceEEEEEEE----cCcceeEEeecCCCC----hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI----EDCTLAAIKRANPQS----EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 584 (851)
+|+..+.||+|+||.||+++. .++..+|+|++.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 367889999876532 22346688899999999 599999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++|+||+++++|.+++... .++++.++..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998543 457889999999999999999994 89999999999999999999999999998764
Q ss_pred CCCCccccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.... ........|+..|+|||.+.. ..++.++||||||+++|+|++|+.|+...... ....+........
T Consensus 156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~----- 227 (290)
T cd05613 156 HEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS----- 227 (290)
T ss_pred cccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc-----
Confidence 3211 112223568899999999875 35788999999999999999999998643221 1111111111100
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
...++......+.+++.+||+.+|.+|| ++++++.|
T Consensus 228 ------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0122344556789999999999999997 88999888
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=294.08 Aligned_cols=259 Identities=15% Similarity=0.170 Sum_probs=182.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCc----ceeEEeecCCCChhhH-----------HHHHHHHHHHHhcCCcceeeEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDC----TLAAIKRANPQSEQGL-----------AEFETEIEMLSKLRHRHLVSLIG 576 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~HpnIv~l~g 576 (851)
.++|.+.++||+|+||.||+|...+. ..+++|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36788999999999999999987543 4556665433222111 11223344556678999999999
Q ss_pred EEccCC----cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 577 FCDEQN----EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 577 ~~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+ .+++||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 775443 34677776643 555555322 235678889999999999999995 89999999999999999999
Q ss_pred EEEeeccccccCCCCCcc-----ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH
Q 047215 653 AKMSDFGLSKTGPSMEHT-----HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l 727 (851)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+|+||++|+.||.........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~-- 242 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL-- 242 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--
Confidence 999999999754321110 1122346999999999999999999999999999999999999999765322211
Q ss_pred HHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 728 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
..... .+....+..+.+. .+.++..+.+++..|++.+|++||+++++++.|
T Consensus 243 ~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAK----CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhH----HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10000 0001111111111 123457799999999999999999999998765
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=299.47 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=198.5
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-CCc
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-QNE 583 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~ 583 (851)
+...+++|+..+.||+|+||.||++... ++..+++|++... .....+.+..|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446789999999999999999999854 6788999987542 23345678899999999999999999998855 567
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++++||+ +++|.+++... ++++.....++.|+++||.|||+ .+++||||||+|||+++++.+||+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999998 46888887532 47788888999999999999995 8999999999999999999999999999875
Q ss_pred CCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH---------HHHHHH
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL---------ADWAMK 733 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l---------~~~~~~ 733 (851)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||........... .+|...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3221 123456889999998765 5789999999999999999999998865432111100 001110
Q ss_pred HhhhcccccccCccCCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 WQKQRSLKSIIDPHLKGNYS-----PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 ~~~~~~~~~i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.........+..-......+ +..+..+.+++.+||+.+|++|||+++++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000011111 2345779999999999999999999999999
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=296.23 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=196.3
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
|...+.||+|+||.||+|+.. .+..+++|++... .......+.+|++++++++|||++++++++..+...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445567999999999999864 5678899987643 233446788999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+. |+|.+.+.... .++++.++..++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 57777664432 468999999999999999999995 8999999999999999999999999999864221
Q ss_pred ccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 671 HVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.....|+..|+|||++. ...++.++|||||||++|||++|+.|+........ ....... .. +.
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~-~~-----~~ 239 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-DS-----PT 239 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc-CC-----CC
Confidence 12346888999999984 45688999999999999999999998865432211 1111100 00 11
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
. .....+..+.+++.+||+.+|.+||++.+++.| +|++.
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~---------~~~~~ 278 (313)
T cd06633 240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH---------DFVRR 278 (313)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC---------cccCC
Confidence 1 112234568999999999999999999999999 88764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=301.41 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=193.2
Q ss_pred CCceeeeeeeecceEEEEEEEcC---cceeEEeecCCC--ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc----CCc
Q 047215 514 NFDESLMIGVGGFGKVFKGEIED---CTLAAIKRANPQ--SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE----QNE 583 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~----~~~ 583 (851)
+|+..+.||+|+||.||+++... +..+|+|++... .....+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788899999999999998653 568899987643 223345678899999999 59999999997532 245
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++++||+. ++|.+.+.. ...+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899886 588888844 3468899999999999999999995 8999999999999999999999999999975
Q ss_pred CCCCCc--cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH---------HHH
Q 047215 664 GPSMEH--THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA---------DWA 731 (851)
Q Consensus 664 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~---------~~~ 731 (851)
...... ........|+..|+|||.+.+ ..++.++|||||||++++|++|+.||............ ++.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 432111 111233568999999998765 57899999999999999999999988754322111000 000
Q ss_pred HHHhhhc------ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 732 MKWQKQR------SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 732 ~~~~~~~------~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.... .........+ ....+.....+.+++.+||+.+|.+|||+.+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000000 01112235678999999999999999999999999
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=298.44 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=193.5
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.|+..+.||+|+||.||+|+.. ++..+++|.+... ......++.+|++++++++|+|++++++++..+...++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3555678999999999999864 5677889887532 33445678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+. |+|.+.+.... .++++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 997 57777764332 458899999999999999999995 8999999999999999999999999999875322
Q ss_pred cccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 670 THVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.....++..|+|||.+. ...++.++|||||||++|||++|+.|+........ ...... .. .+
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~~-----~~ 232 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NE-----SP 232 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhh-cC-----CC
Confidence 12345788999999974 35688899999999999999999998765322111 111100 00 01
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. .....+..+.+++.+||+.+|.+||++++++.|
T Consensus 233 ~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 233 AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred Cc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11 122345668999999999999999999999999
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=321.42 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=190.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-------- 581 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-------- 581 (851)
.++|+..++||+||||.|||++.+ ||..+|||++... +........+|+.+|++|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 467888889999999999999965 7899999998765 445556788999999999999999997532110
Q ss_pred --------------------------------------------------------------------------------
Q 047215 582 -------------------------------------------------------------------------------- 581 (851)
Q Consensus 582 -------------------------------------------------------------------------------- 581 (851)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC
Q 047215 582 -------------------------------NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630 (851)
Q Consensus 582 -------------------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~ 630 (851)
..+||-||||+.-+|++++..+.... .....++++.+|++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH-- 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH-- 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH--
Confidence 02578899999988888885544221 45678899999999999999
Q ss_pred CCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC----------------CCCccccccccccCCcccCccccccc---
Q 047215 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP----------------SMEHTHVSTAVKGSFGYLDPEYFWRQ--- 691 (851)
Q Consensus 631 ~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~--- 691 (851)
+.+||||||||.||+||+...|||+|||+|.... ........+...||.-|+|||.+.+.
T Consensus 715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 4899999999999999999999999999997611 00111134567899999999999755
Q ss_pred CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC--CCCChhHHHHHHHHHHHhcc
Q 047215 692 QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK--GNYSPESLEKFGEIAEKCLD 769 (851)
Q Consensus 692 ~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~--~~~~~~~~~~l~~l~~~Cl~ 769 (851)
+|+.|+|+||+||||+||+. ||...++. +.-+. .+. ++.+. ..+..+..+.-..+++++++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--------a~iL~---~LR---~g~iP~~~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMER--------ASILT---NLR---KGSIPEPADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHH--------HHHHH---hcc---cCCCCCCcccccccchHHHHHHHHHhc
Confidence 49999999999999999983 34433211 11111 111 11221 22333444456789999999
Q ss_pred cCCCCCCCHHHHHHH
Q 047215 770 DEGKNRPTMGEVLWH 784 (851)
Q Consensus 770 ~dP~~RPt~~evl~~ 784 (851)
.||.+|||+.|+|.+
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999987
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=305.32 Aligned_cols=270 Identities=21% Similarity=0.290 Sum_probs=199.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC----------
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ---------- 581 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~---------- 581 (851)
.+|...+.||+|+||.||+|... .+..+++|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67889999999999999999864 5778999988766666667889999999999999999999876543
Q ss_pred ----CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEEe
Q 047215 582 ----NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMS 656 (851)
Q Consensus 582 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl~ 656 (851)
...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 588887743 358899999999999999999994 8999999999999997 56689999
Q ss_pred eccccccCCCCCc-cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH---
Q 047215 657 DFGLSKTGPSMEH-THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA--- 731 (851)
Q Consensus 657 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~--- 731 (851)
|||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875322111 111123357889999998754 56889999999999999999999999754332211100000
Q ss_pred ------HHHhh-h-cccc-cccCccC-CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 732 ------MKWQK-Q-RSLK-SIIDPHL-KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 732 ------~~~~~-~-~~~~-~i~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..... . .... ....+.. .....+.....+.+++.+||+.||.+|||++|++.| +|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h---------~~~~~ 305 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH---------PYMSC 305 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC---------Ccccc
Confidence 00000 0 0000 0000000 000112344668899999999999999999999999 88864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=295.79 Aligned_cols=268 Identities=25% Similarity=0.311 Sum_probs=194.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccC-------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------- 581 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------- 581 (851)
.++|+..++||+|+||.||+|... +++.+++|++..... .....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 567889998754322 2234677899999999999999999987433
Q ss_pred -CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 582 -NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
..+++|+||+.+ +|...+... ...+++.++..++.|+++||.|||+ .+++||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999975 666666443 3468999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCcc---------ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHH
Q 047215 661 SKTGPSMEHT---------HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW 730 (851)
Q Consensus 661 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~ 730 (851)
++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.|+..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8753321111 11233457888999998865 4589999999999999999999999875443322111100
Q ss_pred HHH------Hhhhccccccc----CccCCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 731 AMK------WQKQRSLKSII----DPHLKGN---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 731 ~~~------~~~~~~~~~i~----d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
... +.....+.... ....... ......+.+.+++.+||+.+|.+|||+.|++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000 00000000000 0000000 001223568899999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=306.75 Aligned_cols=270 Identities=27% Similarity=0.384 Sum_probs=208.2
Q ss_pred ceeeeeeeecceEEEEEEE-cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------CcEEEE
Q 047215 516 DESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------NEMILV 587 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~lV 587 (851)
...+.||+|+||.||+|+. ..|..+|||.+... .....+...+|+++|++|+|||||++++.-+.. ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3445799999999999994 67899999998875 334456678899999999999999999986554 367999
Q ss_pred EEecCCcchhhhccCC-CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE--cCCC--eEEEeeccccc
Q 047215 588 YEYMANGTLRSHLFGS-DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL--DENF--VAKMSDFGLSK 662 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl--d~~~--~~kl~DFGla~ 662 (851)
||||.+|||...|... +...|++.+.+.++.+++.||.||| +++|+||||||.||++ ..+| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999999654 3456999999999999999999999 5999999999999999 2333 57999999999
Q ss_pred cCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
..... .....+.||..|++||.... ..|+..+|.|||||++||.+||..||.+........-..|...........
T Consensus 173 el~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 173 ELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred cCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 75432 35677889999999999984 889999999999999999999999998865543222233332222221111
Q ss_pred cccCccC------------CCCCChhHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHHHHh
Q 047215 742 SIIDPHL------------KGNYSPESLEKFGEIAEKCLDDEGKNRP--TMGEVLWHLEYVLQL 791 (851)
Q Consensus 742 ~i~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--t~~evl~~L~~~~~~ 791 (851)
-..++.. ....+......+-+.+..+|..+|++|- ...+....+..+++.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 1111111 1223344556677888899999999998 777777777777654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=308.33 Aligned_cols=261 Identities=28% Similarity=0.387 Sum_probs=216.3
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEc-
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCD- 579 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~- 579 (851)
..++.+...++-|++.+.||.|.+|.||+++. ++++.+|+|+...... ..++...|.++|+.+ +|||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44556666788899999999999999999985 5678889998776543 346778899999988 6999999999983
Q ss_pred ----cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEE
Q 047215 580 ----EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKM 655 (851)
Q Consensus 580 ----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl 655 (851)
.++++|||||||.+|+..|++++.....+.|..+..|++.+++||.+|| +..+||||||-.||||+.++.+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence 4579999999999999999998877788999999999999999999999 588999999999999999999999
Q ss_pred eeccccccCCCCCccccccccccCCcccCccccccc-----CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-----QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW 730 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~ 730 (851)
+|||++..... ......+..||+.|||||++... .|+..+|+||||++..||.-|.+|+.+..|...
T Consensus 165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------ 236 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------ 236 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------
Confidence 99999876332 22234556799999999999743 477899999999999999999999887665322
Q ss_pred HHHHhhhcccccc-cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 731 AMKWQKQRSLKSI-IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 731 ~~~~~~~~~~~~i-~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+..| -.|...-.-+..-.+++-+++..||.+|..+||++.++|+|
T Consensus 237 ---------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 ---------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111 12222223456677889999999999999999999999999
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=279.13 Aligned_cols=274 Identities=23% Similarity=0.309 Sum_probs=211.2
Q ss_pred hcCCcee-eeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEc----cCCcE
Q 047215 512 TNNFDES-LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCD----EQNEM 584 (851)
Q Consensus 512 t~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~----~~~~~ 584 (851)
+++|.+. ++||-|-.|.|-....+ .+...|+|++... ...++|+++.-+. .|||||+++++++ ....+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455443 57999999999988764 4667899988653 3347788876655 5999999999874 34678
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeecccc
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLS 661 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla 661 (851)
++|||.|+||.|...++.+....++++++..|..||+.|+.|||+ .+|.||||||+|+|.. .|-.+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccc
Confidence 999999999999999998888899999999999999999999995 9999999999999995 5668999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
+... ......+.+-|+.|.|||++...+|+..+|+||+||++|-|+||.+||........ + .+...
T Consensus 212 K~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-s----------pgMk~ 277 (400)
T KOG0604|consen 212 KETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-S----------PGMKR 277 (400)
T ss_pred cccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-C----------hhHHh
Confidence 8632 12334567889999999999999999999999999999999999999986543211 0 11111
Q ss_pred cccCccC--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCC--CCCcccchhhhhhhh
Q 047215 742 SIIDPHL--KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR--QNSFSSSQALGEFAE 816 (851)
Q Consensus 742 ~i~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~--~~~~~~~~~~~~~~~ 816 (851)
+|....+ ..+-...+++..+++++.+|..+|++|.|++|+++| +|...... +.....+..+++..+
T Consensus 278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h---------pwi~~~~~vp~tpl~t~~~l~~a~e 347 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH---------PWINQYEAVPQTPLSTSRMLKEAVE 347 (400)
T ss_pred HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC---------chhcccccCCCCCchhhhhcchhhh
Confidence 1211111 111124567889999999999999999999999999 88764432 333344444444443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=301.27 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=197.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC-----
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN----- 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----- 582 (851)
..++|+..+.||+|+||.||++.. .++..+|+|+.... .......+.+|+.++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999985 46788999987543 2333456889999999999999999999986553
Q ss_pred -cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 583 -EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
..++||||+ +++|.+++.. ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 6789888753 358899999999999999999994 89999999999999999999999999998
Q ss_pred ccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhc-H--------HHHH
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN-L--------ADWA 731 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~-l--------~~~~ 731 (851)
+..... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||.......... . .++.
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 763321 123457889999999875 468999999999999999999999987543211100 0 0011
Q ss_pred HHHhhhc------ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 732 MKWQKQR------SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 732 ~~~~~~~------~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....... .+.......+ ....+.+...+.+++.+||+.||.+|||+.+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1000000 0000000000 01123445568899999999999999999999999
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=290.53 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=193.6
Q ss_pred CCceeeeeeeecceEEEEEEEcCc-ceeEEeecC---CC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRAN---PQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~-~~vavK~~~---~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
+|.+.++||+|+||.||++..... ...++|... .. .......+..|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 467788999999999999986432 233333332 21 223344577899999999999999999999999999999
Q ss_pred EEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 588 YEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||+++++|.+++.. .....+++.++..++.|+++||.|||+ .+++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 234568999999999999999999994 89999999999999975 569999999987643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+..... ........ .
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~---------~ 219 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV---------E 219 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH---------c
Confidence 221 122345678899999999888899999999999999999999998854321 11111111 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+...+..+.+++.+||+.+|++||++.|+++|
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01112234556678999999999999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=293.05 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=198.4
Q ss_pred CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
|+..+.||+|++|.||+|+.. +++.+++|...... ....+.+..|+.++++++|||++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999876 47889999887653 334567889999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
+ ++|.+++.... ..+++.++.+++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 8 58999986543 468999999999999999999995 8999999999999999999999999999876432211
Q ss_pred cccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh---------hhcccc
Q 047215 672 VSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ---------KQRSLK 741 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~---------~~~~~~ 741 (851)
......++..|+|||.+.+. .++.++|||||||+++||++|+.|+......+. ........ ....+.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccc
Confidence 12233457789999998766 889999999999999999999988865432211 11111000 000000
Q ss_pred --cccCccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 --SIIDPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 --~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...-+.... ...+.....+.+++.+||+.+|++||++++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 0111235679999999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=290.11 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=194.7
Q ss_pred CCceeeeeeeecceEEEEEEE----cCcceeEEeecCCCC----hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcE
Q 047215 514 NFDESLMIGVGGFGKVFKGEI----EDCTLAAIKRANPQS----EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 584 (851)
+|+..+.||+|++|.||+++. .++..++||.+.... ......+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999974 345778999876431 23345688999999999 699999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+++|+|.+++... ..+++.++..++.|++++|.|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999988543 458899999999999999999995 89999999999999999999999999998764
Q ss_pred CCCCccccccccccCCcccCcccccccC--CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQ--LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.... ........|+..|+|||.+.+.. .+.++||||||++++||++|+.|+....... ...+.......
T Consensus 156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~------ 226 (288)
T cd05583 156 LAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILK------ 226 (288)
T ss_pred cccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHc------
Confidence 3221 11223346889999999987654 7899999999999999999999986432211 11111111100
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+ ..+...+..+.+++.+||+.+|++|||+.++.+.
T Consensus 227 -~~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 227 -SKP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred -cCC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 011 1223344568899999999999999997655433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=302.33 Aligned_cols=261 Identities=22% Similarity=0.308 Sum_probs=197.1
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc----
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE---- 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~---- 583 (851)
..++|+..+.||+|++|.||+|+.. ++..+++|++... .......+.+|+.++++++||||+++++++..++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999875 5678899987643 23344667889999999999999999998765554
Q ss_pred --EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 584 --MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 584 --~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 5699888854 358999999999999999999995 89999999999999999999999999998
Q ss_pred ccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH-H--------HHH
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL-A--------DWA 731 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l-~--------~~~ 731 (851)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... . .+.
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 764221 233457889999999865 4688999999999999999999999865433211100 0 000
Q ss_pred HHHhhhcccccccCc---cCCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 732 MKWQKQRSLKSIIDP---HLKGN---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~---~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.... ....+.. ..... .....+..+.+++.+||+.+|.+|||+.+++.|
T Consensus 241 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSES-ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchh-HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 0000000 00000 011235678999999999999999999999999
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-33 Score=296.30 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=202.1
Q ss_pred eeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 518 SLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
.++||.|.||+||-|.+ +.|+.||||.+.+. ..++...+++|+.+|++++||.||.|-.-|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 46899999999999986 56889999988764 45556789999999999999999999999999999999999995 5
Q ss_pred chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeeccccccCCCCCccc
Q 047215 595 TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 595 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++.+++..+..++|++..-..++.||+.||.||| .++|+|+||||+||||. .--++||||||.||.... ..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence 6666666666788999999999999999999999 59999999999999995 345799999999998543 33
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
....+.||+.|+|||+++.+.|...-|+||.||++|.-++|-.||+....- .+.++ +-.-+..+.-
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQ---------NAaFMyPp~P--- 787 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQ---------NAAFMYPPNP--- 787 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhh---------ccccccCCCc---
Confidence 456788999999999999999999999999999999999999999754221 11111 1111222222
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+......+|+...|+..-++|-|..+.+.|
T Consensus 788 -W~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 -WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 23555668899999999999999999999999
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=278.50 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=206.2
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN 582 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 582 (851)
+.++..-|. ++||+|+|+.|--+. +..+..+|||++.+..........+|++++.+. .|+||++|++|++++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 344444443 369999999998875 678889999999988777788899999999999 5999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC---CeEEEeecc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN---FVAKMSDFG 659 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~---~~~kl~DFG 659 (851)
.+|||||-|.+|+|..+|+.+ ..+++.+..++..+||.||.+|| +++|.||||||+|||-... .-+|||||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999654 46899999999999999999999 5999999999999998543 358999998
Q ss_pred ccccCCC-----CCccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch-hcHH
Q 047215 660 LSKTGPS-----MEHTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ-INLA 728 (851)
Q Consensus 660 la~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~-~~l~ 728 (851)
|..-... ...+....+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+.-..+- .+-.
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8653211 11112234567999999999874 45789999999999999999999999986543221 0000
Q ss_pred HHHHHHhhhcccccccCccCCCCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 729 DWAMKWQKQRSLKSIIDPHLKGNYS----PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 729 ~~~~~~~~~~~~~~i~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+-.+.+ +..-++.|-+..+ ++| ...+...++++...|..++.+|.++.++++|
T Consensus 305 e~Cr~C-Q~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 305 EVCRVC-QNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CccHHH-HHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 000000 1111222333222 233 3456778999999999999999999999999
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=273.53 Aligned_cols=268 Identities=22% Similarity=0.268 Sum_probs=194.1
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-----cceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEcc-CCcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-----CTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDE-QNEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~ 584 (851)
..|+.++.||+|.||.||||.-.+ .+.+|||+++.... .--....+|+.+++.++||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 467888899999999999995432 23679998876522 112346789999999999999999999866 8899
Q ss_pred EEEEEecCCcchhhhccCC---CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC----CeEEEee
Q 047215 585 ILVYEYMANGTLRSHLFGS---DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN----FVAKMSD 657 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~----~~~kl~D 657 (851)
+|++||.++ +|...++-+ ....++...+..|++||+.|++|||+ .=|+||||||.||||..+ |++||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999998 777777432 23568888899999999999999995 779999999999999776 9999999
Q ss_pred ccccccCCCCCccc-cccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc------hhcHHH
Q 047215 658 FGLSKTGPSMEHTH-VSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD------QINLAD 729 (851)
Q Consensus 658 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~------~~~l~~ 729 (851)
||++|.....-..- ....+.-|..|.|||.+.+ ..||.+.|||+.||++.||+|-.+.|......- +.+..+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999754332221 2334567899999999886 579999999999999999999998886532211 111111
Q ss_pred HHHHHhhhcccccccC----cc-----------CCCCCC--------hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 730 WAMKWQKQRSLKSIID----PH-----------LKGNYS--------PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 730 ~~~~~~~~~~~~~i~d----~~-----------l~~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
............++.+ |. .....+ ..-++...+|+.++|..||.+|.|++++++|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111100000000000 00 000000 0011236789999999999999999999999
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-33 Score=326.58 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=203.1
Q ss_pred HhcCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.+-++.....||.|.||.||-|. .+.|...|+|.+... .........+|+.++..++|||+|+++|+-.+.++.+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34556667789999999999997 467788899876543 345556788999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
||||++|+|.+++...+ -+++.-......|++.|+.||| ++|||||||||.||+|+.+|.+|++|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999985443 2445555667889999999999 599999999999999999999999999999764432
Q ss_pred C--ccccccccccCCcccCccccccc---CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 668 E--HTHVSTAVKGSFGYLDPEYFWRQ---QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 668 ~--~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
. .........||+.|||||++.+. .-..++||||+|||.+||+||+.||..... +|+..++-..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~---- 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAA---- 1456 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhc----
Confidence 1 11122456799999999999754 355689999999999999999999975432 3444332111
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.-.+.+|...+..-++++..||+.||+.|.++.|+++|
T Consensus 1457 ----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 ----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11234455677778999999999999999999999998
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=318.04 Aligned_cols=258 Identities=23% Similarity=0.311 Sum_probs=211.7
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 580 (851)
..+++...++|++.++||+|+||.|...+.+ .++++|+|++++. .......|..|-.+|.--+.+-|++|+-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4567778899999999999999999999875 4678899998863 33445789999999999999999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
+..+|||||||+||+|-.++.... ++++.-+...+..|..||+-||+ .|+|||||||.|||||..|.+||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999996554 67888888889999999999994 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccCCcccCccccc----c-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFW----R-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
+..+.. +....+....|||.|++||+++ + +.|++.+|.||+||++|||+.|..||+.. ++++-.
T Consensus 222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY---- 290 (1317)
T KOG0612|consen 222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETY---- 290 (1317)
T ss_pred HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHH----
Confidence 865443 3344456677999999999996 2 57999999999999999999999999753 222221
Q ss_pred hhcccccccCccCCCCCC--hhHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 047215 736 KQRSLKSIIDPHLKGNYS--PESLEKFGEIAEKCLDDEGKNRPT---MGEVLWH 784 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 784 (851)
..|++..-.-.|| .++++..++||++.+. +|+.|.. ++++-.|
T Consensus 291 -----~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 -----GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -----HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1222221111233 4567789999999776 6888887 9999999
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.43 Aligned_cols=240 Identities=26% Similarity=0.341 Sum_probs=195.8
Q ss_pred eeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 521 IGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 521 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
||+|+||.||++... +++.+++|.+.... ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 47788999876542 23456889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 676 (851)
.+++... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 9998554 358999999999999999999995 999999999999999999999999999987643221 123345
Q ss_pred ccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 677 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
.++..|++||.+.+...+.++|+||||+++|||++|+.|+..... ... .... ... ...++...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~---~~~~---------~~~--~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI---YEKI---------LKD--PLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHH---------hcC--CCCCCCCC
Confidence 678899999999988899999999999999999999999854322 111 1111 111 11233344
Q ss_pred HHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTM---GEVLWH 784 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~---~evl~~ 784 (851)
+..+.+++.+||..||.+||++ +++++|
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 5678999999999999999999 788777
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=315.52 Aligned_cols=145 Identities=30% Similarity=0.426 Sum_probs=129.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|.+.++||+|+||.||+|... .+..+|||++... .......+..|+.+++.++||||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999875 5788999987643 2334567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
||+++++|.+++... ..+++..+++++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998543 357888999999999999999995 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=277.19 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=192.8
Q ss_pred eeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEecCCc
Q 047215 518 SLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMANG 594 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~~~g 594 (851)
...||.|.||+|+|-.++ .++..|||+++... .....++..|.+...+- +.||||+++|.+..++..||.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 457999999999999864 67889999988763 46677888888876665 799999999999999999999999964
Q ss_pred chhhh---ccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 595 TLRSH---LFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 595 sL~~~---L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
||..+ ++......+++..+-.|......||.||.. +..|||||+||+|||||..|.+||||||++.... .+-
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DSI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---HHH
Confidence 55333 333344568888888999999999999997 7889999999999999999999999999986532 222
Q ss_pred cccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc-cC
Q 047215 672 VSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP-HL 748 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~-~l 748 (851)
..+.-.|...|||||.+.. ..|+.++||||||++|+|+.||+.|+..... +.+...... .-|| .+
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-------~gdpp~l 290 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-------IGDPPIL 290 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-------cCCCCee
Confidence 3345568999999999963 3589999999999999999999999865432 111111110 1122 22
Q ss_pred CCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNY-SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+. .-.....+..++..||-+|-+.||...+++++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111 12345668999999999999999999999888
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=297.16 Aligned_cols=240 Identities=21% Similarity=0.295 Sum_probs=196.1
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+..|.....+|.|+|+.|-++.. ...+..++|++.... .+-.+|+.++... +||||+++.+.+..+.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56677778899999999988875 455677899887662 2335677666665 79999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE-cCCCeEEEeeccccccCCCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL-DENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl-d~~~~~kl~DFGla~~~~~~~ 668 (851)
.+.++-|.+.+..... .. .++..|+.+|+.++.|||+ +++|||||||+|||+ +..+.++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999998888755442 33 7788899999999999995 999999999999999 68899999999999875443
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
....+-|..|.|||++....|++++|+||||++||+||||+.|+...... ..+ .....
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----------------~~~i~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----------------HTRIQ 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----------------HHhhc
Confidence 23445688999999999999999999999999999999999998754322 111 11112
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.++...+...++|+.+||+.||.+||+|.+++.|
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 234446677789999999999999999999999999
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=250.04 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=198.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+|+..++||+|.||+||||+.. .+..||+|+.... .+.-.....+||.+|+.++|+|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3455668999999999999864 5678999987654 223345678999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
|.. +|..+... -.+.++.+....++.|+++||.++|+ +++.|||+||.|.|++.+|+.|++|||+++...- ..
T Consensus 83 cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgi--pv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PV 155 (292)
T ss_pred hhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCC--ce
Confidence 976 67665433 23568888999999999999999996 9999999999999999999999999999986432 12
Q ss_pred ccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCC-CCCCcchhcHHHHHHHHhhhcc---cccccC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVIN-PTLPKDQINLADWAMKWQKQRS---LKSIID 745 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~---~~~i~d 745 (851)
.......-|..|.+|.++-+. -|+...|+||-||++.||.....|.. +..-.++...+-|......+.. +..+.|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 223445578999999998765 58999999999999999988665544 4433343333333322222221 122223
Q ss_pred ccCCCCCC---------hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYS---------PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
-..-+.++ +.....-++++++.|.-+|.+|.+++++++|
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 22212222 2233445789999999999999999999999
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=276.49 Aligned_cols=225 Identities=20% Similarity=0.179 Sum_probs=179.9
Q ss_pred ecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchhhhccC
Q 047215 524 GGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFG 602 (851)
Q Consensus 524 G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~ 602 (851)
|.+|.||+++. .+++.+|+|++.... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999986 456789999987543 234566666667899999999999999999999999999999998854
Q ss_pred CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcc
Q 047215 603 SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682 (851)
Q Consensus 603 ~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 682 (851)
. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 3 35889999999999999999999 489999999999999999999999999987653221 1223457789
Q ss_pred cCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHH
Q 047215 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGE 762 (851)
Q Consensus 683 ~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 762 (851)
+|||.+....++.++||||+|++++||++|+.|+....... .. ......+...+..+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~----~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NT----HTTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cc----ccccCCcccCCHHHHH
Confidence 99999988889999999999999999999987754321100 00 0001122334567899
Q ss_pred HHHHhcccCCCCCCCH-----HHHHHH
Q 047215 763 IAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 763 l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
++.+||+.||.+||++ +++++|
T Consensus 208 li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HHHHHccCCHHHhcCCCccchHHHHcC
Confidence 9999999999999996 777777
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=295.56 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=183.1
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-----------------cCcceeEEeecCCCChhhHHH--------------HHHH
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-----------------EDCTLAAIKRANPQSEQGLAE--------------FETE 559 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 559 (851)
..++|+..++||+|+||.||+|.. .++..||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 234578999986543322233 3457
Q ss_pred HHHHHhcCCcce-----eeEEEEEcc--------CCcEEEEEEecCCcchhhhccCCC----------------------
Q 047215 560 IEMLSKLRHRHL-----VSLIGFCDE--------QNEMILVYEYMANGTLRSHLFGSD---------------------- 604 (851)
Q Consensus 560 i~~l~~l~HpnI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~L~~~~---------------------- 604 (851)
+.++.+++|.++ ++++++|.. ++..+|||||+++|+|.++|+...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 677888753 357899999999999999986421
Q ss_pred CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccC
Q 047215 605 LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684 (851)
Q Consensus 605 ~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 684 (851)
...++|..+..++.|++++|.|||+ .+|+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 1234677888999999999999995 8999999999999999999999999999875332111 11122335789999
Q ss_pred cccccccCC----------------------CchHHHHHHHHHHHHHHhCCc-CCCCCCCcch------hcHHHHHHHHh
Q 047215 685 PEYFWRQQL----------------------TEKSDVYSFGVVLFEVVCARA-VINPTLPKDQ------INLADWAMKWQ 735 (851)
Q Consensus 685 PE~~~~~~~----------------------t~ksDVwS~GvvL~eLltG~~-p~~~~~~~~~------~~l~~~~~~~~ 735 (851)
||.+..... ..+.||||+||+++||++|.. |+........ ..+..|..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--- 455 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--- 455 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---
Confidence 998854321 134799999999999999875 4432111110 11111111
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEG---KNRPTMGEVLWH 784 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~~ 784 (851)
.......-.......+...+|+.+||..+| .+|+|++|+|+|
T Consensus 456 -------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 -------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000011111123455678999999999766 689999999999
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=276.98 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=198.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCc-ceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 586 (851)
..+|....+||+|+||.|.+|..++. ..+|||++++. ..++.+.-..|-++|... +-|.+++|..+++.-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35788899999999999999986654 57899988764 233445556677777766 57899999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+.+|+|--+++.- +.+.+..+...|..||-||-+||+ ++||.||||..|||||.+|.+||+|||+++....
T Consensus 428 VMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999998888543 457788889999999999999995 9999999999999999999999999999986433
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
......+.+||+.|+|||++..++|+..+|.|||||+||||+.|++||++..+.+. ...|++.
T Consensus 503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---------------F~aI~eh 565 (683)
T KOG0696|consen 503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---------------FQAIMEH 565 (683)
T ss_pred --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHHHHc
Confidence 22345678999999999999999999999999999999999999999987654321 1223332
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 777 (851)
.. .++...+.+...+....|.+.|.+|..
T Consensus 566 nv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 NV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 22 355666677888999999999999964
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=301.82 Aligned_cols=259 Identities=19% Similarity=0.278 Sum_probs=169.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC-----cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEE------Ec
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED-----CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF------CD 579 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~------~~ 579 (851)
..++|+..++||+|+||.||+|+..+ +..+|+|++...... +....| .++...|.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 578899987643221 111111 1222222222222211 35
Q ss_pred cCCcEEEEEEecCCcchhhhccCCCCC------------------CCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCC
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGSDLP------------------PLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVK 641 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk 641 (851)
.+.+.+|||||+++++|.+++...... ......+..++.|++.||+|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 667899999999999999988643211 11233456799999999999995 899999999
Q ss_pred CCCeEEcC-CCeEEEeeccccccCCCCCccccccccccCCcccCccccccc----------------------CCCchHH
Q 047215 642 TTNILLDE-NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ----------------------QLTEKSD 698 (851)
Q Consensus 642 ~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksD 698 (851)
|+|||++. ++.+||+|||+++..... .........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 689999999999754321 12223456789999999965322 2445679
Q ss_pred HHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc----ccccccCccCCCC----C--ChhHHHHHHHHHHHhc
Q 047215 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR----SLKSIIDPHLKGN----Y--SPESLEKFGEIAEKCL 768 (851)
Q Consensus 699 VwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~----~~~~i~d~~l~~~----~--~~~~~~~l~~l~~~Cl 768 (851)
||||||+||||+++..+.... +..+...+...+ .......+....+ + .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999876543221 111111111000 0000111110000 0 0111234568999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 047215 769 DDEGKNRPTMGEVLWH 784 (851)
Q Consensus 769 ~~dP~~RPt~~evl~~ 784 (851)
+.||++|||++|+++|
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999999
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=267.41 Aligned_cols=238 Identities=28% Similarity=0.371 Sum_probs=193.4
Q ss_pred cceEEEEEEEcC-cceeEEeecCCCChhh-HHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchhhhccC
Q 047215 525 GFGKVFKGEIED-CTLAAIKRANPQSEQG-LAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFG 602 (851)
Q Consensus 525 ~fG~Vykg~~~~-~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~ 602 (851)
+||.||+|...+ +..+++|+........ .+.+.+|++.+++++|+|++++++++..+...++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 7889999988765544 68899999999999999999999999999999999999999999999855
Q ss_pred CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcc
Q 047215 603 SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682 (851)
Q Consensus 603 ~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 682 (851)
.. .+++.++..++.+++.+|.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 43 38899999999999999999995 899999999999999999999999999987644321 23345678899
Q ss_pred cCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC-CChhHHHHHH
Q 047215 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN-YSPESLEKFG 761 (851)
Q Consensus 683 ~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~ 761 (851)
++||.+....++.++||||||+++++|++|..|+....... ...++. .. ...... .....+..+.
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~----~~--------~~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKI----GK--------PKPPFPPPEWKISPEAK 218 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH----hc--------cCCCCccccccCCHHHH
Confidence 99999998889999999999999999999998886531111 111110 00 011000 0011556789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 047215 762 EIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 762 ~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+++.+|+..+|.+||++.++++|
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHccCCchhccCHHHHhhC
Confidence 99999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=275.59 Aligned_cols=263 Identities=19% Similarity=0.258 Sum_probs=204.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcC-C-c----ceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-H-R----HLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-p----nIv~l~g~~~~~~~~ 584 (851)
+++|.+...+|+|.||.|-+.... .+..+|||+++..... .+...-|+++|.++. + | .+|++.+|+.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678899999999999999988754 3578999998765443 344577999999994 2 2 478889999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---------------
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE--------------- 649 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~--------------- 649 (851)
|||+|.| +-|+.++|..+.-.+++..++..|+.|+++++++||+ .+++|-||||+|||+..
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 4499999998888899999999999999999999994 99999999999999921
Q ss_pred -----CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch
Q 047215 650 -----NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724 (851)
Q Consensus 650 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~ 724 (851)
+..+||+|||.|..... ....+..|..|.|||++.+-.++..+||||+||||.||.+|...|+.....+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 33589999999986221 12456789999999999999999999999999999999999999987765554
Q ss_pred hcHHHHHHHH--------------hhhccc-----------ccccCccC----CCCCChhHHHHHHHHHHHhcccCCCCC
Q 047215 725 INLADWAMKW--------------QKQRSL-----------KSIIDPHL----KGNYSPESLEKFGEIAEKCLDDEGKNR 775 (851)
Q Consensus 725 ~~l~~~~~~~--------------~~~~~~-----------~~i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~R 775 (851)
..+.+.+..- ...+.+ ....++.. ...........+.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 4443332210 000100 00111000 001113445679999999999999999
Q ss_pred CCHHHHHHH
Q 047215 776 PTMGEVLWH 784 (851)
Q Consensus 776 Pt~~evl~~ 784 (851)
+|+.|+|+|
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999999
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=264.85 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=193.5
Q ss_pred ceeeeeeeecceEEEEEEEcC-cceeEEeecCCCC-hhh-HHHHHHHHHHHHhcCCcceeeEEEEEccC--------CcE
Q 047215 516 DESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQS-EQG-LAEFETEIEMLSKLRHRHLVSLIGFCDEQ--------NEM 584 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--------~~~ 584 (851)
+...+||+|.||+||+|+..+ ++.||+|+....+ ..+ -....+|+++|..|+|+|++.+++.|... ..+
T Consensus 20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 334579999999999998654 5667777654322 222 24567899999999999999999988432 348
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
+||+++|++ +|..+|.+. ...++..++.++..++..||.|+|. ..|+|||+|+.|+|++.++.+||+|||++|..
T Consensus 100 ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 999999988 888887443 3568899999999999999999994 88999999999999999999999999999754
Q ss_pred CCCCcc--ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc-
Q 047215 665 PSMEHT--HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL- 740 (851)
Q Consensus 665 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 740 (851)
...+.. ...+...-|+.|.+||.+.+ +.|+++.|||.-||++.||+|+.+.++......+..++.-...-...+..
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 322211 12234456999999999876 57999999999999999999999888876665555443322111111000
Q ss_pred --------cccc-CccCCCCCC--hhH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 --------KSII-DPHLKGNYS--PES------LEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 --------~~i~-d~~l~~~~~--~~~------~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+- .|...+.+. ++. .+...+|+.++|..||.+|+.+.+++.|
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0110 110011110 111 1357799999999999999999999999
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=270.90 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=198.6
Q ss_pred CceeeeeeeecceEEEEEE-EcCcceeEEeecCCCC--h-----hhHHHHHHHHHHHHhcCCcceeeEEEEEc-cCCcEE
Q 047215 515 FDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQS--E-----QGLAEFETEIEMLSKLRHRHLVSLIGFCD-EQNEMI 585 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~--~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~ 585 (851)
|-...+||+|||+.||||. +.....||+|+-.... . .-.+...+|.++.+.|+||.||++++|+. +.+.+|
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 5556789999999999996 5667889999754321 1 11234668999999999999999999985 556789
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~ 662 (851)
-|+|||++.+|.-+|..++ .++++++..|+.||+.||.||.. -+.+|||-||||.|||| +..|.+||+||||++
T Consensus 545 TVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999999996554 58999999999999999999985 46789999999999999 467899999999999
Q ss_pred cCCCCCcc-----ccccccccCCcccCcccccc----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH
Q 047215 663 TGPSMEHT-----HVSTAVKGSFGYLDPEYFWR----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 663 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~ 733 (851)
.+...... .......||..|++||++.- .+.+.|+||||.||++|..+.|+.||........ +.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL----- 694 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL----- 694 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH-----
Confidence 87654433 23456779999999999863 3678999999999999999999999976543221 11
Q ss_pred HhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+..... ..-...+.+....+.++++||+.--++|....++..+
T Consensus 695 --qeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 695 --QENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred --hhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1111111111 1111124456678999999999999999999888777
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=246.11 Aligned_cols=206 Identities=22% Similarity=0.308 Sum_probs=168.7
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEE
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 585 (851)
+...++......||+|++|.|-+-++ .+|+..|+|++... +.+..+...+|+.+..+. .+|.+|+++|........+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33445555566799999999988875 67899999998765 556667788888887766 7999999999999999999
Q ss_pred EEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 586 LVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+.||.|.. ||..+-.. .....+++.-+-+|+..+.+||.|||+ +..+||||+||+|||++.+|++|+||||++..
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999965 66554321 234568889999999999999999998 88999999999999999999999999999875
Q ss_pred CCCCCccccccccccCCcccCcccccc----cCCCchHHHHHHHHHHHHHHhCCcCCCCCC
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWR----QQLTEKSDVYSFGVVLFEVVCARAVINPTL 720 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~ 720 (851)
..+ +-..+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|+....
T Consensus 199 L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 199 LVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 322 112233568899999999863 379999999999999999999999987643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=253.80 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=200.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 585 (851)
.-++|+..++||+|+|.+|..+++.. .+.+|+|++++. ......-.+.|-.+..+- +||.+|.|..+++....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 44789999999999999999998765 467788876643 333344556677777666 7999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+|.||+++|+|--+++..+ .++++.+......|..||.|||+ +|||.||||..|+|||.+|.+||+|+|+++...
T Consensus 328 fvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999987775543 58888888889999999999995 999999999999999999999999999998643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCC-CcchhcHHHHHHHHhhhccccccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTL-PKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
. ......+.+||+.|+|||++++..|...+|.|++||+++||+.|+.||+--. .....+..++.-+. |+
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------il 472 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------IL 472 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hh
Confidence 3 3344678999999999999999999999999999999999999999997421 11112222222221 11
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT------MGEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 784 (851)
...+ .++...+.....+++.-|++||++|.. +.++-.|
T Consensus 473 ekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred hhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 2222 123344455677888899999999863 4555555
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=288.25 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=190.5
Q ss_pred CCceeeeeeeecceE-EEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGK-VFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~-Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
-|...+++|.|+-|+ ||+|.+++ +.||||++-... ..-..+||..|+.- +|||||++++.-.+++..||+.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEG-REVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCC-ceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355566899999877 69999876 588999987543 23457899999998 5999999999999999999999999
Q ss_pred CCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-----CCeEEEeeccccccC
Q 047215 592 ANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-----NFVAKMSDFGLSKTG 664 (851)
Q Consensus 592 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-----~~~~kl~DFGla~~~ 664 (851)
.. +|++++... +.....-...+.+..|+++||+|||+ .+||||||||.||||+. ..+++|+|||+++..
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 76 999999763 22222224567888999999999996 99999999999999964 368999999999876
Q ss_pred CCCCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhC-CcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 665 PSMEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCA-RAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 665 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
...... .......||-+|+|||++....-+.++||+|+|||+|..++| ..||......+. ++. .....+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl------~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NIL------TGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhh------cCccceee
Confidence 543222 224567799999999999998889999999999999999998 668876543321 110 00011111
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+. -.+++ ...+||.+|++.+|..||++.+||.|
T Consensus 735 -----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 01122 68899999999999999999999999
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=272.50 Aligned_cols=244 Identities=20% Similarity=0.281 Sum_probs=201.7
Q ss_pred eeeeeeecceEEEEEEEcCcc-eeEEeecCC---CChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 518 SLMIGVGGFGKVFKGEIEDCT-LAAIKRANP---QSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~-~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
+-.||-||||.|=+...+... ..|+|.+++ ....+.+....|-.+|..++.|.||+|+-.+.+....||+||-|-+
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 346999999999988766543 256555543 4566677888999999999999999999999999999999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|.|...|+. ++.+.......++..+.+|++|||+ ++||.|||||+|+|||.+|-+||.|||+|+.... ....
T Consensus 505 GElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~KT 576 (732)
T KOG0614|consen 505 GELWTILRD--RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GRKT 576 (732)
T ss_pred chhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc---CCce
Confidence 999999954 4578888888999999999999995 9999999999999999999999999999987443 3345
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
-+.|||+.|.|||++.....+.++|.||||++++||++|.+||....+...-+++-. .+.. -.+|
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--------Gid~-------i~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--------GIDK-------IEFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--------hhhh-------hhcc
Confidence 678999999999999999999999999999999999999999988766433222110 0111 1344
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
........+++++.+..+|.+|.. +.++-+|
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 455566789999999999999986 7888888
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=267.53 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=195.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
....|..++.||-|+||+|.+++. +....+|+|.+.+. .+.+....+.|-.+|..-+.+-||+|+-.|.+++.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 335688899999999999999975 44567899987765 34566778899999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC--
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG-- 664 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~-- 664 (851)
||||++||++-.+|.... -+.+......+..++.|+++.| +.|+|||||||.|||||.+|.+||+||||+.-.
T Consensus 707 VMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccccee
Confidence 999999999999885543 4667777777889999999999 699999999999999999999999999998410
Q ss_pred -------CCCCccc-------------------------------cccccccCCcccCcccccccCCCchHHHHHHHHHH
Q 047215 665 -------PSMEHTH-------------------------------VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVL 706 (851)
Q Consensus 665 -------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL 706 (851)
...+..+ ......||+.|+|||++....++..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0000000 01245699999999999999999999999999999
Q ss_pred HHHHhCCcCCCCCCCcc-hhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC---CHHHHH
Q 047215 707 FEVVCARAVINPTLPKD-QINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP---TMGEVL 782 (851)
Q Consensus 707 ~eLltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl 782 (851)
|||+.|+.||....+.+ +..+..|-. .++-...+..+.+|...+.+| |. +++.|. ..+||-
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~----------~l~~~~~~~ls~e~~~li~kL---c~--sad~RLGkng~d~vK 926 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRN----------FLHIPYQGNLSKEALDLIQKL---CC--SADSRLGKNGADQVK 926 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhh----------ccccccccccCHHHHHHHHHH---hc--Chhhhhcccchhhhh
Confidence 99999999998876654 333444422 223233445566655444333 33 355554 355676
Q ss_pred HH
Q 047215 783 WH 784 (851)
Q Consensus 783 ~~ 784 (851)
.|
T Consensus 927 aH 928 (1034)
T KOG0608|consen 927 AH 928 (1034)
T ss_pred cC
Confidence 66
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=257.02 Aligned_cols=272 Identities=22% Similarity=0.323 Sum_probs=198.9
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-----C---cceeeEEEEEc---
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-----H---RHLVSLIGFCD--- 579 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---pnIv~l~g~~~--- 579 (851)
..+|...++||.|.|++||++.. ++.+.||+|+.+.... -.+....||++|++++ | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36899999999999999999974 5667899998764322 2355688999999984 3 47999999984
Q ss_pred -cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC--------
Q 047215 580 -EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN-------- 650 (851)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~-------- 650 (851)
.+.+.|||+|++ |-+|..+|....-..++...+.+||.||+.||.|||. +.+|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhhh
Confidence 457899999998 5588888887777789999999999999999999998 7899999999999999321
Q ss_pred ---C----------------e-----------------------------------------------------------
Q 047215 651 ---F----------------V----------------------------------------------------------- 652 (851)
Q Consensus 651 ---~----------------~----------------------------------------------------------- 652 (851)
+ .
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence 0 0
Q ss_pred --------------------------------------------------------------------------------
Q 047215 653 -------------------------------------------------------------------------------- 652 (851)
Q Consensus 653 -------------------------------------------------------------------------------- 652 (851)
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence
Q ss_pred EEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc----hhcHH
Q 047215 653 AKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD----QINLA 728 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~----~~~l~ 728 (851)
+||+|||-|+-. ....+.-..|..|.|||++.+..|+..+||||++|+++||+||...|.+..... +..++
T Consensus 393 vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 393 VKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 000000000000 000112235667999999999999999999999999999999999988754332 21221
Q ss_pred HHHH---H---------------HhhhcccccccCccC---------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047215 729 DWAM---K---------------WQKQRSLKSIIDPHL---------KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEV 781 (851)
Q Consensus 729 ~~~~---~---------------~~~~~~~~~i~d~~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 781 (851)
.... . +.+.+.+..|-.-+. +..++.+...++.+++.-||+.+|++|||+.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 1111 0 111122222211111 235678889999999999999999999999999
Q ss_pred HHHHHHHHHhhhhhcccCCC
Q 047215 782 LWHLEYVLQLHEAWMRTDDR 801 (851)
Q Consensus 782 l~~L~~~~~~~~~w~~~~~~ 801 (851)
|+| +|+.....
T Consensus 548 l~h---------PwLn~~~~ 558 (590)
T KOG1290|consen 548 LKH---------PWLNPVAG 558 (590)
T ss_pred hcC---------ccccCCCC
Confidence 999 99986444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-30 Score=253.05 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=200.6
Q ss_pred ceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----CcEEEE
Q 047215 516 DESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NEMILV 587 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~lV 587 (851)
+..+.||.|+||.||..+. ++++.++.|++..- +-..-+.+.+|+++|..++|.|++..++..... .++|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3456799999999999875 57889999987653 333446788999999999999999998876544 367888
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
.|.|.. +|+..+- ...+++...+.-++.||++||+|||+ .+|.||||||.|.|++.|..+||||||++|.....
T Consensus 136 TELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchh
Confidence 998854 8888773 34578888889999999999999996 89999999999999999999999999999975543
Q ss_pred CccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH--------HHHhhhc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA--------MKWQKQR 738 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 738 (851)
+.. ..+...-|..|.|||.+++ +.|+.+.||||.||++.||+..+..|+...|-++.+++.-. ++...++
T Consensus 210 ~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 332 3344456889999999986 47999999999999999999999999888887776554322 2222222
Q ss_pred ccccccCccCC-CCC------C--hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 739 SLKSIIDPHLK-GNY------S--PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 739 ~~~~i~d~~l~-~~~------~--~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
....++....+ .++ + ...-.....+..+++..||++|.+.++++.|+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 22222211111 001 0 122234567888899999999999999999853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=272.24 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=209.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
..++|+....+|.|.+|.|||++. ..+..+|+|.++....+...-.++|+-+++..+|||||.++|.+...+.++++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 446788889999999999999985 5678899999888877778888999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
||.+|+|++.-+. ..++++.++..+++...+||+|||+ .+-+|||||-.|||+++.+.+|++|||.+..... .
T Consensus 93 ycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita--t 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--T 165 (829)
T ss_pred ecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh--h
Confidence 9999999998754 3579999999999999999999996 8899999999999999999999999999765322 2
Q ss_pred cccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC-
Q 047215 670 THVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID- 745 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d- 745 (851)
-..+....||+.|||||+.. .+.|..++|||++|+...||---.+|.....+.... .++.. ..++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk----S~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK----SGFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc----cCCCC
Confidence 22345678999999999874 567999999999999999998777776555443221 11111 1122
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
|.++. ...-.+.+.+|++.||-++|++|||++.+|.|
T Consensus 235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CcccC--CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 22221 23345678999999999999999999999887
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=235.28 Aligned_cols=211 Identities=37% Similarity=0.605 Sum_probs=182.5
Q ss_pred eeeecceEEEEEEEcC-cceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchhh
Q 047215 521 IGVGGFGKVFKGEIED-CTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRS 598 (851)
Q Consensus 521 LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 598 (851)
||+|.+|.||++...+ +..+++|+....... ....+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 778899998766443 45678999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccccCCCCCccccccccc
Q 047215 599 HLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 599 ~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
++.... ..+++..+..++.+++++|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 985542 358899999999999999999995 79999999999999999 89999999999876433211 123345
Q ss_pred cCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhH
Q 047215 678 GSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPES 756 (851)
Q Consensus 678 gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 756 (851)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77899999999877 889999999999999998
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
..+.+++.+|++.+|.+||++.+++++|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3478999999999999999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=229.60 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=192.1
Q ss_pred hcCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccC--CcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQ--NEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~lV 587 (851)
.++|++.+++|+|.+++||.|. ..+...++||.+++.. .+.+.+|+.+|..|+ ||||++|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3678888899999999999997 4566778899988653 356789999999997 99999999998554 567899
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccccCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~ 666 (851)
+||+.+-+...+- +.++...+.....++++||.|+|| .||+|||+||.|+++|. ...++|+|+|||....+
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998876654 457777888899999999999996 99999999999999985 55799999999987544
Q ss_pred CCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCC-CCCcchhcHHHHHHHH--------hh
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINP-TLPKDQINLADWAMKW--------QK 736 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~-~~~~~~~~l~~~~~~~--------~~ 736 (851)
.....+ ...+..|.-||.+.. +.|+..-|+|||||+|.+|+..+.||.. ....+|. +..+.-+ ..
T Consensus 186 ~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL--VkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 186 GKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VKIAKVLGTDELYAYLN 260 (338)
T ss_pred Cceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH--HHHHHHhChHHHHHHHH
Confidence 333222 234567899998864 5789999999999999999999998754 3333332 2222111 00
Q ss_pred h------cccccccCccCCC---CC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 Q------RSLKSIIDPHLKG---NY-----SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ~------~~~~~i~d~~l~~---~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. .....++...-+. .+ ..-..++..+++.+.|..|..+|||++|++.|
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 0111111111100 00 01123668899999999999999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=242.04 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=191.9
Q ss_pred cCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------Cc
Q 047215 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------NE 583 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~ 583 (851)
.+|...+.+|.|.- .|-.+- .-.++.|++|+.... .....+...+|..++..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555566888877 444443 224577888876543 445567788999999999999999999998533 46
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.|+|||+|.. +|...++ -.++-+.+..|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcc
Confidence 7999999965 8888875 246678889999999999999995 9999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc-----
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR----- 738 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 738 (851)
... .-..+....|..|.|||++.+..+.+.+||||.||++.||++|+-.|.+..-- .+|.......+
T Consensus 168 e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-----dQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 168 EDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-----DQWNKIIEQLGTPDPS 239 (369)
T ss_pred cCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-----HHHHHHHHHhcCCCHH
Confidence 322 23455667889999999999989999999999999999999999888754322 22322111110
Q ss_pred ----------------------cccccc-CccCCC--CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 739 ----------------------SLKSII-DPHLKG--NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 739 ----------------------~~~~i~-d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+.+ |..... +.++-....+++++.+||..+|++|.+++++|.|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 001111 111111 1122345668899999999999999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=230.42 Aligned_cols=199 Identities=31% Similarity=0.453 Sum_probs=171.6
Q ss_pred CceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 515 FDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
|+..+.||+|++|.||++...+ +..+++|........ ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999875 778899998876554 67889999999999999999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+++|.+++..... .+++..+..++.+++.+|.+||+ .+++|+||+++||+++.++.++|+|||++........ ..
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence 9999999865432 17899999999999999999995 7999999999999999999999999999876443220 12
Q ss_pred ccccccCCcccCcccc-cccCCCchHHHHHHHHHHHHHHhCCcCCCC
Q 047215 673 STAVKGSFGYLDPEYF-WRQQLTEKSDVYSFGVVLFEVVCARAVINP 718 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~GvvL~eLltG~~p~~~ 718 (851)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334577889999998 677888899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=249.19 Aligned_cols=196 Identities=22% Similarity=0.361 Sum_probs=165.2
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCCh--------hhHHHHHHHHHHHHhcC---CcceeeEEEEEcc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSE--------QGLAEFETEIEMLSKLR---HRHLVSLIGFCDE 580 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~ 580 (851)
.+|...+.+|+|+||.|+.+.++. ...|+||.+.+..- ...-....||++|+.|+ |+||+++++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999998764 45678887765421 11123557999999997 9999999999999
Q ss_pred CCcEEEEEEec-CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 581 QNEMILVYEYM-ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 581 ~~~~~lV~Ey~-~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
++.+||+||-. ++-+|.+++..+ +.+++.+...|+.|++.|+++||+ ++|||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 99999999975 556899998544 569999999999999999999994 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCC
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVIN 717 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~ 717 (851)
.+... .........||.+|.|||++.+.+| ...-|||++|++||.++....|+.
T Consensus 716 saa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98752 2233456789999999999998876 566899999999999988887765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=246.45 Aligned_cols=272 Identities=23% Similarity=0.274 Sum_probs=201.4
Q ss_pred ccCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC------CcceeeE
Q 047215 502 RFTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR------HRHLVSL 574 (851)
Q Consensus 502 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l 574 (851)
++.+-|+. ..+|.+..-.|+|-|++|.+|.. ..+..||||++...... .+.=..|+++|++|. .-|+++|
T Consensus 423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34444443 47788888999999999999975 34678999999876444 344578999999995 3488999
Q ss_pred EEEEccCCcEEEEEEecCCcchhhhccCC-CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCe
Q 047215 575 IGFCDEQNEMILVYEYMANGTLRSHLFGS-DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFV 652 (851)
Q Consensus 575 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~ 652 (851)
+-.|...+++|||+|-+. .+|.++|..- ..-.|....+...+.|+.-||..|. +.+|+|.||||.|||+++ ...
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcce
Confidence 999999999999999774 5899998542 2345778889999999999999999 699999999999999985 467
Q ss_pred EEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH
Q 047215 653 AKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~ 732 (851)
+||||||.|......+.+ ...-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+........+.--+.
T Consensus 576 LKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 999999998764332221 1223557999999999999999999999999999999999887755433222211110
Q ss_pred -----HHhhhcccc---------------------------cccCc------cCCC--CCC---hhHHHHHHHHHHHhcc
Q 047215 733 -----KWQKQRSLK---------------------------SIIDP------HLKG--NYS---PESLEKFGEIAEKCLD 769 (851)
Q Consensus 733 -----~~~~~~~~~---------------------------~i~d~------~l~~--~~~---~~~~~~l~~l~~~Cl~ 769 (851)
.+...+.+. ..+.| .+.. .++ +.....+.+|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 011111000 00111 0111 122 3345678999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 047215 770 DEGKNRPTMGEVLWH 784 (851)
Q Consensus 770 ~dP~~RPt~~evl~~ 784 (851)
.||++|.|..|+|.|
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999999999
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=224.01 Aligned_cols=244 Identities=19% Similarity=0.361 Sum_probs=195.2
Q ss_pred eeeeecceEEEEEEEcCcceeEEeec--CCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 520 MIGVGGFGKVFKGEIEDCTLAAIKRA--NPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~~~vavK~~--~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
+|.+...|+.|+|++++...|| |++ .......-++|..|.-.|+.+.||||++++|.|.....+.++..||+.|+|.
T Consensus 197 kl~e~hsgelwrgrwqgndiva-kil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGNDIVA-KILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCcccccccccCcchhh-hhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 6888999999999998876543 333 2234444578999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEe--eccccccCCCCCccccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMS--DFGLSKTGPSMEHTHVSTA 675 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~ 675 (851)
..|++...--.+-.+..++++++|+|++|||+ .++-|..--|.++.+++|++.+++|+ |--++.. ...
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfq---------e~g 345 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVG 345 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeee---------ccc
Confidence 99998876677888999999999999999997 34445555799999999999998875 2222111 111
Q ss_pred cccCCcccCcccccccCCC---chHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 676 VKGSFGYLDPEYFWRQQLT---EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 676 ~~gt~~y~aPE~~~~~~~t---~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
..-.+.||+||.++..+-+ ..+|+|||.++||||.|...||.+..+.+- . .++.-..++..+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------g---------mkialeglrv~i 410 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------G---------MKIALEGLRVHI 410 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------h---------hhhhhccccccC
Confidence 1235789999999876543 579999999999999999999877655321 1 123334566778
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
++..+..+.+|+.-|+..||.+||.+..++-.||.+.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 8888899999999999999999999999999988753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=235.36 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=195.7
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCc
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 583 (851)
....+.|..+++||+|.|++||++... ....+|+|.+...+.. ....+|+++|.++ -|.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334567888999999999999999754 3567899998876544 4578999999999 59999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEEeeccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSK 662 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~ 662 (851)
..+|+||+++-...+++.. ++..++...++.+..||.++| ..|||||||||.|+|.+ ..++-.|+|||||.
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999998888743 557788889999999999999 59999999999999997 55778999999997
Q ss_pred cCC-----------------C-C----------------C--------ccccccccccCCcccCccccc-ccCCCchHHH
Q 047215 663 TGP-----------------S-M----------------E--------HTHVSTAVKGSFGYLDPEYFW-RQQLTEKSDV 699 (851)
Q Consensus 663 ~~~-----------------~-~----------------~--------~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV 699 (851)
... . . . .........||+||.|||++. ....+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 100 0 0 0 000112346999999999986 4567899999
Q ss_pred HHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH---------hhhcc--cc----------------cc-cCcc----
Q 047215 700 YSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW---------QKQRS--LK----------------SI-IDPH---- 747 (851)
Q Consensus 700 wS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~---------~~~~~--~~----------------~i-~d~~---- 747 (851)
||.|||++.+++++.||...... ...+.+.+.-+ .-.+. +. .+ ....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999998643221 11122211100 00011 00 00 0000
Q ss_pred ---CCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 ---LKGNYSPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 ---l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+......+ .+..+.+++.+||+.||.+|.|++++|+|
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00011112 23368899999999999999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=219.35 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=181.8
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEE-EccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGF-CDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~-~~~~~~~~lV~E 589 (851)
+.|.+.+.||+|.||.+-+++++. .+.+++|.+... ....++|.+|..---.| .|.||+.-++. ++..+.+.+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 467788899999999999999865 456677766543 33457899998765555 58999988875 567778899999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE-c-CCCeEEEeeccccccCCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL-D-ENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl-d-~~~~~kl~DFGla~~~~~~ 667 (851)
|+|.|+|..-+... .+.+....+++.|++.|+.|+|+ +++||||||.+|||| + +..++||||||+.+.....
T Consensus 103 ~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred cCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999888553 36677888999999999999996 999999999999999 3 4458999999998753221
Q ss_pred CccccccccccCCcccCccccccc-----CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQ-----QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.....-+..|.+||.+... ...+.+|||.||++++..+||+.||+.....+ ....+|..-.. +...
T Consensus 177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~--rk~~- 247 (378)
T KOG1345|consen 177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLK--RKNP- 247 (378)
T ss_pred -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhc--ccCc-
Confidence 1223346679999987532 35678999999999999999999998543322 23333322111 1111
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.-|+.-..++ +.+.++.++-|..++++|-...++-++
T Consensus 248 -~~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 -ALPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -cCchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1122222333 346677788899999999655555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=274.84 Aligned_cols=199 Identities=19% Similarity=0.227 Sum_probs=141.1
Q ss_pred hcCC-cceeeEEEEE-------ccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeE
Q 047215 565 KLRH-RHLVSLIGFC-------DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636 (851)
Q Consensus 565 ~l~H-pnIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~ii 636 (851)
.++| +||++++++| .....+++++|++ .++|.++|... ...+++.+++.++.||++||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4566 6888888887 3334678889987 55999999643 3468999999999999999999995 9999
Q ss_pred EcCCCCCCeEEcCC-------------------CeEEEeeccccccCCCCCc--------------cccccccccCCccc
Q 047215 637 HRDVKTTNILLDEN-------------------FVAKMSDFGLSKTGPSMEH--------------THVSTAVKGSFGYL 683 (851)
Q Consensus 637 HrDlk~~NILld~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 683 (851)
||||||+||||+.. +.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4556666666653211000 00011235788999
Q ss_pred CcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHH
Q 047215 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEI 763 (851)
Q Consensus 684 aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 763 (851)
|||++.+..++.++|||||||+||||++|..|+.... .... ... .....+.. .........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~----~~~-----~~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMS----SLR-----HRVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHH----HHH-----HhhcChhh-----hhcCHHHHHH
Confidence 9999999999999999999999999999876643211 0000 100 00111111 1112345688
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 047215 764 AEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 764 ~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
+.+||+.+|.+||++.|+++|..
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHhCCCChhhCcChHHHhhchh
Confidence 89999999999999999999843
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=210.07 Aligned_cols=168 Identities=22% Similarity=0.225 Sum_probs=125.8
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|+|.+++... ..++++.++..++.|+++||+|||+ .+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc------
Confidence 6899988643 3469999999999999999999995 44 999999999999999 9998764321
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .+..+...... .++.. ....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~-------~~~~~-~~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA-------DDPRD-RSNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc-------CCccc-cccH
Confidence 12588999999999999999999999999999999999999865332111 11111111000 00000 0111
Q ss_pred hhHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 754 PESLE--KFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 754 ~~~~~--~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
..... .+.+++.+||+.+|.+||++.|+++|+..+.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 22333 6899999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=217.14 Aligned_cols=167 Identities=20% Similarity=0.137 Sum_probs=128.8
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEc--CcceeEEeecCCC-----ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIE--DCTLAAIKRANPQ-----SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
...++|...+.||+|+||+||+|+.. ++..+|||++... .......|.+|+++|++++|+|+++.+..+ +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 34578999999999999999999864 4677899986533 122356799999999999999999543322 4
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCC-CCCCeEEcCCCeEEEeecccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV-KTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDl-k~~NILld~~~~~kl~DFGla 661 (851)
..+|||||+++++|.... . . ....++.+++++|.|||+ .+|+|||| ||+|||++.++.+||+|||++
T Consensus 92 ~~~LVmE~~~G~~L~~~~---~---~---~~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR---P---H---GDPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHhC---c---c---chHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 579999999999996321 1 1 114678899999999995 89999999 999999999999999999999
Q ss_pred ccCCCCCcc------ccccccccCCcccCccccccc
Q 047215 662 KTGPSMEHT------HVSTAVKGSFGYLDPEYFWRQ 691 (851)
Q Consensus 662 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~ 691 (851)
+........ .......+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 864332211 111356788999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-21 Score=208.40 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=196.5
Q ss_pred CCceeeeeeeecceEEEEEEEcCc--ceeEEeecCCCChhhHHHHHHHHHHHHhcCC----cceeeEEEEE-ccCCcEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDC--TLAAIKRANPQSEQGLAEFETEIEMLSKLRH----RHLVSLIGFC-DEQNEMIL 586 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~g~~-~~~~~~~l 586 (851)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999986553 4678887665533333367889999999873 5888888888 57788899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC-----CeEEEeecccc
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN-----FVAKMSDFGLS 661 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~-----~~~kl~DFGla 661 (851)
||+.+ +.+|.++........++..+.++|+.|++.+|++||+ .|++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 6699998755556789999999999999999999994 999999999999999754 46999999999
Q ss_pred c--cCCCCCc-----ccc-ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH
Q 047215 662 K--TGPSMEH-----THV-STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 662 ~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~ 733 (851)
+ ....... .+. .....||..|+++++..+...+.+.|+||++.++.|++.|..||........... ...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HHH
Confidence 8 3211111 111 1245599999999999999999999999999999999999988865433221100 111
Q ss_pred HhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 734 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
..... .... .....+..+.++...+-..+..++|....+...|......
T Consensus 252 ~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 DPRKL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred Hhhhh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 10000 1110 2233445577777777778999999999998887766543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-22 Score=231.77 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=191.4
Q ss_pred eeeeeeeecceEEEEEEEc-CcceeEEeecC----C-CChhhH-HHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 517 ESLMIGVGGFGKVFKGEIE-DCTLAAIKRAN----P-QSEQGL-AEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~----~-~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
...++|.|.+|.|+..... .......|... . ...... ..+..|+.+-..++|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3557999999977766532 22222222211 1 111111 226678888889999999988888877777766799
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC--CC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP--SM 667 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~--~~ 667 (851)
|+++ +|..++... ..++..++..++.|+..|+.|||+ .||.|||+|++|+++..++.+||+|||.+.... ..
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999998543 357888999999999999999995 999999999999999999999999999986533 22
Q ss_pred CccccccccccCCcccCcccccccCCCch-HHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEK-SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.........+|+..|+|||.+.+..|++. .||||.|+++..|.+|+.||......++.. .........-..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccccc
Confidence 23356677889999999999999999874 799999999999999999987654433221 000000000011
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.-........+...+.++.++|+.+|.+|.|+++|++. +|++..
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d---------~W~~~i 591 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND---------EWIRSI 591 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC---------hHhhhc
Confidence 11112224556678899999999999999999999998 898753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-19 Score=196.67 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=195.4
Q ss_pred CceeeeeeeecceEEEEEEEcCcceeEEeecCCCChh---hHHHHHHHHHHHHhcCCc-ceeeEEEEEccCCcEEEEEEe
Q 047215 515 FDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ---GLAEFETEIEMLSKLRHR-HLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~Ey 590 (851)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999877 66788877655322 467899999999999988 799999999777778999999
Q ss_pred cCCcchhhhccCCCC-CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccccCCCCC
Q 047215 591 MANGTLRSHLFGSDL-PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSKTGPSME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~ 668 (851)
+.+++|.+++..... ..+.......+..|++.++.|+|+ .+++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966644321 268889999999999999999995 8899999999999999888 79999999987533322
Q ss_pred cc----ccccccccCCcccCcccccc---cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 669 HT----HVSTAVKGSFGYLDPEYFWR---QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 669 ~~----~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
.. .......|+..|++||.+.+ ..+....|+||+|++++++++|..|+....... ...............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc---cHHHHHHHHHhcCCc
Confidence 11 12456779999999999987 688999999999999999999999865443210 000011111110000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.................+.+++..|+..+|..|.++.+...+
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000011100012223568899999999999999999888776
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=199.96 Aligned_cols=218 Identities=23% Similarity=0.379 Sum_probs=162.7
Q ss_pred HHhcCCcceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCC
Q 047215 563 LSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKT 642 (851)
Q Consensus 563 l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~ 642 (851)
|+.+.|.|+.+++|.|..+...+.|.+||..|+|+|.+.... ..++|.....+.+++++||.|||+ ..-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence 456899999999999999999999999999999999997643 568999999999999999999996 33339999999
Q ss_pred CCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCccccccc-------CCCchHHHHHHHHHHHHHHhCCcC
Q 047215 643 TNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-------QLTEKSDVYSFGVVLFEVVCARAV 715 (851)
Q Consensus 643 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~GvvL~eLltG~~p 715 (851)
+|+++|..+.+||+|||+.................-...|.|||.++.. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998765321111111222234579999999753 257789999999999999999999
Q ss_pred CCCCCCcch-hcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 716 INPTLPKDQ-INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 716 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
|........ ..++..+.. .....+-|.+... .+..+.+..++..||..+|.+||+++++-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 876332221 122222111 1111122222111 1445578999999999999999999999877665543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=172.42 Aligned_cols=254 Identities=18% Similarity=0.209 Sum_probs=190.0
Q ss_pred hcCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCC-cceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH-RHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|..+++||.|+||.+|.|. ..+|..||||.-+..... ..+.-|.++.+.|+| ..|..+..+..+...-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999997 578899999987765433 356778999999975 677777778888889999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeeccccccCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~~ 666 (851)
.+ +-+|.++..-.. ..++.++++-++-|++.-++|+| .+++|||||||+|+|.. ....+.++||||++...+
T Consensus 92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 88 568888764322 35888999999999999999999 59999999999999996 345789999999986433
Q ss_pred CCcc-----ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 667 MEHT-----HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 667 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
.... +......||.+|.+-....+...+.+.|+=|+|.+|..+..|..||++..+.......+...+.+..-.+.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 2211 12345679999999888878888899999999999999999999999876654432222222111111000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEV 781 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 781 (851)
.+- ...+.++.-.+.-|-..--++-|...-+
T Consensus 247 -----~LC----~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 247 -----VLC----KGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred -----HHh----CCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 111 1223457777778877777777875443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-18 Score=176.50 Aligned_cols=262 Identities=17% Similarity=0.208 Sum_probs=192.0
Q ss_pred cCCceeeeeeeecceEEEEEE-EcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
-+|.+.++||+|+||..+.|+ +-++.+||||.-...++ ..++..|.+..+.|. .++|...+-+-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 367788899999999999997 46788999998765543 346778999999885 68999998888888899999998
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-----CCeEEEeeccccccCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-----NFVAKMSDFGLSKTGP 665 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-----~~~~kl~DFGla~~~~ 665 (851)
+ +-+|.|+..-.. ..++.+.++.||.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+...
T Consensus 106 L-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 558877763333 358999999999999999999995 99999999999999953 4468999999998754
Q ss_pred CCCcc-----ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 666 SMEHT-----HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 666 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
+.... +......||.+||+-....+..-+.+-|+=|+|-+++..|.|..||++.........-+.....++...+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 43221 2345677999999999999999999999999999999999999999986544322111111111111111
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..+ .+..+.++..-+.-.-..+-.+-|..+-+...+..+++
T Consensus 261 ~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 261 EVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 111 11223445555555555666677876655555555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-19 Score=182.68 Aligned_cols=171 Identities=16% Similarity=0.164 Sum_probs=132.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhH---HH------HHHHHHHHHhcCCcceeeEEEEEcc-
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL---AE------FETEIEMLSKLRHRHLVSLIGFCDE- 580 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~---~~------~~~Ei~~l~~l~HpnIv~l~g~~~~- 580 (851)
..++|...++||.|+||.||.... ++..+++|.+.+...... .. +.+|+..+.++.||+|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999765 456799999876532222 22 6899999999999999999887542
Q ss_pred -------CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 581 -------QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 581 -------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
.+..+|+|||++|.+|.++.. ++. ....+++.+|..|| ..+++|||+||+||++++++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence 246899999999999987731 222 24568999999999 49999999999999999888 9
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLl 710 (851)
+|+|||..+........ ..+.....+..++|+||||+.+.-+.
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999987653211110 11344556778999999999887653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-20 Score=214.68 Aligned_cols=246 Identities=19% Similarity=0.235 Sum_probs=182.0
Q ss_pred CCceeeeeeeecceEEEEEEEcCcceeEEeecCCCC-hhhHHHHHHHHHHHH--hcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS-EQGLAEFETEIEMLS--KLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~--~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+++..+.||.+.|=+|.+|+.++|. ++||++.+.. .-....|.++++-++ .++|||.+++.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777888999999999999988887 7888766543 444555655554444 45899999999888888888999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC-CCc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS-MEH 669 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~-~~~ 669 (851)
..+ +|.|.| +.++-+...+...|+.|++.||..+| +.+|+|||||.+||||+.-.-+.|+||.--+.... .+.
T Consensus 103 vkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 866 899988 55567888899999999999999999 59999999999999999988999999987664321 111
Q ss_pred cc----cccccccCCcccCccccccc-----------CCCchHHHHHHHHHHHHHHhC-CcCCCCCCCcchhcHHHHHHH
Q 047215 670 TH----VSTAVKGSFGYLDPEYFWRQ-----------QLTEKSDVYSFGVVLFEVVCA-RAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 670 ~~----~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwS~GvvL~eLltG-~~p~~~~~~~~~~~l~~~~~~ 733 (851)
.. ...+...-.+|+|||.+... ..+++.||||+||++.||++- +++|.-. .+...-..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~ 250 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSG 250 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhcc
Confidence 11 11222334579999988531 278899999999999999985 5555421 11111000
Q ss_pred --HhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 --WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 --~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+.-+..|-|+ .++.++..|++.||++|.++++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 0001112222222 47899999999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-19 Score=179.10 Aligned_cols=138 Identities=16% Similarity=0.126 Sum_probs=106.6
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCChh--h-------HH-----------------HHHHHHHHHHhcCCccee
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ--G-------LA-----------------EFETEIEMLSKLRHRHLV 572 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~HpnIv 572 (851)
+.||+|+||.||+|...+|+.+|||++...... . .. ....|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888899999988654211 0 11 223499999999887764
Q ss_pred eEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 573 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
....+.. ...+|||||++++++...+.. ..++++.+...++.|++.+|.|||+ ..+|+||||||+|||++ ++.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCc
Confidence 4333322 223899999999877654322 2468889999999999999999942 48999999999999998 478
Q ss_pred EEEeecccccc
Q 047215 653 AKMSDFGLSKT 663 (851)
Q Consensus 653 ~kl~DFGla~~ 663 (851)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=172.31 Aligned_cols=140 Identities=19% Similarity=0.160 Sum_probs=110.1
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChh--------------------------hHHHHHHHHHHHHhcCCcce
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ--------------------------GLAEFETEIEMLSKLRHRHL 571 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~HpnI 571 (851)
.+.||+|+||.||+|+..+|+.+|||+....... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878899999987754211 01224679999999999987
Q ss_pred eeEEEEEccCCcEEEEEEecCCcchhhh-ccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC
Q 047215 572 VSLIGFCDEQNEMILVYEYMANGTLRSH-LFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN 650 (851)
Q Consensus 572 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~ 650 (851)
.....+... ..+|||||++++++... +.. .+++..+..+++.|++.+|.+||+ ..+|+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence 554444332 24899999998865433 322 356778899999999999999994 48999999999999999 8
Q ss_pred CeEEEeeccccccCC
Q 047215 651 FVAKMSDFGLSKTGP 665 (851)
Q Consensus 651 ~~~kl~DFGla~~~~ 665 (851)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=166.47 Aligned_cols=186 Identities=17% Similarity=0.109 Sum_probs=137.1
Q ss_pred eeeeeeeecceEEEEEEEcCcceeEEeecCCCChh----hHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEec
Q 047215 517 ESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ----GLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
....|++|+||+||.+.- .+..++.+.+...... ....|.+|+++|++|. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456799999999997765 4455565555543321 1225889999999995 5889999987 4579999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCC-CCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV-KTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDl-k~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
++.+|...+.. ....++.|++.+|.++|+ .||+|||| ||.|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998754311 123577899999999995 99999999 799999999999999999999854332210
Q ss_pred -------cc----ccccccCCcccCccccccc-CCC-chHHHHHHHHHHHHHHhCCcCCCCC
Q 047215 671 -------HV----STAVKGSFGYLDPEYFWRQ-QLT-EKSDVYSFGVVLFEVVCARAVINPT 719 (851)
Q Consensus 671 -------~~----~~~~~gt~~y~aPE~~~~~-~~t-~ksDVwS~GvvL~eLltG~~p~~~~ 719 (851)
+. ......++.|++|+..... ..+ ...+.++-|.-+|.++|++.+....
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 00 1123367888888865432 233 6789999999999999999775443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=174.96 Aligned_cols=230 Identities=19% Similarity=0.276 Sum_probs=147.6
Q ss_pred ceeeeeeeecceEEEEEEEcC-cceeEEeecCCC---ChhhHHHHHHHHHHHHhcC----------CcceeeEEEEEc--
Q 047215 516 DESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQ---SEQGLAEFETEIEMLSKLR----------HRHLVSLIGFCD-- 579 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~----------HpnIv~l~g~~~-- 579 (851)
...+.||.|+++.||.++..+ ++..++|..... .....+.+++|.-....+. |-.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 345689999999999999765 678888875432 3445677777776655533 222332222221
Q ss_pred -------cC---C-----cEEEEEEecCCcchhhhcc---CC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcC
Q 047215 580 -------EQ---N-----EMILVYEYMANGTLRSHLF---GS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639 (851)
Q Consensus 580 -------~~---~-----~~~lV~Ey~~~gsL~~~L~---~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrD 639 (851)
.. . ..+++|+-+ .++|.+++. .. ....+....++.+..|+++.+++||+ .|++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecc
Confidence 11 1 236777777 468877753 21 12234455667788999999999996 9999999
Q ss_pred CCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCccccccc--------CCCchHHHHHHHHHHHHHHh
Q 047215 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ--------QLTEKSDVYSFGVVLFEVVC 711 (851)
Q Consensus 640 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~t~ksDVwS~GvvL~eLlt 711 (851)
|||+|++++.+|.++|+||+....... .... ...+..|.+||..... .++.+.|.|++|+++|.|+|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999988765221 1111 2345789999987542 58899999999999999999
Q ss_pred CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCC
Q 047215 712 ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNR 775 (851)
Q Consensus 712 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 775 (851)
++.|+....+...... .+ ..+. +.++.++.|+..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986543321110 11 1233 677889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=199.11 Aligned_cols=202 Identities=22% Similarity=0.214 Sum_probs=163.9
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC---CcceeeEEEEEccC
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR---HRHLVSLIGFCDEQ 581 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~ 581 (851)
..+.+.....|.+.+.||+|+||+||+|...+++.+|+|.-++.+... |--=.+++.||+ -+.|..+...+.-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 344555667899999999999999999998889999999988876543 222233445555 23344444444566
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-------CCCeEE
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-------ENFVAK 654 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-------~~~~~k 654 (851)
+.-+||+||.+.|+|.+++. ..+-++|.-.+.++.|+++-+++|| ..+|||+||||.|+||. ++.-++
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceE
Confidence 77899999999999999996 4456899999999999999999999 59999999999999993 345699
Q ss_pred EeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCc
Q 047215 655 MSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA 714 (851)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~ 714 (851)
|+|||.+-.+............++|-.+-.+|+..+++++..+|.|.+.-+++.||-|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999876544444445677889999999999999999999999999999999999974
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-18 Score=170.80 Aligned_cols=139 Identities=31% Similarity=0.490 Sum_probs=84.2
Q ss_pred EEEEEecCCCCCcCCCCcccccccccCCCcccccCCCcccccCcceEec-cCCCccccchhhHHHhhccCCCcccccccc
Q 047215 219 TMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIRNSSNITYA-STNDSSVAPLLVYETARTMSNTEVLEKRFN 297 (851)
Q Consensus 219 ~~~Rin~Gg~~~~~~~d~~~~r~W~~d~~~~~~~~s~~~~~~~~~~~~~-~~~~~~~~P~~vy~tA~~~~~~~~~~~~~~ 297 (851)
.++||||||+..+ +.....|++|..|..+................ ......+.++.||||+|.+.. +
T Consensus 1 ~~~~IN~Gg~~~~----~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--------~ 68 (174)
T PF11721_consen 1 VVLRINAGGPAYT----DSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--------S 68 (174)
T ss_dssp EEEEEEETSSSEE----ETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--------S
T ss_pred CEEEEECCCCccc----CCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--------c
Confidence 4789999999862 34556799998875443311000000000001 112245678899999999533 4
Q ss_pred eeeeeecCCCCceEEEEEeeeEEEec------CCeEEEEEEEcCccccCCcchhhhcCCCCceeEEEeE-eccccccee
Q 047215 298 MSWKFEVDPNFDYFVRLHFCELVYEK------ANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYF-DAVSSKIET 369 (851)
Q Consensus 298 lt~~~~vd~~~~Y~v~LhF~Ei~~~~------~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~~~~~-~~~~~~~~~ 369 (851)
|+|.+|+.+++.|.|+|||||++... .|+|+|||+|||++++++|||...+|+...+.++.+. ..+.++.+.
T Consensus 69 f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~ 147 (174)
T PF11721_consen 69 FSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLN 147 (174)
T ss_dssp EEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEE
T ss_pred eEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEE
Confidence 99999965999999999999997766 8999999999999999999999999988778888773 455666655
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=167.22 Aligned_cols=135 Identities=16% Similarity=0.180 Sum_probs=105.3
Q ss_pred eeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhc-----CCcceeeEEEEEccCC---c-EEEE
Q 047215 517 ESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-----RHRHLVSLIGFCDEQN---E-MILV 587 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~g~~~~~~---~-~~lV 587 (851)
..++||+|+||.||. .......+||+.........+.+.+|+.+++++ +||||++++|+++++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 356899999999996 333333478887765455567899999999999 5799999999998763 3 3478
Q ss_pred EEe--cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHH-HHhhcCCCCCeEEcCCCCCCeEEcC----CCeEEEeeccc
Q 047215 588 YEY--MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL-HYLHTGAERGIIHRDVKTTNILLDE----NFVAKMSDFGL 660 (851)
Q Consensus 588 ~Ey--~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL-~yLHs~~~~~iiHrDlk~~NILld~----~~~~kl~DFGl 660 (851)
+|| +++|+|.+++... .+++. ..++.+++.++ +|||+ ++|+||||||+|||++. +.+++|+||+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 999 6689999999543 24444 35677888777 99995 99999999999999963 34899999554
Q ss_pred c
Q 047215 661 S 661 (851)
Q Consensus 661 a 661 (851)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-18 Score=192.52 Aligned_cols=225 Identities=24% Similarity=0.278 Sum_probs=176.3
Q ss_pred eeeeecceEEEEEE----EcCcceeEEeecCCCChhh--HHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEecC
Q 047215 520 MIGVGGFGKVFKGE----IEDCTLAAIKRANPQSEQG--LAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 520 ~LG~G~fG~Vykg~----~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
.+|+|.||.|+..+ .+.+..+++|......... ......|-.++..++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998753 3445666777655432211 114556888888886 9999999999999999999999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
+|+|...+.... .++..........++-+++++| +.+++|||+|++||+++.+|.+++.|||+++.....+.
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999998885543 4666777777788899999999 59999999999999999999999999999986332221
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
.|||..|||||+++ .....+|.||||++++||+||-.||.. +. . ..|. +.....
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~------~---------~~Il--~~~~~~ 206 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT------M---------KRIL--KAELEM 206 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH------H---------HHHh--hhccCC
Confidence 28999999999998 567889999999999999999988875 10 1 1111 112245
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCH
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTM 778 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 778 (851)
+.+....++.++..++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 66777788899999999999999754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=170.17 Aligned_cols=213 Identities=16% Similarity=0.178 Sum_probs=151.3
Q ss_pred CCcceeeEEEEEcc---------------------------CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHH
Q 047215 567 RHRHLVSLIGFCDE---------------------------QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIG 619 (851)
Q Consensus 567 ~HpnIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ 619 (851)
+|||||++.+.|.+ +..+|+||.-.+. +|+++|..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999876532 2357899988766 8998885543 455677778999
Q ss_pred HHHHHHHhhcCCCCCeEEcCCCCCCeEE--cCC--CeEEEeeccccccCCCC----CccccccccccCCcccCccccccc
Q 047215 620 AARGLHYLHTGAERGIIHRDVKTTNILL--DEN--FVAKMSDFGLSKTGPSM----EHTHVSTAVKGSFGYLDPEYFWRQ 691 (851)
Q Consensus 620 ia~gL~yLHs~~~~~iiHrDlk~~NILl--d~~--~~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~ 691 (851)
+++|+.||| +++|.|||+|+.|||| |++ -...|+|||++-..... ......-..-|...-||||+....
T Consensus 350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 6999999999999999 333 35789999997543221 111111233477789999998643
Q ss_pred C------CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHH
Q 047215 692 Q------LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAE 765 (851)
Q Consensus 692 ~------~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~ 765 (851)
+ --.|+|.|+.|.+.||+++...||...... ..+.. ..++ ...+..+..++..+++++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r----------~Yqe----~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTR----------TYQE----SQLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechh----------hhhh----hhCCCCcccCChHHHHHHH
Confidence 2 125899999999999999999999862111 01110 0111 1112345667778999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCC
Q 047215 766 KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801 (851)
Q Consensus 766 ~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~ 801 (851)
..|+.||++|++..-+...|.--+.....|......
T Consensus 492 ~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~ 527 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMME 527 (598)
T ss_pred HHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcc
Confidence 999999999999887777777666666677654433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.4e-16 Score=160.51 Aligned_cols=134 Identities=23% Similarity=0.335 Sum_probs=111.6
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCCh--------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE--------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 455677887553321 1124578899999999999998888787777888999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+++++|.+++.... + ++..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999884322 2 788999999999999994 8999999999999999 78999999999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.3e-16 Score=161.23 Aligned_cols=141 Identities=16% Similarity=0.122 Sum_probs=110.4
Q ss_pred cCCceeeeeeeecceEEEEEE--EcCcceeEEeecCCCChh------------------------hHHHHHHHHHHHHhc
Q 047215 513 NNFDESLMIGVGGFGKVFKGE--IEDCTLAAIKRANPQSEQ------------------------GLAEFETEIEMLSKL 566 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l 566 (851)
.-|.+.+.||+|+||.||+|. ..+++.+|+|........ ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347778899999999999998 567899999987643210 112357899999999
Q ss_pred CCc--ceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC-eEEcCCCCC
Q 047215 567 RHR--HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG-IIHRDVKTT 643 (851)
Q Consensus 567 ~Hp--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~-iiHrDlk~~ 643 (851)
.|. .+.+++++ ...++||||+++++|...+... ..+...+...++.|++.+|.+||+ .+ ++||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence 753 34455543 2358999999998887654222 245566678999999999999995 88 999999999
Q ss_pred CeEEcCCCeEEEeecccccc
Q 047215 644 NILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 644 NILld~~~~~kl~DFGla~~ 663 (851)
||+++ +++++|+|||++..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.2e-17 Score=178.76 Aligned_cols=173 Identities=27% Similarity=0.407 Sum_probs=130.5
Q ss_pred cEEEEEEecCCcchhhhccCC-CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 583 EMILVYEYMANGTLRSHLFGS-DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
.++|.|++|...+|.++|..+ .....++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999643 34557788899999999999998 68999999999999999999999999998
Q ss_pred ccCCCCC----ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhC-CcCCCCCCCcchhcHHHHHHHHhh
Q 047215 662 KTGPSME----HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCA-RAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 662 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG-~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
....... .....+...||..||+||.+.+..|+.|+||||||++|+||+.- ...+. +
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------r 465 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------R 465 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------H
Confidence 6544332 12234567799999999999999999999999999999999862 11111 1
Q ss_pred hcccccc----cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 QRSLKSI----IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ~~~~~~i----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+.++ ++|....+++. -..|+.+++.+.|.+||++.++.-|
T Consensus 466 ~~t~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred HHhhhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHhhh
Confidence 1111222 22222222222 2579999999999999955554333
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.7e-16 Score=156.78 Aligned_cols=130 Identities=24% Similarity=0.339 Sum_probs=105.0
Q ss_pred eeeeecceEEEEEEEcCcceeEEeecCCCC--------hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQS--------EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.||+|+||.||+|.+. +..+++|...... ......+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999954 5677888754321 112356788999999999887665555555666779999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
++++|.+.+..... .++.+++.+|.+||+ .+++|||++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743210 789999999999994 9999999999999999 88999999999876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.3e-16 Score=182.26 Aligned_cols=136 Identities=22% Similarity=0.269 Sum_probs=110.8
Q ss_pred CCceeeeeeeecceEEEEEEEcCcceeEEeecCCC-------ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ-------SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.|...++||+|+||.||+|.+.+...++.++.... .....+.+.+|++++++++|++++....++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34556789999999999998766544332222211 11223568899999999999999988888877778899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
||||+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ .++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998873 457789999999999994 899999999999999 678999999999876
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-16 Score=183.18 Aligned_cols=210 Identities=24% Similarity=0.335 Sum_probs=145.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCc-ceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..+|+.+++|..|++|.||..+++.. +..|+|+ ++.+.. .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-----lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-----LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-----hhc--cccccCCccee------------------
Confidence 36899999999999999999987643 4556643 322111 110 22222333333
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC---
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM--- 667 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~--- 667 (851)
|+-...+.... +++- +++.+++|||+ .+|+|||+||.|.+|..-|.+|+.|||+++.+.-.
T Consensus 136 ---gDc~tllk~~g--~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG--PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCC--CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 45555554332 2322 12678999995 99999999999999999999999999998753211
Q ss_pred ----------CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 668 ----------EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 668 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
......+.++||+.|+|||++..+.|...+|+|++|+|+||.+-|+.||.+..+++-... ..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~------vi-- 271 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------VI-- 271 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh------hh--
Confidence 001112467899999999999999999999999999999999999999988766543111 00
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 777 (851)
-|.....+-.+..+.++++++.++|+.+|..|--
T Consensus 272 ------sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 272 ------SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ------hhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 0111111223344566899999999999999953
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=154.51 Aligned_cols=141 Identities=19% Similarity=0.130 Sum_probs=110.2
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCCh----------------------hhHHHHHHHHHHHHh
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE----------------------QGLAEFETEIEMLSK 565 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~ 565 (851)
+......|...+.||+|+||.||++...++..++||++..... .....+..|+.++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333334666788999999999999988899999997654220 011236789999999
Q ss_pred cCCc--ceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCC
Q 047215 566 LRHR--HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTT 643 (851)
Q Consensus 566 l~Hp--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~ 643 (851)
+.|+ .+.+.++. ...++||||+++++|...... ....+++.+++.++.++|+ .+++||||||+
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~ 154 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEF 154 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcc
Confidence 9887 45555543 345899999999999766421 3456788999999999995 89999999999
Q ss_pred CeEEcCCCeEEEeecccccc
Q 047215 644 NILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 644 NILld~~~~~kl~DFGla~~ 663 (851)
||++++++.++|+|||++..
T Consensus 155 Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred cEEEcCCCcEEEEECCcccc
Confidence 99999999999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-14 Score=137.32 Aligned_cols=134 Identities=19% Similarity=0.181 Sum_probs=114.1
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCC--cceeeEEEEEccCCcEEEEEEecCCcc
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH--RHLVSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
.+.||+|.++.||++..++ ..+++|....... ...+..|+.+++.++| .++.+++++...++..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999766 6678888765543 4678999999999976 599999999988889999999999877
Q ss_pred hhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 596 LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 596 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+..+ +......++.+++++|.+||.....+++|+|++|+||++++.+.++++|||+++.
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7544 4566778899999999999964445899999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.1e-14 Score=141.59 Aligned_cols=136 Identities=20% Similarity=0.187 Sum_probs=98.2
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChh--hHHH----------------------HHHHHHHHHhcCCc--ce
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ--GLAE----------------------FETEIEMLSKLRHR--HL 571 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~Hp--nI 571 (851)
.+.||+|+||.||+|...++..+|||+....... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888889999987653211 1111 13566666666543 34
Q ss_pred eeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC
Q 047215 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF 651 (851)
Q Consensus 572 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~ 651 (851)
.+++++ ...++||||++++.+......... .. .+...++.+++.++.++|+ +.+++||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 455543 245899999999654322111100 11 6678899999999999994 48999999999999999 89
Q ss_pred eEEEeecccccc
Q 047215 652 VAKMSDFGLSKT 663 (851)
Q Consensus 652 ~~kl~DFGla~~ 663 (851)
.++|+|||.+..
T Consensus 152 ~~~liDfg~a~~ 163 (187)
T cd05119 152 KVYIIDVPQAVE 163 (187)
T ss_pred cEEEEECccccc
Confidence 999999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.2e-14 Score=140.38 Aligned_cols=151 Identities=26% Similarity=0.360 Sum_probs=87.9
Q ss_pred ceEEecCCCCccccCCcceeccCCCCCccc-cccCC----cccccCCCCCCCCCcccccceeeeccCceeeEe-eccceE
Q 047215 24 SFLINCGTNSSVNVDGRKWVGDLASNNNVT-LSSSG----IAATTDSLSGDSIYEPLYKTARVFADGLNYTFE-IIAGNY 97 (851)
Q Consensus 24 ~~~i~cG~~~~~~~~~~~~~~D~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~t~R~f~~~~~y~~~-~~~g~~ 97 (851)
.++||||++..++.+|++|.+|....+..+ +.... ..............+++|+|.|+-+..++|.+| +++|.|
T Consensus 2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y 81 (174)
T PF11721_consen 2 VLRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGTY 81 (174)
T ss_dssp EEEEEETSSSEEETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-EEE
T ss_pred EEEEECCCCcccCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCcEE
Confidence 379999998888889999999963222212 11110 000111111112223599999986668999999 689999
Q ss_pred EEEEEeccCCCCC----cccccceEEEEEcceEEeecCCCCccccccccccccCCCCCcccceEEEE-EeeccCCeEEEE
Q 047215 98 IVRLHFCPFPFED----YNVNKSSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEY-FLGVDLDKLMIE 172 (851)
Q Consensus 98 ~~R~~f~~~~~~~----~~~~~~~f~v~~~g~~~l~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~~~~~~~~~i~ 172 (851)
.|||||....+.. -......|||.+||.++|.+||.. +.+.+.+ .++.+++ -+.++++.|.|+
T Consensus 82 ~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~---------~~~G~~~---~~~~~~~~~v~v~dg~L~i~ 149 (174)
T PF11721_consen 82 TVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIY---------AEAGGFN---KAAVRRFFNVTVTDGTLNIQ 149 (174)
T ss_dssp EEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HH---------HHHSSSS------EEEEEEEEEETTEEETT
T ss_pred EEEEEeccccccccccccCCCceEEEEEecceEEEeccCHH---------HHcCCCc---eEEEEEEEEEEEeCCcEEEE
Confidence 9999999887775 335567999999999999999963 3322211 2456666 455666799999
Q ss_pred Eec-----------CCCcceeeeee
Q 047215 173 FIP-----------SKGSFGFINAI 186 (851)
Q Consensus 173 f~~-----------~~~~~~fi~~i 186 (851)
|.. ...+.|.||||
T Consensus 150 f~~~~~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 150 FVWAGKGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEE--SEEEEEEESSSSSSSEEEE
T ss_pred EEecCCCcEEeeccccCCCcEEeeC
Confidence 996 34455777776
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.4e-15 Score=173.27 Aligned_cols=255 Identities=24% Similarity=0.284 Sum_probs=191.5
Q ss_pred CCceeeeeeeecceEEEEEEEcC--cceeEEeecCCCC--hhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIED--CTLAAIKRANPQS--EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.|...+.||+|+|+.|-...... ...+++|.+.... .........|..+-..+. |+|++++++.....+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 44455669999999998776432 3345666655443 333444556888877886 999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccccCCC-
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSKTGPS- 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~- 666 (851)
+|..++++.+-+........+....-....|+..++.|+|. ..++.||||||+|.+++..+ ..+++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999998843333345666777889999999999994 48999999999999999999 999999999986555
Q ss_pred CCcccccccccc-CCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 667 MEHTHVSTAVKG-SFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 667 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....| .
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~-------------~ 244 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSW-------------K 244 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceee-------------c
Confidence 344444556778 9999999999874 556789999999999999999988875443321 11111 1
Q ss_pred CccC--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 745 DPHL--KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 745 d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+... .............+++.+++..+|..|.+.+++-.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 245 SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 1110 011223344557788999999999999999998777
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=3e-13 Score=160.80 Aligned_cols=154 Identities=27% Similarity=0.392 Sum_probs=109.7
Q ss_pred eEEecCCCCcc---ccC------CcceeccCC--CCCccccccCCcccccCCCCCCCCCc--ccccceeeecc---Ccee
Q 047215 25 FLINCGTNSSV---NVD------GRKWVGDLA--SNNNVTLSSSGIAATTDSLSGDSIYE--PLYKTARVFAD---GLNY 88 (851)
Q Consensus 25 ~~i~cG~~~~~---~~~------~~~~~~D~~--~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~t~R~f~~---~~~y 88 (851)
||||||+.... +.. +|.|.+|.. .+.....+....+.++ .. .+..+ .+|+|||.+.. ..+|
T Consensus 194 ~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~--~~-~~~~~P~~VyqTA~~~~~~~~~lty 270 (623)
T PLN03150 194 KRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKA--SN-APNFYPESLYQSALVSTDTQPDLSY 270 (623)
T ss_pred EEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccc--cC-CCccChHHHhhhhccccCCCCceEE
Confidence 79999976432 221 699999942 0101111112222221 12 23222 39999999965 5789
Q ss_pred eEeec-cceEEEEEEeccCCCCCcccccceEEEEEcceEEeecCCCCccccccccccccCCCCCcccceEEEEEeeccCC
Q 047215 89 TFEII-AGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLD 167 (851)
Q Consensus 89 ~~~~~-~g~~~~R~~f~~~~~~~~~~~~~~f~v~~~g~~~l~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 167 (851)
.|+|. .|.|+|||||+++...........|+|++||.+++++|+.. .. .+ ....++++++.+.++++
T Consensus 271 ~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~---------~~-~g--~~~~~~~~~~~v~~~~g 338 (623)
T PLN03150 271 TMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIV---------KM-SG--ERYTALVLNKTVAVSGR 338 (623)
T ss_pred EeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChh---------hh-cC--CcccceEEEeEEeecCC
Confidence 99995 68999999999997654345678899999999999999963 00 11 12458899999998877
Q ss_pred eEEEEEecCCCcceeeeeeEEEeccc
Q 047215 168 KLMIEFIPSKGSFGFINAIEIVPVVD 193 (851)
Q Consensus 168 ~~~i~f~~~~~~~~fi~~iEl~~~~~ 193 (851)
.+.|+|+|..++.||||||||+.+-.
T Consensus 339 ~l~isl~p~~~s~pilNaiEI~~~~~ 364 (623)
T PLN03150 339 TLTIVLQPKKGTHAIINAIEVFEIIT 364 (623)
T ss_pred eEEEEEeeCCCCcceeeeeeeeeccc
Confidence 89999999988889999999999876
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.7e-13 Score=141.15 Aligned_cols=134 Identities=18% Similarity=0.196 Sum_probs=102.5
Q ss_pred eeee-eecceEEEEEEEcCcceeEEeecCCCC-------------hhhHHHHHHHHHHHHhcCCcce--eeEEEEEccCC
Q 047215 519 LMIG-VGGFGKVFKGEIEDCTLAAIKRANPQS-------------EQGLAEFETEIEMLSKLRHRHL--VSLIGFCDEQN 582 (851)
Q Consensus 519 ~~LG-~G~fG~Vykg~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~ 582 (851)
..|| .||.|+||+....+ ..+++|+..... ......+.+|++++.+|+|+++ ++.++++..+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~~-~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPG-VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeCC-ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 89999999998764 456777664311 1223567889999999998875 67777754322
Q ss_pred ----cEEEEEEecCC-cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEee
Q 047215 583 ----EMILVYEYMAN-GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 583 ----~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~D 657 (851)
..++|+|++++ .+|.+++... +++.. .+.+++.+|.+|| +.||+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 6898887442 33333 3678999999999 49999999999999999989999999
Q ss_pred cccccc
Q 047215 658 FGLSKT 663 (851)
Q Consensus 658 FGla~~ 663 (851)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.6e-12 Score=146.29 Aligned_cols=139 Identities=19% Similarity=0.212 Sum_probs=100.8
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCChhhH----------------------------------------HHHHH
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL----------------------------------------AEFET 558 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 558 (851)
+.||.|++|+||+|++.+|+.||||+..+...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999876532111 02555
Q ss_pred HHHHHHhcC-----CcceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHH-HHHHhhcCCC
Q 047215 559 EIEMLSKLR-----HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR-GLHYLHTGAE 632 (851)
Q Consensus 559 Ei~~l~~l~-----HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~-gL~yLHs~~~ 632 (851)
|.+.+.+++ ++++.-..-+....+..+|||||+++++|.+.+..... .. .+.+++..++. .+..+| .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence 666666652 34433222233334567999999999999887643211 11 34556666666 467888 4
Q ss_pred CCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 633 ~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
.|++|+|+||.||+++++++++++|||++...
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 89999999999999999999999999998763
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.9e-13 Score=138.83 Aligned_cols=205 Identities=24% Similarity=0.361 Sum_probs=141.7
Q ss_pred HHHHHhcCCcceeeEEEEEcc-----CCcEEEEEEecCCcchhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCCC
Q 047215 560 IEMLSKLRHRHLVSLIGFCDE-----QNEMILVYEYMANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGAE 632 (851)
Q Consensus 560 i~~l~~l~HpnIv~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~~ 632 (851)
..-|-++.|-|||+++.|+.+ ..+..++.|||..|+|..+|+... ...+......+++-||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 334556789999999998854 346799999999999999996532 3456777778999999999999997 77
Q ss_pred CCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC--CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHH
Q 047215 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM--EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVV 710 (851)
Q Consensus 633 ~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLl 710 (851)
++|+|+++.++.|++..++-+|+.----....+.. ........-.+-++|.+||+-.....+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999998888421111100000 0111112234678999999988888899999999999999998
Q ss_pred hCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 711 CARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 711 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+..-.......- .. +......+- .+. ...-++++.+|++..|..||+|++++.|
T Consensus 277 ilEiq~tnseS~~---~~--------ee~ia~~i~-~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKV---EV--------EENIANVII-GLE-------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCccee---eh--------hhhhhhhee-ecc-------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 7753211110000 00 000111100 000 0112457899999999999999999988
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-11 Score=137.13 Aligned_cols=250 Identities=20% Similarity=0.216 Sum_probs=177.6
Q ss_pred cCCceeeeeee--ecceEEEEEEE---cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcE
Q 047215 513 NNFDESLMIGV--GGFGKVFKGEI---EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~--G~fG~Vykg~~---~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 584 (851)
..|...+.+|. |.+|.||.+.. .+...+|+|+-+.. .......=.+|+...+++ .|+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34555677999 99999999986 34566788873322 223333335677777777 499999988889999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHH----HHHHhhcCCCCCeEEcCCCCCCeEEcCC-CeEEEeecc
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR----GLHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFG 659 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~----gL~yLHs~~~~~iiHrDlk~~NILld~~-~~~kl~DFG 659 (851)
++-+|++. .+|..+.+... ..++...+..+..+... ||.++|+ .+++|-|+||.||++..+ ...+++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 99999886 67777765432 33566677777777777 9999996 899999999999999988 889999999
Q ss_pred ccccCCCCCccc---cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 660 LSKTGPSMEHTH---VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 660 la~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
+........... ......|...|++||..+ .-++...|+|++|.+.+|..++-.......... | .+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W----~~ 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W----SQ 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------c----cc
Confidence 987654433221 122335778899999884 467899999999999999999876554331110 1 01
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.... . +..++-.....++...+..+++.+|..|++.+.+..+
T Consensus 338 ~r~~---~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 LRQG---Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccc---c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1110 0 1111222223345558999999999999998887665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-10 Score=114.68 Aligned_cols=131 Identities=18% Similarity=0.125 Sum_probs=95.9
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCccee-eEEEEEccCCcEEEEEEecCCcch
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV-SLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
.+.|+.|.++.||+.+.. +..+++|....... ....+..|+.+++.+.+.+++ +++.+.. ...++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999866 56688898755432 223567899999998765554 4454433 345899999999887
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC--CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA--ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.+.. .....++.+++++|..||+.. ..+++|+|+++.||+++ ++.++++|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 112345678999999999622 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.1e-10 Score=129.86 Aligned_cols=144 Identities=16% Similarity=0.141 Sum_probs=93.0
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhh------------------------------H--------
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQG------------------------------L-------- 553 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~------------------------------~-------- 553 (851)
.+|+. +.||+|++|+||+|++.+ |+.||||+..+.-... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45766 689999999999999987 9999999987652110 0
Q ss_pred --HHHHHHHHHHHhcC----CcceeeEEEEE-ccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHH-HHH
Q 047215 554 --AEFETEIEMLSKLR----HRHLVSLIGFC-DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR-GLH 625 (851)
Q Consensus 554 --~~~~~Ei~~l~~l~----HpnIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~-gL~ 625 (851)
-+|.+|+..+.+++ +.+.+.+-.++ .-.++.+|||||++|+.|.+.-.-... ..+ +..++...++ -+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g~d---~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-GTD---MKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-CCC---HHHHHHHHHHHHHH
Confidence 12445555555553 33333332222 224567899999999999774211111 111 1122222221 122
Q ss_pred HhhcCCCCCeEEcCCCCCCeEEcCCC----eEEEeeccccccC
Q 047215 626 YLHTGAERGIIHRDVKTTNILLDENF----VAKMSDFGLSKTG 664 (851)
Q Consensus 626 yLHs~~~~~iiHrDlk~~NILld~~~----~~kl~DFGla~~~ 664 (851)
.++ ..|++|+|+||.||+++.++ +++++|||++...
T Consensus 275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 333 48999999999999999888 9999999998753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=124.09 Aligned_cols=167 Identities=16% Similarity=0.191 Sum_probs=124.8
Q ss_pred EEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhh
Q 047215 533 EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQ 612 (851)
Q Consensus 533 ~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~ 612 (851)
+..++.++.|...+..+........+-++.|+.++||||++++...+.++..|||+|-+. .|..++.. +....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHH
Confidence 345667777777666655444556778899999999999999999999999999999874 45555522 33556
Q ss_pred hHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccC
Q 047215 613 RLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692 (851)
Q Consensus 613 ~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 692 (851)
....+.||+.||.+||. +.+++|++|....|+|+..|+.||++|.++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 67778999999999997 78999999999999999999999999998764322221 111111223466676553322
Q ss_pred CCchHHHHHHHHHHHHHHhC
Q 047215 693 LTEKSDVYSFGVVLFEVVCA 712 (851)
Q Consensus 693 ~t~ksDVwS~GvvL~eLltG 712 (851)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-09 Score=112.18 Aligned_cols=142 Identities=19% Similarity=0.282 Sum_probs=112.1
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCC--cceeeEEEEEccCC---cEEEEEEecC
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRH--RHLVSLIGFCDEQN---EMILVYEYMA 592 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~---~~~lV~Ey~~ 592 (851)
+.|+.|..+.||+.+..++..+++|....... .....+..|.++++.+.+ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987767888998665322 235678899999999975 44677888876643 6689999999
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC------------------------------------------
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG------------------------------------------ 630 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~------------------------------------------ 630 (851)
+.++.+.+.. ..++..++..++.++++.|..||+.
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876532 3467778888899999999999852
Q ss_pred -----------CCCCeEEcCCCCCCeEEcC--CCeEEEeecccccc
Q 047215 631 -----------AERGIIHRDVKTTNILLDE--NFVAKMSDFGLSKT 663 (851)
Q Consensus 631 -----------~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~ 663 (851)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1355799999999999998 67789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.9e-09 Score=117.69 Aligned_cols=152 Identities=28% Similarity=0.414 Sum_probs=99.4
Q ss_pred ceEEecCCCC--cccc---CCcceeccCCCCCccccccCCcccccCCCCCCCCCcc--cccceeeeccC-----ceeeEe
Q 047215 24 SFLINCGTNS--SVNV---DGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEP--LYKTARVFADG-----LNYTFE 91 (851)
Q Consensus 24 ~~~i~cG~~~--~~~~---~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~t~R~f~~~-----~~y~~~ 91 (851)
-+|+|||+.. .... -+|.|.+...+......+....+. ... ...+..+| +|+|||.-... .+|.|
T Consensus 180 ~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~-~~~-~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~- 256 (347)
T PF12819_consen 180 VYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNIN-INS-SNNPYDAPSAVYQTARTPSNSSDPLNLTWSF- 256 (347)
T ss_pred EEeecCCCcccccCCCCCcceeeccccccCccccccccceeee-ccc-CCccCcChHHHHHhhhcccccccceEEEecc-
Confidence 4899999876 3222 379999741111111111111111 111 22233333 99999987433 35666
Q ss_pred eccc-eEEEEEEeccCCCCCcccccceEEEEEcceEEeecCCCCccccccccccccCCCCCcccceEEEEEeeccCC-eE
Q 047215 92 IIAG-NYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLD-KL 169 (851)
Q Consensus 92 ~~~g-~~~~R~~f~~~~~~~~~~~~~~f~v~~~g~~~l~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~ 169 (851)
+.++ .|+||||||.+....-+.....|+|.+||.++..++++. -+ .....++++++++.++++ .+
T Consensus 257 ~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~------~~-------~~~~~~~~~d~~~~~~~~~~~ 323 (347)
T PF12819_consen 257 VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPP------YL-------GADTVPYYSDYVVNVPDSGFL 323 (347)
T ss_pred CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcc------cc-------cCcceEeecceEEEecCCCEE
Confidence 6665 799999999998754334468999999999998877752 01 112346788999988765 78
Q ss_pred EEEEecCCCc--ceeeeeeEEEec
Q 047215 170 MIEFIPSKGS--FGFINAIEIVPV 191 (851)
Q Consensus 170 ~i~f~~~~~~--~~fi~~iEl~~~ 191 (851)
.|++.|+..+ -|+|||+||+.+
T Consensus 324 ~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 324 NISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EEEEEeCCCCCcCceeEeeeeEeC
Confidence 9999999866 599999999864
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.4e-09 Score=105.18 Aligned_cols=134 Identities=17% Similarity=0.157 Sum_probs=96.1
Q ss_pred eeeeeecceEEEEEEEcC-------cceeEEeecCCCC----------------------hhhHHHH----HHHHHHHHh
Q 047215 519 LMIGVGGFGKVFKGEIED-------CTLAAIKRANPQS----------------------EQGLAEF----ETEIEMLSK 565 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~Ei~~l~~ 565 (851)
..||.|.-+.||.|...+ +..+|||+.+... ......+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 4678998643210 0011223 379999999
Q ss_pred cCC--cceeeEEEEEccCCcEEEEEEecCCcchhh-hccCCCCCCCchhhhHHHHHHHHHHHHHh-hcCCCCCeEEcCCC
Q 047215 566 LRH--RHLVSLIGFCDEQNEMILVYEYMANGTLRS-HLFGSDLPPLTWKQRLDACIGAARGLHYL-HTGAERGIIHRDVK 641 (851)
Q Consensus 566 l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-Hs~~~~~iiHrDlk 641 (851)
+.. -++.+++++ ...+|||||+.++.+.. .|.. ..++..+...+..+++.+|..| | +.++||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 853 466666765 46789999998754422 2211 1244456677889999999999 6 5899999999
Q ss_pred CCCeEEcCCCeEEEeecccccc
Q 047215 642 TTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 642 ~~NILld~~~~~kl~DFGla~~ 663 (851)
+.|||++ ++.+.|+|||.+..
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHEEEE-CCcEEEEECCCcee
Confidence 9999997 46799999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.2e-10 Score=124.72 Aligned_cols=248 Identities=19% Similarity=0.191 Sum_probs=175.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc--CcceeEEeecCCCChhhHHH--HHHHHHHHHhc-CCcceeeEEEEEccCCcEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE--DCTLAAIKRANPQSEQGLAE--FETEIEMLSKL-RHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 585 (851)
-..+|..+..||.|.|+.|++...+ ++..+++|...+.......+ -..|+.+...+ .|.++++....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567888999999999999987643 56778888776653322222 23567676666 5888888887777777888
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC-CeEEEeeccccccC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKTG 664 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~~ 664 (851)
+--||++++++...+ .-...+....++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||+....
T Consensus 343 ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence 999999999887665 223456778889999999999999994 999999999999999775 88999999997531
Q ss_pred CCCCccccccccccCCccc--CcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 665 PSMEHTHVSTAVKGSFGYL--DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.... ......-++. +|+......+-.+.|++|||.-..|.+++........ .| ..
T Consensus 418 ~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~----------~~ 474 (524)
T KOG0601|consen 418 AFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS----------LT 474 (524)
T ss_pred ceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc----------ee
Confidence 1111 1111222333 5555556678889999999999999999865322211 01 11
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
+....+. .. +.....+..+.+.+...++..||.+.++..|.+..
T Consensus 475 i~~~~~p-~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 IRSGDTP-NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eeccccc-CC-CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111111 11 12226678888999999999999999888775544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2e-08 Score=97.72 Aligned_cols=130 Identities=25% Similarity=0.337 Sum_probs=99.1
Q ss_pred eeeeecceEEEEEEEcCcceeEEeecCCCC---h-----hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQS---E-----QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~---~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.+++|+-+.+|.+.+.+.. +++|.-.+.. + -....-.+|.++|.+++--.|...+=+..+.+...|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775544 4555432221 1 11234667999999987666665555666777889999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
++-.|.+.|... ...++..+-+-+.-|| +.+|||+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888443 3567777888889999 59999999999999998765 99999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.3e-09 Score=128.44 Aligned_cols=248 Identities=20% Similarity=0.248 Sum_probs=166.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-cceeEEe---ecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-CTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK---~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.+.|.+.+-+-+|.++.++.+.-.. +...++| ....-.....+....+-.++-..+||-+++..--+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3556666677889999988764321 1111222 11111112222333333333334567777665555567788999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
++|..+++|...|+... ..+..-.......+...++|||+ ..++|||++|.|+|...++..+++|||........
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999987654 34444444445566778999995 55899999999999999999999999843210000
Q ss_pred -----------------------------CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCC
Q 047215 668 -----------------------------EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINP 718 (851)
Q Consensus 668 -----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~ 718 (851)
+.........||+.|++||...+..-...+|.|++|++++|.++|..|++.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000112346699999999999999999999999999999999999999987
Q ss_pred CCCcchhcHHHHHHHHhhhcccccccCccC-CCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 047215 719 TLPKDQINLADWAMKWQKQRSLKSIIDPHL-KGNYSPESLEKFGEIAEKCLDDEGKNRPTMG 779 (851)
Q Consensus 719 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 779 (851)
..+... +..+..... ....+.+.....++++...+..+|.+|-.+.
T Consensus 1038 ~tpq~~---------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI---------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh---------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 655432 111221111 1223455667788999999999999998876
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.5e-08 Score=94.67 Aligned_cols=143 Identities=20% Similarity=0.213 Sum_probs=101.5
Q ss_pred eeeeeeeecceEEEEEEEcCcceeEEe-ecCCCC-------hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 517 ESLMIGVGGFGKVFKGEIEDCTLAAIK-RANPQS-------EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~~~~~vavK-~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
...+|-+|+-+.|+++.+.+.+. .|| ++.+.- .-......+|+++|.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~-iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAA-IIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCcee-EEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 35578899999999999876543 444 333321 122345778999999987545544444444445567999
Q ss_pred EecCC-cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC---eEEEeecccccc
Q 047215 589 EYMAN-GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF---VAKMSDFGLSKT 663 (851)
Q Consensus 589 Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~ 663 (851)
||+++ .++.+++......+.........+..+-+.+.-|| ...|||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 47777776544333334444788889999999999 59999999999999995433 468999999865
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.6e-07 Score=103.56 Aligned_cols=166 Identities=17% Similarity=0.223 Sum_probs=125.7
Q ss_pred eEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEc----cCCcEEEEEEecCC-cchhhhc
Q 047215 527 GKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD----EQNEMILVYEYMAN-GTLRSHL 600 (851)
Q Consensus 527 G~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~L 600 (851)
.+.||+.. -+|..+++|++.....+.......-+++++++.|+|+|++..++. .+..+++||+|.|+ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56789874 578889999984433333334456788999999999999998875 34578999999986 5777765
Q ss_pred cCCC-------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 601 FGSD-------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 601 ~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
+... ....++..++.++.|++.||.++|+ .|+.-+-|.+++||++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 2346778899999999999999996 88888999999999999999999988876543221
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA 714 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~ 714 (851)
.. |-+.+ -.+-|.=.||.+++.|.||..
T Consensus 447 ~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 10 11111 235788899999999999964
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.5e-07 Score=98.36 Aligned_cols=139 Identities=14% Similarity=0.095 Sum_probs=96.9
Q ss_pred eeeecceEEEEEEEcCcceeEEeecCCCChh-----------hHHHHHHHHHHHHhcCCc--ceeeEEEEEcc-----CC
Q 047215 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ-----------GLAEFETEIEMLSKLRHR--HLVSLIGFCDE-----QN 582 (851)
Q Consensus 521 LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~-----~~ 582 (851)
+-+-....|.+..++ |+.+.||+....... ....+.+|...+.+|..- ...+++++.+. ..
T Consensus 30 v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 333333446666654 456888876543311 111478899999888533 33344555532 23
Q ss_pred cEEEEEEecCCc-chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-------CCeEE
Q 047215 583 EMILVYEYMANG-TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-------NFVAK 654 (851)
Q Consensus 583 ~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-------~~~~k 654 (851)
.-++|+|++++- +|.+++......+.....+..++.+++..+.-|| ..||+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 578999999986 7888874322233455677789999999999999 599999999999999975 57899
Q ss_pred Eeecccccc
Q 047215 655 MSDFGLSKT 663 (851)
Q Consensus 655 l~DFGla~~ 663 (851)
|+||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.3e-07 Score=91.92 Aligned_cols=124 Identities=20% Similarity=0.224 Sum_probs=82.0
Q ss_pred EEEEEEEcCcceeEEeecCCCC--------------------------hhhHHHHHHHHHHHHhcCCc--ceeeEEEEEc
Q 047215 528 KVFKGEIEDCTLAAIKRANPQS--------------------------EQGLAEFETEIEMLSKLRHR--HLVSLIGFCD 579 (851)
Q Consensus 528 ~Vykg~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~ 579 (851)
.||.|...++..+|+|...... ........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4888888888888998644210 00123467899999999755 566666553
Q ss_pred cCCcEEEEEEecC--CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHh-hcCCCCCeEEcCCCCCCeEEcCCCeEEEe
Q 047215 580 EQNEMILVYEYMA--NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYL-HTGAERGIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 580 ~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-Hs~~~~~iiHrDlk~~NILld~~~~~kl~ 656 (851)
..+|||||++ +..+..+. ... ++..+...++.+++..+..+ | ..+|||+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 4479999998 65554433 111 22456677788888866664 5 5899999999999999988 99999
Q ss_pred ecccccc
Q 047215 657 DFGLSKT 663 (851)
Q Consensus 657 DFGla~~ 663 (851)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.8e-06 Score=91.66 Aligned_cols=258 Identities=14% Similarity=0.158 Sum_probs=154.8
Q ss_pred eeeeeecceEEEEE-EEcCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEE------ccC-CcEEEEEE
Q 047215 519 LMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFC------DEQ-NEMILVYE 589 (851)
Q Consensus 519 ~~LG~G~fG~Vykg-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~------~~~-~~~~lV~E 589 (851)
+.||+|+-+.+|-- ...+ . +.|+.......... +.+.+|... .||-+-.-+.|= -.. ...-++|.
T Consensus 17 r~LgqGgea~ly~l~e~~d--~-VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 17 RPLGQGGEADLYTLGEVRD--Q-VAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred ccccCCccceeeecchhhc--h-hheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 46999999999853 2222 1 23433322222112 233344444 566444323221 112 22567777
Q ss_pred ecCCcc-hhhhcc----CCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 590 YMANGT-LRSHLF----GSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 590 y~~~gs-L~~~L~----~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
.+++.. +.+++. ....+...|...+++++.+|.+.+-|| +.|.+-+|+.++|+|+++++.+.|.|=..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence 766542 233332 123456889999999999999999999 599999999999999999999999974433222
Q ss_pred CCCCccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhC-CcCCCCCCCcch-hcHHHHHHHHhhh
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCA-RAVINPTLPKDQ-INLADWAMKWQKQ 737 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG-~~p~~~~~~~~~-~~l~~~~~~~~~~ 737 (851)
..........|...|.+||.-. +-.-+...|.|.+||++++|+.| +.||.+...... ..-.+- ....
T Consensus 168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~ 241 (637)
T COG4248 168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAH 241 (637)
T ss_pred ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhc
Confidence 1222334456888999999765 34567789999999999999887 778765321100 000000 0000
Q ss_pred cccccccCc--cC---CCCCC-hhHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHHHHh
Q 047215 738 RSLKSIIDP--HL---KGNYS-PESLEKFGEIAEKCLDDE--GKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 738 ~~~~~i~d~--~l---~~~~~-~~~~~~l~~l~~~Cl~~d--P~~RPt~~evl~~L~~~~~~ 791 (851)
+......+. .+ ....+ .-.++.+..+..+|+... +.-|||++..+..|..+.+.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 111111110 00 11122 234467888888998754 46799999998888776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.3e-06 Score=90.18 Aligned_cols=132 Identities=22% Similarity=0.189 Sum_probs=94.6
Q ss_pred eeeeeeeecceEEEEEEEcCcceeEEeecCCCCh----------------------hhHHHHHHHHHHHHhcCCc--cee
Q 047215 517 ESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE----------------------QGLAEFETEIEMLSKLRHR--HLV 572 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~Hp--nIv 572 (851)
+...||.|.-+.||.|...++..++||.-+.... -.....++|.+.|.+|.-. .|.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 3457999999999999999999999995432210 1123467899999999654 777
Q ss_pred eEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe
Q 047215 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 573 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~ 652 (851)
+.+++ +...+||||.++-.|...- ++....-.|+..|++-+.-+- ..|+||+|+..-||+++++|.
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence 77766 5678999999986665432 122333334444444444333 388999999999999999999
Q ss_pred EEEeeccccc
Q 047215 653 AKMSDFGLSK 662 (851)
Q Consensus 653 ~kl~DFGla~ 662 (851)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999996554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-06 Score=85.58 Aligned_cols=138 Identities=17% Similarity=0.147 Sum_probs=105.0
Q ss_pred eeeecceEEEEEEEcCcceeEEeecCCC---C---hhhHHHHHHHHHHHHhcCC--cceeeEEEEEc-c----CCcEEEE
Q 047215 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQ---S---EQGLAEFETEIEMLSKLRH--RHLVSLIGFCD-E----QNEMILV 587 (851)
Q Consensus 521 LG~G~fG~Vykg~~~~~~~vavK~~~~~---~---~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~-~----~~~~~lV 587 (851)
-|+||-+.|++-.+++. .+-+|+.... + +.+...|.+|+..|.+|.. -.+.+++ ++. . .-+-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36799999998777665 5778876522 1 3466789999999999953 3355555 332 1 1246899
Q ss_pred EEecCC-cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe--EEEeecccccc
Q 047215 588 YEYMAN-GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV--AKMSDFGLSKT 663 (851)
Q Consensus 588 ~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~--~kl~DFGla~~ 663 (851)
+|-+++ -+|.+++......+.+..++..+..+++..+.-|| +.++.|+|+.++|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 58888886655556778888899999999999999 499999999999999986666 99999987764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.5e-07 Score=107.69 Aligned_cols=153 Identities=21% Similarity=0.286 Sum_probs=104.2
Q ss_pred HHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc-----c--ccccccccCCcccCccccc
Q 047215 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH-----T--HVSTAVKGSFGYLDPEYFW 689 (851)
Q Consensus 617 ~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-----~--~~~~~~~gt~~y~aPE~~~ 689 (851)
+.+++.||.|+|. ..++||+.|.|++|.++.++..||+.|+.+........ . ....-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455689999996 78899999999999999999999999998754332111 0 0111122456799999999
Q ss_pred ccCCCchHHHHHHHHHHHHHHhCCcC-CCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhc
Q 047215 690 RQQLTEKSDVYSFGVVLFEVVCARAV-INPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCL 768 (851)
Q Consensus 690 ~~~~t~ksDVwS~GvvL~eLltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl 768 (851)
....+.++|+||+||+++-+..|+.+ +........ .......+..-...++...+.++++=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch-------------hhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 98999999999999999999855443 322111000 0000011111111234556677888888999
Q ss_pred ccCCCCCCCHHHHHHH
Q 047215 769 DDEGKNRPTMGEVLWH 784 (851)
Q Consensus 769 ~~dP~~RPt~~evl~~ 784 (851)
..++..||++.+++..
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.28 E-value=4e-06 Score=86.07 Aligned_cols=106 Identities=24% Similarity=0.263 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHHhcCC--cceeeEEEEEccC----CcEEEEEEecCCc-chhhhccCCCCCCCchhhhHHHHHHHHHHHH
Q 047215 553 LAEFETEIEMLSKLRH--RHLVSLIGFCDEQ----NEMILVYEYMANG-TLRSHLFGSDLPPLTWKQRLDACIGAARGLH 625 (851)
Q Consensus 553 ~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~----~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~ 625 (851)
.....+|...+.+|.. -.+.+.+++.+.. ...++|+|++++. +|.+++..... .+......++.++++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467788888888853 3455666666543 2458999999874 79888855322 556677889999999999
Q ss_pred HhhcCCCCCeEEcCCCCCCeEEcCCC---eEEEeecccccc
Q 047215 626 YLHTGAERGIIHRDVKTTNILLDENF---VAKMSDFGLSKT 663 (851)
Q Consensus 626 yLHs~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~ 663 (851)
-|| ..+|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 49999999999999998877 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=6.2e-06 Score=94.92 Aligned_cols=144 Identities=16% Similarity=0.216 Sum_probs=97.1
Q ss_pred CCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhH----------------------------------------
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL---------------------------------------- 553 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~---------------------------------------- 553 (851)
.|+. +.|+.++-|+||+|++.+|+.||||+..+.-....
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 3443 47899999999999999999999999876532211
Q ss_pred HHHHHHHHHHHhcC-----CcceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHH-HHHh
Q 047215 554 AEFETEIEMLSKLR-----HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARG-LHYL 627 (851)
Q Consensus 554 ~~~~~Ei~~l~~l~-----HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~g-L~yL 627 (851)
-++.+|...+.+++ .|++.-..=|.+-.+...|+|||++|-.+.+...... ...+.+. ++..++++ +..+
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~ 281 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQL 281 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHH
Confidence 01445666565553 3444433334444567899999999998888742222 2233333 33333322 2222
Q ss_pred hcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 628 Hs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
- ..+++|.|..|.||+++.++++.+.|||+.....
T Consensus 282 ~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 L---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred H---hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2 3789999999999999999999999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.8e-05 Score=82.27 Aligned_cols=139 Identities=13% Similarity=0.158 Sum_probs=84.7
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc--eeeEEEEEccCCcEEEEEEecCCcc-
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH--LVSLIGFCDEQNEMILVYEYMANGT- 595 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~~~gs- 595 (851)
..||+|..+.||+.. +...++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 468999999999842 3345677765433 2345688999999986433 4677888877778899999999863
Q ss_pred hhhhc---------------------cCCCCCCCchhhhHH-HHH----------HHH-HHHHHhhcC-CCCCeEEcCCC
Q 047215 596 LRSHL---------------------FGSDLPPLTWKQRLD-ACI----------GAA-RGLHYLHTG-AERGIIHRDVK 641 (851)
Q Consensus 596 L~~~L---------------------~~~~~~~l~~~~~~~-i~~----------~ia-~gL~yLHs~-~~~~iiHrDlk 641 (851)
+...+ |.............. +-. .+. ....+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 111000111000000 000 000 012222211 13457899999
Q ss_pred CCCeEEcCCCeEEEeecccccc
Q 047215 642 TTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 642 ~~NILld~~~~~kl~DFGla~~ 663 (851)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.4e-05 Score=79.36 Aligned_cols=143 Identities=18% Similarity=0.166 Sum_probs=85.3
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCc--ceeeEEEEEc---cCCcEEEEEEecC
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHR--HLVSLIGFCD---EQNEMILVYEYMA 592 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~---~~~~~~lV~Ey~~ 592 (851)
++.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999887 57788886554 4556788899999888533 3456666442 2334799999999
Q ss_pred Ccchhh----------------hc---cCC--CCCCCchhh---------hHHH------------HHHHHH-HHHHhhc
Q 047215 593 NGTLRS----------------HL---FGS--DLPPLTWKQ---------RLDA------------CIGAAR-GLHYLHT 629 (851)
Q Consensus 593 ~gsL~~----------------~L---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLHs 629 (851)
+..+.. .+ +.. ...+..+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 111111100 0000 011111 2333332
Q ss_pred ----CCCCCeEEcCCCCCCeEEc-CCCeEEEeecccccc
Q 047215 630 ----GAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKT 663 (851)
Q Consensus 630 ----~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~ 663 (851)
.....++|+|+.+.|||++ +++++.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1356799999999999999 667778999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00012 Score=73.82 Aligned_cols=103 Identities=22% Similarity=0.262 Sum_probs=82.9
Q ss_pred HHHHHHHHhcCC-cceeeEEEEEccCCcEEEEEEecCCcchhhhccC-CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC
Q 047215 557 ETEIEMLSKLRH-RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFG-SDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634 (851)
Q Consensus 557 ~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~ 634 (851)
..|.-+++.+.+ +++.+++|+|-. +++.||...+++...-.. .....-+|..+.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999976 699999999943 689999998766432000 11124689999999999999999999766667
Q ss_pred eEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 635 IIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 635 iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+...|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.8e-05 Score=78.60 Aligned_cols=139 Identities=17% Similarity=0.178 Sum_probs=85.2
Q ss_pred eeeecc-eEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEecCCcchhh
Q 047215 521 IGVGGF-GKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEYMANGTLRS 598 (851)
Q Consensus 521 LG~G~f-G~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 598 (851)
|-.|.. ..||+...++ ..+.+|+..... .....+|+++++.+. +--+.+++++...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444554 7889987654 567778776543 345678999998884 4445577887776667899999999987764
Q ss_pred hc-------------------cCCCCC--CCc--hhhhHHHHH--------------------HHHHHHHHhhc----CC
Q 047215 599 HL-------------------FGSDLP--PLT--WKQRLDACI--------------------GAARGLHYLHT----GA 631 (851)
Q Consensus 599 ~L-------------------~~~~~~--~l~--~~~~~~i~~--------------------~ia~gL~yLHs----~~ 631 (851)
.. +..... +.. .......+. .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 111100 110 000000000 01111222211 11
Q ss_pred CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 632 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
...++|+|+.+.|||++++..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35589999999999999988889999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.5e-07 Score=100.24 Aligned_cols=180 Identities=19% Similarity=0.120 Sum_probs=130.2
Q ss_pred eeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc-eeeEEEEEccCCcEEEEEEecCCc-chh
Q 047215 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH-LVSLIGFCDEQNEMILVYEYMANG-TLR 597 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~Ey~~~g-sL~ 597 (851)
.+++|++++++|.+--..+....+.+... ....-++++|.+++||| .+..++-++.+...+++++++..+ +..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 47899999999987444344445544432 34466899999999999 788888888888999999999887 222
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (851)
.... ...-.+..-+...+++.-+++|++||+ ..-+||| ||+..+ ...|..||+......... ......
T Consensus 324 ~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 324 LEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred ccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence 2111 111123334556677778899999996 3358888 777655 678999999876543321 344567
Q ss_pred cCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCC
Q 047215 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVI 716 (851)
Q Consensus 678 gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~ 716 (851)
+|+.|+|||+.....+..+.|+|+.++-..++--|-+|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 899999999999999999999999998777776665543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=75.10 Aligned_cols=152 Identities=20% Similarity=0.199 Sum_probs=100.3
Q ss_pred ccCHHHHHHHhcCCceee---eeeeecceEEEEEEEcCcceeEEeecCCCChhhH------------------------H
Q 047215 502 RFTLAEIRVATNNFDESL---MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL------------------------A 554 (851)
Q Consensus 502 ~~~~~~l~~~t~~f~~~~---~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~------------------------~ 554 (851)
..++..+....++..+.. .|..|.-+.||+|.-.++..+|+|+......... .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345555555555554444 4557888899999988888999998654321110 1
Q ss_pred HHHHHHHHHHhcC--CcceeeEEEEEccCCcEEEEEEecCCcc-hhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC
Q 047215 555 EFETEIEMLSKLR--HRHLVSLIGFCDEQNEMILVYEYMANGT-LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631 (851)
Q Consensus 555 ~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~ 631 (851)
-..+|..-|+++. +-.+.+.+++.. -.|||||+.... -.-.|... ++...+...+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--
Confidence 1345777788773 555666666653 379999996541 11122111 12222456666677777777763
Q ss_pred CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 632 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
..++||+||..-|||+. ++.+.|+|+|-|..
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 47899999999999999 88999999998764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00025 Score=88.00 Aligned_cols=79 Identities=18% Similarity=0.315 Sum_probs=57.5
Q ss_pred eeeeeeecceEEEEEEEcCc---ceeEEeecCCCC-hhhHHHHHHHHHHHHhcC-Ccce--eeEEEEEccC---CcEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDC---TLAAIKRANPQS-EQGLAEFETEIEMLSKLR-HRHL--VSLIGFCDEQ---NEMILV 587 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnI--v~l~g~~~~~---~~~~lV 587 (851)
.+.++.|.+..+|+-+..++ ..+++|+..... ......+.+|.++|+.+. |+++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 55689999999999876654 345666654432 223457889999999995 6665 7888888664 467899
Q ss_pred EEecCCcch
Q 047215 588 YEYMANGTL 596 (851)
Q Consensus 588 ~Ey~~~gsL 596 (851)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >KOG3593 consensus Predicted receptor-like serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=1.3e-05 Score=81.75 Aligned_cols=71 Identities=21% Similarity=0.532 Sum_probs=62.5
Q ss_pred chhhHHHhhccCCCcccccccceeeeeecCCCCceEEEEEeeeEEEecCCeEEEEEEEc-CccccCCcchhhhcCCCCce
Q 047215 276 PLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYIN-NRTAENNFDIFVQAGGKNRG 354 (851)
Q Consensus 276 P~~vy~tA~~~~~~~~~~~~~~lt~~~~vd~~~~Y~v~LhF~Ei~~~~~~~R~FdI~in-~~~~~~~~di~~~~~~~~~~ 354 (851)
...+|||+|.... .|.|..|.+..+.|.+.|.|||+++...++.+|||-+| ++.+.+++||+-..|+-+.+
T Consensus 107 d~ily~ter~nee--------tFgyd~pik~dgdyalvlkfaevyF~~~q~kvfdvrln~sh~vVk~ldi~~~vg~rg~A 178 (355)
T KOG3593|consen 107 DIILYQTERYNEE--------TFGYDVPIKEDGDYALVLKFAEVYFKTCQHKVFDVRLNCSHCVVKALDIFDQVGDRGKA 178 (355)
T ss_pred hhhhhhhcccchh--------hhcccccccCCCceehhhhHHHHHHHhhhhhheeeeeccceeEEeccchhhhcCCCccc
Confidence 6779999999533 36788898888999999999999999999999999999 99999999999998855544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00048 Score=70.10 Aligned_cols=138 Identities=17% Similarity=0.150 Sum_probs=90.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHH---------HHHHHHHHHhcCC---cceeeEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAE---------FETEIEMLSKLRH---RHLVSLIGFC 578 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~H---pnIv~l~g~~ 578 (851)
..++|...+++-......|.+-..++ ...++|..........+. ..+++..+.+++- -....++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 45778887777777766676666555 566888776654332222 2344554444432 2222222222
Q ss_pred -----ccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 579 -----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 579 -----~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
.-....+|+|||++|-.|.++.. ++. .++-.++..+.-|| +.|+.|+|..|.|+++.+++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-E
Confidence 22345679999999988866531 222 24455677899999 59999999999999998654 9
Q ss_pred EEeecccccc
Q 047215 654 KMSDFGLSKT 663 (851)
Q Consensus 654 kl~DFGla~~ 663 (851)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00014 Score=83.63 Aligned_cols=138 Identities=17% Similarity=0.189 Sum_probs=90.1
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCChhhH-------------------------------------HHHHHHHH
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL-------------------------------------AEFETEIE 561 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~Ei~ 561 (851)
+.||.-+.|+||+|++++|+.||||+..+.-+... -+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 46999999999999999999999998876532210 01445555
Q ss_pred HHHhc----CCcc------eeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC
Q 047215 562 MLSKL----RHRH------LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631 (851)
Q Consensus 562 ~l~~l----~Hpn------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~ 631 (851)
-..++ .|-+ |.+++ ..-.....|+||||+|..+.|.-.-.. ..++...+..-+.++..-+- .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qI-----f 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQI-----F 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHH-----H
Confidence 44443 3444 22222 233457799999999998876642211 12344443333333221122 2
Q ss_pred CCCeEEcCCCCCCeEEcC----CCeEEEeeccccccC
Q 047215 632 ERGIIHRDVKTTNILLDE----NFVAKMSDFGLSKTG 664 (851)
Q Consensus 632 ~~~iiHrDlk~~NILld~----~~~~kl~DFGla~~~ 664 (851)
..|++|+|-.|.||++.. ++++.+-|||+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 468999999999999983 678999999998753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00077 Score=68.31 Aligned_cols=128 Identities=24% Similarity=0.292 Sum_probs=88.4
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCC----------------hhhHHHHHHHHHHHHhcC------CcceeeEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS----------------EQGLAEFETEIEMLSKLR------HRHLVSLI 575 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------HpnIv~l~ 575 (851)
...||+|+.-.||. +.+....+||+..... .....+..+|+.-..++. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 44799999999984 3444445777766554 223456777777776666 88999999
Q ss_pred EEEccCCcEEEEEEecCC--c----chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC
Q 047215 576 GFCDEQNEMILVYEYMAN--G----TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649 (851)
Q Consensus 576 g~~~~~~~~~lV~Ey~~~--g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~ 649 (851)
|+.+++.-.-+|+|.+.. | +|.+++.... ++. +..+.+.+ -..||- +..|+.+|++|.||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~---f~~~l~---~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDE---FKRYLL---DHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHH---HHHHHH---HcCCeecCCCcccEEEEe
Confidence 999999999999998743 2 4677774332 444 33333333 345555 477999999999999942
Q ss_pred ---CC-eEEEee
Q 047215 650 ---NF-VAKMSD 657 (851)
Q Consensus 650 ---~~-~~kl~D 657 (851)
.. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 22 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00062 Score=71.38 Aligned_cols=139 Identities=16% Similarity=0.153 Sum_probs=76.8
Q ss_pred eeeeeecce-EEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCc---ceeeEEEEEccC---CcEEEEEEec
Q 047215 519 LMIGVGGFG-KVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHR---HLVSLIGFCDEQ---NEMILVYEYM 591 (851)
Q Consensus 519 ~~LG~G~fG-~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~~~---~~~~lV~Ey~ 591 (851)
+.|+.|+.. .||+.. ..+++|..... .....+.+|.++|..+... -+.+.++.+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 488742 24566664432 2345788999999888532 344445544332 2348899999
Q ss_pred CCcchhhhc------------------cCCCCCC--C-------------chhhhH--HHH-------HHHHHH-HH-Hh
Q 047215 592 ANGTLRSHL------------------FGSDLPP--L-------------TWKQRL--DAC-------IGAARG-LH-YL 627 (851)
Q Consensus 592 ~~gsL~~~L------------------~~~~~~~--l-------------~~~~~~--~i~-------~~ia~g-L~-yL 627 (851)
+|.++.+.. |.-.... . .|.... .+. .+.+.. +. ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 997764331 1110000 0 011000 000 011111 11 11
Q ss_pred hc--CCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 628 HT--GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 628 Hs--~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+. .....++|+|+.+.|||++++...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 0234589999999999999876677999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0019 Score=70.20 Aligned_cols=77 Identities=13% Similarity=0.043 Sum_probs=56.2
Q ss_pred eeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCC---cceeeEEEEEcc---CCcEEEEEEe
Q 047215 517 ESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH---RHLVSLIGFCDE---QNEMILVYEY 590 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~g~~~~---~~~~~lV~Ey 590 (851)
..+.||.|..+.||+-...+++ +.+|..+... ....|..|.+.|+.|.- -.+.+++++|.. .+..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3557999999999998766554 4556533211 23578899999998853 367788888754 4678999999
Q ss_pred cCCcch
Q 047215 591 MANGTL 596 (851)
Q Consensus 591 ~~~gsL 596 (851)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00076 Score=81.98 Aligned_cols=198 Identities=22% Similarity=0.224 Sum_probs=133.9
Q ss_pred HHHHHHHHHHHHhcCCcceeeEEEEEccCCcE----EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhh
Q 047215 553 LAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM----ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLH 628 (851)
Q Consensus 553 ~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH 628 (851)
.....-|+..+..+.|+|++.++.|-.++... .+..|++..-++..++... ...+....+....++.+||.|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH
Confidence 34455688888999999999999997554333 3445677777777777443 45677888888999999999999
Q ss_pred cCCCCCeEEcCCCCC---CeEEcCCCeEEEe--eccccccCCCCCccccccccccCCcccCcccccccCCCch--HHHHH
Q 047215 629 TGAERGIIHRDVKTT---NILLDENFVAKMS--DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK--SDVYS 701 (851)
Q Consensus 629 s~~~~~iiHrDlk~~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k--sDVwS 701 (851)
+ ....|.-+..+ +-..+.++.+.++ ||+..+..+...... ...-+..+.+||......++.+ .|+|+
T Consensus 304 ~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 S---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred H---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence 6 44445444444 4444566777777 888877654433221 1223456788887766555444 79999
Q ss_pred HHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047215 702 FGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEV 781 (851)
Q Consensus 702 ~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 781 (851)
+|..+..+..|..+..... .+.+-+. ........+...+|+..++++|++..++
T Consensus 378 lgll~~~~~~~~~i~~~~~----------------------~~~~~l~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA----------------------VPVSLLD----VLSTSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCccccccc----------------------chhhhhc----cccchhhhhhhhhhcchhhhhccchhhh
Confidence 9999999998864322110 0000010 0111146788999999999999999999
Q ss_pred HHH
Q 047215 782 LWH 784 (851)
Q Consensus 782 l~~ 784 (851)
+.|
T Consensus 432 l~~ 434 (1351)
T KOG1035|consen 432 LTH 434 (1351)
T ss_pred hhc
Confidence 999
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0013 Score=69.85 Aligned_cols=137 Identities=16% Similarity=0.140 Sum_probs=77.3
Q ss_pred eeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce-eeEEEEEccCCcEEEEEEecCCcchhhh
Q 047215 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL-VSLIGFCDEQNEMILVYEYMANGTLRSH 599 (851)
Q Consensus 521 LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 599 (851)
+..|-...+|+... ++..+++|..........-+..+|.++++.+....+ .++++.+. -++||||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998873 445667776544322211245789999998864333 34444432 3699999998765431
Q ss_pred -----------------ccCCC--CCCCchhhhH-HHH---------HHHHHHHHHhhc-----CCCCCeEEcCCCCCCe
Q 047215 600 -----------------LFGSD--LPPLTWKQRL-DAC---------IGAARGLHYLHT-----GAERGIIHRDVKTTNI 645 (851)
Q Consensus 600 -----------------L~~~~--~~~l~~~~~~-~i~---------~~ia~gL~yLHs-----~~~~~iiHrDlk~~NI 645 (851)
||... ..+++....+ ... ..+...+..+-. .....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 1111111111 100 011111222211 1134689999999999
Q ss_pred EEcCCCeEEEeecccccc
Q 047215 646 LLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 646 Lld~~~~~kl~DFGla~~ 663 (851)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0028 Score=63.85 Aligned_cols=125 Identities=27% Similarity=0.378 Sum_probs=88.9
Q ss_pred cCCceeeeeeeecc-eEEEEEEEcCcceeEEeecCC---CCh------------------hhHHHHHHHHHHHHhcC---
Q 047215 513 NNFDESLMIGVGGF-GKVFKGEIEDCTLAAIKRANP---QSE------------------QGLAEFETEIEMLSKLR--- 567 (851)
Q Consensus 513 ~~f~~~~~LG~G~f-G~Vykg~~~~~~~vavK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 567 (851)
.+++..+.||.|.- |.|||.++.+. .+|+|.... ... .-...|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 99999998765 789998221 110 11235888999988885
Q ss_pred Ccce--eeEEEEEccC------------------CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHh
Q 047215 568 HRHL--VSLIGFCDEQ------------------NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627 (851)
Q Consensus 568 HpnI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL 627 (851)
+.++ |+++||..-. ....||.||++... .++ .+-+.++.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4566 9999997211 12357777775422 122 23345666778889
Q ss_pred hcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 628 Hs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
| +.+|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---HCCeeeccCcccccc-----CCEEEecccC
Confidence 9 599999999999986 4589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0099 Score=66.77 Aligned_cols=75 Identities=19% Similarity=0.180 Sum_probs=53.9
Q ss_pred eeeeeecceEEEEEEEcCc-ceeEEeecCCCC-------hhhHHHHHHHHHHHHhcC---CcceeeEEEEEccCCcEEEE
Q 047215 519 LMIGVGGFGKVFKGEIEDC-TLAAIKRANPQS-------EQGLAEFETEIEMLSKLR---HRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV 587 (851)
+.||-|.+..||+....++ +.++||...+.. +...+.+..|.+.|+.+. ..++.+++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999998877 478899754221 224556778888888863 245667777743 457899
Q ss_pred EEecCCcc
Q 047215 588 YEYMANGT 595 (851)
Q Consensus 588 ~Ey~~~gs 595 (851)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0029 Score=66.11 Aligned_cols=140 Identities=18% Similarity=0.202 Sum_probs=80.7
Q ss_pred eeeeeecceEEEEEEEcC--cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce-eeEEEEEccCCcEEEEEEecCCcc
Q 047215 519 LMIGVGGFGKVFKGEIED--CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL-VSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
+.|..|-...+|+....+ +..+++|........ ..+-.+|+.+++.+...++ .++++.+.. .++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence 457778888999988664 566778866543222 2233578999998854333 344444332 48999999876
Q ss_pred hhhh-------c----------cCCCC---------CCC-chhhhHHH-------------------------HHHHHHH
Q 047215 596 LRSH-------L----------FGSDL---------PPL-TWKQRLDA-------------------------CIGAARG 623 (851)
Q Consensus 596 L~~~-------L----------~~~~~---------~~l-~~~~~~~i-------------------------~~~ia~g 623 (851)
+... + |.... ... .|..+..+ +.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 0 11110 011 11111111 1111111
Q ss_pred H-HHhhc-CCCCCeEEcCCCCCCeEEcC-CCeEEEeecccccc
Q 047215 624 L-HYLHT-GAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKT 663 (851)
Q Consensus 624 L-~yLHs-~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~ 663 (851)
| ..+.. .....++|+|+.+.|||+++ +..+.++||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 11111 12356999999999999997 57899999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0015 Score=63.73 Aligned_cols=127 Identities=21% Similarity=0.250 Sum_probs=83.7
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
.+.|++|.+|.||+|.+.++ .+|+|+....++ ...+..|.++|..+.--++.+=+-.+.. -.+.|||..|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-EVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeeccCc-eEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchh
Confidence 45799999999999998876 567776654433 4578899999999987666544333322 23559999987876
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCC-C-CCeEEcCCCeEEEeecccccc
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVK-T-TNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk-~-~NILld~~~~~kl~DFGla~~ 663 (851)
+.-... +.+++.+ +++.---|. ..||-|+.|. | +||++.+ ..+.|+||.-|..
T Consensus 101 ~~~~~~-----~rk~l~~----vlE~a~~LD---~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG-----DRKHLLR----VLEKAYKLD---RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc-----cHHHHHH----HHHHHHHHH---HhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 654221 2233333 333322222 4678888887 4 4555544 4999999998874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0039 Score=67.65 Aligned_cols=142 Identities=19% Similarity=0.181 Sum_probs=85.1
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc--eeeEEEE------EccCCcEEEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH--LVSLIGF------CDEQNEMILVYE 589 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~------~~~~~~~~lV~E 589 (851)
.+.|..|....+|+...+++ .+++|+.... .......|++++..+.+.+ +.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677787789999876555 5677876542 2345677888888885332 4454442 123456789999
Q ss_pred ecCCcchhh----hc----------cC--CC--C-----CCCchhhhH----------HHHHHHHHHHHHhhc----CCC
Q 047215 590 YMANGTLRS----HL----------FG--SD--L-----PPLTWKQRL----------DACIGAARGLHYLHT----GAE 632 (851)
Q Consensus 590 y~~~gsL~~----~L----------~~--~~--~-----~~l~~~~~~----------~i~~~ia~gL~yLHs----~~~ 632 (851)
|++|..+.. .+ |. .. . ....|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 00 10 00 0 011222111 011112333444432 124
Q ss_pred CCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 633 ~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.+++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999988789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0088 Score=65.18 Aligned_cols=140 Identities=24% Similarity=0.293 Sum_probs=82.6
Q ss_pred eeeeeecceEEEEEEEcC-------cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce-eeEEEEEccCCcEEEEEEe
Q 047215 519 LMIGVGGFGKVFKGEIED-------CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL-VSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey 590 (851)
+.|..|-...+|+....+ +..+++|+..... ....+..+|.+++..+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345666677899887655 4667778755433 223455788888888853333 355555542 368999
Q ss_pred cCCcchhhh-c----------------cCCCCC---------CCchhhhHH--------------------------HHH
Q 047215 591 MANGTLRSH-L----------------FGSDLP---------PLTWKQRLD--------------------------ACI 618 (851)
Q Consensus 591 ~~~gsL~~~-L----------------~~~~~~---------~l~~~~~~~--------------------------i~~ 618 (851)
++|..+... + |..... +.-|..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 1 111111 011111100 111
Q ss_pred HHHHHHHHhhc------CCCCCeEEcCCCCCCeEEcCC----CeEEEeecccccc
Q 047215 619 GAARGLHYLHT------GAERGIIHRDVKTTNILLDEN----FVAKMSDFGLSKT 663 (851)
Q Consensus 619 ~ia~gL~yLHs------~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~ 663 (851)
.+..-+..|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334431 135679999999999999874 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.024 Score=62.32 Aligned_cols=141 Identities=16% Similarity=0.199 Sum_probs=77.0
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc--eeeEEE------EEccCCcEEEEEEe
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH--LVSLIG------FCDEQNEMILVYEY 590 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g------~~~~~~~~~lV~Ey 590 (851)
+.|+.|....+|+...+++ .+++|+...... .....|+.++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999886666 467787652222 33344556665553211 233332 11234567899999
Q ss_pred cCCcchhh-----------hc---cCC--C-------CCCC-chhhhHHHH------------HH-HHHHHHHhhc----
Q 047215 591 MANGTLRS-----------HL---FGS--D-------LPPL-TWKQRLDAC------------IG-AARGLHYLHT---- 629 (851)
Q Consensus 591 ~~~gsL~~-----------~L---~~~--~-------~~~l-~~~~~~~i~------------~~-ia~gL~yLHs---- 629 (851)
++|..+.. .| |.. . ...+ .|.+...-. .+ +...+..+..
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 01 110 0 0011 122111111 11 1112223321
Q ss_pred CCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 630 ~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
....++||+|+.+.|||++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1346899999999999999776678999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.04 Score=59.87 Aligned_cols=122 Identities=18% Similarity=0.248 Sum_probs=78.7
Q ss_pred cceeEEeecCC--CChhhHHHHHHHHHHHHhcCC--cceeeEEEEEccCC--cEEEEEEecCCcchhhhccCCCCCCCch
Q 047215 537 CTLAAIKRANP--QSEQGLAEFETEIEMLSKLRH--RHLVSLIGFCDEQN--EMILVYEYMANGTLRSHLFGSDLPPLTW 610 (851)
Q Consensus 537 ~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~L~~~~~~~l~~ 610 (851)
++..++. ... ..........+|..+|+.+.- .-+...+++|..+. ..+.||+|+++..+.+.+.....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~----- 121 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL----- 121 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc-----
Confidence 4455555 221 233445566788888888743 33456678887666 77999999998655444322110
Q ss_pred hhhHHHH-HHHHHHHHHhhc-------------------------------------------------------CCCCC
Q 047215 611 KQRLDAC-IGAARGLHYLHT-------------------------------------------------------GAERG 634 (851)
Q Consensus 611 ~~~~~i~-~~ia~gL~yLHs-------------------------------------------------------~~~~~ 634 (851)
. .+.+ ..+++.|.-||+ .....
T Consensus 122 ~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~ 199 (321)
T COG3173 122 G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV 199 (321)
T ss_pred h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence 1 1122 244555555553 12456
Q ss_pred eEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 635 iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
++|+|+.+.|++++++..+=|.||+++....+
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 99999999999999888899999999987543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.041 Score=60.12 Aligned_cols=143 Identities=15% Similarity=0.146 Sum_probs=82.9
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc--eeeEEEEE------ccCCcEEEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH--LVSLIGFC------DEQNEMILVYE 589 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~------~~~~~~~lV~E 589 (851)
.+.++.|....+|+....+++ +++|+..... .......|++++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~-~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGR-YILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCCc-EEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 456777777899988766554 5677654422 1234556777777774322 34444322 23456789999
Q ss_pred ecCCcchhhh--------------ccC--CC--CC------CCchhhhHH------------HHHHHHHHHHHhhc----
Q 047215 590 YMANGTLRSH--------------LFG--SD--LP------PLTWKQRLD------------ACIGAARGLHYLHT---- 629 (851)
Q Consensus 590 y~~~gsL~~~--------------L~~--~~--~~------~l~~~~~~~------------i~~~ia~gL~yLHs---- 629 (851)
|++|..+... +|. .. .. .-.|..... ....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654211 111 00 00 011211110 01122334555532
Q ss_pred CCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 630 ~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
....+++|+|+.+.||++++++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2357899999999999999888778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0053 Score=65.27 Aligned_cols=132 Identities=18% Similarity=0.126 Sum_probs=88.9
Q ss_pred ceeeeeeeecceEEEEEEEcCcceeEEeecCCCC-----------------hh-----hHHHHHHHHHHHHhcC-C-cce
Q 047215 516 DESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS-----------------EQ-----GLAEFETEIEMLSKLR-H-RHL 571 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~Ei~~l~~l~-H-pnI 571 (851)
...+.||-|.-+.+|.+-..+|++.++|.-.... .. ..-...+|...|+.|. | --|
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 4456899999999999999888888877432110 00 1123556888888884 3 234
Q ss_pred eeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC
Q 047215 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF 651 (851)
Q Consensus 572 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~ 651 (851)
.+.+++ +..++|||++.+-.|...-+-.+ ..++ .-.+..-+.-|. ++|+||+|..-=||+++++.
T Consensus 175 PkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d-----~~~l---y~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 175 PKPIDH----NRHCVVMELVDGYPLRQVRHVED-----PPTL---YDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCcccc----cceeeHHHhhcccceeeeeecCC-----hHHH---HHHHHHHHHHHH---HcCceecccchheeEEecCC
Confidence 455554 46789999998877765532222 2222 222333333444 58999999999999999999
Q ss_pred eEEEeeccccc
Q 047215 652 VAKMSDFGLSK 662 (851)
Q Consensus 652 ~~kl~DFGla~ 662 (851)
.++++||--..
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999996543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.055 Score=58.15 Aligned_cols=31 Identities=26% Similarity=0.441 Sum_probs=26.0
Q ss_pred CCeEEcCCCCCCeEEcCCCe-EEEeecccccc
Q 047215 633 RGIIHRDVKTTNILLDENFV-AKMSDFGLSKT 663 (851)
Q Consensus 633 ~~iiHrDlk~~NILld~~~~-~kl~DFGla~~ 663 (851)
..++|+|+++.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997554 56999998876
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.032 Score=60.13 Aligned_cols=75 Identities=20% Similarity=0.299 Sum_probs=47.9
Q ss_pred ceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC---CcceeeEEEEEccCCcEEEEEEecC
Q 047215 516 DESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR---HRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
+..+.|+-|....+|+.. .+++.+.||... ......|..|.+-|+.|. --.+.+.+++...++..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678888899999877 566677888766 233356888999998883 3457788888877777799999998
Q ss_pred Cc
Q 047215 593 NG 594 (851)
Q Consensus 593 ~g 594 (851)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.054 Score=60.18 Aligned_cols=139 Identities=17% Similarity=0.205 Sum_probs=79.6
Q ss_pred eeeeecceEEEEEEEcC-----cceeEEeecCCCChhhHHHHHHHHHHHHhcCCccee-eEEEEEccCCcEEEEEEecCC
Q 047215 520 MIGVGGFGKVFKGEIED-----CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV-SLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
.|-.|-.-.+|+....+ +..+++|.......... +-.+|..+++.+..-++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34446677888877532 24567777655443322 237799999988544443 455655432 58999987
Q ss_pred cchhhh-----------------ccCCCC----CCCchhhhHHHHHH-----------------HHHHHHH----hhc-C
Q 047215 594 GTLRSH-----------------LFGSDL----PPLTWKQRLDACIG-----------------AARGLHY----LHT-G 630 (851)
Q Consensus 594 gsL~~~-----------------L~~~~~----~~l~~~~~~~i~~~-----------------ia~gL~y----LHs-~ 630 (851)
.+|... +|.... ....|.++.+...+ +...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 111110 01123322222211 1111111 221 1
Q ss_pred CCCCeEEcCCCCCCeEEcC-CCeEEEeecccccc
Q 047215 631 AERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKT 663 (851)
Q Consensus 631 ~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~ 663 (851)
....++|+|+++.|||+++ ++.++++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2456899999999999976 47899999988764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.0028 Score=78.77 Aligned_cols=159 Identities=16% Similarity=0.037 Sum_probs=110.1
Q ss_pred HHHHHHHHHhcCCcceeeEEEEE--ccCCcEEEEEEecCCcchhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCC
Q 047215 556 FETEIEMLSKLRHRHLVSLIGFC--DEQNEMILVYEYMANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGA 631 (851)
Q Consensus 556 ~~~Ei~~l~~l~HpnIv~l~g~~--~~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~ 631 (851)
...|...++...|+++.....-. .+..+.+..++|+..|.+.+.|-+.. .+++...-+...-.+......-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 44455556667898887665544 34567799999999999999874432 233333333322233244444445322
Q ss_pred --CCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHH
Q 047215 632 --ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709 (851)
Q Consensus 632 --~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eL 709 (851)
..-.+|+++|+.|.+|..+.++|+.++|+.+...+. ........+++-|+.|+......++.++|+|..|+.++++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 234789999999999999999999999999842221 1123344577789999999999999999999999999998
Q ss_pred HhCCcCC
Q 047215 710 VCARAVI 716 (851)
Q Consensus 710 ltG~~p~ 716 (851)
--|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 7665443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.17 Score=55.12 Aligned_cols=140 Identities=18% Similarity=0.157 Sum_probs=92.2
Q ss_pred ceeeeeeeecceEEEEEEEcCcceeEEeecCCC-----Ch--------------------h-hHHHHHHHHHHHHhcCCc
Q 047215 516 DESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ-----SE--------------------Q-GLAEFETEIEMLSKLRHR 569 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~-----~~--------------------~-~~~~~~~Ei~~l~~l~Hp 569 (851)
++..+|..|.-+.||.+.-.+|..+|||+.+-. .+ . -.--...|++-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345678999999999999999999999975421 00 0 011244688888888654
Q ss_pred ceeeEEEEEccCCcEEEEEEecCCcc-hhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc
Q 047215 570 HLVSLIGFCDEQNEMILVYEYMANGT-LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD 648 (851)
Q Consensus 570 nIv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld 648 (851)
.|...--... ....|||+|+.... -.-.|.. ..++...+..+-.+++.-|.-|.. ..++||.||.--|+|+-
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE
Confidence 4332211111 23479999986422 2222322 235555666677777777777775 67899999999999984
Q ss_pred CCCeEEEeecccccc
Q 047215 649 ENFVAKMSDFGLSKT 663 (851)
Q Consensus 649 ~~~~~kl~DFGla~~ 663 (851)
+|.+.|+|-+-+..
T Consensus 300 -dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVE 313 (520)
T ss_pred -CCEEEEEEcccccc
Confidence 56899999876643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.37 Score=54.23 Aligned_cols=73 Identities=16% Similarity=0.116 Sum_probs=49.4
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCCh-------hhHHHHHHHHHHHHhcC---CcceeeEEEEEccCCcEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE-------QGLAEFETEIEMLSKLR---HRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV 587 (851)
.+.||-|....||+.... +..++||+..+... .....-..|.+.|+.+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456899999999998764 34578887652211 12333344567776653 347888999987 446889
Q ss_pred EEecCC
Q 047215 588 YEYMAN 593 (851)
Q Consensus 588 ~Ey~~~ 593 (851)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.11 Score=56.45 Aligned_cols=103 Identities=17% Similarity=0.164 Sum_probs=69.2
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
...|++|++. +++|. .+ ....|++.+.++++.+.-++-|.. +.+.-|||+...||||+ +|.+-|+||-++
T Consensus 299 ~y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred eEEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence 3446666654 33442 22 335689999999999888888875 77899999999999999 999999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHH
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSF 702 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~ 702 (851)
|....... ..-...-.|-.+.+.. +.+-+||-+
T Consensus 369 Rl~~~q~~-------isy~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 369 RLSYSQGI-------ISYNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred ecccCCce-------eeccccCchhhhcCcc-ceeeeHHHH
Confidence 96333211 1112233454554333 556666653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.29 Score=54.08 Aligned_cols=79 Identities=24% Similarity=0.269 Sum_probs=49.0
Q ss_pred eeeeecceEEEEEEEcCc-ceeEEeecCCC-------ChhhHHHHHHHHHHHHhcC--Cccee-eEEEEEccCCcEEEEE
Q 047215 520 MIGVGGFGKVFKGEIEDC-TLAAIKRANPQ-------SEQGLAEFETEIEMLSKLR--HRHLV-SLIGFCDEQNEMILVY 588 (851)
Q Consensus 520 ~LG~G~fG~Vykg~~~~~-~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~--HpnIv-~l~g~~~~~~~~~lV~ 588 (851)
.||-|....||++...++ +.++||...+. -+.......-|.+.|+... -|..| +++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478899999999997654 46888864321 1333445566777777663 35444 44433 334557999
Q ss_pred EecCCc-chhhhc
Q 047215 589 EYMANG-TLRSHL 600 (851)
Q Consensus 589 Ey~~~g-sL~~~L 600 (851)
|+++.. .|+..|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998553 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.35 Score=52.83 Aligned_cols=32 Identities=16% Similarity=0.235 Sum_probs=28.9
Q ss_pred CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 632 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
..+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999988765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.35 Score=53.17 Aligned_cols=136 Identities=24% Similarity=0.273 Sum_probs=80.0
Q ss_pred cceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC---Ccc---eeeEEE----EEccCCcEEEEEEecCCc
Q 047215 525 GFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR---HRH---LVSLIG----FCDEQNEMILVYEYMANG 594 (851)
Q Consensus 525 ~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---Hpn---Iv~l~g----~~~~~~~~~lV~Ey~~~g 594 (851)
.-..||+....++.. ++|..... ....+...|+..|..|. .+= |..+=| ....+...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456788888888777 77776654 33456667888887773 222 222222 112223788999999998
Q ss_pred chhh-hc--------------c----C------CCCCCCchhh-------------hHHHHHHHHHHHHHhhcC----CC
Q 047215 595 TLRS-HL--------------F----G------SDLPPLTWKQ-------------RLDACIGAARGLHYLHTG----AE 632 (851)
Q Consensus 595 sL~~-~L--------------~----~------~~~~~l~~~~-------------~~~i~~~ia~gL~yLHs~----~~ 632 (851)
.+.. .- + + .......|.. ......++...+..+++. ..
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8773 11 0 0 0011233430 111222333334444321 12
Q ss_pred CC---eEEcCCCCCCeEEcCCCe-EEEeecccccc
Q 047215 633 RG---IIHRDVKTTNILLDENFV-AKMSDFGLSKT 663 (851)
Q Consensus 633 ~~---iiHrDlk~~NILld~~~~-~kl~DFGla~~ 663 (851)
.. +||+|+.+.||+++.+.. +.+.||+-+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 22 999999999999998874 89999998764
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.051 Score=39.11 Aligned_cols=20 Identities=15% Similarity=0.302 Sum_probs=8.6
Q ss_pred CcceEeeeehhhHHHHHHHH
Q 047215 420 NKWILLVGIGAGIASVVVLA 439 (851)
Q Consensus 420 ~~~~~~i~i~~~i~~vvll~ 439 (851)
++....+++++++.++++++
T Consensus 7 ~~~~vaIa~~VvVPV~vI~~ 26 (40)
T PF08693_consen 7 NSNTVAIAVGVVVPVGVIII 26 (40)
T ss_pred CCceEEEEEEEEechHHHHH
Confidence 34444444444444433333
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.33 Score=52.92 Aligned_cols=31 Identities=32% Similarity=0.433 Sum_probs=26.6
Q ss_pred CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 632 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 467999999999999987 5788999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.035 Score=62.57 Aligned_cols=47 Identities=21% Similarity=0.334 Sum_probs=35.8
Q ss_pred HHHHHHHHHHhcCCcceeeEEEEEccC-CcEEEEEEecCCcchhhhccC
Q 047215 555 EFETEIEMLSKLRHRHLVSLIGFCDEQ-NEMILVYEYMANGTLRSHLFG 602 (851)
Q Consensus 555 ~~~~Ei~~l~~l~HpnIv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~L~~ 602 (851)
.......+++.+.|+|+...+.+.... ....+|+|++. .+|.+.+..
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~ 75 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT 75 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence 345567788999999999999988544 34688899884 488887743
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.19 Score=51.64 Aligned_cols=31 Identities=26% Similarity=0.360 Sum_probs=22.0
Q ss_pred CCeEEcCCCCCCeEE-cCCCeEEEeecccccc
Q 047215 633 RGIIHRDVKTTNILL-DENFVAKMSDFGLSKT 663 (851)
Q Consensus 633 ~~iiHrDlk~~NILl-d~~~~~kl~DFGla~~ 663 (851)
..++|.|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 457899999999999 8899999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 851 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-91 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-90 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-50 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-32 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-21 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 851 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-135 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-130 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-82 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-64 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-63 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-61 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-59 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 4e-59 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-58 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-57 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-57 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-56 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-52 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-52 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-51 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-40 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-38 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-38 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-38 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-38 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-38 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-38 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-38 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-38 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-38 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-38 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-38 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-38 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-37 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-37 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-37 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 4e-37 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 2e-23 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-37 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 8e-37 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-36 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-36 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-36 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-36 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-36 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-36 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-36 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-36 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-36 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-36 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-36 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-36 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-36 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-36 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-36 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 7e-36 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 7e-36 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-36 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 8e-36 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 9e-36 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-35 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-35 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-35 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-35 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-35 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-35 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-35 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-35 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-35 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-35 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-35 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-35 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-35 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-35 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-35 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-35 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 8e-35 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-34 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-34 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-34 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-33 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-30 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-30 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-30 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-30 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-29 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-29 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-29 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-28 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-28 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-28 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-28 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-28 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-27 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-27 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-27 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-27 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-26 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-26 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-26 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-25 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-25 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-24 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-24 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-24 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-24 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-24 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-24 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-24 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-05 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-23 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-23 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-23 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 8e-23 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-23 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-22 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-22 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-22 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-22 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-22 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-22 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-22 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 9e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-21 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-21 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-21 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 6e-21 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 8e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 8e-21 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-20 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 8e-20 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-19 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-19 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-19 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-18 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-11 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-18 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-17 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-17 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-17 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-16 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-16 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-16 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 7e-16 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 8e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 8e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 9e-15 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-14 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-14 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-14 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-14 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-14 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 9e-14 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-13 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-13 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-13 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-13 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-13 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-12 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-10 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-07 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 7e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-05 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 559 bits (1442), Expect = 0.0
Identities = 181/320 (56%), Positives = 231/320 (72%), Gaps = 5/320 (1%)
Query: 477 NSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIED 536
+ + A S L S + R L ++ ATNNFD +IG G FGKV+KG + D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 537 CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTL 596
A+KR P+S QG+ EFETEIE LS RH HLVSLIGFCDE+NEMIL+Y+YM NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 597 RSHLFGSDLP--PLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAK 654
+ HL+GSDLP ++W+QRL+ CIGAARGLHYLHT A IIHRDVK+ NILLDENFV K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 655 MSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA 714
++DFG+SK G ++ TH+ST VKG+ GY+DPEYF + +LTEKSDVYSFGVVLFEV+CAR+
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 715 VINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKN 774
I +LP++ +NLA+WA++ L+ I+DP+L PESL KFG+ A KCL ++
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 775 RPTMGEVLWHLEYVLQLHEA 794
RP+MG+VLW LEY L+L E+
Sbjct: 300 RPSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 405 bits (1042), Expect = e-135
Identities = 102/301 (33%), Positives = 169/301 (56%), Gaps = 20/301 (6%)
Query: 501 KRFTLAEIRVATNNFDESLM------IGVGGFGKVFKGEIEDCTLAAIKR----ANPQSE 550
F+ E++ TNNFDE + +G GGFG V+KG + + T A+K+ + +E
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 71
Query: 551 QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSD-LPPLT 609
+ +F+ EI++++K +H +LV L+GF + +++ LVY YM NG+L L D PPL+
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 610 WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669
W R GAA G+++LH E IHRD+K+ NILLDE F AK+SDFGL++
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729
T +++ + G+ Y+ PE R ++T KSD+YSFGVVL E++ ++ L D
Sbjct: 189 TVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLD 245
Query: 730 WAMK-WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788
+ ++++++ ID + + S+E +A +CL ++ RP + +V L+ +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 789 L 789
Sbjct: 305 T 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-130
Identities = 125/307 (40%), Positives = 185/307 (60%), Gaps = 8/307 (2%)
Query: 500 GKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGL-AEFET 558
KRF+L E++VA++NF ++G GGFGKV+KG + D TL A+KR + QG +F+T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFG--SDLPPLTWKQRLDA 616
E+EM+S HR+L+ L GFC E +LVY YMANG++ S L PPL W +R
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
+G+ARGL YLH + IIHRDVK NILLDE F A + DFGL+K + THV+TAV
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAV 195
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ--INLADWAMKW 734
+G+ G++ PEY + +EK+DV+ +GV+L E++ + + + + L DW
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE--YVLQLH 792
K++ L++++D L+GNY E +E+ ++A C RP M EV+ LE + +
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315
Query: 793 EAWMRTD 799
E W + +
Sbjct: 316 EEWQKEE 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 4e-82
Identities = 62/315 (19%), Positives = 126/315 (40%), Gaps = 27/315 (8%)
Query: 500 GKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETE 559
G + + + G FG V+K ++ + A+K Q +Q + E E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSW-QNEYE 68
Query: 560 IEMLSKLRHRHLVSLIGFCDE----QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD 615
+ L ++H +++ IG ++ L+ + G+L L ++W +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCH 125
Query: 616 ACIGAARGLHYLHTGAER-------GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668
ARGL YLH I HRD+K+ N+LL N A ++DFGL+ + +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 669 HTHVSTAVKGSFGYLDPEYF-----WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
+ G+ Y+ PE +++ + D+Y+ G+VL+E+ + + +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 724 QINLADWAMKWQKQRSLKSII-----DPHLKGNYSP-ESLEKFGEIAEKCLDDEGKNRPT 777
+ + + ++ ++ P L+ + + E E+C D + + R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 778 MGEVLWHLEYVLQLH 792
G V + + +L
Sbjct: 306 AGCVGERITQMQRLT 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-64
Identities = 77/273 (28%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG V K + AIK+ +SE F E+ LS++ H ++V L G C
Sbjct: 16 VGRGAFGVVCKAKWRA-KDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC-- 70
Query: 581 QNEMILVYEYMANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
N + LV EY G+L + L G++ LP T + C+ ++G+ YLH+ + +IHRD
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 640 VKTTNILLDENF-VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
+K N+LL V K+ DFG + + T KGS ++ PE F +EK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL- 757
V+S+G++L+EV+ R P D+I + + W + + ++L
Sbjct: 186 VFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHNGTRPPL---------IKNLP 230
Query: 758 EKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ + +C + RP+M E++ + ++++
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-63
Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G FG V + E + A+K Q + + EF E+ ++ +LRH ++V +G
Sbjct: 45 IGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDL-PPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+ + +V EY++ G+L L S L ++RL A+G++YLH I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVH 162
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS-TAVKGSFGYLDPEYFWRQQLTEK 696
R++K+ N+L+D+ + K+ DFGLS+ T +S + G+ ++ PE + EK
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 697 SDVYSFGVVLFEVVCARAVINPTLPKDQINLAD--WAMKWQKQRSLKSIIDPHLKGNYSP 754
SDVYSFGV+L+E+ + P +N A A+ ++ +R + P
Sbjct: 220 SDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFKCKR-------LEI-----P 261
Query: 755 ESL-EKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+L + I E C +E RP+ ++ L +++
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-61
Identities = 69/324 (21%), Positives = 125/324 (38%), Gaps = 38/324 (11%)
Query: 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEM 562
+E + +N +IG G +G V+KG +++ A+K + + Q E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFIN-EKNIYR 60
Query: 563 LSKLRHRHLVSLIGFC-----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC 617
+ + H ++ I D + E +LV EY NG+L +L W
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLA 117
Query: 618 IGAARGLHYLHTGAERG------IIHRDVKTTNILLDENFVAKMSDFGLSKT------GP 665
RGL YLHT RG I HRD+ + N+L+ + +SDFGLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 666 SMEHTHVSTAVKGSFGYLDPEYF-------WRQQLTEKSDVYSFGVVLFEVV--CARAVI 716
E + + + G+ Y+ PE + ++ D+Y+ G++ +E+ C
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 717 NPTLPKDQINLADWAMKWQKQRSLKSIID-----PHLKGNYSPES--LEKFGEIAEKCLD 769
++P+ Q+ ++ ++ P + S + E E C D
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 770 DEGKNRPTMGEVLWHLEYVLQLHE 793
+ + R T + ++ + E
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWE 321
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-59
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 31/275 (11%)
Query: 521 IGVGGFGKVFKG----EIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSL 574
IG G FG V+KG ++ A+K N + Q L F+ E+ +L K RH +++
Sbjct: 32 IGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+G+ I V ++ +L HL S+ K+ +D ARG+ YLH +
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL- 693
IIHRD+K+ NI L E+ K+ DFGL+ +H + GS ++ PE Q
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 694 --TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751
+ +SDVY+FG+VL+E++ + LP IN D + R S ++ N
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQII-EMVGRGSLSPDLSKVRSN 253
Query: 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ +CL + RP+ +L +E
Sbjct: 254 CPKR----MKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-59
Identities = 71/282 (25%), Positives = 133/282 (47%), Gaps = 41/282 (14%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ----GLAEFETEIEMLSKLRHRHLVSLI 575
+IG+GGFGKV++ A+K A ++ + E ++ + L+H ++++L
Sbjct: 14 IIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G C ++ + LV E+ G L L G +P ++ + ARG++YLH A I
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 636 IHRDVKTTNILLDE--------NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
IHRD+K++NIL+ + N + K++DFGL++ H + G++ ++ PE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEV 185
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD--WAMKWQKQRSLKSIID 745
++ SDV+S+GV+L+E++ +P I+ + + K
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVAMNKLA------- 232
Query: 746 PHLKGNYSPESL-EKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ P + E F ++ E C + + +RP+ +L L
Sbjct: 233 LPI-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-58
Identities = 51/275 (18%), Positives = 111/275 (40%), Gaps = 35/275 (12%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+ G+++KG + +K + S + +F E L H +++ ++G C
Sbjct: 18 LNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 579 DE--QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
L+ +M G+L + L + Q + + ARG+ +LHT E I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIP 135
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL--- 693
+ + ++++DE+ A++S + + S + ++ PE ++
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK--WQKQRSLKSIIDPHLKGN 751
+D++SF V+L+E+V +P ++ + MK + R P +
Sbjct: 189 RRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLR-------PTIPPG 235
Query: 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
SP ++ + C++++ RP ++ LE
Sbjct: 236 ISPH----VSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-57
Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 39/283 (13%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQG-------LAEFETEIEMLSKLRHRHL 571
IG GGFG V KG ++D ++ AIK +G EF+ E+ ++S L H ++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
V L G N +V E++ G L L P+ W +L + A G+ Y+
Sbjct: 86 VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 632 ERGIIHRDVKTTNILLDE-----NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
I+HRD+++ NI L AK++DFGLS+ + H + + G+F ++ PE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPE 196
Query: 687 YFWRQQL--TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744
++ TEK+D YSF ++L+ ++ +I ++ + R
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGKIKFI-NMIREEGLR------ 248
Query: 745 DPHLKGNYSPESL-EKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
P + PE + + E C + K RP ++ L
Sbjct: 249 -PTI-----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-57
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 44/291 (15%)
Query: 520 MIGVGGFGKVFKG----EIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVS 573
+IG G FG+V+ G E+ AI+ + + +E L F+ E+ + RH ++V
Sbjct: 40 LIGKGRFGQVYHGRWHGEV------AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+G C + ++ TL S + + L + +G+ YLH +
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSK---TGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
GI+H+D+K+ N+ D V ++DFGL + G +L PE +
Sbjct: 150 GILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 691 QQL---------TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741
++ SDV++ G + +E+ P A+ WQ +K
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAE--AIIWQMGTGMK 260
Query: 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792
+ E +I C E + RPT +++ LE + + +
Sbjct: 261 PNLSQI---GMGKE----ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-56
Identities = 66/283 (23%), Positives = 112/283 (39%), Gaps = 39/283 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLA-AIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FG+ K + +K E+ F E++++ L H +++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+ + + EY+ GTLR + D W QR+ A G+ YLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 640 VKTTNILLDENFVAKMSDFGLSK------------TGPSMEHTHVSTAVKGSFGYLDPEY 687
+ + N L+ EN ++DFGL++ V G+ ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747
+ EK DV+SFG+VL E++ R +P ++ +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGL-----------------N 235
Query: 748 LKGNYSPES----LEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
++G F I +C D + + RP+ ++ LE
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-52
Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 35/293 (11%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC- 578
IG G +G+V+ G+ +A +K E ETEI +RH +++ I
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVA-VKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADI 101
Query: 579 ---DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT-----G 630
++ L+ +Y NG+L +L L K L + GL +LHT
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLS--KTGPSMEHTHVSTAVKGSFGYLDPE-- 686
+ I HRD+K+ NIL+ +N ++D GL+ + E G+ Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 687 ----YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742
Q +D+YSFG++L+EV R V + + Q+ + S +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQL---PYHDLVPSDPSYED 274
Query: 743 IID--------PHLKGNYSPES-LEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ + P +S + L + G++ +C +R T V L
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 63/297 (21%), Positives = 119/297 (40%), Gaps = 43/297 (14%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC- 578
+G G +G+V++G + A+K + + E+ ETE+ LRH +++ I
Sbjct: 15 CVGKGRYGEVWRGSWQG-ENVAVKIFSSRDEKS-WFRETELYNTVMLRHENILGFIASDM 72
Query: 579 ---DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER-- 633
++ L+ Y G+L +L L L L + A GL +LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 634 ---GIIHRDVKTTNILLDENFVAKMSDFGLS--KTGPSMEHTHVSTAVKGSFGYLDPE-- 686
I HRD+K+ NIL+ +N ++D GL+ + + + + G+ Y+ PE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 687 ----YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI--------NLADWAMK- 733
++ D+++FG+VL+EV R V N + + + + M+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 734 ---WQKQRSLKSIIDPHLKGNYSPES-LEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+QR P++ + + L ++ ++C R T + L
Sbjct: 249 VVCVDQQR-------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-50
Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 35/293 (11%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC- 578
IG G FG+V++G+ +A +K + + E+ E EI LRH +++ I
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVA-VKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 106
Query: 579 ---DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLH-----TG 630
++ LV +Y +G+L +L + +T + + + A GL +LH T
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLS--KTGPSMEHTHVSTAVKGSFGYLDPE-- 686
+ I HRD+K+ NIL+ +N ++D GL+ + G+ Y+ PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 687 ----YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742
+ +++D+Y+ G+V +E+ R I Q+ D S++
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLV---PSDPSVEE 279
Query: 743 IIDPHLKGNYSPE---------SLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ + P +L +I +C G R T + L
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-40
Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 35/281 (12%)
Query: 521 IGVGGFGKVFKGEIEDCTLA-AIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G FG+VF G + A+K A+F E +L + H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
++ + +V E + G + L ++ L K L AA G+ YL + IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
D+ N L+ E V K+SDFG+S+ + + + PE + + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQINLAD---WAMKWQKQRSLKSIIDPHLKGNY--- 752
V+SFG++L+E +L + S + + ++
Sbjct: 298 VWSFGILLWETF---------------SLGASPYPNL------SNQQTRE-FVEKGGRLP 335
Query: 753 SPESL-EKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792
PE + + E+C E RP+ + L+ + + H
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 69/319 (21%), Positives = 119/319 (37%), Gaps = 36/319 (11%)
Query: 486 GTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKR 544
G+ + + R F + + ++ +G GGF V E + D A+KR
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 545 ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ----NEMILVYEYMANGTLRSHL 600
+Q E + E +M H +++ L+ +C + +E L+ + GTL + +
Sbjct: 62 ILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
Query: 601 --FGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658
LT Q L +G RGL +H +G HRD+K TNILL + + D
Sbjct: 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDL 178
Query: 659 GLSKTGPSMEHTHVSTAVK--------GSFGYLDPEYF---WRQQLTEKSDVYSFGVVLF 707
G + A+ + Y PE F + E++DV+S G VL+
Sbjct: 179 GSMNQ-ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 708 EVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKC 767
++ P D + ++ Q L P +S ++
Sbjct: 238 AMMFG------EGPYDMVFQKGDSVALAVQNQLSIPQSPR----HSSA----LWQLLNSM 283
Query: 768 LDDEGKNRPTMGEVLWHLE 786
+ + RP + +L LE
Sbjct: 284 MTVDPHQRPHIPLLLSQLE 302
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 71/214 (33%), Positives = 103/214 (48%), Gaps = 35/214 (16%)
Query: 521 IGVGGFGKVFKGEI---EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLI 575
IG G FG+V K I AAIKR S+ +F E+E+L KL H ++++L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL--------------FGSDLPPLTWKQRLDACIGAA 621
G C+ + + L EY +G L L S L+ +Q L A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
RG+ YL +++ IHRD+ NIL+ EN+VAK++DFGLS+ VK + G
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTMG 201
Query: 682 YL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
L E T SDV+S+GV+L+E+V
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-38
Identities = 65/190 (34%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T AIK P + F E +++ KLRH LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ I V EYM+ G+L L G L Q +D A G+ Y+ +HRD+
Sbjct: 251 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDL 306
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
+ NIL+ EN V K++DFGL++ E+T K + PE + T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 701 SFGVVLFEVV 710
SFG++L E+
Sbjct: 366 SFGILLTELT 375
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G FG+V+ G T A+K + S F E ++ +L+H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
++ I + EYM NG+L L LT + LD A G+ ++ ER IHR
Sbjct: 78 TQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHR 133
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS--------TAVKGSFGYLDPEYFWR 690
D++ NIL+ + K++DFGL++ E+T TA PE
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA---------PEAINY 184
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
T KSDV+SFG++L E+V
Sbjct: 185 GTFTIKSDVWSFGILLTEIV 204
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 69/214 (32%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FGKVF E +D L A+K SE +F+ E E+L+ L+H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHL-------------FGSDLPPLTWKQRLDACIGAA 621
G C E +++V+EYM +G L L PL Q L A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
G+ YL A +HRD+ T N L+ + V K+ DFG+S+ S ++ G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VGGRT 220
Query: 682 YL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
L PE ++ T +SDV+SFGVVL+E+
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSL 574
+IG G FG V+ G + D A+K N +++F TE ++ H +++SL
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 575 IGFC-DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+G C + ++V YM +G LR+ + T K + + A+G+ YL A +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL-----DPEYF 688
+HRD+ N +LDE F K++DFGL++ M + + L E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 689 WRQQLTEKSDVYSFGVVLFEVV 710
Q+ T KSDV+SFGV+L+E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-38
Identities = 65/190 (34%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T AIK P + F E +++ KLRH LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ I V EYM+ G+L L G L Q +D A G+ Y+ +HRD+
Sbjct: 334 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDL 389
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
+ NIL+ EN V K++DFGL++ E+T K + PE + T KSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 701 SFGVVLFEVV 710
SFG++L E+
Sbjct: 449 SFGILLTELT 458
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-38
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ T A+K P S + F E ++ L+H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ I + E+MA G+L L + + +D A G+ ++ +R IHRD+
Sbjct: 255 EPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDL 310
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS--------TAVKGSFGYLDPEYFWRQQ 692
+ NIL+ + V K++DFGL++ E+T TA PE
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA---------PEAINFGS 361
Query: 693 LTEKSDVYSFGVVLFEVV 710
T KSDV+SFG++L E+V
Sbjct: 362 FTIKSDVWSFGILLMEIV 379
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 34/289 (11%)
Query: 521 IGVGGFGKVFKGEIE-----DCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FGKV + A+K P +A+ + EIE+L L H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 575 IGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
G C E + L+ E++ +G+L+ +L + + KQ+L + +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYL---GS 144
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA-----VKGSFGYLDPEY 687
R +HRD+ N+L++ K+ DFGL+K + + + V + PE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----WYAPEC 200
Query: 688 FWRQQLTEKSDVYSFGVVLFEVV--CARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745
+ + SDV+SFGV L E++ C L I M + +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT----- 255
Query: 746 PHLKGNY---SPESL-EKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
LK P + ++ ++ KC + + NR + ++ E +L+
Sbjct: 256 --LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 69/278 (24%), Positives = 106/278 (38%), Gaps = 37/278 (13%)
Query: 514 NFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKL-RHR 569
+F +G G +G+VFK ED L A+KR+ + + A E+ K+ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLP-PLTWKQRLDACIGAARGLHY 626
V L +E + L E +L+ H +G+ LP W D L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL----LALAH 172
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
LH +G++H DVK NI L K+ DFGL + +G Y+ PE
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPE 226
Query: 687 YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746
+ +DV+S G+ + EV C LP WQ+ R + + P
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNM-----ELPHG-------GEGWQQLR--QGYLPP 271
Query: 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
S E + L+ + K R T +L
Sbjct: 272 EFTAGLSSE----LRSVLVMMLEPDPKLRATAEALLAL 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 59/294 (20%), Positives = 116/294 (39%), Gaps = 30/294 (10%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKR---ANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
IG G F +V++ + D A+K+ + + A+ EI++L +L H +++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
E NE+ +V E G L + F + + + L ++H R
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH-VSTAVKGSFGYLDPEYFWRQQ 692
++HRD+K N+ + V K+ D GL + + ++ G+ Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
KSD++S G +L+E+ + D++NL K ++ P +Y
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQ----SPFYGDKMNLYSLCKKIEQCD-----YPPLPSDHY 263
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSFS 806
S E ++ C++ + + RP + V + + A + +
Sbjct: 264 SEE----LRQLVNMCINPDPEKRPDVTYVYDVAKRM----HACTASSLEHHHHH 309
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-38
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSL 574
+IG G FG V+ G + D A+K N +++F TE ++ H +++SL
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 575 IGFC-DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+G C + ++V YM +G LR+ + T K + + A+G+ +L A +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFL---ASK 211
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL-----DPEYF 688
+HRD+ N +LDE F K++DFGL++ M + + L E
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 689 WRQQLTEKSDVYSFGVVLFEVV 710
Q+ T KSDV+SFGV+L+E++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 48/290 (16%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL 571
+F E +IG GGFG+VFK + D IKR +E + E E++ L+KL H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 572 VSLIGFCDEQNEMI----------------LVYEYMANGTLRSHLFGSDLPPLTWKQRLD 615
V G D + + E+ GTL + L L+
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 616 ACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA 675
+G+ Y+H + +I+RD+K +NI L + K+ DFGL + +++ T
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTR 180
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735
KG+ Y+ PE Q ++ D+Y+ G++L E++ +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-----CDTAFETSKF-------- 227
Query: 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785
+ D + + + + +K L + ++RP E+L L
Sbjct: 228 ----FTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 50/191 (26%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 521 IGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G +G+V++G + A+K + + + EF E ++ +++H +LV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+ ++ E+M G L +L + ++ L + + YL ++ IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRN 343
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDV 699
+ N L+ EN + K++DFGLS+ +T K + PE + + KSDV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 700 YSFGVVLFEVV 710
++FGV+L+E+
Sbjct: 403 WAFGVLLWEIA 413
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 520 MIGVGGFGKVFKGEIEDC----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSL 574
+IG G FG V+ GE D AIK + Q + F E ++ L H ++++L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 575 IGFCDEQNEMIL-VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
IG + + YM +G L + T K + + ARG+ YL AE+
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL-----DPEYF 688
+HRD+ N +LDE+F K++DFGL++ + + + L E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWTALESL 200
Query: 689 WRQQLTEKSDVYSFGVVLFEVV 710
+ T KSDV+SFGV+L+E++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELL 222
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 30/191 (15%), Positives = 63/191 (32%), Gaps = 29/191 (15%)
Query: 214 GRGVETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMITANAGSEIRNSSNITYASTNDSS 273
G + ++ +N GG + D S+ I ++ D
Sbjct: 1 GLADKVIWAVNAGGESHVDV----HGIHYRKDPLE-GRVGRASDYGMKLPILRSNPEDQV 55
Query: 274 VAPLLVYETARTMSNTEVLEKRFNMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYI 333
+ Y+T R + + + + +Y + L F E+ + ++ Q++F + +
Sbjct: 56 L-----YQTERYNED--------SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRV 102
Query: 334 NNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLGPDTAVG--------AAGT 385
N T + DIF + G + + ++ L +Q T G
Sbjct: 103 NGHTVVKDLDIFDRVGH-STAHDEIIPISIKKG--KLSVQGEVSTFTGKLSVEFVKGYYD 159
Query: 386 DALLNGLEIFK 396
+ + L I K
Sbjct: 160 NPKVCALFIMK 170
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 2e-23
Identities = 33/167 (19%), Positives = 58/167 (34%), Gaps = 5/167 (2%)
Query: 25 FLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEPLYKTARVFAD 84
+ +N G S V+V G + D +S L + + LY+T R D
Sbjct: 8 WAVNAGGESHVDVHGIHYRKD--PLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED 65
Query: 85 GLNYTFEIIA-GNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISHRNLY 143
Y I G Y++ L F F + F V NG ++ + + H +
Sbjct: 66 SFGYDIPIKEEGEYVLVLKFAEVYFA--QSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAH 123
Query: 144 LQSSGGNSSSISLVKEYFLGVDLDKLMIEFIPSKGSFGFINAIEIVP 190
+ + L + + KL +EF+ + A+ I+
Sbjct: 124 DEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FGKVF E +D L A+K + +F+ E E+L+ L+H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHL--------------FGSDLPPLTWKQRLDACIGA 620
G C + + +I+V+EYM +G L L L Q L
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
A G+ YL A + +HRD+ T N L+ N + K+ DFG+S+ S ++ G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----VGGH 194
Query: 681 GYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
L PE ++ T +SDV+SFGV+L+E+
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 67/200 (33%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G FG V G + AIK R SE+ +F E E++ KL H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
EQ + LV E+M +G L +L + L C+ G+ YL E +IHR
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYL---EEACVIHR 128
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS--------TAVKGSFGYLDPEYFWR 690
D+ N L+ EN V K+SDFG+++ ++T + + PE F
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS---------PEVFSF 179
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
+ + KSDV+SFGV+++EV
Sbjct: 180 SRYSSKSDVWSFGVLMWEVF 199
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 73/307 (23%), Positives = 129/307 (42%), Gaps = 61/307 (19%)
Query: 512 TNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH 570
++F+E ++G G FG+V K D AIK+ +E+ L+ +E+ +L+ L H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 571 LVSLIG-FCDEQNEMI------------LVYEYMANGTLRSHLFGSDLPP-----LTW-K 611
+V + + +N + + EY NGTL + +L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--------- 662
Q L+A L Y+H +GIIHRD+K NI +DE+ K+ DFGL+K
Sbjct: 124 QILEA-------LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 663 ----TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVIN 717
++++A+ G+ Y+ E EK D+YS G++ FE++
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----- 227
Query: 718 PTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT 777
+ +++N+ +K RS+ P N +I +D + RP
Sbjct: 228 FSTGMERVNI------LKKLRSVSIEFPPDFDDNKMKV----EKKIIRLLIDHDPNKRPG 277
Query: 778 MGEVLWH 784
+L
Sbjct: 278 ARTLLNS 284
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G FG V G+ AIK + SE EF E +++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
+Q + ++ EYMANG L ++L +Q L+ C + YL + +HR
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 144
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS--------TAVKGSFGYLDPEYFWR 690
D+ N L+++ V K+SDFGLS+ E+T + PE
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---------PEVLMY 195
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
+ + KSD+++FGV+++E+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIY 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG V++G E T AIK N S + EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--------FGSDLPPLTWKQRLDACIGAARGLH 625
L+G + +++ E M G L+S+L L P + + + A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL-- 683
YL +HRD+ N ++ E+F K+ DFG+++ + T KG G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYET--DYYRKGGKGLLPV 204
Query: 684 ---DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE T SDV+SFGVVL+E+
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G FG V G+ + A+K + SE EF E + + KL H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
++ + +V EY++NG L ++L L Q L+ C G+ +L IHR
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS--------TAVKGSFGYLDPEYFWR 690
D+ N L+D + K+SDFG+++ ++ +A PE F
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA---------PEVFHY 179
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
+ + KSDV++FG++++EV
Sbjct: 180 FKYSSKSDVWAFGILMWEVF 199
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 521 IGVGGFGKVFKGE-----IEDCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FG V+KG + AIK S + E E +++ + + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+G C + + + M G L ++ + + L+ C+ A+G++YL +R
Sbjct: 83 LGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
++HRD+ N+L+ K++DFGL+K + E + + K ++ E + T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 695 EKSDVYSFGVVLFEVV 710
+SDV+S+GV ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 521 IGVGGFGKVFKGEIE-----DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V + + A+K+ +E+ L +FE EIE+L L+H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 576 GFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
G C + L+ EY+ G+LR +L + + L +G+ YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTK 164
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGP-SMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
IHRD+ T NIL++ K+ DFGL+K P E+ V + + PE +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 693 LTEKSDVYSFGVVLFEVV 710
+ SDV+SFGVVL+E+
Sbjct: 225 FSVASDVWSFGVVLYELF 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FGKV K T A+K S L + +E +L ++ H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL----------------------FGSDLPPLTWK 611
L G C + ++L+ EY G+LR L D LT
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671
+ ++G+ YL AE ++HRD+ NIL+ E K+SDFGLS+ +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR---DVYEED 204
Query: 672 VSTAVKGSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
VK S G + E + T +SDV+SFGV+L+E+V
Sbjct: 205 S--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 521 IGVGGFGKVFKGEIE-----DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V + + A+K+ +E+ L +FE EIE+L L+H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 576 GFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
G C + L+ EY+ G+LR +L + + L +G+ YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TK 133
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGP-SMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
IHRD+ T NIL++ K+ DFGL+K P E V + + PE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 693 LTEKSDVYSFGVVLFEVV 710
+ SDV+SFGVVL+E+
Sbjct: 194 FSVASDVWSFGVVLYELF 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 29/211 (13%)
Query: 521 IGVGGFGKVFKGEI----EDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FG V + ++ A+K +A+ + + EF E + + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 575 IGFC------DEQNEMILVYEYMANGTLRSHL----FGSDLPPLTWKQRLDACIGAARGL 624
+G +++ +M +G L + L G + L + + + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL- 683
YL + R IHRD+ N +L E+ ++DFGLS+ + +G L
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSG--DYYRQGCASKLP 202
Query: 684 ----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
E T SDV++FGV ++E++
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 65/304 (21%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLV 572
+G G FGKV + + A+K +E++++S L +H ++V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHL------------FGSDLPPLTWKQRLDACIGA 620
+L+G C ++++ EY G L + L F + + L
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
A+G+ +L A + IHRDV N+LL VAK+ DFGL++ + + S +
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMND--SNYIVKGN 225
Query: 681 GYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTL-----PKDQINLADW 730
L PE + T +SDV+S+G++L+E+ +L P +N
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF--------SLGLNPYPGILVN---- 273
Query: 731 AMKWQKQRSLKSIIDPHLKGNY---SPESL-EKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ K +K Y P + I + C E +RPT ++ L+
Sbjct: 274 ------SKFYK-----LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
Query: 787 YVLQ 790
Q
Sbjct: 323 EQAQ 326
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 59/275 (21%), Positives = 113/275 (41%), Gaps = 24/275 (8%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHR 569
+ IG G FGK + ED IK N S + E E+ +L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
++V +E + +V +Y G L + Q LD + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
+R I+HRD+K+ NI L ++ ++ DFG+++ ++ A G+ YL PE
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICE 198
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
+ KSD+++ G VL+E+ + + ++ + +K P +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVLKIISGSF------PPVS 246
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+YS + + + ++RP++ +L
Sbjct: 247 LHYSYD----LRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 71/303 (23%), Positives = 133/303 (43%), Gaps = 60/303 (19%)
Query: 521 IGVGGFGKVFKGEI--------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V E ++ A+K +E+ L++ +E+EM+ + +H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHL--------------FGSDLPPLTWKQRLDA 616
+++L+G C + + ++ EY + G LR +L +T+K +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL A + IHRD+ N+L+ EN V K++DFGL++ + +
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNI--DYYK 260
Query: 677 KGSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731
K + G L PE + + T +SDV+SFGV+++E+ P +P +++
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------ 314
Query: 732 MKWQKQRSLKSIIDPHLKGNY---SPES-LEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787
K LK + P + + + C RPT +++ L+
Sbjct: 315 FK-------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 788 VLQ 790
+L
Sbjct: 362 ILT 364
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
IG G FG V G+ A+K + F E ++++LRH +LV L+G E
Sbjct: 29 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 581 QNEMI-LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+ + +V EYMA G+L +L L L + + YL +HRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRD 142
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS-------TAVKGSFGYLDPEYFWRQQ 692
+ N+L+ E+ VAK+SDFGL+K T + TA PE ++
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA---------PEALREKK 190
Query: 693 LTEKSDVYSFGVVLFEVV 710
+ KSDV+SFG++L+E+
Sbjct: 191 FSTKSDVWSFGILLWEIY 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 55/210 (26%), Positives = 83/210 (39%), Gaps = 33/210 (15%)
Query: 521 IGVGGFGKVFKGE--------IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV 572
+G G F K+FKG T +K + F M+SKL H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
G C +E ILV E++ G+L ++L + + +L+ A +H+L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFL---EE 131
Query: 633 RGIIHRDVKTTNILLD--------ENFVAKMSDFGLSKTGPSMEHTHVS---TAVKGSFG 681
+IH +V NILL K+SD G+S T +
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP------ 185
Query: 682 YLDPEYFW-RQQLTEKSDVYSFGVVLFEVV 710
PE + L +D +SFG L+E+
Sbjct: 186 ---PECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 37/219 (16%)
Query: 521 IGVGGFGKVFKGEI--------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V E ++ A+K +E+ L++ +E+EM+ + +H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHL--------------FGSDLPPLTWKQRLDA 616
+++L+G C + + ++ EY + G LR +L +T+K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL A + IHRD+ N+L+ EN V K++DFGL++ + +
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNIDYYK-- 214
Query: 677 KGSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
K + G L PE + + T +SDV+SFGV+++E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 521 IGVGGFGKVFKGEIED----CTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FG V +G ++ A+K + + S++ + EF +E + H +++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 575 IGFC-----DEQNEMILVYEYMANGTLRSHL----FGSDLPPLTWKQRLDACIGAARGLH 625
+G C + +++ +M G L ++L + + + L + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL-- 683
YL + R +HRD+ N +L ++ ++DFGLSK + +G +
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYR--QGRIAKMPV 213
Query: 684 ---DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
E + T KSDV++FGV ++E+
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 34/292 (11%)
Query: 521 IGVGGFGKVFKGEIEDC-----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSL 574
+G G FGKV + + A+K Q + ++ EI++L L H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 575 IGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
G C++ + LV EY+ G+LR +L + Q L G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI---GLAQLLLFAQQICEGMAYLH---A 152
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP-SMEHTHVSTAVKGSFGYLDPEYFWRQ 691
+ IHRD+ N+LLD + + K+ DFGL+K P E+ V + PE
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 692 QLTEKSDVYSFGVVLFEVV--CARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
+ SDV+SFGV L+E++ C + PT + I +A M + L L+
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-------LE 265
Query: 750 GNY-------SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794
P + + + C + E RPT ++ L+ V + ++
Sbjct: 266 RGERLPRPDKCPAEVY---HLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-36
Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRH--RHLVSLI 575
IG GG KVF+ E + AIK N Q L + EI L+KL+ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLT----WKQRLDACIGAARGLHYLHT 629
+ + +V E N L S L S + P WK L+A +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEA-------VHTIH- 172
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE--- 686
+ GI+H D+K N L+ + + K+ DFG++ + V + G+ Y+ PE
Sbjct: 173 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 687 --------YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
+ +++ KSDV+S G +L+ + + P + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TP--------FQQIINQIS 275
Query: 739 SLKSIIDPHLKGNYSPESLEK-FGEIAEKCLDDEGKNRPTMGEVLWH 784
L +IIDP+ + + P+ EK ++ + CL + K R ++ E+L H
Sbjct: 276 KLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 12/198 (6%)
Query: 521 IGVGGFGKVFKGEI-----EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V L A+K+ +F+ EI++L L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 576 GFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
G + LV EY+ +G LR L L + L +G+ YL R
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
+HRD+ NIL++ K++DFGL+K ++ V + + PE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 693 LTEKSDVYSFGVVLFEVV 710
+ +SDV+SFGVVL+E+
Sbjct: 207 FSRQSDVWSFGVVLYELF 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 58/197 (29%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 521 IGVGGFGKVFKG----EIEDCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSLI 575
IG G FG V +G AIK S+ +F E + + H H+V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G E I + E G LRS L L + + L YL +
Sbjct: 83 GVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL---ESKRF 137
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF--GYLDPEYFWRQQL 693
+HRD+ N+L+ N K+ DFGLS+ ME + A KG ++ PE ++
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 694 TEKSDVYSFGVVLFEVV 710
T SDV+ FGV ++E++
Sbjct: 195 TSASDVWMFGVCMWEIL 211
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 8e-36
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 37/219 (16%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLV 572
+G G FGKV + + A+K P +E+++LS L H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHL----------------FGSDLPPLTWKQRLDA 616
+L+G C +++ EY G L + L D L + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
A+G+ +L A + IHRD+ NILL + K+ DFGL++ +++
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYV-- 202
Query: 677 KGSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
L PE + T +SDV+S+G+ L+E+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 521 IGVGGFGKVFKG----EIEDCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSLI 575
IG G G+V G + AIK +E+ +F +E ++ + H +++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G ++V EYM NG+L + L D T Q + G G+ YL ++ G
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL---SDLGY 172
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
+HRD+ N+L+D N V K+SDFGLS+ + + +T K + PE + +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 695 EKSDVYSFGVVLFEVV 710
SDV+SFGVV++EV+
Sbjct: 233 SASDVWSFGVVMWEVL 248
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
+G FGKV+KG + E AIK + EF E + ++L+H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--------------FGSDLPPLTWKQRLDACIG 619
L+G + + +++ Y ++G L L + L +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 620 AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS 679
A G+ YL + ++H+D+ T N+L+ + K+SD GL + +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAA--DYYKLLG 188
Query: 680 FGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
L PE + + SD++S+GVVL+EV
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 521 IGVGGFGKVFKGEIEDCTLA-AIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G +G+V++G + +L A+K + + + EF E ++ +++H +LV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
C + ++ E+M G L +L + ++ L + + YL ++ IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA---VKGSFGYLDPEYFWRQQLT 694
RD+ N L+ EN + K++DFGLS+ +T + A +K + PE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAPESLAYNKFS 190
Query: 695 EKSDVYSFGVVLFEVV 710
KSDV++FGV+L+E+
Sbjct: 191 IKSDVWAFGVLLWEIA 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRH--RHLVSLI 575
IG GG KVF+ E + AIK N Q L + EI L+KL+ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLT----WKQRLDACIGAARGLHYLHT 629
+ + +V E N L S L S + P WK L+A +H +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEA-------VHTIH- 144
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE--- 686
+ GI+H D+K N L+ + + K+ DFG++ + V + G+ Y+ PE
Sbjct: 145 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 687 --------YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
+ +++ KSDV+S G +L+ + + P + K
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TP-----FQQIINQISK-- 248
Query: 739 SLKSIIDPHLKGNYSPESLEKFG-EIAEKCLDDEGKNRPTMGEVLWH 784
L +IIDP+ + + P+ EK ++ + CL + K R ++ E+L H
Sbjct: 249 -LHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
IG G FG V G+ A+K + F E ++++LRH +LV L+G E
Sbjct: 201 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 581 QNEMI-LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+ + +V EYMA G+L +L L L + + YL +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRD 314
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS-FGY--LDPEYFWRQQLTEK 696
+ N+L+ E+ VAK+SDFGL+K S+ PE ++ + K
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 697 SDVYSFGVVLFEVV 710
SDV+SFG++L+E+
Sbjct: 367 SDVWSFGILLWEIY 380
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG+V++G++ A+K SEQ +F E ++SK H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARGLHYLH 628
IG + ++ E MA G L+S L S L L A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 629 TGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL-- 683
E IHRD+ N LL VAK+ DFG+++ + KG L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGCAMLPV 209
Query: 684 ---DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE F T K+D +SFGV+L+E+
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 15/197 (7%)
Query: 521 IGVGGFGKVFKGE----IEDCTLAAIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG+V++G + A+K + +F +E ++ L H H+V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G +E+ I + E G L +L + L + + + + YL
Sbjct: 80 GIIEEEPTWI-IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYL---ESINC 134
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF--GYLDPEYFWRQQL 693
+HRD+ NIL+ K+ DFGLS+ +E A ++ PE ++
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 694 TEKSDVYSFGVVLFEVV 710
T SDV+ F V ++E++
Sbjct: 192 TTASDVWMFAVCMWEIL 208
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 67/286 (23%), Positives = 115/286 (40%), Gaps = 32/286 (11%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G +G+ K D + K + +E +E+ +L +L+H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 577 -FCDEQNEMI-LVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYLHT--G 630
D N + +V EY G L S + + L + L L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT-HVSTAVKGSFGYLDPEYFW 689
++HRD+K N+ LD K+ DFGL++ + H + G+ Y+ PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
R EKSD++S G +L+E+ P + + A K ++ + +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIREGKF------RRIP 237
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH---LEYVLQLH 792
YS E EI + L+ + +RP++ E+L + LE+ H
Sbjct: 238 YRYSDE----LNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 65/308 (21%), Positives = 114/308 (37%), Gaps = 64/308 (20%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLV 572
+G G FGKV A+K + +E++M+++L H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHL---------------------FGSDLPPLTWK 611
+L+G C + L++EY G L ++L DL LT++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671
L A+G+ +L + +HRD+ N+L+ V K+ DFGL++ +
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMSDS 226
Query: 672 VSTAVKGSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726
V L PE + T KSDV+S+G++L+E+ P +P D
Sbjct: 227 N--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 727 LADWAMKWQKQRSLKSIIDPHLKGNY---SPES-LEKFGEIAEKCLDDEGKNRPTMGEVL 782
++ + P E+ I + C + + RP+ +
Sbjct: 285 YK------------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326
Query: 783 WHLEYVLQ 790
L L
Sbjct: 327 SFLGCQLA 334
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 70/286 (24%), Positives = 120/286 (41%), Gaps = 48/286 (16%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRH--RHLVSLI 575
IG GG KVF+ E + AIK N Q L + EI L+KL+ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLT----WKQRLDACIGAARGLHYLHT 629
+ + +V E N L S L S + P WK L+A +H +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEA-------VHTIH- 125
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE--- 686
+ GI+H D+K N L+ + + K+ DFG++ + V + G+ Y+ PE
Sbjct: 126 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 687 --------YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
+ +++ KSDV+S G +L+ + + P + +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TP--------FQQIINQIS 228
Query: 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
L +IIDP+ + + + ++ + CL + K R ++ E+L H
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG+V++G++ A+K SEQ +F E ++SK H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARGLHYLH 628
IG + ++ E MA G L+S L S L L A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 629 TGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL-- 683
E IHRD+ N LL VAK+ DFG+++ + KG L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAMLPV 250
Query: 684 ---DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE F T K+D +SFGV+L+E+
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 521 IGVGGFGKVFKGEI----EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG+V G + + AIK +E+ +F E ++ + H +++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G + +++V EYM NG+L S L D T Q + G A G+ YL ++ G
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMGY 168
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT-HVSTAVKGSFGYLDPEYFWRQQLT 694
+HRD+ NIL++ N V K+SDFGL + + + K + PE ++ T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 695 EKSDVYSFGVVLFEVV 710
SDV+S+G+VL+EV+
Sbjct: 229 SASDVWSYGIVLWEVM 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 69/308 (22%), Positives = 122/308 (39%), Gaps = 64/308 (20%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLV 572
+G G FG+V + + C A+K + +E+++L + H ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 573 SLIGFCDEQNE-MILVYEYMANGTLRSHL--------------FGSDLPPLTWKQRLDAC 617
+L+G C + ++++ E+ G L ++L LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
A+G+ +L A R IHRD+ NILL E V K+ DFGL++ + +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYV--R 206
Query: 678 GSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTL---PKDQINLAD 729
L PE + + T +SDV+SFGV+L+E+ +L P
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF--------SLGASP-------- 250
Query: 730 WAMKWQKQRSLKSIIDPHLKGNY---SPES-LEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785
+ + + LK +P+ + + C E RPT E++ HL
Sbjct: 251 ----YPGVKIDEEFCR-RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305
Query: 786 EYVLQLHE 793
+LQ +
Sbjct: 306 GNLLQANA 313
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 521 IGVGGFGKVFKGEI---EDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V KG + A+K + E E ++ +L + ++V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G C+ ++ M+ V E G L +L + + K ++ + G+ YL E
Sbjct: 85 GICEAESWML-VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYL---EESNF 138
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA-----VKGSFGYLDPEYFWR 690
+HRD+ N+LL AK+SDFGLSK + E+ + + VK + PE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPECINY 194
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
+ + KSDV+SFGV+++E
Sbjct: 195 YKFSSKSDVWSFGVLMWEAF 214
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 42/224 (18%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVS 573
IG G FG+VF+ E T+ A+K + S A+F+ E ++++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL----------------------FGSDLPPLTWK 611
L+G C M L++EYMA G L L PPL+
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 612 QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671
++L A G+ YL +ER +HRD+ T N L+ EN V K++DFGLS+ ++
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR---NIYSA- 227
Query: 672 VSTAVKGSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
+ PE + + T +SDV+++GVVL+E+
Sbjct: 228 -DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-35
Identities = 58/197 (29%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 521 IGVGGFGKVFKG----EIEDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLI 575
IG G FG V +G AIK S+ +F E + + H H+V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G E I + E G LRS L L + + L YL +
Sbjct: 458 GVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYL---ESKRF 512
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF--GYLDPEYFWRQQL 693
+HRD+ N+L+ N K+ DFGLS+ ME + A KG ++ PE ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 694 TEKSDVYSFGVVLFEVV 710
T SDV+ FGV ++E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 51/197 (25%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 520 MIGVGGFGKVFKG----EIEDCTLA-AIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVS 573
++G G FG V+KG E E + AIK S + E E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L+G C + + + M G L ++ + + L+ C+ A+G++YL +R
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL---EDR 136
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
++HRD+ N+L+ K++DFGL+K + E + + K ++ E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 694 TEKSDVYSFGVVLFEVV 710
T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 521 IGVGGFGKVFKG-----EIEDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSL 574
IG G FG+V+KG + AIK +E+ +F E ++ + H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
G + M+++ EYM NG L L D + Q + G A G+ YL A
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL---ANMN 167
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS----------TAVKGSFGYLD 684
+HRD+ NIL++ N V K+SDFGLS+ + TA
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA--------- 218
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVV 710
PE ++ T SDV+SFG+V++EV+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 13/197 (6%)
Query: 521 IGVGGFGKVFKGEIEDCTLA-----AIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG V KG + IK Q + + L H H+V
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L+G C + + V +Y+ G+L H+ L + L+ + A+G++YL E
Sbjct: 80 LLGLCPGSSLQL-VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
G++HR++ N+LL +++DFG++ P + + + K ++ E +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 694 TEKSDVYSFGVVLFEVV 710
T +SDV+S+GV ++E++
Sbjct: 195 THQSDVWSYGVTVWELM 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 521 IGVGGFGKVFKGEIEDC---TLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V +G AIK + + E E +++ +L + ++V LI
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLI 76
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G C + M+ V E G L L G + + + G+ YL E+
Sbjct: 77 GVCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYL---EEKNF 131
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA-----VKGSFGYLDPEYFWR 690
+HRD+ N+LL AK+SDFGLSK + + + + + +K + PE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINF 187
Query: 691 QQLTEKSDVYSFGVVLFEVV 710
++ + +SDV+S+GV ++E +
Sbjct: 188 RKFSSRSDVWSYGVTMWEAL 207
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 61/297 (20%), Positives = 108/297 (36%), Gaps = 46/297 (15%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRH 570
+F+ +G GGFG VF+ + D AIKR P E + E++ L+KL H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 571 LVSLIGFCDEQNEMI------------LVYEYMANGTLRSHLFG-SDLPPLTWKQRLDAC 617
+V E+N + + L+ + G + L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK----------TGPSM 667
+ A + +LH +G++HRD+K +NI + V K+ DFGL M
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
T G+ Y+ PE + K D++S G++LFE++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP--------------F 227
Query: 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ + + ++++ P L P + + L RP ++ +
Sbjct: 228 STQMERVRTLTDVRNLKFPPLFTQKYPC----EYVMVQDMLSPSPMERPEAINIIEN 280
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 37/219 (16%)
Query: 521 IGVGGFGKVFKGEI--------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V E T A+K +E+ L++ +E+EM+ + +H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHL--------------FGSDLPPLTWKQRLDA 616
+++L+G C + + ++ EY + G LR +L + L+ K +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL A + IHRD+ N+L+ E+ V K++DFGL++ + H
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIHHI--DYYK 248
Query: 677 KGSFGYL-----DPEYFWRQQLTEKSDVYSFGVVLFEVV 710
K + G L PE + + T +SDV+SFGV+L+E+
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 13/198 (6%)
Query: 521 IGVGGFGKVFKGE----IEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG V +GE A+K + + +F E+ + L HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L G + V E G+L L + A G+ YL +
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYL---ESK 140
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
IHRD+ N+LL + K+ DFGL + + +H + K F + PE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 693 LTEKSDVYSFGVVLFEVV 710
+ SD + FGV L+E+
Sbjct: 201 FSHASDTWMFGVTLWEMF 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIG- 576
IG G F V+KG + E A ++ F+ E EML L+H ++V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 577 ---FCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
+ ++LV E M +GTL+++L F + K C +GL +LHT
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 632 ERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
IIHRD+K NI + K+ D GL+ ++ + AV G+ ++ PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-E 203
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
++ E DVY+FG+ + E+ + + QI K S + P +K
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASFDKVAIPEVK- 260
Query: 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
EI E C+ R ++ ++L H
Sbjct: 261 -----------EIIEGCIRQNKDERYSIKDLLNH 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 521 IGVGGFGKVFKGE--IEDCTLA-AIKRANP-QSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G FG V +G + + AIK + E E +++ +L + ++V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
C + M+ V E G L L G + + + G+ YL E+ +
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYL---EEKNFV 458
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA-----VKGSFGYLDPEYFWRQ 691
HR++ N+LL AK+SDFGLSK + + + + + +K + PE +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFR 514
Query: 692 QLTEKSDVYSFGVVLFEVV 710
+ + +SDV+S+GV ++E +
Sbjct: 515 KFSSRSDVWSYGVTMWEAL 533
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 2e-30
Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 31/242 (12%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGF 577
+G GGFG V + + AIK+ + E + EI+++ KL H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 578 CDEQNEM------ILVYEYMANGTLRSHLFGSD-LPPLTWKQ--RLDACIGAARGLHYLH 628
D ++ +L EY G LR +L + L L + I +A L YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLH 138
Query: 629 TGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
E IIHRD+K NI+L + + K+ D G +K ++ + T G+ YL P
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAP 192
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745
E +++ T D +SFG + FE + P LP Q ++W + KS
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR---PFLPNWQ------PVQWHGKVREKSNEH 243
Query: 746 PH 747
Sbjct: 244 IV 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 45/215 (20%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 521 IGVGGFGKV---------------FKGEIEDCTLAAIKRANPQSEQGLAE-FETEIEMLS 564
+ G F K+ K +E + S + + F+ E+++++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGA---- 620
+++ + ++ G +E+ ++YEYM N ++ + + + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 621 --ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG 678
Y+H E+ I HRDVK +NIL+D+N K+SDFG S+ M + + G
Sbjct: 159 SVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY---MVDKKIKGSR-G 212
Query: 679 SFGYLDPEYFWRQQLT--EKSDVYSFGVVLFEVVC 711
++ ++ PE+F + K D++S G+ L+ +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 64/321 (19%), Positives = 113/321 (35%), Gaps = 66/321 (20%)
Query: 508 IRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL- 566
+ V +F ++G G G + + D A+KR P+ + E+++L +
Sbjct: 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESD 75
Query: 567 RHRHLVSLIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGA 620
H +++ ++ + E A TL + P +Q
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQ-------T 127
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDE-----NFVAKMSDFGLSK-TGPSMEHTHVST 674
GL +LH I+HRD+K NIL+ A +SDFGL K +
Sbjct: 128 TSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 675 AVKGSFGYLDPEYF---WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731
V G+ G++ PE ++ T D++S G V + V+ + P
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-----SHP---------- 229
Query: 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWH 784
+ K ++ I L G S + L K + + + RP+ VL H
Sbjct: 230 --FGKSLQRQANI---LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284
Query: 785 LEYVLQLHEAWMRTDDRQNSF 805
+ + ++Q F
Sbjct: 285 ---------PFFWSLEKQLQF 296
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 64/337 (18%), Positives = 111/337 (32%), Gaps = 66/337 (19%)
Query: 478 STANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGE-IED 536
S A G G + R + ++ GGF V++ + +
Sbjct: 6 SLGGASGRDQSDFVGQT-VELGELRLRVRR------------VLAEGGFAFVYEAQDVGS 52
Query: 537 CTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFC-------DEQNEMILVY 588
A+KR E+ E+ + KL H ++V D L+
Sbjct: 53 GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 589 EYMANGTLRSHLFGSDLP-PLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647
+ G L L + PL+ L R + ++H + IIHRD+K N+LL
Sbjct: 113 TELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLL 171
Query: 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAVK-----------GSFGYLDPE---YFWRQQL 693
K+ DFG + T S + +A + + Y PE + +
Sbjct: 172 SNQGTIKLCDFGSA-TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 694 TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753
EK D+++ G +L+ + P + + I + G YS
Sbjct: 231 GEKQDIWALGCILYLLCFR------QHPFED-------------GAKLRI----VNGKYS 267
Query: 754 -PESL---EKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
P F + L + R ++ EV+ L+
Sbjct: 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 14/195 (7%)
Query: 520 MIGVGGFGKVFKGEIEDCTLA---AIK--RANPQSEQGLAE-FETEIEMLSKLRHRHLVS 573
++G GG G V++ E D A+K S+ + E +L+ H+V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ F + ++ + + L + L PL + + L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
G HRDVK NIL+ + A + DFG++ + T + V G+ Y+ PE F
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212
Query: 694 TEKSDVYSFGVVLFE 708
T ++D+Y+ VL+E
Sbjct: 213 TYRADIYALTCVLYE 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 56/300 (18%)
Query: 512 TNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKL-R 567
T F E IG G FG VFK + D + AIKR+ E+ + L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 568 HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWKQRLDACIGAARGLH 625
H H+V E + M++ EY G+L + + + D + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 626 YLHTGAERGIIHRDVKTTNILLDEN-------------------FVAKMSDFGLSKTGPS 666
Y+H ++H D+K +NI + + K+ D G
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---R 183
Query: 667 MEHTHVSTAVKGSFGYLDPEYFWRQQL--TEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724
+ V +G +L E ++ K+D+++ + + A LP++
Sbjct: 184 ISSPQV---EEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE-----PLPRN- 233
Query: 725 INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+W + ++ P + S E F E+ + + + + RP+ ++ H
Sbjct: 234 ------GDQWHE---IRQGRLPRIPQVLSQE----FTELLKVMIHPDPERRPSAMALVKH 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGF 577
++G G VF+G + L AIK N S + E E+L KL H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 578 CDEQN--EMILVYEYMANGTLRSHLF-GSDLPPLTWKQ--RLDACIGAARGLHYLHTGAE 632
+E +L+ E+ G+L + L S+ L + + + +++L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLR---E 130
Query: 633 RGIIHRDVKTTNILL----DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
GI+HR++K NI+ D V K++DFG ++ +E ++ G+ YL P+ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMY 187
Query: 689 WRQQL--------TEKSDVYSFGVVLFEVVC 711
R L D++S GV +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 62/323 (19%), Positives = 111/323 (34%), Gaps = 75/323 (23%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCD 579
+G G G V A+KR EI++L++ H +++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYYCSET 79
Query: 580 EQNEMILVYEYMANGTL-----RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+ + E N L ++ +L + A G+ +LH
Sbjct: 80 TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLK 135
Query: 635 IIHRDVKTTNILLD-------------ENFVAKMSDFGLSK---TGPSMEHTHVSTAVKG 678
IIHRD+K NIL+ EN +SDFGL K +G S T+++ G
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS-G 194
Query: 679 SFGYLDPEYF-------WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731
+ G+ PE +++LT D++S G V + ++ P
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG-----KHP---------- 239
Query: 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIA---------EKCLDDEGKNRPTMGEVL 782
K +I ++G +S + ++ + + + +D + RPT +VL
Sbjct: 240 -FGDKYSRESNI----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294
Query: 783 WHLEYVLQLHEAWMRTDDRQNSF 805
H ++ F
Sbjct: 295 RH---------PLFWPKSKKLEF 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 521 IGVGGFGKVFKGEIEDCTLA---AIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSL 574
+G GG V+ E D L AIK E+ L FE E+ S+L H+++VS+
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
I +E + LV EY+ TL ++ PL+ ++ G+ + H +
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
I+HRD+K NIL+D N K+ DFG++K T + + G+ Y PE +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATD 190
Query: 695 EKSDVYSFGVVLFE 708
E +D+YS G+VL+E
Sbjct: 191 ECTDIYSIGIVLYE 204
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGF 577
++G G VF+G + L AIK N S + E E+L KL H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 578 CDEQN--EMILVYEYMANGTLRSHLFG-SDLPPLTWKQ--RLDACIGAARGLHYLHTGAE 632
+E +L+ E+ G+L + L S+ L + + + +++L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLR---E 130
Query: 633 RGIIHRDVKTTNILL----DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
GI+HR++K NI+ D V K++DFG ++ +E ++ G+ YL P+ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMY 187
Query: 689 WRQQL--------TEKSDVYSFGVVLFEVVC 711
R L D++S GV +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 36/225 (16%), Positives = 73/225 (32%), Gaps = 23/225 (10%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLA------AIKRANPQSEQGLAEFETEI 560
E ++ + ++G G F +V++ D A +K P + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 561 EMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL---FGSDLPPLTWKQRLDAC 617
E L + QN +LV E + GTL + + + + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILL-----------DENFVAKMSDFGLSKTGPS 666
+ + +H + IIH D+K N +L D + + D G S
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
+ TA + G+ E + + D + ++ ++
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 520 MIGVGGFGKVFKGEIEDCTLA---AIK--RANPQSEQG-LAEFETEIEMLSKLRHRHLVS 573
++G GG +V D A+K RA+ + F E + + L H +V+
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 574 L--IGFCDEQNEMI--LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
+ G + + +V EY+ TLR + P+T K+ ++ A + L++ H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH- 133
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST-AVKGSFGYLDPEYF 688
+ GIIHRDVK NI++ K+ DFG+++ ++ T AV G+ YL PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCAR 713
+ +SDVYS G VL+EV+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 75/280 (26%), Positives = 119/280 (42%), Gaps = 46/280 (16%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FGKV+K E LAA K +SE+ L ++ EIE+L+ H ++V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
++ ++ E+ G + + + LT Q C L++LH + IIHRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRD 142
Query: 640 VKTTNILLDENFVAKMSDFG----LSKTGPSMEHTHVSTA------VKGSFGYLDPEYFW 689
+K N+L+ +++DFG KT + + T V D Y
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPY-- 199
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---P 746
K+D++S G+ L E+ A I P P ++N M R L I P
Sbjct: 200 ----DYKADIWSLGITLIEM----AQIEP--PHHELN----PM-----RVLLKIAKSDPP 240
Query: 747 HLK--GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
L +S E F + + LD + RP+ ++L H
Sbjct: 241 TLLTPSKWSVE----FRDFLKIALDKNPETRPSAAQLLEH 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 40/204 (19%), Positives = 75/204 (36%), Gaps = 27/204 (13%)
Query: 520 MIGVGGFGKVFKGEIEDCTLA----AIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSL 574
I GG G ++ D + +K + E + L+++ H +V +
Sbjct: 87 CIAHGGLGWIYLAL--DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 575 IGFCDEQNEMI-----LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
F + + +V EY+ +L+ L + + + L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH- 199
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
G+++ D+K NI+L E + K+ D G + + G+ G+ PE
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSR---INSF---GYLYGTPGFQAPEIV- 249
Query: 690 RQQLTEKSDVYSFGVVLFEVVCAR 713
R T +D+Y+ G L +
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIK-------RANPQSEQGLAEFETEI 560
+ A +F+ +G G FG V+ E + + A+K Q E+
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ----LRREV 60
Query: 561 EMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGA 620
E+ S LRH +++ L G+ + + L+ EY GT+ L + D A
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTA 112
Query: 621 ------ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVST 674
A L Y H + +IHRD+K N+LL K++DFG S PS T
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---D 166
Query: 675 AVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
G+ YL PE + EK D++S GV+ +E +
Sbjct: 167 LC-GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
++G G +G V+ G ++ + AIK + + EI + L+H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 579 DEQNEMILVYEYMANGTLRS---HLFGSDLPPLTWKQRLDACIGAA--RGLHYLHTGAER 633
E + + E + G+L + +G PL ++ GL YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLH---DN 141
Query: 634 GIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
I+HRD+K N+L++ + V K+SDFG SK + G+ Y+ PE +
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 693 L--TEKSDVYSFGVVLFE 708
+ +D++S G + E
Sbjct: 200 RGYGKAADIWSLGCTIIE 217
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLS 564
+ ++FD +G G FG V+ E ++ + A+K ++ + E + EIE+ S
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGA---- 620
LRH +++ + + ++ + L+ E+ G L L R D A
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--------QKHGRFDEQRSATFME 121
Query: 621 --ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME-HTHVSTAVK 677
A LHY H ER +IHRD+K N+L+ K++DFG S PS+ T +
Sbjct: 122 ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-----MC 173
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
G+ YL PE + EK D++ GV+ +E +
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 85/312 (27%), Positives = 131/312 (41%), Gaps = 63/312 (20%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G FG+VFKG + + AIK + ++E + + + EI +LS+ ++ G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDL---PPLTWKQRLDACIGAARGLHYLHTGAERGI 635
+ ++ ++ EY+ G+ DL PL Q +GL YLH
Sbjct: 90 LKDTKLWIIMEYLGGGSA------LDLLEPGPLDETQIATILREILKGLDYLH---SEKK 140
Query: 636 IHRDVKTTNILLDENFVAKMSDFG----LSKTGPSMEHTHVST----AVKGSFGYLDPEY 687
IHRD+K N+LL E+ K++DFG L+ T +T V T A PE
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMA---------PEV 190
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID-- 745
+ K+D++S G+ E+ A P P +++ M + L I
Sbjct: 191 IKQSAYDSKADIWSLGITAIEL----ARGEP--PHSELH----PM-----KVLFLIPKNN 235
Query: 746 -PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH---------LEYVLQLHEAW 795
P L+GNYS E E CL+ E RPT E+L H Y+ +L + +
Sbjct: 236 PPTLEGNYSKP----LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRY 291
Query: 796 MRTDDRQNSFSS 807
R Q+ S
Sbjct: 292 KRWKAEQSHDDS 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-27
Identities = 62/376 (16%), Positives = 107/376 (28%), Gaps = 99/376 (26%)
Query: 522 GVGGFGKVFKG-EIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
G V ++R N S + + + E+ + H ++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD----ACI--GAARGLHYLHTGAE 632
NE+ +V +MA G+ + DL + ++ A I G + L Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAK------DLICTHFMDGMNELAIAYILQGVLKALDYIH---H 146
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLS----------KTGPSMEHTHVSTAVKGSFGY 682
G +HR VK ++IL+ + +S + + V
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV-------- 198
Query: 683 LDPEYFW------RQQL---TEKSDVYSFGV-------------------VLFE------ 708
W +Q L KSD+YS G+ +L E
Sbjct: 199 --L--PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 709 --------VVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKF 760
+ ++P+ L+D + S +SP F
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH----F 310
Query: 761 GEIAEKCLDDEGKNRPTMGEVLWH-------------LEYVLQLHEAWMRTDDRQNSFSS 807
E+CL RP+ +L H L +L+ + Q+ S
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370
Query: 808 SQALGEFAEREAEDGQ 823
E E
Sbjct: 371 GIFGLVTNLEELEVDD 386
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G GGF K F+ + + + A K ++ + EI + L H+H+V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGA------ARGLHYLHT 629
GF ++ + + +V E +L ++ L G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH--------KRRKALTEPEARYYLRQIVLGCQYLH- 158
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKGSFGYLDPE 686
+IHRD+K N+ L+E+ K+ DFGL+ + + + G+ Y+ PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LCGTPNYIAPE 211
Query: 687 YFWRQQLTEKSDVYSFGVVLFEVVC 711
++ + + DV+S G +++ ++
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLV 236
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 71/328 (21%), Positives = 127/328 (38%), Gaps = 58/328 (17%)
Query: 477 NSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATN---NFDESLMIGVGGFGKVFKG- 532
+ ++ S +T + L + + D + IG G G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 533 EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592
E A+K + + +Q E+ ++ +H ++V + E+ ++ E++
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125
Query: 593 NGTLRSHLFGSDL---PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649
G L +D+ L +Q C + L YLH +G+IHRD+K+ +ILL
Sbjct: 126 GGAL------TDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTL 176
Query: 650 NFVAKMSDFG----LSKTGPSMEHTHVST----AVKGSFGYLDPEYFWRQQLTEKSDVYS 701
+ K+SDFG +SK P + V T A PE R + D++S
Sbjct: 177 DGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMA---------PEVISRSLYATEVDIWS 226
Query: 702 FGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---PHLKGN--YSPES 756
G+++ E+ P P + + +++K + D P LK + SP
Sbjct: 227 LGIMVIEM----VDGEP--PYFSDS----PV-----QAMKRLRDSPPPKLKNSHKVSPV- 270
Query: 757 LEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ E+ L + + R T E+L H
Sbjct: 271 ---LRDFLERMLVRDPQERATAQELLDH 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 33/207 (15%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+G GGF K F+ + + + A K ++ + EI + L H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHYL 627
GF ++ + + +V E +L ++ L AR G YL
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH--------KRRKALTEP--EARYYLRQIVLGCQYL 131
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKGSFGYLD 684
H +IHRD+K N+ L+E+ K+ DFGL+ + + + G+ Y+
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LCGTPNYIA 183
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVVC 711
PE ++ + + DV+S G +++ ++
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLV 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 31/302 (10%), Positives = 65/302 (21%), Gaps = 54/302 (17%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLI 575
+ VG VF ++E A+K S L ++L
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 576 GFC--------------------------DEQNEMILVYEYMANGTLRS-----HLFGSD 604
+L+ + L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 605 LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664
R L +G++H N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQ--QLTEKSDVYSFGVVLFEVVCARAVINPTLPK 722
+ Y E+ T + + G+ ++ V C P
Sbjct: 245 GTRGPASSVPV-----TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL---PFGLV 296
Query: 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVL 782
W + S+ P+ ++ + + L+ + + R E +
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTP--LPDFVK---TLIGRFLNFDRRRRLLPLEAM 351
Query: 783 WH 784
Sbjct: 352 ET 353
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G F +VF + L A+K + E EI +L K++H ++V+L +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 580 EQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
LV + ++ G L R D + +Q L A + YLH E
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI-QQVLSA-------VKYLH---EN 125
Query: 634 GIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
GI+HRD+K N+L +EN ++DFGLSK ME + + G+ GY+ PE +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 691 QQLTEKSDVYSFGVVLF 707
+ ++ D +S GV+ +
Sbjct: 182 KPYSKAVDCWSIGVITY 198
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/301 (18%), Positives = 106/301 (35%), Gaps = 45/301 (14%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G FG+V + + + A+K+ + + E+ + L +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119
Query: 579 DEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
E + + E + G+L + D Q L GL YLH R
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-------EGLEYLH---TR 169
Query: 634 GIIHRDVKTTNILLDEN-FVAKMSDFGLSK--TGPSMEHTHVST-AVKGSFGYLDPEYFW 689
I+H DVK N+LL + A + DFG + + + ++ + G+ ++ PE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
+ K D++S ++ ++ + + I +
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC----HPWT----QYFRGPLCLKIASEPPPI--REIP 279
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH----LEYVLQLHEAWMRT--DDRQN 803
+ +P + ++ L E +R + E+ L+ V L W + R N
Sbjct: 280 PSCAPL----TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN 335
Query: 804 S 804
S
Sbjct: 336 S 336
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 55/281 (19%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G G V+ ++ AI++ N Q + EI ++ + ++ ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDL---PPLTWKQRLDACIGAARGLHYLHTGAERGII 636
+E+ +V EY+A G+L +D+ + Q C + L +LH +I
Sbjct: 88 VGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 637 HRDVKTTNILLDENFVAKMSDFG----LSKTGPSMEHTHVST----AVKGSFGYLDPEYF 688
HRD+K+ NILL + K++DFG ++ S T V T A PE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMA---------PEVV 188
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID--- 745
R+ K D++S G++ E+ P P N + R+L I
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEM----IEGEP--PYLNEN----PL-----RALYLIATNGT 233
Query: 746 PHLKG--NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
P L+ S F + +CL+ + + R + E+L H
Sbjct: 234 PELQNPEKLSAI----FRDFLNRCLEMDVEKRGSAKELLQH 270
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G F V++ I AIK + + + E+++ +L+H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGA------ARGLHYLHTG 630
+ ++ N + LV E NG + +L + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL-------KNRVKPFSENEARHFMHQIITGMLYLH-- 129
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKGSFGYLDPEY 687
GI+HRD+ +N+LL N K++DFGL+ K +T + G+ Y+ PE
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-----LCGTPNYISPEI 183
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVC 711
R +SDV+S G + + ++
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLI 207
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 37/313 (11%), Positives = 85/313 (27%), Gaps = 80/313 (25%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIK----------------------------RANPQSE 550
++G + + E + N +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 551 QGLAEFETEIEMLSKLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHL-----FGSD 604
+ F +++ + + ++ + D L++ S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 605 LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664
L RL + R L LH G++H ++ +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQL-----------TEKSDVYSFGVVLFEVVCAR 713
S G+ PE R+ T D ++ G+V++ + CA
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 714 AVINPTLPKDQINLADWAMKWQKQRS--LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDE 771
P + ++W + K +++++ E L
Sbjct: 311 L---PITKDAALGGSEWIFRSCKNIPQPVRALL--------------------EGFLRYP 347
Query: 772 GKNRPTMGEVLWH 784
++R + +
Sbjct: 348 KEDRLLPLQAMET 360
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 37/309 (11%), Positives = 85/309 (27%), Gaps = 67/309 (21%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLR-------- 567
++G + E + + + + E+ L LR
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 568 --------------HRHLVSLIGFCDEQNEMILVYEYM----ANGTLRSHL-----FGSD 604
+I ++ +M ++ + L++ S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 605 LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664
L RL + R L LH G++H ++ +I+LD+ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQ-----LTEKSDVYSFGVVLFEVVCARAVINPT 719
+ + + Q +T D ++ G+ ++ + CA
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------ 314
Query: 720 LPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS-PESLEKFGEIAEKCLDDEGKNRPTM 778
LP + + + + P+ + + E L ++R
Sbjct: 315 LPNT-------------DDAALGGSEWIFRSCKNIPQPVR---ALLEGFLRYPKEDRLLP 358
Query: 779 GEVLWHLEY 787
+ + EY
Sbjct: 359 LQAMETPEY 367
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 39/282 (13%)
Query: 512 TNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH 570
FD +G G +G V+K E + AIK+ +S+ L E EI ++ + H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+V G + ++ +V EY G++ + LT + +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLH-- 142
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLS-KTGPSME--HTHVSTAVKGSFGYLDPEY 687
IHRD+K NILL+ AK++DFG++ + +M +T + T ++ PE
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-----WMAPEV 196
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID-- 745
+D++S G+ E+ A P P I+ M R++ I
Sbjct: 197 IQEIGYNCVADIWSLGITAIEM----AEGKP--PYADIH----PM-----RAIFMIPTNP 241
Query: 746 -PHLKG--NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
P + +S F + ++CL + R T ++L H
Sbjct: 242 PPTFRKPELWSDN----FTDFVKQCLVKSPEQRATATQLLQH 279
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 75/285 (26%), Positives = 118/285 (41%), Gaps = 50/285 (17%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIG-- 576
+G G +G+V+KG ++ LAAIK + ++ E + EI ML K HR++ + G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 577 ----FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+++ LV E+ G++ + + L + C RGL +LH +
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---Q 147
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTA------VKGSFGYL 683
+IHRD+K N+LL EN K+ DFG+S +T + T V
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 207
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
D Y KSD++S G+ E+ A P P ++ M R+L I
Sbjct: 208 DATY------DFKSDLWSLGITAIEM----AEGAP--PLCDMH----PM-----RALFLI 246
Query: 744 ID---PHLKG-NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
P LK +S + F E CL RP +++ H
Sbjct: 247 PRNPAPRLKSKKWSKK----FQSFIESCLVKNHSQRPATEQLMKH 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 72/318 (22%), Positives = 121/318 (38%), Gaps = 81/318 (25%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRAN------PQSEQGLAEFETEIEMLSKLR----H 568
++G GGFG VF G + D AIK E+ +L K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR------ 622
++ L+ + + Q +LV E LF D +T K L G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLF--DY--ITEKGPLGE--GPSRCFFGQV 148
Query: 623 --GLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS 679
+ + H+ RG++HRD+K NIL+D AK+ DFG + + G+
Sbjct: 149 VAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD-GT 201
Query: 680 FGYLDPEYFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
Y PE+ R Q + V+S G++L+++VC +P ++
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD------IPFERD------------- 242
Query: 739 SLKSIIDPHLKGNY------SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792
+ I L+ SP+ + +CL + +RP++ E+L
Sbjct: 243 --QEI----LEAELHFPAHVSPDCC----ALIRRCLAPKPSSRPSLEEILLD-------- 284
Query: 793 EAWMRTDDRQNSFSSSQA 810
WM+T + S+
Sbjct: 285 -PWMQTPAEDVPLNPSKG 301
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 52/280 (18%), Positives = 112/280 (40%), Gaps = 49/280 (17%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FG V + E + K N + EI ++++L H L++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 580 EQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
++ EM+L+ E+++ G L + +Q + GL ++H E
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH---EH 168
Query: 634 GIIHRDVKTTNILL--DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
I+H D+K NI+ + K+ DFGL+ + + + + PE R+
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 692 QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751
+ +D+++ GV+ + ++ ++P +D +L+++ + +
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG---LSPFAGEDD------------LETLQNV----KRCD 266
Query: 752 YSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWH 784
+ + + F ++ L E + R T+ + L H
Sbjct: 267 WEFDE-DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 83/316 (26%), Positives = 122/316 (38%), Gaps = 71/316 (22%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--------RANPQSEQGLAEFETEIEMLSKLRHRHL 571
+G G G+V E + C AI+ + + ETEIE+L KL H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 572 VSLIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLH 625
+ + F D ++ +V E M G L L + Q L A +
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLA-------VQ 253
Query: 626 YLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
YLH E GIIHRD+K N+LL +E+ + K++DFG SK + T + + G+ Y
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 307
Query: 683 LDPE---YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS 739
L PE D +S GV+LF + P + Q S
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG------YPPFSEHR---------TQVS 352
Query: 740 LKSIIDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLH 792
LK I G Y+ E + E++E K L + K R T E L H
Sbjct: 353 LKDQI---TSGKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH-------- 400
Query: 793 EAWMRTDDRQNSFSSS 808
W++ +D + F
Sbjct: 401 -PWLQDEDMKRKFQDL 415
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 72/307 (23%), Positives = 118/307 (38%), Gaps = 68/307 (22%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK-----RANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
IG G F KV I AIK + NP S Q L E+ ++ L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHY 626
+ + + L+ EY + G + +L R+ AR + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVA--------HGRMKE--KEARSKFRQIVSAVQY 129
Query: 627 LHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHTHVSTAVKGSFGYLD 684
H ++ I+HRD+K N+LLD + K++DFG S T G+ Y
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAA 181
Query: 685 PEYFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
PE F ++ + DV+S GV+L+ +V LP D NL + L+
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNL----------KELRER 225
Query: 744 IDPHLKGNYS-PESLEKFGE-IAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801
+ L+G Y P + E + ++ L R T+ +++ W+
Sbjct: 226 V---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD---------RWINAGHE 273
Query: 802 QNSFSSS 808
++
Sbjct: 274 EDELKPF 280
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 78/282 (27%), Positives = 114/282 (40%), Gaps = 55/282 (19%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR---ANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G FG V+ ++ + + AIK+ + QS + + E+ L KLRH + + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
++ LV EY L PL + GA +GL YLH +I
Sbjct: 122 CYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 176
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW------- 689
HRDVK NILL E + K+ DFG + + ++ V T P +W
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIM-APANSFVGT----------P--YWMAPEVIL 223
Query: 690 ---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID- 745
Q K DV+S G+ E+ A P P +N AM +L I
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL----AERKP--PLFNMN----AM-----SALYHIAQN 268
Query: 746 --PHLK-GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
P L+ G++S F + CL ++RPT +L H
Sbjct: 269 ESPALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLKH 306
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/294 (23%), Positives = 109/294 (37%), Gaps = 58/294 (19%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G V AIKR N + + + E EI+ +S+ H ++VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD-ACIGAA-----RGLHYLHTGAE 632
++E+ LV + ++ G++ + LD + I GL YLH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFG----LSKTGPSME----HTHVST-------AVK 677
G IHRDVK NILL E+ +++DFG L+ G T V T ++
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA---VINPTLPKDQINLADWAM-- 732
GY K+D++SFG+ E+ A P +
Sbjct: 200 QVRGY-----------DFKADIWSFGITAIELATGAAPYHKYPPM----------KVLML 238
Query: 733 --KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ + D + Y F ++ CL + + RPT E+L H
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPTAAELLRH 288
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 62/208 (29%), Positives = 89/208 (42%), Gaps = 36/208 (17%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--------RANPQSEQGLAEFETEIEMLSKLRHRHL 571
+G G G+V E + C AIK + + ETEIE+L KL H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 572 VSLIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLH 625
+ + F D ++ +V E M G L L + Q L A +
Sbjct: 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLA-------VQ 128
Query: 626 YLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
YLH E GIIHRD+K N+LL +E+ + K++DFG SK + T + + G+ Y
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 683 LDPE---YFWRQQLTEKSDVYSFGVVLF 707
L PE D +S GV+LF
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILF 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 68/321 (21%), Positives = 126/321 (39%), Gaps = 57/321 (17%)
Query: 484 GSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAI 542
GS K + LT G+R+ + N+ + +G G G+V+K + + A+
Sbjct: 1 GSSGSSGKQTGYLTIGGQRY-----QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55
Query: 543 K--RANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSH 599
K R + +++ +++++ K ++V G ++ + E M GT
Sbjct: 56 KQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GT---- 108
Query: 600 LFGSDLPPLTWKQRLD------ACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653
++ + + + + L+YL + G+IHRDVK +NILLDE
Sbjct: 109 --CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQI 164
Query: 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE-----KSDVYSFGVVLFE 708
K+ DFG+S + G Y+ PE T+ ++DV+S G+ L E
Sbjct: 165 KLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 709 VVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---PHLKGN--YSPESLEKFGEI 763
+ A + + L ++ P L G+ +S + F
Sbjct: 222 L----ATGQFPYK-------NCKTDF---EVLTKVLQEEPPLLPGHMGFSGD----FQSF 263
Query: 764 AEKCLDDEGKNRPTMGEVLWH 784
+ CL + + RP ++L H
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEH 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 65/299 (21%), Positives = 110/299 (36%), Gaps = 49/299 (16%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G G VFK + A K + + E+++L + ++V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-RNQIIRELQVLHECNSPYIVGFYGA 99
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
E+ + E+M G+L + + I +GL YL + I+H
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 155
Query: 638 RDVKTTNILLDENFVAKMSDFGLS-KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEK 696
RDVK +NIL++ K+ DFG+S + SM ++ V G+ Y+ PE + +
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQ 210
Query: 697 SDVYSFGVVLFEVVCAR--------------------AVINPTLPKDQINLADWAMKWQK 736
SD++S G+ L E+ R T P+ +
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 737 QRSLKSIID----------PHL-KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
R +I + P L G +S E F + KCL R + +++ H
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLE----FQDFVNKCLIKNPAERADLKQLMVH 325
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 64/304 (21%), Positives = 109/304 (35%), Gaps = 79/304 (25%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRAN------PQSEQGLAEFETEIEMLSKLRHR--HL 571
+G GGFG V+ G + D AIK E+ +L K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------G 623
+ L+ + + + +L+ E LF D +T + L AR
Sbjct: 111 IRLLDWFERPDSFVLILERPEPV---QDLF--DF--ITERGALQE--ELARSFFWQVLEA 161
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFV-AKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
+ + H G++HRD+K NIL+D N K+ DFG ++ T + G+ Y
Sbjct: 162 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFD-GTRVY 214
Query: 683 LDPEYFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741
PE+ + + V+S G++L+++VC +P + +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHD---------------E 253
Query: 742 SIIDPHLKGNY------SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795
I ++G S E + CL +RPT E+ H W
Sbjct: 254 EI----IRGQVFFRQRVSSECQ----HLIRWCLALRPSDRPTFEEIQNH---------PW 296
Query: 796 MRTD 799
M+
Sbjct: 297 MQDV 300
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G FG+V + A+K + + + E+++L +L H +++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 577 FCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
F +++ LV E G L R D + +Q L + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII-RQVLSG-------ITYMH-- 143
Query: 631 AERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
+ I+HRD+K N+LL ++ ++ DFGLS E + G+ Y+ PE
Sbjct: 144 -KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEV 199
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVC 711
EK DV+S GV+L+ ++
Sbjct: 200 L-HGTYDEKCDVWSTGVILYILLS 222
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 25/201 (12%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G +G+V + A K+ + + F+ EIE++ L H +++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 580 EQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ ++ LV E G L + SD + K L A + Y H +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM-KDVLSA-------VAYCH---KL 125
Query: 634 GIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
+ HRD+K N L + K+ DFGL+ + + G+ Y+ P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVL-E 181
Query: 691 QQLTEKSDVYSFGVVLFEVVC 711
+ D +S GV+++ ++C
Sbjct: 182 GLYGPECDEWSAGVMMYVLLC 202
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 40/252 (15%), Positives = 85/252 (33%), Gaps = 42/252 (16%)
Query: 549 SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHL---FGSDL 605
S + +I + ++ V + + + + + L+ + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 606 PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--- 662
+ I A + +LH +G++HRD+K +NI + V K+ DFGL
Sbjct: 161 REHGVCLHIFIQI--AEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 663 -------TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV 715
M T G+ Y+ PE + K D++S G++LFE++ +
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS--- 272
Query: 716 INPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAE---KCLDDEG 772
M ++ R + + + +K+ + L
Sbjct: 273 ------------FSTQM--ERVRIITDVR----NLKFPLLFTQKYPQEHMMVQDMLSPSP 314
Query: 773 KNRPTMGEVLWH 784
RP +++ +
Sbjct: 315 TERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 23/81 (28%), Positives = 33/81 (40%), Gaps = 2/81 (2%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKR-ANPQSEQGLAEFETEIEMLSKLRHRH 570
+F+ +G GGFG VF+ + D AIKR P E + E++ L+KL H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 571 LVSLIGFCDEQNEMILVYEYM 591
+V E E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMD 86
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 68/307 (22%), Positives = 128/307 (41%), Gaps = 67/307 (21%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK------RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G F V K + A K ++ + E E E+ +L ++RH ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 574 LIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
L + + +++L+ E ++ G L + L + KQ LD G+HYL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL-KQILD-------GVHYL 124
Query: 628 HTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
H + I H D+K NI+L N K+ DFG++ +E + + G+ ++
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFV 178
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
PE + L ++D++S GV+ + ++ +P L + + Q +L +I
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGETK------------QETLTNI 223
Query: 744 IDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWM 796
NY + E F +E + L + K R T+ + L H +W+
Sbjct: 224 ----SAVNYDFDE-EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH---------SWI 269
Query: 797 RTDDRQN 803
+ R+N
Sbjct: 270 KAIRRRN 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRAN-PQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
+G G FG V E IK N +S+ + + E EIE+L L H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 579 DEQNEMILVYEYMANGTL--RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
++ + M +V E G L R + L+ + L Y H + ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 637 HRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
H+D+K NIL + K+ DFGL++ + ST G+ Y+ PE F ++ +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVF-KRDV 202
Query: 694 TEKSDVYSFGVVLFEVVC 711
T K D++S GVV++ ++
Sbjct: 203 TFKCDIWSAGVVMYFLLT 220
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 39/212 (18%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK--------RANPQSEQGLAEFETEIEMLSKLRHRHL 571
+G G FG V+ E +K + L + EI +LS++ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------G 623
+ ++ + Q LV E +G LF + RLD A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG---LDLF--AF--IDRHPRLDE--PLASYIFRQLVSA 142
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS---KTGPSMEHTHVSTAVKGSF 680
+ YL + IIHRD+K NI++ E+F K+ DFG + + G +T G+
Sbjct: 143 VGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF-YTFC-----GTI 193
Query: 681 GYLDPEYFWRQQLT-EKSDVYSFGVVLFEVVC 711
Y PE + +++S GV L+ +V
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 69/311 (22%), Positives = 126/311 (40%), Gaps = 60/311 (19%)
Query: 514 NFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV 572
++ ++G G FG+V K E A K + + E + EI ++++L H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 573 SLIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHY 626
L + +N+++LV EY+ G L S+ L KQ + G+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIRH 202
Query: 627 LHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
+H + I+H D+K NIL D + K+ DFGL++ + G+ +L
Sbjct: 203 MH---QMYILHLDLKPENILCVNRDAKQI-KIIDFGLARR---YKPREKLKVNFGTPEFL 255
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
PE ++ +D++S GV+ + ++ ++P L + +L +I
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSG---LSPFLGDND------------AETLNNI 300
Query: 744 IDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWM 796
L + E E+F +I+E K L E R + E L H W+
Sbjct: 301 ----LACRWDLED-EEFQDISEEAKEFISKLLIKEKSWRISASEALKH---------PWL 346
Query: 797 RTDDRQNSFSS 807
+ S+
Sbjct: 347 SDHKLHSRLSA 357
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 15/197 (7%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G +G+V + AIK R S ++ E+ +L L H +++ L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+++ LV E G L + G+ YLH + I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 638 RDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
RD+K N+LL +++ + K+ DFGLS E+ G+ Y+ PE R++
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPEVL-RKKYD 215
Query: 695 EKSDVYSFGVVLFEVVC 711
EK DV+S GV+LF ++
Sbjct: 216 EKCDVWSIGVILFILLA 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 61/302 (20%), Positives = 116/302 (38%), Gaps = 62/302 (20%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FG V + E A K E EI+ +S LRH LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 580 EQNEMILVYEYMANGTL-------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+ NEM+++YE+M+ G L + + + +Q GL ++H E
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM-RQVCK-------GLCHMH---E 273
Query: 633 RGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
+H D+K NI+ N + K+ DFGL+ ++ G+ + PE
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAE 329
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
+ + +D++S GV+ + ++ ++P ++ +L+++
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG---LSPFGGEND------------DETLRNV----KS 370
Query: 750 GNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQ 802
+++ + F I+E K L + R T+ + L H W+ +
Sbjct: 371 CDWNMDD-SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH---------PWLTPGNAP 420
Query: 803 NS 804
Sbjct: 421 GR 422
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 45/210 (21%), Positives = 85/210 (40%), Gaps = 37/210 (17%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK---------RANPQSEQGLAEFETEIEMLSKL-RHR 569
+G G V + C A+K + + ++ E+++L K+ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARG 623
+++ L + LV++ M G L + L + + + L+
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM-RALLEV------- 136
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
+ LH + I+HRD+K NILLD++ K++DFG S ++ V G+ YL
Sbjct: 137 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYL 190
Query: 684 DPE------YFWRQQLTEKSDVYSFGVVLF 707
PE ++ D++S GV+++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMY 220
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 26/208 (12%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK-------------RANPQSEQGLAEFETEIEMLSKL 566
+G G +G+V E + AIK N E+ E EI +L L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 567 RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHY 626
H +++ L +++ LV E+ G L + + G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICY 161
Query: 627 LHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
LH + I+HRD+K NILL + K+ DFGLS + G+ Y+
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYI 215
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
PE +++ EK DV+S GV+++ ++C
Sbjct: 216 APEVL-KKKYNEKCDVWSCGVIMYILLC 242
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-23
Identities = 68/327 (20%), Positives = 128/327 (39%), Gaps = 73/327 (22%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK------RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G F V K E A K + + + E E+ +L +++H ++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 574 LIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
L + + ++IL+ E +A G L + L + KQ L+ ++YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL-KQILNG-------VYYL 130
Query: 628 HTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
H I H D+K NI+L K+ DFGL+ ++ + + G+ ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
PE + L ++D++S GV+ + ++ +P L + Q +L ++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTK------------QETLANV 229
Query: 744 IDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWM 796
NY E E F + + L + K R T+ + L H W+
Sbjct: 230 ----SAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH---------PWI 275
Query: 797 RTDD------RQNSFSSSQALGEFAER 817
+ D R+ S + + +FA R
Sbjct: 276 KPKDTQQALSRKASAVNMEKFKKFAAR 302
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 8e-23
Identities = 54/242 (22%), Positives = 92/242 (38%), Gaps = 55/242 (22%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK-----RANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
IG G +G V E + + AIK + + + + +TE+ ++ KL H ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 575 IGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIG--------- 619
+++ + LV E G L K ++ C
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 620 ----------------AAR-------GLHYLHTGAERGIIHRDVKTTNILL--DENFVAK 654
+ LHYLH +GI HRD+K N L +++F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 655 MSDFGLSK---TGPSMEHTHVSTAVKGSFGYLDPE--YFWRQQLTEKSDVYSFGVVLFEV 709
+ DFGLSK + E+ ++T G+ ++ PE + K D +S GV+L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 710 VC 711
+
Sbjct: 270 LM 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 68/315 (21%), Positives = 124/315 (39%), Gaps = 67/315 (21%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK------RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G F V K E A K + E E E+ +L ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 574 LIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
L + + +++L+ E ++ G L + L + KQ LD G++YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI-KQILD-------GVNYL 131
Query: 628 HTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
H + I H D+K NI+L K+ DFGL+ +E + G+ ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFV 185
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743
PE + L ++D++S GV+ + ++ +P L + Q +L +I
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTK------------QETLANI 230
Query: 744 IDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWM 796
+Y + E F + +E K L E + R T+ E L H W+
Sbjct: 231 ----TAVSYDFDE-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH---------PWI 276
Query: 797 RTDDRQNSFSSSQAL 811
D Q + +++
Sbjct: 277 TPVDTQQAMVRRESV 291
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK------RANPQSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G F V K E A K + E E E+ +L ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 574 LIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
L + + +++L+ E ++ G L + L + KQ LD G++YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI-KQILD-------GVNYL 131
Query: 628 HTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683
H + I H D+K NI+L K+ DFGL+ +E + G+ ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFV 185
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLF 707
PE + L ++D++S GV+ +
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITY 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 26/199 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G F V + A K N S + + E E + KL+H ++V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 578 CDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
E++ LV++ + G L R +D +Q L++ + Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILES-------IAYCH--- 122
Query: 632 ERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
GI+HR++K N+LL + K++DFGL+ + + G+ GYL PE
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVL 179
Query: 689 WRQQLTEKSDVYSFGVVLF 707
+ ++ D+++ GV+L+
Sbjct: 180 KKDPYSKPVDIWACGVILY 198
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 39/280 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQS-EQGLAEFETEIE-MLSKLRHRHLVSLIGF 577
IG G +G V K + A+KR E+ + +++ ++ ++V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA--RGLHYLHTGAERGI 635
+ + + E M+ + + + + + + I A + L++L I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKI 147
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE----YFWRQ 691
IHRD+K +NILLD + K+ DFG+S + + T G Y+ PE RQ
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQ---LVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 692 QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---PHL 748
+SDV+S G+ L+E+ A PK ++ Q L ++ P L
Sbjct: 205 GYDVRSDVWSLGITLYEL----ATGRFPYPKWN------SVFDQ----LTQVVKGDPPQL 250
Query: 749 K----GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+SP F CL + RP E+L H
Sbjct: 251 SNSEEREFSPS----FINFVNLCLTKDESKRPKYKELLKH 286
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 35/226 (15%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK----RANPQSEQGLAEFETEIEMLSKLRHRHLVSL- 574
+G G +GKV + E A+K + + G A + EI++L +LRH++++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 575 -IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLH 625
+ + +E+ +M +V EY G + D P ++R + A GL
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--ML--DSVP---EKRFP--VCQAHGYFCQLIDGLE 123
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
YLH +GI+H+D+K N+LL K+S G+++ +GS + P
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 686 EYFWRQQLTE--KSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729
E K D++S GV L+ + P + N+
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL------YPFEGDNIYK 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 26/197 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G V++ + A+K ++ TEI +L +L H +++ L +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 580 EQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
E+ LV E + G L + + D KQ L+A + YLH E
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV-KQILEA-------VAYLH---EN 167
Query: 634 GIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
GI+HRD+K N+L + K++DFGLSK +EH + V G+ GY PE
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRG 224
Query: 691 QQLTEKSDVYSFGVVLF 707
+ D++S G++ +
Sbjct: 225 CAYGPEVDMWSVGIITY 241
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--------RANPQSEQGLAEFETEIEMLSKLR-HRH 570
IG G V + A+K + Q E+ E +L ++ H H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGL 624
+++LI + + M LV++ M G L + L + + + L+A +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-RSLLEA-------V 213
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
+LH I+HRD+K NILLD+N ++SDFG S +E + G+ GYL
Sbjct: 214 SFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLA 267
Query: 685 PE------YFWRQQLTEKSDVYSFGVVLF 707
PE ++ D+++ GV+LF
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILF 296
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 66/315 (20%), Positives = 111/315 (35%), Gaps = 67/315 (21%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK-----RANPQSEQGLAEFETEIEMLSKLRHRHLVSL 574
IG G F V + E A+K + + + E + L+H H+V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 575 IGFCDEQNEMILVYEYMANGTL--RSHLFGSDLPPLT-------WKQRLDACIGAARGLH 625
+ + +V+E+M L + +Q L+A L
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA-------LR 144
Query: 626 YLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
Y H + IIHRDVK +LL + + K+ FG++ E V+ G+ +
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHF 199
Query: 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742
+ PE R+ + DV+ GV+LF ++ P + K+R +
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCL---PF----------YG---TKERLFEG 243
Query: 743 IIDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795
I +KG Y ++ I+E + L + R T+ E L H W
Sbjct: 244 I----IKGKYKMNP-RQWSHISESAKDLVRRMLMLDPAERITVYEALNH---------PW 289
Query: 796 MRTDDRQNSFSSSQA 810
++ DR
Sbjct: 290 LKERDRYAYKIHLPE 304
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+GVG FGKV GE A+K R +S + + + EI+ L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHYLH 628
+ +V EY++ G L ++ R++ AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI--------CKHGRVE--EMEARRLFQQILSAVDYCH 128
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
++HRD+K N+LLD + AK++DFGLS E S GS Y PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVI 182
Query: 689 WRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ + D++S GV+L+ ++C LP D ++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGT------LPFDDEHV 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQS-EQGLAEFETEIEM-LSKLRHRHLVSLIGF 577
+G G +G V K + + A+KR Q ++++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLP-PLTWKQRLDACIGAARGLHYLHTGAERGII 636
+ ++ + E M + + D + + + L +LH+ + +I
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVI 132
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE----YFWRQQ 692
HRDVK +N+L++ KM DFG+S + G Y+ PE ++
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---PHLK 749
+ KSD++S G+ + E+ A++ P W + + LK +++ P L
Sbjct: 190 YSVKSDIWSLGITMIEL----AILRF--P-----YDSWGTPF---QQLKQVVEEPSPQLP 235
Query: 750 -GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+S E F + +CL K RPT E++ H
Sbjct: 236 ADKFSAE----FVDFTSQCLKKNSKERPTYPELMQH 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 26/199 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRAN--PQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G F V + A K N S + + E E + KL+H ++V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 578 CDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
E++ LV++ + G L R +D +Q L++ + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILES-------IAYCH--- 145
Query: 632 ERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
GI+HR++K N+LL + K++DFGL+ + + G+ GYL PE
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVL 202
Query: 689 WRQQLTEKSDVYSFGVVLF 707
+ ++ D+++ GV+L+
Sbjct: 203 KKDPYSKPVDIWACGVILY 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 26/203 (12%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGFC 578
+G G +G+V A+K + + E + EI + L H ++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHYLHTG 630
E N L EY + G L + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLHG- 123
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFW 689
GI HRD+K N+LLDE K+SDFGL+ + ++ G+ Y+ PE
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 690 RQQLT-EKSDVYSFGVVLFEVVC 711
R++ E DV+S G+VL ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-22
Identities = 67/312 (21%), Positives = 114/312 (36%), Gaps = 63/312 (20%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G FG+V K + A+K + + E+E+L KL H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 578 CDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
++ + +V E G L R D + KQ + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-KQVFSG-------ITYMH--- 138
Query: 632 ERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+ I+HRD+K NILL +++ K+ DFGLS + G+ Y+ PE
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVL 195
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748
R EK DV+S GV+L+ ++ P + ++ I+
Sbjct: 196 -RGTYDEKCDVWSAGVILYILLSGTP---PF----------YG------KNEYDILKRVE 235
Query: 749 KGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801
G Y+ + ++ I++ K L R T + L H W++
Sbjct: 236 TGKYAFDL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH---------PWIQKYSS 285
Query: 802 QNSFSSSQALGE 813
+ S E
Sbjct: 286 ETPTISDLPSLE 297
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 29/200 (14%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G FG+V K + A+K +A+ +++ + E+E+L KL H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFE 88
Query: 577 FCDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
++ + +V E G L R D + KQ + Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-KQVFSG-------ITYMH-- 138
Query: 631 AERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
+ I+HRD+K NILL +++ K+ DFGLS + G+ Y+ PE
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEV 194
Query: 688 FWRQQLTEKSDVYSFGVVLF 707
R EK DV+S GV+L+
Sbjct: 195 L-RGTYDEKCDVWSAGVILY 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFE---TEIEMLS 564
V ++F+ IG G FGKV + + + A+K N Q E E++++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 565 KLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD-------- 615
L H LV+L F DE++ M +V + + G LR HL Q+
Sbjct: 71 GLEHPFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHL-----------QQNVHFKEETVK 118
Query: 616 ---ACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672
+ A L YL + IIHRD+K NILLDE+ ++DF ++ +
Sbjct: 119 LFICELVMA--LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQ 170
Query: 673 STAVKGSFGYLDPEYFWRQQLTEKS---DVYSFGVVLFEVVCAR 713
T + G+ Y+ PE F ++ S D +S GV +E++ R
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 56/233 (24%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK---------------RANPQSEQGLAEFET------ 558
IG G +G V D T A+K R P+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 559 -----EIEMLSKLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWK 611
EI +L KL H ++V L+ D+ NE + +V+E + G + ++P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VM--EVPT---L 131
Query: 612 QRLDACIGAAR--------GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
+ L AR G+ YLH + IIHRD+K +N+L+ E+ K++DFG+S
Sbjct: 132 KPLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT---EKSDVYSFGVVLFEVVCAR 713
+S V G+ ++ PE + + DV++ GV L+ V +
Sbjct: 187 -FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 26/203 (12%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGFC 578
+G G +G+V A+K + + E + EI + L H ++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHYLHTG 630
E N L EY + G L + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLHG- 123
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFW 689
GI HRD+K N+LLDE K+SDFGL+ + ++ G+ Y+ PE
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 690 RQQLT-EKSDVYSFGVVLFEVVC 711
R++ E DV+S G+VL ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 61/220 (27%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+G G FGKV + A+K R + E EI L LRH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHYLH 628
++++V EY A G L ++ K+R+ R + Y H
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYI--------VEKKRMT--EDEGRRFFQQIICAIEYCH 125
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
I+HRD+K N+LLD+N K++DFGLS S GS Y PE
Sbjct: 126 R---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVI 179
Query: 689 WRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ + DV+S G+VL+ ++ R LP D +
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR------LPFDDEFI 213
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 70/319 (21%), Positives = 109/319 (34%), Gaps = 63/319 (19%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
IG G FG L A+K R E + EI LRH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHYLH 628
+ ++ EY + G L + R AR G+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI--------CNAGRFSE--DEARFFFQQLLSGVSYCH 133
Query: 629 TGAERGIIHRDVKTTNILLDENFVA--KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
I HRD+K N LLD + K+ DFG SK+ S+ H+ + V G+ Y+ PE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV-GTPAYIAPE 187
Query: 687 YFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745
RQ+ + +DV+S GV L+ ++ P + R + I
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA------YPFEDPEEP---------RDYRKTIQ 232
Query: 746 PHLKGNYSPESLEKFGEIAE----KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801
L YS + + + R ++ E+ H +W +
Sbjct: 233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH---------SWFLKNLP 283
Query: 802 QNSFSSSQALGEFAEREAE 820
+ + S +F E E
Sbjct: 284 ADLMNESNTGSQFQEPEQP 302
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-21
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK---RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIG 576
+GVG FGKV G+ A+K R +S + + EI+ L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR--------GLHYLH 628
+++ +V EY++ G L ++ RLD +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI--------CKNGRLD--EKESRRLFQQILSGVDYCH 133
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
++HRD+K N+LLD + AK++DFGLS E S GS Y PE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVI 187
Query: 689 WRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+ + D++S GV+L+ ++C LP D ++
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGT------LPFDDDHV 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-21
Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G F V + ++ A S + + E E + L+H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 578 CDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
E+ L+++ + G L R + +D +Q L+A + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-QQILEA-------VLHCH--- 127
Query: 632 ERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+ G++HR++K N+LL + K++DFGL+ E G+ GYL PE
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA-GTPGYLSPEVL 185
Query: 689 WRQQLTEKSDVYSFGVVLF 707
+ + D+++ GV+L+
Sbjct: 186 RKDPYGKPVDLWACGVILY 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHR-HLVSLIG 576
+G G F V + A K + + + AE EI +L + +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLT-------WKQRLDACIGAARGLHYLHT 629
+ +E+IL+ EY A G + S ++ KQ L+ G++YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLH- 148
Query: 630 GAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPE 686
+ I+H D+K NILL K+ DFG+S+ + H + G+ YL PE
Sbjct: 149 --QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPE 203
Query: 687 YFWRQQLTEKSDVYSFGVVLF 707
+T +D+++ G++ +
Sbjct: 204 ILNYDPITTATDMWNIGIIAY 224
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 56/301 (18%), Positives = 115/301 (38%), Gaps = 61/301 (20%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FG V + E K + + EI +L+ RHR+++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 580 EQNEMILVYEYMANGTL-------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
E+++++E+++ + L ++ Q + L +LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV-HQVCE-------ALQFLH---S 120
Query: 633 RGIIHRDVKTTNILL--DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
I H D++ NI+ + K+ +FG ++ ++ + + Y PE
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
++ +D++S G +++ ++ INP L + Q+ +++I +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSG---INPFLAETN------------QQIIENI----MNA 218
Query: 751 NYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQN 803
Y+ + E F EI+ + L E K+R T E L H W++ +
Sbjct: 219 EYTFDE-EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH---------PWLKQKIERV 268
Query: 804 S 804
S
Sbjct: 269 S 269
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 8e-21
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGEIEDC-TLAAIK---RANPQSEQGLAEFETEIEMLS 564
+ + F + ++G GGFG+VF +++ L A K + + +G E ++L+
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 565 KLRHRHLVSLIGFCDEQNEMI-LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR- 622
K+ R +VSL + E + LV M G +R H++ D +++ A A+
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-AIFYTAQI 298
Query: 623 --GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSF 680
GL +LH +R II+RD+K N+LLD++ ++SD GL+ + + G+
Sbjct: 299 VSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTP 353
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR 713
G++ PE ++ D ++ GV L+E++ AR
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-20
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGEIEDC-TLAAIK---RANPQSEQGLAEFETEIEMLS 564
V N F + ++G GGFG+V ++ + A K + + +G A E ++L
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR-- 622
K+ R +VSL + ++ + LV M G L+ H++ + A AA
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR---AVFYAAEIC 296
Query: 623 -GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
GL LH I++RD+K NILLD++ ++SD GL+ P + V G+ G
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVG 350
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVVCAR 713
Y+ PE ++ T D ++ G +L+E++ +
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 34/262 (12%), Positives = 76/262 (29%), Gaps = 54/262 (20%)
Query: 521 IGVGGFGKVFKGEIEDCTLA---AIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSL 574
G + ++ D L A+ +PQ + L E + LS++ + +
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
+ + ++V E++ G+L+ S P + A A H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV----GAIRAMQSLAAAADAAH---RAG 149
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
+ + + +S G V +
Sbjct: 150 VALSIDHPSRVR-------------VSIDG---------DVVLAYPATMPDA-------N 180
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
+ D+ G L+ ++ R + + + A+ + + I+P P
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEPADIDRDIP 233
Query: 755 ESLEKFGEIAEKCLDDEGKNRP 776
+ +A + + +G R
Sbjct: 234 FQIS---AVAARSVQGDGGIRS 252
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 66/321 (20%), Positives = 117/321 (36%), Gaps = 55/321 (17%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGF 577
++G G +V + A+K Q + E+EML + + HR+++ LI F
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 578 CDEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
+E++ LV+E M G++ R H + + + A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV-QDVASA-------LDFLH--- 128
Query: 632 ERGIIHRDVKTTNILL---DENFVAKMSDFGLSK------TGPSMEHTHVSTAVKGSFGY 682
+GI HRD+K NIL ++ K+ DF L + + T GS Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187
Query: 683 LDPEYFWRQQLTEKS-----DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
+ PE D++S GV+L+ ++ P + W
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY----PPFVGRCGSDCGWDRGEACP 243
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ + +G Y + + I+ K L + K R + +VL H
Sbjct: 244 ACQNMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH------ 296
Query: 791 LHEAWMRTDDRQNSFSSSQAL 811
W++ +N+ + L
Sbjct: 297 ---PWVQGCAPENTLPTPMVL 314
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 38/227 (16%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEM 562
E+R+ ++F+ +IG G F +V K + + + + + ++ F E ++
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 563 LSKLRHRHLVSLI-GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
L R + L F DE + LV EY G L + L + I A
Sbjct: 115 LVNGDRRWITQLHFAFQDENY-LYLVMEYYVGGDLLTLL-----------SKFGERIPAE 162
Query: 622 R----------GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671
+ +H G +HRD+K NILLD +++DFG +
Sbjct: 163 MARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219
Query: 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVY-------SFGVVLFEVVC 711
AV G+ YL PE + Y + GV +E+
Sbjct: 220 SLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 48/225 (21%), Positives = 89/225 (39%), Gaps = 36/225 (16%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEM 562
++R+ +F+ +IG G FG+V K + + + + A F E ++
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 563 LSKLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
L + + +L F D+ N + LV +Y G L + L + + +
Sbjct: 128 LVNGDSKWITTLHYAFQDDNN-LYLVMDYYVGGDLLTLL-----------SKFEDRLPEE 175
Query: 622 R----------GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671
+ +H + +HRD+K NIL+D N +++DFG
Sbjct: 176 MARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 672 VSTAVKGSFGYLDPEYFWRQQLTEKS-----DVYSFGVVLFEVVC 711
S AV G+ Y+ PE + + D +S GV ++E++
Sbjct: 233 SSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 45/198 (22%), Positives = 84/198 (42%), Gaps = 27/198 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFC 578
+G G F K + A+K + + E + EI L H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEVF 75
Query: 579 DEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+Q LV E + G L + H ++ + ++ + A + ++H +
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM-RKLVSA-------VSHMH---D 124
Query: 633 RGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
G++HRD+K N+L ++N K+ DFG ++ P ++ + T + Y PE
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPC-FTLHYAAPELLN 182
Query: 690 RQQLTEKSDVYSFGVVLF 707
+ E D++S GV+L+
Sbjct: 183 QNGYDESCDLWSLGVILY 200
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHRHLVSLIGF 577
IG G +G VFK + + AIK+ + + + EI ML +L+H +LV+L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 578 CDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWK----QRLDACIGAARGLHYLHTGA 631
+ + LV+EY + T+ L + +P K Q L + +++ H
Sbjct: 71 FRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTL-------QAVNFCH--- 119
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGL--SKTGPSMEHTH-VST 674
+ IHRDVK NIL+ ++ V K+ DFG TGPS + V+T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIK---RANPQSEQGLAEFETEIEMLS 564
+ +F ++G G F V E+ AIK + + E + E +++S
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 565 KLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACI 618
+L H V L F D++ + Y NG L ++ F
Sbjct: 86 RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGSFDET----------CTRF 134
Query: 619 GAA---RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA 675
A L YLH +GIIHRD+K NILL+E+ +++DFG +K + +
Sbjct: 135 YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
G+ Y+ PE + + SD+++ G +++++V
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET--EIEMLSKLRHRHLVSLIGF 577
+G G +G V K + + AIK+ + + + EI++L +LRH +LV+L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 578 CDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWK----QRLDACIGAARGLHYLHTGA 631
C ++ LV+E++ + T+ L F + L + Q + G+ + H
Sbjct: 93 CKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQII-------NGIGFCH--- 141
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT--GPSMEHTH-VST 674
IIHRD+K NIL+ ++ V K+ DFG ++T P + V+T
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-18
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGEIEDC-TLAAIK---RANPQSEQGLAEFETEIEMLS 564
+ N+F +IG GGFG+V+ D + A+K + + +QG E MLS
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 565 KL---RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
+ +V + +++ + + M G L HL + + A I
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--I 302
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME-HTHVSTAVKGSF 680
GL ++H R +++RD+K NILLDE+ ++SD GL+ + H V T
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH----- 354
Query: 681 GYLDPEYFWRQQLTEKS-DVYSFGVVLFEVVCAR 713
GY+ PE + + S D +S G +LF+++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 29/220 (13%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEM 562
++R+ +++ +IG G FG+V K + + + + A F E ++
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 563 LSKLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD---ACI 618
++ +V L F D++ + +V EYM G L + + + A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMS---------NYDVPEKWARF 172
Query: 619 GAAR---GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA 675
A L +H G IHRDVK N+LLD++ K++DFG TA
Sbjct: 173 YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 676 VKGSFGYLDPEYFWRQQLTEK----SDVYSFGVVLFEVVC 711
V G+ Y+ PE Q D +S GV L+E++
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 4e-18
Identities = 55/247 (22%), Positives = 94/247 (38%), Gaps = 35/247 (14%)
Query: 553 LAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQ 612
+ + + + R L S+ + + + +++ LT +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 613 RLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672
+ A+G+ +L A R IHRD+ NILL E V K+ DFGL++ +
Sbjct: 195 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 246
Query: 673 STAVKGSFGYLD-----PEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
V+ L PE + + T +SDV+SFGV+L+E+ A P + D+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 728 ADWAMKWQKQRSLKSIIDPHLKGNY---SPE-SLEKFGEIAEKCLDDEGKNRPTMGEVLW 783
LK +P+ + + + C E RPT E++
Sbjct: 307 ------------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348
Query: 784 HLEYVLQ 790
HL +LQ
Sbjct: 349 HLGNLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 28/151 (18%), Positives = 58/151 (38%), Gaps = 18/151 (11%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLV 572
+G G FG+V + + C A+K + +E+++L + H ++V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 573 SLIGFC-DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
+L+G C ++++ E+ G L ++L +R + +G +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGKD 140
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662
G I D+K + + + S F K
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 40/197 (20%), Positives = 80/197 (40%), Gaps = 21/197 (10%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGF 577
++G+G GKV + A+K + E++ + H+V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 578 CDEQNEMI----LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ + ++ E M G L S + T ++ + + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SH 147
Query: 634 GIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
I HRDVK N+L +++ V K++DFG +K + T + Y+ PE
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTPC-YTPYYVAPEVLGP 203
Query: 691 QQLTEKSDVYSFGVVLF 707
++ + D++S GV+++
Sbjct: 204 EKYDKSCDMWSLGVIMY 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 14/160 (8%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET---EIEMLSKLRHRHLVSLIG 576
+G G + V+KG A+K SE+G T EI ++ +L+H ++V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS--TAIREISLMKELKHENIVRLYD 70
Query: 577 FCDEQNEMILVYEYMAN---GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+N++ LV+E+M N + S G+ L +GL + H E
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---EN 127
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGL--SKTGPSMEHTH 671
I+HRD+K N+L+++ K+ DFGL + P +
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/287 (18%), Positives = 97/287 (33%), Gaps = 61/287 (21%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFC 578
IGVG + + A+K + EIE+L + +H ++++L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDVY 85
Query: 579 DEQNEMILVYEYMANGTL------RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
D+ + +V E M G L + + + + YLH
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-FTITKT-------VEYLH---A 134
Query: 633 RGIIHRDVKTTNILL----DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+G++HRD+K +NIL ++ DFG +K + + T + ++ PE
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTANFVAPEVL 192
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD----WAMKWQKQRSLKSII 744
RQ D++S GV+L+ L + + I
Sbjct: 193 ERQGYDAACDIWSLGVLLY-----------------TMLTGYTPFANGPDDTPEEILARI 235
Query: 745 DPHLKGNYSPESLEKFGEIAE-------KCLDDEGKNRPTMGEVLWH 784
G +S + +++ K L + R T VL H
Sbjct: 236 ---GSGKFSLSG-GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS 564
RV N F+ ++G G FGKV K + +K+ ++ +A TE +L
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 565 KLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR 622
RH L +L Q + V EY G L HL + + A I +A
Sbjct: 204 NSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA- 260
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
L YLH +E+ +++RD+K N++LD++ K++DFGL K G ++ G+ Y
Sbjct: 261 -LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEY 315
Query: 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
L PE D + GVV++E++C
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 27/172 (15%)
Query: 513 NNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET---EIEMLSKLRH 568
+ + +G G + V+KG L A+K + E+G T E+ +L L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC--TAIREVSLLKDLKH 59
Query: 569 RHLVSLIGFCDEQNEMILVYEYMAN---GTLRSHLFGSDLPPLTWK----QRLDACIGAA 621
++V+L + + LV+EY+ L G+ + K Q L
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLL------- 110
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL--SKTGPSMEHTH 671
RGL Y H + ++HRD+K N+L++E K++DFGL +K+ P+ + +
Sbjct: 111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 26/164 (15%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQ-GLAEFET---EIEMLSKLRHRHLVSLI 575
IG G +G VFK E + A+KR + G+ + EI +L +L+H+++V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS--SALREICLLKELKHKNIVRLH 67
Query: 576 GFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWK----QRLDACIGAARGLHYLHT 629
++ LV+E+ + L+ + DL P K Q L +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL-------KGLGFCH- 118
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGL--SKTGPSMEHTH 671
R ++HRD+K N+L++ N K+++FGL + P ++
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 32/216 (14%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFE---TEIEMLS 564
+ FD +G G FG+V E A+K + Q L + E E +L
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 565 KLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLD-------- 615
+ LV L F D N + +V EY+A G + SHL R
Sbjct: 97 AVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRI--------GRFSEPHARFYA 147
Query: 616 ACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA 675
A I YLH +I+RD+K N+L+D+ +++DFG +K T T
Sbjct: 148 AQIVLT--FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 202
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
L PE + + D ++ GV+++E+
Sbjct: 203 -----EALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 27/165 (16%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQ-GLAEFET---EIEMLSKLRHRHLVSLI 575
IG G +G V+K + A+K+ +E G+ T EI +L +L H ++V L+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS--TAIREISLLKELNHPNIVKLL 68
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTW-------KQRLDACIGAARGLHYLH 628
+N++ LV+E++ + L+ + S L + Q L +GL + H
Sbjct: 69 DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL-------QGLAFCH 120
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHTH 671
++HRD+K N+L++ K++DFGL++ P +TH
Sbjct: 121 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 31/166 (18%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFE----T---EIEMLSKLRHRHLVS 573
+G G +G V+K + + A+KR +E E T EI +L +L H ++VS
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAED-----EGIPSTAIREISLLKELHHPNIVS 83
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWK----QRLDACIGAARGLHYL 627
LI + + LV+E+M L+ L + L K Q L RG+ +
Sbjct: 84 LIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLL-------RGVAHC 135
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGL--SKTGPSMEHTH 671
H + I+HRD+K N+L++ + K++DFGL + P +TH
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS 564
+V N+FD ++G G FGKV K + +++ ++ +A TE +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 565 KLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR 622
RH L +L Q + V EY G L HL + + A I +A
Sbjct: 61 NTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA- 117
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
L YLH R +++RD+K N++LD++ K++DFGL K G + G+ Y
Sbjct: 118 -LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEY 171
Query: 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
L PE D + GVV++E++C
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 68/318 (21%), Positives = 117/318 (36%), Gaps = 80/318 (25%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFET-EIEMLSKLRHRHLVSLIGF-- 577
IG G FG VF+ ++ + AIK+ F+ E++++ ++H ++V L F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 578 ----CDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWK----QRLDACIGAARGL 624
++ + LV EY+ T+ +P L K Q L R L
Sbjct: 103 SNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL-------RSL 154
Query: 625 HYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKT-GPSMEHTH-VST----AVK 677
Y+H+ GI HRD+K N+LLD V K+ DFG +K + + + A
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRA-- 209
Query: 678 GSFGYLDPE-YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL--------- 727
PE F T D++S G V+ E++ + + DQ+
Sbjct: 210 -------PELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262
Query: 728 -ADW-AM----------KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNR 775
M + + + P P+++ ++ + L+ R
Sbjct: 263 REQIKTMNPNYMEHKFPQIRPH-PFSKVFRPRT----PPDAI----DLISRLLEYTPSAR 313
Query: 776 PTMGEVLWHLEYVLQLHE 793
T E L H + +L
Sbjct: 314 LTAIEALCH-PFFDELRT 330
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 31/166 (18%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFE----T---EIEMLSKLRHRHLVS 573
IG G +G V+K + A+K+ + E E T EI +L +L+H ++V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKED-----EGIPSTTIREISILKELKHSNIVK 64
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHL--FGSDLPPLTWK----QRLDACIGAARGLHYL 627
L + ++LV+E++ L+ L L +T K Q L G+ Y
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL-------NGIAYC 116
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHTH 671
H +R ++HRD+K N+L++ K++DFGL++ P ++TH
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIE--M 562
+ + F+ ++G G FGKVF + L A+K + + T++E +
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 563 LSKLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLD 615
L ++ H +V L Q E + L+ +++ G L + L F + D
Sbjct: 80 LVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE----------D 127
Query: 616 ACIGAAR---GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672
A L +LH GII+RD+K NILLDE K++DFGLSK ++H
Sbjct: 128 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKK 182
Query: 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
+ + G+ Y+ PE R+ T+ +D +SFGV++FE++
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 31/168 (18%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR----ANPQSEQGLAEFET---EIEMLSKLRHRHLV 572
+G G F V+K + + AIK+ +++ G+ T EI++L +L H +++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINR--TALREIKLLQELSHPNII 75
Query: 573 SLIGFCDEQNEMILVYEYMAN---GTLRSHLFGSDLPPLTWK----QRLDACIGAARGLH 625
L+ ++ + LV+++M ++ + L P K L +GL
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTL-------QGLE 126
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT--GPSMEHTH 671
YLH + I+HRD+K N+LLDEN V K++DFGL+K+ P+ +TH
Sbjct: 127 YLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 36/204 (17%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFC 578
+G+G GKV + A+K Q + E+E+ + + H+V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 579 DEQNEMI----LVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC-----IGAARGLHYLHT 629
+ +V E + G L S + T + +A IG A + YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER---EASEIMKSIGEA--IQYLH- 178
Query: 630 GAERGIIHRDVKTTNILL---DENFVAKMSDFGLSK---TGPSMEHTHVSTAVKGSFGYL 683
I HRDVK N+L N + K++DFG +K + S+ T T Y+
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-TTPCYTP-----YYV 230
Query: 684 DPEYFWRQQLTEKSDVYSFGVVLF 707
PE ++ + D++S GV+++
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMY 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 3e-15
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS 564
R+ +F+ +++G G FGKV KG E + +K+ + + E +L+
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 565 K-LRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
+ L L Q + V EY+ G L H+ A I A
Sbjct: 397 LPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI--A 452
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
GL +L +GII+RD+K N++LD K++DFG+ K + + G+
Sbjct: 453 IGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPD 507
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
Y+ PE Q + D ++FGV+L+E++
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 31/172 (18%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQ-GLAEFET----EIEMLSKLR---HRHL 571
IGVG +G V+K + A+K + G E+ +L +L H ++
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 572 VSLI-----GFCDEQNEMILVYEYMAN--GTLRSHLFGSDLPPLTWK----QRLDACIGA 620
V L+ D + ++ LV+E++ T LP T K Q L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL------ 130
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTH 671
RGL +LH I+HRD+K NIL+ K++DFGL++ M T
Sbjct: 131 -RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIK----RANPQSEQGLAEFETEI 560
++ F+ ++G GG+GKVF + A+K ++ + A + E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 561 EMLSKLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHL-----FGSDLPPLTWKQR 613
+L +++H +V L Q + L+ EY++ G L L F D
Sbjct: 73 NILEEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------- 121
Query: 614 LDACIGAAR---GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670
AC A L +LH ++GII+RD+K NI+L+ K++DFGL K +
Sbjct: 122 -TACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDG 175
Query: 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
V+ G+ Y+ PE R D +S G ++++++
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 50/178 (28%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFE----T---EIEMLSKLRHRHLV 572
+G G +G+V+K + AIKR + E+ E T E+ +L +L+HR+++
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-----EGVPGTAIREVSLLKELQHRNII 96
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA----------- 621
L + + L++EY +DL K+ +D +
Sbjct: 97 ELKSVIHHNHRLHLIFEYAE----------NDL-----KKYMDKNPDVSMRVIKSFLYQL 141
Query: 622 -RGLHYLHTGAERGIIHRDVKTTNILLDENFVA-----KMSDFGL--SKTGPSMEHTH 671
G+++ H R +HRD+K N+LL + + K+ DFGL + P + TH
Sbjct: 142 INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFE---TEIEMLS 564
+ + +F +G G FG+V + A+K + L + E E MLS
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 565 KLRHRHLVSLIG-FCDEQNEMILVYEYMANGTLRSHL-----FGSDLPPLTWKQRLDACI 618
+ H ++ + G F D Q + ++ +Y+ G L S L F + A
Sbjct: 62 IVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNP----------VAKF 110
Query: 619 GAAR---GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA 675
AA L YLH + II+RD+K NILLD+N K++DFG +K P + +T T
Sbjct: 111 YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP 167
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
Y+ PE + + D +SFG++++E++
Sbjct: 168 -----DYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 34/161 (21%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET-EIEMLSKLRHRHLVSLIGF- 577
IG G FG V++ + L AIK+ F+ E++++ KL H ++V L F
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 578 ---CDEQNEMIL--VYEYMANGTL-----RSHLFGSDLPPLTWK----QRLDACIGAARG 623
++++E+ L V +Y+ T+ LP + K Q R
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF-------RS 168
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKT 663
L Y+H+ GI HRD+K N+LLD + V K+ DFG +K
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 42/188 (22%), Positives = 73/188 (38%), Gaps = 44/188 (23%)
Query: 517 ESLMIGVGGFGKVFKG---EIEDCTLAAIKRAN----PQSEQGLAEFETEIEMLSKLRHR 569
E +G G +G V+K + +D A+K+ S EI +L +L+H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78
Query: 570 HLVSLIGFCDEQNEMI--LVYEYM---------ANGTLRSHLFGSDLPPLTWK----QRL 614
+++SL + L+++Y + +++ LP K Q L
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 615 DACIGAARGLHYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSK--TGPSME 668
G+HYLH ++HRD+K NIL+ E K++D G ++ P
Sbjct: 139 -------DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 669 HTHVSTAV 676
+ V
Sbjct: 189 LADLDPVV 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 52/264 (19%)
Query: 559 EIEMLSKLRHRHLVSLI------GFCDEQNEMILVYEYMA---NGTLRSHLFGSDLPPLT 609
E+ ++ + H++++ L+ +E ++ +V E M ++ L + L
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL 133
Query: 610 WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669
+ Q L G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++T +
Sbjct: 134 Y-QML-------CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
Query: 670 T--HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+V T Y PE E D++S G ++ E++ + T DQ N
Sbjct: 183 MTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237
Query: 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787
+I+ G PE ++K + +NRP + +
Sbjct: 238 ---------------VIE--QLGTPCPEFMKKLQPTVRTYV----ENRPKYAGYSFEKLF 276
Query: 788 VLQLHEAWMRTDDRQNSFSSSQAL 811
+ D N +SQA
Sbjct: 277 ----PDVLFPADSEHNKLKASQAR 296
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 38/205 (18%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIG-F 577
+G G + +VF+ I + +K P ++ + + EI++L LR ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 578 CDEQNEM-ILVYEYMANGTLRSHLFGSDLPPLT-------WKQRLDACIGAARGLHYLHT 629
D + LV+E++ N + LT + L + L Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL-------KALDYCHS 148
Query: 630 GAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTG-PSMEHTH-VSTAVKGSFGYLDPE 686
GI+HRDVK N+++D E+ ++ D+GL++ P E+ V++ + PE
Sbjct: 149 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPE 200
Query: 687 YFWRQQLTEKS-DVYSFGVVLFEVV 710
Q+ + S D++S G +L ++
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 40/163 (24%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFE----T---EIEMLSKLRHRHLV 572
IG G FG+VFK + A+K+ ++E+ E T EI++L L+H ++V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEK-----EGFPITALREIKILQLLKHENVV 79
Query: 573 SLIG--------FCDEQNEMILVYEYMAN---GTLRSHLFGSDLPPLTWK----QRLDAC 617
+LI + + + LV+++ + G L + K L
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLL--- 134
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660
GL+Y+H I+HRD+K N+L+ + V K++DFGL
Sbjct: 135 ----NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 43/233 (18%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAE--FET---------EIEMLSKLRHR 569
I G +G V G + AIKR G EI +L+ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 570 HLVSLI-----GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWK-------QRLDAC 617
+++ L +++ LV E M T + + ++ + L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHIL--- 144
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT--HVSTA 675
GLH LH G++HRD+ NILL +N + DF L++ + + +V+
Sbjct: 145 ----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 676 VKGSFGYLDPEY-FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
Y PE + T+ D++S G V+ E+ +A+ + +Q+N
Sbjct: 198 W-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGEIEDC-TLAAIK-------RANPQSEQGLAE---FE 557
++ +F M+G G FGKVF E + AIK + E + E
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 558 TEIEMLSKLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLD 615
H L + FC Q + + V EY+ G L H+ L+
Sbjct: 73 LAW------EHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 616 ACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTA 675
A I L +LH +GI++RD+K NILLD++ K++DFG+ K M +
Sbjct: 125 AEIILG--LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--MLGDAKTNT 177
Query: 676 VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
G+ Y+ PE Q+ D +SFGV+L+E++
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 16/210 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS 564
R+ +F+ +++G G FGKV KG E + +K+ + + E +L+
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 565 K-LRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
+ L L Q + V EY+ G L H+ A I
Sbjct: 76 LPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
L +L +GII+RD+K N++LD K++DFG+ K + + G+
Sbjct: 134 --LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPD 186
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
Y+ PE Q + D ++FGV+L+E++
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 46/271 (16%), Positives = 99/271 (36%), Gaps = 59/271 (21%)
Query: 453 REKSSDPKNNSPGWWPLFFHRGTLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVAT 512
+++ + ++ G H + + + K + ++ R + + +
Sbjct: 3 SHEAAAAQQHNSG----TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD----- 53
Query: 513 NNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKR-ANPQSEQGLAEFET--EIEMLSKLRH 568
++ +IG G +G V + + + + AIK+ + + EI +L++L H
Sbjct: 54 -RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-RILREIAILNRLNH 111
Query: 569 RHLVSLI-----GFCDEQNEMILVYEYMANGTLRSHLFGSDL-------PPLTWK----- 611
H+V ++ ++ +E+ +V E SD LT
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA----------DSDFKKLFRTPVYLTELHIKTL 161
Query: 612 --QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS-----KTG 664
L G+ Y+H+ GI+HRD+K N L++++ K+ DFGL+
Sbjct: 162 LYNLL-------VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQLTE 695
+ + + ++QLT
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS 564
+ +FD +IG G + KV K + +K+ ++ + +TE +
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 565 K-LRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
+ H LV L Q E + V EY+ G L H+ P + A I A
Sbjct: 65 QASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
L+YLH ERGII+RD+K N+LLD K++D+G+ K G + ++ G+
Sbjct: 123 --LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPN 175
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
Y+ PE + D ++ GV++FE++
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS 564
R+ +NF+ ++G G FGKV K + + +K+ + + TE +LS
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 565 K-LRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
H L L FC Q + V E++ G L H+ S + A I +A
Sbjct: 79 LARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA 136
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
L +LH ++GII+RD+K N+LLD K++DFG+ K G + + + G+
Sbjct: 137 --LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--ICNGVTTATFCGTPD 189
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
Y+ PE D ++ GV+L+E++C
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 58/205 (28%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR-ANPQSEQGLAEFET---------EIEMLSKLRHR 569
IG G +G V+ + AIK+ FE EI +L++L+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREITILNRLKSD 85
Query: 570 HLVSLI-----GFCDEQNEMILVYEYMANGTLRSHLFGSDL-------PPLTWK------ 611
+++ L + +E+ +V E SDL LT +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIA----------DSDLKKLFKTPIFLTEEHIKTIL 135
Query: 612 -QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670
L G +++H GIIHRD+K N LL+++ K+ DFGL++T S + T
Sbjct: 136 YNLL-------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 671 HVSTAVKGSFGYLDPEYFWRQQLTE 695
++ ++ + ++QLT
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR-ANPQSEQGLAEFET--EIEMLSKLRHRHLVSLI- 575
+G G +G V + + A+K+ + P A+ T E+ +L ++H +++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKHMKHENVIGLLD 95
Query: 576 -----GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRL-DACIG-----AARGL 624
+E N++ LV M G+DL + Q+L D + RGL
Sbjct: 96 VFTPARSLEEFNDVYLVTHLM----------GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
Y+H+ IIHRD+K +N+ ++E+ K+ DFGL++ +V+T Y
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRA 197
Query: 685 PE-YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
PE + D++S G ++ E++ R + T DQ+ L
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 59/222 (26%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIK-------RANPQSEQGLAEFETEI 560
++F +IG G FGKV + A+K + + ++E +
Sbjct: 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE--RNV 91
Query: 561 EMLSKLRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRL---- 614
+L ++H LV L Q + V +Y+ G L HL QR
Sbjct: 92 -LLKNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFYHL-----------QRERCFL 137
Query: 615 --DACIGAAR---GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669
A AA L YLH I++RD+K NILLD ++DFGL K +EH
Sbjct: 138 EPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEH 192
Query: 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
++ G+ YL PE +Q D + G VL+E++
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLS 564
+ +FD +IG G + KV K + +K+ ++ + +TE +
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107
Query: 565 K-LRHRHLVSLIGFCDEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
+ H LV L Q E + V EY+ G L H+ P + A I A
Sbjct: 108 QASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFG 681
L+YLH ERGII+RD+K N+LLD K++D+G+ K G + ++ G+
Sbjct: 166 --LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPN 218
Query: 682 YLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711
Y+ PE + D ++ GV++FE++
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 39/176 (22%)
Query: 521 IGVGGFGKVFKGEIEDCT--LAAIKRANPQSEQGLAEFE----T---EIEMLSKLR---H 568
IG G +GKVFK A+KR Q+ + E + E+ +L L H
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-----EGMPLSTIREVAVLRHLETFEH 73
Query: 569 RHLVSLI-----GFCDEQNEMILVYEYMAN--GTLRSHLFGSDLPPLTWK----QRLDAC 617
++V L D + ++ LV+E++ T + +P T K Q L
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL--- 130
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHV 672
RGL +LH ++HRD+K NIL+ + K++DFGL++ M T V
Sbjct: 131 ----RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 42/164 (25%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET---------EIEMLSKLRHRH 570
IG G +G V + + AIK+ +P FE EI++L + RH +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHEN 86
Query: 571 LVSLI-----GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA------CIG 619
++ + ++ ++ +V + M +DL L Q L
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLM----------ETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 620 AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
RGL Y+H+ ++HRD+K +N+LL+ K+ DFGL++
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 57/303 (18%), Positives = 111/303 (36%), Gaps = 50/303 (16%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR-ANPQSEQGLAEFET--EIEMLSKLRHRHLVSLI- 575
+G G +G V + AIK+ + P + A+ E+ +L ++H +++ L+
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAYRELLLLKHMQHENVIGLLD 90
Query: 576 -----GFCDEQNEMILVYEYMA---NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
+ LV +M + + L + Q L +GL Y+
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY-QML-------KGLKYI 142
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPE 686
H+ G++HRD+K N+ ++E+ K+ DFGL++ M +V T Y PE
Sbjct: 143 HSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-YVVTRW-----YRAPE 193
Query: 687 -YFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745
+ D++S G ++ E++ + + DQ+ ++ + D
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 746 PHLK------GNYSPESL-EKFGEIAEKCLD--------DEGKNRPTMGEVLWHLEYVLQ 790
K + + F + + D D K R T + L H +
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK-RLTAAQALTH-PFFEP 311
Query: 791 LHE 793
+
Sbjct: 312 FRD 314
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 51/229 (22%), Positives = 94/229 (41%), Gaps = 44/229 (19%)
Query: 559 EIEMLSKLRHRHLVSLI------GFCDEQNEMILVYEYMA---NGTLRSHLFGSDLPPLT 609
E+ ++ + H++++SL+ +E ++ LV E M ++ L + L
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 170
Query: 610 WKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669
+ Q L G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++T +
Sbjct: 171 Y-QML-------CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 670 T--HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
+V T Y PE E D++S G ++ E+V + + DQ N
Sbjct: 220 MTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274
Query: 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP 776
+I+ G PE ++K +++ K
Sbjct: 275 ---------------VIE--QLGTPCPEFMKKLQPTVRNYVENRPKYAG 306
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 50/244 (20%), Positives = 91/244 (37%), Gaps = 65/244 (26%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFET---------EIEMLSKLRHRH 570
+G G +G V + AIK+ P F+ EI++L +H +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHEN 70
Query: 571 LVSLI-----GFCDEQNEMILVYEYMANGTLRSHLFGSDL------PPLTWK-------Q 612
++++ + NE+ ++ E M +DL L+ Q
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELM----------QTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 613 RLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672
L R + LH +IHRD+K +N+L++ N K+ DFGL++ +
Sbjct: 121 TL-------RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 673 STAVKGSF--GYLD------PEY-FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
+ S ++ PE + + DV+S G +L E+ R + +
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 724 QINL 727
Q+ L
Sbjct: 231 QLLL 234
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 57/315 (18%), Positives = 112/315 (35%), Gaps = 63/315 (20%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIK--RANPQ-SEQGLAEFETEIEMLSKLR-------- 567
+G G F V+ + + + T A+K R + +E EI++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE----DEIKLLQRVNDADNTKED 81
Query: 568 ---HRHLVSLIGFCDEQNE----MILVYEYMANGTLRSHLFGSDLPPLTW-------KQR 613
H++ L+ + + +++V+E + L + + + + KQ
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE------NFVAKMSDFGLSKTGPSM 667
L L Y+H GIIH D+K N+L++ K++D G +
Sbjct: 141 LLG-------LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CW 187
Query: 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727
H + +++ Y PE +D++S ++FE++ + P
Sbjct: 188 YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787
D + II+ L G L G+ + G R W LE
Sbjct: 247 DD---------HIAQIIE--LLGELPSYLLRN-GKYTRTFFNSRGLLRNISKLKFWPLED 294
Query: 788 VLQLHEAWMRTDDRQ 802
VL + + + ++
Sbjct: 295 VLTEKYKFSKDEAKE 309
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 69/311 (22%), Positives = 119/311 (38%), Gaps = 65/311 (20%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR-ANPQSEQGLAEFET---------EIEMLSKLRHR 569
+G G +G V + AIK+ P F++ E+ +L +RH
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRP--------FQSELFAKRAYRELRLLKHMRHE 84
Query: 570 HLVSLI------GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRL-DACIG--- 619
+++ L+ D+ + LV +M G+DL L ++L + I
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFM----------GTDLGKLMKHEKLGEDRIQFLV 134
Query: 620 --AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
+GL Y+H GIIHRD+K N+ ++E+ K+ DFGL++ S +V T
Sbjct: 135 YQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 190
Query: 678 GSFGYLDPEY-FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736
Y PE + T+ D++S G ++ E++ + + + DQ+
Sbjct: 191 ----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246
Query: 737 QRSLKSIIDPHLK------GNYSPESLEKFGEIA--------EKCLDDEGKNRPTMGEVL 782
++ + K + A EK L + + R T GE L
Sbjct: 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 783 WHLEYVLQLHE 793
H Y LH+
Sbjct: 307 AH-PYFESLHD 316
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 509 RVATNNFDESLMIGVGGFGKVF----KGEIEDCTLAAIK--------RANPQSEQGLAEF 556
+V NF+ ++G G +GKVF + L A+K + +E
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR--- 106
Query: 557 ETEIEMLSKLRHRH-LVSLIGFCDEQNE--MILVYEYMANGTLRSHL-----FGSDLPPL 608
TE ++L +R LV+L Q E + L+ +Y+ G L +HL F
Sbjct: 107 -TERQVLEHIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRERFTEH---- 159
Query: 609 TWKQRLDACIGAAR---GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665
+ I L +LH + GII+RD+K NILLD N ++DFGLSK
Sbjct: 160 ------EVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210
Query: 666 SMEHTHVSTAVKGSFGYLDPE--YFWRQQLTEKSDVYSFGVVLFEVVC 711
+ E G+ Y+ P+ + D +S GV+++E++
Sbjct: 211 ADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 68/348 (19%), Positives = 123/348 (35%), Gaps = 77/348 (22%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF-- 577
G G FG V G E AIK+ E + ++ L+ L H ++V L +
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFY 89
Query: 578 ---CDEQNEM--ILVYEYMANGTL----RSH-LFGSDLPPLTWK----QRLDACIGAARG 623
++ ++ +V EY+ TL R++ PP+ K Q + R
Sbjct: 90 TLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLI-------RS 141
Query: 624 LHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKT-GPSMEHTH-VST----A- 675
+ LH + + HRD+K N+L++ + K+ DFG +K PS + + + A
Sbjct: 142 IGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200
Query: 676 --VKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV------------INPTL- 720
+ G+ Y T D++S G + E++ + I L
Sbjct: 201 ELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 721 --PKDQI-----NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGK 773
++ + + D + K ++ + E+ ++ L +
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVF-SDHSLKDAKEAY----DLLSALLQYLPE 304
Query: 774 NRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAED 821
R E L H Y +LH+ N+ + L F E E
Sbjct: 305 ERMKPYEALCH-PYFDELHDP---ATKLPNNKDLPEDLFRFLPNEIEV 348
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 65/350 (18%), Positives = 130/350 (37%), Gaps = 106/350 (30%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKR-ANPQSEQGLAEFET---------EIEMLSKLR-H 568
+G G +G V+K + + A+K+ + F+ EI +L++L H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFREIMILTELSGH 68
Query: 569 RHLVSL--IGFCDEQNEMILVYEYMANGTLRSHLFGSDL------PPLTWK-------QR 613
++V+L + D ++ LV++YM +DL L Q
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYM----------ETDLHAVIRANILEPVHKQYVVYQL 118
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673
+ + + YLH+G G++HRD+K +NILL+ K++DFGLS++ ++ +
Sbjct: 119 I-------KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 674 TAVKGSFGYLDP--------EY----FWR--------QQLTEKSDVYSFGVVLFEVVCAR 713
+ + + +Y ++R + T+ D++S G +L E++C +
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
Query: 714 AVINPTLPKDQINL-----------------ADWAMKWQKQRSLKSIIDPHLKGNYSPES 756
+ + +Q+ + +A + K I K + +
Sbjct: 229 PIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW 288
Query: 757 LEKFGEIA-------------EKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
+I +K L R + + L H +V H
Sbjct: 289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH-PFVSIFHN 337
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 36/177 (20%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLI---- 575
+G GG G VF + + AIK+ Q + EI+++ +L H ++V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 576 ----------GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRL-DACIG----- 619
G E N + +V EYM +DL + + L +
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM----------ETDLANVLEQGPLLEEHARLFMYQ 128
Query: 620 AARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKT-GPSMEHTHVST 674
RGL Y+H+ ++HRD+K N+ ++ E+ V K+ DFGL++ P H +
Sbjct: 129 LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 39/162 (24%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFC 578
+G+G GKV + A+K + E+E+ + + H+V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 579 DE----QNEMILVYEYMANGTL------RSHLF-----GSDLPPLTWKQRLDACIGAARG 623
+ + +++V E + G L R S++ K +A
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI----MKSIGEA------- 129
Query: 624 LHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSK 662
+ YLH I HRDVK N+L N + K++DFG +K
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 4e-10
Identities = 34/201 (16%), Positives = 55/201 (27%), Gaps = 53/201 (26%)
Query: 510 VATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIK--------RANPQSEQGLAEFETEIE 561
+ T IG G FG+VF+ I D T AIK N ++ E EI
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 562 MLSKL---------RHRHLVSLIGFCDEQ------------------------------N 582
+ +L R + L Q +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKT 642
++ +V E+ G + + L HRD+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 643 TNILLDENFVAKMSDFGLSKT 663
N+LL + + K+ K+
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKS 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 46/243 (18%), Positives = 86/243 (35%), Gaps = 78/243 (32%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF-- 577
+G G FG V + +IE A+K+ E++++ L H +++ L+ +
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----RELDIMKVLDHVNIIKLVDYFY 70
Query: 578 ------------------------------------CDEQNEMILVYEYMA---NGTLRS 598
+ + ++ EY+ + L+S
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 599 HL-FGSDLPPLTWK----QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFV 652
+ G +P Q R + ++H+ GI HRD+K N+L++ ++
Sbjct: 131 FIRSGRSIPMNLISIYIYQLF-------RAVGFIHSL---GICHRDIKPQNLLVNSKDNT 180
Query: 653 AKMSDFGLSK-TGPSMEHTH-VST----AVKGSFGYLDPE-YFWRQQLTEKSDVYSFGVV 705
K+ DFG +K PS + + A PE + T D++S G V
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRFYRA---------PELMLGATEYTPSIDLWSIGCV 231
Query: 706 LFE 708
E
Sbjct: 232 FGE 234
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 4e-09
Identities = 89/600 (14%), Positives = 175/600 (29%), Gaps = 186/600 (31%)
Query: 322 EKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLGPDTAVG 381
R+F ++ + E FV+ R + + S I+T Q T +
Sbjct: 61 VSGTLRLFWTLLSKQ--EEMVQKFVE------EVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 382 AAGTDALLNGLEIF-KFSQNGNLASVERFDSSGNPVGH---------SNKWILLVG-IGA 430
D L N ++F K+ +V R P K +L+ G +G+
Sbjct: 113 IEQRDRLYNDNQVFAKY-------NVSRLQ----PYLKLRQALLELRPAKNVLIDGVLGS 161
Query: 431 GIASVVVLAVIFALLFCYCKNWREKSSDPKNNSPGWW--------------PL--FFHRG 474
G + V L V C +++ + K + +W L ++
Sbjct: 162 G-KTWVALDV--------CLSYKVQC---KMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 475 TLNSTANAKGSGTQYLKGSVALTRAGKRFTLAEIRVATNNFDESLMI--GV--GGFGKVF 530
N T+ + S L+ + +A R L ++ L++ V F
Sbjct: 210 DPNWTSRSDHSSNIKLR--IHSIQAELRRLLKS-----KPYENCLLVLLNVQNAKAWNAF 262
Query: 531 KGEIEDCT-------------LAAIKRANPQSEQ---GLAEFETEIEMLSK--------L 566
C L+A + + L E + +L K L
Sbjct: 263 NLS---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDL 318
Query: 567 RHR------HLVSLIG-FCDEQNEMILVYEYMANGTLRSHLFGS--DLPPLTWKQRLDAC 617
+S+I + ++++ L + + S L P +++ D
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILL-----------DENFVAKMSDFGLSKTGPS 666
+ ILL V K+ + L + P
Sbjct: 379 ----------------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726
+ + YL+ + +L + ++ R+++ D N
Sbjct: 423 ESTISIPS------IYLE----LKVKLENEYALH------------RSIV------DHYN 454
Query: 727 LADWAMKWQKQRSLKSIIDP--------HLKGNYSPESLEKFGEIAEKCLDD---EGKNR 775
+ + + +D HLK E E+ LD E K R
Sbjct: 455 IPK---TFDSDDLIPPYLDQYFYSHIGHHLKN---IEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 776 PT------MGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQALGEFAEREAEDGQDAPTTD 829
G +L + L+ ++ ++ +D + A+ +F + E+ + TD
Sbjct: 509 HDSTAWNASGSIL-NTLQQLKFYKPYICDNDPKYE-RLVNAILDFLPKIEENLICSKYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 46/364 (12%), Positives = 101/364 (27%), Gaps = 86/364 (23%)
Query: 67 SGDSIYEPLYKTARVFADGL--NYTF------------EIIAGNYIV---RLHFCPFPFE 109
+ + + + + L NY F ++ YI RL+ F
Sbjct: 74 KQEEMVQ------KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 110 DYNVN-KSSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGVDLDK 168
YNV+ + + L L +N+ + G+ + + + V L
Sbjct: 128 KYNVSRLQPYLKLRQALLELR--------PAKNVLIDGVLGSGKT-WVALD----VCLSY 174
Query: 169 LMIEFIPSKG---SFGFINAIE-IVPVVDKLFAD-TINKVGGNDVNFNLSGRGVETMYRL 223
+ + K + N+ E ++ ++ KL N +D + N+ R L
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 224 N--VGGPEIKPS-------RDPDLWRMWEADSSYMITANAGSEIRNSSNITYASTNDSSV 274
+ + ++ W + ++T R + S ++
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT------RFKQVTDFLSAATTTH 288
Query: 275 APLLVYETARTMSNT-EVLEKRFNMSWK------FEVDPNFDYFVRLH---FCELVYEKA 324
L + T +L K + + +P E + +
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP-------RRLSIIAESIRDGL 341
Query: 325 NQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFD--AV---SSKI-----ETLWIQL 374
++N + + +R FD +V S+ I +W +
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNV--LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 375 GPDT 378
Sbjct: 400 IKSD 403
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 39/208 (18%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIK--RANPQ-SEQGLAEFETEIEMLSKLRHR------ 569
+IG G FG+V K + A+K R + Q EI +L LR +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTW-------KQRLDACIGAAR 622
+++ ++ +N + + +E ++ L + + + L
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQC------ 212
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVA--KMSDFGLSKTGPSMEHTHVSTAVKGSF 680
L LH + IIH D+K NILL + + K+ DFG S EH V T ++ F
Sbjct: 213 -LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF 264
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFE 708
Y PE + D++S G +L E
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 48/201 (23%), Positives = 76/201 (37%), Gaps = 23/201 (11%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIK--RANPQ-SEQGLAEFETEIEMLSKLRHR------ 569
+IG G FG+V K + AIK + Q E+ +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116
Query: 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
++V L +N + LV+E ++ L L ++ ++ L +L T
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 630 GAERGIIHRDVKTTNILL--DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
E IIH D+K NILL + K+ DFG S + ++ F Y PE
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPEV 229
Query: 688 FWRQQLTEKSDVYSFGVVLFE 708
D++S G +L E
Sbjct: 230 LLGMPYDLAIDMWSLGCILVE 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 15/162 (9%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSK 565
E+RV N + IG G FG ++ G I AIK +++ E ++
Sbjct: 4 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKM 60
Query: 566 LRH-RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624
++ + ++ E + ++V E + G LF + K L +
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 625 HYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSK 662
Y+H + IHRDVK N L+ N V + DFGL+K
Sbjct: 119 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY-IIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 15/162 (9%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSK 565
E RV N F IG G FG+++ G I+ AIK N +++ +E ++
Sbjct: 2 EPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE--SKIYRI 58
Query: 566 LR-HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624
L+ + ++ F E + +LV + + G LF L+ K L +
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 625 HYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSK 662
++H + +HRD+K N L+ N V + DFGL+K
Sbjct: 117 EFVH---SKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 16/150 (10%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH-RHLVSLIGFC 578
IG G FG +F+G + + AIK +S+ E L + ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE--YRTYKLLAGCTGIPNVYYFG 75
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
E +LV + + G L + K A + +H E+ +++R
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130
Query: 639 DVKTTNILL------DENFVAKMSDFGLSK 662
D+K N L+ + N + + DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIY-VVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 37/167 (22%), Positives = 61/167 (36%), Gaps = 17/167 (10%)
Query: 504 TLAEIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEM 562
++ + V NF IG G FG++ G+ + AIK +S E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLE--YRF 57
Query: 563 LSKLRH-RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
+L + + F +V E + G LF + K L I
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLI 115
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILL------DENFVAKMSDFGLSK 662
+ Y+H + +I+RDVK N L+ + + + DF L+K
Sbjct: 116 SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 49/230 (21%), Positives = 80/230 (34%), Gaps = 65/230 (28%)
Query: 520 MIGVGGFGKVFKG--EIEDCTLAAIK--RANPQ-SEQGLAEFETEIEMLSKLRHR----- 569
+G G FGKV + + A+K R + E EI +L K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENK 81
Query: 570 -HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTW-------KQRLDACIGAA 621
V + + + M + +E + L ++ P Q A
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHA----- 135
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVA-------------------KMSDFGLSK 662
L +LH E + H D+K NIL + +++DFG +
Sbjct: 136 --LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 663 TGPSMEHTHVSTAVKGSFGYLDPE----YFWRQQLTEKSDVYSFGVVLFE 708
+ +H H +T V Y PE W + DV+S G +LFE
Sbjct: 190 ---TFDHEHHTTIVATRH-YRPPEVILELGW----AQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 64/339 (18%), Positives = 112/339 (33%), Gaps = 98/339 (28%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIK--RANPQ-SEQGLAEFETEIEMLSKLRHR-----H 570
+G G FG+V + I++ A+K R + + E ++L K+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK----IEADILKKIQNDDINNNN 97
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTW-------KQRLDACIGAARG 623
+V G + M L++E + +L + ++ + L A
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKA------- 149
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV--STAVK---- 677
L+YL + + H D+K NILLD+ + K T + ST +K
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 678 GSFGYLD--------------PE------YFWRQQLTEKSDVYSFGVVLFE--------- 708
G + PE + SD++SFG VL E
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTGSLLFR 260
Query: 709 -------VVCARAVINPTLPKDQINLA----------------DWAMKWQKQRSLKSIID 745
+ ++I P +PK+ + A W S+K +
Sbjct: 261 THEHMEHLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV-- 317
Query: 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
Y E F + L + RP+ E+L H
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 61/381 (16%), Positives = 102/381 (26%), Gaps = 129/381 (33%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLR--------H 568
+G G F V+ I+ A+K ++ + EI +L +R
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRNSDPNDPNR 100
Query: 569 RHLVSLIG-----------FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDAC 617
+V L+ C +V+E + + L + S+ L
Sbjct: 101 EMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HLLKWIIKSNYQGLPLPCVKKII 152
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILL------------------------------ 647
+GL YLHT + IIH D+K NILL
Sbjct: 153 QQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 648 -------------------DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
E K++D G + T Y E
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTEDIQTR----QYRSLEVL 265
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN----LA-----------DWAMK 733
+D++S + FE+ + P ++ +A +
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325
Query: 734 WQKQR-------SLKSIIDPHL---------KGNYSPESLEKFGEIAEKCLDDEGKNRPT 777
+ + LK I K +S E F + L+ + R T
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385
Query: 778 MGEVLWHLEYVLQLHEAWMRT 798
E L H W+ +
Sbjct: 386 AAECLRH---------PWLNS 397
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 25/181 (13%), Positives = 54/181 (29%), Gaps = 60/181 (33%)
Query: 521 IGVGGFGKVFKGE---------IEDCTLAAIK--RANPQ--SEQGLAEFETEIEMLSKLR 567
G +++ ++K + + +EQ + + ++K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 568 HRHLVSLIGF-------CDEQNEMILVYEYMANGTLRSHLFGSDL---------PPLTWK 611
+ L+ + LV G L L+ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSALDVSPKHVLSER 159
Query: 612 -------QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLS 661
+ LDA L +LH E +H +V NI + D++ V ++ +G +
Sbjct: 160 SVLQVACRLLDA-------LEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFA 208
Query: 662 K 662
Sbjct: 209 F 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 43/233 (18%), Positives = 79/233 (33%), Gaps = 71/233 (30%)
Query: 520 MIGVGGFGKVFKG--EIEDCTLAAIK--RANPQ-SEQGLAEFETEIEMLSKLRHR----- 569
+G G FGKV + A+K + + E +EI++L L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR----SEIQVLEHLNTTDPNST 76
Query: 570 -HLVSLIGFCDEQNEMILVYEYM-ANGTLRSHLFGSDLPPLTW-------KQRLDACIGA 620
V ++ + + + +V+E + + + + P Q +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIRKMAYQICKS---- 130
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLDENFVA-------------------KMSDFGLS 661
+++LH + H D+K NIL ++ K+ DFG +
Sbjct: 131 ---VNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 662 KTGPSMEHTHVSTAVKGSFGYLDPE------YFWRQQLTEKSDVYSFGVVLFE 708
+ + H ST V Y PE + ++ DV+S G +L E
Sbjct: 185 ----TYDDEHHSTLVSTRH-YRAPEVILALGW------SQPCDVWSIGCILIE 226
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 29/173 (16%), Positives = 62/173 (35%), Gaps = 44/173 (25%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK---------RANPQ--SEQGLAEFETEIEMLSKLRHR 569
IG GGFG ++ ++ N +E + + E + K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 570 HLVSLIGFC----------DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWK-------Q 612
+ +G + ++ ++ + G+ ++ ++ + K +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 613 RLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSK 662
LD L Y+H E +H D+K +N+LL + + V + D+GL+
Sbjct: 161 ILDI-------LEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 34/178 (19%), Positives = 58/178 (32%), Gaps = 57/178 (32%)
Query: 521 IGVGGFGKVFKGE----IEDCTLAAIKRANPQSEQGLAEFETEI-----EMLSKLRHRHL 571
IG GGFG ++ E +K ++ +E + + + K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 572 VSLIGF----------CDEQNEMILVYEYMANGTLRSHLFGSDL-------PPLTWK--- 611
+ +G ++ +V E G DL
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVME----------RLGIDLQKISGQNGTFKKSTVL 154
Query: 612 ----QRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSK 662
+ LD L Y+H E +H D+K N+LL + + V ++D+GLS
Sbjct: 155 QLGIRMLDV-------LEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 851 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.85 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.66 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.56 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.54 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.36 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.34 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.46 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.7 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=462.11 Aligned_cols=261 Identities=29% Similarity=0.443 Sum_probs=212.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|...++||+|+||+||+|++. +++.||||++...+....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778889999999999999874 367899999988888888899999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCC-------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 587 VYEYMANGTLRSHLFGSD-------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
|||||++|+|.++|+... ..+++|.++++|+.|+|+||+|||+ ++||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999996532 2469999999999999999999996 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~ 732 (851)
||+|||+++.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~-- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDC-- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHH--
Confidence 9999999987544444444456779999999999999999999999999999999999 899987543221 1111
Q ss_pred HHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 733 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
. ..+ .+...+..+++.+.+|+.+||+.||++|||++||+++|+.+.+..
T Consensus 273 -i-~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 273 -I-TQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp -H-HHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred -H-HcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1 111 112344567778999999999999999999999999999887654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=457.06 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=217.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|...+.||+|+||+||+|++. ++..||||++...+....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999864 467899999988887888899999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCC-----------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEE
Q 047215 587 VYEYMANGTLRSHLFGS-----------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKM 655 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl 655 (851)
|||||++|+|.++|+.. ....++|.++++|+.|+|+||+|||+ ++||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 24579999999999999999999996 89999999999999999999999
Q ss_pred eeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......+ +.. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~---~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---CI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HH
Confidence 99999986443333333445679999999999999999999999999999999999 899987543221 111 11
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
..+. ....+..+++.+.+|+.+||+.||++|||++|+++.|+.+.+.
T Consensus 244 -~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 -TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 1234456777899999999999999999999999998877553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=454.07 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=211.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
.+++..++||+|+||+||+|++. +++.||||++... .....++|.+|+.+|++++|||||+++|+|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999873 4578999998765 3344678999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC
Q 047215 586 LVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF 651 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~ 651 (851)
||||||++|+|.++|+... ...++|.++++|+.|||+||+|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 9999999999999996432 2468999999999999999999996 8999999999999999999
Q ss_pred eEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHH
Q 047215 652 VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADW 730 (851)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~ 730 (851)
.+||+|||+++.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHH
Confidence 999999999986543333334456679999999999999999999999999999999998 88888754322 11111
Q ss_pred HHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 731 AMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 731 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
...+ .....+..++..+.+|+.+||+.||++||||+||+++|+
T Consensus 260 ----i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 260 ----IRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp ----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1111 112345677788999999999999999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=444.79 Aligned_cols=262 Identities=25% Similarity=0.464 Sum_probs=208.6
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
...+++...++||+|+||+||+|++++ .+|||+++.. +....+.|.+|+++|++++|||||+++|+|.+ +.++||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 345678889999999999999999765 4788887643 45667889999999999999999999999975 568999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
||||++|+|.++|+... .+++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999997543 469999999999999999999996 89999999999999999999999999999875443
Q ss_pred CccccccccccCCcccCcccccc---cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWR---QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||........ .......+ ..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~----~~ 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRG----YA 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTT----CC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcC----CC
Confidence 33344456789999999999964 3699999999999999999999999976443221 11111111 11
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.|.+ ...+..+++.+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 256 ~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 256 SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2222 2344567788999999999999999999999999998653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=448.98 Aligned_cols=270 Identities=23% Similarity=0.380 Sum_probs=222.1
Q ss_pred CHHHHHHHhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCC-hhhHHHHHHHHHHHHhcCC-cceeeEE
Q 047215 504 TLAEIRVATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQS-EQGLAEFETEIEMLSKLRH-RHLVSLI 575 (851)
Q Consensus 504 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H-pnIv~l~ 575 (851)
...+++...++|+..++||+|+||+||+|++.+ ++.||||++.... ....+.|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 445667778899999999999999999998653 3578999987653 4456789999999999965 9999999
Q ss_pred EEEcc-CCcEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCC
Q 047215 576 GFCDE-QNEMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640 (851)
Q Consensus 576 g~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDl 640 (851)
|+|.+ ++.++||||||++|+|.++|+... ...++|.+++.++.|||+||+|||+ ++||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCcc
Confidence 99965 467899999999999999996432 3458999999999999999999996 89999999
Q ss_pred CCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCC
Q 047215 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPT 719 (851)
Q Consensus 641 k~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~ 719 (851)
||+||||++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987544333334456789999999999999999999999999999999998 89998764
Q ss_pred CCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 720 LPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 720 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
...+. .......+ .+...+..+++.+.+++.+||+.||++|||+.|+++||+.+++.
T Consensus 292 ~~~~~------~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KIDEE------FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSHH------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHH------HHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 33221 11111111 12234455677899999999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=445.53 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=206.9
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||+||+|+. .+++.||||++... .....+.|.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999986 46789999998654 44556789999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
||++|+|.++|.......+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 9999999999976666678899999999999999999995 9999999999999999999999999999986432 1
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+ ....... +.. +
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~-~~~-----~--- 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIIS-GSF-----P--- 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH-TCC-----C---
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHc-CCC-----C---
Confidence 223355789999999999999999999999999999999999999997643221 1111111 110 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+..++..+.+|+.+||+.||++|||++|+++|
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234456679999999999999999999999999
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=440.57 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=215.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
..|+..++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 67899999987655555667899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+..... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP 225 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CC
Confidence 99999999864 358999999999999999999996 89999999999999999999999999999864332 22
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||....+.+. . .... . ...+.+ .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~~i~-~-----~~~~~~--~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M---KMIR-D-----NLPPRL--K 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HHHH-H-----SSCCCC--S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---HHHH-c-----CCCCCC--C
Confidence 34567899999999999999999999999999999999999999976432211 1 1111 1 111111 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
....+++.+++|+.+||+.||++|||++|+++| +|+...
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H---------p~~~~~ 330 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH---------PFLAKA 330 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC---------GGGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC---------HhhcCC
Confidence 234556779999999999999999999999999 998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=431.24 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=201.6
Q ss_pred ceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc----CCcEEEEE
Q 047215 516 DESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE----QNEMILVY 588 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~lV~ 588 (851)
+..++||+|+||+||+|+.. .+..||+|++... .....+.|.+|+++|++|+|||||++++++.. ++.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999875 5678999987643 44556789999999999999999999999854 45689999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC--eEEcCCCCCCeEEc-CCCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG--IIHRDVKTTNILLD-ENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~--iiHrDlk~~NILld-~~~~~kl~DFGla~~~~ 665 (851)
|||++|+|.++|... ..+++.++..++.||+.||+|||+ ++ ||||||||+||||+ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999643 468999999999999999999995 55 99999999999997 57999999999998632
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||........ ..... ..+
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~~~i-~~~------- 245 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRV-TSG------- 245 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHH-TTT-------
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HHHHH-HcC-------
Confidence 2 23446789999999999865 699999999999999999999999965432211 11111 111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.....++..+++.+.+|+.+||+.||++|||++|+++| +|+++
T Consensus 246 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H---------p~~~~ 288 (290)
T 3fpq_A 246 -VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH---------AFFQE 288 (290)
T ss_dssp -CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGC-
T ss_pred -CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC---------ccccC
Confidence 11111223344568999999999999999999999999 99864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=434.58 Aligned_cols=263 Identities=20% Similarity=0.212 Sum_probs=212.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.+.|...++||+|+||.||+|+.. .++.||||++..... ..+|+.+|++++|||||++++++.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888889999999999999974 578999999875422 24699999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccccCCCCCc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~~ 669 (851)
|++|+|.++|... ..+++.++..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999643 469999999999999999999995 8999999999999999887 699999999986543221
Q ss_pred c---ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 670 T---HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 670 ~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+.. ... ... +
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i---~~~--------~ 272 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKI---ASE--------P 272 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHH---HHS--------C
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHH---HcC--------C
Confidence 1 1223467999999999999999999999999999999999999999765443221 111 000 0
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh----hhhhccc
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL----HEAWMRT 798 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~----~~~w~~~ 798 (851)
.....+++.+++.+.+++.+||+.||.+|||+.|++++|...++. ..+|..+
T Consensus 273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 001123456667799999999999999999999999999888763 3467653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=431.60 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=216.5
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|++.++||+|+||+||+|+. .+++.+|||++... .....+.+.+|+++|++|+|||||++++++++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999986 46789999998643 2334577999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|||++|+|.++|... ..+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999643 468999999999999999999996 999999999999999999999999999998755434
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
........+||+.|||||++.+..|+.++||||+||+||||+||+.||......+ +. .... .. .
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~---~~i~-~~--------~- 250 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IF---AKII-KL--------E- 250 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-HT--------C-
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-cC--------C-
Confidence 4444566789999999999999999999999999999999999999997543211 11 1111 11 1
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
..++...++.+++|+.+||+.||++|||++|++.+-+ + +..+|++.-+
T Consensus 251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~-i--~~Hp~F~~id 298 (311)
T 4aw0_A 251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP-L--KAHPFFESVT 298 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH-H--HTSGGGTTCC
T ss_pred -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH-H--HCCCCcCCCC
Confidence 1233445567899999999999999999998765522 1 1238886543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=441.75 Aligned_cols=257 Identities=21% Similarity=0.357 Sum_probs=216.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.+.|+..++||+|+||.||+|+.. .++.||||++........+.+.+|+.+|++++|||||++++++..++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999874 5789999998766666667789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
|++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+..... .
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V 301 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--C
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCC--C
Confidence 9999999998643 48999999999999999999996 89999999999999999999999999999864332 2
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||....+.+. . ... ... ..+.+
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~~i-~~~-----~~~~~-- 367 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M---KMI-RDN-----LPPRL-- 367 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HHH-HHS-----CCCCC--
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---HHH-HcC-----CCCCC--
Confidence 234567899999999999999999999999999999999999999975432211 1 111 111 11111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.....+++.+++|+.+||+.||++|||++|+|+| +|+...
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H---------p~~~~~ 407 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH---------PFLAKA 407 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC---------GGGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC---------HHhcCC
Confidence 1223455679999999999999999999999999 998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=430.75 Aligned_cols=268 Identities=24% Similarity=0.332 Sum_probs=201.2
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC----cEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN----EMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~lV~ 588 (851)
+++...++||+|+||+||+|++. ++.||||++...... ...+..|+..+.+++|||||+++|+|.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 45677889999999999999974 678999998754322 223445666777899999999999997653 589999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC-----CCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG-----AERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~-----~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
|||++|+|.++|+.. +++|.++++++.|+|+||+|||+. .+++||||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999654 589999999999999999999963 134899999999999999999999999999986
Q ss_pred CCCCCcc--ccccccccCCcccCccccccc------CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc----h-----hc
Q 047215 664 GPSMEHT--HVSTAVKGSFGYLDPEYFWRQ------QLTEKSDVYSFGVVLFEVVCARAVINPTLPKD----Q-----IN 726 (851)
Q Consensus 664 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~----~-----~~ 726 (851)
....... ......+||+.|||||++.+. .++.++|||||||+||||+||+.|+....... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 4332221 122346799999999999754 47889999999999999999988764322111 1 11
Q ss_pred HHHHHHHHhhhcccccccCccCCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 727 LADWAMKWQKQRSLKSIIDPHLKGN-YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..+. .... .....+|.+... .+.+++..+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 238 ~~~~-~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEM-RKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHH-HHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-HHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1111 1111 111122222211 124567889999999999999999999999999987754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=417.49 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=196.4
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||+||+|+. .+++.+|||++... .......+.+|+++|++++|||||++++++.+++.++|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999986 46789999988653 2334567999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+ +|+|.+++... .++++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 999 68999998554 469999999999999999999996 8999999999999999999999999999986432
Q ss_pred ccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.......+||+.|||||++.+..+ +.++||||+||+||||+||+.||...... +...... .+.
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~-~~~-------- 228 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNIS-NGV-------- 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HTC--------
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-cCC--------
Confidence 223345789999999999998876 58999999999999999999999754221 1111111 110
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..++...++.+++|+.+||+.||++|||++|+++| +|++.
T Consensus 229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h---------pw~k~ 268 (275)
T 3hyh_A 229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD---------DWFKV 268 (275)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC---------HHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC---------ccccc
Confidence 12233455678999999999999999999999999 88764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=425.95 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=204.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|++.+.||+|+||+||+|+.. .++.+|||++... .......+.+|+++|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 3578999988654 22234468899999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|||||++|+|.++|... ..+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999653 468999999999999999999996 8999999999999999999999999999986432
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
. .......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+ + ..... ..
T Consensus 179 ~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~~~i~-~~-------- 241 (304)
T 3ubd_A 179 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---T---MTMIL-KA-------- 241 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-HC--------
T ss_pred C--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---H---HHHHH-cC--------
Confidence 1 223345789999999999999999999999999999999999999997643221 1 11111 11
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHHhhhhhccc
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~L~~~~~~~~~w~~~ 798 (851)
. ..++..+++.+++|+.+||+.||++||| ++|+++| +|++.
T Consensus 242 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H---------p~f~~ 287 (304)
T 3ubd_A 242 K--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH---------SFFST 287 (304)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS---------GGGTT
T ss_pred C--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC---------ccccC
Confidence 1 1234455677999999999999999998 5899999 88865
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=409.12 Aligned_cols=292 Identities=60% Similarity=1.061 Sum_probs=258.5
Q ss_pred cccCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc
Q 047215 501 KRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580 (851)
Q Consensus 501 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 580 (851)
.++++.++...+++|+..+.||+|+||.||+|+..++..+|+|+.........+.+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45566677778899999999999999999999988889999999888777778889999999999999999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCC--CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDL--PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
++..++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999976542 358999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
|+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+......|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99986443333333445668999999999999999999999999999999999999998877777777888887777777
Q ss_pred ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
.+..++++.+....+++++..+.+++.+||+.||++|||+.|++++|+.+++.++.|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~~ 320 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCCC
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccCc
Confidence 778888888888888999999999999999999999999999999999998876654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=407.47 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=192.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC--------
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN-------- 582 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-------- 582 (851)
++|+..+.||+|+||+||+|+.. +++.+|||++... .....+.+.+|+++|++|+|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999864 6788999988654 3344567999999999999999999999986543
Q ss_pred ----cEEEEEEecCCcchhhhccCCCC-CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEee
Q 047215 583 ----EMILVYEYMANGTLRSHLFGSDL-PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~D 657 (851)
.+|||||||++|+|.+++..... ....+..++.++.|++.||+|||+ ++||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976432 234556688999999999999996 8999999999999999999999999
Q ss_pred ccccccCCCCCcc----------ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH
Q 047215 658 FGLSKTGPSMEHT----------HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL 727 (851)
Q Consensus 658 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l 727 (851)
||+|+........ ......+||+.|||||++.+..|+.++|||||||+||||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999864332111 12234679999999999999999999999999999999996 55321 111
Q ss_pred HHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 728 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
...... +...... .......+.+.+|+.+||+.||.+|||+.|+++| +|+++.
T Consensus 234 ~~~~~~---------~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h---------~~~~~~ 286 (299)
T 4g31_A 234 VRTLTD---------VRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN---------AVFEDL 286 (299)
T ss_dssp HHHHHH---------HHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS---------GGGCCC
T ss_pred HHHHHH---------HhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC---------HhhCCC
Confidence 110111 0010110 0112334557889999999999999999999999 898754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=410.64 Aligned_cols=271 Identities=21% Similarity=0.309 Sum_probs=208.2
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc------CCc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE------QNE 583 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~ 583 (851)
++|++.+.||+|+||+||+|+. ..++.||||++... .....+.+.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999986 46789999998754 33445678899999999999999999998753 467
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+|||||||+ |+|.+++... .++++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 6899998553 479999999999999999999996 9999999999999999999999999999986
Q ss_pred CCCC--CccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 664 GPSM--EHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 664 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
.... .........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....++................
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 4322 122234567899999999998875 5799999999999999999999999865443332211110000000000
Q ss_pred cc-----------ccCccCCC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 741 KS-----------IIDPHLKG---NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 741 ~~-----------i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.. .+.+.... ...+..++.+.+|+.+||+.||.+|||++|+|+| +|+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H---------p~f~~ 350 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH---------PFLAK 350 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS---------GGGTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC---------HhhCc
Confidence 00 00000000 0012345678999999999999999999999999 88864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=399.82 Aligned_cols=270 Identities=20% Similarity=0.285 Sum_probs=204.0
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 584 (851)
...++|++.++||+|+||+||+|+.+ .++.||+|++..... ...+.+|+++|+++ +|||||++++++..++.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999753 357899998865533 35678999999998 699999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC-CeEEEeecccccc
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKT 663 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~ 663 (851)
+||||||++|+|.+++. .+++.++..++.|++.||+|||+ ++||||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999983 48899999999999999999995 999999999999999876 8999999999975
Q ss_pred CCCCCc--------------------------cccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCC
Q 047215 664 GPSMEH--------------------------THVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVI 716 (851)
Q Consensus 664 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~ 716 (851)
...... .......+||+.|+|||++.+. .++.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 332111 0112345799999999999775 5899999999999999999999999
Q ss_pred CCCCCcc-hhcHHH----------HHHHHhhhc----------------cc--ccccCccC---------CCCCChhHHH
Q 047215 717 NPTLPKD-QINLAD----------WAMKWQKQR----------------SL--KSIIDPHL---------KGNYSPESLE 758 (851)
Q Consensus 717 ~~~~~~~-~~~l~~----------~~~~~~~~~----------------~~--~~i~d~~l---------~~~~~~~~~~ 758 (851)
....... +..... +........ .. .....|.+ ........++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6543321 111100 000000000 00 00000000 0011123456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 759 KFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 759 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+++|+.+||+.||++|||++|+|+| +|+++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~H---------p~f~~ 358 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLH---------PFFKD 358 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS---------GGGTT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC---------cccCC
Confidence 78999999999999999999999999 99864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=417.89 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=215.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|++.+.||+|+||.||+|+.. .++.+|+|++........+.+.+|+++|++|+|||||++++++..++.++||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999874 67899999988777777788999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC--CCeEEEeeccccccCCCCCc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE--NFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~~ 669 (851)
++|+|.++|.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++. .+.+||+|||+++.....
T Consensus 237 ~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 237 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred CCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 9999999985432 469999999999999999999995 99999999999999975 489999999999875432
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
......+||+.|||||++.+..|+.++||||+||+||||++|+.||......+. ...... . +..+.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~-~------~~~~~ 376 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKS-C------DWNMD 376 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHT-T------CCCCC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHh-C------CCCCC
Confidence 223456899999999999999999999999999999999999999976533221 111110 0 00111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.......++.+++|+.+||+.||.+|||+.|+|+| +|++..
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H---------pw~~~~ 417 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH---------PWLTPG 417 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS---------TTTSCC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC---------cCcCCC
Confidence 11123345678999999999999999999999999 888754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=390.32 Aligned_cols=287 Identities=43% Similarity=0.738 Sum_probs=245.1
Q ss_pred CcccCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCCh-hhHHHHHHHHHHHHhcCCcceeeEEEEE
Q 047215 500 GKRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE-QGLAEFETEIEMLSKLRHRHLVSLIGFC 578 (851)
Q Consensus 500 ~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 578 (851)
.+.+++.++....++|...+.||+|+||.||+|+..+++.+|||++..... .....+.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 367899999999999999999999999999999988899999999876532 2234689999999999999999999999
Q ss_pred ccCCcEEEEEEecCCcchhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEe
Q 047215 579 DEQNEMILVYEYMANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~ 656 (851)
..++..++||||+++|+|.+++.... ..++++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 3459999999999999999999997323399999999999999999999999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCC--CCcchhcHHHHHHHH
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPT--LPKDQINLADWAMKW 734 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~--~~~~~~~l~~~~~~~ 734 (851)
|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||... .........+|....
T Consensus 177 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999864332 222334556999999999999999999999999999999999999998631 122334566777666
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
........+.+..+...++.+.+..+.+++.+||+.||.+|||++|++++|+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 66667777788888888889999999999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=411.79 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=205.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC------ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ------SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|++.++||+|+||.||+|+.. .++.+|||++... ..........++.+++.++|||||++++++.+++.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999875 5789999987542 1111222334566777889999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
||||||++|+|.++|... ..+++.++..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999653 468999999999999999999994 999999999999999999999999999998643
Q ss_pred CCCccccccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.. .....+||+.|||||++. +..|+.++|||||||+||||++|+.||......+...+.. . +.
T Consensus 344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~---------i~ 407 (689)
T 3v5w_A 344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---M---------TL 407 (689)
T ss_dssp SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---H---------HH
T ss_pred CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---h---------hc
Confidence 22 234568999999999996 4689999999999999999999999997543332211111 1 01
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHHHHhhhhhcccC
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.. ...++...++.+++|+.+||+.||.+|++ ++|+++| +|++.-
T Consensus 408 ~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H---------pfF~~i 456 (689)
T 3v5w_A 408 TM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES---------PFFRSL 456 (689)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS---------GGGTTC
T ss_pred CC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC---------ccccCC
Confidence 00 11233445567899999999999999998 7999999 776643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=381.16 Aligned_cols=262 Identities=25% Similarity=0.464 Sum_probs=216.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEc--------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE--------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ 581 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 581 (851)
.++|...+.||+|+||.||+|+.. ++..+|||++... .....+.+.+|+++++++ +||||++++++|..+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999863 3457899998765 445567899999999999 899999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE
Q 047215 582 NEMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl 647 (851)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999986543 2358899999999999999999995 899999999999999
Q ss_pred cCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhc
Q 047215 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQIN 726 (851)
Q Consensus 648 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~ 726 (851)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986544333233344567889999999999999999999999999999999 888886543222
Q ss_pred HHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 727 LADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
+... . .. ......+..++..+.+++.+||+.||.+|||+.|++++|+.++.+.
T Consensus 314 ~~~~---~-~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 LFKL---L-KE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHH---H-HT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHH---H-hc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 1 11 1112234556678999999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.67 Aligned_cols=281 Identities=35% Similarity=0.650 Sum_probs=230.0
Q ss_pred cccCHHHHHHHhcCCcee------eeeeeecceEEEEEEEcCcceeEEeecCCC----ChhhHHHHHHHHHHHHhcCCcc
Q 047215 501 KRFTLAEIRVATNNFDES------LMIGVGGFGKVFKGEIEDCTLAAIKRANPQ----SEQGLAEFETEIEMLSKLRHRH 570 (851)
Q Consensus 501 ~~~~~~~l~~~t~~f~~~------~~LG~G~fG~Vykg~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~Hpn 570 (851)
..|++.++..++++|... +.||+|+||.||+|.. ++..+|+|++... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 578999999999999988 8999999999999986 5678899987643 2344678999999999999999
Q ss_pred eeeEEEEEccCCcEEEEEEecCCcchhhhccCC-CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC
Q 047215 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGS-DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649 (851)
Q Consensus 571 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~ 649 (851)
|+++++++..++..++||||+++|+|.+++... ...++++..+..++.|++.||.|||+ .+++||||||+|||++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998643 23568999999999999999999995 89999999999999999
Q ss_pred CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH
Q 047215 650 NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729 (851)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~ 729 (851)
++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ +..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 99999999999986544333333345679999999998865 489999999999999999999999976543322 122
Q ss_pred HHHHHhh-hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 730 WAMKWQK-QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 730 ~~~~~~~-~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+...... ...+...+++.+ ...+...+..+.+++.+||+.||.+|||+++++++|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222221 122233444443 3456778889999999999999999999999999998763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=367.22 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=216.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|...++||+|+||.||+|+.. ++..+|+|++........+.|.+|++++++++||||+++++++..++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367888999999999999999875 5788999998877777888999999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999996543 468999999999999999999995 89999999999999999999999999999764322111
Q ss_pred c------------cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 671 H------------VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 671 ~------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
. ......||+.|+|||++.+..++.++||||||+++|||++|..|+....+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--------- 235 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--------- 235 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC---------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh---------
Confidence 0 1124579999999999999999999999999999999999999887644432210000
Q ss_pred ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhh
Q 047215 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794 (851)
Q Consensus 739 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (851)
.....+.. .+..++..+.+++.+||+.||.+|||++++++.|+.+......
T Consensus 236 -~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 236 -VRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -HHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -hhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00011111 1234445689999999999999999999999999988765443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=366.37 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=213.9
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|+..+.||+|+||.||+|.. .+++.+|+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999985 56788999998766555567889999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999998654 48899999999999999999996 899999999999999999999999999987643322
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.... ....... .+ ..
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~------~~--~~ 236 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNG------TP--EL 236 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHC------SC--CC
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC------CC--CC
Confidence 1234567999999999999999999999999999999999999999754332111 1111111 01 11
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+...+..+.+++.+||+.||.+|||++|+++| +|++.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h---------~~~~~ 275 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH---------QFLKI 275 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC---------GGGGG
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC---------hhhcc
Confidence 2234566779999999999999999999999999 88864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=377.09 Aligned_cols=272 Identities=23% Similarity=0.384 Sum_probs=219.6
Q ss_pred ccCHHHHHHHhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceee
Q 047215 502 RFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVS 573 (851)
Q Consensus 502 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~ 573 (851)
.+...+++...++|...+.||+|+||.||+|++. +++.+|||++... .....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455667778899999999999999999999742 3478999998764 344557799999999999 7999999
Q ss_pred EEEEEccCC-cEEEEEEecCCcchhhhccCCCC-----------------------------------------------
Q 047215 574 LIGFCDEQN-EMILVYEYMANGTLRSHLFGSDL----------------------------------------------- 605 (851)
Q Consensus 574 l~g~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~----------------------------------------------- 605 (851)
++++|...+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999997754 48999999999999999965432
Q ss_pred -----------------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 606 -----------------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 606 -----------------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 128899999999999999999996 899999999999999999999999999998654333
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||........ .......+
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~--------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEG--------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHT---------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcC---------
Confidence 3333455678999999999999999999999999999999998 9999876543221 11111111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..+++.+.+++.+||+.||.+|||++|+++||+.+++.
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 11122344556799999999999999999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=370.38 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=211.4
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|...+.||+|+||.||+|+. ..++.||||++... .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36799999999999999999987 57789999987653 4455677899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999998554 358899999999999999999995 89999999999999999999999999999753322
Q ss_pred ccccccccccCCcccCcccccccCCC-chHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
......+||+.|+|||++.+..++ .++|||||||++|||++|+.||......+ ...... .+ .
T Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~-~~--------~ 230 (328)
T 3fe3_A 168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVL-RG--------K 230 (328)
T ss_dssp --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HC--------C
T ss_pred --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hC--------C
Confidence 223556799999999999988775 89999999999999999999997643211 111111 11 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...+...+..+.+++.+||+.||.+|||++|+++| +|+..
T Consensus 231 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h---------~~~~~ 270 (328)
T 3fe3_A 231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD---------RWINA 270 (328)
T ss_dssp --CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC---------TTTTT
T ss_pred --CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC---------HhhcC
Confidence 12233455678999999999999999999999999 88764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=370.48 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=207.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-Ccc----eeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCT----LAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|+..++||+|+||.||+|+.. ++. .+++|.+... .....+.|.+|+.++++++||||++++++|..+ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 67888999999999999999864 333 3578877543 345567899999999999999999999999875 4789
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|+||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999986543 468999999999999999999996 8999999999999999999999999999986443
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ... +.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~-------------~~ 233 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI-------------LE 233 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH-------------HH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHH-------------HH
Confidence 333333344567889999999999999999999999999999999 9998876433221 111 11
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
.......+..++..+.+++.+||+.||.+|||+.|++++|+.+.+....+..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~ 285 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHHBC
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhhhh
Confidence 1111223455667799999999999999999999999999988766555543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=365.60 Aligned_cols=267 Identities=22% Similarity=0.315 Sum_probs=220.9
Q ss_pred cccCHHHHHHHhcC----------CceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCc
Q 047215 501 KRFTLAEIRVATNN----------FDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHR 569 (851)
Q Consensus 501 ~~~~~~~l~~~t~~----------f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hp 569 (851)
..++.++++.+++. |+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 56788888887764 777789999999999999976 6889999998877666678899999999999999
Q ss_pred ceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC
Q 047215 570 HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649 (851)
Q Consensus 570 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~ 649 (851)
||+++++++...+..++||||+++|+|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECC
Confidence 999999999999999999999999999999854 358999999999999999999995 89999999999999999
Q ss_pred CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH
Q 047215 650 NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729 (851)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~ 729 (851)
++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~-- 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A-- 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H--
T ss_pred CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H--
Confidence 9999999999987643321 12345679999999999999999999999999999999999999987543211 1
Q ss_pred HHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 730 WAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 730 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...... ...+.+ ......+..+.+++.+||+.||.+|||++|+++| +|+..
T Consensus 250 -~~~~~~------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h---------p~~~~ 300 (321)
T 2c30_A 250 -MKRLRD------SPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH---------PFLLQ 300 (321)
T ss_dssp -HHHHHH------SSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS---------GGGGG
T ss_pred -HHHHhc------CCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC---------hhhcc
Confidence 111111 111111 1123455678999999999999999999999999 88764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.34 Aligned_cols=273 Identities=22% Similarity=0.337 Sum_probs=210.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC----cEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN----EMIL 586 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~l 586 (851)
..++|+..++||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++.... .+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3478999999999999999999876 67899999865433 3445677999999999999999999997643 4799
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCC----------CeEEcCCCCCCeEEcCCCeEEEe
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER----------GIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~----------~iiHrDlk~~NILld~~~~~kl~ 656 (851)
||||+++|+|.+++... .+++.++..++.|++.||.|||+ . +|+||||||+|||++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999653 48999999999999999999995 6 99999999999999999999999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccc-----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~ 731 (851)
|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999976443333223344679999999999986 45677899999999999999999999765443222211110
Q ss_pred HHHhhh-----cccccccCccCCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 732 MKWQKQ-----RSLKSIIDPHLKGN-YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 732 ~~~~~~-----~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
...... ........+.+... ....++..+.+|+.+||+.||.+|||++|+++.|+.+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000000 00001111111111 1234667799999999999999999999999999988764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=367.63 Aligned_cols=259 Identities=24% Similarity=0.319 Sum_probs=209.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999875 67889999876543 23346688999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999544 458999999999999999999995 89999999999999999999999999999764332333
Q ss_pred ccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....| ... ...
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~----~~~---------~~~ 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEK---------KTY 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH----HTT---------CTT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH----hcc---------ccc
Confidence 33445679999999999987765 7899999999999999999999976443221 11111 111 000
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.......+..+.+|+.+||+.||.+|||++|+++| +|+...
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h---------~~~~~~ 268 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD---------RWYNKP 268 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC---------TTTTCC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC---------hhhccc
Confidence 11123455678899999999999999999999999 888653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=367.28 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=206.3
Q ss_pred HHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 507 EIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 507 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
++....++|++.+.||+|+||.||+|+. .++.+|||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3344557899999999999999999986 4677899987654 345567899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCC--eEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 585 ILVYEYMANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERG--IIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~--iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999996543 2248899999999999999999995 77 999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+. .......
T Consensus 187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~~---- 254 (309)
T 3p86_A 187 RLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGFK---- 254 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHHS----
T ss_pred cccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc----
Confidence 753321 1123446799999999999999999999999999999999999999875432211 1111000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
......+..++..+.+++.+||+.||.+|||++++++.|+.+++
T Consensus 255 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 -----CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -----CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11122344556679999999999999999999999999886653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=380.53 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=212.5
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
..++|...+.||+|+||.||+|+.. +++.||||.+... .......|.+|+++|++++||||++++++|..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4467888999999999999999986 6788999998755 3344567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999986432 358899999999999999999996 899999999999999999999999999998633221
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.........++..|+|||.+....++.++|||||||++|||++ |+.|+......+ .. ..... .
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~----~~~~~---------~ 331 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TR----EFVEK---------G 331 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HH----HHHHT---------T
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHc---------C
Confidence 1111122335778999999998999999999999999999998 888886543211 11 11111 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..++..+.+++.+||+.||.+|||++++++.|+.+.+.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11223445667899999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=367.34 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=211.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|.+.++||+|+||.||+|+.. .+..+|||++... .....+.|.+|+.++++++||||+++++++..++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467889999999999999999974 3456999998765 45556789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 468999999999999999999995 8999999999999999999999999999986443
Q ss_pred CCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 667 MEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 667 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ + .....
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~---~~~~~--------- 268 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---V---ISSVE--------- 268 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H---HHHHH---------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---H---HHHHH---------
Confidence 221 112233456788999999999999999999999999999999 998886543221 1 11111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.......+..++..+.+++.+||+.||.+|||+.|+++.|+.+++.
T Consensus 269 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 269 -EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1111223445667899999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=374.17 Aligned_cols=264 Identities=24% Similarity=0.436 Sum_probs=216.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc--------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE--------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
..++|...++||+|+||.||+|+.. .+..+|||++... .......+.+|+++++++ +||||++++++|..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578899999999999999999863 2357899998765 445567899999999999 99999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
++..++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 999999999999999999996543 2458999999999999999999995 89999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchh
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQI 725 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~ 725 (851)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999986544333333445567899999999999999999999999999999999 88888654321
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
+...... . ......+..++..+.+++.+||+.||.+|||++|++++|+.+.....
T Consensus 301 ---~~~~~~~-~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 301 ---ELFKLLK-E---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp ---HHHHHHH-T---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ---HHHHHHH-c---------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111111 1 11122334556779999999999999999999999999998876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=365.57 Aligned_cols=271 Identities=24% Similarity=0.383 Sum_probs=210.0
Q ss_pred hcCCceeeeeeeecceEEEEEEE-----cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-----EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~ 584 (851)
.++|+..+.||+|+||.||+|++ .+++.+|||++........+.+.+|++++++++||||++++++|.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788899999999999999985 3568899999988777778899999999999999999999999854 4568
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999996543 358899999999999999999995 89999999999999999999999999999864
Q ss_pred CCCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH----hhhcc
Q 047215 665 PSMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW----QKQRS 739 (851)
Q Consensus 665 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~----~~~~~ 739 (851)
..... ........++..|+|||.+.+..++.++||||||+++|||++|..|+...... ........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhHHH
Confidence 33221 12223445778899999999999999999999999999999999887532110 00000000 00000
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..+.+........+..++..+.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 001111112223455667789999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.56 Aligned_cols=270 Identities=20% Similarity=0.299 Sum_probs=209.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..++||+|+||.||+|+..+++.+|+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36799999999999999999999889999999986542 2335678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++ +|.+.+.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-- 172 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence 9985 7877775543 458999999999999999999995 89999999999999999999999999999864321
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc---cc----
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS---LK---- 741 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~---- 741 (851)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ......... ..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQE 249 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGTT
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhhc
Confidence 122334568999999999876 5689999999999999999999999976554432211 111110000 00
Q ss_pred ---------cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 742 ---------SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 742 ---------~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
...+........+..++.+.+|+.+||+.||.+|||++|+++| +|++..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h---------p~f~~~~ 308 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH---------PYFKDLD 308 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS---------GGGTTSC
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC---------cccccCC
Confidence 0000000000112344678999999999999999999999999 9987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.75 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=212.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|+..+.||+|+||.||+|+..++..+|+|++..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 367888999999999999999998888899999876533 3467899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++..... ...
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT 162 (269)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc-ccc
Confidence 9999999996543 468999999999999999999995 89999999999999999999999999999764321 111
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ........ ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~----------~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTG----------FRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTT----------CCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcC----------ccC
Confidence 2234456788999999999999999999999999999999 888886543221 11111110 111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..+...+..+.+++.+||+.||.+|||++|++++|+.+.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 2233345678999999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.67 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=215.1
Q ss_pred HhcCCceeeeeeeecceEEEEEEE------cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
..++|...+.||+|+||.||+|+. .++..+|+|++... .....+.+.+|++++++++||||+++++++..++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 457889999999999999999986 23478999998764 44556789999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCC----------------------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCC
Q 047215 584 MILVYEYMANGTLRSHLFGSDL----------------------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVK 641 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk 641 (851)
.++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999965332 348899999999999999999995 899999999
Q ss_pred CCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCC
Q 047215 642 TTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTL 720 (851)
Q Consensus 642 ~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~ 720 (851)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986543333223344567889999999999999999999999999999999 998887654
Q ss_pred CcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 721 PKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.... ... .... .....+..+++.+.+++.+||+.||.+|||+.|++++|+.+..
T Consensus 258 ~~~~---~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PERL---FNL----LKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGGH---HHH----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH---HHH----hhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3221 111 1111 1112334556779999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=373.73 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=203.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..++||+|+||.||+|+.. .+..+|||++... .....+.|.+|+.++++++||||++++++|..++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 367888999999999999999865 4677999998765 44556789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999996543 468999999999999999999995 8999999999999999999999999999986433
Q ss_pred CCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 667 MEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 667 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ + .... .
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~---~~~i-~-------- 264 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---V---IKAV-D-------- 264 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---H---HHHH-H--------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHH-H--------
Confidence 2111 11223345788999999999999999999999999999998 998886543211 1 1111 1
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
.......+..++..+.+++.+||+.||.+||+++++++.|+.+.+..
T Consensus 265 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 11111223456677999999999999999999999999999887643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=359.22 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=215.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEE------cCcceeEEeecCCCC-hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQS-EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 582 (851)
..++|...+.||+|+||.||+|+. ..+..+|+|++.... ....+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 446888999999999999999985 345789999987653 34567899999999999 9999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCCC----------------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 583 EMILVYEYMANGTLRSHLFGSDL----------------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
..++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999865432 258999999999999999999996 89999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchh
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQI 725 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~ 725 (851)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 99999999999999987544333333344567889999999999999999999999999999999 8888865433211
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.. ..... ......+...+..+.+++.+||+.||.+|||+.|++++|+.+++.
T Consensus 257 -~~----~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 -FY----KMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -HH----HHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HH----HHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 11111 111122334556799999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=374.61 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=211.9
Q ss_pred hcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
.++|...+.||+|+||.||+|++. .+..||||++... .......+.+|+.++++++||||+++++++..+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999853 3467999998654 455566799999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCC-----CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC---CeEEEe
Q 047215 585 ILVYEYMANGTLRSHLFGSD-----LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN---FVAKMS 656 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~---~~~kl~ 656 (851)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.+ ..+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996432 2458999999999999999999996 899999999999999844 459999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ +. ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~---~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL---EFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH---HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHH
Confidence 9999974321112222334567899999999999999999999999999999998 888886543211 11 1111
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
.+ .....+..++..+.+|+.+||+.||.+|||+.+++++|+.+.+..+
T Consensus 301 -~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 301 -SG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp -TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -cC---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 11 1112234556679999999999999999999999999998876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=367.76 Aligned_cols=264 Identities=26% Similarity=0.434 Sum_probs=214.1
Q ss_pred HHHHHhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc
Q 047215 507 EIRVATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579 (851)
Q Consensus 507 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 579 (851)
.+....++|+..+.||+|+||.||+|+..+ ++.+|+|++... .....+.+.+|+.++++++||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344567899999999999999999998753 478999998765 4445678999999999999999999999999
Q ss_pred cCCcEEEEEEecCCcchhhhccCCC----------------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEE
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGSD----------------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiH 637 (851)
.++..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 9999999999999999999986532 2568999999999999999999995 89999
Q ss_pred cCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCC
Q 047215 638 RDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVI 716 (851)
Q Consensus 638 rDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~ 716 (851)
|||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999875332222222344568899999999999999999999999999999999 88888
Q ss_pred CCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 717 NPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 717 ~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
......+ ..... ..+.. ...+..++..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 278 ~~~~~~~------~~~~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMAHEE------VIYYV-RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSCHHH------HHHHH-HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCChHH------HHHHH-hCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 6543211 11111 11111 1233455677999999999999999999999999988654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=365.31 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=212.2
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
+...++|...+.||+|+||.||+|+.. .+..+|+|++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345678999999999999999999862 3457899998754 334457899999999999 89999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCC---------------------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcC
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDL---------------------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrD 639 (851)
++..++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 9999999999999999999965432 347899999999999999999995 8999999
Q ss_pred CCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCC
Q 047215 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINP 718 (851)
Q Consensus 640 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~ 718 (851)
|||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999976433222223344567889999999999999999999999999999998 9988876
Q ss_pred CCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 719 TLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 719 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
...... .. .... .......+..+++.+.+++.+||+.||.+|||+.+++++|+.++.
T Consensus 278 ~~~~~~--~~----~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 278 IPVDAN--FY----KLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCSHH--HH----HHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcHHH--HH----HHHh---------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 533221 11 1111 111122334556779999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=366.52 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=206.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
.+.|+..+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|+.+|++++||||+++++++..++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 578899998765432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC----eEEEeeccc
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF----VAKMSDFGL 660 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~----~~kl~DFGl 660 (851)
++||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999543 469999999999999999999995 8999999999999998776 799999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ...... ...
T Consensus 166 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~---~~~i~~-~~~ 235 (361)
T 2yab_A 166 AHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---T---LANITA-VSY 235 (361)
T ss_dssp CEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H---HHHHHT-TCC
T ss_pred ceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHh-cCC
Confidence 9864332 12345679999999999999999999999999999999999999997643211 1 111110 000
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
-+++. .....+..+++|+.+||+.||.+|||+.|+++|
T Consensus 236 --~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 --DFDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111 112345678999999999999999999999999
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=364.49 Aligned_cols=248 Identities=26% Similarity=0.340 Sum_probs=207.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. +++.+|+|++... .......+.+|+.+|++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67899999999999999999875 5788999988643 2334567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999998543 358899999999999999999995 89999999999999999999999999999853221
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ..... .. .
T Consensus 159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~~~i~-~~--------~- 221 (337)
T 1o6l_A 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---FELIL-ME--------E- 221 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-HC--------C-
T ss_pred -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---H---HHHHH-cC--------C-
Confidence 122345679999999999999999999999999999999999999997543211 1 11111 01 1
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
..++...+..+.+++.+||+.||.+|| +++|+++|
T Consensus 222 -~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 123344556789999999999999999 99999999
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.18 Aligned_cols=262 Identities=21% Similarity=0.339 Sum_probs=207.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-Ccce----eEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTL----AAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
++|+..++||+|+||.||+|+.. ++.. +++|.+... .......+.+|+.++++++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999864 3333 677776543 2344456788999999999999999999996 567899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999996542 468999999999999999999996 8999999999999999999999999999987554
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........||..|+|||++.+..++.++|||||||++|||++ |+.||......+. .+. ....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~------- 233 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDL----LEKG------- 233 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHH----HHTT-------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHH----HHcC-------
Confidence 443334455678889999999999999999999999999999999 9999876543221 111 1111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
.....+..++..+.+++.+||+.||.+|||+.|++++|+.+......+
T Consensus 234 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~ 281 (325)
T 3kex_A 234 --ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRY 281 (325)
T ss_dssp --CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHH
T ss_pred --CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 011122334455789999999999999999999999999886554444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=376.71 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=209.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC-cEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN-EMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~lV~E 589 (851)
..++|+..+.||+|+||.||+|... ++.||||.+.... ..+.|.+|+++|++++||||++++++|.... ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888999999999999999976 5689999987654 4578999999999999999999999986654 7999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
||++|+|.+++.......+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999976555557899999999999999999995 89999999999999999999999999999853221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....++..|+|||.+.+..++.++|||||||+||||++ |+.||......+. .. .. .. ..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~---~i-~~---------~~ 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP---RV-EK---------GY 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH---HH-HT---------TC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HH-Hc---------CC
Confidence 122357889999999999999999999999999999998 9988875433221 11 11 11 11
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
+...+..++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 223445667789999999999999999999999999987754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=365.64 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=202.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCC--cceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRH--RHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~lV 587 (851)
.++|++.+.||+|+||.||++...+++.+|||++... .....+.+.+|+.+|++++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4678899999999999999999888899999987643 44556789999999999976 9999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|| +.+|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 5688999999654 468899999999999999999995 8999999999999997 578999999999875433
Q ss_pred CccccccccccCCcccCcccccc-----------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWR-----------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~------- 228 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S------- 228 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H-------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----H-------
Confidence 33323345679999999999865 678999999999999999999999996543211 0
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+..++++.....++...+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 229 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1112233333334445555678999999999999999999999999
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.86 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=209.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|+..+.||+|+||.||+|...++..+|+|++...... .+++.+|++++++++||||+++++++..++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 45688999999999999999999998888999998765432 46789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EY 175 (283)
T ss_dssp CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HH
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccc-cc
Confidence 99999999996532 458999999999999999999995 89999999999999999999999999999764321 11
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...... ...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~~~~~~----------~~~ 239 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQ----------GLR 239 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHHT----------TCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------HHHHhc----------ccC
Confidence 12233456788999999999999999999999999999998 9888865432211 111111 111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
...+...++.+.+++.+||+.||.+|||++|++++|+.+.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 12233445679999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=363.91 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=198.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..++||+|+||+||+|+.. +++.+|||++... .......+..|+..+.++ +||||++++++|..++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999976 6889999987653 334444556666666665 8999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+ +++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 999 668888875543 468999999999999999999996 89999999999999999999999999998764322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.|+..... |. .. .....
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~-~~---------~~~~~ 269 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQ-QL---------RQGYL 269 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HH-HH---------TTTCC
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HH-HH---------hccCC
Confidence 22344569999999999876 799999999999999999999776543210 10 00 00111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...++...++.+.+++.+||+.||++|||++|+++| +|+++
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h---------p~~~~ 310 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL---------PVLRQ 310 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS---------GGGSC
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC---------ccccC
Confidence 111122345679999999999999999999999999 88763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.83 Aligned_cols=270 Identities=21% Similarity=0.280 Sum_probs=212.4
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC--cEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN--EMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~lV~ 588 (851)
++|...++||+|+||.||+|+... ++.+|||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 578889999999999999998754 7889999987543 344577889999999999999999999987654 789999
Q ss_pred EecCCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE----cCCCeEEEeecccccc
Q 047215 589 EYMANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSKT 663 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla~~ 663 (851)
||+++|+|.+++.... ...+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999996643 2348999999999999999999995 899999999999999 8888999999999986
Q ss_pred CCCCCccccccccccCCcccCccccc--------ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch-hcHHHHHHHH
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFW--------RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ-INLADWAMKW 734 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~-~~l~~~~~~~ 734 (851)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ..........
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 43322 223456999999999986 57889999999999999999999999976433222 1111111111
Q ss_pred hhhccccccc-----------CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 735 QKQRSLKSII-----------DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 735 ~~~~~~~~i~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
........+. +.......+......+.+++.+||+.||++|||++|+++|..+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111000 01112245678888999999999999999999999999997643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=360.87 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=209.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|...+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|+.+|++++||||+++++++..++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56889999999999999999875 578899998765422 23578999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC----eEEEeecccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF----VAKMSDFGLS 661 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~----~~kl~DFGla 661 (851)
+||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999543 468999999999999999999995 8999999999999998877 8999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........
T Consensus 166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~--- 233 (326)
T 2y0a_A 166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVN--- 233 (326)
T ss_dssp EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHTC---
T ss_pred eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHhcC---
Confidence 8643221 22345799999999999999999999999999999999999999875432211 11111000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
...........+..+.+|+.+||+.||.+|||++|+++| +|+...+
T Consensus 234 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h---------p~~~~~~ 279 (326)
T 2y0a_A 234 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH---------PWIKPKD 279 (326)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS---------TTTSCCS
T ss_pred ----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC---------CCccCCc
Confidence 000000112345668999999999999999999999999 8886543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=383.00 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=211.1
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
...++|+..+.||+|+||.||+|+.+++..||||++.... ...+.|.+|+.+|++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3457788899999999999999999888889999987654 34678999999999999999999999997 567899999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.++|.......+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-E 338 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-H
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-c
Confidence 9999999999976544468889999999999999999996 89999999999999999999999999999864321 1
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
........+|..|+|||++....++.++|||||||+||||++ |+.||......+ +. .... .+ .
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~---~~i~-~~---------~ 402 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI---RALE-RG---------Y 402 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH---HHHH-HT---------C
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHH-cC---------C
Confidence 111233456789999999999999999999999999999999 998886543221 11 1111 11 1
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
....+..+++.+.+|+.+||+.||.+|||++++++.|+.
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 112344567789999999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=364.67 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=213.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|+..+.||+|+||.||+|... ++..+|+|.+..........+.+|+.+|++++||||+++++++..++..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367999999999999999999875 5778999998877666667899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc--CCCeEEEeeccccccCCCCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD--ENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld--~~~~~kl~DFGla~~~~~~~ 668 (851)
+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999986543 468999999999999999999995 8999999999999997 45789999999998643322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ........ ...
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~---~~~i~~~~-------~~~ 269 (387)
T 1kob_A 206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---T---LQNVKRCD-------WEF 269 (387)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H---HHHHHHCC-------CCC
T ss_pred ---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCC-------CCC
Confidence 2334579999999999999999999999999999999999999997543211 1 11111100 011
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
........+..+.+|+.+||+.||.+|||+.|+++| +|+....
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h---------p~~~~~~ 312 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH---------PWLKGDH 312 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS---------TTTSSCC
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC---------ccccCCc
Confidence 111223455678999999999999999999999999 8887543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=383.02 Aligned_cols=257 Identities=22% Similarity=0.386 Sum_probs=214.4
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
...+|...++||+|+||.||+|++.. +..||||.+.... ...+.|.+|+.+|++++||||++++++|..++..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678889999999999999999875 6789999987653 346789999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
||++|+|.++|.......+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 9999999999976656679999999999999999999995 899999999999999999999999999998753322
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
........++..|+|||++....++.++|||||||+||||++ |+.||......+ +.+. +....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~-------------~~~~~ 436 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL-------------LEKDY 436 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH-------------HHTTC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------HHcCC
Confidence 122234456789999999999999999999999999999999 888886543221 1111 11122
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
....+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2234456677899999999999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=354.74 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=205.6
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|+||.||+|+...++.+|+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47888999999999999999988788999998865432 2346788999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++ +|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--V 154 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--c
Confidence 985 8988886543 468899999999999999999995 89999999999999999999999999998753221 1
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc---cc---c-
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS---LK---S- 742 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~---~- 742 (851)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +.. ......... .. .
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGS
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHHCCCChhhchhhhcc
Confidence 12234568999999999976 4589999999999999999999999875432221 111 111100000 00 0
Q ss_pred -ccCccCC-------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 743 -IIDPHLK-------GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 743 -i~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..++... ..+....++.+.+|+.+||+.||++|||++|+++| +|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h---------p~f~~ 286 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH---------AYFKE 286 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS---------GGGGC
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC---------cchhh
Confidence 0011110 01123456778999999999999999999999999 88864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=362.79 Aligned_cols=269 Identities=23% Similarity=0.369 Sum_probs=198.7
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEcCcc----eeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIEDCT----LAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ 581 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~----~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 581 (851)
+....++|+..+.||+|+||.||+|+..... .+|||++... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3345678999999999999999999865432 7899988764 445567899999999999999999999999776
Q ss_pred CcE------EEEEEecCCcchhhhccCC----CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC
Q 047215 582 NEM------ILVYEYMANGTLRSHLFGS----DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF 651 (851)
Q Consensus 582 ~~~------~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~ 651 (851)
... ++||||+++|+|.+++... ....+++.++..++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCC
Confidence 655 9999999999999998532 22358999999999999999999996 8999999999999999999
Q ss_pred eEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHH
Q 047215 652 VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADW 730 (851)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~ 730 (851)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~- 250 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---YN- 250 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH-
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---HH-
Confidence 999999999986443333233334557889999999999999999999999999999999 8888876443221 11
Q ss_pred HHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 731 AMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 731 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
..... .....+..++..+.+++.+||+.||.+|||+.++++.|+.++.- +|..
T Consensus 251 --~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~--~~~~ 303 (323)
T 3qup_A 251 --YLIGG----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH--LSVL 303 (323)
T ss_dssp --HHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred --HHhcC----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH--hhhc
Confidence 11000 01123345567799999999999999999999999999988754 5554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=360.18 Aligned_cols=265 Identities=22% Similarity=0.359 Sum_probs=207.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-Ccce----eEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTL----AAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
.++|+..++||+|+||.||+|+.. ++.. +++|.+... .....+.+.+|+.++++++||||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999864 3433 467766543 4455678999999999999999999999998754 88
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+|+||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999986543 468999999999999999999995 899999999999999999999999999998654
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+. ... +
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~-------------~ 232 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI-------------L 232 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH-------------H
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHH-------------H
Confidence 3333333344557889999999999999999999999999999999 9999876543321 111 1
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
........+..++..+.+++.+||+.||.+|||+.|+++.|+.+.+....+..
T Consensus 233 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 285 (327)
T 3lzb_A 233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBC
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEE
Confidence 11111223445666799999999999999999999999999998876665544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=367.98 Aligned_cols=276 Identities=18% Similarity=0.262 Sum_probs=211.3
Q ss_pred hcCCceeeeeeee--cceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVG--GFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G--~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..++||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3678999999999 99999999976 6788999988654 34556778899999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|||||++|+|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999977655679999999999999999999995 8999999999999999999999999998764321
Q ss_pred CC-----ccccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh---h
Q 047215 667 ME-----HTHVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ---K 736 (851)
Q Consensus 667 ~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~---~ 736 (851)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .+..... .
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCcccc
Confidence 11 1111233468999999999987 6899999999999999999999999976443322100 0000000 0
Q ss_pred ------------------hccccccc---Cc------cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 737 ------------------QRSLKSII---DP------HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 737 ------------------~~~~~~i~---d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
........ .+ ......+...+..+.+|+.+||+.||.+|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h----- 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH----- 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS-----
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC-----
Confidence 00000000 00 00011233455679999999999999999999999999
Q ss_pred HhhhhhcccCC
Q 047215 790 QLHEAWMRTDD 800 (851)
Q Consensus 790 ~~~~~w~~~~~ 800 (851)
+|++...
T Consensus 335 ----p~f~~~~ 341 (389)
T 3gni_B 335 ----SFFKQIK 341 (389)
T ss_dssp ----GGGGGC-
T ss_pred ----HHHHHHh
Confidence 8886543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=356.82 Aligned_cols=271 Identities=23% Similarity=0.403 Sum_probs=217.6
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEE------cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeE
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEI------EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSL 574 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l 574 (851)
+...++....++|...+.||+|+||.||+|+. .+++.+|||++... .....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455566678999999999999999999975 34578999998765 334556799999999999 79999999
Q ss_pred EEEEccCC-cEEEEEEecCCcchhhhccCCCC--------------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcC
Q 047215 575 IGFCDEQN-EMILVYEYMANGTLRSHLFGSDL--------------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639 (851)
Q Consensus 575 ~g~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrD 639 (851)
++++...+ ..++||||+++|+|.+++..... ..+++.++..++.|++.||.|||+ .+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987654 58999999999999999966442 238899999999999999999996 8999999
Q ss_pred CCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCC
Q 047215 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINP 718 (851)
Q Consensus 640 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~ 718 (851)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543333233345568899999999999999999999999999999998 8888865
Q ss_pred CCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 719 TLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 719 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
...... + .... ..+. ....+...+..+.+++.+||+.||.+|||+.|++++|+.+++.
T Consensus 254 ~~~~~~--~---~~~~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDEE--F---CRRL-KEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSHH--H---HHHH-HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHH--H---HHHh-ccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 432221 1 1111 1110 1112334456789999999999999999999999999988753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=354.51 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=197.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--------------------------hhHHHHHHHHHHHHh
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--------------------------QGLAEFETEIEMLSK 565 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~ 565 (851)
++|...+.||+|+||.||+|+.. +++.+|||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67899999999999999999864 578899998765421 123568899999999
Q ss_pred cCCcceeeEEEEEcc--CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCC
Q 047215 566 LRHRHLVSLIGFCDE--QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTT 643 (851)
Q Consensus 566 l~HpnIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~ 643 (851)
++||||+++++++.. .+..++||||+++++|.+++.. .++++.++..++.|++.||+|||+ .+|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 999999999999976 5689999999999999987633 468999999999999999999996 89999999999
Q ss_pred CeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccC---CCchHHHHHHHHHHHHHHhCCcCCCCCC
Q 047215 644 NILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ---LTEKSDVYSFGVVLFEVVCARAVINPTL 720 (851)
Q Consensus 644 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~eLltG~~p~~~~~ 720 (851)
|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999997643321 1234457999999999998665 4789999999999999999999986532
Q ss_pred CcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 721 PKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ..+...... . .+.....+..++.+.+++.+||+.||.+|||+.|+++|
T Consensus 245 ~------~~~~~~~~~-~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 I------MCLHSKIKS-Q--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H------HHHHHHHHH-C--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H------HHHHHHHhc-c--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1 111111111 1 01111123445679999999999999999999999999
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=359.75 Aligned_cols=264 Identities=24% Similarity=0.453 Sum_probs=215.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc--------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE--------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
..++|...+.||+|+||.||+|+.. ++..+|+|++... .......+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 4567999998765 445567899999999999 89999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCC--------------CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDL--------------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
++..++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 9999999999999999999965432 348899999999999999999995 89999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchh
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQI 725 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~ 725 (851)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 99999999999999986544332223344567889999999998899999999999999999999 888886542211
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
...... .+ .....+..++..+.+++.+||+.||.+|||+.|++++|+.++....
T Consensus 268 ----~~~~~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 ----LFKLLK-EG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ----HHHHHH-HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ----HHHHHh-cC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111111 11 0112234556679999999999999999999999999999887543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=350.14 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=210.1
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|+..+.||+|+||.||+|+..++..+|+|++..... ..+++.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3467889999999999999999998888899999876543 346789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-Y 159 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-E
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh-h
Confidence 99999999986532 358899999999999999999995 899999999999999999999999999998644322 1
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ......... .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~----------~ 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGH----------R 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC----------C
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCC----------C
Confidence 22234456778999999999899999999999999999999 888886543221 111111100 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
...+...++.+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111233456789999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=348.40 Aligned_cols=250 Identities=27% Similarity=0.481 Sum_probs=196.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCC----hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS----EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|+..+.||+|+||.||+|... +..+|+|++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367889999999999999999975 6788999876542 23356789999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC---eEEcCCCCCCeEEcC--------CCeEEEe
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG---IIHRDVKTTNILLDE--------NFVAKMS 656 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~---iiHrDlk~~NILld~--------~~~~kl~ 656 (851)
|||+++++|.+++.. ..+++.++..++.|++.||.|||+ .+ ++||||||+|||++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999854 358999999999999999999996 55 999999999999986 7789999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
|||+++..... ......||+.|+|||.+.+..++.++||||||++++||++|+.||........ ...
T Consensus 159 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~--- 225 (271)
T 3dtc_A 159 DFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYG--- 225 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHH---
T ss_pred cCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHh---
Confidence 99999753321 12245689999999999999999999999999999999999999875432111 111
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
+.........+..+++.+.+++.+||+.||.+|||+.|++++|+.
T Consensus 226 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 ------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111122223345566779999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=378.77 Aligned_cols=271 Identities=20% Similarity=0.259 Sum_probs=215.9
Q ss_pred CHHHHHHHhcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEc
Q 047215 504 TLAEIRVATNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579 (851)
Q Consensus 504 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 579 (851)
.+.+++...++|+..++||+|+||+||+|+... ++.+|+|++.... ......+.+|+.++.+++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 456677778999999999999999999999764 6789999886421 122334889999999999999999999999
Q ss_pred cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
+++.++||||||++|+|.++|... ...+++..+..++.|++.||+|||+ .+||||||||+||||+.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999653 2468999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+++..... ........+||+.|+|||++. ...++.++|||||||++|||++|+.||......+. . ...
T Consensus 221 la~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~---~~i 293 (437)
T 4aw2_A 221 SCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---Y---GKI 293 (437)
T ss_dssp TCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHH
T ss_pred hhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---H---Hhh
Confidence 99764332 222234467999999999997 45789999999999999999999999976432211 1 111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKN--RPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
.... ....-|.. ....++.+++|+.+||..+|++ ||+++|+++| +|++.-+
T Consensus 294 ~~~~--~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H---------pff~~i~ 346 (437)
T 4aw2_A 294 MNHK--ERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH---------PFFSGID 346 (437)
T ss_dssp HTHH--HHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS---------GGGTTCC
T ss_pred hhcc--ccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC---------CccCCCC
Confidence 1100 00111111 1234566899999999888888 9999999999 8876544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.59 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=200.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..+.||+|+||.||+|.... +..+|+|+.... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678899999999999999998643 356899987764 4455678999999999999999999999985 467899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999996543 468999999999999999999995 8999999999999999999999999999986433
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... .. ..
T Consensus 169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~---i~-~~------- 233 (281)
T 1mp8_A 169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR---IE-NG------- 233 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH---HH-TT-------
T ss_pred ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHH---HH-cC-------
Confidence 211 12233456789999999999999999999999999999997 8888876543221 111 10 10
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..++..+.+++.+||+.||.+|||+.|++++|+.+++.
T Consensus 234 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01123445667799999999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=374.40 Aligned_cols=267 Identities=22% Similarity=0.277 Sum_probs=213.6
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 580 (851)
+.+++...++|+..++||+|+||.||+|+.. +++.+|+|++... .......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4456667789999999999999999999975 4678999987642 11223457899999999999999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
++.++|||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999998653 48899999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccC----CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ----LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
++...... .......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||......+. ......
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMN 287 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHHh
Confidence 97643322 12234568999999999998765 88999999999999999999999975432211 111111
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKN--RPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
... . +........+..+++|+.+||+.+|.+ ||+++|+++| +|++..+
T Consensus 288 ~~~--~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H---------p~f~~~~ 337 (410)
T 3v8s_A 288 HKN--S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH---------LFFKNDQ 337 (410)
T ss_dssp HHH--H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS---------GGGCCSS
T ss_pred ccc--c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC---------ccccCCC
Confidence 000 0 000111234567899999999999988 9999999999 8876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=366.55 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=203.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 586 (851)
-++|+..++||+|+||.||+|+.. +++.+|+|++... .......+.+|..+++++ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999875 5788999988653 233456788999999998 79999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999998554 358999999999999999999995 8999999999999999999999999999985322
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ..... ..
T Consensus 177 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~---~~~i~---------~~ 239 (353)
T 3txo_A 177 --NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---L---FEAIL---------ND 239 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH---------HC
T ss_pred --CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---H---HHHHH---------cC
Confidence 1223445689999999999999999999999999999999999999997643221 1 11111 11
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM------GEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 784 (851)
. ..++...+..+.+++.+||+.||.+||++ +|+++|
T Consensus 240 ~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 E--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 12233455678999999999999999998 899999
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=353.65 Aligned_cols=261 Identities=23% Similarity=0.383 Sum_probs=217.8
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
...++|+..+.||+|+||.||+|.... +..+|+|.+.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 355789999999999999999999765 6788999887543 34678999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999977666779999999999999999999995 899999999999999999999999999998654322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........ .+. +...
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~-------------~~~~ 228 (288)
T 3kfa_A 166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YEL-------------LEKD 228 (288)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH-------------HHTT
T ss_pred -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-------------Hhcc
Confidence 223344557889999999999999999999999999999999 8888865433221 111 1111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 12223445567799999999999999999999999999877653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.81 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=201.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHh--cCCcceeeEEEEEcc----CCcEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSK--LRHRHLVSLIGFCDE----QNEMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~----~~~~~ 585 (851)
.++|+..+.||+|+||.||+|+. +++.+|||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999987 5778999998653 33456667777766 799999999998643 45689
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC-----CCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA-----ERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~-----~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
+||||+++|+|.+++.. ..+++.++++++.|++.||+|||+.. +++|+||||||+|||++.++.+||+|||+
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999999954 35899999999999999999999211 38999999999999999999999999999
Q ss_pred cccCCCCCcc--ccccccccCCcccCccccccc------CCCchHHHHHHHHHHHHHHhC----------CcCCCCCCCc
Q 047215 661 SKTGPSMEHT--HVSTAVKGSFGYLDPEYFWRQ------QLTEKSDVYSFGVVLFEVVCA----------RAVINPTLPK 722 (851)
Q Consensus 661 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~eLltG----------~~p~~~~~~~ 722 (851)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++| +.||....+.
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 8753222111 112334799999999999876 456799999999999999999 7777654333
Q ss_pred chhcHHHHHHHHhhhcccccccCccCCC-CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 723 DQINLADWAMKWQKQRSLKSIIDPHLKG-NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
... ........... ...+.+.. ..+..++..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 240 ~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPS-FEDMRKVVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCC-HHHHHHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc-hhhhhHHHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 11111111111 11111111 12345778899999999999999999999999998864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.30 Aligned_cols=252 Identities=17% Similarity=0.240 Sum_probs=206.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|...+.||+|+||.||+|+.. ++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999875 56788999887543 3456789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC--CCeEEEeeccccccCCCCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE--NFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~ 668 (851)
+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999985533 468999999999999999999995 89999999999999986 7899999999998643322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......... . ..++.
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~-~--~~~~~- 225 (321)
T 1tki_A 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAE-Y--TFDEE- 225 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-C--CCCHH-
T ss_pred ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCC-C--CCChh-
Confidence 2344678999999999998889999999999999999999999997643221 111111110 0 00000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+..+.+++.+||+.||.+|||+.|+++|
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 012345678999999999999999999999999
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=367.98 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=202.0
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcC--CcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLR--HRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.+|...+.||+|+||.||++...+++.+|||++... .....+.+.+|+.+|++++ ||||+++++++..++..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 468999999999999999999888889999987643 4455678999999999996 599999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
| +.+++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 6788999999654 368889999999999999999995 8999999999999995 5789999999998654332
Q ss_pred ccccccccccCCcccCcccccc-----------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR-----------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
.........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~------- 276 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK------- 276 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HH-------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HH-------
Confidence 2223345679999999999865 468999999999999999999999996543211 11
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+..++++.....++...+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 277 --~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 112233333333344445678999999999999999999999999
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=367.63 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=205.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..++||+|+||.||+++.. +++.+|+|++... .......+..|..++.++ +||||+++++++..++.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999975 4678899987643 233345688899999887 89999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|..++... ..+++.++..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999998653 358999999999999999999995 8999999999999999999999999999985322
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch--hcHHHHHHHHhhhccccccc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ--INLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~i~ 744 (851)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....+........
T Consensus 206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~------- 276 (396)
T 4dc2_A 206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------- 276 (396)
T ss_dssp T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-------
T ss_pred C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-------
Confidence 1 2234567899999999999999999999999999999999999999964322111 1111111111111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM------GEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 784 (851)
.. ..++...+..+.+|+.+||+.||.+||++ +|+++|
T Consensus 277 -~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 -KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -CC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -cc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11 12344456678999999999999999984 799988
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=380.82 Aligned_cols=257 Identities=29% Similarity=0.442 Sum_probs=207.1
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
...++|...++||+|+||.||+|..+++..||||++.... ...+.|.+|+++|++++||||+++++++.. +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3457788899999999999999999888889999987654 235689999999999999999999999976 67899999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.++|.......+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 334 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence 9999999999965444568999999999999999999995 899999999999999999999999999998643221
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
........++..|+|||.+....++.++|||||||+||||++ |+.||......+ . .... .. ..
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~---~~~i-~~---------~~ 398 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQV-ER---------GY 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---HHHH-HT---------TC
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---H---HHHH-Hc---------CC
Confidence 112233457889999999999999999999999999999999 888886543221 1 1111 11 11
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
+...+..+++.+.+++.+||+.||.+|||++++++.|+.+
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2233456677899999999999999999999999998743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=360.04 Aligned_cols=265 Identities=24% Similarity=0.377 Sum_probs=213.7
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
+...++|...+.||+|+||.||+|.... ...+|+|.+... .....+.+.+|+.+++++ +||||++++++|..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445789999999999999999998643 236899988765 344567799999999999 89999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCC------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSD------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD 648 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld 648 (851)
++..++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence 999999999999999999985421 3457899999999999999999996 8999999999999999
Q ss_pred CCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcH
Q 047215 649 ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINL 727 (851)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l 727 (851)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ .
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence 999999999999975433222222334567889999999999999999999999999999999 8888875433221 1
Q ss_pred HHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 728 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
. ..... ......+..++..+.+++.+||+.||.+|||+.|++++|+.+.+.
T Consensus 277 ~----~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 Y----KLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp H----HHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1 11111 111122334456789999999999999999999999999877654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.53 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=203.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|+..+.||+|+||.||+|+.. .+..+|+|++... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367899999999999999999864 5778999987433 344567899999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++... .++++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999998543 368999999999999999999995 89999999999999999999999999999864322
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........ .. +.
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-~~-----~~ 231 (294)
T 4eqm_A 165 S-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-SV-----PN 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-CC-----CC
T ss_pred c-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-cC-----CC
Confidence 1 122334569999999999999999999999999999999999999997543211 11111111 00 11
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRP-TMGEVLWHLE 786 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~ 786 (851)
.........++.+.+++.+||+.||.+|| +++++.+.|+
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 11122344567799999999999999999 7888877765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.25 Aligned_cols=268 Identities=21% Similarity=0.310 Sum_probs=206.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..++||+|+||+||+|+.. +++.+|+|++... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999875 5788999987644 33445778899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++ +|.+.+... ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence 9986 454444332 2468999999999999999999996 89999999999999999999999999999764321
Q ss_pred cccccccccCCcccCcccccccC-CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc------ccc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQ-LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS------LKS 742 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 742 (851)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.|+........ ............. ...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcc
Confidence 12234457899999999997765 89999999999999999999988654432211 1111111110000 000
Q ss_pred ccC---------ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 743 IID---------PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 743 i~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+ ........+..+..+.+|+.+||+.||++|||++|+++| +|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---------p~f~~ 288 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH---------PYFSD 288 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGTT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC---------ccccc
Confidence 000 000112223456778999999999999999999999999 99864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=361.94 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=206.9
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|+..+.||+|+||.||+|... ++..+|+|++... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999875 5788999988654 3455678999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC---CeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN---FVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~---~~~kl~DFGla~~~~ 665 (851)
||+++|+|.+.+... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999998543 468999999999999999999995 899999999999999754 469999999998643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ..... .+..
T Consensus 183 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~---~~~i~-~~~~----- 247 (362)
T 2bdw_A 183 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL---YAQIK-AGAY----- 247 (362)
T ss_dssp TC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHH-HTCC-----
T ss_pred CC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHH-hCCC-----
Confidence 22 1233467999999999999999999999999999999999999998754321 11 11111 1110
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
.........++..+.+|+.+||+.||.+|||+.|+++|.
T Consensus 248 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 248 -DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp -CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred -CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 001111134556789999999999999999999999993
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.11 Aligned_cols=250 Identities=19% Similarity=0.305 Sum_probs=206.4
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~ 588 (851)
++|...+.||+|+||.||+|+.+ +..+|+|++... .....+.|.+|+.++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888999999999999999976 677899988754 345567899999999999999999999999876 7889999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC--eEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG--IIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~--iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||+++|+|.+++.......+++.++..++.|++.||.|||+ .+ ++||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987665679999999999999999999995 77 99999999999999999999999988654211
Q ss_pred CCccccccccccCCcccCcccccccCC---CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQL---TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~--------- 223 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKV--------- 223 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHH---------
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHH---------
Confidence 23468999999999986544 448999999999999999999986543211 11111
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.........+..++..+.+++.+||+.||.+|||++|+++.|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111122233445667799999999999999999999999998866
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=356.69 Aligned_cols=270 Identities=24% Similarity=0.329 Sum_probs=204.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC-----hhhHHHHHHHHHHHHhcC---CcceeeEEEEEccC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS-----EQGLAEFETEIEMLSKLR---HRHLVSLIGFCDEQ 581 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~ 581 (851)
..++|+..++||+|+||.||+|+. .+++.+|+|++.... ......+.+|+.++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 567889999875321 122345677888877765 99999999999765
Q ss_pred C-----cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEe
Q 047215 582 N-----EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 582 ~-----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~ 656 (851)
. ..++||||++ |+|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999997 599999977766669999999999999999999996 899999999999999999999999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........
T Consensus 163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~ 236 (308)
T 3g33_A 163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIG 236 (308)
T ss_dssp SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhC
Confidence 99999764322 2234567899999999999999999999999999999999999999765432221 11111110
Q ss_pred hcccccc------cCccCCC-------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 737 QRSLKSI------IDPHLKG-------NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 737 ~~~~~~i------~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
......+ ....+.. ...++.++.+.+|+.+||+.||.+|||+.|+++| +|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---------~~~~~~ 303 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH---------SYLHKD 303 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS---------TTC---
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC---------ccccCC
Confidence 0000000 0000000 0112455778999999999999999999999999 998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=364.13 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=196.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|...+.||+|+||.||+++.. .++.+|+|++..... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999975 678899998865432 236688999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe--EEEeeccccccCCCCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV--AKMSDFGLSKTGPSME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~--~kl~DFGla~~~~~~~ 668 (851)
+++|+|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 9999999998543 358999999999999999999995 89999999999999987665 99999999874222
Q ss_pred ccccccccccCCcccCcccccccCCCch-HHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEK-SDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
........||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ........ ....
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~---------~~~~ 238 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRI---------LSVK 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHH---------HTTC
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHH---------hcCC
Confidence 112234569999999999988887766 8999999999999999999976433221 11111111 1111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
.........+..+.+|+.+||+.||.+|||+.|+++|.+.
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 1111112345678999999999999999999999999443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=361.02 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=204.1
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|.+.+.||+|+||.||+|+. ..++.+|+|++.... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6789999999999999999996 567889999876431 222457889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+ +|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 68998888543 358999999999999999999995 89999999999999999999999999999864322
Q ss_pred ccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
......+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........ ...+...
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~- 223 (336)
T 3h4j_B 162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC- 223 (336)
T ss_dssp --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS-
T ss_pred --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC-
Confidence 22345679999999999988776 7899999999999999999999975432211 1111111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....+...+..+.+|+.+||+.||.+|||++|+++|
T Consensus 224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 112344556778999999999999999999999999
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.60 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=200.9
Q ss_pred hcCCceeeeeeeecceEEEEEEE----cCcceeEEeecCCCC----hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI----EDCTLAAIKRANPQS----EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
.++|+..+.||+|+||.||+++. ..++.+|+|++.... ......+.+|+.+|++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999987 467889999987542 2344568899999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999998543 358899999999999999999995 8999999999999999999999999999875
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ......
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~---~~~i~~------- 235 (327)
T 3a62_A 171 SIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---T---IDKILK------- 235 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHHH-------
T ss_pred cccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---H---HHHHHh-------
Confidence 3221 122345679999999999999999999999999999999999999997543211 1 111111
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHHhhhhhccc
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L~~~~~~~~~w~~~ 798 (851)
.. ..+++..+..+.+++.+||+.||.+|| +++|+++| +|++.
T Consensus 236 --~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h---------p~f~~ 282 (327)
T 3a62_A 236 --CK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH---------PFFRH 282 (327)
T ss_dssp --TC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS---------GGGSS
T ss_pred --CC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC---------CcccC
Confidence 01 123344556789999999999999999 88999999 77754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.22 Aligned_cols=274 Identities=22% Similarity=0.284 Sum_probs=213.0
Q ss_pred cccCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-----CcceeeE
Q 047215 501 KRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-----HRHLVSL 574 (851)
Q Consensus 501 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l 574 (851)
..+++.+.....++|...++||+|+||.||+|+. .+++.+|||++... ......+..|+.+++++. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3455566666778999999999999999999987 46788999998743 344567788999999996 9999999
Q ss_pred EEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-----
Q 047215 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE----- 649 (851)
Q Consensus 575 ~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~----- 649 (851)
++++...+..++||||+ +++|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccc
Confidence 99999999999999999 8999999977666679999999999999999999995 89999999999999975
Q ss_pred --------------------CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHH
Q 047215 650 --------------------NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709 (851)
Q Consensus 650 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eL 709 (851)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999863321 2345789999999999999999999999999999999
Q ss_pred HhCCcCCCCCCCcchhcHHHHH---------HHHhhhcccccccCccCCCCCC--------------------hhHHHHH
Q 047215 710 VCARAVINPTLPKDQINLADWA---------MKWQKQRSLKSIIDPHLKGNYS--------------------PESLEKF 760 (851)
Q Consensus 710 ltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~~~i~d~~l~~~~~--------------------~~~~~~l 760 (851)
++|+.||......+........ ................+....+ ....+.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 9999999765432221111110 0000000000000000000000 1112568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 047215 761 GEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 761 ~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+|+.+||+.||.+|||++|+|+|
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhcCChhhCCCHHHHhcC
Confidence 899999999999999999999999
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=360.14 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=196.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
..++|+..+.||+|+||.||+|+.. .++.+|||++.... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999976 46789999987543 34568899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEeeccccccCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~~~~~ 666 (851)
|+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999998553 458999999999999999999995 89999999999999975 88999999999986432
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ + ...... .. .
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i~~-~~------~ 268 (349)
T 2w4o_A 204 ---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRILN-CE------Y 268 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHHHT-TC------C
T ss_pred ---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHHHh-CC------C
Confidence 1223446799999999999999999999999999999999999999875433211 1 111111 00 0
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
..........+..+.+|+.+||+.||++|||+.|+++| +|+....
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h---------p~~~~~~ 313 (349)
T 2w4o_A 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH---------PWVTGKA 313 (349)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS---------TTTTSTT
T ss_pred ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC---------cccCCCc
Confidence 11111223456679999999999999999999999999 9987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.79 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=205.9
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67899999999999999999875 6788999988643 1234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999653 358899999999999999999994 8999999999999999999999999999986432
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ....+
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i---------~~~~~ 220 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKI---------LNAEL 220 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH---------HHCCC
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHH---------HhCCC
Confidence 1234679999999999999999999999999999999999999997543211 11111 11111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
.++...+..+.+++.+||+.||.+|| +++|+++|
T Consensus 221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 23344556789999999999999999 89999999
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.36 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=210.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|+..+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 456888999999999999999998888889999887543 335788999999999999999999999874 568999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence 999999999965433468999999999999999999995 899999999999999999999999999998643322 1
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......++..|+|||.+.+..++.++||||||++++||++ |+.||......+ . ...... + ..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~~-~---------~~ 228 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V---IQNLER-G---------YR 228 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---HHHHHT-T---------CC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H---HHHHhc-c---------cC
Confidence 22234457889999999998899999999999999999999 888886543211 1 111111 1 11
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
...+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 12234456679999999999999999999999999987764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=357.49 Aligned_cols=272 Identities=20% Similarity=0.311 Sum_probs=196.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467888999999999999999864 57889999886543 3344678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCC----CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 590 YMANGTLRSHLFGS----DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 590 y~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
|++ |+|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5998887432 22458899999999999999999995 899999999999999999999999999997643
Q ss_pred CCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc---ccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR---SLK 741 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~ 741 (851)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .......... ...
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhh
Confidence 211 12234568999999999976 46899999999999999999999999765432221 1111110000 000
Q ss_pred c---c--cCccC------------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCC
Q 047215 742 S---I--IDPHL------------KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801 (851)
Q Consensus 742 ~---i--~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~ 801 (851)
. . ..+.+ ........+..+.+|+.+||+.||.+|||++|+++| +|+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h---------p~f~~~~~ 302 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH---------PWFAEYYH 302 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS---------GGGGGGCC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC---------hhhhcccc
Confidence 0 0 00000 000112345678999999999999999999999999 88875443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=369.73 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=205.3
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|+..+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46799999999999999999986 467889999876543 344567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~ 665 (851)
||+++|+|.+.+... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999988654 468999999999999999999995 8999999999999998 56889999999997644
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ..... .+..
T Consensus 165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~---~~~i~-~~~~----- 230 (444)
T 3soa_A 165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---L---YQQIK-AGAY----- 230 (444)
T ss_dssp TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHH-HTCC-----
T ss_pred CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---H---HHHHH-hCCC-----
Confidence 322 22345679999999999999999999999999999999999999986543211 1 11111 1110
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..........++.+.+|+.+||+.||.+|||+.|+|+|
T Consensus 231 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 -DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01111123455679999999999999999999999999
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=353.11 Aligned_cols=264 Identities=16% Similarity=0.153 Sum_probs=210.8
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||+|+. .+++.+|||.+..... ...+.+|+++++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36789999999999999999986 5678899998765432 24588999999999 99999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe-----EEEeeccccccC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV-----AKMSDFGLSKTG 664 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~-----~kl~DFGla~~~ 664 (851)
|+ +++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999998654 3468999999999999999999995 89999999999999998887 999999999864
Q ss_pred CCCCccc-----cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 665 PSMEHTH-----VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 665 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 3222111 12456799999999999999999999999999999999999999987544332222221111111100
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
. ..+ ...++ .+.+++..||+.||.+||+++++++.|+.+.+..
T Consensus 241 ~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 I-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp H-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 000 11233 7999999999999999999999999999777543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.14 Aligned_cols=270 Identities=23% Similarity=0.289 Sum_probs=205.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999975 47889999876543 3345678899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-- 155 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--
Confidence 99999999988543 458999999999999999999995 89999999999999999999999999999764322
Q ss_pred cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH---------HHHhhhcc
Q 047215 670 THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA---------MKWQKQRS 739 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~ 739 (851)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ..+.....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 122334578999999999976 67899999999999999999999999765443322111110 00000000
Q ss_pred cc--cccCccCCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 740 LK--SIIDPHLKGN---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 740 ~~--~i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.. .+.++..... ..+..+..+.+|+.+||+.||.+|||++|+++| +|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h---------p~f~~ 290 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH---------PYFEN 290 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS---------GGGTT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC---------hHHHh
Confidence 00 0111110000 002345678999999999999999999999999 99864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=361.69 Aligned_cols=278 Identities=22% Similarity=0.324 Sum_probs=214.0
Q ss_pred cCCceeeeeeeecceEEEEEEE-----cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEc--cCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-----EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD--EQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~ 585 (851)
++|+..+.||+|+||.||+|++ ..+..+|||++........+.+.+|++++++++||||+++++++. ..+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6788999999999999999984 356789999998887777788999999999999999999999885 556789
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999986532 358999999999999999999995 899999999999999999999999999998654
Q ss_pred CCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 666 SMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.... ........||..|+|||++.+..++.++||||||+++|||++|+.|+......... ...+.............+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHHh
Confidence 3222 12233456888899999999999999999999999999999999887542211000 000000000000011111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
........+..+++.+.+++.+||+.||.+|||++|++++|+.+......|
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 222233345566778999999999999999999999999998775544443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=360.02 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=214.4
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEE
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLI 575 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~ 575 (851)
+...+++...++|...+.||+|+||.||+|+.. .+..+|+|.+... .......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455566788999999999999999999864 3578999998755 334556799999999999999999999
Q ss_pred EEEccCCcEEEEEEecCCcchhhhccCC--------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE
Q 047215 576 GFCDEQNEMILVYEYMANGTLRSHLFGS--------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL 647 (851)
Q Consensus 576 g~~~~~~~~~lV~Ey~~~gsL~~~L~~~--------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl 647 (851)
+++..++..++||||+++|+|.+++... ....+++.++++++.|++.||.|||+ ++|+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 9999999999999999999999998542 12457899999999999999999995 899999999999999
Q ss_pred cCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhc
Q 047215 648 DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQIN 726 (851)
Q Consensus 648 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~ 726 (851)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 247 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---- 247 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----
Confidence 9999999999999875432222222334457889999999999999999999999999999999 77777653221
Q ss_pred HHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 727 LADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
+...... .+.. ...+..++..+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 248 --~~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 248 --QVLRFVM-EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp --HHHHHHH-TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HHHHHHH-cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1111111 1110 122345567799999999999999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.14 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=206.0
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57889999999999999999975 5778999988653 344566788999999988 899999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999998643 358999999999999999999995 89999999999999999999999999999853221
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh--cHHHHHHHHhhhcccccccC
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI--NLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~i~d 745 (851)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......... ..
T Consensus 164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--------~~ 233 (345)
T 3a8x_A 164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LE 233 (345)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--------HH
T ss_pred --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--------Hc
Confidence 12234568999999999999999999999999999999999999999653221110 0011111111 11
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM------GEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 784 (851)
.. ..++...+..+.+++.+||+.||.+||++ +|+++|
T Consensus 234 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11 12334556678999999999999999995 789888
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=354.31 Aligned_cols=269 Identities=20% Similarity=0.256 Sum_probs=213.4
Q ss_pred HHHHHHHhcCCcee-eeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEc
Q 047215 505 LAEIRVATNNFDES-LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCD 579 (851)
Q Consensus 505 ~~~l~~~t~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~ 579 (851)
+...+...+.|... ++||+|+||.||+|+.. +++.+|+|++... .......+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444455677776 88999999999999875 5788999987653 334467889999999999 5699999999999
Q ss_pred cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEe
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMS 656 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~ 656 (851)
.++..++||||+++|+|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999999977666779999999999999999999995 89999999999999987 7899999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ......
T Consensus 177 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~ 247 (327)
T 3lm5_A 177 DFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLNISQ 247 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH
T ss_pred eCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHHHHh
Confidence 99999864322 122345799999999999999999999999999999999999999865432211 111110
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCC
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~ 801 (851)
. ...........++..+.+++.+||+.||.+|||++|+++| +|++..+.
T Consensus 248 ~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h---------~~~~~~~~ 296 (327)
T 3lm5_A 248 V-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH---------SWLQQWDF 296 (327)
T ss_dssp T-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC---------GGGCCCCT
T ss_pred c-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC---------Hhhccccc
Confidence 0 0111122234456779999999999999999999999999 88875443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.29 Aligned_cols=257 Identities=28% Similarity=0.398 Sum_probs=211.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|...+.||+|+||.||+|...++..+|+|++..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 367888999999999999999998888899999876543 3467899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..... ...
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT 160 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc-ccc
Confidence 9999999986543 468899999999999999999995 89999999999999999999999999999764321 111
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....... + ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~-~---------~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDIST-G---------FRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHT-T---------CCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhc-C---------CcC
Confidence 2233457788999999999999999999999999999999 888876543211 1111111 0 011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..+...+..+.+++.+||+.||.+|||+++++++|+.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1223445678999999999999999999999999988764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=362.04 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=206.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. .++.+|+|++... .......+.+|+.+|++++||||+++++++...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67899999999999999999875 4678999987643 2334567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999999653 468999999999999999999995 89999999999999999999999999999864322
Q ss_pred ccccccccccCCcccCcccccc---cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR---QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
......+||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.. ....
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~--------- 234 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFET--------- 234 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHH---------
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhh---------
Confidence 22345679999999999974 458999999999999999999999997544332221111 1110
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-MGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 784 (851)
....++...+..+.+|+.+||+.||.+||+ ++++++|
T Consensus 235 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 235 --TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 011234455677999999999999999998 8888888
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=363.75 Aligned_cols=248 Identities=24% Similarity=0.291 Sum_probs=199.1
Q ss_pred eeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCCcc
Q 047215 517 ESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
..++||+|+||.||+|+. .++..+|+|++........+.+.+|+++|++++||||+++++++..++..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999986 4578899999987776777889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE--cCCCeEEEeeccccccCCCCCccccc
Q 047215 596 LRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL--DENFVAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 596 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl--d~~~~~kl~DFGla~~~~~~~~~~~~ 673 (851)
|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 173 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~ 245 (373)
T 2x4f_A 173 LFDRIIDES-YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL 245 (373)
T ss_dssp EHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence 999885432 358899999999999999999995 899999999999999 677899999999998643322 22
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYS 753 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 753 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........ .. +.....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~--~~-----~~~~~~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACR--WD-----LEDEEF 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC--CC-----SCSGGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcc--CC-----CChhhh
Confidence 345699999999999999999999999999999999999999875432211 11111110 00 001111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 754 PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...++.+.+|+.+||+.||.+|||++|+++|
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2345678999999999999999999999999
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=344.25 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=210.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|+||.||+|+.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57889999999999999999875 6788999987643 334457889999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998543 468999999999999999999995 89999999999999999999999999998754322222
Q ss_pred ccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....| .... ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~---------~~ 227 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEKK---------TY 227 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH----HTTC---------TT
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh----hhcc---------cc
Confidence 23345678999999999987665 7899999999999999999999976443221 11111 1110 00
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.......+..+.+++.+||+.||.+|||++|+++| +|++..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~---------~~~~~~ 268 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD---------RWYNKP 268 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC---------TTTTCC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC---------ccccCh
Confidence 01123445678999999999999999999999999 888643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.74 Aligned_cols=264 Identities=16% Similarity=0.167 Sum_probs=211.8
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||+|+. .+++.+|+|++.... ....+.+|+.+++++ +|+|++++++++..+...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999986 567889999876443 234578899999999 79999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe-----EEEeeccccccC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV-----AKMSDFGLSKTG 664 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~-----~kl~DFGla~~~ 664 (851)
|+ +++|.+++.... .++++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999996543 358999999999999999999994 89999999999999987765 999999999864
Q ss_pred CCCCcc-----ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 665 PSMEHT-----HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 665 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 332211 123456799999999999999999999999999999999999999987544333222222111111111
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
. +.+ ...+++.+.+++.+||+.||.+|||++++++.|+.+.+.
T Consensus 242 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 L-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp H-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H-----HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 111 123456799999999999999999999999999988754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.98 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=199.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC--------
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN-------- 582 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-------- 582 (851)
++|+..+.||+|+||.||+|+.. +++.+|||++... .....+.+.+|+++|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57889999999999999999976 6789999998654 3445678999999999999999999999985443
Q ss_pred -------------------------------------------------cEEEEEEecCCcchhhhccCCC-CCCCchhh
Q 047215 583 -------------------------------------------------EMILVYEYMANGTLRSHLFGSD-LPPLTWKQ 612 (851)
Q Consensus 583 -------------------------------------------------~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~ 612 (851)
..++||||+++|+|.+++.... .....+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2899999999999999996643 23345667
Q ss_pred hHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc----------ccccccccCCcc
Q 047215 613 RLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT----------HVSTAVKGSFGY 682 (851)
Q Consensus 613 ~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y 682 (851)
++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999995 89999999999999999999999999999864432111 122345799999
Q ss_pred cCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHH
Q 047215 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGE 762 (851)
Q Consensus 683 ~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 762 (851)
+|||++.+..++.++|||||||++|||++|..|+.. ........ ... .. ........+.+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~~-~~~--------~~-~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITDV-RNL--------KF-PLLFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHHH-HTT--------CC-CHHHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHHh-hcc--------CC-CcccccCChhHHH
Confidence 999999999999999999999999999998654210 01100000 000 00 0111334466799
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 763 IAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 763 l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
++.+||+.||.+|||++|+++| +|++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~---------~~f~ 330 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN---------AIFE 330 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS---------TTCC
T ss_pred HHHHHccCCCCcCCCHHHHhhc---------hhhh
Confidence 9999999999999999999999 8875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=344.69 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=209.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|...+.||+|+||.||+|+..+ +..+|+|.+... .....+.+.+|+.++++++||||+++++++..+ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4678899999999999999998643 235899988765 445567899999999999999999999998754 5689
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999986532 458899999999999999999995 8999999999999999999999999999986433
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ...
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~----~~~------- 230 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVL----EKG------- 230 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHH----HHT-------
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHH----hcC-------
Confidence 211 12234457889999999999999999999999999999998 9999875433221 1111 011
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (851)
.....+..+++.+.+++.+||+.||.+|||+.|++++|+.+.+....
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 231 --DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 01112334556799999999999999999999999999998876554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=361.89 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=206.7
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCc
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 583 (851)
....++|...++||+|+||.||+|+.. +++.+|+|++.... ......+..|..++.++ +||||+++++++...+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345588999999999999999999975 57889999886531 23456678899999987 89999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++||||+++|+|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999643 358899999999999999999996 8999999999999999999999999999985
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ..... ..
T Consensus 168 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~~~i~-~~----- 233 (345)
T 1xjd_A 168 NMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L---FHSIR-MD----- 233 (345)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-HC-----
T ss_pred cccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHHH-hC-----
Confidence 3221 122345689999999999999999999999999999999999999997543211 1 11111 00
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMG-EVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~~ 784 (851)
.+ .++...+..+.+++.+||+.||.+||++. ++++|
T Consensus 234 -~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 234 -NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11 22334556789999999999999999998 89888
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.86 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=202.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|+..+.||+|+||.||+|... ++..+|+|++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999865 45688999875432 22346788999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999998543 358899999999999999999994 89999999999999999999999999998653321
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .......
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~----------- 221 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISR----------- 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-----------
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHh-----------
Confidence 2234578999999999999999999999999999999999999987543211 1111110
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
....++...+..+.+++.+||+.||.+|||++|+++|
T Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1112334455678999999999999999999999999
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=352.02 Aligned_cols=263 Identities=25% Similarity=0.421 Sum_probs=206.9
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
.++|...+.||+|+||.||+|+... +..+|+|.+... .......+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567788999999999999998653 235899998764 3445667999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999986542 468999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 666 SMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 666 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ + ..... .+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~---~~~~~-~~----- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---V---MKAIN-DG----- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHH-TT-----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---H---HHHHH-CC-----
Confidence 3211 111223446789999999999999999999999999999999 998886543211 1 11111 11
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhh
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (851)
.....+..++..+.+++.+||+.||.+||++.+++++|+.+.+....
T Consensus 267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 11122345667799999999999999999999999999988765443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=344.32 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=210.5
Q ss_pred cCCceee-eeeeecceEEEEEEEc---CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESL-MIGVGGFGKVFKGEIE---DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|...+ .||+|+||.||+|... .+..+|+|++... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999853 5677999998765 445667899999999999999999999999 45679999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++++|.+++... ...+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999998643 3468999999999999999999995 89999999999999999999999999999865332
Q ss_pred Ccc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 668 EHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 668 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .... ...+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----i~~~------- 229 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQG------- 229 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHH----HHTT-------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HhcC-------
Confidence 221 12233457889999999998899999999999999999998 999987643321 1111 1111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
.....+..++..+.+++.+||+.||.+||++.+++++|+.+....
T Consensus 230 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 230 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 112234556678999999999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=346.06 Aligned_cols=259 Identities=29% Similarity=0.532 Sum_probs=197.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|...++||+|+||.||+|+..+ .+|+|++... .....+.|.+|++++++++||||+++++++. ....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 4678999999999999999998654 4788887644 4556678999999999999999999999764 456899999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999986543 568999999999999999999995 8999999999999999999999999999976443223
Q ss_pred cccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 670 THVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. + ......+.. .+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~~~~~----~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IEMVGRGSL----SP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--H----HHHHHHTSC----CC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--H----HHHhccccc----Cc
Confidence 33334567999999999986 66789999999999999999999999976433221 1 111111111 11
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.+ ......++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 246 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 246 DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11 122345667899999999999999999999999998865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=351.61 Aligned_cols=268 Identities=24% Similarity=0.409 Sum_probs=204.2
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEcC----cceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEE
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 578 (851)
+.++....++|...+.||+|+||.||+|+... +..+|+|++... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34445566889999999999999999998643 347899988754 445567899999999999999999999999
Q ss_pred ccCC-----cEEEEEEecCCcchhhhccC----CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC
Q 047215 579 DEQN-----EMILVYEYMANGTLRSHLFG----SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649 (851)
Q Consensus 579 ~~~~-----~~~lV~Ey~~~gsL~~~L~~----~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~ 649 (851)
...+ ..++||||+++|+|.+++.. .....+++.+++.++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcC
Confidence 7654 35999999999999998842 234568999999999999999999995 89999999999999999
Q ss_pred CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHH
Q 047215 650 NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLA 728 (851)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~ 728 (851)
++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH
Confidence 99999999999976443322222344567889999999999999999999999999999999 777876543322 11
Q ss_pred HHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 729 DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 729 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.. .. .+ .....+..++..+.+++.+||+.||.+|||+.+++++|+.+++.
T Consensus 260 ~~---~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 DY---LL-HG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HH---HH-TT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HH-cC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 10 00 01123345567799999999999999999999999999988653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=360.46 Aligned_cols=254 Identities=21% Similarity=0.248 Sum_probs=203.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-----ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-----SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
.+.|+..+.||+|+||.||+|+.. +++.+|||++... .....+.+.+|+.++++++||||+++++++..++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357899999999999999999864 5788999987532 1224577999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe---EEEeeccc
Q 047215 586 LVYEYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV---AKMSDFGL 660 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~---~kl~DFGl 660 (851)
+||||+++|+|.+.+... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877532 23458899999999999999999995 89999999999999976554 99999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+. .... .+..
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~-~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGII-KGKY 249 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHH-HTCC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHH-cCCC
Confidence 97643321 123445799999999999999999999999999999999999999975311 111 1111 1100
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+... ...+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 250 --~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 --KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011000 2345678999999999999999999999999
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.07 Aligned_cols=245 Identities=20% Similarity=0.284 Sum_probs=206.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+|++++||||+++++++..++..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999975 5788999987643 2234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999653 358999999999999999999995 89999999999999999999999999999864321
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... ..
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~---------~~- 254 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVS---------GK- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH---------CC-
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHHc---------CC-
Confidence 234679999999999999999999999999999999999999997543211 1111111 11
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
..++...+..+.+++.+||+.||.+||+ ++|+++|
T Consensus 255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1233445667999999999999999998 9999999
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.80 Aligned_cols=272 Identities=25% Similarity=0.376 Sum_probs=211.2
Q ss_pred CceeeeeeeecceEEEEEEEc-----CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcEEE
Q 047215 515 FDESLMIGVGGFGKVFKGEIE-----DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEMIL 586 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~l 586 (851)
|+..++||+|+||.||++.+. +++.+|||++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 5678999998765 34556789999999999999999999999976 467899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 38999999999999999999995 8999999999999999999999999999986543
Q ss_pred CCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......+.........+.+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHHHHHHHHh
Confidence 222 12234456888999999999999999999999999999999999887642111 0000000000000011111222
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
.......+..++..+.+|+.+||+.||.+|||++|+++.|+.+.+...
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 222333455667789999999999999999999999999988765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.31 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=185.7
Q ss_pred eeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 519 LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
++||+|+||.||+|... +++.+|||++... ....+.+|+.+++++. ||||+++++++..+...++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999875 5788999998643 3456788999999997 99999999999999999999999999999
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC---eEEEeeccccccCCCCCccccc
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF---VAKMSDFGLSKTGPSMEHTHVS 673 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~~~~~~~~~~~ 673 (851)
.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 94 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~ 166 (325)
T 3kn6_A 94 FERIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL 166 (325)
T ss_dssp HHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence 9999654 468999999999999999999995 8999999999999997655 8999999999864332 1223
Q ss_pred cccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh-cHHHHHHHHhhhcccccccCccCCCCC
Q 047215 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI-NLADWAMKWQKQRSLKSIIDPHLKGNY 752 (851)
Q Consensus 674 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~~~ 752 (851)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+..... ..+.. ......
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~------~~~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDF------SFEGEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCC------CCCSHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCC------CCCccc
Confidence 4556899999999999999999999999999999999999999764332111 111111111 11100 011111
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCC
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~ 801 (851)
....++.+.+|+.+||+.||.+|||++|+++| +|++....
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h---------~w~~~~~~ 279 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN---------EWLQDGSQ 279 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC---------GGGCTTCC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC---------hhhccCcc
Confidence 12356779999999999999999999999999 99875433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=371.64 Aligned_cols=271 Identities=21% Similarity=0.260 Sum_probs=214.5
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEE
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 578 (851)
+.+.+++...++|+..++||+|+||.||+++.. +++.+|+|++... .......+.+|+.++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666777899999999999999999999975 6789999998643 122334588999999999999999999999
Q ss_pred ccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
..++.++|||||+++|+|.++|.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999996432 368899999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCccccc-------ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW-------RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~ 731 (851)
|+++...... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+. .
T Consensus 207 Gla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~ 279 (412)
T 2vd5_A 207 GSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------Y 279 (412)
T ss_dssp TTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H
T ss_pred hhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------H
Confidence 9997643322 12233467999999999997 35689999999999999999999999976432211 1
Q ss_pred HHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNR---PTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
....... .....|. .....+..+++|+.+||+ +|.+| |+++|+++| +|+...+
T Consensus 280 ~~i~~~~--~~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H---------pff~~i~ 335 (412)
T 2vd5_A 280 GKIVHYK--EHLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH---------PFFFGLD 335 (412)
T ss_dssp HHHHTHH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS---------GGGTTCC
T ss_pred HHHHhcc--cCcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC---------CCcCCCC
Confidence 1111100 0011111 123445678999999999 99998 699999999 7776543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=358.36 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=206.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..++||+|+||.||+|+... ++.+|+|++... .....+.+..|..++..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4789999999999999999999764 678999988653 223456788999999988 89999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999643 358999999999999999999995 8999999999999999999999999999985322
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ..... ..
T Consensus 174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~---~~~i~---------~~ 236 (353)
T 2i0e_A 174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---FQSIM---------EH 236 (353)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH---------HC
T ss_pred C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---H---HHHHH---------hC
Confidence 1 122345679999999999999999999999999999999999999997543211 1 11111 11
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
. ..++...+..+.+|+.+||+.||.+||+ ++++++|
T Consensus 237 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1233455667999999999999999995 6899988
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=344.86 Aligned_cols=252 Identities=27% Similarity=0.511 Sum_probs=203.8
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhh-------HHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQG-------LAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
.++|+..+.||+|+||.||+|+. .+++.+|+|++....... .+.+.+|+.++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36889999999999999999987 467889999886543211 167899999999999999999999997665
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC--eEEcCCCCCCeEEcCCCe-----EEEe
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG--IIHRDVKTTNILLDENFV-----AKMS 656 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~--iiHrDlk~~NILld~~~~-----~kl~ 656 (851)
++||||+++|+|.+.+.... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 79999999999998886543 468999999999999999999995 77 999999999999987776 9999
Q ss_pred eccccccCCCCCccccccccccCCcccCccccc--ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW--RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
|||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||........ .. ....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~---~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KF---INMI 242 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HH---HHHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HH---HHHH
Confidence 9999975322 233467899999999984 55688999999999999999999999976443221 11 1111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
. ........+..+++.+.+++.+||+.||.+|||++|+++.|+.
T Consensus 243 ~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 R---------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H---------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred h---------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 1122223445566779999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=343.61 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=209.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|+..+.||+|+||.||+|... ++..+|+|++... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999875 5788999987543 4455678899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe---EEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV---AKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~---~kl~DFGla~~~~ 665 (851)
||+++++|.+.+... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999998888543 458999999999999999999995 89999999999999976554 9999999997643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... . ..... .+..
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~---~~~~~-~~~~----- 224 (284)
T 3kk8_A 160 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YAQIK-AGAY----- 224 (284)
T ss_dssp SS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-HTCC-----
T ss_pred cC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---H---HHHHH-hccc-----
Confidence 22 12234578999999999999999999999999999999999999986543221 1 11111 1110
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
..........++.+.+++.+||+.||.+|||++|+++| +|+...
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h---------~~~~~~ 268 (284)
T 3kk8_A 225 -DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV---------PWICNR 268 (284)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS---------HHHHSC
T ss_pred -cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC---------ccccCC
Confidence 01111123445678999999999999999999999999 787643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=349.58 Aligned_cols=254 Identities=27% Similarity=0.471 Sum_probs=199.6
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
++|+..+.||+|+||.||+|+.. ++.+|+|++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 57888999999999999999876 567899998654 345789999999999999999999999874 5799999999
Q ss_pred CcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe-EEEeeccccccCCCCCcc
Q 047215 593 NGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV-AKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 593 ~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~-~kl~DFGla~~~~~~~~~ 670 (851)
+|+|.+++.... ...+++.+++.++.|+++||.|||+...++|+||||||+|||++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999997543 235788999999999999999999533378999999999999988775 899999998753221
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...| ... .+ ...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~--~~~-~~---------~~~ 223 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMW--AVH-NG---------TRP 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHH--HHH-TT---------CCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHH--HHh-cC---------CCC
Confidence 2234689999999999999999999999999999999999999875432211 0111 110 11 011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.....++..+.+++.+||+.||.+|||+++++++|+.+.+
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2223455678999999999999999999999999987753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.42 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-c-------ceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-C-------TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
.++|...+.||+|+||.||+|+... + ..+|+|.+........+.+.+|++++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3678889999999999999998653 2 4689999877766777889999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe--------EEE
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV--------AKM 655 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~--------~kl 655 (851)
.++||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999996543 348899999999999999999995 89999999999999988877 999
Q ss_pred eeccccccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+++.... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........ .....
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----KLQFY 231 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHH
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----HHHHh
Confidence 99999875322 123457899999999987 7799999999999999999997665543322211 01111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.. .+. .+...+..+.+++.+||+.||.+|||++|++++|+.+.
T Consensus 232 ~~--------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 232 ED--------RHQ----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HT--------TCC----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred hc--------cCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 10 011 11222345889999999999999999999999988554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=359.38 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=193.7
Q ss_pred cCCcee-eeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHh-cCCcceeeEEEEEcc----CCcEE
Q 047215 513 NNFDES-LMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSK-LRHRHLVSLIGFCDE----QNEMI 585 (851)
Q Consensus 513 ~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~----~~~~~ 585 (851)
++|... ++||+|+||.||++... ++..+|||++... ..+.+|+.++.+ .+||||+++++++.. ++.++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 466665 68999999999999875 5778999998632 456788888755 489999999998864 66789
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~ 662 (851)
|||||+++|+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999977655679999999999999999999995 89999999999999987 7899999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh-cHHHHHHHHhhhcccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI-NLADWAMKWQKQRSLK 741 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~ 741 (851)
..... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... ...... ..+..
T Consensus 213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~- 284 (400)
T 1nxk_A 213 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY- 284 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC-
T ss_pred ccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc-
Confidence 64321 2234567899999999999999999999999999999999999999765433211 111111 01110
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.......++..+.+|+.+||+.||.+|||+.|+++|
T Consensus 285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111113455678999999999999999999999999
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=381.95 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=210.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|...++||+|+||.||+|++.++..||||++.... ...+.|.+|+++|++++||||++++++|.. +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346788899999999999999999888889999987654 335689999999999999999999999976 678999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
|++|+|.++|.......+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++..... ..
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EY 418 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ce
Confidence 999999999965444568999999999999999999995 89999999999999999999999999999864321 11
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......++..|+|||++....++.++|||||||+||||++ |+.||......+ + .... .. ..+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~---~~~i-~~---------~~~ 482 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQV-ER---------GYR 482 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---H---HHHH-HT---------TCC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHH-Hc---------CCC
Confidence 12233456789999999999999999999999999999999 888886543221 1 1111 11 111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
...+..++..+.+|+.+||+.||++|||++++++.|+.
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 22345667789999999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=356.32 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=204.2
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-----ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-----SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
....++|+..+.||+|+||.||+|+.. ++..+|+|++... .....+.+.+|++++++++||||+++++++..++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345678999999999999999999874 5678899987542 3455678999999999999999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCC--------------------------------------CCCCCchhhhHHHHHHHHHHH
Q 047215 583 EMILVYEYMANGTLRSHLFGS--------------------------------------DLPPLTWKQRLDACIGAARGL 624 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~--------------------------------------~~~~l~~~~~~~i~~~ia~gL 624 (851)
..++||||+++|+|.+++... ....+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999988420 011245777889999999999
Q ss_pred HHhhcCCCCCeEEcCCCCCCeEEcCCC--eEEEeeccccccCCCCC--ccccccccccCCcccCcccccc--cCCCchHH
Q 047215 625 HYLHTGAERGIIHRDVKTTNILLDENF--VAKMSDFGLSKTGPSME--HTHVSTAVKGSFGYLDPEYFWR--QQLTEKSD 698 (851)
Q Consensus 625 ~yLHs~~~~~iiHrDlk~~NILld~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksD 698 (851)
+|||+ .+|+||||||+|||++.++ .+||+|||+++...... .........||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 99996 8999999999999998766 89999999997532211 1112345679999999999975 68899999
Q ss_pred HHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 047215 699 VYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM 778 (851)
Q Consensus 699 VwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 778 (851)
||||||++|||++|+.||......+. ........ . ..........+..+.+|+.+||+.||.+|||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~--~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKK--L-----CFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC--C-----CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcc--c-----ccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 99999999999999999875432211 11111110 0 00111112345679999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhccc
Q 047215 779 GEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 779 ~evl~~L~~~~~~~~~w~~~ 798 (851)
.|+++| +|++.
T Consensus 326 ~~~l~h---------p~~~~ 336 (345)
T 3hko_A 326 MRALQH---------PWISQ 336 (345)
T ss_dssp HHHHHS---------HHHHT
T ss_pred HHHhcC---------hhhcc
Confidence 999999 77764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=375.21 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=211.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
..++|+..++||+|+||.||+|+.. +++.+|+|++... .......+.+|+.+|++++||||+++++++..++..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 6789999988643 22345668899999999999999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.......+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999977665669999999999999999999996 8999999999999999999999999999986433
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ..
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i-~~--------- 403 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLV-KE--------- 403 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHH-HH---------
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHh-hc---------
Confidence 21 223457999999999999989999999999999999999999999765432211 1111111 00
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
....++...+..+.+|+.+||+.||.+|| +++|+++|
T Consensus 404 -~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 -VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01123344556799999999999999999 78999999
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.76 Aligned_cols=271 Identities=23% Similarity=0.289 Sum_probs=202.2
Q ss_pred cCCcee-eeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDES-LMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~-~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+.|.+. ++||+|+||.||+|+. .+++.+|||++..........+.+|++++.++ +||||+++++++..++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 6799999999999985 46788999998776656677899999999995 79999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe---EEEeeccccccCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV---AKMSDFGLSKTGPS 666 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~---~kl~DFGla~~~~~ 666 (851)
|+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999653 358899999999999999999996 89999999999999987765 99999999875332
Q ss_pred CCc-----cccccccccCCcccCcccccc-----cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 667 MEH-----THVSTAVKGSFGYLDPEYFWR-----QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 667 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.............
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111 111234569999999999975 5688999999999999999999999976543221000000000000
Q ss_pred hcccccccCccCCCCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 737 QRSLKSIIDPHLKGNYS----PESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
......+..... .++ ...+..+.+|+.+||+.||.+|||++|+++| +|++..
T Consensus 247 ~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h---------p~~~~~ 302 (316)
T 2ac3_A 247 NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH---------PWVQGC 302 (316)
T ss_dssp HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS---------TTCC--
T ss_pred HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC---------hhhcCC
Confidence 000000111111 111 1245678999999999999999999999999 998753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.51 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=206.4
Q ss_pred CCceeeeeeeecceEEEEEEEcCc----ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE-EEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDC----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM-ILV 587 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~-~lV 587 (851)
.|...++||+|+||.||+|+..+. ..+|+|.+... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 455668999999999999986432 36899988764 445567899999999999999999999999766655 999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+.+|+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999996633 568999999999999999999995 89999999999999999999999999999754322
Q ss_pred C--ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 668 E--HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 668 ~--~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
. .........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+....... .+.... ...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~----~~~------- 244 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFL----AQG------- 244 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHH----HTT-------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHh----hcC-------
Confidence 1 1112234567889999999999999999999999999999999766654432221 111111 010
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..++..+.+++.+||+.||.+|||++++++.|+.++..
T Consensus 245 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 245 --RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11122344556799999999999999999999999999988754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=357.48 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=201.6
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.+.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588899999999999999986 567889999886542 33456789999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||++ |+|.+++.... .++++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 68877774322 468999999999999999999996 8999999999999999999999999999976432
Q ss_pred CccccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .........
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~------ 269 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE------ 269 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC------
Confidence 12356899999999985 5678999999999999999999999986543211 111111111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.+ .+...+..+.+++.+||+.||.+|||++++++|
T Consensus 270 ~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111 123345668999999999999999999999999
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=359.02 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=197.2
Q ss_pred cCCceeeeeeeecceEEEEEEEcC--c--ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc-cCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED--C--TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD-EQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~--~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~l 586 (851)
..|+..++||+|+||.||+|+..+ + ..+|+|.+... .....+.|.+|+.++++++||||++++++|. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346778899999999999998642 2 35789988654 3455678999999999999999999999975 4568899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.... ..+++.++..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999996543 458899999999999999999995 8999999999999999999999999999986432
Q ss_pred CCcc--ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 667 MEHT--HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 667 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||......+ ..... ..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~---- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGR---- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTC----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCC----
Confidence 2211 12234457889999999999999999999999999999999 555555433322 11111 0110
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
....+..++..+.+++.+||+.||.+|||++|++++|+.+...
T Consensus 314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1112344567799999999999999999999999999987653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=346.37 Aligned_cols=263 Identities=24% Similarity=0.424 Sum_probs=207.5
Q ss_pred cCCceeeeeeeecceEEEEEEE-----cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC--CcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-----EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ--NEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 584 (851)
+.|+..+.||+|+||.||+|++ ..++.+|+|++... .....+.+.+|++++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999984 35788999998754 334557899999999999999999999999766 678
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999985433 458999999999999999999995 89999999999999999999999999999865
Q ss_pred CCCCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCC---------cchhcHHHHHHHH
Q 047215 665 PSMEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLP---------KDQINLADWAMKW 734 (851)
Q Consensus 665 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~---------~~~~~l~~~~~~~ 734 (851)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 254 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN-- 254 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH--
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH--
Confidence 432221 223445688899999999999999999999999999999999887532110 00001111111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.+........+..+++.+.+++.+||+.||.+|||++++++.|+.++
T Consensus 255 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 --------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp --------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111122344556678999999999999999999999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.93 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=205.9
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|...+.||+|+||.||+|+.. +++.+|||++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67888999999999999999975 67899999886432 233567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 999999999999543 468999999999999999999994 89999999999999999999999999999864332
Q ss_pred ccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... + .... .+..
T Consensus 170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~---~~~i---------~~~~ 232 (476)
T 2y94_A 170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L---FKKI---------CDGI 232 (476)
T ss_dssp --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H---HHHH---------HTTC
T ss_pred --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H---HHHH---------hcCC
Confidence 22345679999999999988765 789999999999999999999997543221 1 1111 1111
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ..+...+..+.+|+.+||+.||.+|||++|+++|
T Consensus 233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1 1223345678999999999999999999999999
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=357.77 Aligned_cols=271 Identities=14% Similarity=0.168 Sum_probs=207.4
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCCChhhH-----------HHHHHHHHHHHhcCCcceee
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQSEQGL-----------AEFETEIEMLSKLRHRHLVS 573 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~HpnIv~ 573 (851)
..++|...++||+|+||.||+|.... ++.+|||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998765 36789998776543211 12344566677788999999
Q ss_pred EEEEEccC----CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-
Q 047215 574 LIGFCDEQ----NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD- 648 (851)
Q Consensus 574 l~g~~~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld- 648 (851)
+++++... ...+|||||+ +++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 99998654 4589999999 99999998653 2569999999999999999999996 8999999999999998
Q ss_pred -CCCeEEEeeccccccCCCCCc-----cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCc
Q 047215 649 -ENFVAKMSDFGLSKTGPSMEH-----THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPK 722 (851)
Q Consensus 649 -~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~ 722 (851)
.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999976432111 11123455999999999999999999999999999999999999999753322
Q ss_pred chhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
.. ...+... .....+..++++.+. ...++..+.+++..||+.+|.+||+++++++.|+.+++..
T Consensus 268 ~~--~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PK--YVRDSKI-RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HH--HHHHHHH-HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH--HHHHHHH-HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11 1111111 111223333333332 1234567899999999999999999999999999887643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=352.15 Aligned_cols=261 Identities=30% Similarity=0.466 Sum_probs=207.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-Ccce--eEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTL--AAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..+.||+|+||.||+|+.. ++.. +++|++... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999864 3443 488887653 344556789999999999 899999999999999999999
Q ss_pred EEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 588 YEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
|||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999996543 3468999999999999999999995 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAM 732 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~ 732 (851)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 252 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH
Confidence 9999999874221 112233457889999999998899999999999999999998 999886543211 111
Q ss_pred HHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047215 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAW 795 (851)
Q Consensus 733 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w 795 (851)
.. .. ......+..++..+.+++.+||+.||.+|||++|++++|+.+++....+
T Consensus 253 ~~-~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 253 KL-PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp HG-GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred Hh-hc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 11 11 1112233455677999999999999999999999999999887654443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=361.80 Aligned_cols=267 Identities=22% Similarity=0.372 Sum_probs=193.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccC--CcE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQ--NEM 584 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~ 584 (851)
..++|+..+.||+|+||.||+|.. ..++.||||++... .......+.+|+.+++++. ||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 347899999999999999999986 46788999988643 4455677889999999997 99999999999644 478
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++|||||+ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999998 6899888653 58899999999999999999996 89999999999999999999999999999753
Q ss_pred CCC-------------------CccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch
Q 047215 665 PSM-------------------EHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724 (851)
Q Consensus 665 ~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~ 724 (851)
... ..........||+.|+|||++.+ ..++.++|||||||+++||++|+.||......++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 221 01112344679999999999976 6799999999999999999999999976543332
Q ss_pred hcHHHHHHHHhhhccccccc------------------CccCCC------------CCChhHHHHHHHHHHHhcccCCCC
Q 047215 725 INLADWAMKWQKQRSLKSII------------------DPHLKG------------NYSPESLEKFGEIAEKCLDDEGKN 774 (851)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~i~------------------d~~l~~------------~~~~~~~~~l~~l~~~Cl~~dP~~ 774 (851)
.....-.........+..+. ...... .....+++.+.+|+.+||+.||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 21110000000000000000 000000 001134567899999999999999
Q ss_pred CCCHHHHHHH
Q 047215 775 RPTMGEVLWH 784 (851)
Q Consensus 775 RPt~~evl~~ 784 (851)
|||++|+++|
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999999
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.48 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=203.1
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc----ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEE-ccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFC-DEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~l 586 (851)
.+|+..++||+|+||.||+|+..+. ..+++|.+... .....+.+.+|+.++++++||||++++++| ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 5688889999999999999986432 35788887764 445567899999999999999999999996 45668899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999996543 467899999999999999999995 8999999999999999999999999999986433
Q ss_pred CCc--cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcC-CCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 667 MEH--THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV-INPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 667 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.| +......+ .... ... +
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~-~----- 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQ-G----- 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHT-T-----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---Hhc-C-----
Confidence 221 1122345678899999999999999999999999999999996554 43332221 1111 100 0
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.....+..++..+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 249 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 249 ----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111223445679999999999999999999999999998765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.01 Aligned_cols=268 Identities=21% Similarity=0.375 Sum_probs=200.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChh-hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQ-GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|...+.||+|+||.||+|+.. +++.+|+|++...... ....+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999975 6788999988654322 122456799999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
++ |+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 154 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence 98 58888876543 468899999999999999999995 89999999999999999999999999999753321 1
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh---ccccccc--
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ---RSLKSII-- 744 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i~-- 744 (851)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ......... .....+.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGC
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcc
Confidence 22334568999999999876 57899999999999999999999999765433221 111111100 0000000
Q ss_pred -------CccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 745 -------DPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 745 -------d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.+.... ...+..+..+.+|+.+||+.||.+|||++|+++| +|+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---------p~f~~~ 288 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH---------PFFLSL 288 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS---------GGGGGG
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC---------hhhhhc
Confidence 000000 0112345678999999999999999999999999 898753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=347.44 Aligned_cols=275 Identities=25% Similarity=0.344 Sum_probs=204.5
Q ss_pred CHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhc--CCcceeeEEEEEccC
Q 047215 504 TLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL--RHRHLVSLIGFCDEQ 581 (851)
Q Consensus 504 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~g~~~~~ 581 (851)
+...-....++|+..+.||+|+||.||+|+.. +..+|||++.... ...+..|.+++..+ +||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 33444445678999999999999999999876 7889999885432 23445566666554 899999999999776
Q ss_pred ----CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC-----CCCeEEcCCCCCCeEEcCCCe
Q 047215 582 ----NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA-----ERGIIHRDVKTTNILLDENFV 652 (851)
Q Consensus 582 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~-----~~~iiHrDlk~~NILld~~~~ 652 (851)
...++||||+++|+|.+++... .+++.++..++.|++.||+|||+.. +.+|+||||||+|||++.++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 7899999999999999999553 5899999999999999999999510 129999999999999999999
Q ss_pred EEEeeccccccCCCCCccc--cccccccCCcccCcccccccCCCch------HHHHHHHHHHHHHHhC----------Cc
Q 047215 653 AKMSDFGLSKTGPSMEHTH--VSTAVKGSFGYLDPEYFWRQQLTEK------SDVYSFGVVLFEVVCA----------RA 714 (851)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~k------sDVwS~GvvL~eLltG----------~~ 714 (851)
+||+|||+++......... ......||+.|+|||++.+...+.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997543222111 1124579999999999987766654 9999999999999999 45
Q ss_pred CCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 715 VINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN-YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 715 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
|+....+... ..... ....... ...+.+... .+..++..+.+++.+||+.||.+|||+.|++++|+.+.+.
T Consensus 261 p~~~~~~~~~-~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 261 PYHDLVPSDP-SYEDM-REIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTTTSCSSC-CHHHH-HHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cHhhhcCCCC-chhhh-HHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 5544322221 11111 1111111 111111111 1236788899999999999999999999999999988754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.82 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=207.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
.++|...+.||+|+||.||+|+.. .+..+|||++... .......+.+|+.++++++||||+++++++..++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 468999999999999999999842 4568999998754 445567899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCC-----CCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEe
Q 047215 585 ILVYEYMANGTLRSHLFGSDL-----PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMS 656 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~ 656 (851)
++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++ .+..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965432 458899999999999999999995 8999999999999998 45569999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..+ ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~---~~- 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE---FV- 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH---HH-
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHH---HH-
Confidence 9999874322222222334567899999999999999999999999999999998 888886542211 111 11
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
..+ .....+..++..+.+++.+||+.||.+|||+.+++++|+.+.+..+
T Consensus 259 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 259 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred hcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 111 0112234456679999999999999999999999999998876443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=372.07 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=201.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|+..++||+|+||.||+|+.. ++..+|||++... .......+.+|+.++++++||||++++++|...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 5788999988643 334456778899999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+ +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999998543 368999999999999999999994 378999999999999999999999999999853321
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.......+||+.|+|||++.+..++.++|||||||+||||++|+.||....... +. ..... ..
T Consensus 303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~---------~~ 365 (446)
T 4ejn_A 303 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---ELILM---------EE 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH---------CC
T ss_pred --CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HH---HHHHh---------CC
Confidence 222345679999999999999999999999999999999999999997543211 11 11110 01
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHHhhhhhccc
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L~~~~~~~~~w~~~ 798 (851)
..++...+..+.+|+.+||+.||.+|| +++|+++| +|+..
T Consensus 366 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h---------p~f~~ 410 (446)
T 4ejn_A 366 --IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH---------RFFAG 410 (446)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS---------GGGTT
T ss_pred --CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC---------ccccC
Confidence 123344556789999999999999999 99999999 88764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=350.13 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=210.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
.++|+..+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357889999999999999999875 578899998765422 1357899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC----eEEEeeccc
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF----VAKMSDFGL 660 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~----~~kl~DFGl 660 (851)
++||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999653 468999999999999999999995 8999999999999999887 799999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ........
T Consensus 166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~--- 233 (321)
T 2a2a_A 166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSV--- 233 (321)
T ss_dssp CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTT---
T ss_pred ceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhc---
Confidence 97643321 2234568999999999999999999999999999999999999987543211 11111100
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
....++. .....+..+.+++.+||+.||.+|||++|+++| +|+...+
T Consensus 234 ~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h---------p~~~~~~ 280 (321)
T 2a2a_A 234 SYDFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH---------PWITPVD 280 (321)
T ss_dssp CCCCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS---------TTTSCSS
T ss_pred ccccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC---------ccccCCC
Confidence 0000111 112344668999999999999999999999999 8876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.92 Aligned_cols=247 Identities=19% Similarity=0.291 Sum_probs=204.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|...+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4678999999999999999998754 567899988766555677899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccccCCCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~~~ 667 (851)
+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999988543 358899999999999999999995 899999999999999 78899999999999764332
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ ...... .+..
T Consensus 163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~------- 224 (277)
T 3f3z_A 163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIR-EGTF------- 224 (277)
T ss_dssp S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCC-------
T ss_pred c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hCCC-------
Confidence 2 23345689999999998654 8999999999999999999999987543211 111111 1100
Q ss_pred CCCCCCh----hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSP----ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+. ..++.+.+++.+||+.||.+|||+.|+++|
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 ---TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 345678999999999999999999999999
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=376.25 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=205.0
Q ss_pred cCCceee-eeeeecceEEEEEEEc---CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESL-MIGVGGFGKVFKGEIE---DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
+++...+ .||+|+||.||+|.+. ++..||||++... .....+.|.+|+++|++++|||||+++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444444 7999999999999874 4567999998765 33456889999999999999999999999976 569999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++|+|.++|... ...+++.++..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999654 3568999999999999999999996 89999999999999999999999999999864332
Q ss_pred Cc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 668 EH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 668 ~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+ +... ...+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~----i~~~------- 555 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQG------- 555 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHH----HHTT-------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcC-------
Confidence 21 111223446789999999999999999999999999999998 999987654322 1111 1111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.....+..++..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 556 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 556 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1123445677889999999999999999999999999886643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=357.20 Aligned_cols=271 Identities=21% Similarity=0.289 Sum_probs=213.7
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC--cEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN--EMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~lV~ 588 (851)
++|...++||+|+||.||+|+... ++.+|||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 578889999999999999999754 7889999987543 334567889999999999999999999987654 789999
Q ss_pred EecCCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE----cCCCeEEEeecccccc
Q 047215 589 EYMANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL----DENFVAKMSDFGLSKT 663 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla~~ 663 (851)
||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996543 2348999999999999999999995 899999999999999 7888899999999986
Q ss_pred CCCCCccccccccccCCcccCcccccc--------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWR--------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....... .+......
T Consensus 166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~ 240 (396)
T 4eut_A 166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (396)
T ss_dssp CCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred ccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence 4332 22334679999999999875 56788999999999999999999999754332211 11111111
Q ss_pred hhc---ccccc---c--------CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 736 KQR---SLKSI---I--------DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 736 ~~~---~~~~i---~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
... ....+ . +.......+......+.+++.+||+.||++|||+.|++++++.+++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111 00000 0 11112245577888999999999999999999999999999888653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=341.73 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=188.7
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|...+.||+|+||.||+|+. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5788999999999999999986 467889999886432 123467899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++.... .++++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999986542 468999999999999999999995 899999999999999999999999999987643221
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+....
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~- 228 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLAD- 228 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC-
T ss_pred C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcc-
Confidence 1 123456899999999999999999999999999999999999998754332110 1111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...+...+..+.+++.+||+.||.+|||++++++| +|+..
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h---------~~~~~ 268 (278)
T 3cok_A 229 -YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH---------PFMSR 268 (278)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS---------TTTC-
T ss_pred -cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC---------ccccC
Confidence 12233455678999999999999999999999999 88764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=352.97 Aligned_cols=271 Identities=20% Similarity=0.301 Sum_probs=199.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
..++|...++||+|+||.||+|+. .+++.+|||++..... .....+.+|++++++++||||+++++++..++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346899999999999999999985 4678899999875432 3345678999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE-----cCCCeEEEeeccccc
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL-----DENFVAKMSDFGLSK 662 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl-----d~~~~~kl~DFGla~ 662 (851)
|||++ |+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99998 5999998554 358999999999999999999996 899999999999999 456679999999997
Q ss_pred cCCCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh--hcc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK--QRS 739 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~ 739 (851)
..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. ......... ...
T Consensus 186 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 186 AFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLPDDTT 261 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTT
T ss_pred ccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCCchhh
Confidence 53221 1123345689999999999874 5899999999999999999999999764332211 111111000 000
Q ss_pred ccccc--------CccCCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 740 LKSII--------DPHLKGN-----YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 740 ~~~i~--------d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
..... .+..... .....+..+.+|+.+||+.||.+|||++|+++| +|++..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---------p~f~~~~ 326 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH---------PYFSHND 326 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS---------GGGSSSC
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC---------cccCCCC
Confidence 00000 0000000 011245678999999999999999999999999 9987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=343.71 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=201.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|...+.||+|+||.||+++.. ++..+|+|++... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57888999999999999999874 5678899987654 334467899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccccCC
Q 047215 591 MANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 591 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~ 665 (851)
+++|+|.+.+... ....+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988532 23568999999999999999999995 899999999999999 456889999999997643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. .......||+.|+|||.+. ..++.++||||||+++|||++|+.||......+. ...... . .
T Consensus 179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~-~------~ 241 (285)
T 3is5_A 179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATY-K------E 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-C------C
T ss_pred Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------Hhhhcc-C------C
Confidence 22 2234456899999999985 5789999999999999999999999875432111 111100 0 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
+.... .....++.+.+++.+||+.||.+|||+.|+++| +|++
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h---------p~f~ 283 (285)
T 3is5_A 242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH---------EWFK 283 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS---------GGGG
T ss_pred ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC---------HHhh
Confidence 11110 011234568899999999999999999999999 8875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=365.45 Aligned_cols=267 Identities=21% Similarity=0.261 Sum_probs=207.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhc------CCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKL------RHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~g~~~~~~~~ 584 (851)
..+|+..++||+|+||.||+|... .++.||||++... ......+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999865 4788999998754 33456778899998887 577999999999999999
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe--EEEeeccccc
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV--AKMSDFGLSK 662 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~--~kl~DFGla~ 662 (851)
++||||+. ++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 699999877666679999999999999999999996 89999999999999999887 9999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH-------h
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW-------Q 735 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~-------~ 735 (851)
..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||......+... ...... .
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~--~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA--CMIELLGMPSQKLL 323 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHH
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHcCCCCHHHH
Confidence 53221 234578999999999999999999999999999999999999987654332211 111100 0
Q ss_pred hh-cccccccCcc---------------------------C-----CC----CCChhHHHHHHHHHHHhcccCCCCCCCH
Q 047215 736 KQ-RSLKSIIDPH---------------------------L-----KG----NYSPESLEKFGEIAEKCLDDEGKNRPTM 778 (851)
Q Consensus 736 ~~-~~~~~i~d~~---------------------------l-----~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 778 (851)
.. ......++.. + .. .......+.+.+|+.+||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 00 0000000000 0 00 0011224668999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhcccC
Q 047215 779 GEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 779 ~evl~~L~~~~~~~~~w~~~~ 799 (851)
+|+|+| +|++..
T Consensus 404 ~e~L~H---------pw~~~~ 415 (429)
T 3kvw_A 404 GQALRH---------PWLRRR 415 (429)
T ss_dssp HHHHTS---------TTTC--
T ss_pred HHHhCC---------hhhccC
Confidence 999999 998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.69 Aligned_cols=272 Identities=23% Similarity=0.380 Sum_probs=199.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHH--HHhcCCcceeeEEEEE-----ccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEM--LSKLRHRHLVSLIGFC-----DEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~HpnIv~l~g~~-----~~~~~~ 584 (851)
-++|+..+.||+|+||.||+|+. +++.+|||++..... ..+..|.++ +..++||||+++++.+ ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36889999999999999999986 567899999864432 334444444 4558999999999854 233467
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCC---------CeEEcCCCCCCeEEcCCCeEEE
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER---------GIIHRDVKTTNILLDENFVAKM 655 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~---------~iiHrDlk~~NILld~~~~~kl 655 (851)
++||||+++|+|.+++.... .++.++.+++.|++.||.|||+ . +|+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 89999999999999996543 5889999999999999999995 5 9999999999999999999999
Q ss_pred eeccccccCCCCC------ccccccccccCCcccCcccccc-------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCc
Q 047215 656 SDFGLSKTGPSME------HTHVSTAVKGSFGYLDPEYFWR-------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPK 722 (851)
Q Consensus 656 ~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~ 722 (851)
+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999997643211 1112234569999999999976 46778999999999999999998877553322
Q ss_pred chhc--HH---------HHHHHHhhhcccccccCccCCCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 723 DQIN--LA---------DWAMKWQKQRSLKSIIDPHLKGN--YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 723 ~~~~--l~---------~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.... .. +......... ...+.+... ....++..+.+|+.+||+.||.+|||++|+++.|+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSRE----KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTS----CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhccc----ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1110 00 0000000000 111111111 12346778999999999999999999999999988765
Q ss_pred HhhhhhcccCC
Q 047215 790 QLHEAWMRTDD 800 (851)
Q Consensus 790 ~~~~~w~~~~~ 800 (851)
..|.+...
T Consensus 318 ---~~~~~~~~ 325 (336)
T 3g2f_A 318 ---MIWERNKS 325 (336)
T ss_dssp ---HCCCC---
T ss_pred ---HHHHhccc
Confidence 46765433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=344.49 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=206.6
Q ss_pred HhcCCceee-eeeeecceEEEEEEEc---CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 511 ATNNFDESL-MIGVGGFGKVFKGEIE---DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 511 ~t~~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
..++|...+ .||+|+||.||+|... .+..+|||++.... ....+.+.+|++++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 446777777 9999999999999653 35788999987542 33467899999999999999999999999 56778
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999999654 458899999999999999999995 89999999999999999999999999999764
Q ss_pred CCCCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 665 PSMEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 665 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... ....+
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~~---- 236 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----MLEKG---- 236 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTT----
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcC----
Confidence 332221 12233456789999999998889999999999999999999 999887543221 111 11111
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 237 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 -----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11123445667799999999999999999999999999877643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.37 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=201.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc----CCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE----QNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~ 585 (851)
..|...+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677889999999999999874 5567888887643 45556789999999999999999999998854 45689
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC--eEEcCCCCCCeEEc-CCCeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG--IIHRDVKTTNILLD-ENFVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~--iiHrDlk~~NILld-~~~~~kl~DFGla~ 662 (851)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999543 458899999999999999999995 66 99999999999997 88999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
..... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||........ ...... .+
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~-~~---- 245 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVT-SG---- 245 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHT-TT----
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHh-cc----
Confidence 53322 223456899999999886 4699999999999999999999999875433211 111111 11
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
......+...++.+.+++.+||+.||.+|||++|+++| +|+++
T Consensus 246 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h---------~~f~~ 288 (290)
T 1t4h_A 246 ----VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH---------AFFQE 288 (290)
T ss_dssp ----CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGC-
T ss_pred ----CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC---------ccccc
Confidence 00111122334568999999999999999999999999 88864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=342.72 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=200.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-CCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-QNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~lV~Ey 590 (851)
.++|+..+.||+|+||.||+|+.. +..+|+|.+.... ..+.+.+|++++++++||||+++++++.. ++..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999875 6788999987543 45678999999999999999999999754 4578999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999965433347889999999999999999995 89999999999999999999999999998753321
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... .. . ....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~---~~-~---------~~~~ 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP---RV-E---------KGYK 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH---HH-T---------TTCC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HH-h---------cCCC
Confidence 123357889999999999999999999999999999998 888886543221 111 11 0 1111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
...+..++..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 22344556779999999999999999999999999988754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=353.98 Aligned_cols=269 Identities=24% Similarity=0.399 Sum_probs=212.3
Q ss_pred hcCCceeeeeeeecceEEEEEEE-----cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC--cE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-----EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN--EM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~ 584 (851)
.++|+..+.||+|+||.||++++ .++..+|+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 357889999998877777788999999999999999999999986544 78
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999996543 458999999999999999999995 89999999999999999999999999999865
Q ss_pred CCCCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh------
Q 047215 665 PSMEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ------ 737 (851)
Q Consensus 665 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~------ 737 (851)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ++.......
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-------~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-------EFMRMIGNDKQGQMI 268 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-------HHHHHHCTTCCTHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-------HHHHhhccccchhhh
Confidence 432221 122334577889999999988999999999999999999999987653210 000000000
Q ss_pred -cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 738 -RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 738 -~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
..+.+.+........+..++..+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000111111112223455667899999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=349.35 Aligned_cols=271 Identities=22% Similarity=0.265 Sum_probs=202.7
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChh-----hHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQ-----GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
...++|+..+.||+|+||.||+|+.. +++.+|+|++...... ....+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 5788999998753221 12467899999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++||||+++ +|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999986 8888875543 468899999999999999999995 8999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+......+. +....... .......
T Consensus 162 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~-~~~~~~~ 236 (346)
T 1ua2_A 162 FGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETL-GTPTEEQ 236 (346)
T ss_dssp TTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHH-CCCCTTT
T ss_pred ccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHc-CCCChhh
Confidence 4322 122344678999999999975 4589999999999999999999988876533221 11111111 0000000
Q ss_pred cc------CccC---CCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 743 II------DPHL---KGNY-----SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 743 i~------d~~l---~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.. +... .... ....+..+.+|+.+||+.||.+|||++|+++| +|+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h---------~~f~~~ 298 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------KYFSNR 298 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS---------GGGTSS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC---------hhhhcC
Confidence 00 0000 0001 13345779999999999999999999999999 888654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=367.25 Aligned_cols=262 Identities=22% Similarity=0.260 Sum_probs=196.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------C
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------N 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 582 (851)
.++|+..+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+|++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999864 5788999998754 445567789999999999999999999999544 4
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..+||||||+++ |.+.+.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 679999999865 5555532 38899999999999999999996 899999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH-----------
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA----------- 731 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~----------- 731 (851)
.... ........||+.|+|||++.+..++.++|||||||+||||++|+.||.+....++.......
T Consensus 213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 6432 22234567999999999999999999999999999999999999999765433221111000
Q ss_pred -----HHHhhhc-ccc-----cccCccCCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 732 -----MKWQKQR-SLK-----SIIDPHLKGN---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 732 -----~~~~~~~-~~~-----~i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.... ... ..+...+... ........+.+|+.+||+.||.+|||++|+++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000 0000000000 001125679999999999999999999999999
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.18 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=203.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||++... +++.+|+|++..... ...+|++++.++ +||||+++++++..++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999875 578899999865433 235688888888 79999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC----CeEEEeeccccccCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN----FVAKMSDFGLSKTGP 665 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~~~ 665 (851)
|+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999998654 468999999999999999999995 899999999999998432 359999999998643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+ .... ..+.
T Consensus 172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i-~~~~------ 239 (342)
T 2qr7_A 172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARI-GSGK------ 239 (342)
T ss_dssp CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHH-HHCC------
T ss_pred CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHH-ccCC------
Confidence 221 223456789999999999988899999999999999999999999975432221111 1111 1111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
..+........+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 11112223445677999999999999999999999999933
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.87 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=207.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|...+.||+|+||.||+++.. +++.+|+|.+..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 367889999999999999999875 6788999998766555556789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccccCCCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~~~ 667 (851)
+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||+ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999999988543 358899999999999999999995 899999999999999 7889999999999875322
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... + ..... .+.. .
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~i~-~~~~------~ 225 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---L---FEKIK-EGYY------E 225 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHH-HCCC------C
T ss_pred ---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHH-cCCC------C
Confidence 12234568999999999999999999999999999999999999986543211 1 11111 1100 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.........+..+.+++.+||+.||.+|||++|+++| +|+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h---------~~~~~ 267 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH---------PWIDG 267 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS---------HHHHS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC---------ccccC
Confidence 1112233456679999999999999999999999999 77764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.18 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=206.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
+.|...+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888999999999999999864 57889999886543 34567899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.. .++++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 173 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 173 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence 999999999854 358999999999999999999995 899999999999999999999999999997643221
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... . .... ... ..+.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~~-~~~-----~~~~--- 238 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---V---LFLI-PKN-----NPPT--- 238 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHH-HHS-----CCCC---
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---H---HHHh-hcC-----CCCC---
Confidence 12234568999999999999999999999999999999999999986543211 1 1111 111 1111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 785 (851)
.+...+..+.+++.+||+.||.+|||+.|+++|.
T Consensus 239 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 239 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 2234456689999999999999999999999993
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=362.16 Aligned_cols=258 Identities=28% Similarity=0.390 Sum_probs=196.5
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--------hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--------EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ 581 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 581 (851)
..++|...+.||+|+||.||+|... +++.+|||++.... ......+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3578999999999999999999864 56889999875421 1222358899999999999999999999864
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC---CeEEEeec
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN---FVAKMSDF 658 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~---~~~kl~DF 658 (851)
+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ ..+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence 4589999999999999998544 468999999999999999999995 899999999999999654 45999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccc---cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR---QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
|+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.+..
T Consensus 287 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i---- 357 (419)
T 3i6u_A 287 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI---- 357 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH----
T ss_pred ccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH----
Confidence 99986432 223345679999999999863 6788999999999999999999999975433221 11111
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+... ..+. .....+..+.+++.+||+.||.+|||++|+++| +|+++
T Consensus 358 ~~~~~~--~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h---------p~~~~ 405 (419)
T 3i6u_A 358 TSGKYN--FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH---------PWLQD 405 (419)
T ss_dssp HTTCCC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS---------GGGCC
T ss_pred hcCCCC--CCch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC---------cccCC
Confidence 111000 0000 012345678999999999999999999999999 88864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=355.55 Aligned_cols=276 Identities=21% Similarity=0.259 Sum_probs=206.8
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCC-----------hhhHHHHHHHHHHHHhcCCcce
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS-----------EQGLAEFETEIEMLSKLRHRHL 571 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~-----------~~~~~~~~~Ei~~l~~l~HpnI 571 (851)
....++....++|...+.||+|+||.||+|...++..+|||++.... ....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34677888899999999999999999999998889999999875432 1223779999999999999999
Q ss_pred eeEEEEE-----ccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 572 VSLIGFC-----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 572 v~l~g~~-----~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
+++++++ ......++||||++ |+|.+.+... ...+++.++..++.|++.||.|||+ .+|+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 9999998 33446899999998 6888887644 3468999999999999999999996 89999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~ 725 (851)
++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999753221 22334568999999999876 67999999999999999999999999765432211
Q ss_pred cHHHHHHHHhhhcc-----------cccccCccC-------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 726 NLADWAMKWQKQRS-----------LKSIIDPHL-------KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 726 ~l~~~~~~~~~~~~-----------~~~i~d~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
. .......... ........+ .....+..++.+.+|+.+||+.||.+|||++|+++|
T Consensus 244 ~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--- 317 (362)
T 3pg1_A 244 N---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH--- 317 (362)
T ss_dssp H---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS---
T ss_pred H---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC---
Confidence 1 1110000000 000000000 001123345678999999999999999999999999
Q ss_pred HHHhhhhhccc
Q 047215 788 VLQLHEAWMRT 798 (851)
Q Consensus 788 ~~~~~~~w~~~ 798 (851)
+|++.
T Consensus 318 ------p~f~~ 322 (362)
T 3pg1_A 318 ------PYFES 322 (362)
T ss_dssp ------GGGTT
T ss_pred ------chhhh
Confidence 88764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=346.00 Aligned_cols=275 Identities=24% Similarity=0.353 Sum_probs=210.9
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHh--cCCcceeeEEEEEcc
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSK--LRHRHLVSLIGFCDE 580 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~ 580 (851)
.++..-....++|...+.||+|+||.||+|+.. ++.+|||++... ....+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 344444455678999999999999999999974 788999998643 34567889999887 789999999999977
Q ss_pred CC----cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC-----CCCeEEcCCCCCCeEEcCCC
Q 047215 581 QN----EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA-----ERGIIHRDVKTTNILLDENF 651 (851)
Q Consensus 581 ~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~-----~~~iiHrDlk~~NILld~~~ 651 (851)
.. ..++||||+++|+|.+++... .+++.+++.++.|++.||.|||+.. +.+|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 65 899999999999999999653 5899999999999999999999311 38999999999999999999
Q ss_pred eEEEeeccccccCCCCCcc--ccccccccCCcccCccccccc------CCCchHHHHHHHHHHHHHHhC----------C
Q 047215 652 VAKMSDFGLSKTGPSMEHT--HVSTAVKGSFGYLDPEYFWRQ------QLTEKSDVYSFGVVLFEVVCA----------R 713 (851)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~eLltG----------~ 713 (851)
.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999753322211 122345799999999999765 334789999999999999999 5
Q ss_pred cCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 714 AVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN-YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 714 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.||....+.. .....+...... ....+.+... .+.+++..+.+|+.+||+.||.+|||++|++++|+.+.+
T Consensus 265 ~p~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 265 LPYYDLVPSD-PSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CTTTTTSCSS-CCHHHHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccCcCc-ccHHHHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 6665433221 112222211111 1111211111 124677889999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=348.92 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=197.4
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc----
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE---- 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~---- 583 (851)
.++|+..+.||+|+||.||+|+. .+++.+|||++... .......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36799999999999999999986 56788999998764 33445678999999999999999999999865543
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++||||+++|+|.+++... .++++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 49999999999999999643 368999999999999999999995 8999999999999999999999999999976
Q ss_pred CCCCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 664 GPSMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 664 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ..........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~--- 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDP--- 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCC---
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCC---
Confidence 433211 122234568999999999999999999999999999999999999987543221 1111111110
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+ .......+..+.+++.+||+.||.+||+..+++.+
T Consensus 237 -~~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 237 -IPP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp -CCH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -CCc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 000 00112345678999999999999999999888887
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=349.87 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=204.6
Q ss_pred cccCHHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcC--CcceeeEEE
Q 047215 501 KRFTLAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLR--HRHLVSLIG 576 (851)
Q Consensus 501 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--HpnIv~l~g 576 (851)
..+.+..+....++|...+.||+|+||.||++...+++.+|+|++... .....+.+.+|+.++++++ ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 344444455566789999999999999999999888889999987643 4455678999999999997 599999999
Q ss_pred EEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEe
Q 047215 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMS 656 (851)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~ 656 (851)
++..++..++||| +.+++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+++ +.+||+
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEEC
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEe
Confidence 9999999999999 6788999999654 368899999999999999999995 89999999999999964 899999
Q ss_pred eccccccCCCCCccccccccccCCcccCcccccc-----------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh
Q 047215 657 DFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR-----------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725 (851)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~ 725 (851)
|||+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 246 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-- 246 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--
Confidence 9999986443322222344568999999999875 478999999999999999999999986543211
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
... ..+.++.....++...+..+.+++.+||+.||.+|||+.|+++|
T Consensus 247 ---~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 ---SKL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---HHH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHH---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 11222222233344445679999999999999999999999999
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.57 Aligned_cols=247 Identities=20% Similarity=0.321 Sum_probs=205.7
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh--------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE--------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
.++|...+.||+|+||.||+|+. .++..+|||++..... .....+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999985 4678899998765421 13345778999999999999999999999999
Q ss_pred cEEEEEEecCCc-chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 583 EMILVYEYMANG-TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 583 ~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
..++||||+..| +|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999877 999998654 368999999999999999999995 89999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
+..... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 178 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------- 235 (335)
T 3dls_A 178 AYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------- 235 (335)
T ss_dssp EECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------
T ss_pred eECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------
Confidence 864332 12334679999999999988876 8899999999999999999999864211
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...... ..+...+..+.+|+.+||+.||.+|||++|+++| +|+..
T Consensus 236 --~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h---------p~~~~ 280 (335)
T 3dls_A 236 --TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD---------PWVTQ 280 (335)
T ss_dssp --GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC---------TTTTC
T ss_pred --HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC---------ccccC
Confidence 001111 1122345668999999999999999999999999 88764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=358.49 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=205.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||+|+.. ++..+|+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999875 5788999988765 44556789999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 183 (360)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc----
Confidence 99999999999653 358899999999999999999995 3489999999999999999999999999986421
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHH-------------------
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW------------------- 730 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~------------------- 730 (851)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1122345789999999999999999999999999999999999999976432211000000
Q ss_pred ----HHHHhhhc----ccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 731 ----AMKWQKQR----SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 731 ----~~~~~~~~----~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
........ ....+.............+..+.+|+.+||+.||.+|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000 0000000011111112345679999999999999999999999999
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.43 Aligned_cols=259 Identities=20% Similarity=0.334 Sum_probs=204.9
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|....+||+|+||.||+|+. .++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556899999999999986 456789999987766666788999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccccCCCCCc
Q 047215 592 ANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 592 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~ 669 (851)
++++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+|||++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9999999986542 3456788899999999999999995 89999999999999987 8999999999997643221
Q ss_pred cccccccccCCcccCcccccccC--CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQ--LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ .. + ..... .
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~--~--~~~~~---------~ 242 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AM--F--KVGMF---------K 242 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HH--H--HHHHH---------C
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HH--H--hhccc---------c
Confidence 1223456899999999997653 89999999999999999999999864322111 00 0 00000 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.....+...+..+.+++.+||+.||++|||++|+++| +|++..
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~---------~~~~~~ 285 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD---------EFLKVS 285 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS---------GGGCC-
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC---------hhhhhc
Confidence 1122344556678999999999999999999999999 888643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=341.61 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=201.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC----hhhHHHHHHHHHHHHhcCCcceeeEEEEE--ccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS----EQGLAEFETEIEMLSKLRHRHLVSLIGFC--DEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~--~~~~~~~ 585 (851)
++|...+.||+|+||.||++... ++..+|+|++.... ......+.+|++++++++||||+++++++ ...+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 68999999999999999999874 56789999886532 23457899999999999999999999998 5566899
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||++++ |.+++.......+++.++..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999976 7677755555679999999999999999999995 899999999999999999999999999998654
Q ss_pred CCCccccccccccCCcccCcccccccC--CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQ--LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... +...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~-~~~---- 229 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIG-KGS---- 229 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-HCC----
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHh-cCC----
Confidence 333333334566899999999997654 478999999999999999999998754221 1111111 110
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+..++..+.+++.+||+.||.+|||++|+++|
T Consensus 230 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12233455678999999999999999999999999
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.01 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=202.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|+..+.||+|+||.||+|+.. +++.+|+|++... .......+.+|+..+.++ +||||+++++++..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999875 6788999987753 334556788999999999 999999999999999999999
Q ss_pred EEecCCcchhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC----------------
Q 047215 588 YEYMANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---------------- 649 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---------------- 649 (851)
|||+++|+|.+++.... ...+++.++..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999996432 2568999999999999999999995 89999999999999984
Q ss_pred ---CCeEEEeeccccccCCCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh
Q 047215 650 ---NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725 (851)
Q Consensus 650 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~ 725 (851)
...+||+|||++...... ....||+.|+|||.+.+. .++.++|||||||+++||++|++++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 447999999998764331 223589999999999766 66789999999999999999987653221
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+. .. ..+. ....+..++..+.+++.+||+.||.+|||+.|+++| +|+..
T Consensus 236 ---~~~-~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h---------~~~~~ 285 (289)
T 1x8b_A 236 ---QWH-EI-RQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH---------SVLLS 285 (289)
T ss_dssp ---HHH-HH-HTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC---------TTC--
T ss_pred ---HHH-HH-HcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC---------hHhhh
Confidence 010 00 1111 112234455679999999999999999999999999 88764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=364.02 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=190.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc-----cCCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD-----EQNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-----~~~~ 583 (851)
.++|+..++||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999864 6788999988653 4445678999999999999999999999993 3367
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+++||||+. |+|.+++... ..+++..+..++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 999999985 7999988553 468999999999999999999996 8999999999999999999999999999986
Q ss_pred CCCCCcc-------------------------ccccccccCCcccCcccc-cccCCCchHHHHHHHHHHHHHHh------
Q 047215 664 GPSMEHT-------------------------HVSTAVKGSFGYLDPEYF-WRQQLTEKSDVYSFGVVLFEVVC------ 711 (851)
Q Consensus 664 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~GvvL~eLlt------ 711 (851)
....... ......+||+.|+|||++ ....++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 4321110 123455789999999986 56679999999999999999999
Q ss_pred -----CCcCCCCCCCcch-----------------hcHHHHHHHHhhhcc--------------cccccCccCC---CCC
Q 047215 712 -----ARAVINPTLPKDQ-----------------INLADWAMKWQKQRS--------------LKSIIDPHLK---GNY 752 (851)
Q Consensus 712 -----G~~p~~~~~~~~~-----------------~~l~~~~~~~~~~~~--------------~~~i~d~~l~---~~~ 752 (851)
|+++|.+...... .+............. ....+..... ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 4555543221000 000000000000000 0000000000 011
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+..+..+.+|+.+||+.||.+|||++|+|+| +|++.
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H---------p~f~~ 402 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAH---------PFFKE 402 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS---------GGGTT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcC---------Hhhhh
Confidence 12345678999999999999999999999999 88764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=342.54 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=201.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|+..+.||+|+||.||+|+.. +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999976 578899998764321 23678999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC----eEEEeecccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF----VAKMSDFGLS 661 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~----~~kl~DFGla 661 (851)
+||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999998543 468999999999999999999995 8999999999999998776 8999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~--- 227 (283)
T 3bhy_A 160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAVN--- 227 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC---
T ss_pred eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhcc---
Confidence 7643221 2234568999999999999999999999999999999999999987543211 111111000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...........+..+.+++.+||+.||.+|||+.|+++|
T Consensus 228 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 ----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000000112345668999999999999999999999999
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.75 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=197.7
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------C
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------N 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 582 (851)
.++|...+.||+|+||.||+|.. ..++.||||++... .....+.+.+|+++|++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999987 46788999998653 344456789999999999999999999999765 3
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+ +++|.+++.. ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 7899999865 358899999999999999999996 899999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh----
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ---- 737 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 737 (851)
..... .....||+.|+|||++.+ ..++.++||||+||+++||++|+.||......++.............
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 64321 234568999999999887 68999999999999999999999999765433221111000000000
Q ss_pred -----------cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 738 -----------RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 738 -----------~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.......+ ....+..+..+.+|+.+||+.||.+|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000001 11223456679999999999999999999999999
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=344.23 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=203.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc----------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE---------- 580 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~---------- 580 (851)
.++|+..+.||+|+||.||+|+.. +++.+|+|++.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 367899999999999999999975 67889999987654 346789999999999999999998854
Q ss_pred ------CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEE
Q 047215 581 ------QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAK 654 (851)
Q Consensus 581 ------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~k 654 (851)
....++||||+++|+|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 4568999999999999999976555678999999999999999999995 8999999999999999999999
Q ss_pred EeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 655 MSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+... ..+...
T Consensus 163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~- 230 (284)
T 2a19_B 163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD- 230 (284)
T ss_dssp ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH-
T ss_pred ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH-
Confidence 99999987643322 223456899999999999999999999999999999999998765311 111111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
+....+ +...+..+.+++.+||+.||.+|||+.|++++|+.+.
T Consensus 231 --------~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 --------LRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------HHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------hhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111111 2233456889999999999999999999999988653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=366.92 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=209.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|...++||+|+||.||+++.. +++.+|+|++.... ......+.+|+++|++++||||+++++++...+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999975 57899999986432 23456788999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCC--CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 588 YEYMANGTLRSHLFGSD--LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
|||+++|+|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986543 4568999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...... .
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~---------~ 407 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL---------E 407 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH---------H
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh---------h
Confidence 321 123345899999999999999999999999999999999999999976532211 111111111 1
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
.. ..++...+..+.+|+.+||+.||.+||++ +++++|
T Consensus 408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 11 12334556778999999999999999964 889888
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.84 Aligned_cols=265 Identities=24% Similarity=0.377 Sum_probs=202.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||.||+|+.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 67889999999999999999975 4788999987554 33345668899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 105 FVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp CCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 99999999887543 358999999999999999999995 89999999999999999999999999999754321
Q ss_pred cccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH---------HHHHHhhhcc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD---------WAMKWQKQRS 739 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~---------~~~~~~~~~~ 739 (851)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...... +...+.....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 1223345689999999999875 78999999999999999999999987654322211100 0000111111
Q ss_pred cccccCccCCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 LKSIIDPHLKGNY-----SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ~~~i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+.+.... .+.+++.+.+|+.+||+.||.+|||++|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111 12456779999999999999999999999999
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.75 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=204.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+.. ++..+|+|++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67889999999999999999875 46788999875431 223467899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999998653 358899999999999999999994 89999999999999999999999999998753321
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..... ....
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~---------~~~~- 228 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRI---------VNVD- 228 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH---------HTTC-
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHH---------hccc-
Confidence 1234568999999999999999999999999999999999999986542211 11111 1111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..++...+..+.+++.+||+.||.+|||++|+++|
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 12334455678999999999999999999999999
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=340.88 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=200.1
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|...+.||+|+||.||+|.. .++..+|+|++... .......+.+|+.++++++||||+++++++..++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5789999999999999999986 46788999988653 3455678999999999999999999999999999999999
Q ss_pred EecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 589 EYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 589 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||+++|+|.+++.. .....+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998853 223568899999999999999999995 8999999999999999999999999999876432
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~-------- 253 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-C-------- 253 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-T--------
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-c--------
Confidence 11 1223456899999999999999999999999999999999999998653221 1111111111 1
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
..........+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111111234456799999999999999999999999999877643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.51 Aligned_cols=265 Identities=17% Similarity=0.232 Sum_probs=208.4
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEE-ccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC-DEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~lV~E 589 (851)
.++|+..+.||+|+||.||+|+. .+++.+|+|++..... ...+.+|+.++++++|++++..+.++ ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999996 5778999998765433 24688999999999988877766665 66678899999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccccCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~~ 666 (851)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 899999986332 468999999999999999999995 899999999999999 5889999999999976433
Q ss_pred CCcc-----ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 667 MEHT-----HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 667 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence 2211 1124567999999999999999999999999999999999999999865433322222221111111000
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
+.+ ...+++.+.+++.+||+.||.+|||++++++.|+.+....
T Consensus 240 ----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 ----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 011 1234466899999999999999999999999999876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=336.70 Aligned_cols=267 Identities=17% Similarity=0.229 Sum_probs=205.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEE-ccCCcEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC-DEQNEMILVY 588 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~lV~ 588 (851)
..++|+..+.||+|+||.||+|+. .+++.+|+|+...... ...+.+|+.++++++|++++..++++ ..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 347899999999999999999986 5678899997654322 23578899999999988877777666 6677889999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~ 665 (851)
||+ +++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999986432 358999999999999999999995 899999999999999 789999999999998643
Q ss_pred CCCcc-----ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 666 SMEHT-----HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 666 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 32211 1223567999999999999999999999999999999999999999865443332222221111111000
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (851)
+.+ ....++.+.+++.+||+.||++|||++++++.|+.+.+...
T Consensus 240 -----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 -----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 001 12234579999999999999999999999999998876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.08 Aligned_cols=275 Identities=21% Similarity=0.317 Sum_probs=205.1
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--------C
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--------Q 581 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--------~ 581 (851)
++|+..++||+|+||.||+|+. .+++.+|+|++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6799999999999999999997 567899999876542 2334578899999999999999999999876 4
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
+..++||||+++ +|.+.+.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 568999999985 7777665433 458999999999999999999995 89999999999999999999999999999
Q ss_pred ccCCCCC--ccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 662 KTGPSME--HTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 662 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
+...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7643221 1122345678999999999876 468999999999999999999999987654332211111000000000
Q ss_pred ccccc-----cCc-c-CCCC-CC-hh------HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCC
Q 047215 739 SLKSI-----IDP-H-LKGN-YS-PE------SLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDR 801 (851)
Q Consensus 739 ~~~~i-----~d~-~-l~~~-~~-~~------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~ 801 (851)
....+ .+. . .... .. .+ ..+.+.+|+.+||+.||.+|||++|+++| +|+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---------p~f~~~~~ 320 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH---------DFFWSDPM 320 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGGSSSC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC---------CCcCCCCC
Confidence 00000 000 0 0000 00 00 13558899999999999999999999999 99875433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.54 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=204.6
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEc----cCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD----EQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~l 586 (851)
.++|+..+.||+|+||.||+++. .+++.+|+|++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999987 567899999987777777788999999999999999999999986 3457899
Q ss_pred EEEecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 587 VYEYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
||||+++|+|.+++... ....+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988542 34568999999999999999999996 89999999999999999999999999998753
Q ss_pred CCCCccc-------cccccccCCcccCcccccccC---CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 665 PSMEHTH-------VSTAVKGSFGYLDPEYFWRQQ---LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 665 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ ..... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~---~ 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA---V 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH---H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH---h
Confidence 2111100 112345799999999987543 78999999999999999999998853111000 01000 0
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
............+..+.+++.+||+.||.+|||+++++++|+.+
T Consensus 261 ----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 261 ----------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp ----------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 00111112234556799999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=351.09 Aligned_cols=261 Identities=27% Similarity=0.403 Sum_probs=202.5
Q ss_pred cCHHHHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 503 FTLAEIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
+.+.++....++|+..+.||+|+||.||+|+. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34444555678999999999999999999997 467889999886543 3346789999999999 89999999999865
Q ss_pred ------CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEE
Q 047215 581 ------QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAK 654 (851)
Q Consensus 581 ------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~k 654 (851)
.+..++||||+++|+|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 5688999999999999999976555678999999999999999999995 8999999999999999999999
Q ss_pred EeeccccccCCCCCccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH
Q 047215 655 MSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729 (851)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~ 729 (851)
|+|||++...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 170 l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 242 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred EeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----
Confidence 9999998764321 11223456899999999987 56789999999999999999999999865432211
Q ss_pred HHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 730 WAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 730 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..... .. ..+.+ .+...+..+.+++.+||+.||.+|||++++++|
T Consensus 243 -~~~~~-~~-----~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 -LFLIP-RN-----PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HHHHH-HS-----CCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHhh-cC-----ccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 01 01111 123345678999999999999999999999999
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.06 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=188.8
Q ss_pred HhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC-h-hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS-E-QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~-~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
..++|+..+.||+|+||.||+|+. .+++.+|+|++.... . ...+.+.++...++.++||||+++++++..++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 347899999999999999999987 467889999987642 2 2233455555668888999999999999999999999
Q ss_pred EEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCC-CeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 588 YEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~-~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
|||++ |+|.+++.. .....+++.++..++.|++.||.|||+ . +++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99998 588777643 234568999999999999999999996 6 9999999999999999999999999999764
Q ss_pred CCCCccccccccccCCcccCcccc----cccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYF----WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
... .......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .+ ......
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~--- 229 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QL----KQVVEE--- 229 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HH----HHHHHS---
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HH----HHHhcc---
Confidence 322 122334689999999996 566799999999999999999999999875322111 11 111111
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..........+..+.+++.+||+.||.+|||+.|+++|
T Consensus 230 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 230 ------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11111123445678999999999999999999999999
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=350.84 Aligned_cols=254 Identities=16% Similarity=0.182 Sum_probs=205.4
Q ss_pred HHhcCCceeeeeeeecceEEEEEE------EcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC---CcceeeEEEEEcc
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGE------IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR---HRHLVSLIGFCDE 580 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~ 580 (851)
...++|...++||+|+||.||+|. ...++.+|+|++.... ..++..|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 4567889999987654 346778888888886 9999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCC---CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC--------
Q 047215 581 QNEMILVYEYMANGTLRSHLFGS---DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-------- 649 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-------- 649 (851)
++..+|||||+++|+|.+++... ....+++.++..++.|++.||+|||+ .+||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999531 34569999999999999999999995 89999999999999998
Q ss_pred ---CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhc
Q 047215 650 ---NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726 (851)
Q Consensus 650 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~ 726 (851)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999975332223334456779999999999999999999999999999999999999885432211
Q ss_pred HHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHH
Q 047215 727 LADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNR-PTMGEVLWHLEYVLQ 790 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~evl~~L~~~~~ 790 (851)
......+.. . ...+.+.+++..||+.+|.+| |+++++.+.|+.+++
T Consensus 293 ---------------~~~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ---------------CKPEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---------------EEECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------------eeechhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 001111111 1 235668899999999999998 578888888776554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.65 Aligned_cols=270 Identities=24% Similarity=0.341 Sum_probs=191.7
Q ss_pred HHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
...++|+..+.||+|+||.||+|+. .++..+|||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999985 467889999886543 34456788999999999999999999999999999999
Q ss_pred EEecCCcchhhhccC------CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 588 YEYMANGTLRSHLFG------SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~------~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
|||+++++|.+++.. .....+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998853 124568999999999999999999995 89999999999999999999999999998
Q ss_pred ccCCCCC---ccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh
Q 047215 662 KTGPSME---HTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737 (851)
Q Consensus 662 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (851)
+...... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~-~ 241 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTL-Q 241 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH-T
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHh-c
Confidence 7543221 1112234568999999999876 57899999999999999999999998765433211 0000 1
Q ss_pred cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 738 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...................+..+.+++.+||+.||.+|||+.|+++| +|+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h---------~~~~~ 293 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH---------KFFQK 293 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS---------TTC--
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC---------hhhhc
Confidence 11111110001111223345678999999999999999999999999 88764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.89 Aligned_cols=263 Identities=22% Similarity=0.251 Sum_probs=204.7
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC--------CcceeeEEEEEc---
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR--------HRHLVSLIGFCD--- 579 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~g~~~--- 579 (851)
.++|+..++||+|+||.||+|+. .+++.+|||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 37899999999999999999986 45788999998754 344577899999999995 888999999987
Q ss_pred -cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCC-CeEEcCCCCCCeEEcCCC------
Q 047215 580 -EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRDVKTTNILLDENF------ 651 (851)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~-~iiHrDlk~~NILld~~~------ 651 (851)
.+...++||||+ +++|.+.+.......+++.++..++.|++.||+|||+ + +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 667899999999 5566666654444679999999999999999999996 6 999999999999998775
Q ss_pred -------------------------------------------eEEEeeccccccCCCCCccccccccccCCcccCcccc
Q 047215 652 -------------------------------------------VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688 (851)
Q Consensus 652 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 688 (851)
.+||+|||+++..... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 8999999999764321 2345689999999999
Q ss_pred cccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh-hccc-----------ccccCc----------
Q 047215 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK-QRSL-----------KSIIDP---------- 746 (851)
Q Consensus 689 ~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~~-----------~~i~d~---------- 746 (851)
.+..++.++|||||||+||||++|+.||............+....... .+.. ......
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999986544322111111111100 0000 000000
Q ss_pred c---------CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 747 H---------LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 747 ~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. -....+...+..+.+|+.+||+.||++|||++|+++|
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 0112456778889999999999999999999999999
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.19 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=191.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEE--------cc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFC--------DE 580 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~--------~~ 580 (851)
...+|+..++||+|+||.||+|+.. +++.+|+|++........+.+.+|+.+++++. ||||+++++++ ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4468899999999999999999964 67889999987777777788999999999996 99999999998 44
Q ss_pred CCcEEEEEEecCCcchhhhccC-CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC--eEEcCCCCCCeEEcCCCeEEEee
Q 047215 581 QNEMILVYEYMANGTLRSHLFG-SDLPPLTWKQRLDACIGAARGLHYLHTGAERG--IIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~--iiHrDlk~~NILld~~~~~kl~D 657 (851)
....++||||++ |+|.+++.. ....++++.+++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 456899999996 799888754 223469999999999999999999995 77 99999999999999999999999
Q ss_pred ccccccCCCCCccc----------cccccccCCcccCcccc---cccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch
Q 047215 658 FGLSKTGPSMEHTH----------VSTAVKGSFGYLDPEYF---WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724 (851)
Q Consensus 658 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~ 724 (851)
||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998643321110 11244689999999998 56788999999999999999999999986432211
Q ss_pred hcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 725 INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
+.............+..+.+|+.+||+.||.+|||+.|++++|+.+...
T Consensus 261 ------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 ------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111111222334588999999999999999999999999877653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=351.41 Aligned_cols=266 Identities=14% Similarity=0.163 Sum_probs=208.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC---------cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceee---------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED---------CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVS--------- 573 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~--------- 573 (851)
.++|...+.||+|+||.||+|+... ++.+|+|.+... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998764 788999998654 35789999999999999998
Q ss_pred ------EEEEEcc-CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 574 ------LIGFCDE-QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 574 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
+++++.. ++..++||||+ +++|.+++.......+++.+++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 6777765 77889999999 9999999976544679999999999999999999996 89999999999999
Q ss_pred EcCCC--eEEEeeccccccCCCCCc-----cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCC
Q 047215 647 LDENF--VAKMSDFGLSKTGPSMEH-----THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPT 719 (851)
Q Consensus 647 ld~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~ 719 (851)
++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 999999999976432111 11123457999999999999999999999999999999999999998765
Q ss_pred CCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 720 LPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 720 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
.+.. ..+........ .....+.++... ....+..+.+++.+||+.||.+|||++++++.|+.+.+..
T Consensus 272 ~~~~-~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LPNT-EDIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTCH-HHHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcCH-HHHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 3221 11111111111 111111111110 1233467999999999999999999999999999877543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=362.54 Aligned_cols=242 Identities=14% Similarity=0.175 Sum_probs=192.4
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCC---CChhhHHHHHHHH---HHHHhcCCcceeeEE-------EE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANP---QSEQGLAEFETEI---EMLSKLRHRHLVSLI-------GF 577 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei---~~l~~l~HpnIv~l~-------g~ 577 (851)
.++|...+.||+|+||.||+|+. .+++.+|||++.. ......+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 5688999999863 3445567899999 555566899999998 66
Q ss_pred EccCC-----------------cEEEEEEecCCcchhhhccCCC-----CCCCchhhhHHHHHHHHHHHHHhhcCCCCCe
Q 047215 578 CDEQN-----------------EMILVYEYMANGTLRSHLFGSD-----LPPLTWKQRLDACIGAARGLHYLHTGAERGI 635 (851)
Q Consensus 578 ~~~~~-----------------~~~lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~i 635 (851)
+..++ ..+|||||+ +|+|.+++.... ...+++..++.++.|++.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 65553 389999999 689999986421 2235568889999999999999996 899
Q ss_pred EEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCccccccc-----------CCCchHHHHHHHH
Q 047215 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-----------QLTEKSDVYSFGV 704 (851)
Q Consensus 636 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwS~Gv 704 (851)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985221 2344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 705 VLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 705 vL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+||||++|+.||........ ...+... ...+++.+.+|+.+||+.||.+|||+.|+++|
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999865432211 1111110 12344668999999999999999999999999
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=354.47 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=166.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----Cc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~ 583 (851)
.++|...++||+|+||.||+|+.. .++.||||++... .....+.+.+|+++|++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999864 5678999998754 444567889999999999999999999999766 57
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++||||++ |+|.+++... ..+++.++..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999987 5999998653 468999999999999999999996 8999999999999999999999999999986
Q ss_pred CCCCCcc--------------------ccccccccCCcccCcccc-cccCCCchHHHHHHHHHHHHHHhCCcCC
Q 047215 664 GPSMEHT--------------------HVSTAVKGSFGYLDPEYF-WRQQLTEKSDVYSFGVVLFEVVCARAVI 716 (851)
Q Consensus 664 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~GvvL~eLltG~~p~ 716 (851)
....... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 4332111 123556799999999986 5667999999999999999999854443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=375.90 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=200.2
Q ss_pred eeeeeecceEEEEEEEc---CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIE---DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||.||+|.+. .++.+|||++... .....+++.+|+++|++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 4567999998764 33446789999999999999999999999964 568999999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc-ccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH-THV 672 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-~~~ 672 (851)
|+|.++|... ..+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++....... ...
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999543 468999999999999999999995 8999999999999999999999999999986433221 122
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+ +. ..... .....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~---------~~~~~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEK---------GERMG 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHT---------TCCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHc---------CCCCC
Confidence 334457889999999999999999999999999999998 999987643321 11 11111 11223
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.+..++..+.+|+.+||+.||++|||++++++.|+.+..
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 445667789999999999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=339.35 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=205.4
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|...+.||+|+||.||+++.. .++.+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 67888999999999999999976 4677899987543 3445678899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999988543 368999999999999999999995 899999999999999999999999999997643221
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....... ..
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~---------~~- 231 (294)
T 2rku_A 170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKK---------NE- 231 (294)
T ss_dssp --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHT---------TC-
T ss_pred --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhh---------cc-
Confidence 12334568999999999999999999999999999999999999986543211 1111111 00
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+...+..+.+++.+||+.||++|||++|+++|
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11233445678999999999999999999999999
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.46 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=204.7
Q ss_pred hcCCceeeeeeeecceEEEEEEE----cCcceeEEeecCCCC----hhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI----EDCTLAAIKRANPQS----EQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 582 (851)
.++|+..++||+|+||.||+++. ..++.+|||++.... ....+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 367899999886532 23345677899999999 6999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999653 358899999999999999999995 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
..... .........||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ...........
T Consensus 208 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~--- 281 (355)
T 1vzo_A 208 EFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 281 (355)
T ss_dssp ECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC---
T ss_pred ecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc---
Confidence 64321 2222344679999999999985 4578999999999999999999999975433221 11111111100
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 784 (851)
...++...+..+.+|+.+||+.||.+|| |++|+++|
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1123445566789999999999999999 99999999
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=349.57 Aligned_cols=265 Identities=21% Similarity=0.337 Sum_probs=210.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChh-----------------hHHHHHHHHHHHHhcCCcceeeE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQ-----------------GLAEFETEIEMLSKLRHRHLVSL 574 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~HpnIv~l 574 (851)
.++|...+.||+|+||.||+|+. ++..+|+|++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 8889999987643211 11789999999999999999999
Q ss_pred EEEEccCCcEEEEEEecCCcchhhh------ccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc
Q 047215 575 IGFCDEQNEMILVYEYMANGTLRSH------LFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD 648 (851)
Q Consensus 575 ~g~~~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld 648 (851)
++++...+..++||||+++|+|.++ +.......+++.++..++.|++.||.|||+ +.+++||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999999 655446789999999999999999999994 48999999999999999
Q ss_pred CCCeEEEeeccccccCCCCCccccccccccCCcccCccccccc-CCCc-hHHHHHHHHHHHHHHhCCcCCCCCCCcchhc
Q 047215 649 ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTE-KSDVYSFGVVLFEVVCARAVINPTLPKDQIN 726 (851)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~ 726 (851)
.++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-- 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--
T ss_pred CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Confidence 9999999999999764322 23456789999999999877 6666 99999999999999999999976543211
Q ss_pred HHHHHHHHhhhccccccc------CccC---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 727 LADWAMKWQKQRSLKSII------DPHL---KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~------d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
+ .... ......... .+.. ........+..+.+++.+||+.||.+|||++|+++| +|+.
T Consensus 261 ~---~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h---------p~f~ 327 (348)
T 2pml_X 261 L---FNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH---------EWLA 327 (348)
T ss_dssp H---HHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS---------GGGT
T ss_pred H---HHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC---------cccc
Confidence 1 1111 111110000 0000 000113456779999999999999999999999999 8886
Q ss_pred c
Q 047215 798 T 798 (851)
Q Consensus 798 ~ 798 (851)
.
T Consensus 328 ~ 328 (348)
T 2pml_X 328 D 328 (348)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.72 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=206.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|...+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367889999999999999999875 4678899987543 345567889999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988543 468999999999999999999995 89999999999999999999999999999764322
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-------~- 258 (335)
T 2owb_A 195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-------Y- 258 (335)
T ss_dssp T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-------C-
T ss_pred c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcCC-------C-
Confidence 1 12344568999999999999999999999999999999999999986543211 111111110 1
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+...+..+.+++.+||+.||.+|||++|+++|
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223445668999999999999999999999999
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=343.79 Aligned_cols=268 Identities=18% Similarity=0.282 Sum_probs=210.5
Q ss_pred hcCCceeeeeeeecceEEEEEEE--cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc------eeeEEEEEccCCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI--EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH------LVSLIGFCDEQNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~~~~~ 583 (851)
.++|+..+.||+|+||.||+|.. .++..+|||++... ....+.+.+|++++++++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999986 35788999998754 344577899999999998765 9999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC--------------
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-------------- 649 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-------------- 649 (851)
.++||||+ +++|.+++......++++.++..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 8899999977665678999999999999999999995 89999999999999987
Q ss_pred -----CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch
Q 047215 650 -----NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724 (851)
Q Consensus 650 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~ 724 (851)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999763321 2345789999999999999999999999999999999999999976543322
Q ss_pred hcHHHHHHH-----Hhhhccccc---------------------ccCccC-CCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 047215 725 INLADWAMK-----WQKQRSLKS---------------------IIDPHL-KGNYSPESLEKFGEIAEKCLDDEGKNRPT 777 (851)
Q Consensus 725 ~~l~~~~~~-----~~~~~~~~~---------------------i~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 777 (851)
......... +........ ...+.. .......+++.+.+|+.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 111111000 000000000 000000 01123456788999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhccc
Q 047215 778 MGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 778 ~~evl~~L~~~~~~~~~w~~~ 798 (851)
+.|+++| +|++.
T Consensus 323 ~~ell~h---------p~f~~ 334 (339)
T 1z57_A 323 LREALKH---------PFFDL 334 (339)
T ss_dssp HHHHTTS---------GGGGG
T ss_pred HHHHhcC---------HHHHH
Confidence 9999999 88864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.73 Aligned_cols=270 Identities=23% Similarity=0.332 Sum_probs=208.5
Q ss_pred HhcCCceeeeeeeecceEEEEEEE--cCcceeEEeecCCCC--hhhHHHHHHHHHHHHhc---CCcceeeEEEEEc----
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEI--EDCTLAAIKRANPQS--EQGLAEFETEIEMLSKL---RHRHLVSLIGFCD---- 579 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~--~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~---- 579 (851)
..++|+..+.||+|+||.||+|+. .++..+|+|++.... ......+.+|+.+++++ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 467889999875432 22233566788777766 8999999999986
Q ss_pred -cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 580 -EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
.....++||||++ |+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678899999998 699999876655669999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh-
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ- 737 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~- 737 (851)
|+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCC
Confidence 99976332 2223456789999999999999999999999999999999999999876533221 1111111000
Q ss_pred --ccccc-------ccC---ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 738 --RSLKS-------IID---PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 738 --~~~~~-------i~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
..... ... ......+....+..+.+|+.+||+.||.+|||+.|+++| +|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h---------p~~~~~ 303 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH---------PYFQDL 303 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS---------GGGTTC
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC---------cccccc
Confidence 00000 000 000011223456778999999999999999999999999 888653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.63 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=205.6
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEcc--CCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDE--QNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~--~~~~~lV~ 588 (851)
++|+..++||+|+||.||+|+. .+++.+|+|++.... .+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999986 567889999987543 457889999999997 9999999999977 67789999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccccCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSKTGPSM 667 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~ 667 (851)
||+++++|.+++. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999883 37889999999999999999995 8999999999999999766 8999999999764332
Q ss_pred CccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh--------hc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK--------QR 738 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~ 738 (851)
. ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+......... ..
T Consensus 185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHT
T ss_pred C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHh
Confidence 2 2234568999999999977 6799999999999999999999999865433211 11111110000 00
Q ss_pred cc------ccc--------cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 739 SL------KSI--------IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 739 ~~------~~i--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.. ..+ .............+..+.+|+.+||+.||.+|||++|+++| +|+..-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h---------p~f~~~ 326 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH---------PYFYTV 326 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS---------GGGTTC
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC---------ccHhhh
Confidence 00 000 00011111223356789999999999999999999999999 998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.75 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=196.2
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|...+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 67889999999999999999975 67889999876432 233567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 999999999998543 358899999999999999999995 89999999999999999999999999999764332
Q ss_pred ccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ....... .+.
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~-------- 227 (276)
T 2h6d_A 165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIR-GGV-------- 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCC--------
T ss_pred --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhh-cCc--------
Confidence 12234568999999999987765 68999999999999999999998653211 1111111 110
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+...+..+.+++.+||+.||.+|||++|+++|
T Consensus 228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01223445678999999999999999999999999
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.02 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=203.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEE--ccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFC--DEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~--~~~~~~~l 586 (851)
.++|+..+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367889999999999999999875 6788999988654 345567899999999999999999999987 45678999
Q ss_pred EEEecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCCCCC-----eEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 587 VYEYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGAERG-----IIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~-----iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
||||+++|+|.+++... ....+++.+++.++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998642 23458999999999999999999996 56 9999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
+++..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+. ... ..+.
T Consensus 162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~i-~~~~ 232 (279)
T 2w5a_A 162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA---GKI-REGK 232 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHH-HHTC
T ss_pred hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH---HHH-hhcc
Confidence 99764322 11223456899999999999999999999999999999999999998754321 111 111 1111
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ...+...+..+.+++.+||+.||.+|||++|++++
T Consensus 233 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 233 F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1 12233455679999999999999999999999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.47 Aligned_cols=264 Identities=16% Similarity=0.142 Sum_probs=197.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCCChh-----------hHHHHHHHHHHHHhcCCcceeeEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQSEQ-----------GLAEFETEIEMLSKLRHRHLVSLIG 576 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~HpnIv~l~g 576 (851)
.++|...+.||+|+||.||+|+.. .+..+|+|+....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 5678899987755322 1234678889999999999999999
Q ss_pred EEcc----CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-
Q 047215 577 FCDE----QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF- 651 (851)
Q Consensus 577 ~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~- 651 (851)
++.. +...++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 9977 77899999999 999999996543 68999999999999999999996 8999999999999998877
Q ss_pred -eEEEeeccccccCCCCC-----ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh
Q 047215 652 -VAKMSDFGLSKTGPSME-----HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725 (851)
Q Consensus 652 -~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~ 725 (851)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~- 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV- 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-
Confidence 99999999997643211 11112455799999999999999999999999999999999999999964322211
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
.......... . ........... ...++..+.+++.+||+.||.+|||++++++.|+.
T Consensus 269 ~~~~~~~~~~-~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 269 AVQTAKTNLL-D-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHHHHH-H-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHHHHHHhhc-c-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111111110 0 00000000000 11345679999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.37 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=194.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHH-HHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEM-LSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|+..++||+|+||.||+|+.. ++..+|+|++.... ......+..|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999975 46788999876542 2334456677776 567899999999999999999999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999998653 358889999999999999999995 8999999999999999999999999999975322
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..... ...
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i---------~~~ 254 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNI---------LNK 254 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHH---------HHS
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHH---------Hhc
Confidence 1 122345689999999999999999999999999999999999999997542211 11111 111
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM----GEVLWH 784 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~~ 784 (851)
.+ .+++..+..+.+|+.+||+.||.+||++ .++++|
T Consensus 255 ~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 255 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 11 1233455678999999999999999997 466666
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=350.80 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=205.0
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--------hhHHHHHHHHHHHHhc-CCcceeeEEEE
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--------QGLAEFETEIEMLSKL-RHRHLVSLIGF 577 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~HpnIv~l~g~ 577 (851)
.....++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999985 688999998765431 1245688999999999 79999999999
Q ss_pred EccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEee
Q 047215 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~D 657 (851)
+...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998543 468999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccCCcccCcccccc------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHH
Q 047215 658 FGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWA 731 (851)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~ 731 (851)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~-- 315 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLR-- 315 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH--
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHH--
Confidence 99987643322 2344679999999999864 358899999999999999999999986542211 111
Q ss_pred HHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 732 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. ..+... ...+. ....+..+.+++.+||+.||.+|||++|+++|
T Consensus 316 -~i-~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 316 -MI-MEGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -HH-HHTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HH-HhCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 111000 00000 01234568999999999999999999999999
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.16 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=204.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|++.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999976 4788999998877666778899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..... ..
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TL 171 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HH
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccc--cc
Confidence 99999999885432 458999999999999999999995 8999999999999999999999999998753110 11
Q ss_pred ccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 671 HVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.......||+.|+|||++. ...++.++||||||+++|||++|+.|+....... ......... .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~----- 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSD-P----- 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-C-----
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccC-C-----
Confidence 1123356899999999984 6678999999999999999999999987543211 111111110 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
+. ...+...+..+.+++.+||+.||.+|||+.++++| +|+..
T Consensus 240 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h---------~~~~~ 281 (302)
T 2j7t_A 240 PT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH---------PFVSS 281 (302)
T ss_dssp CC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS---------TTTTT
T ss_pred cc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC---------hHHhh
Confidence 00 11234455679999999999999999999999999 89864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=354.02 Aligned_cols=254 Identities=13% Similarity=0.061 Sum_probs=185.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHHHHHHHHHhc--CCcceeeEE-------EEEc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFETEIEMLSKL--RHRHLVSLI-------GFCD 579 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l--~HpnIv~l~-------g~~~ 579 (851)
.+|...+.||+|+||.||+|+.. +++.+|||++.... ....+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999964 67889999987753 24456678886555555 699988755 4443
Q ss_pred cC-----------------CcEEEEEEecCCcchhhhccCCCCCCCchhhh------HHHHHHHHHHHHHhhcCCCCCeE
Q 047215 580 EQ-----------------NEMILVYEYMANGTLRSHLFGSDLPPLTWKQR------LDACIGAARGLHYLHTGAERGII 636 (851)
Q Consensus 580 ~~-----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~------~~i~~~ia~gL~yLHs~~~~~ii 636 (851)
.. ...+|||||++ |+|.+++.... ..+.+..+ ..++.|++.||+|||+ ++|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence 22 34899999999 89999996532 23455566 7888999999999995 8999
Q ss_pred EcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCc
Q 047215 637 HRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARA 714 (851)
Q Consensus 637 HrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~ 714 (851)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999986422 1113456799999999987 789999999999999999999999
Q ss_pred CCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 715 VINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 715 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
||....+...... ............+.......++..+.+|+.+||+.||++|||+.|+++|
T Consensus 292 Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9986543321100 0000000111111112223566789999999999999999999999999
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=366.00 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=205.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|+..++||+|+||.||+|+.. .++.+|||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467899999999999999999875 6788999987543 234567899999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccccC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTG 664 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~ 664 (851)
|||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999988654 468999999999999999999996 899999999999999 56789999999999764
Q ss_pred CCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+ .. ... ..+...
T Consensus 180 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i-~~~~~~--- 245 (484)
T 3nyv_A 180 EASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---IL---KKV-EKGKYT--- 245 (484)
T ss_dssp CCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-HHCCCC---
T ss_pred cccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHH-HcCCCC---
Confidence 3321 2344579999999999866 69999999999999999999999997643221 11 111 111100
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.........++.+.+|+.+||+.||.+|||+.|+++|
T Consensus 246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0001113456779999999999999999999999999
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=354.94 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=197.8
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-------
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE------- 580 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------- 580 (851)
....++|...+.||+|+||.||+|+. .+++.+|||++...... ..+|++++++++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44568899999999999999999986 56789999988654322 2479999999999999999999833
Q ss_pred -------------------------------CCcEEEEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHh
Q 047215 581 -------------------------------QNEMILVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYL 627 (851)
Q Consensus 581 -------------------------------~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yL 627 (851)
....++||||++ |+|.+.+.. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999998 587777643 2345689999999999999999999
Q ss_pred hcCCCCCeEEcCCCCCCeEEc-CCCeEEEeeccccccCCCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHH
Q 047215 628 HTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVV 705 (851)
Q Consensus 628 Hs~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvv 705 (851)
|+ .+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||+
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 94 8999999999999997 68999999999998643322 22345689999999998764 59999999999999
Q ss_pred HHHHHhCCcCCCCCCCcchhcHHHHHHHHh--------h-hcccccccCccC-----CCCCChhHHHHHHHHHHHhcccC
Q 047215 706 LFEVVCARAVINPTLPKDQINLADWAMKWQ--------K-QRSLKSIIDPHL-----KGNYSPESLEKFGEIAEKCLDDE 771 (851)
Q Consensus 706 L~eLltG~~p~~~~~~~~~~~l~~~~~~~~--------~-~~~~~~i~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~d 771 (851)
+|||++|+.||......++. ........ . ........-+.+ ...++...+..+.+|+.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~~~~--~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQL--VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999999765433221 11111000 0 000001111111 11123345677999999999999
Q ss_pred CCCCCCHHHHHHH
Q 047215 772 GKNRPTMGEVLWH 784 (851)
Q Consensus 772 P~~RPt~~evl~~ 784 (851)
|.+|||+.|+++|
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999999
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=344.38 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=201.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEc-----------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD----------- 579 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----------- 579 (851)
.++|...+.||+|+||.||+|.... ++.+|+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3678899999999999999999764 7889999988777777888999999999999999999999873
Q ss_pred ---cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEE
Q 047215 580 ---EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKM 655 (851)
Q Consensus 580 ---~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl 655 (851)
..+..++||||++ |+|.+++.. .++++.++..++.|++.||+|||+ .+|+||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 699999854 358899999999999999999995 8999999999999997 6779999
Q ss_pred eeccccccCCCCC-ccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH
Q 047215 656 SDFGLSKTGPSME-HTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 656 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~ 733 (851)
+|||+++...... .........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. .....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~ 239 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILE 239 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHH
Confidence 9999998643211 1112234457999999998865 68999999999999999999999999765432211 11100
Q ss_pred Hhh----------hcccc-----cccCccCC-CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 734 WQK----------QRSLK-----SIIDPHLK-GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 734 ~~~----------~~~~~-----~i~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
... ..... ....+... ....+..+..+.+++.+||+.||.+|||++|+++| +|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h---------p~~~ 310 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH---------PYMS 310 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS---------HHHH
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC---------cccc
Confidence 000 00000 00000000 00112345679999999999999999999999999 7776
Q ss_pred cC
Q 047215 798 TD 799 (851)
Q Consensus 798 ~~ 799 (851)
..
T Consensus 311 ~~ 312 (320)
T 2i6l_A 311 IY 312 (320)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.89 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=198.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC--c--ceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED--C--TLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~--~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 584 (851)
.++|+..+.||+|+||.||+|++.. + ..+|+|++... .....+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3678899999999999999998642 2 25899988754 3345678999999999999999999999998765 8
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++|+||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999986532 458899999999999999999995 89999999999999999999999999999865
Q ss_pred CCCCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 665 PSMEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 665 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
...... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... +........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~----- 240 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKE----- 240 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTS-----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHcc-----
Confidence 432221 12234557889999999998889999999999999999999 99888654321 111111111
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
......+..++..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 241 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 241 ----GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1111223455677999999999999999999999999988653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=363.46 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=202.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|++.++||+|+||.||+|+.. +++.+|||++... .......+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 367999999999999999999875 6788999987542 2234577899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~ 665 (851)
||+++|+|.+.+... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999988543 368999999999999999999995 8999999999999994 56689999999997543
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+ + ..... .+..
T Consensus 176 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~~~i~-~~~~----- 239 (486)
T 3mwu_A 176 QN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---I---LKRVE-TGKY----- 239 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-HTCC-----
T ss_pred CC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-hCCC-----
Confidence 22 22344579999999999875 59999999999999999999999997643221 1 11111 1110
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..........+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 240 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001113455678999999999999999999999999
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=364.35 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=199.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|...+.||+|+||.||+|+.. .+..+|+|++.... ......+.+|+.++++++||||++++++|...+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999975 56788999876542 334577899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~~~~ 665 (851)
||+++|+|.+.+... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999988543 458899999999999999999995 89999999999999975 4569999999997643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.. .......||+.|+|||++. ..++.++|||||||++|||++|+.||......+ ...... .+.. ..+
T Consensus 191 ~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~--~~~ 257 (494)
T 3lij_A 191 NQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVE-KGKY--TFD 257 (494)
T ss_dssp TT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCC--CCC
T ss_pred CC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCC--CCC
Confidence 22 2234567999999999986 569999999999999999999999997643321 111111 1110 001
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.. .....+..+.+|+.+||+.||.+|||+.|+++|.+
T Consensus 258 ~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 258 SP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp SG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 11 11234567899999999999999999999999943
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.71 Aligned_cols=268 Identities=23% Similarity=0.322 Sum_probs=206.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----CcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~ 584 (851)
.++|...+.||+|+||.||+|... ++..+|||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999864 56789999987543 34457789999999999999999999999654 468
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||++ |+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999998 5999988543 48999999999999999999995 89999999999999999999999999999864
Q ss_pred CCCCc-cccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc---
Q 047215 665 PSMEH-THVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS--- 739 (851)
Q Consensus 665 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 739 (851)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ........
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~ 255 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED 255 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCHHH
Confidence 32211 112244579999999998754 45899999999999999999999999765544332111 11000000
Q ss_pred ------------cccccCccCC--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 740 ------------LKSIIDPHLK--GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 740 ------------~~~i~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
......+... ....+..+..+.+|+.+||+.||.+|||++|+++| +|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---------p~~~~ 319 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH---------PYLEQ 319 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS---------GGGTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC---------cchhh
Confidence 0000000000 00112345678999999999999999999999999 88764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.96 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=201.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
..++|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 47889999887543 34678999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 99999999998532 2468999999999999999999995 89999999999999999999999999999764321
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... .. ..+.+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~-----~~~~~- 245 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIP-TN-----PPPTF- 245 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HS-----CCCCC-
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHh-cC-----CCccc-
Confidence 1122345689999999999999999999999999999999999999875432111 11110 00 01111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+...+..+.+++.+||+.||.+|||+.++++|
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223445679999999999999999999999999
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.50 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=193.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN------ 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 582 (851)
.++|...+.||+|+||.||+|... .++.+|||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999864 5788999988653 3445577899999999999999999999997654
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++ +|.+.+.. .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 78887742 48899999999999999999995 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH---------HH---
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA---------DW--- 730 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~---------~~--- 730 (851)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ++
T Consensus 176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 6332 11233457899999999999999999999999999999999999999765332111000 00
Q ss_pred ----HHHHhhhc-c-----cccccCccCCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 731 ----AMKWQKQR-S-----LKSIIDPHLKGN---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 731 ----~~~~~~~~-~-----~~~i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...+.... . ............ .....+..+.+|+.+||+.||.+|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 0 000000000000 012236789999999999999999999999999
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=351.26 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=189.5
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------C
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------N 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 582 (851)
.++|...+.||+|+||.||+|.. .++..||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999985 46788999998653 344567788999999999999999999998654 5
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++|+|++ +++|.+++.. ..+++.++..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 6899998854 458999999999999999999996 899999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
.... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||......++.................
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6332 1234578999999999876 689999999999999999999999997654332221110000000000000
Q ss_pred cc--------cC--ccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 742 SI--------ID--PHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 742 ~i--------~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+ +. +.... ...+..+..+.+|+.+||+.||.+|||++|+++| +|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h---------p~~~~ 317 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH---------AYFAQ 317 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGTT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC---------hhhhh
Confidence 00 00 00000 0012335678999999999999999999999999 88764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.29 Aligned_cols=257 Identities=28% Similarity=0.388 Sum_probs=201.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC--------hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS--------EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
.++|...+.||+|+||.||+|+.. +++.+|||.+.... ......+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999875 56789999876432 122345889999999999999999999997654
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCe---EEEeecc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFV---AKMSDFG 659 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~---~kl~DFG 659 (851)
.++||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999998543 468999999999999999999995 89999999999999986654 9999999
Q ss_pred ccccCCCCCccccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (851)
+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ +.....
T Consensus 163 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~---- 233 (322)
T 2ycf_A 163 HSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT---- 233 (322)
T ss_dssp TCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH----
T ss_pred cceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH----
Confidence 9986432 12233456899999999974 56789999999999999999999999975433221 111111
Q ss_pred hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 737 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+... ..+.. ....+..+.+++.+||+.||.+|||+.|+++| +|++.
T Consensus 234 ~~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h---------~~~~~ 280 (322)
T 2ycf_A 234 SGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH---------PWLQD 280 (322)
T ss_dssp HTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS---------GGGCC
T ss_pred hCccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC---------cCcCC
Confidence 11100 00111 12345678999999999999999999999999 88764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.33 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=208.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---------hhhHHHHHHHHHHHHhcC-CcceeeEEEEEcc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---------EQGLAEFETEIEMLSKLR-HRHLVSLIGFCDE 580 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~ 580 (851)
.++|+..+.||+|+||.||+|+.. +++.+|||++.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999975 57889999886542 123456889999999995 9999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccc
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGL 660 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 660 (851)
++..++||||+++++|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999998643 468999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCcccCccccc------ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFW------RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||....... . ....
T Consensus 171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~ 241 (298)
T 1phk_A 171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M---LRMI 241 (298)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHH
T ss_pred hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---H---HHHH
Confidence 87643221 223456899999999985 4568899999999999999999999986542211 1 1111
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
. .+.. ..........+..+.+++.+||+.||.+|||+.|+++| +|++.
T Consensus 242 ~-~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h---------~~~~~ 289 (298)
T 1phk_A 242 M-SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH---------PFFQQ 289 (298)
T ss_dssp H-HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS---------GGGCT
T ss_pred h-cCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC---------hHhhh
Confidence 1 1110 01111123456779999999999999999999999999 88864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=362.94 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=201.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-------------hhHHHHHHHHHHHHhcCCcceeeEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-------------QGLAEFETEIEMLSKLRHRHLVSLIG 576 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~HpnIv~l~g 576 (851)
..++|...++||+|+||.||+|+.. .+..+|+|++..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999975 467899998765321 33567899999999999999999999
Q ss_pred EEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC---eE
Q 047215 577 FCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF---VA 653 (851)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~---~~ 653 (851)
++..++..++||||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999988543 458999999999999999999996 8999999999999998765 69
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~ 733 (851)
||+|||+++..... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+. ...
T Consensus 189 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI------IKK 258 (504)
T ss_dssp EECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 99999999864332 1234457999999999986 5699999999999999999999999976432211 111
Q ss_pred HhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 734 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. .+... .+.. .....+..+.+|+.+||+.||.+|||++|+++|
T Consensus 259 i~-~~~~~--~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VE-KGKYY--FDFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH-HCCCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-cCCCC--CCcc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 11100 0000 002345678999999999999999999999999
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=351.85 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=198.6
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC------cEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN------EMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------~~~l 586 (851)
.+|...++||+|+||.||+|+...+..+|+|++...... ..+|++++++++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 568899999999999999999877767888877544322 246999999999999999999985433 3789
Q ss_pred EEEecCCcchhhhcc-CCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEEeeccccccC
Q 047215 587 VYEYMANGTLRSHLF-GSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTG 664 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~-~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~ 664 (851)
||||++++.+..... ......+++..+..++.|+++||+|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998765544332 1223568899999999999999999996 8999999999999999 8999999999999864
Q ss_pred CCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh--------
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ-------- 735 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~-------- 735 (851)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......++. ........
T Consensus 193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHH
T ss_pred cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHHH
Confidence 3222 12345689999999998764 5999999999999999999999999765433221 11111000
Q ss_pred h-hcccccccCccCC-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 736 K-QRSLKSIIDPHLK-----GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 736 ~-~~~~~~i~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
. ........-+... ..++...+..+.+|+.+||+.||.+|||+.|+++| +|++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---------p~f~~ 327 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH---------PFFDE 327 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS---------GGGST
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC---------hhhhh
Confidence 0 0000000001110 01223356679999999999999999999999999 88764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=345.71 Aligned_cols=268 Identities=23% Similarity=0.262 Sum_probs=208.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcC-Cc-----ceeeEEEEEccCCc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HR-----HLVSLIGFCDEQNE 583 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~l~g~~~~~~~ 583 (851)
..++|...++||+|+||.||+|+.. +++.||||++... ......+..|+.+++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999865 5678999998753 344567788999998885 44 49999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc--CCCeEEEeecccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD--ENFVAKMSDFGLS 661 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld--~~~~~kl~DFGla 661 (851)
.++||||++ |+|.+++.......+++..+..++.|++.||.|||+ .+.+|+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 599999977665679999999999999999999994 247899999999999994 5788999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh----
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ---- 737 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 737 (851)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ........
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~---~i~~~~~~~~~~ 280 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN---KIVEVLGIPPAH 280 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSCCHH
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHH
Confidence 864321 234578999999999999999999999999999999999999998654332211 11110000
Q ss_pred -----c----ccccccCcc------------C-------------------------CCCCChhHHHHHHHHHHHhcccC
Q 047215 738 -----R----SLKSIIDPH------------L-------------------------KGNYSPESLEKFGEIAEKCLDDE 771 (851)
Q Consensus 738 -----~----~~~~i~d~~------------l-------------------------~~~~~~~~~~~l~~l~~~Cl~~d 771 (851)
. .+..+.+.. . ...........+.+|+.+||+.|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 0 000000000 0 00011233467999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 772 GKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 772 P~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
|++|||++|+|+| +|++.
T Consensus 361 P~~Rpta~e~L~h---------p~f~~ 378 (382)
T 2vx3_A 361 PKTRIQPYYALQH---------SFFKK 378 (382)
T ss_dssp TTTSCCHHHHTTS---------GGGCC
T ss_pred hhhCCCHHHHhcC---------ccccc
Confidence 9999999999999 99864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=354.51 Aligned_cols=259 Identities=25% Similarity=0.312 Sum_probs=194.7
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC------CcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ------NEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~ 585 (851)
.+|+..++||+|+||.||+|+.. .+..||||++..... .+.+|+++|++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 578899998865422 234799999999999999999988432 2367
Q ss_pred EEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCC-CeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDEN-FVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~ 662 (851)
+||||+++ +|.+.+.. .....+++..+..++.|+++||.|||+ .+|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55555432 223568999999999999999999994 899999999999999954 678999999998
Q ss_pred cCCCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh------
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ------ 735 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~------ 735 (851)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......++ +.+......
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 643221 12345689999999999764 799999999999999999999999976543222 111111100
Q ss_pred --h-hcccccccCccCCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 736 --K-QRSLKSIIDPHLKG-----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 736 --~-~~~~~~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. .....+...+.+.. .+++..+..+.+|+.+||+.||.+|||+.|+++|
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 00011111111111 0223445779999999999999999999999999
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=338.55 Aligned_cols=269 Identities=22% Similarity=0.301 Sum_probs=205.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC-----CcE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ-----NEM 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~ 584 (851)
.++|...+.||+|+||.||+|+.. +++.+|||++... .......+.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999975 5788999998754 334456788999999999999999999998654 678
Q ss_pred EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 585 ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
++||||++ |+|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 699998855 358999999999999999999995 89999999999999999999999999999764
Q ss_pred CCCCccc--------cccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh
Q 047215 665 PSMEHTH--------VSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 665 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
....... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHh
Confidence 3211110 1223568999999998764 789999999999999999999999987653222111 011100
Q ss_pred hhcc----cc--------cccC--ccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 736 KQRS----LK--------SIID--PHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 736 ~~~~----~~--------~i~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
.... .. +... +.... ...+..+..+.+|+.+||+.||.+|||++|+++| +|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h---------p~~~ 310 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH---------PYLQ 310 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC---------cccc
Confidence 0000 00 0000 00000 0112455678999999999999999999999999 8887
Q ss_pred cC
Q 047215 798 TD 799 (851)
Q Consensus 798 ~~ 799 (851)
..
T Consensus 311 ~~ 312 (353)
T 2b9h_A 311 TY 312 (353)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.08 Aligned_cols=257 Identities=20% Similarity=0.292 Sum_probs=198.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
-++|...+.||+|+||.||+|+.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 378999999999999999999875 6788999988654 233457799999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++++|.+++... .++++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999998643 368999999999999999999995 89999999999999999999999999998764332
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
. ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........ . ...+
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~-~---~~~~- 254 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQ-A---IPRP- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHS-C---CCCG-
T ss_pred c-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhcc-C---CCCc-
Confidence 1 11223456899999999999999999999999999999999999998653211 01111110 0 0000
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRP-TMGEVLWHLEYV 788 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 788 (851)
...++.++..+.+++.+||+.||++|| +++++++.|+.+
T Consensus 255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 112334556689999999999999999 999999987744
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.63 Aligned_cols=276 Identities=20% Similarity=0.224 Sum_probs=195.4
Q ss_pred HHHHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc--
Q 047215 507 EIRVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE-- 583 (851)
Q Consensus 507 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-- 583 (851)
+.....++|...+.||+|+||.||+|+.. ++..+|||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44556789999999999999999999974 57889999875542 223456788889999999999999999855433
Q ss_pred -----EEEEEEecCCcchhhhccC--CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEE
Q 047215 584 -----MILVYEYMANGTLRSHLFG--SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKM 655 (851)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl 655 (851)
.++||||++++ |.+.+.. .....+++..+..++.|++.||.|||. ...+|+||||||+|||++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 88999999875 4333321 234568899999999999999999992 1389999999999999996 899999
Q ss_pred eeccccccCCCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .......
T Consensus 174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~ 248 (360)
T 3e3p_A 174 CDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRVL 248 (360)
T ss_dssp CCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHH
T ss_pred eeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHHc
Confidence 9999998644322 22345689999999998654 4899999999999999999999999765432221 1111100
Q ss_pred -----------hhhcccccccC------ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 735 -----------QKQRSLKSIID------PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 735 -----------~~~~~~~~i~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
..........+ ...........+..+.+|+.+||+.||.+|||+.|+++| +|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h---------p~f~ 319 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH---------PYFD 319 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS---------GGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC---------cccc
Confidence 00000000000 001112223467789999999999999999999999999 8886
Q ss_pred cC
Q 047215 798 TD 799 (851)
Q Consensus 798 ~~ 799 (851)
..
T Consensus 320 ~~ 321 (360)
T 3e3p_A 320 EL 321 (360)
T ss_dssp GG
T ss_pred cc
Confidence 53
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=373.53 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=208.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 585 (851)
..++|+..++||+|+||.||+|+.. .++.+|||++... .....+.+..|..+|..+ +||+|+++++++...+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3478999999999999999999975 4678999988643 233456788899999988 7999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
|||||+++|+|.++|... ..+++.++..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999654 358999999999999999999996 899999999999999999999999999998533
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......+ + .. .+..
T Consensus 494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~---~~---------~i~~ 556 (674)
T 3pfq_A 494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---FQ---------SIME 556 (674)
T ss_dssp CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HH---------HHHS
T ss_pred cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---H---HH---------HHHh
Confidence 221 22455789999999999999999999999999999999999999997643211 1 11 1111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM-----GEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 784 (851)
.. ..++...+..+.+|+.+||+.||.+||++ +|+++|
T Consensus 557 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 557 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 11 12344566779999999999999999997 899888
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.95 Aligned_cols=272 Identities=20% Similarity=0.250 Sum_probs=186.7
Q ss_pred CCce-eeeeeeecceEEEEEEEc---CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEE--ccCCcEEEE
Q 047215 514 NFDE-SLMIGVGGFGKVFKGEIE---DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC--DEQNEMILV 587 (851)
Q Consensus 514 ~f~~-~~~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~--~~~~~~~lV 587 (851)
.|+. .++||+|+||.||+|+.. .+..+|||++..... ...+.+|+.+|++++||||+++++++ ..+...++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 347999999999999975 467899999875432 24678999999999999999999999 557789999
Q ss_pred EEecCCcchhhhccC-------CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE----cCCCeEEEe
Q 047215 588 YEYMANGTLRSHLFG-------SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL----DENFVAKMS 656 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~-------~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl----d~~~~~kl~ 656 (851)
|||+++ +|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 77777642 122358999999999999999999996 899999999999999 778999999
Q ss_pred eccccccCCCCC-ccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc-------hhcH
Q 047215 657 DFGLSKTGPSME-HTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD-------QINL 727 (851)
Q Consensus 657 DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~-------~~~l 727 (851)
|||+++...... .........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ...+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 999998643221 1122345679999999999987 459999999999999999999999997543211 0011
Q ss_pred HHHHHHHhh--hcccccc-------------cCccCCC--------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 728 ADWAMKWQK--QRSLKSI-------------IDPHLKG--------NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 728 ~~~~~~~~~--~~~~~~i-------------~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
......+.. ......+ ....... .........+.+|+.+||+.||.+|||++|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111100000 0000000 0000000 0001114568899999999999999999999999
Q ss_pred HHHHHHhhhhhcccCC
Q 047215 785 LEYVLQLHEAWMRTDD 800 (851)
Q Consensus 785 L~~~~~~~~~w~~~~~ 800 (851)
+|+....
T Consensus 335 ---------p~f~~~~ 341 (405)
T 3rgf_A 335 ---------PYFLEDP 341 (405)
T ss_dssp ---------GGGTSSS
T ss_pred ---------hhhccCC
Confidence 9987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=341.22 Aligned_cols=268 Identities=19% Similarity=0.300 Sum_probs=206.2
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-----------CcceeeEEEEEcc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-----------HRHLVSLIGFCDE 580 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~g~~~~ 580 (851)
++|...+.||+|+||.||+|+. .+++.+|||++... ......+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 6799999999999999999986 56788999998743 344567889999999886 8999999999875
Q ss_pred CC----cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCC-CeEEcCCCCCCeEEc------C
Q 047215 581 QN----EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRDVKTTNILLD------E 649 (851)
Q Consensus 581 ~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~-~iiHrDlk~~NILld------~ 649 (851)
.+ ..++||||+ +++|.+++.......+++.++..++.|++.||+|||+ + +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 44 789999999 8999999976555669999999999999999999996 6 999999999999994 4
Q ss_pred CCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH
Q 047215 650 NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD 729 (851)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~ 729 (851)
.+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............+
T Consensus 174 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 45899999999976432 1234568999999999999999999999999999999999999997644221111111
Q ss_pred HHHHHhh-hcc---------------------cccccCc---------cCCCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 047215 730 WAMKWQK-QRS---------------------LKSIIDP---------HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTM 778 (851)
Q Consensus 730 ~~~~~~~-~~~---------------------~~~i~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 778 (851)
....... .+. ...+... .....++...+..+.+|+.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111000 000 0000000 00123556788899999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhcccC
Q 047215 779 GEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 779 ~evl~~L~~~~~~~~~w~~~~ 799 (851)
+|+++| +|+...
T Consensus 329 ~ell~h---------p~f~~~ 340 (373)
T 1q8y_A 329 GGLVNH---------PWLKDT 340 (373)
T ss_dssp HHHHTC---------GGGTTC
T ss_pred HHHhhC---------hhhhcc
Confidence 999999 898753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=340.08 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=202.4
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc-----
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE----- 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----- 583 (851)
.++|...+.||+|+||.||+|+.. +++.+|||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367888999999999999999874 5788999998654 33445778999999999999999999999977654
Q ss_pred -EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 584 -MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 584 -~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
.++||||++ |+|.+++.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 699888732 48999999999999999999995 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh----
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ---- 737 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 737 (851)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ........
T Consensus 175 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTE 246 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH---HHHHHHCBCCHH
T ss_pred CCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHH
Confidence 6322 1234568999999999876 689999999999999999999999997653322111 11000000
Q ss_pred --------------cccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 738 --------------RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 738 --------------~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+.....+.+ ....+..+..+.+|+.+||+.||.+|||++|+++| +|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h---------p~f~~ 311 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH---------PFFEP 311 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS---------GGGTT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC---------cchhh
Confidence 00000000011 12234556789999999999999999999999999 88764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=345.21 Aligned_cols=262 Identities=20% Similarity=0.313 Sum_probs=201.8
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcE----
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEM---- 584 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~---- 584 (851)
.++|...+.||+|+||.||+|... +++.+|||++... .......+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999864 5788999998764 344467889999999999999999999999877655
Q ss_pred --EEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 585 --ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 585 --~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
++||||++ ++|.+.+. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 68888873 248999999999999999999995 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhh--hc-
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK--QR- 738 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~--~~- 738 (851)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ........ ..
T Consensus 193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~ 265 (371)
T 4exu_A 193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPGTEF 265 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCHHH
T ss_pred cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCcHHH
Confidence 5322 1234568999999999987 789999999999999999999999997643222111 10000000 00
Q ss_pred -----------ccccccCccCCC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 739 -----------SLKSIIDPHLKG---NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 739 -----------~~~~i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
....+. ..... ...+..+..+.+|+.+||+.||.+|||++|+++| +|++.
T Consensus 266 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h---------p~f~~ 329 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLP-QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH---------PFFEP 329 (371)
T ss_dssp HTTCSCHHHHHHHHHSC-CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS---------GGGTT
T ss_pred HHHhhhhhhhhhhhccC-CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC---------ccccc
Confidence 000000 00000 0112345679999999999999999999999999 88763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.50 Aligned_cols=265 Identities=17% Similarity=0.219 Sum_probs=209.2
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCC-cceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH-RHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|.+.++||+|+||.||+|+. .++..||||++...... ..+..|+++++.++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999986 56788999986654332 357889999999976 566666667778888999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE---cCCCeEEEeeccccccCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---DENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~~ 666 (851)
|+ +++|.+++.... ..+++.+++.++.||+.||.|||+ ++||||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999986432 468999999999999999999995 899999999999999 6889999999999986433
Q ss_pred CCcc-----ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 667 MEHT-----HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 667 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 2211 11235679999999999999999999999999999999999999998765443332222222211111111
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
.+ ...++..+.+|+.+||+.+|.+||+++++++.|+.+....
T Consensus 239 ~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 AL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11 1123456899999999999999999999999999887643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=332.31 Aligned_cols=258 Identities=25% Similarity=0.430 Sum_probs=199.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc----------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE---------- 580 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~---------- 580 (851)
.++|+..+.||+|+||.||+|+.. +++.+|||++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999964 678899998854 34456788999999999999999999998754
Q ss_pred ---CCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEee
Q 047215 581 ---QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSD 657 (851)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~D 657 (851)
.+..++||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 467899999999999999996533 457788999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCC------------ccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch
Q 047215 658 FGLSKTGPSME------------HTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724 (851)
Q Consensus 658 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~ 724 (851)
||+++...... .........||+.|+|||++.+. .++.++|||||||++|||++ |+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----- 231 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----- 231 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----
Confidence 99997643211 01122345689999999999764 78999999999999999998 33211
Q ss_pred hcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 725 INLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
....+....... ....+...++...+..+.+++.+||+.||.+|||++++++| +|+..
T Consensus 232 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h---------~~~~~ 289 (303)
T 1zy4_A 232 MERVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS---------GWLPV 289 (303)
T ss_dssp HHHHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS---------SCSCC
T ss_pred hhHHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC---------CCcCC
Confidence 111111111111 11222334455666779999999999999999999999999 99864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=338.50 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=175.9
Q ss_pred hcCCceee-eeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc----CCcEE
Q 047215 512 TNNFDESL-MIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE----QNEMI 585 (851)
Q Consensus 512 t~~f~~~~-~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~ 585 (851)
.++|...+ +||+|+||.||+|+.. +++.+|||++.... ....+....++.+.||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46888854 6999999999999876 57899999986532 122223334566799999999999865 45689
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~ 662 (851)
+||||+++|+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999987666679999999999999999999995 89999999999999975 5569999999997
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ......
T Consensus 180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~------ 246 (336)
T 3fhr_A 180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIR------ 246 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhh------
Confidence 63321 22345689999999999888999999999999999999999999865433211000 000000
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.............++..+.+|+.+||+.||.+|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000011111223456679999999999999999999999999
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=367.37 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEcC----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE 583 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 583 (851)
....++|+..+.||+|+||.||+|.... +..+|+|+.... .....+.|.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445789999999999999999998743 356899987764 4445578999999999999999999999995 457
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 899999999999999996543 458999999999999999999996 8999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .. .... .+
T Consensus 541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~---~~i~-~~---- 608 (656)
T 2j0j_A 541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRIE-NG---- 608 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHH-HT----
T ss_pred cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HH---HHHH-cC----
Confidence 53322 112234457889999999999999999999999999999997 888886543221 11 1111 11
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....+..++..+.+++.+||+.||.+|||+.+++++|+.+++.
T Consensus 609 -----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 01123445667899999999999999999999999999988653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=338.10 Aligned_cols=268 Identities=18% Similarity=0.262 Sum_probs=206.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-Cc-ceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc------eeeEEEEEccCCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH------LVSLIGFCDEQNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~~~~~ 583 (851)
.++|+..+.||+|+||.||+|... .+ ..+|+|++... ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999864 33 68999998754 344567889999999998776 9999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEE----------------
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILL---------------- 647 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILl---------------- 647 (851)
.++||||+ +++|.+.+.......+++.++..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 5667677665555679999999999999999999995 899999999999999
Q ss_pred ---cCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcch
Q 047215 648 ---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQ 724 (851)
Q Consensus 648 ---d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~ 724 (851)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56889999999999763221 2345789999999999999999999999999999999999999976543222
Q ss_pred hcHHHHHHH-----Hhhhcccccc-cCc-------------------cC--CCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 047215 725 INLADWAMK-----WQKQRSLKSI-IDP-------------------HL--KGNYSPESLEKFGEIAEKCLDDEGKNRPT 777 (851)
Q Consensus 725 ~~l~~~~~~-----~~~~~~~~~i-~d~-------------------~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 777 (851)
......... +......... ... .+ ........+..+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 111111000 0000000000 000 00 00112344668999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhccc
Q 047215 778 MGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 778 ~~evl~~L~~~~~~~~~w~~~ 798 (851)
+.|+++| +|+..
T Consensus 328 ~~e~l~h---------p~f~~ 339 (355)
T 2eu9_A 328 LAEALLH---------PFFAG 339 (355)
T ss_dssp HHHHTTS---------GGGGG
T ss_pred HHHHhcC---------hhhcC
Confidence 9999999 88875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=335.16 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=181.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHH-HHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIE-MLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|...+.||+|+||.||+|... +++.+|||++... .......+..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999975 6788999988764 3344455666666 677789999999999999999999999
Q ss_pred EecCCcchhhhccC---CCCCCCchhhhHHHHHHHHHHHHHhhcCCCC-CeEEcCCCCCCeEEcCCCeEEEeeccccccC
Q 047215 589 EYMANGTLRSHLFG---SDLPPLTWKQRLDACIGAARGLHYLHTGAER-GIIHRDVKTTNILLDENFVAKMSDFGLSKTG 664 (851)
Q Consensus 589 Ey~~~gsL~~~L~~---~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~-~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 664 (851)
||+++ +|.+++.. .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77776642 224568999999999999999999996 6 9999999999999999999999999999764
Q ss_pred CCCCccccccccccCCcccCcccc----cccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYF----WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .....
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~~~~ 242 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----------QLTQV 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCC
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----------HHHHH
Confidence 321 112334689999999998 466799999999999999999999999875322100 00001
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+.+........+..+.+|+.+||+.||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11111122222223456779999999999999999999999999
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=345.80 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=189.9
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+.|...++||+|+||+||.+...+++.||||++... ..+.+.+|+.+|+++ +||||+++++++..++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556889999999998776677899999987643 235678899999987 8999999999999999999999999
Q ss_pred CCcchhhhccCCCCCC-----CchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-------------CCeE
Q 047215 592 ANGTLRSHLFGSDLPP-----LTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-------------NFVA 653 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~-----l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-------------~~~~ 653 (851)
+ |+|.+++....... ..+.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999997643211 2445678899999999999996 89999999999999965 4589
Q ss_pred EEeeccccccCCCCCcc--ccccccccCCcccCcccccc-------cCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcc
Q 047215 654 KMSDFGLSKTGPSMEHT--HVSTAVKGSFGYLDPEYFWR-------QQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKD 723 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~ 723 (851)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999865432211 11234579999999999975 678999999999999999999 888886543221
Q ss_pred hhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 724 QINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. . ... +. . ..+..........+..+.+++.+||+.||.+|||+.|+++|
T Consensus 248 ~----~----i~~-~~-~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 S----N----IIR-GI-F--SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp H----H----HHH-TC-C--CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H----H----Hhc-CC-C--CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0 0 000 00 0 01111222245677889999999999999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.65 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=201.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|+..+.||+|+||.||+|+.. +++.+|+|++... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999875 6788999987543 2345678999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~~~~ 665 (851)
||+++++|.+.+... ..+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999888543 358899999999999999999995 89999999999999965 4479999999987643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+ ...... .+... .+
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~--~~ 242 (287)
T 2wei_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVE-TGKYA--FD 242 (287)
T ss_dssp CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCCC--CC
T ss_pred CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-cCCCC--CC
Confidence 221 1223458899999999865 48999999999999999999999987543211 111111 11100 00
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
. ......+..+.+++.+||+.||.+|||+.|+++|
T Consensus 243 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 L----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp S----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 0012345678999999999999999999999999
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=341.16 Aligned_cols=264 Identities=22% Similarity=0.378 Sum_probs=202.8
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN 582 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 582 (851)
..+.....++|+..+.||+|+||.||+|+..+ .+++|++... .....+.+.+|+.++++++||||+++++++..++
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34444456889999999999999999998764 4788877643 2334456788999999999999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
..++||||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999996543 468999999999999999999995 8999999999999998 6799999999987
Q ss_pred cCCCCC---ccccccccccCCcccCcccccc---------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHH
Q 047215 663 TGPSME---HTHVSTAVKGSFGYLDPEYFWR---------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADW 730 (851)
Q Consensus 663 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~ 730 (851)
...... .........||+.|+|||.+.. ..++.++||||||+++|||++|+.||....... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~ 251 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------I 251 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------H
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H
Confidence 532211 1122234568999999999874 458999999999999999999999987543221 1
Q ss_pred HHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 731 AMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 731 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
..... .+ ..+.+. ...++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 252 ~~~~~-~~-----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 252 IWQMG-TG-----MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHH-TT-----CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHHhc-cC-----CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11 111111 11234458899999999999999999999999886654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=333.41 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=196.1
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChh------hHHHHHHHHHHHHhc----CCcceeeEEEE
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQ------GLAEFETEIEMLSKL----RHRHLVSLIGF 577 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~HpnIv~l~g~ 577 (851)
....++|...+.||+|+||.||+|+. .+++.+|+|++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999986 46788999998654321 223466799999999 89999999999
Q ss_pred EccCCcEEEEEEe-cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEE
Q 047215 578 CDEQNEMILVYEY-MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKM 655 (851)
Q Consensus 578 ~~~~~~~~lV~Ey-~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl 655 (851)
+...+..++|+|+ +++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 7899999999653 358999999999999999999995 8999999999999999 8999999
Q ss_pred eeccccccCCCCCccccccccccCCcccCcccccccCCC-chHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT-EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+++..... ......||..|+|||++.+..+. .++||||||+++|||++|+.||.... + .
T Consensus 182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----~ 245 (312)
T 2iwi_A 182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----I 245 (312)
T ss_dssp CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----H
T ss_pred EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----H
Confidence 999998864332 12345689999999999877664 58999999999999999999885320 0 0
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.. .. ..++...+..+.+++.+||+.||++|||++|+++| +|++..
T Consensus 246 ~~---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~---------~~~~~~ 290 (312)
T 2iwi_A 246 LE---------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD---------PWMQTP 290 (312)
T ss_dssp HH---------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS---------TTTCC-
T ss_pred hh---------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC---------hhhcCc
Confidence 00 00 11234455678999999999999999999999999 887643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=342.68 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=190.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
...+|...++||+|+||+||.....+++.||||++...... .+.+|+++|+++ +|||||++++++..++..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 44678889999999999976655667889999998764332 356899999999 79999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-----CCCeEEEeeccccccC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-----ENFVAKMSDFGLSKTG 664 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-----~~~~~kl~DFGla~~~ 664 (851)
|++ |+|.+++.... ..+.+.++..++.|++.||+|||+ .+|+||||||+|||++ ....+||+|||+++..
T Consensus 99 ~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 997 69999987654 345566778999999999999996 8999999999999994 3346889999999864
Q ss_pred CCCCc-cccccccccCCcccCccccc---ccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 665 PSMEH-THVSTAVKGSFGYLDPEYFW---RQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 665 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||........ .......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~- 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGAC- 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCC-
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccC-
Confidence 43211 12234567999999999997 4678889999999999999999 8888754322110 0000000
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
..+.. .........+.+|+.+||+.||.+|||++|+++|
T Consensus 246 ----~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 ----SLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ----CCTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----Ccccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00001 1123445668899999999999999999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.12 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=181.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCCh--hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE--QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.++|+..+.||+|+||.||+|+.. +++.+|||++..... ...+.+.++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367888999999999999999975 678899999875432 22334555556788889999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+ ++.+..++. .....+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 999 445544443 223568999999999999999999995 238999999999999999999999999998753321
Q ss_pred ccccccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 669 HTHVSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.......||+.|+|||++. ...++.++||||||+++|||++|+.||....... +.........
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~----- 246 (318)
T 2dyl_A 179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEE----- 246 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSC-----
T ss_pred --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccC-----
Confidence 1223456899999999994 5678999999999999999999999987532211 1111111110
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.+.+. .....+..+.+++.+||+.||.+|||++|+++|
T Consensus 247 -~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 -PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01111 112345668999999999999999999999999
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=335.57 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=203.0
Q ss_pred HHHHHhcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh------hhHHHHHHHHHHHHhcC--CcceeeEEEE
Q 047215 507 EIRVATNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE------QGLAEFETEIEMLSKLR--HRHLVSLIGF 577 (851)
Q Consensus 507 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--HpnIv~l~g~ 577 (851)
+.....++|+..+.||+|+||.||+|+. .+++.+|||++..... .....+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999986 4678899998764321 12245678999999996 5999999999
Q ss_pred EccCCcEEEEEEecCC-cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc-CCCeEEE
Q 047215 578 CDEQNEMILVYEYMAN-GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKM 655 (851)
Q Consensus 578 ~~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld-~~~~~kl 655 (851)
+..++..++|+|++.+ ++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++ +++.+||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 9999999999999986 8999998543 468899999999999999999995 8999999999999999 7899999
Q ss_pred eeccccccCCCCCccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHH
Q 047215 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKW 734 (851)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~ 734 (851)
+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... + .
T Consensus 192 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~----~ 255 (320)
T 3a99_A 192 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----I 255 (320)
T ss_dssp CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----H
T ss_pred eeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h----h
Confidence 999999864322 2234568999999999987765 788999999999999999999885321 0 0
Q ss_pred hhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 735 QKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 735 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
. ... . .++...+..+.+++.+||+.||.+|||++|+++| +|++.
T Consensus 256 ~-~~~------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h---------p~~~~ 299 (320)
T 3a99_A 256 I-RGQ------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH---------PWMQD 299 (320)
T ss_dssp H-HCC------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS---------GGGSS
T ss_pred h-ccc------c----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC---------HhhcC
Confidence 0 000 0 1223345668999999999999999999999999 88764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=350.27 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=202.7
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc------CCcE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE------QNEM 584 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~ 584 (851)
++|...++||+|+||.||+|.. .++..+|||++... .....+.+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999986 45788999998764 45556789999999999999999999999865 6788
Q ss_pred EEEEEecCCcchhhhccCCC-CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC---eEEEeeccc
Q 047215 585 ILVYEYMANGTLRSHLFGSD-LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF---VAKMSDFGL 660 (851)
Q Consensus 585 ~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~---~~kl~DFGl 660 (851)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 3468999999999999999999996 8999999999999998665 499999999
Q ss_pred cccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc-
Q 047215 661 SKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS- 739 (851)
Q Consensus 661 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 739 (851)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..|.........
T Consensus 171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence 9864332 2234467999999999999999999999999999999999999998754211 111110000000
Q ss_pred ---cccccC------c--cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 740 ---LKSIID------P--HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 740 ---~~~i~d------~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...... . ......+...+..+.+++.+||+.||.+|||++|+++|
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 000000 0 11223456688999999999999999999999997766
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=349.89 Aligned_cols=240 Identities=20% Similarity=0.311 Sum_probs=193.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEc--CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCc-----
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE--DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNE----- 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----- 583 (851)
.++|.+.++||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 5788999988654 44556678999999999999999999999977665
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.+|||||+++++|.+++.. .+++.+++.++.|++.||.|||+ ++||||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988743 68999999999999999999995 899999999999999986 899999999986
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... ....||+.|+|||++.+. ++.++|||||||+|+||++|..|+....... +
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~ 284 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------L 284 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------C
T ss_pred cccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-------------------c
Confidence 4322 345699999999998765 4999999999999999999988765421110 0
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-MGEVLWHLEYVL 789 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~L~~~~ 789 (851)
. ........+..+.+++.+||+.||.+||+ ++++.+.|..++
T Consensus 285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 00001223467899999999999999996 555555555544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=311.15 Aligned_cols=227 Identities=21% Similarity=0.344 Sum_probs=180.9
Q ss_pred cCCcee-eeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHH-HhcCCcceeeEEEEEcc----CCcEE
Q 047215 513 NNFDES-LMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEML-SKLRHRHLVSLIGFCDE----QNEMI 585 (851)
Q Consensus 513 ~~f~~~-~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~----~~~~~ 585 (851)
++|... ++||+|+||.||++.. .+++.+|+|++... ..+.+|+.++ +.++||||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 566666 7799999999999987 46788999998642 4567899888 55689999999999876 67889
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~ 662 (851)
+||||+++|+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999999999999977665679999999999999999999995 89999999999999987 7899999999986
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
... +..++.++|||||||++|||++|+.||......... ......
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~ 213 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR 213 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence 421 234678999999999999999999998654322100 000011
Q ss_pred ccCccCCCCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHLKGNYS----PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+..... ..+ ..++..+.+++.+||+.||.+|||++|+++|
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111111 112 2346779999999999999999999999999
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=307.26 Aligned_cols=230 Identities=11% Similarity=0.099 Sum_probs=185.7
Q ss_pred hcCCceeeeeeeecceEEEEEEEcC-cceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIED-CTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
.++|++.+.||+|+||.||+|+... ++.+|||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999754 7889999987652 34457899999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
|||+++++|.+++... ....++.+++.|++.||+|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999432 3455789999999999999995 899999999999999999999998443
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
|++ .++.++|||||||++|||++|+.||........... ........
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQ 221 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccC
Confidence 333 378999999999999999999999986544321100 00000000
Q ss_pred CC--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 748 LK--GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 748 l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.. ......++..+.+++.+||+.||.+| |+.|+++.|+.+..
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00 01123456679999999999999999 99999999987653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=323.15 Aligned_cols=243 Identities=18% Similarity=0.180 Sum_probs=185.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCC--------hhhHHHHHHHHHHHHhcC---------CcceeeE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS--------EQGLAEFETEIEMLSKLR---------HRHLVSL 574 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------HpnIv~l 574 (851)
.++|+..+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35678889999999999999997 67889999886542 233477899999999886 7777777
Q ss_pred EEEE-----------------c-------------cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHH
Q 047215 575 IGFC-----------------D-------------EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624 (851)
Q Consensus 575 ~g~~-----------------~-------------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL 624 (851)
.+.+ . .++..+|||||+++|++.+.+.. ..+++.++..++.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6653 2 26889999999999987777643 4588999999999999999
Q ss_pred HHhh-cCCCCCeEEcCCCCCCeEEcCCC--------------------eEEEeeccccccCCCCCccccccccccCCccc
Q 047215 625 HYLH-TGAERGIIHRDVKTTNILLDENF--------------------VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYL 683 (851)
Q Consensus 625 ~yLH-s~~~~~iiHrDlk~~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 683 (851)
+||| + .+|+||||||+|||++.++ .+||+|||+++.... ....||+.|+
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence 9999 6 8999999999999999887 999999999986322 2347999999
Q ss_pred CcccccccCCCchHHHHHHHHH-HHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc-ccCccCCCCCChhHHHHHH
Q 047215 684 DPEYFWRQQLTEKSDVYSFGVV-LFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS-IIDPHLKGNYSPESLEKFG 761 (851)
Q Consensus 684 aPE~~~~~~~t~ksDVwS~Gvv-L~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-i~d~~l~~~~~~~~~~~l~ 761 (851)
|||++.+.. +.++||||++++ .+++++|..|+.. ..|....... .... ..............++.+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh-hhhhhccCcccchhhhhhcCHHHH
Confidence 999998776 999999998777 7778888776631 1121111100 0000 0111111122346788999
Q ss_pred HHHHHhcccCCCCCCCHHHHH-HH
Q 047215 762 EIAEKCLDDEGKNRPTMGEVL-WH 784 (851)
Q Consensus 762 ~l~~~Cl~~dP~~RPt~~evl-~~ 784 (851)
+|+.+||+.| |++|++ +|
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999999 89
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.42 Aligned_cols=242 Identities=15% Similarity=0.170 Sum_probs=183.3
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCC-cce---------e-----
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRH-RHL---------V----- 572 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H-pnI---------v----- 572 (851)
+.+|...++||+|+||.||+|+. .+++.||||++.... ....+.|.+|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999995 567899999887432 2336789999999999977 211 1
Q ss_pred -e------EEEEEcc-----CCcEEEEEEecCCcchhhhcc-----CCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCe
Q 047215 573 -S------LIGFCDE-----QNEMILVYEYMANGTLRSHLF-----GSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635 (851)
Q Consensus 573 -~------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~L~-----~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~i 635 (851)
. ++.++.. ....+++|+++ +++|.+++. ......+++..++.++.|+++||+|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 1 1111111 22456777755 689998884 3334568899999999999999999995 899
Q ss_pred EEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccc----------cccCCCchHHHHHHHHH
Q 047215 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF----------WRQQLTEKSDVYSFGVV 705 (851)
Q Consensus 636 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDVwS~Gvv 705 (851)
|||||||+||||+.++.+||+|||+++.... ......| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999876322 1344567 999999999 55668999999999999
Q ss_pred HHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 706 LFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 706 L~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+|||++|+.||........ ...++.. ....++.+.+|+.+||+.||++|||+.|+++|
T Consensus 307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999975432211 1111111 11234669999999999999999999999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-28 Score=283.06 Aligned_cols=184 Identities=19% Similarity=0.102 Sum_probs=128.4
Q ss_pred eeeecceEEEEEE-EcCcceeEEeecCCC----------ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEEE
Q 047215 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQ----------SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 521 LG~G~fG~Vykg~-~~~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.+.|++|.+..++ .--|..+++|.+... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566666665543 334677888877543 123456799999999999 7999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||++|++|.++|... .+++.. +|+.||+.||+|||+ +|||||||||+||||++++++||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~- 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD- 392 (569)
T ss_dssp ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC-
Confidence 999999999999654 345543 588999999999995 99999999999999999999999999999864332
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV 715 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p 715 (851)
.......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 -~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 222345789999999999975 467789999999999887666543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=230.86 Aligned_cols=154 Identities=16% Similarity=0.220 Sum_probs=118.4
Q ss_pred EEEEEEecCCCCCcCCCCcccccccccCCCccc-ccCCCcccccCcceEeccCCCccccchhhHHHhhccCCCccccccc
Q 047215 218 ETMYRLNVGGPEIKPSRDPDLWRMWEADSSYMI-TANAGSEIRNSSNITYASTNDSSVAPLLVYETARTMSNTEVLEKRF 296 (851)
Q Consensus 218 ~~~~Rin~Gg~~~~~~~d~~~~r~W~~d~~~~~-~~~s~~~~~~~~~~~~~~~~~~~~~P~~vy~tA~~~~~~~~~~~~~ 296 (851)
|++|||||||+.++ |..||.|.+|..|.. +..+.. ...+.+ ...+++|+.||||||.+..
T Consensus 5 ~~~~~INcGg~~~~----d~~gr~w~~D~~~~~~g~~~~~----~~~~~~---~~~~~~~~~lY~TaR~~~~-------- 65 (174)
T 2jwp_A 5 KVIWAVNAGGESHV----DVHGIHYRKDPLEGRVGRASDY----GMKLPI---LRSNPEDQVLYQTERYNED-------- 65 (174)
T ss_dssp HEEEEEEETSSSEE----ETTTEEECSSCSSTTCCCCCCC----CTTSCC---SSSCHHHHHTTTCCCCCCS--------
T ss_pred cEEEEEECCCCCcc----CCCCCEEcCCcCcccCCccccc----ccceEe---cccCCCCchhhhhhccCCC--------
Confidence 58999999998864 257899999987642 211111 111111 1235689999999999643
Q ss_pred ceeeeeecCCCCceEEEEEeeeEEEecCCeEEEEEEEcCccccCCcchhhhcCCCCceeEEEeEec-------------c
Q 047215 297 NMSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDA-------------V 363 (851)
Q Consensus 297 ~lt~~~~vd~~~~Y~v~LhF~Ei~~~~~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~~~~~~~-------------~ 363 (851)
+|+|.+|++++++|+|||||||+...+.++|+|||||||++++++|||..++++ ..|++++|... +
T Consensus 66 ~~tY~f~v~~~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~~~ 144 (174)
T 2jwp_A 66 SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVST 144 (174)
T ss_dssp CEEEEEECCSCEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEEEE
T ss_pred CeEEEEEeCCCeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeeecc
Confidence 699999999899999999999998888999999999999999999999999987 68889988633 2
Q ss_pred cccceeeeEEeCCccCCCCCCchhhcccccccccc
Q 047215 364 SSKIETLWIQLGPDTAVGAAGTDALLNGLEIFKFS 398 (851)
Q Consensus 364 ~~~~~~l~~s~~~~~~~~~~~~~~~lng~Ei~~~~ 398 (851)
.++. |+|.+.|.. ..+|+|||+||++..
T Consensus 145 ~~g~--L~I~f~p~~-----~~~a~inaIEI~~~~ 172 (174)
T 2jwp_A 145 FTGK--LSVEFVKGY-----YDNPKVCALFIMKGT 172 (174)
T ss_dssp CCSE--EEEEEECSS-----SCSSSEEEEEEESSC
T ss_pred cCCe--EEEEEeccC-----CCCcEEEEEEEEeCc
Confidence 3343 558888642 258999999999864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-25 Score=257.24 Aligned_cols=183 Identities=19% Similarity=0.171 Sum_probs=142.5
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCCh--------hhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE--------QGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.++||+|+||.||+|+.. +..+++|+...... ...+.+.+|+++|++++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 457999999999999654 45667776433211 123458999999999999999976666667778899999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+++++|.+++.. +..++.|+++||.|||+ ++|+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999854 66899999999999995 89999999999999999 999999999987543211
Q ss_pred cc-----cccccccCCcccCcccccc--cCCCchHHHHHHHHHHHHHHhCCcCC
Q 047215 670 TH-----VSTAVKGSFGYLDPEYFWR--QQLTEKSDVYSFGVVLFEVVCARAVI 716 (851)
Q Consensus 670 ~~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~eLltG~~p~ 716 (851)
.. ......||+.|||||++.. ..|+..+|+|+..+-.++-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1245679999999999986 67888899999999888887776544
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=206.52 Aligned_cols=153 Identities=22% Similarity=0.275 Sum_probs=113.2
Q ss_pred CceEEecCCCCccccCCcceeccCCCCCccccccCCcccccCCCCCCCCCcccccceeeeccCceeeEeec-cceEEEEE
Q 047215 23 KSFLINCGTNSSVNVDGRKWVGDLASNNNVTLSSSGIAATTDSLSGDSIYEPLYKTARVFADGLNYTFEII-AGNYIVRL 101 (851)
Q Consensus 23 ~~~~i~cG~~~~~~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~~~y~~~~~-~g~~~~R~ 101 (851)
..|+||||++..++.+||+|.+|.........+..+... ... ......+++|+|||+|+...+|.|||. +|+|+|||
T Consensus 6 ~~~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~~~~~~-~~~-~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrL 83 (174)
T 2jwp_A 6 VIWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKL-PIL-RSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVL 83 (174)
T ss_dssp EEEEEEETSSSEEETTTEEECSSCSSTTCCCCCCCCTTS-CCS-SSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEE
T ss_pred EEEEEECCCCCccCCCCCEEcCCcCcccCCcccccccce-Eec-ccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEE
Confidence 579999999888888999999994211000000000000 000 011122459999999999999999996 69999999
Q ss_pred EeccCCCCCcccccceEEEEEcceEEeecCCCCccccccccccccCCCCCcccceEEEEEeec-------------cCCe
Q 047215 102 HFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLGV-------------DLDK 168 (851)
Q Consensus 102 ~f~~~~~~~~~~~~~~f~v~~~g~~~l~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~-------------~~~~ 168 (851)
|||++.+.+ ...+.|||++||++++++|+.... + ++ ..++.++|.+.+ .++.
T Consensus 84 hF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~---------a-g~---~~~~~~~~~~~v~~~~l~i~~~~~~~~g~ 148 (174)
T 2jwp_A 84 KFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDR---------V-GH---STAHDEIIPISIKKGKLSVQGEVSTFTGK 148 (174)
T ss_dssp EEECCSCCC--SSSSCEEEEETTEEEEEEECHHHH---------H-SS---SSCEEEEEEEEEETTEEEETTEEEECCSE
T ss_pred EEeccccCC--CCCeEeEEEECCEEeecCcCHHHh---------h-CC---CeeEEEEEEEEEecCceeeeeeecccCCe
Confidence 999999986 788999999999999999997411 1 11 347888888764 3448
Q ss_pred EEEEEecCCCcceeeeeeEEEecc
Q 047215 169 LMIEFIPSKGSFGFINAIEIVPVV 192 (851)
Q Consensus 169 ~~i~f~~~~~~~~fi~~iEl~~~~ 192 (851)
|+|+|.|.....||||||||++.+
T Consensus 149 L~I~f~p~~~~~a~inaIEI~~~~ 172 (174)
T 2jwp_A 149 LSVEFVKGYYDNPKVCALFIMKGT 172 (174)
T ss_dssp EEEEEECSSSCSSSEEEEEEESSC
T ss_pred EEEEEeccCCCCcEEEEEEEEeCc
Confidence 999999987889999999999865
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.1e-22 Score=211.18 Aligned_cols=153 Identities=16% Similarity=0.068 Sum_probs=122.2
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCCh------------------hhHHHHHHHHHHHHhc
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE------------------QGLAEFETEIEMLSKL 566 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l 566 (851)
+..+......|...+.||+|+||.||+|+..+++.+|+|.+..... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344445566778899999999999999997788999999864321 1356789999999999
Q ss_pred CCcceeeEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 567 RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 567 ~HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
+| +++.+++.. +..++||||+++|+|.+ +. ..+...++.|++.||.|||+ .+|+||||||+|||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NIL 225 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL 225 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEE
Confidence 94 555554433 56699999999999988 42 13455799999999999995 99999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCccccc
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 689 (851)
++ ++.+||+|||+++. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99 99999999999864 33578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=176.09 Aligned_cols=136 Identities=18% Similarity=0.143 Sum_probs=106.4
Q ss_pred CceeeeeeeecceEEEEEEE-cCcce--eEEeecCCCCh------------------------hhHHHHHHHHHHHHhcC
Q 047215 515 FDESLMIGVGGFGKVFKGEI-EDCTL--AAIKRANPQSE------------------------QGLAEFETEIEMLSKLR 567 (851)
Q Consensus 515 f~~~~~LG~G~fG~Vykg~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~Ei~~l~~l~ 567 (851)
|...+.||+|+||.||+|.. .++.. +|||+...... .....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 99998644311 11236889999999998
Q ss_pred Ccce--eeEEEEEccCCcEEEEEEecCC-c----chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCC
Q 047215 568 HRHL--VSLIGFCDEQNEMILVYEYMAN-G----TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640 (851)
Q Consensus 568 HpnI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDl 640 (851)
|+++ ..++++ +..+|||||+.+ | +|.+++.. .++.++..++.|++.+|.|||. ..+|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 8754 344443 356899999942 4 56555421 3466788999999999999993 389999999
Q ss_pred CCCCeEEcCCCeEEEeecccccc
Q 047215 641 KTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 641 k~~NILld~~~~~kl~DFGla~~ 663 (851)
||+|||++. .++|+|||++..
T Consensus 198 kp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEE
T ss_pred CHHHEEEcC--cEEEEECccccc
Confidence 999999998 999999999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=6.3e-15 Score=162.32 Aligned_cols=135 Identities=16% Similarity=0.112 Sum_probs=99.9
Q ss_pred CCceeeeeeeecceEEEEEEEcCcceeEEeecCCCCh--------------hhHH--------HHHHHHHHHHhcCCcce
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE--------------QGLA--------EFETEIEMLSKLRHRHL 571 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~Ei~~l~~l~HpnI 571 (851)
-|.+.+.||+|+||.||+|...+|+.+|||+.+.... .... ...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999998999999997643210 0011 12346667777755443
Q ss_pred e--eEEEEEccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC
Q 047215 572 V--SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649 (851)
Q Consensus 572 v--~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~ 649 (851)
. ..+++. ..+|||||+++++|.+++. ......++.|++.+|.|||. .+||||||||.|||+++
T Consensus 176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQS----RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEEE----TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCCeeeecc----CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 2 223322 3379999999999876642 12446788999999999995 89999999999999987
Q ss_pred CC----------eEEEeecccccc
Q 047215 650 NF----------VAKMSDFGLSKT 663 (851)
Q Consensus 650 ~~----------~~kl~DFGla~~ 663 (851)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 489999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=8e-11 Score=123.90 Aligned_cols=144 Identities=15% Similarity=0.055 Sum_probs=113.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
-..|.....++.|+.+.||+.... +..+++|+...........+.+|+++++.+. |..+.++++++...+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 356877888888899999999855 5678999876532122346889999999994 67788999999888899999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC---------------------------------------
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA--------------------------------------- 631 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~--------------------------------------- 631 (851)
++|.+|.+.+. +..+...++.+++++|..||+..
T Consensus 92 i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 92 ADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred cCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99999987641 12344578889999999999711
Q ss_pred -----------------CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 632 -----------------ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 632 -----------------~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
...++|+|+++.|||++++..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998766677999997653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=3.7e-10 Score=118.15 Aligned_cols=137 Identities=18% Similarity=0.126 Sum_probs=101.1
Q ss_pred CCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc--eeeEEEEEccCCcEEEEEEec
Q 047215 514 NFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH--LVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++....+.+.|..+.||+....++..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333355569999998777778899987654 2245788999999996545 456888888888899999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC----------------------------------------
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA---------------------------------------- 631 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~---------------------------------------- 631 (851)
++.+|. ... . ....++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 998884 211 1 22367788888888888622
Q ss_pred ---------------CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 632 ---------------ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 632 ---------------~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
...++|+|++|.|||++++..+.|+|||.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876678999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=4.4e-09 Score=116.02 Aligned_cols=142 Identities=16% Similarity=0.235 Sum_probs=107.2
Q ss_pred eeeeeeeecceEEEEEEEcCcceeEEeecC--CCC-hhhHHHHHHHHHHHHhcC--CcceeeEEEEEccC---CcEEEEE
Q 047215 517 ESLMIGVGGFGKVFKGEIEDCTLAAIKRAN--PQS-EQGLAEFETEIEMLSKLR--HRHLVSLIGFCDEQ---NEMILVY 588 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~---~~~~lV~ 588 (851)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.|. +..+.++++++... +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45678999999999998765 456777765 322 123456888999999997 45688999999776 4589999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCC-------------------------------------
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA------------------------------------- 631 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~------------------------------------- 631 (851)
||+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998875422 234678888999999999999999621
Q ss_pred ------------------CCCeEEcCCCCCCeEEcCCC--eEEEeecccccc
Q 047215 632 ------------------ERGIIHRDVKTTNILLDENF--VAKMSDFGLSKT 663 (851)
Q Consensus 632 ------------------~~~iiHrDlk~~NILld~~~--~~kl~DFGla~~ 663 (851)
...++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 25799999999999998765 368999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=4.5e-09 Score=113.19 Aligned_cols=187 Identities=16% Similarity=0.157 Sum_probs=122.3
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-Ccc--eeeEEEEEccCC---cEEEEEEec
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRH--LVSLIGFCDEQN---EMILVYEYM 591 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~Ey~ 591 (851)
.+.++.|....||+.. ..+++|+... ......+.+|.++|+.+. +.. +.+++..+...+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3468999999999864 4567777543 234567899999999883 332 445555554433 348999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC-----------------------------------------
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG----------------------------------------- 630 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~----------------------------------------- 630 (851)
+|.+|.+... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875432 2356777788888888888888851
Q ss_pred --------------CCCCeEEcCCCCCCeEEcC--CCeEEEeeccccccCCCCCcccccc------------ccccCCcc
Q 047215 631 --------------AERGIIHRDVKTTNILLDE--NFVAKMSDFGLSKTGPSMEHTHVST------------AVKGSFGY 682 (851)
Q Consensus 631 --------------~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~~~~~~~------------~~~gt~~y 682 (851)
....++|+|+++.||++++ ...+.|+||+.+........-.... ......+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1135899999999999988 5668999999987533211000000 00000011
Q ss_pred cC-cccccccCCCchHHHHHHHHHHHHHHhCCcCC
Q 047215 683 LD-PEYFWRQQLTEKSDVYSFGVVLFEVVCARAVI 716 (851)
Q Consensus 683 ~a-PE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~ 716 (851)
.. |+.... .....+.|+++.+++.+.+|..++
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 232211 123468999999999999997543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=8.6e-06 Score=87.51 Aligned_cols=136 Identities=16% Similarity=0.121 Sum_probs=95.4
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCc---ceeeEEEEEc-cCCcEEEEEEecCC
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHR---HLVSLIGFCD-EQNEMILVYEYMAN 593 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~-~~~~~~lV~Ey~~~ 593 (851)
.+.++.|....||+. +..+++|+.. .......+.+|.++|+.|.+. .+.+.+.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 4556777742 334456789999999999642 3566777763 45667899999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC-------------------------------------------
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG------------------------------------------- 630 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~------------------------------------------- 630 (851)
..|.+... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88876321 1234445555566666666655531
Q ss_pred --------------CCCCeEEcCCCCCCeEEcC---CCe-EEEeecccccc
Q 047215 631 --------------AERGIIHRDVKTTNILLDE---NFV-AKMSDFGLSKT 663 (851)
Q Consensus 631 --------------~~~~iiHrDlk~~NILld~---~~~-~kl~DFGla~~ 663 (851)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 344 58999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=5.9e-06 Score=86.75 Aligned_cols=135 Identities=17% Similarity=0.118 Sum_probs=96.8
Q ss_pred eeeeecce-EEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEEecCCcch
Q 047215 520 MIGVGGFG-KVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYEYMANGTL 596 (851)
Q Consensus 520 ~LG~G~fG-~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (851)
.+..|..| .||+-... ++..+++|+.... ...++.+|...|+.+. +--+.++++++..++..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 35556555 68987654 4456788875432 3457888999999884 43467888999888999999999999887
Q ss_pred hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC----------------------------------------------
Q 047215 597 RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG---------------------------------------------- 630 (851)
Q Consensus 597 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~---------------------------------------------- 630 (851)
.+.... .......++.+++..|.-||+.
T Consensus 108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 765421 1233445666677777777741
Q ss_pred ---------CCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 631 ---------AERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 631 ---------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999887778999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=6.7e-06 Score=90.19 Aligned_cols=81 Identities=5% Similarity=-0.052 Sum_probs=56.3
Q ss_pred eeee-eeecceEEEEEEEc-------CcceeEEeecCCCC---hhhHHHHHHHHHHHHhcC-C--cceeeEEEEEccC--
Q 047215 518 SLMI-GVGGFGKVFKGEIE-------DCTLAAIKRANPQS---EQGLAEFETEIEMLSKLR-H--RHLVSLIGFCDEQ-- 581 (851)
Q Consensus 518 ~~~L-G~G~fG~Vykg~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-H--pnIv~l~g~~~~~-- 581 (851)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.|. + ..+.++++++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999988765 25567777754322 101245778999999884 3 3567888888665
Q ss_pred -CcEEEEEEecCCcchhh
Q 047215 582 -NEMILVYEYMANGTLRS 598 (851)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~ 598 (851)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35789999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00011 Score=81.90 Aligned_cols=75 Identities=19% Similarity=0.127 Sum_probs=49.1
Q ss_pred eeeeeeecceEEEEEEEc-CcceeEEeecCCCCh-------hhHHHHHHHHHHHHhcCC--cc-eeeEEEEEccCCcEEE
Q 047215 518 SLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSE-------QGLAEFETEIEMLSKLRH--RH-LVSLIGFCDEQNEMIL 586 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--pn-Iv~l~g~~~~~~~~~l 586 (851)
.+.||.|..+.||+++.. ++..+++|...+... .....+..|.++|+.+.+ |. +.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457999999999999754 456788887543211 123456789999988742 43 44555553 344689
Q ss_pred EEEecCCc
Q 047215 587 VYEYMANG 594 (851)
Q Consensus 587 V~Ey~~~g 594 (851)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00034 Score=74.03 Aligned_cols=80 Identities=15% Similarity=0.099 Sum_probs=59.5
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-C--cceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-H--RHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H--pnIv~l~g~~~~~~~~~lV~E 589 (851)
..+.....+|.|..+.||+.+..+|+.+++|+...........|..|...|+.|. . --+.+.+++. .-++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3455667899999999999999999999999876554444456889999999884 2 2344556553 2378999
Q ss_pred ecCCcch
Q 047215 590 YMANGTL 596 (851)
Q Consensus 590 y~~~gsL 596 (851)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00035 Score=75.51 Aligned_cols=141 Identities=17% Similarity=0.170 Sum_probs=80.1
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-----CcceeeEE-E--EEccCCcEEEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-----HRHLVSLI-G--FCDEQNEMILVYE 589 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~-g--~~~~~~~~~lV~E 589 (851)
.+.|+.|..+.||+....++. +++|+.... . ..+..|..+++.|. .|.++... | +...++..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGA-VCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTEE-EEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCC-EEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 345666778999999876665 788887652 2 33445566666553 24443311 1 1123567899999
Q ss_pred ecCCcchh--------------hhccC--CCC--C--------CCchhhh------------------------------
Q 047215 590 YMANGTLR--------------SHLFG--SDL--P--------PLTWKQR------------------------------ 613 (851)
Q Consensus 590 y~~~gsL~--------------~~L~~--~~~--~--------~l~~~~~------------------------------ 613 (851)
|+++..+. ..+|. ... + ...|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 01111 000 0 0122211
Q ss_pred -HHHHHHHHHHHHHhhc----------CCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 614 -LDACIGAARGLHYLHT----------GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 614 -~~i~~~ia~gL~yLHs----------~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
..+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111123345666652 1257899999999999998888999999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00074 Score=72.39 Aligned_cols=77 Identities=14% Similarity=0.146 Sum_probs=60.3
Q ss_pred ceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC---CcceeeEEEEEccCCcEEEEEEecC
Q 047215 516 DESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR---HRHLVSLIGFCDEQNEMILVYEYMA 592 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV~Ey~~ 592 (851)
...+.|+.|....+|+.... +..+++|+.... ....+..|...|+.|. ...+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34567899999999998864 456678876532 3567889999999884 3568889999888888999999999
Q ss_pred Ccch
Q 047215 593 NGTL 596 (851)
Q Consensus 593 ~gsL 596 (851)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0012 Score=73.91 Aligned_cols=79 Identities=14% Similarity=0.166 Sum_probs=47.6
Q ss_pred CCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccccccc-ccCCcccCccccccc---CCCchHHHHHHHHHHH
Q 047215 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV-KGSFGYLDPEYFWRQ---QLTEKSDVYSFGVVLF 707 (851)
Q Consensus 632 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~ 707 (851)
...++|+|+++.|||++.++ ++|+||+.+......-. ..... .-...|++|+..... .-....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 57899999999999998776 99999999876332110 00000 001235555544311 1122355567777777
Q ss_pred HHHhCC
Q 047215 708 EVVCAR 713 (851)
Q Consensus 708 eLltG~ 713 (851)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0037 Score=66.99 Aligned_cols=158 Identities=14% Similarity=0.125 Sum_probs=86.1
Q ss_pred cCHHHHHHHhcCCce-----eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc--eeeEE
Q 047215 503 FTLAEIRVATNNFDE-----SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH--LVSLI 575 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~-----~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~ 575 (851)
++.+++...-..|.. .+.|+.|....+|+....++ .+++|...... ....+..|+.+++.|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344455444444543 34566788889999987766 46788766521 1234566888877774222 23333
Q ss_pred EE------EccCCcEEEEEEecCCcchhh--------------hccC--C--CCCC------CchhhhHH----------
Q 047215 576 GF------CDEQNEMILVYEYMANGTLRS--------------HLFG--S--DLPP------LTWKQRLD---------- 615 (851)
Q Consensus 576 g~------~~~~~~~~lV~Ey~~~gsL~~--------------~L~~--~--~~~~------l~~~~~~~---------- 615 (851)
.. ....+..+++++|+++..+.. .+|. . .... ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112356789999999865421 0111 0 0000 12322110
Q ss_pred --HHHHHHHHHHHhhc----CCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 616 --ACIGAARGLHYLHT----GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 616 --i~~~ia~gL~yLHs----~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+...+.+.++.|+. .....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01113344555542 1245799999999999998876668999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0046 Score=69.35 Aligned_cols=73 Identities=18% Similarity=0.168 Sum_probs=49.2
Q ss_pred eeeeeeecceEEEEEEEcC--------cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce-eeEEEEEccCCcEEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIED--------CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL-VSLIGFCDEQNEMILVY 588 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~lV~ 588 (851)
.+.|+.|-...||+....+ +..+++|+...... ...+.+|..+++.|...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4467888889999998753 35677777643211 1455679999988853333 567777653 3899
Q ss_pred EecCCcch
Q 047215 589 EYMANGTL 596 (851)
Q Consensus 589 Ey~~~gsL 596 (851)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0052 Score=66.24 Aligned_cols=142 Identities=12% Similarity=0.103 Sum_probs=72.9
Q ss_pred eeeeeecceE-EEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCC--cceeeEEEEEccCCcEEEEEEecCCcc
Q 047215 519 LMIGVGGFGK-VFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH--RHLVSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 519 ~~LG~G~fG~-Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.++...+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465555444 6676654355566665544321 234557777777642 23556777665444 78999987755
Q ss_pred hhhhcc---------------------CCC---CCCCchhhhH-------H-------------HHHHHHHHHHHhh---
Q 047215 596 LRSHLF---------------------GSD---LPPLTWKQRL-------D-------------ACIGAARGLHYLH--- 628 (851)
Q Consensus 596 L~~~L~---------------------~~~---~~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 628 (851)
+.+.+. ... .+.+...... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543321 111 1111110000 0 0001111222221
Q ss_pred cCCCCCeEEcCCCCCCeEEcCC----CeEEEeeccccccCC
Q 047215 629 TGAERGIIHRDVKTTNILLDEN----FVAKMSDFGLSKTGP 665 (851)
Q Consensus 629 s~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~~~ 665 (851)
......++|||+.+.|||++.+ ..+.|+||+.+....
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1124679999999999999874 689999999887643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0077 Score=66.24 Aligned_cols=140 Identities=18% Similarity=0.180 Sum_probs=81.2
Q ss_pred eeeeeecceEEEEEEEcC--------cceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEE
Q 047215 519 LMIGVGGFGKVFKGEIED--------CTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+.|..|-...+|+....+ +..+++|+.-. .........+|.++++.|. +.-..++++++..+ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 356667788899988642 35667776532 2234566778999998884 32235677777642 9999
Q ss_pred ecCCcchhhh-----------------ccCCC----CCCC-chhhhHHHHHHHH-------------------HHHHH--
Q 047215 590 YMANGTLRSH-----------------LFGSD----LPPL-TWKQRLDACIGAA-------------------RGLHY-- 626 (851)
Q Consensus 590 y~~~gsL~~~-----------------L~~~~----~~~l-~~~~~~~i~~~ia-------------------~gL~y-- 626 (851)
|+++..|... ||... ..+. -|.++.+...++. ..+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 11111 1111 2344444433321 11222
Q ss_pred --hhc-CCCCCeEEcCCCCCCeEEcCC----CeEEEeecccccc
Q 047215 627 --LHT-GAERGIIHRDVKTTNILLDEN----FVAKMSDFGLSKT 663 (851)
Q Consensus 627 --LHs-~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~ 663 (851)
|.. .....++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 123568999999999999876 7899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0046 Score=65.70 Aligned_cols=71 Identities=13% Similarity=0.097 Sum_probs=44.1
Q ss_pred eeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce-eeEEEEEccCCcEEEEEEec-CCcc
Q 047215 518 SLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL-VSLIGFCDEQNEMILVYEYM-ANGT 595 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~-~~gs 595 (851)
.+.|+.|....+|+. ..+++|+....... ..+..+|+.+++.+...++ .++++++.+ .-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 567889999999998 45677776543221 1223568888887743233 455655433 347899999 6555
Q ss_pred h
Q 047215 596 L 596 (851)
Q Consensus 596 L 596 (851)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0076 Score=60.09 Aligned_cols=100 Identities=14% Similarity=0.150 Sum_probs=64.6
Q ss_pred CcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcccc
Q 047215 593 NGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHV 672 (851)
Q Consensus 593 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 672 (851)
.-+|.+.|...+ .++++++++.+|.|.++.|.-+-.. ..+ ..+=+.+..|+|..+|.+...+ ..+.
T Consensus 32 ~vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 347888885543 5799999999999999998876210 011 1233446899999999888764 1110
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC 711 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt 711 (851)
.....+.+||... ...+.+.=|||+|++||.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122467888763 456789999999999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.015 Score=65.62 Aligned_cols=74 Identities=16% Similarity=0.148 Sum_probs=47.3
Q ss_pred eeeeeeecceEEEEEEEcC-cceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce-eeEEEEEccCCcEEEEEEecCCcc
Q 047215 518 SLMIGVGGFGKVFKGEIED-CTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL-VSLIGFCDEQNEMILVYEYMANGT 595 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~lV~Ey~~~gs 595 (851)
.+.|+.|-...+|+....+ +..+++|+....... .-+-.+|..+++.|...++ .++++.+.. .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4468888889999998765 356677765433211 1122579999998864444 467777742 25999999866
Q ss_pred h
Q 047215 596 L 596 (851)
Q Consensus 596 L 596 (851)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.31 E-value=0.016 Score=62.10 Aligned_cols=141 Identities=13% Similarity=0.127 Sum_probs=81.5
Q ss_pred eeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc--eeeEEEE-----EccCCcEEEEEEec
Q 047215 519 LMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH--LVSLIGF-----CDEQNEMILVYEYM 591 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~-----~~~~~~~~lV~Ey~ 591 (851)
..|+ |....||+....++..+++|...... .....+..|..+++.|.... +.+++.. ...++..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887777778899876432 12356677888888774222 3444433 11244568899999
Q ss_pred CCcchhh----h----------cc----CCC---CCCCchhhh----------------------HHHHHHHHHHHHHhh
Q 047215 592 ANGTLRS----H----------LF----GSD---LPPLTWKQR----------------------LDACIGAARGLHYLH 628 (851)
Q Consensus 592 ~~gsL~~----~----------L~----~~~---~~~l~~~~~----------------------~~i~~~ia~gL~yLH 628 (851)
++..+.. . +| ... ....++... ...+..++..+.-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 0 11 000 111121110 011111122222211
Q ss_pred c-CCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 629 T-GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 629 s-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1245689999999999999 4 899999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.013 Score=64.24 Aligned_cols=74 Identities=14% Similarity=0.111 Sum_probs=44.2
Q ss_pred eeeeeeecceEEEEEEEcCc---------ceeEEeecCCCChhhHHHHHHHHHHHHhcCCcc-eeeEEEEEccCCcEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIEDC---------TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRH-LVSLIGFCDEQNEMILV 587 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~---------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV 587 (851)
.+.|+.|....+|+....++ ..+++|+...... ...+...|..+++.+...+ ..++++... -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 34577788889999887542 4667776544322 2223467888888885333 346665542 2789
Q ss_pred EEecCCcch
Q 047215 588 YEYMANGTL 596 (851)
Q Consensus 588 ~Ey~~~gsL 596 (851)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.21 E-value=0.039 Score=59.64 Aligned_cols=32 Identities=16% Similarity=0.234 Sum_probs=28.3
Q ss_pred CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 632 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999988765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.34 E-value=0.33 Score=53.93 Aligned_cols=74 Identities=12% Similarity=0.057 Sum_probs=47.0
Q ss_pred eeeeeeecceEEEEEEEcC--------cceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEE
Q 047215 518 SLMIGVGGFGKVFKGEIED--------CTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~ 588 (851)
.+.|..|-...+|+....+ +..+++++...... ..-+-.+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3457677788899988753 45667777544322 2223367888888884 322345565443 27899
Q ss_pred EecCCcch
Q 047215 589 EYMANGTL 596 (851)
Q Consensus 589 Ey~~~gsL 596 (851)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.46 E-value=2.2 Score=46.87 Aligned_cols=30 Identities=33% Similarity=0.379 Sum_probs=25.1
Q ss_pred CeEEcCCCCCCeEE------cCCCeEEEeecccccc
Q 047215 634 GIIHRDVKTTNILL------DENFVAKMSDFGLSKT 663 (851)
Q Consensus 634 ~iiHrDlk~~NILl------d~~~~~kl~DFGla~~ 663 (851)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999988754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.70 E-value=3.3 Score=41.08 Aligned_cols=115 Identities=8% Similarity=0.103 Sum_probs=78.8
Q ss_pred cCCcceeeEEEEEccCCcEEEEEEecCCc-chhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCC
Q 047215 566 LRHRHLVSLIGFCDEQNEMILVYEYMANG-TLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTN 644 (851)
Q Consensus 566 l~HpnIv~l~g~~~~~~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~N 644 (851)
..||+.++. .+-..++.+.+.|+.-+++ ++.. + ..++...+++++.+|+....++++ =+|--|.|+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 368988877 4666666777777655432 2222 3 346778999999999888766653 5788899999
Q ss_pred eEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCC
Q 047215 645 ILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVI 716 (851)
Q Consensus 645 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~ 716 (851)
++++.++.+++.-.|+-...+ |. .+++..=.-.+=+++..+++++..|
T Consensus 110 L~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999888744322 21 1222233345667888888887655
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 851 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-72 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 6e-72
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 19/273 (6%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
IG G FG V+KG+ + + Q L F+ E+ +L K RH +++ +G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
++ +V ++ +L HL + + +D A+G+ YLH + IIHRD+
Sbjct: 76 -PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDL 130
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ---LTEKS 697
K+ NI L E+ K+ DFGL+ +H + GS ++ PE Q + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 698 DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757
DVY+FG+VL+E++ + LP IN D + + L +
Sbjct: 191 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLSPDLSK-----VRSNCP 239
Query: 758 EKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ + +CL + RP ++L +E + +
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (549), Expect = 3e-64
Identities = 68/305 (22%), Positives = 126/305 (41%), Gaps = 36/305 (11%)
Query: 503 FTLAEIRVATNNFDESL---------MIGVGGFGKVFKGEI----EDCTLAAIKRANPQ- 548
FT + A F + + +IG G FG+V G + + AIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPL 608
+E+ +F +E ++ + H +++ L G + ++++ E+M NG+L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125
Query: 609 TWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668
T Q + G A G+ YL +HRD+ NIL++ N V K+SDFGLS+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 669 HTHVSTAV---KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725
T+ K + PE ++ T SDV+S+G+V++EV+ P +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237
Query: 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHL 785
D I+ + + ++ C + +RP G+++ L
Sbjct: 238 TNQDVINA----------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 786 EYVLQ 790
+ +++
Sbjct: 288 DKMIR 292
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-63
Identities = 66/292 (22%), Positives = 128/292 (43%), Gaps = 27/292 (9%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
IG G FG+V++G+ A+K + + E+ E EI LRH +++ I ++
Sbjct: 11 IGKGRFGEVWRGKWRG-EEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNK 68
Query: 581 QN----EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA----- 631
N ++ LV +Y +G+L +L +T + + + A GL +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT--HVSTAVKGSFGYLDPEYFW 689
+ I HRD+K+ NIL+ +N ++D GL+ S T G+ Y+ PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 690 RQ------QLTEKSDVYSFGVVLFEVVCARAVINPTL----PKDQINLADWAMKWQKQRS 739
+ +++D+Y+ G+V +E+ ++ P + +D +++ ++
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 740 LKSIIDPHLKGNY-SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ + P++ + S E+L +I +C G R T + L + Q
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-63
Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 28/274 (10%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC-D 579
IG G FG V G+ A+K + F E ++++LRH +LV L+G +
Sbjct: 15 IGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
E+ + +V EYMA G+L +L L L + + YL +HRD
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 128
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDV 699
+ N+L+ E+ VAK+SDFGL+K S + T K + PE ++ + KSDV
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDV 183
Query: 700 YSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEK 759
+SFG++L+E+ +P +I L D + +K P
Sbjct: 184 WSFGILLWEIYSFG-----RVPYPRIPLKDVVPRVEKGY------KMDAPDGCPPA---- 228
Query: 760 FGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
E+ + C + RP+ ++ LE+ ++ HE
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLEH-IKTHE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-62
Identities = 70/266 (26%), Positives = 114/266 (42%), Gaps = 21/266 (7%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T A+K Q F E ++ +L+H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
Q + ++ EYM NG+L L LT + LD A G+ ++ ER IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
+ NIL+ + K++DFGL++ E+ K + PE T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 701 SFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKF 760
SFG++L E+V + P + ++ ++L+ N E
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLERGYRMVRPDNCPEE----L 239
Query: 761 GEIAEKCLDDEGKNRPTMGEVLWHLE 786
++ C + ++RPT + LE
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-61
Identities = 78/285 (27%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 514 NFDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQSEQG-LAEFETEIEMLSKLRH 568
+F+E +IG G FG V+ G + D A+K N ++ G +++F TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 569 RHLVSLIGFC-DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
+++SL+G C + ++V YM +G LR+ + P T K + + A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL 146
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHTHVSTAVKGSFGYLDP 685
+ + +HRD+ N +LDE F K++DFGL++ + H T K ++
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745
E Q+ T KSDV+SFGV+L+E++ P +N D + + R L
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRL----- 253
Query: 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
L+ Y P+ L E+ KC + + RP+ E++ + +
Sbjct: 254 --LQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (529), Expect = 2e-61
Identities = 75/315 (23%), Positives = 131/315 (41%), Gaps = 47/315 (14%)
Query: 505 LAEIRVATNNFDESLMIGVGGFGKVFKGE------IEDCTLAAIKRANPQ-SEQGLAEFE 557
L + NN + IG G FG+VF+ E T+ A+K + S A+F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 558 TEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDL------------ 605
E ++++ + ++V L+G C M L++EYMA G L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 606 ----------PPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKM 655
PPL+ ++L A G+ YL ER +HRD+ T N L+ EN V K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 656 SDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAV 715
+DFGLS+ S ++ ++ PE + + T +SDV+++GVVL+E+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 716 INPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNR 775
+ +++ + + D ++ LE + C +R
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACPENCPLE-LYNLMRLCWSKLPADR 286
Query: 776 PTMGEVLWHLEYVLQ 790
P+ + L+ + +
Sbjct: 287 PSFCSIHRILQRMCE 301
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-61
Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 21/278 (7%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV 572
+ IG G FG V G + AIK +F E E++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
L G C EQ + LV+E+M +G L + + + L C+ G+ YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLE---E 119
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
+IHRD+ N L+ EN V K+SDFG+++ ++T ST K + PE F +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSR 178
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
+ KSDV+SFGV+++EV + ++ + + + P L
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRL---A 227
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
S +I C + ++RP +L L + +
Sbjct: 228 STH----VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-61
Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 21/274 (7%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLV 572
+ +G G FG V G+ AIK S EF E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
L G C +Q + ++ EYMANG L ++L +Q L+ C + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
+ +HRD+ N L+++ V K+SDFGLS+ E+T S K + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSK 177
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
+ KSD+++FGV+++E+ +P ++ ++ A I L+
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLG-----KMPYERFTNSETAEH----------IAQGLRLYR 222
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ EK I C ++ RPT +L ++
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 1e-60
Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 21/279 (7%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDC-TLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL 571
+ +G G +G+V++G + A+K + + + EF E ++ +++H +L
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 572 VSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
V L+G C + ++ E+M G L +L + ++ L + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
++ IHRD+ N L+ EN + K++DFGLS+ + K + PE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191
Query: 692 QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751
+ + KSDV++FGV+L+E+ P + Q+ +++ +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELLEKDYRME 236
Query: 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
EK E+ C +RP+ E+ E + Q
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-60
Identities = 63/286 (22%), Positives = 118/286 (41%), Gaps = 26/286 (9%)
Query: 507 EIRVATNNFD-ESLMIGVGGFGKVFKGEI---EDCTLAAIKRANPQSEQG-LAEFETEIE 561
++ + +N + +G G FG V +G + AIK +E+ E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 562 MLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAA 621
++ +L + ++V LIG C + ++LV E G L L G + + +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVS 119
Query: 622 RGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK-TGPSMEHTHVSTAVKGSF 680
G+ YL + +HRD+ N+LL AK+SDFGLSK G + +A K
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 681 GYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740
+ PE ++ + +SDV+S+GV ++E + P ++ + ++ + +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGKRM 231
Query: 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ PE + + C + ++RP V +
Sbjct: 232 E----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-60
Identities = 60/306 (19%), Positives = 117/306 (38%), Gaps = 37/306 (12%)
Query: 508 IRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGL-AEFETEIEMLSK 565
+ + ++F++ +G G G VFK + A K + + + + + E+++L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 566 LRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLH 625
++V G E+ + E+M G+L L + + + I +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
YL + I+HRDVK +NIL++ K+ DFG+S ++ + G+ Y+ P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSP 172
Query: 686 EYFWRQQLTEKSDVYSFGVVLFEVVCAR-----------------------AVINPTLPK 722
E + +SD++S G+ L E+ R A P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 723 DQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIA----EKCLDDEGKNRPTM 778
L+ + M + ++ ++D + F KCL R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 779 GEVLWH 784
+++ H
Sbjct: 293 KQLMVH 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-59
Identities = 75/266 (28%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE 580
+G G FG+V+ G T AIK P F E +++ KLRH LV L
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 82
Query: 581 QNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDV 640
+ + +V EYM+ G+L L G L Q +D A G+ Y+ +HRD+
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 139
Query: 641 KTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVY 700
+ NIL+ EN V K++DFGL++ E+T K + PE + T KSDV+
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVW 198
Query: 701 SFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKF 760
SFG++L E+ V P + ++ ++ + PE E
Sbjct: 199 SFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPCPPECPESL 243
Query: 761 GEIAEKCLDDEGKNRPTMGEVLWHLE 786
++ +C E + RPT + LE
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-59
Identities = 69/291 (23%), Positives = 125/291 (42%), Gaps = 26/291 (8%)
Query: 510 VATNNFDESLMIGVGGFGKVFKGEIED-----CTLAAIKRANPQ-SEQGLAEFETEIEML 563
+ + +IG G FG+V+KG ++ AIK +E+ +F E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 564 SKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARG 623
+ H +++ L G + M+++ EYM NG L L D + Q + G A G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAG 122
Query: 624 LHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGY 682
+ YL +HRD+ NIL++ N V K+SDFGLS+ E T+ ++ K +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 683 LDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742
PE ++ T SDV+SFG+V++EV+ L ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MK 224
Query: 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
I+ + + ++ +C E RP +++ L+ +++ +
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-59
Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 26/270 (9%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FGKV+K + E LAA K + +SE+ L ++ EI++L+ H ++V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+N + ++ E+ A G + + + + PLT Q C L+YLH + IIHRD
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 135
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-----T 694
+K NIL + K++DFG+S + G+ ++ PE +
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
K+DV+S G+ L E+ P ++N +K K +S
Sbjct: 194 YKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPPTLAQPSR----WSS 243
Query: 755 ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
F + +KCL+ R T ++L H
Sbjct: 244 N----FKDFLKKCLEKNVDARWTTSQLLQH 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 9e-59
Identities = 82/315 (26%), Positives = 140/315 (44%), Gaps = 40/315 (12%)
Query: 513 NNFDESLMIGVGGFGKVFKGEIEDCTL---AAIKRANPQ-SEQGLAEFETEIEMLSKL-R 567
N+ +IG G FG+V K I+ L AAIKR S+ +F E+E+L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 568 HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLP--------------PLTWKQR 613
H ++++L+G C+ + + L EY +G L L S + L+ +Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 614 LDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVS 673
L ARG+ YL ++ IHRD+ NIL+ EN+VAK++DFGLS+ E
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 674 TAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733
T + ++ E T SDV+S+GV+L+E+V P + A+ K
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
+ L+ ++ ++ +C ++ RP+ ++L L +L+ +
Sbjct: 239 LPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 794 AWMRTDDRQNSFSSS 808
++ T + +
Sbjct: 289 TYVNTTLYEKFTYAG 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-58
Identities = 66/303 (21%), Positives = 123/303 (40%), Gaps = 46/303 (15%)
Query: 513 NNFDESLMIGVGGFGKVFKG------EIEDCTLAAIKRANPQSEQG-LAEFETEIEMLSK 565
N + ++G G FGKV + A+K +++ +E++M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 566 L-RHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFG---------------------S 603
L H ++V+L+G C + L++EY G L ++L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 604 DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663
DL LT++ L A+G+ +L + +HRD+ N+L+ V K+ DFGL++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKD 723
S + V + ++ PE + T KSDV+S+G++L+E+ P +P D
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 724 QINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLW 783
+I K + + E+ I + C + + RP+ +
Sbjct: 274 AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 784 HLE 786
L
Sbjct: 320 FLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-58
Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 41/294 (13%)
Query: 521 IGVGGFGKVFKGEI------EDCTLAAIKRANPQSEQG-LAEFETEIEMLSKL-RHRHLV 572
+G G FGKV + + A+K P + +E+++LS L H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 573 SLIGFCDEQNEMILVYEYMANGTLRSHLFGS----------------DLPPLTWKQRLDA 616
+L+G C +++ EY G L + L D L + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
A+G+ +L + IHRD+ NILL + K+ DFGL++ + + V
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736
+ ++ PE + T +SDV+S+G+ L+E+ + P +P D
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----------- 256
Query: 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+I + + + +I + C D + RPT +++ +E +
Sbjct: 257 ---FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 7e-58
Identities = 76/311 (24%), Positives = 119/311 (38%), Gaps = 34/311 (10%)
Query: 515 FDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANP---QSEQGLAEFETEIEMLSKLRHRH 570
F + IG G FG V+ + + + AIK+ + QS + + E+ L KLRH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+ G ++ LV EY PL + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH-- 132
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF-- 688
+IHRDVK NILL E + K+ DFG + + G+ ++ PE
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILA 185
Query: 689 -WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747
Q K DV+S G+ E+ + P +N + P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNE------SPA 233
Query: 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSFSS 807
L+ + E F + CL ++RPT +L H +VL+ + D Q + +
Sbjct: 234 LQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLKH-RFVLRERPPTVIMDLIQRTKDA 289
Query: 808 SQALGEFAERE 818
+ L R+
Sbjct: 290 VRELDNLQYRK 300
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-57
Identities = 64/272 (23%), Positives = 104/272 (38%), Gaps = 27/272 (9%)
Query: 521 IGVGGFGKVFKGEIED---CTLAAIKRANPQSEQG--LAEFETEIEMLSKLRHRHLVSLI 575
+G G FG V KG + A+K ++ E E ++ +L + ++V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 576 GFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGI 635
G C E +LV E G L +L + + K ++ + G+ YL
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 636 IHRDVKTTNILLDENFVAKMSDFGLSK-TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
+HRD+ N+LL AK+SDFGLSK + T K + PE + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
KSDV+SFGV+++E P + ++ +K
Sbjct: 189 SKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSEVTAMLEKGE------RMGCPAGCPR 237
Query: 755 ESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
E ++ C + +NRP V L
Sbjct: 238 E----MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-57
Identities = 68/327 (20%), Positives = 133/327 (40%), Gaps = 31/327 (9%)
Query: 506 AEIRVATNN-FDESLMIGVGGFGKVFKGE-IEDCTLAAIKRA-----NPQSEQGLAEFET 558
A +R+ F + ++G G FG V+KG I + I A S + E
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 559 EIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI 618
E +++ + + H+ L+G C L+ + M G L ++ + + L+ C+
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCV 118
Query: 619 GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG 678
A+G++YL R ++HRD+ N+L+ K++DFGL+K + E + + K
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738
++ E + T +SDV+S+GV ++E++ + +P +I
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------------- 222
Query: 739 SLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798
SI++ + P I KC + +RP E++ + + + ++
Sbjct: 223 --SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280
Query: 799 DDRQN----SFSSSQALGEFAEREAED 821
+ S + S + E D
Sbjct: 281 QGDERMHLPSPTDSNFYRALMDEEDMD 307
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 65/280 (23%), Positives = 106/280 (37%), Gaps = 26/280 (9%)
Query: 520 MIGVGGFGKVFKGEI----EDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSL 574
IG G FG V +G AIK + + E F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 575 IGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG 634
IG E N + ++ E G LRS L + + L YL +
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 635 IIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
+HRD+ N+L+ N K+ DFGLS+ + ++ K ++ PE ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFT 187
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
SDV+ FGV ++E++ + P + D + + + N P
Sbjct: 188 SASDVWMFGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGE------RLPMPPNCPP 236
Query: 755 ESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794
+ KC + RP E+ L +L+ +A
Sbjct: 237 T----LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-56
Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 27/280 (9%)
Query: 514 NFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRH 570
+++ IG G +G+ K D + K + S E +E+ +L +L+H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 571 LVSLIGFCDEQNE--MILVYEYMANGTLRSHLF--GSDLPPLTWKQRLDACIGAARGLHY 626
+V ++ + +V EY G L S + + L + L L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 627 LH--TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
H + ++HRD+K N+ LD K+ DFGL++ T + A G+ Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744
PE R EKSD++S G +L+E+ P + + A K ++ +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIREGK------ 230
Query: 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ YS E EI + L+ + +RP++ E+L +
Sbjct: 231 FRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILEN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-56
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G F V+KG E A + ++ F+ E EML L+H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 578 C----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ ++LV E M +GTL+++L + K C +GL +LHT
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT-RTP 133
Query: 634 GIIHRDVKTTNILL-DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
IIHRD+K NI + K+ D GL+ ++ + AV G+ ++ PE + ++
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-EEK 188
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
E DVY+FG+ + E+ + P ++ + + + ++
Sbjct: 189 YDESVDVYAFGMCMLEMATSE------YP--------YSECQNAAQIYRRVTSGVKPASF 234
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
++ + EI E C+ R ++ ++L H
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 3e-55
Identities = 58/265 (21%), Positives = 110/265 (41%), Gaps = 23/265 (8%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
IG G G V+ ++ AI++ N Q + EI ++ + ++ ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+E+ +V EY+A G+L + + + Q C + L +LH +IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 640 VKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDV 699
+K+ NILL + K++DFG + + + G+ ++ PE R+ K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 700 YSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEK 759
+S G++ E++ P N + + L S
Sbjct: 200 WSLGIMAIEMIEGE------PPYLNENPLRALYLIATNGTPELQNPEKL----SAI---- 245
Query: 760 FGEIAEKCLDDEGKNRPTMGEVLWH 784
F + +CLD + + R + E+L H
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQH 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-55
Identities = 65/288 (22%), Positives = 116/288 (40%), Gaps = 37/288 (12%)
Query: 501 KRFTLAEIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIK---RANPQSEQGLAEF 556
+++ L +F+ +G G FG V+ + + A+K +A + +
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 557 ETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDA 616
E+E+ S LRH +++ L G+ + + L+ EY GT+ L L ++
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 111
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
A L Y H + +IHRD+K N+LL K++DFG S PS T +
Sbjct: 112 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----L 164
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736
G+ YL PE + EK D++S GV+ +E + + P + + + +
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISR 218
Query: 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
++ + ++ + L RP + EVL H
Sbjct: 219 -------VEFTFPDFVTEG----ARDLISRLLKHNPSQRPMLREVLEH 255
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 7e-53
Identities = 65/275 (23%), Positives = 102/275 (37%), Gaps = 22/275 (8%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRH 570
++D +G G +G+V A+K + + E + EI + L H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+V G E N L EY + G L + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
GI HRD+K N+LLDE K+SDFGL+ + + G+ Y+ PE R
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 691 QQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
++ E DV+S G+VL ++ + Q +DW K K ID
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKK-IDSAPL 237
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ K L + R T+ ++
Sbjct: 238 ------------ALLHKILVENPSARITIPDIKKD 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 62/274 (22%), Positives = 102/274 (37%), Gaps = 27/274 (9%)
Query: 521 IGVGGFGKVFKGEIEDCT----LAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVS 573
+G G FG V +GE + + A+K P + + +F E+ + L HR+L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L G M +V E G+L L + A G+ YL +
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSK-TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
IHRD+ N+LL + K+ DFGL + + +H + K F + PE +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNY 752
+ SD + FGV L+E+ L QI L I +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDKEGERLPR 236
Query: 753 SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786
+ + + +C + ++RPT + L
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 184 bits (468), Expect = 2e-52
Identities = 56/267 (20%), Positives = 107/267 (40%), Gaps = 23/267 (8%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FG V + E A K E EI+ +S LRH LV+L +
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
+ NEM+++YE+M+ G L + ++ + ++ +GL ++H E +H D
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 640 VKTTNILL--DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKS 697
+K NI+ + K+ DFGL+ ++ G+ + PE + + +
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 698 DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757
D++S GV+ + ++ + + + + +S +D S +
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETL---------RNVKSCDWNMDDSAFSGISED-- 255
Query: 758 EKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ K L + R T+ + L H
Sbjct: 256 --GKDFIRKLLLADPNTRMTIHQALEH 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 67/295 (22%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 521 IGVGGFGKVFKGE--------IEDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRH 570
+G G FG+V E T A+K +E+ L++ +E+EM+ + +H++
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPP--------------LTWKQRLDA 616
+++L+G C + + ++ EY + G LR +L P L+ K +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 617 CIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAV 676
ARG+ YL + IHRD+ N+L+ E+ V K++DFGL++ +++ +T
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736
+ ++ PE + + T +SDV+SFGV+L+E+ P +P ++
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------------ 245
Query: 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791
L ++ + + + + C RPT +++ L+ ++ L
Sbjct: 246 ---LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-52
Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 40/312 (12%)
Query: 513 NNFDESLMIGVGGFGKVFKGE------IEDCTLAAIKRANP-QSEQGLAEFETEIEMLSK 565
S +G G FG V++G E T AIK N S + EF E ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 566 LRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLF--------GSDLPPLTWKQRLDAC 617
H+V L+G + +++ E M G L+S+L L P + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
A G+ YL+ +HRD+ N ++ E+F K+ DFG+++ ++
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
++ PE T SDV+SFGVVL+E+ L +Q+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------ 244
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797
L+ +++ L + + E+ C K RP+ E++ + + M
Sbjct: 245 --LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI-------KEEME 294
Query: 798 TDDRQNSFSSSQ 809
R+ SF S+
Sbjct: 295 PGFREVSFYYSE 306
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 40/295 (13%)
Query: 521 IGVGGFGKVFKG------EIEDCTLAAIKRANPQSEQG-LAEFETEIEMLSKLRHRH-LV 572
+G G FG+V + + C A+K + +E+++L + H +V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 573 SLIGFCDEQNEMI-LVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDAC 617
+L+G C + + ++ E+ G L ++L LT + +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 618 IGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVK 677
A+G+ +L R IHRD+ NILL E V K+ DFGL++ +
Sbjct: 141 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 678 GSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
++ PE + + T +SDV+SFGV+L+E+ A P + + + +
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRR--- 249
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792
LK +PE + C E RPT E++ HL +LQ +
Sbjct: 250 --LKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 5e-50
Identities = 54/267 (20%), Positives = 111/267 (41%), Gaps = 23/267 (8%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FG V + E + K N + EI ++++L H L++L +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
++ EM+L+ E+++ G L + D ++ + ++ A GL ++H E I+H D
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 640 VKTTNILLD--ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKS 697
+K NI+ + + K+ DFGL+ + + + + PE R+ + +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 698 DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757
D+++ GV+ + ++ + + + Q + D + SPE
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETL---------QNVKRCDWEFDEDAFSSVSPE-- 258
Query: 758 EKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ + L E + R T+ + L H
Sbjct: 259 --AKDFIKNLLQKEPRKRLTVHDALEH 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 8e-50
Identities = 59/299 (19%), Positives = 115/299 (38%), Gaps = 29/299 (9%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKG-EIEDCTLAAIKRANPQ---SEQGLAEFETEIEMLS 564
+ +F ++G G F V E+ AIK + E + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624
+L H V L + ++ Y NG L ++ + L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSAL 121
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
YLH +GIIHRD+K NILL+E+ +++DFG +K + + G+ Y+
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744
PE + + SD+++ G +++++V P ++ + +K +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL---PPFRAGNEYLIFQKIIK----------L 225
Query: 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQN 803
+ + P+ ++ EK L + R E+ + L+ H + + +N
Sbjct: 226 EYDFPEKFFPK----ARDLVEKLLVLDATKRLGCEEMEGYGP--LKAH-PFFESVTWEN 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-47
Identities = 51/293 (17%), Positives = 116/293 (39%), Gaps = 27/293 (9%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCD 579
+G G FG V + E K + + EI +L+ RHR+++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRD 639
E+++++E+++ + + S L ++ + L +LH I H D
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 640 VKTTNILLD--ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKS 697
++ NI+ + K+ +FG ++ ++ + + Y PE ++ +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 698 DVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESL 757
D++S G +++ ++ NP L + + + + + D S E++
Sbjct: 185 DMWSLGTLVYVLLSGI---NPFLAETNQQI------IENIMNAEYTFDEEAFKEISIEAM 235
Query: 758 EKFGEIAEKCLDDEGKNRPTMGEVLWH---LEYVLQLHEAWMRTDDRQNSFSS 807
+ ++ L E K+R T E L H + + ++ +RT + + +
Sbjct: 236 ----DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 2e-45
Identities = 66/277 (23%), Positives = 110/277 (39%), Gaps = 28/277 (10%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRANP---QSEQGLAEFETEIEMLSKLRHRHLVSLI 575
++G GG +V + A+K + F E + + L H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 576 GFCDEQNE----MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
+ + +V EY+ TLR + P+T K+ ++ A + L++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH--- 128
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWR 690
+ GIIHRDVK NI++ K+ DFG+++ S + AV G+ YL PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
+ +SDVYS G VL+EV+ P + A + ++ I
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE---DPIPPSARHE 239
Query: 751 NYSPESLEKFGEIAEKCLDDEGKNRP-TMGEVLWHLE 786
S + + K L +NR T E+ L
Sbjct: 240 GLSAD----LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 29/296 (9%)
Query: 511 ATNNFDESLMIGVGGFGKVFKGE--IEDCTLAAIKRANPQS--EQGLAEFETEIEMLSKL 566
A ++ IG G +GKVFK A+KR Q+ E E+ +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 567 ---RHRHLVSLIGFC-----DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACI 618
H ++V L C D + ++ LV+E++ ++L P + + D
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123
Query: 619 GAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKG 678
RGL +LH ++HRD+K NIL+ + K++DFGL++ T+V
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVV 177
Query: 679 SFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL----------A 728
+ Y PE + D++S G + E+ + + + DQ+
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 729 DWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
DW R + + E ++ KCL R + L H
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (406), Expect = 1e-44
Identities = 59/288 (20%), Positives = 113/288 (39%), Gaps = 38/288 (13%)
Query: 514 NFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANP---------QSEQGLAEFETEIEML 563
N++ ++G G V + C A+K + + ++ E+++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 564 SKLR-HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAAR 622
K+ H +++ L + LV++ M G L +L ++ L+ K+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 623 GLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGY 682
+ LH + I+HRD+K NILLD++ K++DFG S ++ V G+ Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSY 175
Query: 683 LDPEYFW------RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736
L PE ++ D++S GV+++ ++ P + Q+ + M
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHRKQMLMLRMIMSGNY 232
Query: 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
Q +YS ++ + L + + R T E L H
Sbjct: 233 Q------FGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEALAH 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 3e-44
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQG-LAEFETEIEMLSKLRHRHLVSLIGF 577
++G G F +V E L AIK ++ +G E EI +L K++H ++V+L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
+ + L+ + ++ G L + + T + + YLH + GI+H
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH---DLGIVH 130
Query: 638 RDVKTTNILL---DENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLT 694
RD+K N+L DE+ +SDFGLSK + V + G+ GY+ PE ++ +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSP 754
+ D +S GV+ + ++C P ++ L + +K + + D + S
Sbjct: 188 KAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYE------FDSPYWDDISD 238
Query: 755 ESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ ++ + + R T + L H
Sbjct: 239 S----AKDFIRHLMEKDPEKRFTCEQALQH 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (403), Expect = 2e-43
Identities = 59/285 (20%), Positives = 105/285 (36%), Gaps = 36/285 (12%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKR------ANPQSEQGLAEFETEIEMLSK 565
N+F +IG GGFG+V+ + + A+K Q E + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 LRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLH 625
+V + +++ + + M G L HL S + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLE 121
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
++H R +++RD+K NILLDE+ ++SD GL+ + G+ GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 174
Query: 686 EYFWRQQ-LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744
E + +D +S G +LF+++ + KD+ + +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 224
Query: 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMG-----EVLWH 784
L ++SPE + E L + R EV
Sbjct: 225 AVELPDSFSPE----LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 5e-43
Identities = 52/294 (17%), Positives = 94/294 (31%), Gaps = 27/294 (9%)
Query: 507 EIRVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSK 565
E+RV N + IG G FG ++ G I AIK +++ + E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 566 LRHRHLVSLIGFCDEQNEM-ILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624
++ + I +C + + ++V E + F S + K L +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRI 116
Query: 625 HYLHTGAERGIIHRDVKTTNIL---LDENFVAKMSDFGLSK-----TGPSMEHTHVSTAV 676
Y+H + IHRDVK N L + + + DFGL+K + +
Sbjct: 117 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 677 KGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQK 736
G+ Y + + + D+ S G VL + + + +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK- 232
Query: 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
S L Y E F C ++P + +
Sbjct: 233 ----MSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-43
Identities = 54/287 (18%), Positives = 108/287 (37%), Gaps = 22/287 (7%)
Query: 514 NFDESLMIGVGGFGKVFKGE-IEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRH 570
NF + IG G +G V+K + A+K R + ++E + EI +L +L H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
+V L+ +N++ LV+E++ + L+ + S L + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 631 AERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
++HRD+K N+L++ K++DFGL++ + + V +
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 691 QQLTEKSDVYSFGVVLFEVVCAR-------------AVINPTLPKDQINLADWAMKWQKQ 737
+ + D++S G + E+V R + D++ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
S P + + + L + R + L H
Sbjct: 238 PSFPKWARQDFSKVVPPLDED-GRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-42
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 23/293 (7%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAE-FETEIEMLSKLRHRHLVSLIGF 577
IG G +G V + + AIK+ +P Q + EI++L + RH +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 578 CDEQNEMILVYEYMANGTLRSHLFG-SDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
+ Y+ + + L+ L+ RGL Y+H ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 131
Query: 637 HRDVKTTNILLDENFVAKMSDFGLSKT-GPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-T 694
HRD+K +N+LL+ K+ DFGL++ P +HT T + Y PE + T
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 695 EKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG---- 750
+ D++S G +L E++ R + DQ+N + Q L II+ +
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251
Query: 751 ----------NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
P + K ++ +K L R + + L H Y+ Q ++
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH-PYLEQYYD 303
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (391), Expect = 2e-42
Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 36/281 (12%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRH 568
+F +G G FG+V + A+K + + + E MLS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLH 628
++ + G + ++ ++ +Y+ G L S L S P + A + L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121
Query: 629 TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYF 688
+ II+RD+K NILLD+N K++DFG +K P + +T G+ Y+ PE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748
+ + D +SFG++++E++ P N K +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNA-------ELRF 220
Query: 749 KGNYSPESLEKFGEIAEKCLDDEGKNR-----PTMGEVLWH 784
++ + ++ + + + R +V H
Sbjct: 221 PPFFNED----VKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 4e-42
Identities = 54/278 (19%), Positives = 108/278 (38%), Gaps = 20/278 (7%)
Query: 521 IGVGGFGKVFKGEIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFC 578
IG G +G V+K + A+K R + E + EI +L +L+H ++V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
+ ++LV+E++ + L + G+ Y H +R ++HR
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 639 DVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSD 698
D+K N+L++ K++DFGL++ + + + ++ + D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 699 VYSFGVVLFEVVCARAVINPTLPKDQI----------NLADWA--MKWQKQRSLKSIIDP 746
++S G + E+V + DQ+ N +W + K ++ +P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
++ E ++ K L + R T + L H
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-42
Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 33/287 (11%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAE-----FETEIEMLSKLRHRHLVS 573
+G G F V+K + AIK+ + EI++L +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L+ ++ + LV+++M S LT + +GL YLH +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 634 GIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL 693
I+HRD+K N+LLDEN V K++DFGL+K+ S + T + Y PE + ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177
Query: 694 -TEKSDVYSFGVVLFEVVCARAV---------------INPTLPKDQINLADWAMKWQKQ 737
D+++ G +L E++ T ++Q +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+S I H+ + L ++ + R T + L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLL----DLIQGLFLFNPCARITATQALKM 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 7e-42
Identities = 65/278 (23%), Positives = 107/278 (38%), Gaps = 30/278 (10%)
Query: 513 NNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANP---QSEQGLAEFETEIEMLSK-LR 567
+F M+G G FGKVF E + AIK + + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 568 HRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYL 627
H L + + + V EY+ G L H+ + GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFL 119
Query: 628 HTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEY 687
H +GI++RD+K NILLD++ K++DFG+ K + G+ Y+ PE
Sbjct: 120 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174
Query: 688 FWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747
Q+ D +SFGV+L+E++ + +P +D+ L +P
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQ---SPFHGQDEEELFHSIRMD----------NPF 221
Query: 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTM-GEVLWH 784
E ++ K E + R + G++ H
Sbjct: 222 YPRWLEKE----AKDLLVKLFVREPEKRLGVRGDIRQH 255
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-42
Identities = 61/314 (19%), Positives = 116/314 (36%), Gaps = 36/314 (11%)
Query: 520 MIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGF 577
++G+G GKV + A+K + E+E+ + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 578 CD----EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
+ + +++V E + G L S + T ++ + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 634 GIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWR 690
I HRDVK N+L N + K++DFG +K S + Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGP 187
Query: 691 QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750
++ + D++S GV+++ ++C LA + R +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQA 810
S E + L E R T+ E + H +++Q + Q +S+
Sbjct: 243 EVSEE----VKMLIRNLLKTEPTQRMTITEFMNH-PWIMQSTKV------PQTPLHTSRV 291
Query: 811 LGEFAEREAEDGQD 824
L E ER + ++
Sbjct: 292 LKEDKERWEDVKEE 305
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 61/305 (20%), Positives = 123/305 (40%), Gaps = 41/305 (13%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANP------QSEQGLAEFETEIEMLSKLRHRHLVS 573
+G G F V K E A K + + E E+ +L +++H ++++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 574 LIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAER 633
L + + ++IL+ E +A G L L + LT ++ + G++YLH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 634 GIIHRDVKTTNILLDENFVA----KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
I H D+K NI+L + V K+ DFGL+ ++ + + G+ ++ PE
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVN 189
Query: 690 RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749
+ L ++D++S GV+ + ++ + ++ ++ +
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---------LANVSAVNYEFEDEYF 240
Query: 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSFSSSQ 809
N S + + L + K R T+ + L H W++ D Q + SS+
Sbjct: 241 SNTSAL----AKDFIRRLLVKDPKKRMTIQDSLQH---------PWIKPKDTQQALSSAW 287
Query: 810 ALGEF 814
+ +F
Sbjct: 288 SHPQF 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-41
Identities = 69/331 (20%), Positives = 119/331 (35%), Gaps = 35/331 (10%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR 567
R ++ ++ +IG G FG V++ + + L AIK+ E++++ KL
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLD 71
Query: 568 HRHLVSLIGFCDEQNE------MILVYEYMANGTLRSHLFGSDLP-PLTWKQRLDACIGA 620
H ++V L F E + LV +Y+ R S L
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 621 ARGLHYLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS 679
R L Y+H GI HRD+K N+LLD + V K+ DFG +K E + +
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSR 186
Query: 680 FGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL------------ 727
+ F T DV+S G VL E++ + + DQ+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 728 ADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787
+ I + P + + + + L+ R T E H +
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH-SF 305
Query: 788 VLQLHEAWMRTDDRQNSFSSSQALGEFAERE 818
+L + ++ + + + AL F +E
Sbjct: 306 FDELRDPNVKLPNGR----DTPALFNFTTQE 332
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (377), Expect = 9e-41
Identities = 43/282 (15%), Positives = 88/282 (31%), Gaps = 28/282 (9%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHR-HLVSLIGFC 578
IG G FG +F+G + + AIK +S+ + E L + ++ F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHR 638
E +LV + + G L + K A + +H E+ +++R
Sbjct: 71 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125
Query: 639 DVKTTNILLDENFV-----AKMSDFGLSK-----TGPSMEHTHVSTAVKGSFGYLDPEYF 688
D+K N L+ + DFG+ K + G+ Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 689 WRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748
++ + + D+ + G V + + + ++ L+ +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA--- 242
Query: 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790
+ E F + + P + VL+
Sbjct: 243 --GFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-39
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 42/276 (15%)
Query: 520 MIGVGGFGKVFKG-EIEDCTLAAIKRANPQSEQGLAE------FETEIEMLSKLRHRH-- 570
++G GGFG V+ G + D AIK E E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 571 LVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG 630
++ L+ + + + +L+ E L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH-- 127
Query: 631 AERGIIHRDVKTTNILLDEN-FVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFW 689
G++HRD+K NIL+D N K+ DFG + V T G+ Y PE+
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 690 RQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748
+ + V+S G++L+++VC P ++I + Q + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGD---IPFEHDEEII--------RGQVFFRQRVSSEC 231
Query: 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
+ + CL +RPT E+ H
Sbjct: 232 Q------------HLIRWCLALRPSDRPTFEEIQNH 255
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 73/285 (25%), Positives = 110/285 (38%), Gaps = 33/285 (11%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGE-IEDCTLAAIKRANPQ---SEQGLAEFETEIEMLS 564
+V N+FD ++G G FGKV A+K + ++ +A TE +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 565 KLRHRHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGL 624
RH L +L + + V EY G L HL S T ++ L
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 625 HYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
YLH R +++RD+K N++LD++ K++DFGL K G S T G+ YL
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744
PE D + GVV++E++C R LP + +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME------- 220
Query: 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMG-----EVLWH 784
+ SPE + L + K R G EV+ H
Sbjct: 221 EIRFPRTLSPE----AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 56/293 (19%), Positives = 111/293 (37%), Gaps = 34/293 (11%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G FG+VFK + A+K+ ++ E EI++L L+H ++V+LI
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 578 CDEQ--------NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHT 629
C + + LV+++ + + L T + GL+Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH- 134
Query: 630 GAERGIIHRDVKTTNILLDENFVAKMSDFGLSK--TGPSMEHTHVSTAVKGSFGYLDPEY 687
I+HRD+K N+L+ + V K++DFGL++ + + T + Y PE
Sbjct: 135 --RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 688 FWRQQL-TEKSDVYSFGVVLFEVVCARAV---------------INPTLPKDQINLADWA 731
++ D++ G ++ E+ + + ++ + D
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 732 MKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
++K +K + ++ +K L + R + L H
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 55/280 (19%), Positives = 103/280 (36%), Gaps = 22/280 (7%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G +G VFK + E + A+K R + E + EI +L +L+H+++V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 578 CDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIH 637
++ LV+E+ + + + + +GL + H+ R ++H
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL--LKGLGFCHS---RNVLH 124
Query: 638 RDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKS 697
RD+K N+L++ N K+++FGL++ + S V + F + +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 698 DVYSFGVVLFEVVCAR-------------AVINPTLPKDQINLADWAMKWQKQRSLKSII 744
D++S G + E+ A I L K +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784
N P+ ++ + L R + E L H
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 5e-36
Identities = 62/320 (19%), Positives = 120/320 (37%), Gaps = 39/320 (12%)
Query: 477 NSTANAKGSGTQYLKGSVALTRAG---KRFTLAEIRVATNNFDESLMIGVGGFGKVFKGE 533
N+ A KGS + +K +A + K T ++ + FD +G G FG+V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 534 -IEDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589
E A+K + Q + + E +L + LV L + + + +V E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE 649
Y+A G + SHL + + YLH +I+RD+K N+L+D+
Sbjct: 122 YVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ 176
Query: 650 NFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEV 709
+++DFG +K T + G+ L PE + + D ++ GV+++E+
Sbjct: 177 QGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 710 VCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLD 769
P I + + + + ++S + ++ L
Sbjct: 232 AAGYP---PFFADQPIQIYEKIVSGK----------VRFPSHFSSD----LKDLLRNLLQ 274
Query: 770 DEGKNR-----PTMGEVLWH 784
+ R + ++ H
Sbjct: 275 VDLTKRFGNLKNGVNDIKNH 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 37/298 (12%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIK--RANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G +G V + AIK QSE E+ +L +RH +++ L+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 578 C------DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
D+ + LV +M GT L L + +GL Y+H
Sbjct: 86 FTPDETLDDFTDFYLVMPFM--GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH--- 138
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
GIIHRD+K N+ ++E+ K+ DFGL++ + ++ V +
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWYRAPEVILNWM 194
Query: 692 QLTEKSDVYSFGVVLFEVVCAR---------------AVINPTLPKDQINLADWAMKWQK 736
+ T+ D++S G ++ E++ + + T P + +
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 737 QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEA 794
+ L + + S + EK L + + R T GE L H Y LH+
Sbjct: 255 MKGLPELEKKDFASILTNASPL-AVNLLEKMLVLDAEQRVTAGEALAH-PYFESLHDT 310
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 65/292 (22%), Positives = 114/292 (39%), Gaps = 35/292 (11%)
Query: 509 RVATNNFDESLMIGVGGFGKVFKGE----IEDCTLAAIKRANP----QSEQGLAEFETEI 560
+V NF+ ++G G +GKVF + L A+K Q + TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 561 EMLSKLRHR-HLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIG 619
++L +R LV+L + ++ L+ +Y+ G L +HL + I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIY 134
Query: 620 AARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGS 679
+ L + GII+RD+K NILLD N ++DFGLSK + E + G+
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 193
Query: 680 FGYLDPEYFWRQQ--LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ 737
Y+ P+ + D +S GV+++E++ + P + N + +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILK 250
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMG-----EVLWH 784
+P S ++ ++ L + K R G E+ H
Sbjct: 251 S------EPPYPQEMSAL----AKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 3e-32
Identities = 55/291 (18%), Positives = 107/291 (36%), Gaps = 41/291 (14%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFC 578
+G G + +VF+ I + +K P ++ + + EI++L LR ++++L
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 99
Query: 579 DEQNE--MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGII 636
+ LV+E++ N + LT + L Y H GI+
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIM 151
Query: 637 HRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-T 694
HRDVK N+++D E+ ++ D+GL++ S + PE Q+
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 695 EKSDVYSFGVVLFEVVCAR-----------------AVINPTLPKDQINLADWAMKWQKQ 737
D++S G +L ++ + V+ D I+ + + +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 738 RSLKSIIDPHLKGNYSPESLEKFGEIA----EKCLDDEGKNRPTMGEVLWH 784
L + E+ A +K L + ++R T E + H
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 56/298 (18%), Positives = 110/298 (36%), Gaps = 45/298 (15%)
Query: 521 IGVGGFGKVFKG-EIEDCTLAAIKRANP--QSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
IG G G V + AIK+ + Q++ E+ ++ + H++++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 578 C------DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGA 631
+E ++ LV E M + D ++ G+ +LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKHLH--- 136
Query: 632 ERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQ 691
GIIHRD+K +NI++ + K+ DFGL++ + + + T + Y PE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 692 QLTEKSDVYSFGVVLFEVVCAR----------------AVINPTLPKDQINLADWAMKWQ 735
E D++S G ++ E+V + + P+ L +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 736 KQR-SLKSIIDPHLKGNYSPESLEKFGEIA--------EKCLDDEGKNRPTMGEVLWH 784
+ R + P L + + + ++ K L + R ++ + L H
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 57/295 (19%), Positives = 107/295 (36%), Gaps = 33/295 (11%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANP--QSEQGLAEFETEIEMLSKLRHRHLVSLIGF 577
+G G +G V + A+K+ + QS E+ +L ++H +++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 578 CDEQN-----EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAE 632
+ + ++ L + + LT RGL Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---S 139
Query: 633 RGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQ 692
IIHRD+K +N+ ++E+ K+ DFGL++ +V+T +
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNWMH 195
Query: 693 LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL------ADWAMKWQKQRSLKSIIDP 746
+ D++S G ++ E++ R + T DQ+ L A +K S +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 747 HLKGNYSPESLEK--------FGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHE 793
+ ++ EK L + R T + L H Y Q H+
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH-AYFAQYHD 309
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 2e-24
Identities = 43/311 (13%), Positives = 98/311 (31%), Gaps = 50/311 (16%)
Query: 521 IGVGGFGKVFKGE-IEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH----------- 568
+G G F V+ + + + T A+K + E EI++L ++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 569 RHLVSLIGFCDEQNEMILVYEYMANGTLRSHLFGSDL---PPLTWKQRLDACIGAARGLH 625
H++ L+ + + + + + L + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 626 YLHTGAERGIIHRDVKTTNILLD-ENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLD 684
Y+H GIIH D+K N+L++ + + ++ G + + T + Y
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 685 PEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK----------- 733
PE +D++S ++FE++ + P D +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 734 -WQKQRSLKSIIDPH-------------------LKGNYSPESLEKFGEIAEKCLDDEGK 773
+ + ++ + K +S + ++ + L + +
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317
Query: 774 NRPTMGEVLWH 784
R G ++ H
Sbjct: 318 KRADAGGLVNH 328
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 2e-16
Identities = 30/201 (14%), Positives = 59/201 (29%), Gaps = 42/201 (20%)
Query: 520 MIGVGGFGKVFKGEIEDCTLAAIK----------RANPQSEQGLAEFETEIEMLSKLRHR 569
++G G VF E +K + + + G F ++ R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 570 HLVSLIGFCD----EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLH 625
L L G ++ E + L + + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVA 117
Query: 626 YLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDP 685
+ RGI+H D+ N+L+ E + + DF S V +G L+
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQS----------VEVGEEGWREILER 163
Query: 686 EY-----FWRQQLTEKSDVYS 701
+ ++ + + D+ S
Sbjct: 164 DVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 851 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.3 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 96.18 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 96.04 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=429.08 Aligned_cols=262 Identities=27% Similarity=0.497 Sum_probs=208.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
..++|+..++||+|+||+||+|++++ .||||++... .....+.|.+|+++|++++|||||+++|++.+ +.++|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 45778889999999999999998754 4899987643 45667889999999999999999999999865 5689999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|||++|+|.++|.... ..+++.+++.++.|+|+||+|||+ ++||||||||+||||+.++.+||+|||+++......
T Consensus 83 Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp ECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred ecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999996543 468999999999999999999996 899999999999999999999999999998755433
Q ss_pred ccccccccccCCcccCcccccc---cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR---QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.........||+.|||||++.+ ..++.++|||||||+||||+||+.||....+.... ......+ ...
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~----~~~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRG----YLS 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHT----SCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----CCC
Confidence 3344456789999999999964 35899999999999999999999999765433221 1111111 111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
|.+ ...+..+++.+.+|+.+||+.||++|||++|++++|+.+.+
T Consensus 229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 12344566789999999999999999999999999997764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=424.77 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=211.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..+.||+|+||+||+|+.. +++.+|||++.... ....+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999874 67889999986543 33446789999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.++|... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999643 469999999999999999999995 89999999999999999999999999999875443333
Q ss_pred ccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
......+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... .. ..... ...
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~----~~~~~---------~~~ 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS----DWKEK---------KTY 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH----HHHTT---------CTT
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH----HHhcC---------CCC
Confidence 44556789999999999988776 67899999999999999999999754332211 11 11111 111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.......++.+.+|+.+||+.||++|||++|+++| +|++..
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h---------pwf~~~ 266 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD---------RWYNKP 266 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC---------TTTTCC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC---------HhhCcC
Confidence 11123445678899999999999999999999999 998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=422.61 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=204.6
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|+..+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|+|..++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35788899999999999999999888889999987643 34578999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.... ..++|..+++++.|+|+||+|||+ ++|+||||||+||||+.++.+||+|||+++....... .
T Consensus 83 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 9999999986543 468899999999999999999995 8999999999999999999999999999986543222 2
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......||+.|+|||++.+..++.++|||||||+||||+|++.|+....... .+. .... .+ ....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~---~~i~-~~---------~~~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVV---EDIS-TG---------FRLY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHH---HHHH-HT---------CCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHH---HHHH-hc---------CCCC
Confidence 2334578999999999999999999999999999999999765554432221 111 1111 11 1112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.+..+++.+.+|+.+||+.||++|||++|++++|+.+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 334556779999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=423.54 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=212.6
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++|+..+.||+|+||+||+|++++++.||||++.... ...+.|.+|+++|++++|||||+++|+|.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 456788899999999999999999888899999987543 345689999999999999999999999865 567999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+++|+|.+++......+++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+++..... ..
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY 164 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCC-cc
Confidence 999999998866555569999999999999999999995 89999999999999999999999999999875432 22
Q ss_pred ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 671 HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
.......||+.|+|||++.+..++.++|||||||+||||+||+.|+........ +.. .. .. ....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~---~i-~~---------~~~~ 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQ---NL-ER---------GYRM 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH---HH-HT---------TCCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHH---HH-Hh---------cCCC
Confidence 233456789999999999999999999999999999999997766554332211 111 11 11 1112
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
..+..+++.+.+|+.+||+.||++||||+||++.|+...
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 234456677999999999999999999999999988543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-50 Score=427.15 Aligned_cols=260 Identities=23% Similarity=0.400 Sum_probs=217.3
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
+...++|+..+.||+|+||+||+|++. .++.||||++.... ...++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 344578888999999999999999976 47789999987543 3467899999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
||||++|+|.++|.......+++..++.++.|+|+||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999977666789999999999999999999995 89999999999999999999999999999875432
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
.........||+.|+|||++.+..++.++|||||||++|||++|+.|+........ +. . ++...
T Consensus 169 -~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~----~---------~i~~~ 232 (287)
T d1opja_ 169 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY----E---------LLEKD 232 (287)
T ss_dssp -SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH----H---------HHHTT
T ss_pred -CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HH----H---------HHhcC
Confidence 22233445689999999999999999999999999999999998877655433221 11 1 11112
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.....+..+++.+.+|+.+||+.||++|||++|+++.|+.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22334556677899999999999999999999999887643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-49 Score=422.37 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=202.7
Q ss_pred cCCceeeeeeeecceEEEEEEEcC-c---ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED-C---TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..++||+|+||+||+|+++. + ..||||++... .....+.|.+|+++|++++|||||+++|+|..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778899999999999998742 2 35788987654 555667899999999999999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
||||++|+|.+++.... ..++|.++++++.|+|+||+|||+ ++||||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999886543 468999999999999999999996 89999999999999999999999999999865432
Q ss_pred Cccc---cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 668 EHTH---VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 668 ~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... ......||+.|||||.+.+..++.++|||||||+||||+| |+.||......+ +.. ...
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~---~i~-------- 247 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VIN---AIE-------- 247 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHH--------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHH---HHH--------
Confidence 2211 1223457999999999999999999999999999999998 788886543221 111 111
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
...+...+..++..+.+|+.+||+.||++|||+.|++++|+.+++
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 --QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111223445677889999999999999999999999999998765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=414.64 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=208.0
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCc-----ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDC-----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
.+.|+..++||+|+||+||+|.++.. ..||||++... ......+|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999987643 36899998654 4455567999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+|||||.+|+|.+++.... ..++|.++++++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998875443 469999999999999999999995 899999999999999999999999999998644
Q ss_pred CCC-ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 666 SME-HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
... .........||+.|+|||++.+..++.++|||||||+||||++++.|+.......+ +. .. +
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~---~~----------i 226 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VM---KA----------I 226 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH---HH----------H
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HH---HH----------H
Confidence 322 22233445689999999999999999999999999999999998777654433221 11 11 1
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
....+...+..++..+.+|+.+||+.||++|||+.||++.|+.+++..
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 112223445567788999999999999999999999999999887643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=415.72 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=207.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|++.+.||+|+||+||+|+.. +++.+|+|++... .....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999975 5788999987643 2234567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|+++||+|||+ ++||||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999999998643 368999999999999999999995 89999999999999999999999999999864332
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ..... ..
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~---------~~-- 219 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRIS---------RV-- 219 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH---------TT--
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------HHHHH---------cC--
Confidence 23456799999999999999999999999999999999999999965432211 11111 11
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
...++..+++.+.+|+.+||+.||++|||++|+++|
T Consensus 220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 112344556779999999999999999999999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=417.29 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=214.1
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|+..+.||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||||++++++..++..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999986 467899999987655555678999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++... .+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence 999999987543 58999999999999999999995 899999999999999999999999999998643322 2
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........ .+ ...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~------~~--~~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG------TP--ELQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC------SC--CCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCC------CC--CCC
Confidence 23456799999999999999999999999999999999999999975432211 11111111 01 112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.+..+++.+++|+.+||+.||.+|||++|+++| +|++.
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H---------p~~~~ 275 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH---------QFLKI 275 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC---------GGGGG
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC---------HhhCC
Confidence 334566779999999999999999999999999 99864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=423.67 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=210.3
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcCc------ceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCC
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIEDC------TLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQN 582 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~~------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 582 (851)
..++|+..++||+|+||+||+|+.... ..||+|++... .......+.+|+.+|+++ +|||||+++++|...+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 457899999999999999999986532 35788987654 344556789999999998 8999999999999999
Q ss_pred cEEEEEEecCCcchhhhccCCC---------------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCC
Q 047215 583 EMILVYEYMANGTLRSHLFGSD---------------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVK 641 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk 641 (851)
..+||||||++|+|.++|+... ...+++.+++.++.|+++||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 9999999999999999996543 2358999999999999999999996 899999999
Q ss_pred CCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCC
Q 047215 642 TTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTL 720 (851)
Q Consensus 642 ~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~ 720 (851)
|+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986544333333455678999999999999999999999999999999998 888887543
Q ss_pred CcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 721 PKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.... +.. ++....+...+..+++.+.+|+.+||+.||++|||++||++||.
T Consensus 272 ~~~~--~~~-------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN--FYK-------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH--HHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH--HHH-------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3221 111 11111223345566778999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=415.59 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=213.6
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
+.|++.+.||+|+||+||+|+.. ++..+|||++........+.|.+|+++|++++|||||++++++..++..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56888999999999999999874 57889999988777777788999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.... .++++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ 165 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence 9999999875432 468999999999999999999995 8999999999999999999999999999875321 112
Q ss_pred cccccccCCcccCccccc-----ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 672 VSTAVKGSFGYLDPEYFW-----RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
......||+.|+|||++. ...|+.++|||||||+||||+||+.||....+.+.. ..... ... +
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~-~~~-----~ 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAK-SEP-----P 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHH-SCC-----C
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHc-CCC-----C
Confidence 234567999999999984 456899999999999999999999999765443221 11111 100 1
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
. ...+..+++.+.+|+.+||+.||.+|||++|+++| +|++.
T Consensus 234 ~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h---------p~~~~ 274 (288)
T d2jfla1 234 T--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH---------PFVTV 274 (288)
T ss_dssp C--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS---------GGGCC
T ss_pred C--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC---------cccCC
Confidence 1 12234556779999999999999999999999999 99863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=407.32 Aligned_cols=254 Identities=28% Similarity=0.392 Sum_probs=212.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|+..++||+|+||+||+|+++++..||||++..... ..++|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368889999999999999999998888999999876433 3578999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.+++.... ..+++..+.+++.|+|+||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence 9999999875543 458899999999999999999995 8999999999999999999999999999986443222 2
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ + .... ..+ .+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~---~~~i-~~~---------~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T---AEHI-AQG---------LRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H---HHHH-HTT---------CCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---H---HHHH-HhC---------CCC
Confidence 2334668999999999999999999999999999999998 788886543221 1 1111 111 112
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEY 787 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 787 (851)
..+..+++.+.+|+.+||+.||++|||++|+++||.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2334556779999999999999999999999999853
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=408.10 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=209.4
Q ss_pred hcCCceee-eeeeecceEEEEEEEc---CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 512 TNNFDESL-MIGVGGFGKVFKGEIE---DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 512 t~~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.++|...+ +||+|+||+||+|.++ ++..||||++... .....+.|.+|+++|++++|||||+++|+|.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35566666 4999999999999764 3457899998765 44556789999999999999999999999965 56899
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
|||||++|+|.+++.... ..+++.++.+++.|+|+||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 86 vmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999875443 468999999999999999999996 8999999999999999999999999999987543
Q ss_pred CCcc-ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 667 MEHT-HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 667 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.... .......||+.|+|||++....++.++|||||||++|||+| |+.||......+ +.. ....+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~----~i~~~------ 228 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----FIEQG------ 228 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----HHHTT------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcC------
Confidence 3222 22344568999999999999999999999999999999998 899987543321 111 11111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
.+...++.+++.+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 229 ---~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 229 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112345567778999999999999999999999999887553
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=412.93 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=196.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--CCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--QNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV 587 (851)
++|+..+.||+|+||+||+|+.. +++.+|+|++... .....+.+.+|+++|++++|||||++++++.+ ++.++||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999864 6788999988654 44556779999999999999999999999853 5678999
Q ss_pred EEecCCcchhhhccCC--CCCCCchhhhHHHHHHHHHHHHHhhcCC--CCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 588 YEYMANGTLRSHLFGS--DLPPLTWKQRLDACIGAARGLHYLHTGA--ERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLHs~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
|||+++|+|.+++... ....+++.+++.++.|++.||+|||+.. ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 3457999999999999999999999621 23599999999999999999999999999987
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... ........||+.|||||++.+..++.++|||||||++|||+||+.||......+ +. ... ..+..
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~---~~i-~~~~~--- 231 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA---GKI-REGKF--- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHH-HHTCC---
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH---HHH-HcCCC---
Confidence 4332 223345789999999999999999999999999999999999999997543211 11 111 11111
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+ ..+...++.+.+|+.+||+.||.+|||++|+++|
T Consensus 232 --~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 --R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1 2233455679999999999999999999999999
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=407.68 Aligned_cols=245 Identities=26% Similarity=0.413 Sum_probs=197.2
Q ss_pred ceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc----CCcEEEEE
Q 047215 516 DESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE----QNEMILVY 588 (851)
Q Consensus 516 ~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~lV~ 588 (851)
+..++||+|+||+||+|+.. ++..||+|++... .....+.|.+|+++|++++|||||++++++.. +..++|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999875 5678899987643 44556789999999999999999999999854 45689999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCC--eEEcCCCCCCeEEc-CCCeEEEeeccccccCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERG--IIHRDVKTTNILLD-ENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~--iiHrDlk~~NILld-~~~~~kl~DFGla~~~~ 665 (851)
||+++|+|.+++... ..+++.++..++.|+++||+|||+ ++ |+||||||+||||+ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999543 468999999999999999999995 55 99999999999996 57899999999998632
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
. .......||+.|||||++.+ +++.++|||||||+||||++|+.||........ + .... ..+
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~---~~~i-~~~------- 228 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRRV-TSG------- 228 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHHH-TTT-------
T ss_pred C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H---HHHH-HcC-------
Confidence 2 22345689999999999865 699999999999999999999999965432211 1 1111 111
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....++...++.+.+|+.+||+.||++|||++|+++|
T Consensus 229 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 -VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00111223345568999999999999999999999999
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=426.02 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=207.0
Q ss_pred HhcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
..++|+..++||+|+||+||+|+.. +++.+|+|++... .......+.+|+.+|++++|||||+++++|.++++++|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999964 6788999998654 3444578999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|||++|+|.+++... ..+++.++..++.|++.||.|||+ .++|+||||||+||||+.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~--- 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 156 (322)
T ss_dssp ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH---
T ss_pred EcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC---
Confidence 999999999999654 358999999999999999999996 3589999999999999999999999999998532
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHH-HHHHHH--------h----
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLA-DWAMKW--------Q---- 735 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~-~~~~~~--------~---- 735 (851)
........||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+....+..... ...... .
T Consensus 157 -~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 157 -DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp -HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred -CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 12234568999999999999999999999999999999999999999765432210000 000000 0
Q ss_pred ------hh----cc----cccccCccCCCCCC-hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 736 ------KQ----RS----LKSIIDPHLKGNYS-PESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 736 ------~~----~~----~~~i~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.. .. ...+... .....+ ...+..+.+|+.+||+.||.+|||++|+|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTS-CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhcc-CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 00 0000000 000111 1234668999999999999999999999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=406.13 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=199.7
Q ss_pred eeeeeecceEEEEEEEcC---cceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEecCC
Q 047215 519 LMIGVGGFGKVFKGEIED---CTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYMAN 593 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~~~ 593 (851)
++||+|+||+||+|.+++ ++.||||++... +....+.|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998653 357899998654 33445789999999999999999999999965 467899999999
Q ss_pred cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc-ccc
Q 047215 594 GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH-THV 672 (851)
Q Consensus 594 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-~~~ 672 (851)
|+|.+++... .++++.++++++.|||.||+|||+ ++||||||||+||||+.++.+||+|||+++....... ...
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999998654 468999999999999999999995 8999999999999999999999999999986543322 222
Q ss_pred ccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 673 STAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 673 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +.. ....+ .+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~----~i~~~---------~~~~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----MLEKG---------ERMG 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTT---------CCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHH----HHHcC---------CCCC
Confidence 344678999999999999999999999999999999998 888887543221 111 11111 1223
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.+..++..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 4456677899999999999999999999998887643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=412.75 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=208.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-Ccc----eeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCT----LAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 586 (851)
.+|+..++||+|+||+||+|++. +++ .||+|++... +.+..++|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 332 5788887654 445677899999999999999999999999864 5788
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCC
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 666 (851)
++||+.+|+|.+.+... ...+++.++++++.|||.||+|||+ ++||||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999887654 3568999999999999999999996 8999999999999999999999999999987554
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
...........||+.|+|||++.+..++.++|||||||+||||+| |+.||......+ +.... ..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~~-------- 228 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EK-------- 228 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----HH--------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----Hc--------
Confidence 333333445678999999999999999999999999999999999 666765443222 11111 11
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
..+...++.+++.+.+|+.+||+.||.+|||+.|++++|+.+.+....+..
T Consensus 229 -~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~~~~ 279 (317)
T d1xkka_ 229 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279 (317)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHHHBC
T ss_pred -CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHhhcc
Confidence 112234456677899999999999999999999999999988766555543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=409.69 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=205.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
.++|++.+.||+|+||+||+|+++++..||||++.... ...+.|.+|+.+|++++|||||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46789999999999999999999888889999987543 345789999999999999999999999954 5689999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|..++.......++|.+++.++.|||.||+|||+ .+|+||||||+||||+.++.+||+|||+++..... ...
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYT 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC-Cce
Confidence 99999999876555679999999999999999999995 89999999999999999999999999999864332 222
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGN 751 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 751 (851)
......||+.|+|||++....++.++|||||||+||||+||+.|+.......+ ...+ .. ......
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~---i~----------~~~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ---VE----------RGYRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH---HH----------TTCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH---HH----------hcCCCC
Confidence 23446789999999999999999999999999999999998776654432211 1111 11 111223
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 047215 752 YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLE 786 (851)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 786 (851)
.+..+++.+.+++.+||+.||++|||+++|++.|+
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 45566778999999999999999999999988766
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9e-47 Score=414.46 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=215.8
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|++.+.||+|+||.||+|+. .++..+|||++........+.+.+|+++|++++|||||++++++.+++.++||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 467899999998777777788999999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc--CCCeEEEeeccccccCCCCCc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD--ENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld--~~~~~kl~DFGla~~~~~~~~ 669 (851)
++|+|.+++.... ..+++.++..++.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 106 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 9999999985443 469999999999999999999995 9999999999999995 4688999999999864332
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......||+.|||||++.+..++.++|||||||++|||++|+.||......+ ......... ....
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-------~~~~ 245 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCD-------WNMD 245 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-------CCSC
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CCCC
Confidence 22345679999999999999999999999999999999999999997543221 111111110 1111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
......+++.+++|+.+||+.||++|||++|+++| +|++...
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h---------p~~~~~~ 287 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH---------PWLTPGN 287 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS---------TTTSCTT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC---------cccCCCC
Confidence 11223455678999999999999999999999999 8987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=410.77 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=210.5
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|++.+.||+|+||+||+|+.. +++.+|||++... .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999874 6788999987643 2334567999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999988543 468999999999999999999995 899999999999999999999999999998755433
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
........+||+.|+|||++.+..++.++|||||||+||||++|+.||....+.+ +. .. +...
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~~---------i~~~-- 225 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IF---QK---------IIKL-- 225 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HH---------HHTT--
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HH---HH---------HHcC--
Confidence 3334456689999999999999999999999999999999999999997643221 11 11 1111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...++...++.+++|+.+||+.||++|||++|++++.+ ++ ..+|++.
T Consensus 226 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~-i~--~Hpff~~ 272 (288)
T d1uu3a_ 226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP-LK--AHPFFES 272 (288)
T ss_dssp CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH-HH--TSGGGTT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH-HH--cCCccCC
Confidence 11233455667899999999999999999999877633 21 2377764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=412.34 Aligned_cols=266 Identities=26% Similarity=0.430 Sum_probs=215.7
Q ss_pred HHHHHHHhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEE
Q 047215 505 LAEIRVATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGF 577 (851)
Q Consensus 505 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 577 (851)
+.+++...++|+..+.||+|+||+||+|++. +++.||||++... ..+..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455667789999999999999999999864 3468999998765 34456789999999999999999999999
Q ss_pred EccCCcEEEEEEecCCcchhhhccCCC----------------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCe
Q 047215 578 CDEQNEMILVYEYMANGTLRSHLFGSD----------------------LPPLTWKQRLDACIGAARGLHYLHTGAERGI 635 (851)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~i 635 (851)
|...+..++||||+++|+|.++|+... ...+++.+++.++.|++.||+|||+ +++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence 999999999999999999999985321 2358899999999999999999995 899
Q ss_pred EEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCc-
Q 047215 636 IHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA- 714 (851)
Q Consensus 636 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~- 714 (851)
|||||||+|||||.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986443333334455678999999999999999999999999999999999975
Q ss_pred CCCCCCCcchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 715 VINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 715 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
|+......+ + .... ..+. ....+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 242 p~~~~~~~e---~---~~~v-~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEE---V---IYYV-RDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHH---H---HHHH-HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHH---H---HHHH-HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 444332211 1 1111 1111 12234556678999999999999999999999999988653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-47 Score=410.86 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=197.3
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC-hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS-EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
.+.|+..++||+|+||+||+|+.. +++.+|||++.... ......+.+|+++|++++|||||++++++.+++.++||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999875 57889999986543 2334568899999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeeccccccCCC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPS 666 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~~ 666 (851)
||++|+|.++|... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999653 469999999999999999999995 8999999999999994 578999999999986432
Q ss_pred CCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCc
Q 047215 667 MEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDP 746 (851)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 746 (851)
.......+||+.|||||++.+..++.++|||||||+||||++|+.||......+ +.. .... . +.
T Consensus 163 ---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~-~------~~ 226 (307)
T d1a06a_ 163 ---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFE---QILK-A------EY 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHT-T------CC
T ss_pred ---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-c------CC
Confidence 222345679999999999999999999999999999999999999997543221 111 1111 0 11
Q ss_pred cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 747 HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 747 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.......+..++.+.+|+.+||+.||.+|||++|+++| +|++.
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h---------p~~~~ 269 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH---------PWIAG 269 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS---------TTTTS
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC---------HhhCC
Confidence 11222334556779999999999999999999999999 99864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-46 Score=410.33 Aligned_cols=258 Identities=19% Similarity=0.307 Sum_probs=215.4
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey~ 591 (851)
++|++.+.||+|+||.||+|+. .++..+|||++..........+.+|+++|++++|||||++++++.+++.++||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 468899999988776666778899999999999999999999999999999999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc--CCCeEEEeeccccccCCCCCc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD--ENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld--~~~~~kl~DFGla~~~~~~~~ 669 (851)
++|+|.+.+... ..++++.++..++.||+.||+|||+ ++||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999999877543 3469999999999999999999995 9999999999999997 6789999999999875432
Q ss_pred cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......||+.|+|||++.+..++.++|||||||+||||+||+.||......+. ..... .. +....
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~-~~------~~~~~ 248 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVK-RC------DWEFD 248 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHH-HC------CCCCC
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hC------CCCCC
Confidence 233456799999999999999999999999999999999999999975432211 11111 11 11111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.......++.+.+|+.+||+.||.+|||++|+++| +|++..
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H---------p~~~~~ 289 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH---------PWLKGD 289 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS---------TTTSSC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC---------HhhCCC
Confidence 22233455678999999999999999999999999 898753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=406.86 Aligned_cols=268 Identities=24% Similarity=0.386 Sum_probs=207.2
Q ss_pred HHHHHHhcCCceeeeeeeecceEEEEEEEcC------cceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEE
Q 047215 506 AEIRVATNNFDESLMIGVGGFGKVFKGEIED------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGF 577 (851)
Q Consensus 506 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~ 577 (851)
.+++...++|+..++||+|+||.||+|+... ++.||||++... .....+.+.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 4445556789999999999999999998642 357899998754 445566788888888887 68999999999
Q ss_pred Ecc-CCcEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCC
Q 047215 578 CDE-QNEMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKT 642 (851)
Q Consensus 578 ~~~-~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~ 642 (851)
+.. +..+++|||||++|+|.++|+... ...+++.+++.++.|+++||+|||+ ++||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCc
Confidence 865 456899999999999999986432 2458999999999999999999996 8999999999
Q ss_pred CCeEEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCc-CCCCCCC
Q 047215 643 TNILLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA-VINPTLP 721 (851)
Q Consensus 643 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~-p~~~~~~ 721 (851)
+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||.. ||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987554444444456789999999999999999999999999999999999865 5543322
Q ss_pred cchhcHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 722 KDQINLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 722 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.+. .......+ .....+..+++.+.+++.+||+.||++|||++|+++||+.+++.
T Consensus 243 ~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 DEE------FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp SHH------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH------HHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 211 11111111 11233445667799999999999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=410.47 Aligned_cols=246 Identities=27% Similarity=0.393 Sum_probs=202.6
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC---hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS---EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
..|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588899999999999999986 467889999876543 344567999999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|||++|+|..++... .++++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999997766433 468999999999999999999995 8999999999999999999999999999986322
Q ss_pred ccccccccccCCcccCcccccc---cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWR---QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID 745 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 745 (851)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+. ...... +. .
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~-~~-----~ 231 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NE-----S 231 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SC-----C
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-CC-----C
Confidence 234579999999999864 4689999999999999999999999875432211 111111 10 1
Q ss_pred ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 746 PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 746 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+.+ .+...++.+.+|+.+||+.||.+|||++|+++|
T Consensus 232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 123345679999999999999999999999999
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=407.33 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=210.3
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC------ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ------SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|+..+.||+|+||+||+|+. .+++.+|||++... .....+.+.+|+.+|++++|||||++++++.+++.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6799999999999999999997 46789999987543 1223578999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC----eEEEeecccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF----VAKMSDFGLS 661 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~----~~kl~DFGla 661 (851)
||||||++|+|.++|... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999998553 369999999999999999999995 8999999999999998766 5999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
+..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ...... ..
T Consensus 165 ~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~-~~-- 232 (293)
T d1jksa_ 165 HKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSA-VN-- 232 (293)
T ss_dssp EECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHT-TC--
T ss_pred hhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHHh-cC--
Confidence 864322 223456789999999999999999999999999999999999999976432211 111111 00
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCCCCCCc
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDDRQNSF 805 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~~~~~~ 805 (851)
.......+..++..+++|+.+||+.||++|||++|+++| +|++..+.+...
T Consensus 233 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h---------p~~~~~~~~~~l 283 (293)
T d1jksa_ 233 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH---------PWIKPKDTQQAL 283 (293)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS---------TTTCC-------
T ss_pred ----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC---------cccCCCChhHhh
Confidence 001111112345678999999999999999999999999 999765544433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=401.73 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=201.9
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC----cceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED----CTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
..++|+..+.||+|+||.||+|++.. +..||||.+... .....+.|.+|+++|++++|||||+++|+|. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 34678999999999999999998643 346788888654 4445678999999999999999999999996 46789
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ ++||||||||+|||++.++.+||+|||+++...
T Consensus 84 iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999999875443 468999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.. .........||+.|+|||++.+..++.++|||||||+||||+| |+.|+......+ +.... ..+
T Consensus 160 ~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~~------ 225 (273)
T d1mp8a_ 160 DS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENG------ 225 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTT------
T ss_pred CC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcC------
Confidence 32 2223345668999999999999999999999999999999998 777776554322 11111 111
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.....++.+++.+.+|+.+||+.||++|||++||+++|+.+++.
T Consensus 226 ---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11134456677899999999999999999999999999988754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=398.13 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=200.8
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-CCcEEEEEEec
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-QNEMILVYEYM 591 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~lV~Ey~ 591 (851)
++|+..+.||+|+||.||+|+++ ++.||||+++... ..+.|.+|++++++++||||++++|+|.+ ++.++|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 56788899999999999999985 5679999986543 34779999999999999999999999854 56789999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCccc
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHTH 671 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 671 (851)
++|+|.++|+......++|..+++++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC-----
Confidence 99999999976544568999999999999999999996 8999999999999999999999999999986332
Q ss_pred cccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCCC
Q 047215 672 VSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLKG 750 (851)
Q Consensus 672 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 750 (851)
......+|..|+|||++.+..++.++|||||||++|||+| |+.|+...... .+..+. ....+.
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i-------------~~~~~~ 219 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV-------------EKGYKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH-------------TTTCCC
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH-------------HcCCCC
Confidence 1233468899999999999999999999999999999998 56665443222 222221 111223
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 751 NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
+++..+++.+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 4455666789999999999999999999999999988753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=402.79 Aligned_cols=259 Identities=30% Similarity=0.463 Sum_probs=206.6
Q ss_pred cCCceeeeeeeecceEEEEEEEcCc-c--eeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDC-T--LAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~-~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..++||+|+||+||+|++.+. . .||||++... .....++|.+|+++|+++ +|||||+++|+|..++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6788889999999999999987543 2 4678887544 444567899999999999 799999999999999999999
Q ss_pred EEecCCcchhhhccCC--------------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 588 YEYMANGTLRSHLFGS--------------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
|||+++|+|.++|+.. ....+++.++.+++.|||+||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999654 24579999999999999999999996 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK 733 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~ 733 (851)
||+|||+++.... ........||..|+|||.+....++.++|||||||++|||++|..|+....... .+.+ .
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~---~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYE---K 238 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---H
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHH---H
Confidence 9999999986332 112234568999999999999999999999999999999999876433222211 1111 1
Q ss_pred HhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 047215 734 WQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLH 792 (851)
Q Consensus 734 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (851)
... ..+...+..+++.+.+|+.+||+.||++||||+||+++|+.+++..
T Consensus 239 -i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 239 -LPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -GGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111 1122344566778999999999999999999999999999887533
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=398.25 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=215.8
Q ss_pred HHhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEccC
Q 047215 510 VATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDEQ 581 (851)
Q Consensus 510 ~~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 581 (851)
...++|+..++||+|+||.||+|++. .++.||||++... .......|.+|+.+++++ +|||||+++|+|..+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34578888999999999999999863 3468999998765 344566799999999999 699999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCCC----------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCe
Q 047215 582 NEMILVYEYMANGTLRSHLFGSD----------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNI 645 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NI 645 (851)
+..+||||||++|+|.++|+... ...+++.++.+++.||++||+|||+ +++|||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 99999999999999999986432 2368999999999999999999995 8999999999999
Q ss_pred EEcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh
Q 047215 646 LLDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI 725 (851)
Q Consensus 646 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~ 725 (851)
|++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++.|+.........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998765544444455678999999999999999999999999999999999965554433322111
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
+. .. +....+...+..++..+.+|+.+||+.||++|||++|+++.|+.++.
T Consensus 257 -~~----~~---------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 -FY----KM---------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp -HH----HH---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HH----HH---------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 11 11 11112223334556779999999999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=395.92 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=204.9
Q ss_pred eeeeeeecceEEEEEEEcCc----ceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-CCcEEEEEEec
Q 047215 518 SLMIGVGGFGKVFKGEIEDC----TLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-QNEMILVYEYM 591 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~lV~Ey~ 591 (851)
.++||+|+||+||+|++.+. ..||||++... +....++|.+|+++|++++|||||+++|+|.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999987442 25889988753 55667889999999999999999999999864 56899999999
Q ss_pred CCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc-
Q 047215 592 ANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT- 670 (851)
Q Consensus 592 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~- 670 (851)
++|+|.+++.... ..+++.++++++.|+|+||.|||+ .+|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999886543 457888999999999999999995 89999999999999999999999999999865432221
Q ss_pred -ccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccCC
Q 047215 671 -HVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHLK 749 (851)
Q Consensus 671 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 749 (851)
.......||+.|+|||.+....++.++||||||++||||+||+.|+....... ....+. . .+. +
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i---~-~g~---------~ 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---L-QGR---------R 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---H-TTC---------C
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH---H-cCC---------C
Confidence 22334568999999999999999999999999999999999888876543221 111111 1 110 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 750 GNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
...+..+++.+.+|+.+||+.||++||||.||+++|+.+++
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12334556779999999999999999999999999998864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=397.64 Aligned_cols=262 Identities=25% Similarity=0.452 Sum_probs=210.2
Q ss_pred HhcCCceeeeeeeecceEEEEEEEcC--------cceeEEeecCCC-ChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc
Q 047215 511 ATNNFDESLMIGVGGFGKVFKGEIED--------CTLAAIKRANPQ-SEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE 580 (851)
Q Consensus 511 ~t~~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 580 (851)
..++|+..+.||+|+||.||+|+... +..||||++... ......++.+|...+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34688889999999999999998532 347899998765 345567899999999998 89999999999999
Q ss_pred CCcEEEEEEecCCcchhhhccCCC--------------CCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeE
Q 047215 581 QNEMILVYEYMANGTLRSHLFGSD--------------LPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNIL 646 (851)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NIL 646 (851)
++..++||||+++|+|.++|.... ...+++.++++++.|++.||+|||+ ++||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 999999999999999999996543 2468999999999999999999995 99999999999999
Q ss_pred EcCCCeEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchh
Q 047215 647 LDENFVAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQI 725 (851)
Q Consensus 647 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~ 725 (851)
++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999999986544333334455678999999999999999999999999999999998 56666543221
Q ss_pred cHHHHHHHHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 726 NLADWAMKWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 726 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.+. ..... ......+..+++.+.+|+.+||+.||.+|||+.||++.|+.+..+
T Consensus 245 ~~~----~~i~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ELF----KLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHH----HHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HHHHc---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111 11111 112233445567799999999999999999999999999988754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-45 Score=400.40 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=210.1
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|++.+.||+|+||+||+|+. .+++.+|||++... .....+.+.+|+.+|++++|||||++++++..++.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5689999999999999999997 45789999998643 2334577899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|||++|+|..++.... .+++.++..++.|++.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999885543 57888889999999999999994 89999999999999999999999999999874332
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
....+||+.|||||++.+..++.++|||||||+||||++|+.||......+. ..... .+ .
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~-~~--------~- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKIL-NA--------E- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH-HC--------C-
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHH-cC--------C-
Confidence 2356899999999999999999999999999999999999999976432211 11111 11 1
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHHhhhhhcccC
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L~~~~~~~~~w~~~~ 799 (851)
..+++..++.+.+++.+||+.||.+|| |++++++| +|++.-
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H---------p~f~~i 263 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH---------PWFKEV 263 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS---------GGGSSC
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC---------cccccC
Confidence 123344556789999999999999996 99999999 887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=401.94 Aligned_cols=248 Identities=26% Similarity=0.340 Sum_probs=208.3
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+. .+++.+|||++... .....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999986 46789999998643 2334577899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
|||++|+|.+++... ..+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999998654 358889999999999999999996 899999999999999999999999999998643322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
......+||+.|+|||++.+..|+.++||||+||+||||++|+.||......+ +. ... ..+ .
T Consensus 160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~---~~i-~~~------~--- 221 (337)
T d1o6la_ 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---ELI-LME------E--- 221 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-HHC------C---
T ss_pred --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HH---HHH-hcC------C---
Confidence 23345789999999999999999999999999999999999999997653221 11 111 111 1
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
..++...++.+++|+.+||+.||.+||+ ++|+++|
T Consensus 222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1233445567899999999999999994 8999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=393.35 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=198.1
Q ss_pred cCCceeeeeeeecceEEEEEEEcC--c--ceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIED--C--TLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~--~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|+..+.||+|+||+||+|++.. + ..||||++... .....++|.+|+.+|++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998643 2 36899988654 34456789999999999999999999999976 4678
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
+||||+++|+|.+++.... .++++.++++++.|+|+||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998875433 468999999999999999999996 899999999999999999999999999998754
Q ss_pred CCCc-cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHh-CCcCCCCCCCcchhcHHHHHHHHhhhcccccc
Q 047215 666 SMEH-THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVC-ARAVINPTLPKDQINLADWAMKWQKQRSLKSI 743 (851)
Q Consensus 666 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLlt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 743 (851)
.... ........||..|+|||.+.+..++.++|||||||++|||+| |+.||......+ .. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~---~~i--------- 227 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKI--------- 227 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHH---------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH---HHH---------
Confidence 3322 223344568889999999999999999999999999999998 888886543221 11 111
Q ss_pred cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 744 IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 744 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
.........+..++..+.+|+.+||+.||++|||+.||++.|.++
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122233455667799999999999999999999998887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-45 Score=387.35 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=209.8
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh---------hhHHHHHHHHHHHHhcC-CcceeeEEEEEccC
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE---------QGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQ 581 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~ 581 (851)
++|+..++||+|+||+||+|+. .+++.+|||++..... ...+.+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999986 5678999998765421 12346889999999997 99999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
+..|||||||++|+|.++|... .++++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999653 469999999999999999999995 89999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccc------cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHh
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWR------QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQ 735 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (851)
+..... .......||+.|+|||++.+ ..++.++||||+||+||||++|+.||....+.+. ....
T Consensus 158 ~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-------~~~i 227 (277)
T d1phka_ 158 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------LRMI 227 (277)
T ss_dssp EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH
T ss_pred eEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-------HHHH
Confidence 864332 22345679999999999863 3578899999999999999999999976532211 1111
Q ss_pred hhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 736 KQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 736 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+.. ..........++.+++|+.+||+.||++|||++|+++| +|+++
T Consensus 228 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h---------~~~~~ 275 (277)
T d1phka_ 228 MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH---------PFFQQ 275 (277)
T ss_dssp HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS---------GGGCT
T ss_pred HhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC---------HHHHH
Confidence 11111 11122234566779999999999999999999999999 89864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=398.98 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=212.5
Q ss_pred HHHhcCCceeeeeeeecceEEEEEEEc------CcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccC
Q 047215 509 RVATNNFDESLMIGVGGFGKVFKGEIE------DCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQ 581 (851)
Q Consensus 509 ~~~t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 581 (851)
+...++|+..+.||+|+||+||+|++. +++.||||++... .......|.+|+.++++++|||||+++|+|..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 334578889999999999999999864 3468999998754 445556799999999999999999999999999
Q ss_pred CcEEEEEEecCCcchhhhccCC--------CCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeE
Q 047215 582 NEMILVYEYMANGTLRSHLFGS--------DLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVA 653 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~--------~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~ 653 (851)
+..++|||||++|+|.+++... ....+++.++.+++.|+|+||.|||+ ++|+||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceE
Confidence 9999999999999999988532 23457899999999999999999995 899999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCc-CCCCCCCcchhcHHHHHH
Q 047215 654 KMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARA-VINPTLPKDQINLADWAM 732 (851)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~-p~~~~~~~~~~~l~~~~~ 732 (851)
||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||+. |+... .. .++..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~-----~~~~~ 246 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SN-----EQVLR 246 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CH-----HHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-CH-----HHHHH
Confidence 9999999986544333334455678999999999999999999999999999999999964 44332 21 11111
Q ss_pred HHhhhcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 047215 733 KWQKQRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYV 788 (851)
Q Consensus 733 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 788 (851)
... +.. ....+..++..+.+++.+||+.+|++|||++||+++|+..
T Consensus 247 ~i~---------~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 FVM---------EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHH---------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHH---------hCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111 111 1223445667899999999999999999999999997643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=388.61 Aligned_cols=264 Identities=22% Similarity=0.241 Sum_probs=201.3
Q ss_pred eeeeeeeecceEEEEEEEc-CcceeEEeecCCCChh-----hHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 517 ESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQ-----GLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
..++||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.+|++++|||||++++++..++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 5789999998654221 134688999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
++++++..++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-- 154 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-- 154 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc--
Confidence 999888777633 3468899999999999999999995 999999999999999999999999999997643322
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccC----
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIID---- 745 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d---- 745 (851)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.... ..............+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhccchhcc
Confidence 22334579999999999865 4689999999999999999999999876543322111 111100000000000
Q ss_pred --cc-C--CCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 746 --PH-L--KGNY-----SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 746 --~~-l--~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
.. . .... ....++.+.+|+.+||+.||++|||++|+|+| +|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H---------p~f~~~ 286 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------KYFSNR 286 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS---------GGGTSS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC---------HhhCCC
Confidence 00 0 0000 12345679999999999999999999999999 998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-45 Score=400.67 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=210.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 588 (851)
++|+..+.||+|+||.||+|+.. +++.+|||++... .....+.+.+|+++|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999874 6889999987642 2234567899999999999999999999999999999999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 668 (851)
||+.+|+|.+++... ..+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999998554 368999999999999999999995 89999999999999999999999999999874322
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.....||+.|||||++.+..++.++|||||||+||||+||+.||....+.. + ..... .+ .
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~i~-~~--------~- 254 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---I---YEKIV-SG--------K- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-HC--------C-
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---H---HHHHh-cC--------C-
Confidence 234679999999999999999999999999999999999999997543211 1 11111 11 0
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHHhhhhhcccC
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L~~~~~~~~~w~~~~ 799 (851)
...+...++.+.+++.+||+.||.+|+ |++++++| +|++..
T Consensus 255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H---------p~f~~~ 300 (350)
T d1rdqe_ 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH---------KWFATT 300 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS---------GGGTTC
T ss_pred -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC---------ccccCC
Confidence 122344556789999999999999994 99999999 887643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=395.73 Aligned_cols=269 Identities=24% Similarity=0.320 Sum_probs=200.1
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC----cEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN----EMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~lV~ 588 (851)
.+|...+.||+|+||.||+|+++ ++.||||++...... ...+..|+..+.+++|||||+++|+|...+ .++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 45677889999999999999974 678999998643221 222344555566789999999999996543 689999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC-----CCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG-----AERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~-----~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
|||++|+|.++|+.. .++|.++++++.|+|.||+|||+. .+++||||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999654 589999999999999999999963 146999999999999999999999999999986
Q ss_pred CCCCCcc--ccccccccCCcccCccccccc------CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcc----h-----hc
Q 047215 664 GPSMEHT--HVSTAVKGSFGYLDPEYFWRQ------QLTEKSDVYSFGVVLFEVVCARAVINPTLPKD----Q-----IN 726 (851)
Q Consensus 664 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~----~-----~~ 726 (851)
....... .......||+.|+|||++... .++.++|||||||+||||+||+.|+....... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 4332221 123456799999999998754 26789999999999999999988764322111 1 11
Q ss_pred HHHHHHHHhhhcccccccCccCCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 047215 727 LADWAMKWQKQRSLKSIIDPHLKGN-YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQL 791 (851)
Q Consensus 727 l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 791 (851)
.. ...... ......|.+... .+.+++..+.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 238 ~~-~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VE-EMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HH-HHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-HHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 11 111111 111122222111 1235667799999999999999999999999999877643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=394.56 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=200.8
Q ss_pred cCCceee-eeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhc-CCcceeeEEEEEcc----CCcEE
Q 047215 513 NNFDESL-MIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKL-RHRHLVSLIGFCDE----QNEMI 585 (851)
Q Consensus 513 ~~f~~~~-~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~----~~~~~ 585 (851)
++|.+.+ +||+|+||.||+|+. .+++.||||++... ..+.+|+.++.++ +|||||+++++++. +..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788764 699999999999986 56789999998642 4567899987655 89999999999854 56789
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC---CCeEEEeeccccc
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE---NFVAKMSDFGLSK 662 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~ 662 (851)
||||||++|+|.++|.......+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999977655679999999999999999999995 99999999999999975 5679999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
...... ......||+.|+|||++.+..|+.++|||||||+||||+||+.||........... ....
T Consensus 163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-----------~~~~ 228 (335)
T d2ozaa1 163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----------MKTR 228 (335)
T ss_dssp ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------C
T ss_pred eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----------HHHH
Confidence 644322 23456799999999999999999999999999999999999999975433221100 0011
Q ss_pred ccCccC--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 743 IIDPHL--KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 743 i~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
+..... ........++.+.+|+.+||+.||++|||+.|+++|
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 111113456789999999999999999999999999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-44 Score=398.02 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=201.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCC---hhhHHHHH---HHHHHHHhcCCcceeeEEEEEccCCcEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQS---EQGLAEFE---TEIEMLSKLRHRHLVSLIGFCDEQNEMI 585 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~---~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 585 (851)
++|++.++||+|+||.||+|+.. +++.+|||++.... ......+. .|+++++.++|||||++++++..++.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999975 57899999875321 11222333 4467777788999999999999999999
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
||||||++|+|.++|... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999554 457899999999999999999995 999999999999999999999999999998643
Q ss_pred CCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccccc
Q 047215 666 SMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSII 744 (851)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 744 (851)
.. ......||+.|+|||++.. ..++.++|||||||+||||+||+.||......+...+. . .+.
T Consensus 159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~--------~~~ 222 (364)
T d1omwa3 159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----R--------MTL 222 (364)
T ss_dssp SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----H--------HSS
T ss_pred CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H--------hcc
Confidence 22 2344679999999999974 57999999999999999999999999765443321111 0 011
Q ss_pred CccCCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047215 745 DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPT-----MGEVLWH 784 (851)
Q Consensus 745 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 784 (851)
. ....++...++.+.+|+.+||+.||.+||| ++|+++|
T Consensus 223 ~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 T--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp S--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred c--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1 111223345567899999999999999999 7999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-44 Score=383.03 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=201.2
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC---ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC----c
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ---SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN----E 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~ 583 (851)
.++|++.+.||+|+||+||+|+. .+++.+|||++... .......|.+|+++|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999986 56889999998654 3344567999999999999999999999986543 4
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.+|||||+++|+|.+++... .++++.++..++.|++.||+|||+ ++||||||||+|||++.++..+|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999988544 468999999999999999999995 8999999999999999999999999999875
Q ss_pred CCCC-CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 664 GPSM-EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 664 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.... ..........||+.|+|||++.+..++.++|||||||+||||+||+.||....+.+ .........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~---- 230 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRED---- 230 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCC----
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcC----
Confidence 4322 22223445679999999999999999999999999999999999999997543221 111111111
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP-TMGEVLWHLEYV 788 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 788 (851)
+.......+..++.+.+++.+||+.||.+|| |++++++.|..+
T Consensus 231 ---~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 ---PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ---CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1111112234556799999999999999999 899988877655
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=389.45 Aligned_cols=252 Identities=17% Similarity=0.238 Sum_probs=206.2
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
.++|++.+.||+|+||+||+|... +++.+|||.+.....+ ...+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999875 5788999998765433 45688999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC--CCeEEEeeccccccCCCCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE--NFVAKMSDFGLSKTGPSME 668 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~ 668 (851)
|++|+|.++|.... .++++.++..++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 99999999996543 368999999999999999999995 89999999999999974 458999999999864332
Q ss_pred ccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCccC
Q 047215 669 HTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPHL 748 (851)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 748 (851)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+. ........ . .++..
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~~~-~--~~~~~- 225 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAE-Y--TFDEE- 225 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-C--CCCHH-
T ss_pred --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-C--CCChh-
Confidence 223456789999999999999999999999999999999999999976533211 11111100 0 00000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047215 749 KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWH 784 (851)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 784 (851)
.....+..+++|+.+||+.||.+|||++|+++|
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011345668999999999999999999999999
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=392.55 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=204.3
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC---ChhhHHHHHHHHHHHH-hcCCcceeeEEEEEccCCcEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ---SEQGLAEFETEIEMLS-KLRHRHLVSLIGFCDEQNEMILV 587 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~HpnIv~l~g~~~~~~~~~lV 587 (851)
++|+..+.||+|+||+||+|+.. +++.+|||++... .....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999875 5788999998643 2233456677777665 68999999999999999999999
Q ss_pred EEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCC
Q 047215 588 YEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 588 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 667 (851)
||||++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999643 358889999999999999999996 89999999999999999999999999999864332
Q ss_pred CccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccccccCcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKSIIDPH 747 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 747 (851)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+. . ... ..+ .+
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~---~~i-~~~------~~- 220 (320)
T d1xjda_ 157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---F---HSI-RMD------NP- 220 (320)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHH-HHC------CC-
T ss_pred --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---H---HHH-HcC------CC-
Confidence 2223456799999999999999999999999999999999999999976533211 1 111 111 11
Q ss_pred CCCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047215 748 LKGNYSPESLEKFGEIAEKCLDDEGKNRPTMG-EVLWH 784 (851)
Q Consensus 748 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~~ 784 (851)
.++..++..+.+|+.+||+.||.+|||+. |+++|
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 23344556799999999999999999995 89888
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.6e-44 Score=382.45 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=207.0
Q ss_pred cCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~Ey 590 (851)
++|+..++||+|+||+||+|+..+++.||||++.... ....+.+.+|+.+|++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999889999999986543 33357899999999999999999999999999999999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCcc
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEHT 670 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 670 (851)
+.++.+..+... ...+++.++..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 998887777643 3569999999999999999999995 899999999999999999999999999997633221
Q ss_pred ccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc---ccc---
Q 047215 671 HVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL---KSI--- 743 (851)
Q Consensus 671 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~i--- 743 (851)
.......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+................. ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 12334468999999999875 45799999999999999999999999765432221111000000000000 000
Q ss_pred ------cCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcc
Q 047215 744 ------IDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMR 797 (851)
Q Consensus 744 ------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~ 797 (851)
..+..........++.+.+|+.+||+.||++|||++|+++| +|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H---------p~f~ 285 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH---------AYFK 285 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS---------GGGG
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC---------cccC
Confidence 00000111223445678999999999999999999999999 8876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=383.69 Aligned_cols=269 Identities=22% Similarity=0.332 Sum_probs=205.4
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCC--hhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQS--EQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++|||||++++++..++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 567899999986542 2345788999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
|+.++. .+++.......+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~-~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQDL-KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSEEH-HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecCCch-hhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC--
Confidence 997654 444444445679999999999999999999995 89999999999999999999999999999764322
Q ss_pred cccccccccCCcccCcccccccC-CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhh--ccccccc-C
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQ-LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQ--RSLKSII-D 745 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~i~-d 745 (851)
........||+.|+|||.+.... ++.++|||||||++|||++|+.||......+... ......... .....+. .
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGS
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhccccccc
Confidence 22334557999999999887655 5899999999999999999999997653322111 101100000 0000000 0
Q ss_pred ccCCCCC-----------ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 746 PHLKGNY-----------SPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 746 ~~l~~~~-----------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
+...... .+..+..+.+|+.+||+.||++|||++|+++| +|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H---------~ff~~ 288 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH---------PFFQD 288 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS---------GGGTT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC---------Hhhcc
Confidence 0000000 12334678999999999999999999999999 99864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=384.75 Aligned_cols=273 Identities=22% Similarity=0.311 Sum_probs=205.1
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-C-cceeEEeecCCC--ChhhHHHHHHHHHHHHhc---CCcceeeEEEEEc-----
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-D-CTLAAIKRANPQ--SEQGLAEFETEIEMLSKL---RHRHLVSLIGFCD----- 579 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~----- 579 (851)
.++|++.++||+|+||+||+|+.. . ++.||||++... .......+.+|+.+|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 378999999999999999999863 3 567899987543 222233466788777766 7999999999984
Q ss_pred cCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecc
Q 047215 580 EQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFG 659 (851)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFG 659 (851)
.....+++|||++++++...... ....+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 34578999999999877654433 34568899999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 660 LSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 660 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
+++... .........||+.|+|||++.+..++.++||||+||++|||++|+.||....+.+................
T Consensus 162 ~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 162 LARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp SCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 987632 22334567899999999999999999999999999999999999999976543322111110000000000
Q ss_pred cc------c-cc---CccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccCC
Q 047215 740 LK------S-II---DPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTDD 800 (851)
Q Consensus 740 ~~------~-i~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~~ 800 (851)
.. . .. .+.....+....++.+.+|+.+||+.||++|||++|+|+| +|+++-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H---------pff~~i~ 300 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH---------PYFQDLE 300 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS---------GGGTTCC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC---------hhhcCch
Confidence 00 0 00 0000011223455678999999999999999999999999 9987543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=380.88 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=199.9
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCCh------hhHHHHHHHHHHHHhcC--CcceeeEEEEEccCCc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSE------QGLAEFETEIEMLSKLR--HRHLVSLIGFCDEQNE 583 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~ 583 (851)
++|++.++||+|+||+||+|+. .+++.||||++..... .....+.+|+.+|++++ |||||++++++..++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999986 4678999998754211 11234678999999996 8999999999999999
Q ss_pred EEEEEEecCC-cchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeecccc
Q 047215 584 MILVYEYMAN-GTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLS 661 (851)
Q Consensus 584 ~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla 661 (851)
.++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 6777777443 468999999999999999999995 99999999999999985 579999999999
Q ss_pred ccCCCCCccccccccccCCcccCcccccccCC-CchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccc
Q 047215 662 KTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQL-TEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSL 740 (851)
Q Consensus 662 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (851)
+.... .......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... . .. ..
T Consensus 159 ~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~-~~-- 219 (273)
T d1xwsa_ 159 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------II-RG-- 219 (273)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HH-HC--
T ss_pred eeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hh-hc--
Confidence 86432 22345679999999999987765 577999999999999999999986421 0 00 00
Q ss_pred ccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 741 KSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 741 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.. .++...++.+.+|+.+||+.||++|||++|+++| +|+++
T Consensus 220 ----~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h---------p~~~~ 260 (273)
T d1xwsa_ 220 ----QV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH---------PWMQD 260 (273)
T ss_dssp ----CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS---------GGGSS
T ss_pred ----cc----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC---------HhhCC
Confidence 01 1223345668999999999999999999999999 99864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=373.13 Aligned_cols=273 Identities=21% Similarity=0.299 Sum_probs=202.1
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc--------C
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE--------Q 581 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--------~ 581 (851)
++|++.++||+|+||+||+|+. ++++.||||++... .......+.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999996 57889999987543 33445678999999999999999999998854 3
Q ss_pred CcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccc
Q 047215 582 NEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLS 661 (851)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 661 (851)
+..++||||++++.+..... ....+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 56899999999888776553 33468889999999999999999995 89999999999999999999999999999
Q ss_pred ccCCCCCcc--ccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc
Q 047215 662 KTGPSMEHT--HVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR 738 (851)
Q Consensus 662 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (851)
+........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+.................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 764432211 122345799999999998765 68999999999999999999999997643322211111110000000
Q ss_pred ccccccCcc-------CCC-CCC-h------hHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhcccC
Q 047215 739 SLKSIIDPH-------LKG-NYS-P------ESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRTD 799 (851)
Q Consensus 739 ~~~~i~d~~-------l~~-~~~-~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~~ 799 (851)
......... ... ... . ...+.+.+|+.+||+.||++|||++|+++| +|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H---------pff~~~ 311 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH---------DFFWSD 311 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS---------GGGSSS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC---------hhhccC
Confidence 000000000 000 000 0 113457789999999999999999999999 999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=375.70 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC------
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN------ 582 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 582 (851)
.++|+..++||+|+||+||+|+. .+++.||||++... +....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999986 45889999998754 4445667899999999999999999999997654
Q ss_pred cEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccc
Q 047215 583 EMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSK 662 (851)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 662 (851)
.+++||||+ +.+|..+++. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 5577777643 358999999999999999999995 999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHH-----Hhh
Q 047215 663 TGPSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMK-----WQK 736 (851)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~-----~~~ 736 (851)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||................. ...
T Consensus 170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 6432 1244679999999999876 4679999999999999999999999976543222111110000 000
Q ss_pred ----------hcccccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 737 ----------QRSLKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 737 ----------~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...........+ ........+.+.+|+.+||+.||.+|||++|+|+| +|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H---------p~f~~ 306 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH---------PYFES 306 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS---------GGGTT
T ss_pred hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC---------hhhCc
Confidence 000000000000 11123345668899999999999999999999999 89864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-42 Score=375.71 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=198.4
Q ss_pred CCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc------CCcEEE
Q 047215 514 NFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE------QNEMIL 586 (851)
Q Consensus 514 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~~l 586 (851)
+|+..++||+|+||+||+|+.. .++.||||++...... +.+|+++|++++||||+++++++.. ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999974 5789999998654322 3479999999999999999999843 235799
Q ss_pred EEEecCCcchhhhccC-CCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC-eEEEeeccccccC
Q 047215 587 VYEYMANGTLRSHLFG-SDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF-VAKMSDFGLSKTG 664 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~ 664 (851)
|||||+++.+..+... .....+++.++..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755444321 234568999999999999999999995 9999999999999999765 8999999999864
Q ss_pred CCCCccccccccccCCcccCcccccc-cCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHH------HHhhh
Q 047215 665 PSMEHTHVSTAVKGSFGYLDPEYFWR-QQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAM------KWQKQ 737 (851)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~------~~~~~ 737 (851)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+......... .+...
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 3322 2334579999999998865 579999999999999999999999997654332211110000 00000
Q ss_pred -cccccccCccC-----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 738 -RSLKSIIDPHL-----KGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 738 -~~~~~i~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
.......-+.. .....+..++.+.+|+.+||+.||++|||++|+|+| +|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H---------p~f~~ 308 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH---------SFFDE 308 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC---------Hhhcc
Confidence 00000000110 111123455678999999999999999999999999 88864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=371.59 Aligned_cols=272 Identities=22% Similarity=0.295 Sum_probs=201.9
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC-ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCC----cEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ-SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQN----EMI 585 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~ 585 (851)
+.+|+..++||+|+||+||+|+. .+++.+|||++... .....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999985 57889999998754 3444567899999999999999999999996543 335
Q ss_pred EEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCC
Q 047215 586 LVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGP 665 (851)
Q Consensus 586 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 665 (851)
++++|+.+|+|.+++... .+++.++..++.|++.||+|||+ ++||||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555677799999999643 58999999999999999999995 899999999999999999999999999997643
Q ss_pred CCCc-cccccccccCCcccCccccc-ccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc----
Q 047215 666 SMEH-THVSTAVKGSFGYLDPEYFW-RQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS---- 739 (851)
Q Consensus 666 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---- 739 (851)
.... ........||+.|+|||++. ...++.++||||+||+++||++|+.||......+................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3211 12234567999999999985 45679999999999999999999999976543322211111000000000
Q ss_pred -----ccc-ccCccCCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 740 -----LKS-IIDPHLKG----NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 740 -----~~~-i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
... ...+.... ...+..+..+.+|+.+||+.||.+|||++|+|+| +|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h---------pf~~~ 300 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH---------PYLEQ 300 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS---------GGGTT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC---------Hhhcc
Confidence 000 00000000 0112334568999999999999999999999999 88764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=360.04 Aligned_cols=268 Identities=21% Similarity=0.293 Sum_probs=209.6
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEccCCcEEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 589 (851)
++|+..++||+|+||+||+|+. .+++.||||+++.. .......+.+|+.+|++++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999996 46788999987543 33456789999999999999999999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeeccccccCCCCCc
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKTGPSMEH 669 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 669 (851)
++.+++|..++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999998887544 467899999999999999999995 8999999999999999999999999999987443222
Q ss_pred cccccccccCCcccCcccccccC-CCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhc---cc---cc
Q 047215 670 THVSTAVKGSFGYLDPEYFWRQQ-LTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQR---SL---KS 742 (851)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~---~~ 742 (851)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+ ............ .. ..
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhh
Confidence 223445788999999987654 69999999999999999999999765432221 111111111100 00 00
Q ss_pred ccC---------ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 743 IID---------PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 743 i~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
..+ ..-.....+...+.+.+|+.+||+.||++|||++|+|+| +|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H---------p~f~~ 288 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH---------PYFSD 288 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS---------GGGSS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC---------hhhcC
Confidence 000 000112234455678999999999999999999999999 99864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-40 Score=362.94 Aligned_cols=263 Identities=18% Similarity=0.248 Sum_probs=203.0
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEc--cCCcEEEEE
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCD--EQNEMILVY 588 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~--~~~~~~lV~ 588 (851)
++|++.++||+|+||+||+|+. .+++.||||++.... .+.+.+|+++|++++ ||||+++++++. ....+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999987 567899999987543 456889999999995 999999999986 345799999
Q ss_pred EecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-CCeEEEeeccccccCCCC
Q 047215 589 EYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-NFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 589 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~~ 667 (851)
||+++++|..+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999998764 358999999999999999999995 99999999999999985 457999999999864332
Q ss_pred CccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchh-cHHHH------HHHHhhhcc
Q 047215 668 EHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQI-NLADW------AMKWQKQRS 739 (851)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~-~l~~~------~~~~~~~~~ 739 (851)
. ......||+.|+|||.+.+. .++.++||||+||+++||++|+.||......... ..... ...+.....
T Consensus 184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2 23456789999999998765 5799999999999999999999998765432211 00000 000000000
Q ss_pred c------ccccC--------ccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 740 L------KSIID--------PHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 740 ~------~~i~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
. ..+.. ...........++.+.+|+.+||+.||++|||++|+|+| +|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H---------p~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH---------PYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC---------cccCC
Confidence 0 00000 001111123455678999999999999999999999999 99875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=356.32 Aligned_cols=261 Identities=16% Similarity=0.185 Sum_probs=196.2
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcceeeE-EEEEccCCcEEEEEEe
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHLVSL-IGFCDEQNEMILVYEY 590 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l-~g~~~~~~~~~lV~Ey 590 (851)
++|++.+.||+|+||.||+|+. .+++.||||++..... ..++..|++++++++|+|++.. .++...++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999986 4578999998765432 2457889999999987765555 5555777888999999
Q ss_pred cCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEc---CCCeEEEeeccccccCCCC
Q 047215 591 MANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLD---ENFVAKMSDFGLSKTGPSM 667 (851)
Q Consensus 591 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~~~ 667 (851)
+.+ +|.+.+... ...+++.++..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LGP-SLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCC-BHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cCC-chhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 955 555554332 2468999999999999999999995 8999999999999985 4668999999999864332
Q ss_pred Cc-----cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhccccc
Q 047215 668 EH-----THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLKS 742 (851)
Q Consensus 668 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (851)
.. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---- 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence 21 122345679999999999999999999999999999999999999997654433222211111110000
Q ss_pred ccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 047215 743 IIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVL 789 (851)
Q Consensus 743 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 789 (851)
..+.+ ...+++.+.+++.+||+.+|++||+++++.+.|+.+.
T Consensus 236 -~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 -PIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -CHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -ChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00111 1234566899999999999999999999988877654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-40 Score=352.18 Aligned_cols=263 Identities=16% Similarity=0.180 Sum_probs=207.5
Q ss_pred hcCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCCChhhHHHHHHHHHHHHhcCC-cceeeEEEEEccCCcEEEEEE
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH-RHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E 589 (851)
.++|++.++||+|+||+||+|+.. +++.+|||.+..... ...+.+|++.++.+.| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999964 678899998754432 2356789999999965 899999999999999999999
Q ss_pred ecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcC-----CCeEEEeeccccccC
Q 047215 590 YMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDE-----NFVAKMSDFGLSKTG 664 (851)
Q Consensus 590 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~-----~~~~kl~DFGla~~~ 664 (851)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+ ++||||||||+|||++. ++.+||+|||+++..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 679988885443 468999999999999999999994 99999999999999964 578999999999864
Q ss_pred CCCCc-----cccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc
Q 047215 665 PSMEH-----THVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS 739 (851)
Q Consensus 665 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (851)
..... ........||+.|||||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 32211 1123456799999999999999999999999999999999999999986554433322222211111111
Q ss_pred cccccCccCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 047215 740 LKSIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQ 790 (851)
Q Consensus 740 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 790 (851)
.. .+ ...+++.+.+++..|++.+|++||+++.+.+.|+.+++
T Consensus 237 ~~-----~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 LR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hH-----Hh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 11 11 12344668999999999999999999999888877654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=365.38 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=207.1
Q ss_pred cCCceeeeeeeecceEEEEEEEc----CcceeEEeecCCC----ChhhHHHHHHHHHHHHhcCC-cceeeEEEEEccCCc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE----DCTLAAIKRANPQ----SEQGLAEFETEIEMLSKLRH-RHLVSLIGFCDEQNE 583 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~ 583 (851)
++|+..++||+|+||+||+|+.. .++.+|||.+... .....+.+.+|+++|++++| |||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 4678999987643 22334568899999999966 899999999999999
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.+++|||+.+|+|.+++.... .+.+.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999986543 46788899999999999999995 8999999999999999999999999999976
Q ss_pred CCCCCccccccccccCCcccCccccccc--CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcccc
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQ--QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRSLK 741 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (851)
.... .........|++.|++||.+.+. .++.++|||||||+||||++|+.||......+..... .....
T Consensus 179 ~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~------ 249 (322)
T d1vzoa_ 179 FVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL------ 249 (322)
T ss_dssp CCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH------
T ss_pred hccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcc------
Confidence 4332 22233456799999999999754 5788999999999999999999999776544322111 11110
Q ss_pred cccCccCCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHHHhhhhhccc
Q 047215 742 SIIDPHLKGNYSPESLEKFGEIAEKCLDDEGKNRP-----TMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 742 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L~~~~~~~~~w~~~ 798 (851)
.. ...++...++.+.+|+.+||+.||.+|| |++|+++| +|++.
T Consensus 250 ---~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H---------pff~~ 297 (322)
T d1vzoa_ 250 ---KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH---------LFFQK 297 (322)
T ss_dssp ---HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS---------GGGTT
T ss_pred ---cC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC---------HhhcC
Confidence 00 1123345667799999999999999999 58999999 88764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=365.29 Aligned_cols=266 Identities=21% Similarity=0.269 Sum_probs=195.8
Q ss_pred cCCceeeeeeeecceEEEEEEEc-CcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEc------cCCc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEIE-DCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCD------EQNE 583 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~------~~~~ 583 (851)
++|++.++||+|+||+||+|+.. +++.+|||++... +......+.+|+.+|++++|||||++++++. ..+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999875 5889999998654 4455567899999999999999999999985 3468
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+|+||||+.++.+... . ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~-~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH-T----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhh-h----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 8999999987655544 2 347899999999999999999996 8999999999999999999999999999876
Q ss_pred CCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHH---------H----
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLAD---------W---- 730 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~---------~---- 730 (851)
... ........||+.|+|||++.+..++.++||||+||+++||++|+.||............. +
T Consensus 169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 332 223345678999999999999999999999999999999999999997553222111000 0
Q ss_pred ---HHHHhhhc-cc-----ccccCccCCC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 731 ---AMKWQKQR-SL-----KSIIDPHLKG---NYSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 731 ---~~~~~~~~-~~-----~~i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
........ .. .......... ......+..+.+|+.+||+.||++|||++|+|+| +|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H---------pw~~~ 316 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH---------PYINV 316 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS---------TTTGG
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC---------cccCC
Confidence 00000000 00 0000000000 1113356788999999999999999999999999 88864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=365.12 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=200.5
Q ss_pred hcCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCC--ChhhHHHHHHHHHHHHhcCCcceeeEEEEEcc-----CCc
Q 047215 512 TNNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQ--SEQGLAEFETEIEMLSKLRHRHLVSLIGFCDE-----QNE 583 (851)
Q Consensus 512 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~ 583 (851)
.++|+..++||+|+||+||+|+. .+++.||||++... +....+.+.+|+++|++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999986 56889999998754 34455678999999999999999999999853 334
Q ss_pred EEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 584 MILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 584 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.+++++|+.+|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 56777888999999998543 58999999999999999999995 8999999999999999999999999999875
Q ss_pred CCCCCccccccccccCCcccCccccccc-CCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcHHHHHHHHhhhcc---
Q 047215 664 GPSMEHTHVSTAVKGSFGYLDPEYFWRQ-QLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINLADWAMKWQKQRS--- 739 (851)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 739 (851)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........... .........
T Consensus 171 ~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~~~~~ 242 (348)
T d2gfsa1 171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAEL 242 (348)
T ss_dssp CT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHH
T ss_pred cC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChHH
Confidence 32 223456789999999987665 568999999999999999999999976533221111 110000000
Q ss_pred --------cccccC--ccCCC-C---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhhhccc
Q 047215 740 --------LKSIID--PHLKG-N---YSPESLEKFGEIAEKCLDDEGKNRPTMGEVLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 740 --------~~~i~d--~~l~~-~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~w~~~ 798 (851)
...... +.... . .....++.+.+|+.+||+.||.+|||++|+|+| +|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H---------p~f~~ 306 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH---------AYFAQ 306 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS---------GGGTT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC---------HhhCC
Confidence 000000 00000 0 012345668999999999999999999999999 89874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-35 Score=328.08 Aligned_cols=269 Identities=19% Similarity=0.252 Sum_probs=197.3
Q ss_pred cCCceeeeeeeecceEEEEEEE-cCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-----------CcceeeEEEEEcc
Q 047215 513 NNFDESLMIGVGGFGKVFKGEI-EDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-----------HRHLVSLIGFCDE 580 (851)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~g~~~~ 580 (851)
++|++.++||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3589999999999999999986 568899999987543 33467788999998875 5789999998854
Q ss_pred --CCcEEEEEEecCCcch-hhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCC------
Q 047215 581 --QNEMILVYEYMANGTL-RSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENF------ 651 (851)
Q Consensus 581 --~~~~~lV~Ey~~~gsL-~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~------ 651 (851)
....+++++++..+.. ...........+++..+..++.|++.||+|||+ ..+|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 3566777777655543 333334445678889999999999999999996 58999999999999997654
Q ss_pred eEEEeeccccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHHHHHHhCCcCCCCCCCcchhcH----
Q 047215 652 VAKMSDFGLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVLFEVVCARAVINPTLPKDQINL---- 727 (851)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~eLltG~~p~~~~~~~~~~~l---- 727 (851)
.+|++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||.+.........
T Consensus 170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999875322 22345799999999999999999999999999999999999999876433221111
Q ss_pred HHHHHHHh-------hhc-----------ccccccCc---------cCCCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 047215 728 ADWAMKWQ-------KQR-----------SLKSIIDP---------HLKGNYSPESLEKFGEIAEKCLDDEGKNRPTMGE 780 (851)
Q Consensus 728 ~~~~~~~~-------~~~-----------~~~~i~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 780 (851)
........ ... ....+... ..........+..+.+|+.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11111000 000 00000000 0122344667788999999999999999999999
Q ss_pred HHHHHHHHHHhhhhhccc
Q 047215 781 VLWHLEYVLQLHEAWMRT 798 (851)
Q Consensus 781 vl~~L~~~~~~~~~w~~~ 798 (851)
+|+| +|+++
T Consensus 325 ~L~H---------p~f~~ 333 (362)
T d1q8ya_ 325 LVNH---------PWLKD 333 (362)
T ss_dssp HHTC---------GGGTT
T ss_pred HhcC---------cccCC
Confidence 9999 99874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=3e-21 Score=192.06 Aligned_cols=168 Identities=16% Similarity=0.127 Sum_probs=120.5
Q ss_pred eeeeeeeecceEEEEEEEcCcceeEEeecCCCCh------------------hhHHHHHHHHHHHHhcCCcceeeEEEEE
Q 047215 517 ESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSE------------------QGLAEFETEIEMLSKLRHRHLVSLIGFC 578 (851)
Q Consensus 517 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 578 (851)
+.++||+|+||+||+|+..+++.||||++..... .....+..|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999988899999997643210 1123456789999999999999988764
Q ss_pred ccCCcEEEEEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcCCCCCeEEcCCCCCCeEEcCCCeEEEeec
Q 047215 579 DEQNEMILVYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTGAERGIIHRDVKTTNILLDENFVAKMSDF 658 (851)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~~~~~iiHrDlk~~NILld~~~~~kl~DF 658 (851)
. .+++|||++++.+.+ +++....+++.|++++|+|||+ .+|+||||||+|||++++ .++|+||
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 3 379999999876643 3445667899999999999995 899999999999999865 5899999
Q ss_pred cccccCCCCCccccccccccCCcccCcccccccCCCchHHHHHHHHHH
Q 047215 659 GLSKTGPSMEHTHVSTAVKGSFGYLDPEYFWRQQLTEKSDVYSFGVVL 706 (851)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL 706 (851)
|+|+..............+ .. -.|.+ .+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~~l~rd~---~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILERDV---RN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHHHHH---HH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHHHHH---HH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 9987643221110000000 00 01112 35678889999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=1.3e-06 Score=88.75 Aligned_cols=148 Identities=15% Similarity=0.063 Sum_probs=100.0
Q ss_pred HHHHhcCCceeeeeeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEE
Q 047215 508 IRVATNNFDESLMIGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 508 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~l 586 (851)
++.--..|...+..+-++.+.||+...+++ .+++|+...........+.+|..++..+. |--+.+++.++..++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENE-NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECSSC-EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEeCCC-eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 333345565555433344578998875544 45777766554444456788999988774 4446678888888889999
Q ss_pred EEEecCCcchhhhccCCCCCCCchhhhHHHHHHHHHHHHHhhcC------------------------------------
Q 047215 587 VYEYMANGTLRSHLFGSDLPPLTWKQRLDACIGAARGLHYLHTG------------------------------------ 630 (851)
Q Consensus 587 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs~------------------------------------ 630 (851)
||+++++.++.+.... .....+++.++++.|..||+.
T Consensus 88 v~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999888665421 122334555566666666631
Q ss_pred --------------------CCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 631 --------------------AERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 631 --------------------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
....++|+|+.+.|||++++..+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 122379999999999999877777999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=6.6e-05 Score=75.29 Aligned_cols=130 Identities=19% Similarity=0.191 Sum_probs=86.9
Q ss_pred eeeecc-eEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCC--cceeeEEEEEccCCcEEEEEEecCCcchh
Q 047215 521 IGVGGF-GKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRH--RHLVSLIGFCDEQNEMILVYEYMANGTLR 597 (851)
Q Consensus 521 LG~G~f-G~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (851)
+..|.. +.||+...+++..+++|....... ..+..|...++.+.. -.+.++++++..++..++||+++++-++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 679999888887788887665432 346778888887743 33567788888888999999999987764
Q ss_pred hhccCCCCCCCchhhhHHHHHHHHHHHHHhhc------------------------------------------------
Q 047215 598 SHLFGSDLPPLTWKQRLDACIGAARGLHYLHT------------------------------------------------ 629 (851)
Q Consensus 598 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLHs------------------------------------------------ 629 (851)
+.. .. ...++.++++.|.-||+
T Consensus 95 ~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 95 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 321 00 11122233333333332
Q ss_pred -------CCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 630 -------GAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 630 -------~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
.....++|+|+.+.|||++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0123489999999999999877778999998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.84 E-value=0.00095 Score=71.40 Aligned_cols=76 Identities=18% Similarity=0.106 Sum_probs=47.7
Q ss_pred eeeeeeecceEEEEEEEcC-cceeEEeecCCC-------ChhhHHHHHHHHHHHHhcC-C--cceeeEEEEEccCCcEEE
Q 047215 518 SLMIGVGGFGKVFKGEIED-CTLAAIKRANPQ-------SEQGLAEFETEIEMLSKLR-H--RHLVSLIGFCDEQNEMIL 586 (851)
Q Consensus 518 ~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-H--pnIv~l~g~~~~~~~~~l 586 (851)
.+.||.|....||+.+..+ ++.+++|...+. -+........|.+.|+.+. + ..+.+++.+.. ...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 4468999999999998654 456778854321 1112334556888887662 2 34566666654 35589
Q ss_pred EEEecCCcc
Q 047215 587 VYEYMANGT 595 (851)
Q Consensus 587 V~Ey~~~gs 595 (851)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.30 E-value=0.0042 Score=64.33 Aligned_cols=135 Identities=12% Similarity=0.091 Sum_probs=78.7
Q ss_pred ceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce--eeEEE-----EEccCCcEEEEEEecCCcchhh
Q 047215 526 FGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL--VSLIG-----FCDEQNEMILVYEYMANGTLRS 598 (851)
Q Consensus 526 fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~g-----~~~~~~~~~lV~Ey~~~gsL~~ 598 (851)
--.||+.+.++|..+++|...+. ....+++..|+..+..|...++ +..+. ....++..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999999999999987654 2234667789988888753222 11111 2234567889999998754421
Q ss_pred ------------------hccCCC---CCCCc-------------------hhhhHHHHHHHHHHHHHhh----cCCCCC
Q 047215 599 ------------------HLFGSD---LPPLT-------------------WKQRLDACIGAARGLHYLH----TGAERG 634 (851)
Q Consensus 599 ------------------~L~~~~---~~~l~-------------------~~~~~~i~~~ia~gL~yLH----s~~~~~ 634 (851)
...... ...++ ...+..+...+.+.+..+. +....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 000000 11111 1111111112222233332 223457
Q ss_pred eEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 635 IIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 635 iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899998875
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=96.18 E-value=0.017 Score=51.77 Aligned_cols=81 Identities=16% Similarity=0.240 Sum_probs=65.0
Q ss_pred cCceeeEeeccceEEEEEEeccCCCCCcccccceEEEEEcceEEeecCCCCccccccccccccCCCCCcccceEEEEEee
Q 047215 84 DGLNYTFEIIAGNYIVRLHFCPFPFEDYNVNKSSFGVVANGLKLLSEFSAPGEISHRNLYLQSSGGNSSSISLVKEYFLG 163 (851)
Q Consensus 84 ~~~~y~~~~~~g~~~~R~~f~~~~~~~~~~~~~~f~v~~~g~~~l~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 163 (851)
..+.|.++|+.|.|.|+++|-. ....+|.+.|...+.+|... ..-+.|.|.
T Consensus 63 ~~~~f~v~vPnG~Y~Vtv~~Gd---------~~~~~~~~eg~~~~~~~~g~--------------------~~~~~~~V~ 113 (146)
T d2o14a1 63 SNNTFNVDLPNGLYEVKVTLGN---------TARASVAAEGVFQVINMTGD--------------------GAEDTFQIP 113 (146)
T ss_dssp CSCCEEEECCSEEEEEEEEESS---------CSEEEEEETTEEEEEEEEST--------------------TCEEEEEEE
T ss_pred CCceEEEECCCCeEEEEEEEec---------CCCccEEEeeEEeccccCCc--------------------cEEEEEEEE
Confidence 3467999999999999999953 23457899999888887642 123678888
Q ss_pred ccCCeEEEEEecCC-CcceeeeeeEEEeccc
Q 047215 164 VDLDKLMIEFIPSK-GSFGFINAIEIVPVVD 193 (851)
Q Consensus 164 ~~~~~~~i~f~~~~-~~~~fi~~iEl~~~~~ 193 (851)
+.++.|.|.|.... +..|=||+|||.++++
T Consensus 114 VtDG~L~l~ft~~~~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 114 VTDGQLNLLVTEGKAGTAFTLSALKIKKLSD 144 (146)
T ss_dssp ECSSEEEEEEEESSTTSCCEEEEEEEEEEES
T ss_pred EECCeEEEEEecCCCCCccEEEEEEEEeccc
Confidence 98889999998665 6789999999998875
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=96.04 E-value=0.0028 Score=57.16 Aligned_cols=79 Identities=18% Similarity=0.154 Sum_probs=53.2
Q ss_pred eeeeeecCCCCceEEEEEeeeEEEecCCeEEEEEEEcCccccCCcchhhhcCCCCceeEEEeEecccccceeeeEEeCCc
Q 047215 298 MSWKFEVDPNFDYFVRLHFCELVYEKANQRIFRIYINNRTAENNFDIFVQAGGKNRGYHRDYFDAVSSKIETLWIQLGPD 377 (851)
Q Consensus 298 lt~~~~vd~~~~Y~v~LhF~Ei~~~~~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~~~~ 377 (851)
..|.++| |++.|.|.++|.|. ...++.+.|......+ + +....+.|.+.+.++.|+ |.+...
T Consensus 65 ~~f~v~v-PnG~Y~Vtv~~Gd~-------~~~~~~~eg~~~~~~~-----~---g~~~~~~~~V~VtDG~L~--l~ft~~ 126 (146)
T d2o14a1 65 NTFNVDL-PNGLYEVKVTLGNT-------ARASVAAEGVFQVINM-----T---GDGAEDTFQIPVTDGQLN--LLVTEG 126 (146)
T ss_dssp CCEEEEC-CSEEEEEEEEESSC-------SEEEEEETTEEEEEEE-----E---STTCEEEEEEEECSSEEE--EEEEES
T ss_pred ceEEEEC-CCCeEEEEEEEecC-------CCccEEEeeEEecccc-----C---CccEEEEEEEEEECCeEE--EEEecC
Confidence 5789999 89999999999993 2346667776554432 2 233445566667888888 444322
Q ss_pred cCCCCCCchhhcccccccccc
Q 047215 378 TAVGAAGTDALLNGLEIFKFS 398 (851)
Q Consensus 378 ~~~~~~~~~~~lng~Ei~~~~ 398 (851)
.+. ..+.||++||-+++
T Consensus 127 ~~G----~~~~in~l~I~~~~ 143 (146)
T d2o14a1 127 KAG----TAFTLSALKIKKLS 143 (146)
T ss_dssp STT----SCCEEEEEEEEEEE
T ss_pred CCC----CccEEEEEEEEecc
Confidence 221 36799999998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.69 E-value=0.017 Score=61.20 Aligned_cols=72 Identities=14% Similarity=0.112 Sum_probs=47.6
Q ss_pred eeeeeecceEEEEEEEcCc--------ceeEEeecCCCChhhHHHHHHHHHHHHhcC-CcceeeEEEEEccCCcEEEEEE
Q 047215 519 LMIGVGGFGKVFKGEIEDC--------TLAAIKRANPQSEQGLAEFETEIEMLSKLR-HRHLVSLIGFCDEQNEMILVYE 589 (851)
Q Consensus 519 ~~LG~G~fG~Vykg~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E 589 (851)
+.|+-|-.-.+|+....++ ..+.+++.. .. ....+..+|..+++.+. |.-..++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677788889999987643 233444433 22 22345678999999885 4333477887754 68999
Q ss_pred ecCCcch
Q 047215 590 YMANGTL 596 (851)
Q Consensus 590 y~~~gsL 596 (851)
|+++-.|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.25 E-value=0.016 Score=59.18 Aligned_cols=158 Identities=13% Similarity=0.099 Sum_probs=83.8
Q ss_pred cCHHHHHHHhcCCceeee-----eeeecceEEEEEEEcCcceeEEeecCCCChhhHHHHHHHHHHHHhcCCcce--eeEE
Q 047215 503 FTLAEIRVATNNFDESLM-----IGVGGFGKVFKGEIEDCTLAAIKRANPQSEQGLAEFETEIEMLSKLRHRHL--VSLI 575 (851)
Q Consensus 503 ~~~~~l~~~t~~f~~~~~-----LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~ 575 (851)
++.++++....+|...++ |..|---+.|+.+.++++ +++|+..... ...+...|++++..|.+.++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 456677777777765433 334555778998877765 6788765432 12345557777777743222 1111
Q ss_pred E------EEccCCcEEEEEEecCCcchhhhc--------------c----CCCC----CC-----------------Cch
Q 047215 576 G------FCDEQNEMILVYEYMANGTLRSHL--------------F----GSDL----PP-----------------LTW 610 (851)
Q Consensus 576 g------~~~~~~~~~lV~Ey~~~gsL~~~L--------------~----~~~~----~~-----------------l~~ 610 (851)
- +...+.....++.++.+......- + .... .. ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 112234566777777664432110 0 0000 00 001
Q ss_pred hhhHHHHHHHHHHHHHhh-cCCCCCeEEcCCCCCCeEEcCCCeEEEeecccccc
Q 047215 611 KQRLDACIGAARGLHYLH-TGAERGIIHRDVKTTNILLDENFVAKMSDFGLSKT 663 (851)
Q Consensus 611 ~~~~~i~~~ia~gL~yLH-s~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 663 (851)
......+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111122222222222222 12356899999999999999888788999998754
|